data_2kyy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kyy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.322 -0.251 . . . . 74.31 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 174.43 144.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.744 . . . . 75.22 109.882 -154.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.34 154.43 30.83 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.431 0.293 . . . . 54.24 111.401 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.99 74.61 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.467 0.707 . . . . 72.55 112.423 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.611 HG22 HG11 ' A' ' 102' ' ' VAL . 3.7 m -65.3 -41.72 93.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.708 0.803 . . . . 71.32 110.71 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.0 -38.81 69.58 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.19 -0.914 . . . . 70.53 110.857 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.412 HD13 HG12 ' A' ' 109' ' ' VAL . 61.4 mt -65.03 -40.42 94.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.034 0.534 . . . . 60.3 111.301 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HA ' HD12 ' A' ' 11' ' ' LEU . 33.6 tp -62.42 -46.5 88.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.636 0.774 . . . . 74.44 110.559 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.0 -41.01 86.62 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.744 -1.116 . . . . 72.25 111.514 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.71 -38.48 83.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.472 0.709 . . . . 75.22 111.545 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 8' ' ' LEU . 44.6 mt -60.29 -39.79 88.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.191 0.996 . . . . 73.1 111.155 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.93 -32.28 69.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.765 0.826 . . . . 74.53 111.903 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.07 -46.02 58.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.876 0.87 . . . . 75.52 112.012 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.22 151.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.352 0.596 . . . . 73.54 112.121 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.22 -33.33 61.35 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.853 0.861 . . . . 75.43 111.113 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -147.95 156.52 42.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 73.01 109.958 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -66.44 76.07 0.1 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.865 0.866 . . . . 63.15 111.552 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -61.87 2.29 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.209 1.004 . . . . 74.42 111.996 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -133.98 8.38 3.78 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.024 0.93 . . . . 72.53 110.717 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.62 107.67 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.924 0.89 . . . . 72.13 110.347 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -92.33 148.65 21.96 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.35 1.06 . . . . 70.55 111.24 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.1 54.18 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.314 1.045 . . . . 73.54 109.882 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 65.0 mttm -139.62 141.02 37.13 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 73.01 111.74 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -84.92 164.21 18.49 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 115.308 -0.86 . . . . 74.44 110.449 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' MET . . . -62.65 -31.99 72.95 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.589 0.589 . . . . 75.04 112.589 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -69.61 -21.97 63.53 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.094 0.775 . . . . 71.04 113.094 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.87 -8.45 48.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.701 0.8 . . . . 63.21 111.937 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -55.03 119.95 6.2 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.108 1.363 . . . . 74.01 112.035 -176.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.98 -147.07 18.95 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.95 -0.46 . . . . 53.01 111.95 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -64.07 -25.01 67.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.239 0.616 . . . . 74.31 112.547 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -59.63 -36.92 77.31 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.232 0.613 . . . . 71.44 111.898 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 34.8 t -71.97 -43.62 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.311 0.577 . . . . 71.23 111.105 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.619 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 80.0 mmm -69.65 -40.9 76.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.118 1.155 . . . . 73.25 114.118 -166.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.73 -31.04 71.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.813 0.34 . . . . 73.11 110.909 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 m -67.75 -37.56 82.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.387 0.675 . . . . 75.43 111.004 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.07 -41.09 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.29 0.636 . . . . 72.42 110.86 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.76 -35.07 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.256 0.622 . . . . 64.43 110.39 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.24 63.45 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.807 0.843 . . . . 75.45 112.636 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -99.07 -29.49 12.86 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.307 0.643 . . . . 73.42 111.921 170.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.82 -34.69 75.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 61.5 112.377 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -8.08 58.81 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.545 0.738 . . . . 74.35 112.79 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -81.81 116.42 63.12 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.768 0.827 . . . . 72.41 112.275 -173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.49 111.74 3.39 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.662 2.241 . . . . 73.2 112.438 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.79 19.56 57.7 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.326 0.89 . . . . 72.2 115.326 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.25 21.62 14.53 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 118.716 1.258 . . . . 74.52 111.908 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -40.95 123.05 1.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.637 0.977 . . . . 74.43 113.637 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.64 53.75 0.91 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 116.343 -0.39 . . . . 52.1 113.007 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.81 135.57 12.29 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.423 -1.071 . . . . 70.55 110.423 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.21 128.53 56.27 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.936 0.868 . . . . 73.31 111.914 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.0 mp -112.54 117.81 33.37 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.78 -1.193 . . . . 73.35 107.78 167.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.24 109.83 21.57 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.924 -0.485 . . . . 74.11 109.976 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.7 134.37 40.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.885 0.874 . . . . 74.45 110.575 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.94 28.54 6.16 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 116.293 -0.412 . . . . 64.44 112.13 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.25 138.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.199 0.999 . . . . 75.54 110.252 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -116.71 165.6 13.1 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.864 -1.162 . . . . 63.0 107.864 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -148.58 141.84 25.11 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.387 0.613 . . . . 74.44 111.537 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.04 135.55 53.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.282 1.033 . . . . 74.21 110.536 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 49.6 mm -99.82 118.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.187 0.518 . . . . 73.13 111.515 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 78.6 m-20 -75.99 172.23 13.1 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.846 0.858 . . . . 74.51 111.419 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.52 -21.45 66.62 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.006 0.522 . . . . 73.51 112.144 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HB3' ' HZ3' ' A' ' 61' ' ' LYS . 7.4 mtpm? -71.61 -14.37 62.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.149 0.98 . . . . 73.42 112.168 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.84 35.22 25.42 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.317 -0.713 . . . . 70.53 111.317 -168.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 25.3 t0 -99.86 140.26 34.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.972 0.909 . . . . 74.22 111.395 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -105.76 107.24 18.13 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.392 0.677 . . . . 74.14 110.633 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.54 120.17 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.833 0.853 . . . . 75.33 109.78 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.77 119.42 32.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.188 0.595 . . . . 62.54 110.422 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -121.85 153.52 60.36 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.52 1.128 . . . . 74.41 110.912 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HD3' HD22 ' A' ' 8' ' ' LEU . 89.8 Cg_endo -82.67 141.44 10.96 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.202 1.935 . . . . 71.14 112.738 177.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.87 -26.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.859 0.864 . . . . 73.53 110.681 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 -178.22 53.88 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 121.852 0.696 . . . . 71.14 114.736 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 108' ' ' LEU . 51.4 mt -101.28 142.35 24.43 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.44 110.904 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.79 -27.98 67.93 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.842 2.361 . . . . 75.34 112.424 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -145.49 97.57 4.67 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 107.817 -1.179 . . . . 74.34 107.817 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.34 -51.47 10.94 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.975 3.117 . . . . 72.31 114.689 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 23.1 t70 -64.58 -51.46 62.64 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.325 -0.852 . . . . 53.32 110.551 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.674 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 4.3 ttmp? -59.84 -36.93 77.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.582 0.753 . . . . 73.54 112.839 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.91 -41.82 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.043 0.537 . . . . 74.41 111.249 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.15 -33.35 75.23 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.528 0.731 . . . . 74.25 111.528 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 44.3 mmm-85 -72.41 -51.19 21.46 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.546 0.738 . . . . 74.15 110.886 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.22 -44.49 92.29 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.197 0.999 . . . . 75.12 111.821 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.487 HD22 ' SD ' ' A' ' 97' ' ' MET . 14.7 tp -67.22 -32.81 74.1 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 111.79 0.293 . . . . 64.24 111.79 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.37 96.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.018 0.527 . . . . 75.53 111.212 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 -45.96 90.55 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.412 0.685 . . . . 74.44 111.524 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -53.92 -53.2 55.94 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.994 0.918 . . . . 74.51 111.24 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 10.6 t -72.61 -18.37 61.6 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.865 0.691 . . . . 74.15 112.865 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -88.41 -39.6 14.15 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.386 0.675 . . . . 73.1 112.197 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -92.85 -39.86 10.95 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.371 0.878 . . . . 75.41 113.371 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.619 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 66.8 mtp -68.85 -40.95 79.09 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.13 0.49 . . . . 72.34 111.913 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.4 mt -84.12 151.46 24.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.946 0.898 . . . . 73.35 110.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.491 HD22 ' HA ' ' A' ' 122' ' ' ILE . 8.2 p30 -57.33 -32.27 66.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.382 0.882 . . . . 73.24 113.382 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.38 160.01 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.871 0.868 . . . . 73.24 110.413 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -77.12 103.6 7.14 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.513 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.8 tt -99.04 128.83 45.26 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.486 -0.931 . . . . 73.21 108.486 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.9 ttt85 -98.49 109.61 53.42 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 75.03 110.611 172.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.88 126.77 5.94 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 121.874 1.716 . . . . 74.24 110.311 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.88 100.8 4.92 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.047 -0.524 . . . . 62.31 109.777 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.607 ' HB3' HD13 ' A' ' 108' ' ' LEU . 70.0 mtm -110.15 133.51 53.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.427 0.691 . . . . 74.04 112.228 -171.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.27 136.5 39.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.098 0.959 . . . . 75.1 111.111 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 69.9 mt -88.29 116.02 26.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.404 1.082 . . . . 74.13 111.153 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -125.87 131.54 52.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.598 1.159 . . . . 74.31 110.63 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -92.09 125.66 36.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.26 0.624 . . . . 74.1 111.85 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.611 HG11 HG22 ' A' ' 5' ' ' THR . 12.1 t -121.18 114.04 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.584 1.154 . . . . 74.32 109.38 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.32 30.88 61.91 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.561 0.985 . . . . 72.14 115.561 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.14 8.84 83.22 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 114.219 0.448 . . . . 63.42 114.219 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -107.44 137.62 45.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 72.05 108.896 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.0 m -98.43 117.71 33.47 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.278 0.944 . . . . 75.03 111.854 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.66 163.59 13.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.357 1.063 . . . . 72.04 109.452 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -117.33 115.61 25.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.051 0.54 . . . . 74.24 110.538 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.412 HG12 HD13 ' A' ' 7' ' ' LEU . 78.8 t -82.53 106.43 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.885 -0.783 . . . . 73.13 108.885 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 60.7 t -92.88 100.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.503 -0.925 . . . . 74.53 108.503 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -85.02 115.2 22.71 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.869 -1.06 . . . . 73.45 108.872 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 63.6 t -106.52 98.39 20.05 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.359 0.663 . . . . 75.45 109.273 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.94 162.72 40.3 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.09 1.86 . . . . 74.4 110.519 167.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -70.34 132.97 46.47 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.053 -0.351 . . . . 75.12 110.053 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.34 158.03 24.63 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 122.987 0.515 . . . . 65.51 111.041 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.38 178.92 0.49 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.118 0.967 . . . . 72.03 111.2 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.84 -52.29 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.264 -1.522 . . . . 74.51 113.602 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.1 p -67.66 -48.15 67.5 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 123.711 0.805 . . . . 65.44 111.614 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.686 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -115.22 83.49 1.92 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 103.919 -2.623 . . . . 74.54 103.919 163.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.686 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.0 mttp -50.58 -143.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.131 1 C-N-CA 133.734 4.814 . . . . 75.25 120.989 49.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo 7.15 71.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.253 2.635 . . . . 75.4 115.797 -122.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.594 HG12 ' HA ' ' A' ' 120' ' ' LYS . 35.4 mm -81.54 77.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 114.909 -1.041 . . . . 75.25 108.936 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -88.51 146.87 24.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.646 -0.707 . . . . 75.43 110.955 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? . . . . . 0 CA--C 1.549 0.932 0 CA-C-N 114.946 -1.024 . . . . 73.32 110.102 177.425 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.799 -0.445 . . . . 70.41 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 11.6 ptm180 -99.04 151.66 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.822 0.449 . . . . 75.12 110.572 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.5 p -75.3 159.98 30.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.119 0.967 . . . . 72.34 113.285 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.63 69.65 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.191 0.996 . . . . 75.05 112.132 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -66.74 -48.73 68.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.816 0.846 . . . . 73.13 111.145 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.23 -34.3 74.61 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.007 -0.997 . . . . 75.24 111.358 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.31 -36.5 81.61 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.239 1.016 . . . . 74.41 112.373 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.05 -44.94 94.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.682 0.393 . . . . 74.11 110.393 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.43 -36.34 82.1 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.215 0.606 . . . . 75.24 112.325 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HG2' HG13 ' A' ' 20' ' ' ILE . 4.6 tp10 -66.54 -41.35 88.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.846 0.458 . . . . 73.33 111.246 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.4 mt -57.81 -47.77 81.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.118 0.967 . . . . 74.34 112.163 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.295 0.479 . . . . 64.51 112.295 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.87 -39.52 61.49 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.311 0.644 . . . . 72.5 112.142 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -91.36 143.81 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.543 0.687 . . . . 73.24 111.894 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.51 -13.79 39.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.097 0.959 . . . . 73.34 110.934 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -141.21 136.68 31.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.262 1.025 . . . . 75.25 109.989 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.6 m -74.33 77.25 1.86 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.508 0.671 . . . . 71.34 111.021 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -60.67 2.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.041 -0.982 . . . . 73.21 111.166 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -111.95 -23.23 10.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.718 0.807 . . . . 74.12 111.567 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.545 HG13 ' HG2' ' A' ' 10' ' ' GLU . 21.6 mm -115.4 107.26 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 109.526 -0.546 . . . . 75.23 109.526 -170.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.2 114.52 24.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.884 0.473 . . . . 73.23 110.187 -171.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.97 116.59 23.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.544 0.738 . . . . 70.33 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.44 153.34 33.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.179 0.514 . . . . 70.21 111.638 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -93.54 170.77 9.34 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.351 1.06 . . . . 74.1 111.593 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.74 88.42 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.967 -0.56 . . . . 73.24 110.937 169.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.4 p -57.61 -30.78 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.893 0.877 . . . . 71.51 112.455 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -84.74 -0.25 52.99 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.028 0.751 . . . . 62.44 113.028 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 88.3 mmm -68.49 131.65 45.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.004 0.521 . . . . 74.45 111.421 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.14 -132.76 6.25 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.684 -0.689 . . . . 65.44 111.746 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -39.72 89.46 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.17 0.588 . . . . 75.31 111.409 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 m -53.22 -33.6 53.54 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.564 1.145 . . . . 73.23 113.509 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.46 -35.31 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.152 0.581 . . . . 72.0 111.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.4 mmm -73.91 -41.49 62.03 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.263 0.838 . . . . 73.44 113.263 -164.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -65.34 -26.41 68.02 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 111.746 0.276 . . . . 73.11 111.746 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.0 m -72.24 -41.01 67.3 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 122.316 0.246 . . . . 62.33 111.115 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.4 0.68 . . . . 63.14 111.955 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 pt -63.27 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.651 0.38 . . . . 74.41 111.62 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.89 77.61 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.119 0.568 . . . . 73.43 111.687 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.586 ' HA ' HD21 ' A' ' 45' ' ' LEU . 32.2 m-85 -82.4 -37.29 25.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.474 0.71 . . . . 71.44 111.338 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.7 -23.48 62.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.933 1.086 . . . . 70.41 113.933 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -108.08 -8.51 15.81 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.737 1.014 . . . . 74.34 113.737 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.89 107.06 25.17 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.232 0.469 . . . . 62.22 110.563 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.96 123.68 11.62 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.933 2.422 . . . . 74.15 112.732 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.51 60.7 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-O 119.912 -0.382 . . . . 73.1 114.033 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' A' ' 39' ' ' PHE . 19.1 tp -89.86 13.44 14.51 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 117.713 0.756 . . . . 74.55 111.214 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -32.22 112.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.183 1.793 . . . . 71.21 114.158 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.629 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 103.78 68.63 0.77 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.395 -0.366 . . . . 52.34 112.779 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.06 124.61 5.4 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 109.618 -1.393 . . . . 54.45 109.618 171.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 56.0 m-85 -120.86 127.77 52.21 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.386 0.593 . . . . 61.52 111.819 -169.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -93.3 118.27 31.07 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.33 110.43 22.42 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.666 0.667 . . . . 75.22 109.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 9.3 mp -99.0 132.16 44.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.979 0.912 . . . . 74.42 110.793 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.5 33.15 4.91 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.247 -0.433 . . . . 73.21 112.429 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.6 138.6 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.116 0.566 . . . . 74.25 110.692 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.76 146.99 31.42 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.462 -1.31 . . . . 63.41 107.462 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -128.97 126.47 39.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.024 0.44 . . . . 74.52 110.399 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 123.4 46.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 74.34 109.969 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.52 131.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.578 0.751 . . . . 75.14 111.355 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -87.26 -178.5 6.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.608 0.763 . . . . 73.12 112.394 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.24 -28.55 69.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.584 0.754 . . . . 74.22 111.846 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -82.73 2.11 35.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.308 0.643 . . . . 74.52 112.274 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.36 32.34 58.07 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 120.933 0.185 . . . . 62.22 112.732 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.94 111.54 23.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.756 0.823 . . . . 75.13 110.631 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 m -82.8 115.05 21.53 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.604 0.762 . . . . 75.53 111.046 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.56 122.78 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.873 0.869 . . . . 75.42 110.293 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -95.7 129.04 43.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.483 0.713 . . . . 71.53 110.44 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -137.36 142.41 37.41 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.139 0.976 . . . . 71.51 111.054 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.64 80.19 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.029 2.486 . . . . 75.31 113.931 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.86 -23.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 112.703 0.631 . . . . 73.21 112.703 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.61 -173.46 53.28 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 121.313 0.396 . . . . 72.34 113.886 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 61.1 mt -115.98 124.59 29.57 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.032 0.933 . . . . 74.2 109.78 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.64 -27.02 39.03 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.473 2.115 . . . . 74.3 112.631 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.81 73.82 75.67 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.452 0.701 . . . . 74.33 109.485 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 83.4 Cg_endo -81.03 -28.3 2.56 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.78 2.32 . . . . 74.23 114.483 -170.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.39 -42.9 87.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 74.22 110.771 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.45 -33.86 76.01 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.558 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.14 -47.83 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.034 0.533 . . . . 74.41 110.784 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.455 ' OE1' ' HG ' ' A' ' 99' ' ' LEU . 41.6 tt0 -62.7 -50.28 71.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.873 0.694 . . . . 64.2 112.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -33.96 62.43 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 112.6 0.592 . . . . 74.15 112.6 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.54 -31.2 65.11 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.922 0.489 . . . . 73.01 110.895 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.78 -41.39 83.31 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.68 0.392 . . . . 75.22 111.248 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.83 92.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.896 0.479 . . . . 64.31 111.31 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -52.62 64.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.799 0.84 . . . . 71.13 112.007 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.04 -34.72 77.0 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 111.995 0.368 . . . . 62.54 111.995 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 36.8 t -67.81 -25.99 65.85 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.338 0.517 . . . . 73.43 112.102 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -78.42 -27.37 46.59 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.958 0.725 . . . . 70.31 112.958 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.7 t -106.59 -29.38 9.67 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.32 0.859 . . . . 64.2 113.32 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.1 mmt -67.3 -52.86 35.35 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.037 0.935 . . . . 74.52 111.405 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 mt -90.04 162.0 15.57 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.684 -1.144 . . . . 74.23 110.717 -169.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -29.65 -58.09 0.16 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 126.135 1.774 . . . . 73.42 114.804 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 122' ' ' ILE . 16.9 m -124.16 176.77 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.389 0.675 . . . . 64.33 110.182 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.1 98.77 0.61 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.287 0.565 . . . . 73.44 111.039 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.72 HD13 HG21 ' A' ' 122' ' ' ILE . 2.5 tt -92.02 121.65 33.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 73.35 108.017 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -101.62 99.36 11.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.154 0.582 . . . . 74.55 109.644 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.642 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 4.3 Cg_exo -76.58 168.19 24.16 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.838 1.692 . . . . 74.22 110.787 168.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 43.5 tt0 -105.12 96.99 6.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.066 0.546 . . . . 75.32 109.589 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD11 ' A' ' 108' ' ' LEU . 4.4 mpp? -105.13 134.89 47.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 72.42 111.458 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -139.61 133.79 31.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.074 0.55 . . . . 72.15 111.197 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.455 ' HG ' ' OE1' ' A' ' 78' ' ' GLN . 91.6 mt -84.26 133.29 34.57 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.897 0.879 . . . . 71.53 110.752 174.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -138.17 145.75 41.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.466 1.106 . . . . 73.4 110.595 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.9 119.97 38.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.963 0.505 . . . . 73.43 109.803 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.32 111.73 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.703 -1.221 . . . . 74.13 107.703 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.73 27.59 61.8 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 114.548 0.579 . . . . 71.13 114.548 -168.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.64 -1.02 88.86 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 114.987 0.755 . . . . 72.32 114.987 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 131.9 46.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.612 0.765 . . . . 75.34 109.964 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.6 m -92.4 106.09 18.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.318 0.858 . . . . 74.51 113.318 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.98 156.26 17.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.325 1.05 . . . . 72.21 111.126 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 97' ' ' MET . 50.4 tp -112.93 116.41 29.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.466 0.707 . . . . 62.01 110.78 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.4 113.35 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.389 0.676 . . . . 74.55 109.831 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 45.4 t -105.65 101.37 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 122.898 0.479 . . . . 65.03 110.263 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 40.4 t80 -84.46 128.51 34.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.627 0.771 . . . . 71.52 110.19 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.29 102.61 14.68 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 109.441 -0.578 . . . . 74.45 109.441 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.79 147.66 21.88 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.607 2.204 . . . . 64.41 112.163 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -75.61 134.49 40.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.853 0.358 . . . . 73.41 111.259 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.39 172.87 8.01 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.746 0.818 . . . . 74.44 112.968 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.62 139.31 36.31 Favored 'General case' 0 C--O 1.193 -1.914 0 C-N-CA 123.707 0.803 . . . . 65.1 110.617 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.74 -38.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 115.945 1.831 . . . . 74.33 115.945 -170.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.7 p -65.43 -49.41 69.26 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.864 0.466 . . . . 74.43 111.745 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.623 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 9.0 m-70 -127.93 69.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.88 -2.267 . . . . 71.44 104.88 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 27.8 mtpp -45.06 -152.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.386 1 C-N-CA 132.91 4.484 . . . . 70.2 120.844 58.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo 7.68 65.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.113 2.542 . . . . 70.54 116.153 -126.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.72 HG21 HD13 ' A' ' 93' ' ' LEU . 30.5 mm -80.0 77.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.094 0 CA-C-N 115.361 -0.836 . . . . 65.11 109.184 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -80.76 141.96 34.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.246 -0.433 . . . . 73.04 110.938 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 CA--C 1.55 0.949 0 CA-C-N 115.704 -0.68 . . . . 73.44 109.527 171.227 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.089 -0.338 . . . . 64.32 110.089 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -88.09 146.43 25.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.429 0.692 . . . . 74.44 110.742 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -70.24 166.71 19.48 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 122.997 0.519 . . . . 73.45 111.76 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . . . -62.42 -50.27 72.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.639 0.607 . . . . 64.35 112.639 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -70.47 -28.78 65.26 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 112.009 0.374 . . . . 72.13 112.009 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.55 -46.37 86.26 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.89 0.876 . . . . 70.15 111.256 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.509 HD13 HG12 ' A' ' 109' ' ' VAL . 60.5 mt -65.95 -38.46 88.67 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.722 0.809 . . . . 75.25 112.166 172.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.545 HD23 ' HD3' ' A' ' 68' ' ' PRO . 24.3 tp -59.17 -50.09 75.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.036 0.934 . . . . 75.22 110.399 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.47 -40.31 78.28 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.759 -1.109 . . . . 63.22 111.064 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.83 -41.75 95.49 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.988 0.915 . . . . 75.03 111.843 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 8' ' ' LEU . 29.3 mt -60.3 -38.62 84.23 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.659 1.184 . . . . 72.52 112.149 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -80.17 -28.95 38.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.029 0.531 . . . . 71.15 111.864 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -47.19 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.452 0.701 . . . . 54.13 111.949 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.3 154.8 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.131 0.572 . . . . 73.34 111.115 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.22 -20.61 21.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.011 0.924 . . . . 72.32 111.124 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.85 134.75 30.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.604 1.162 . . . . 75.33 109.688 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -69.6 87.13 0.48 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.88 0.872 . . . . 64.3 110.456 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.06 -64.59 1.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.45 0.7 . . . . 73.21 112.488 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -107.38 -14.05 14.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.43 0.692 . . . . 72.21 110.207 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 mm -109.49 155.17 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.216 -1.031 . . . . 72.32 108.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.46 150.13 10.41 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.87 46.13 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.029 0.532 . . . . 72.15 112.005 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HG3' HG23 ' A' ' 32' ' ' VAL . 74.9 mmtt -130.61 150.37 51.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.182 0.993 . . . . 75.21 110.076 175.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -85.63 165.16 17.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.734 0.814 . . . . 75.22 110.157 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.46 -30.85 68.81 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 120.879 0.371 . . . . 72.24 111.526 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -71.97 -19.25 61.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.649 0.78 . . . . 74.25 112.803 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -84.38 -4.99 59.22 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.527 0.565 . . . . 61.22 112.527 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.681 ' SD ' HD12 ' A' ' 52' ' ' LEU . 83.6 mmm -59.5 108.45 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.315 0.579 . . . . 72.05 111.313 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 142.14 -143.53 12.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 114.878 -1.055 . . . . 71.05 110.863 -171.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -52.57 -39.24 61.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.233 1.013 . . . . 71.33 113.253 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -36.51 75.34 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.065 0.765 . . . . 63.41 113.065 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 23' ' ' LYS . 44.2 t -72.52 -50.34 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 120.968 0.413 . . . . 75.05 110.385 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.55 ' HG3' ' HG3' ' A' ' 88' ' ' MET . 91.3 mmm -57.45 -41.2 80.09 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.57 1.322 . . . . 75.43 114.57 -170.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.18 -34.24 77.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.157 0.583 . . . . 72.04 111.611 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -79.32 -28.48 42.13 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.758 0.823 . . . . 51.41 111.242 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.82 -40.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 123.48 0.712 . . . . 74.54 110.511 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.96 -31.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.507 -0.769 . . . . 73.11 111.134 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' GLU . . . -60.08 -49.96 75.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.228 0.611 . . . . 74.32 112.178 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.28 -27.56 35.06 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.681 . . . . 72.1 111.657 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.66 -32.26 60.1 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.363 0.665 . . . . 64.15 112.275 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -92.57 -17.11 24.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.163 0.585 . . . . 72.52 111.525 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.1 tp10 -75.43 106.88 3.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 123.578 0.751 . . . . 73.23 112.367 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.07 106.12 2.21 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.142 2.561 . . . . 75.42 113.201 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.08 -7.1 40.63 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 114.87 0.708 . . . . 71.34 114.87 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -92.78 -52.43 4.62 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.203 1.002 . . . . 74.14 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 36.93 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 126.296 1.839 . . . . 75.45 115.378 -170.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.09 48.09 64.51 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 116.012 1.165 . . . . 71.23 116.012 166.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.72 152.59 22.56 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.53 -0.628 . . . . 74.14 111.53 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.89 127.1 51.56 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.844 0.822 . . . . 74.33 112.074 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 97.2 mt -115.21 114.04 24.72 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.879 1.271 . . . . 75.11 108.59 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.14 109.06 20.66 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.508 -0.552 . . . . 71.12 109.508 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.718 HD13 HD23 ' A' ' 108' ' ' LEU . 29.9 mt -93.03 132.17 37.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.494 0.718 . . . . 75.02 110.533 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 36.64 4.43 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 121.298 0.388 . . . . 75.23 112.371 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.53 143.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.537 0.735 . . . . 75.4 109.813 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -113.47 154.1 27.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.765 -1.198 . . . . 63.42 107.765 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.407 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 41.7 p90 -145.73 129.03 16.78 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.408 0.623 . . . . 75.31 112.005 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.74 135.61 51.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.835 0.854 . . . . 61.22 110.933 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.6 mt -83.7 123.52 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.737 0.815 . . . . 73.22 110.582 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.408 HD22 ' HB3' ' A' ' 63' ' ' ASP . 29.5 p30 -82.5 -176.3 6.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.795 0.838 . . . . 74.15 112.08 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.77 -14.16 57.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.737 1.014 . . . . 64.12 113.737 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -86.8 -22.89 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.151 0.58 . . . . 64.22 112.021 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.4 16.05 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 116.576 -0.284 . . . . 61.22 112.512 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB3' HD22 ' A' ' 59' ' ' ASN . 23.4 t70 -107.74 132.71 53.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.263 1.025 . . . . 74.32 110.915 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -89.09 119.03 29.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.806 0.842 . . . . 75.42 111.509 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 67.5 t -103.44 120.8 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.169 0.988 . . . . 75.22 110.704 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -94.19 130.69 40.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.271 1.028 . . . . 73.31 110.387 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.87 147.44 48.24 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.877 0.871 . . . . 74.54 110.485 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.545 ' HD3' HD23 ' A' ' 8' ' ' LEU . 83.2 Cg_endo -78.31 108.16 2.43 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.251 1.967 . . . . 64.32 114.534 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 m -91.1 -24.42 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 122.968 0.507 . . . . 74.11 111.199 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 76.58 -170.12 54.95 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 114.81 0.684 . . . . 65.23 114.81 174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -121.57 124.24 27.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.97 0.908 . . . . 73.43 109.979 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.97 -17.04 22.71 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.457 2.105 . . . . 65.42 113.023 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -134.38 59.77 38.97 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.404 1.081 . . . . 75.21 110.223 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' HD22 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -62.06 -36.81 68.39 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.905 2.403 . . . . 73.34 114.265 -162.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.31 -39.27 74.92 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.472 0.709 . . . . 74.22 110.58 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.47 -36.3 80.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.979 0.511 . . . . 73.21 111.205 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.35 -45.6 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 123.474 0.71 . . . . 74.01 110.813 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.9 -49.77 74.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.808 0.843 . . . . 72.42 112.043 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -67.32 -40.67 85.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.279 0.632 . . . . 70.01 111.578 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.9 -36.57 84.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.552 0.741 . . . . 74.53 110.389 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.552 HD21 ' SD ' ' A' ' 97' ' ' MET . 24.3 tp -67.78 -38.27 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.969 0.508 . . . . 74.31 111.282 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.67 90.58 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.99 0.516 . . . . 55.33 111.553 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.8 m -65.76 -48.31 72.28 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.639 0.776 . . . . 74.12 111.721 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.98 -30.36 69.61 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.797 0.439 . . . . 74.42 111.478 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 16.1 t -65.98 -19.91 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.899 -0.5 . . . . 65.33 112.292 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -39.2 17.73 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.455 0.702 . . . . 74.15 112.016 170.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -85.93 -25.67 25.98 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.153 1.168 . . . . 71.32 114.153 -173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.55 ' HG3' ' HG3' ' A' ' 33' ' ' MET . 85.7 mmm -81.91 -58.08 3.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.815 0.846 . . . . 74.34 110.085 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.98 146.55 37.39 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.352 -0.84 . . . . 74.22 111.138 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -50.84 -37.57 43.92 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.997 0.919 . . . . 63.33 113.051 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.2 m -121.1 160.03 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.053 0.941 . . . . 75.1 110.713 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.29 105.34 7.29 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.085 0.554 . . . . 74.51 111.85 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.5 tt -93.24 137.19 32.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.28 -1.378 . . . . 73.44 107.28 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -98.83 104.73 26.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 122.692 0.397 . . . . 74.41 110.131 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.68 119.38 5.69 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.303 1.335 . . . . 63.04 110.667 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 14.3 tp10 -71.65 98.74 1.97 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.373 -0.83 . . . . 74.41 109.826 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD13 ' A' ' 108' ' ' LEU . 60.1 mtm -116.73 127.16 54.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.311 0.644 . . . . 74.14 112.198 -169.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -132.9 128.67 37.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.303 1.041 . . . . 75.1 110.2 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 74' ' ' PRO . 53.6 mt -81.91 132.14 35.26 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.167 0.987 . . . . 72.22 111.408 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 11.4 mm-40 -128.38 128.46 44.55 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.162 0.985 . . . . 73.23 111.1 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.2 117.27 29.7 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.857 0.863 . . . . 74.23 110.986 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.2 t -132.98 117.42 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.565 1.146 . . . . 74.25 110.577 -172.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.3 28.54 27.66 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 116.443 1.337 . . . . 74.22 116.443 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -4.48 67.91 Favored Glycine 0 N--CA 1.484 1.852 0 CA-C-N 117.472 0.636 . . . . 72.15 114.179 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -110.88 119.2 38.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.377 1.071 . . . . 74.13 110.074 -177.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -88.55 103.53 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.982 0.81 . . . . 75.2 110.576 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.44 168.77 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.858 0.863 . . . . 72.32 110.717 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.719 HD13 ' HB3' ' A' ' 97' ' ' MET . 60.1 tp -119.2 119.07 33.04 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.994 0.517 . . . . 73.43 110.577 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.509 HG12 HD13 ' A' ' 7' ' ' LEU . 93.1 t -83.63 111.01 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.135 -0.691 . . . . 70.14 109.135 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 48.1 t -103.5 99.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.527 0.679 . . . . 75.53 110.177 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 58.2 t80 -79.05 119.16 21.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.145 0.978 . . . . 73.13 109.026 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.79 102.49 53.66 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.079 0.952 . . . . 64.1 108.774 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.96 165.48 31.98 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.942 1.761 . . . . 74.2 111.607 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -72.14 136.56 46.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.781 -0.822 . . . . 75.31 108.781 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -71.51 156.35 39.53 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.451 0.7 . . . . 73.24 111.522 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.4 -175.61 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 124.926 1.29 . . . . 72.42 111.601 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.94 -51.56 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 O-C-N 119.756 -1.84 . . . . 74.42 113.614 162.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 t -68.39 -49.94 56.49 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.363 0.529 . . . . 75.32 111.468 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.611 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 8.5 m-70 -117.94 84.65 2.21 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 101.341 -3.577 . . . . 73.11 101.341 165.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.695 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.256 36.2 mtmm -48.79 -140.77 0.0 OUTLIER Pre-proline 0 CA--C 1.577 1.986 1 C-N-CA 133.664 4.786 . . . . 72.32 121.204 50.908 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo 10.16 62.93 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 124.207 3.272 . . . . 65.15 116.136 -121.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.695 HG12 ' HA ' ' A' ' 120' ' ' LYS . 48.5 mm -76.78 116.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.994 0.918 . . . . 73.24 110.344 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -150.52 144.19 25.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.906 0.483 . . . . 73.24 110.16 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 120.912 0.387 . . . . 73.41 110.288 171.782 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.416 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 46.0 ttm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.788 0.328 . . . . 74.41 111.565 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.609 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.0 mmm180 -95.44 157.57 15.84 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.402 1.081 . . . . 71.31 111.037 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -77.45 152.35 34.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.908 0.707 . . . . 62.32 112.908 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.88 -53.05 54.67 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.505 1.122 . . . . 73.12 113.183 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.594 ' HB ' HG11 ' A' ' 102' ' ' VAL . 2.9 t -62.35 -41.5 98.65 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.234 0.613 . . . . 74.31 112.621 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -55.16 -45.31 75.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.495 1.118 . . . . 63.32 111.68 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' A' ' 2' ' ' ARG . 47.3 mt -73.68 -33.27 64.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.306 1.042 . . . . 75.54 112.749 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.36 -31.36 71.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.271 0.628 . . . . 73.02 110.587 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.49 -30.68 69.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.863 0.865 . . . . 75.2 112.802 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.414 ' O ' HG21 ' A' ' 14' ' ' VAL . 29.2 tt0 -60.85 -52.94 62.95 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.875 -0.417 . . . . 74.23 109.875 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.71 -27.46 62.08 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.836 0.854 . . . . 74.14 112.914 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.66 -11.1 60.67 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.214 0.605 . . . . 74.45 111.847 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 -36.11 8.24 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.839 0.856 . . . . 73.21 111.948 172.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 10' ' ' GLU . 29.5 m -117.54 117.54 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.616 0.767 . . . . 75.43 111.241 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.84 -44.49 82.16 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.684 1.193 . . . . 74.23 111.1 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.77 149.57 25.66 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.982 0.913 . . . . 61.35 110.601 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.1 m -87.24 129.64 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.867 0.467 . . . . 75.53 111.982 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.46 -64.94 1.0 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.833 0.453 . . . . 73.23 111.32 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -14.68 9.08 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.569 0.747 . . . . 73.34 112.013 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 49' ' ' TYR . 18.8 mm -113.87 142.99 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 118.193 0.452 . . . . 73.01 110.649 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.27 112.6 14.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.365 0.666 . . . . 61.32 110.632 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.29 118.2 30.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.314 0.645 . . . . 64.11 109.843 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 32' ' ' VAL . 73.6 mmtt -124.11 142.95 50.76 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.848 0.859 . . . . 65.24 110.632 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -89.56 174.76 7.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.548 0.739 . . . . 74.25 110.714 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -37.85 71.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.131 0.572 . . . . 71.3 112.21 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -60.45 -23.56 64.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.162 1.171 . . . . 74.23 114.162 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -88.13 -13.72 40.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.381 0.882 . . . . 72.42 113.381 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.497 ' SD ' HG13 ' A' ' 77' ' ' VAL . 84.4 mtp -58.3 109.16 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.056 0.542 . . . . 75.23 112.24 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.01 -122.46 1.18 Allowed Glycine 0 C--N 1.344 0.988 0 CA-C-N 116.136 -0.483 . . . . 60.3 112.326 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.47 -46.55 63.55 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.518 0.727 . . . . 75.04 111.57 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.6 m -63.86 -37.4 87.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.611 0.764 . . . . 63.41 112.369 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.468 HG22 ' HG3' ' A' ' 23' ' ' LYS . 87.5 t -67.69 -42.33 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.847 0.459 . . . . 74.14 111.192 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.524 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 36.2 tpp -67.6 -47.31 70.07 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.75 0.648 . . . . 73.24 112.75 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.31 -27.24 66.13 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 75.42 113.041 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.456 HG23 HD23 ' A' ' 50' ' ' LEU . 14.7 t -78.22 -29.13 48.16 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 121.615 -0.678 . . . . 73.03 111.91 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.08 -43.21 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 123.055 0.542 . . . . 74.43 109.569 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 122' ' ' ILE . 48.4 mt -53.73 -45.21 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.203 1.001 . . . . 75.42 111.078 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.35 90.72 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.855 0.462 . . . . 54.42 111.611 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.07 -38.88 89.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.923 0.489 . . . . 73.2 111.726 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.53 -30.76 69.64 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.543 0.737 . . . . 64.31 112.721 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -105.63 17.13 24.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.024 0.75 . . . . 72.04 113.024 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -108.25 89.19 5.53 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 122.821 0.449 . . . . 75.12 110.53 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.07 118.92 5.96 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.302 2.001 . . . . 73.04 112.132 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.82 -12.52 32.29 Favored Glycine 0 N--CA 1.477 1.406 0 CA-C-N 115.547 -0.751 . . . . 73.1 113.216 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.25 -7.56 14.83 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.474 0.71 . . . . 75.53 109.754 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -42.87 132.08 3.96 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.923 1.289 . . . . 63.32 113.845 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.89 37.64 2.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.831 -0.622 . . . . 74.02 111.747 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.82 152.67 20.38 Favored Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.698 -0.561 . . . . 71.12 111.698 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 20' ' ' ILE . 98.2 m-85 -120.69 148.74 43.54 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.768 0.784 . . . . 73.34 112.303 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.2 mp -119.93 130.96 55.05 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.893 0.877 . . . . 75.51 109.69 170.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.05 109.47 21.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.568 0.747 . . . . 71.13 109.752 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.519 HD11 HD23 ' A' ' 108' ' ' LEU . 63.5 mt -92.07 127.56 37.58 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.938 -0.393 . . . . 72.42 109.938 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.93 30.86 4.07 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 115.9 -0.591 . . . . 63.04 112.604 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.25 133.35 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.252 0.621 . . . . 74.31 110.365 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.81 176.84 5.04 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.688 -1.227 . . . . 74.43 107.688 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -157.05 144.67 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.566 -0.709 . . . . 75.0 112.454 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.71 128.29 53.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.281 1.032 . . . . 72.03 110.294 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.6 mm -82.62 123.14 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 122.9 0.48 . . . . 73.22 111.049 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.28 154.54 37.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.897 0.879 . . . . 73.54 110.185 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.37 0.26 20.16 Favored 'General case' 0 CA--C 1.559 1.289 0 O-C-N 121.997 -0.44 . . . . 70.51 111.8 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -96.71 3.51 52.37 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.87 0.868 . . . . 73.42 111.494 166.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.56 57.88 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 115.576 0.991 . . . . 71.24 115.576 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.61 148.38 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.105 0.779 . . . . 73.12 113.105 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -96.72 128.29 43.52 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.354 0.662 . . . . 63.11 111.088 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.1 119.15 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 108.781 -0.822 . . . . 75.32 108.781 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.74 113.43 25.49 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.679 0.752 . . . . 75.22 110.382 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.17 145.1 31.8 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.541 1.136 . . . . 73.23 110.143 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 88.6 Cg_endo -96.2 109.31 0.11 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.371 2.047 . . . . 73.43 113.869 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.8 -11.65 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.66 -0.65 . . . . 73.31 111.142 161.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.6 -167.54 54.34 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.466 0.481 . . . . 73.42 113.61 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 77' ' ' VAL . 95.2 mt -99.74 131.43 24.65 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.113 0.965 . . . . 73.13 110.838 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.24 -37.51 61.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.329 2.019 . . . . 74.21 111.218 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 10.8 m-20 -130.52 86.05 54.34 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.004 0.921 . . . . 74.42 109.374 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 -37.34 89.92 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.562 2.841 . . . . 75.22 114.319 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.97 -53.42 46.57 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.009 -0.996 . . . . 65.02 110.92 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 73' ' ' ASP . 67.4 mmtt -64.46 -49.08 72.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 62.1 112.064 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.497 HG13 ' SD ' ' A' ' 28' ' ' MET . 95.3 t -56.51 -40.94 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.709 0.803 . . . . 64.04 112.329 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.41 -46.12 90.02 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.414 0.686 . . . . 72.3 112.004 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.66 -44.7 61.51 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.738 0.815 . . . . 74.32 112.212 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.02 -33.25 75.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.604 0.762 . . . . 71.45 111.926 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -66.76 -45.11 79.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.656 0.265 . . . . 74.42 110.973 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.09 89.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.335 0.654 . . . . 73.42 111.86 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -64.34 -53.04 54.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.107 0.963 . . . . 70.24 111.028 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.29 -33.42 75.26 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.072 -0.513 . . . . 74.03 112.017 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.4 -29.22 63.92 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.486 0.585 . . . . 74.45 112.412 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.26 -42.65 13.59 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.679 0.792 . . . . 65.03 111.341 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -69.33 -28.52 66.31 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.975 1.102 . . . . 73.14 113.975 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.524 ' HG3' ' HE2' ' A' ' 33' ' ' MET . 14.0 mmt -80.25 -60.94 2.14 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.313 0.645 . . . . 63.34 111.769 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 HD23 ' SD ' ' A' ' 33' ' ' MET . 22.7 mt -81.93 159.9 23.5 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.388 -0.823 . . . . 71.13 112.796 -161.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.58 HD22 ' HA ' ' A' ' 122' ' ' ILE . 6.1 p30 -50.65 -52.26 41.46 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.036 0.754 . . . . 75.33 113.036 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.5 m -107.47 171.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.303 0.573 . . . . 73.41 111.441 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.65 99.6 5.09 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.496 -0.775 . . . . 73.23 110.062 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.439 HD11 HG23 ' A' ' 122' ' ' ILE . 3.9 tt -84.53 127.05 33.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.593 -1.262 . . . . 73.3 107.593 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 94.29 15.91 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.391 0.677 . . . . 75.41 110.583 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.01 162.09 23.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.531 2.154 . . . . 74.3 111.692 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.6 tp10 -95.75 128.81 42.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.624 ' HB3' HD13 ' A' ' 108' ' ' LEU . 62.5 mtt -126.29 114.12 17.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.017 0.527 . . . . 72.41 110.277 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -124.15 133.69 53.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.568 0.747 . . . . 75.21 111.008 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.13 125.06 41.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.007 0.923 . . . . 75.5 110.41 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -135.27 146.09 48.21 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.481 0.713 . . . . 63.04 111.156 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -101.21 117.38 34.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.23 0.538 . . . . 72.34 110.739 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.594 HG11 ' HB ' ' A' ' 5' ' ' THR . 88.3 t -126.63 120.08 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.149 1.38 . . . . 74.23 108.375 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.19 60.57 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.109 0.404 . . . . 75.1 114.109 -170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.92 88.03 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 114.152 0.421 . . . . 70.52 114.152 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.2 mmtt -103.01 134.88 45.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.918 0.887 . . . . 74.23 109.928 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.2 m -96.98 123.27 40.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.779 0.718 . . . . 74.42 111.289 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.58 161.5 17.34 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.52 0.728 . . . . 74.21 109.198 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 97' ' ' MET . 35.9 tp -114.89 111.51 21.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.469 -0.567 . . . . 72.3 109.469 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.2 t -84.76 122.27 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.219 -0.66 . . . . 75.13 109.219 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 37.3 t -113.2 99.97 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.458 0.703 . . . . 75.1 110.039 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.68 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 56.8 t80 -84.08 119.61 25.17 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 72.41 110.555 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.42 100.97 28.85 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.931 0.893 . . . . 70.41 109.175 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 176.28 10.17 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.603 2.202 . . . . 73.44 112.356 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.22 156.78 24.38 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.679 0.752 . . . . 73.52 112.934 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' HIS . . . -124.34 141.48 52.04 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.145 0.978 . . . . 74.23 109.898 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.24 150.51 37.03 Favored 'General case' 0 C--O 1.183 -2.4 0 C-N-CA 124.27 1.028 . . . . 63.11 110.933 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.0 t -38.72 -37.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 N-CA-C 115.933 1.827 . . . . 75.13 115.933 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 t -78.36 -39.57 38.89 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 112.909 0.707 . . . . 72.42 112.909 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.644 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 p-80 -136.88 77.31 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.745 -1.576 . . . . 75.23 106.745 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.682 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.263 14.1 ptmm? -51.48 -152.48 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.35 2 C-N-CA 132.81 4.444 . . . . 72.32 122.097 46.338 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo 14.4 62.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 O-C-N 117.239 -2.032 . . . . 73.41 115.844 -123.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.682 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.9 mm -75.67 95.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 114.401 -1.272 . . . . 73.33 109.451 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.3 p90 -110.53 155.18 22.65 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.928 0.491 . . . . 74.55 109.876 169.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HD2' ' SD ' ' A' ' 88' ' ' MET . 5.7 ttpm? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG2' ' HG3' ' A' ' 98' ' ' GLN . 10.3 tpt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.919 -0.4 . . . . 64.03 109.919 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -85.73 123.43 31.1 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.149 0.58 . . . . 75.53 110.607 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -59.47 153.71 18.78 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.103 0.961 . . . . 75.2 112.718 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.82 74.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.653 0.781 . . . . 62.3 112.642 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -65.11 -40.76 94.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.615 0.766 . . . . 73.02 110.931 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.78 -37.53 87.92 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.002 0.921 . . . . 73.21 112.239 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.6 HD12 HG12 ' A' ' 109' ' ' VAL . 68.8 mt -63.0 -41.66 99.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.124 0.569 . . . . 74.52 111.829 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.89 -32.38 69.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 73.23 112.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.14 -40.61 94.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.072 0.549 . . . . 72.03 111.553 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 14' ' ' VAL . 34.6 tt0 -72.61 -50.16 27.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 110.319 -0.252 . . . . 73.35 110.319 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -49.44 -55.78 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.505 1.122 . . . . 71.21 113.119 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -68.49 -20.78 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.445 0.906 . . . . 75.13 113.445 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.32 -29.0 15.87 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.232 0.827 . . . . 73.25 113.232 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 10' ' ' GLU . 23.0 m -111.76 128.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 112.59 0.589 . . . . 75.44 112.59 -172.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.82 -20.93 54.85 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.963 0.905 . . . . 75.31 113.334 164.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -124.49 98.83 5.91 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.547 0.739 . . . . 75.12 110.392 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 p -75.7 94.66 3.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.563 0.745 . . . . 75.54 109.831 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 -63.81 0.99 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.373 0.879 . . . . 53.44 113.373 -167.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -121.55 6.96 10.03 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.11 0.564 . . . . 75.04 112.1 179.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mt -116.6 112.81 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.155 -0.683 . . . . 71.52 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.99 115.97 22.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.969 -0.382 . . . . 72.54 109.969 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.75 131.61 37.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.652 0.781 . . . . 72.53 111.97 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 62.3 mttm -130.0 151.64 50.33 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.097 0.959 . . . . 71.01 110.678 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -90.06 170.73 10.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.085 0.554 . . . . 74.03 111.085 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.38 70.7 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.406 0.682 . . . . 64.44 111.659 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -60.6 -30.16 69.65 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.902 0.881 . . . . 74.23 112.88 171.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -86.89 -2.5 58.64 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.272 0.629 . . . . 75.54 112.646 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.514 ' HE3' ' HB2' ' A' ' 81' ' ' LEU . 12.2 tpt -63.83 123.06 17.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.795 0.838 . . . . 75.43 112.293 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.75 -135.76 5.73 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.644 -0.253 . . . . 71.34 113.116 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -31.19 70.57 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.579 0.752 . . . . 71.54 111.337 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.4 m -62.8 -31.21 72.14 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.499 0.72 . . . . 72.25 111.955 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.593 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 25.9 t -73.36 -44.06 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 120.909 0.385 . . . . 72.14 110.996 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 89' ' ' LEU . 38.1 tpp -62.51 -50.47 71.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.212 -0.903 . . . . 74.23 113.076 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -27.4 69.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.924 0.49 . . . . 72.4 112.287 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.9 m -70.54 -40.32 73.48 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.002 0.521 . . . . 63.34 110.858 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.16 -43.79 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 123.497 0.719 . . . . 74.22 110.665 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.97 -37.54 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.363 0.665 . . . . 74.44 110.735 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.35 -48.41 79.9 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.546 0.738 . . . . 62.44 112.456 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -71.95 -32.45 67.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 120.698 0.285 . . . . 75.13 111.566 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . . . -76.07 -25.68 55.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.317 0.647 . . . . 74.43 112.563 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.75 -33.46 12.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.304 0.642 . . . . 74.1 112.161 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.52 127.16 93.37 Favored Pre-proline 0 CA--C 1.563 1.479 0 O-C-N 122.07 -0.394 . . . . 74.14 111.927 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -58.03 109.94 0.56 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.639 2.893 . . . . 75.23 114.747 -173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.79 26.23 67.64 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.882 0.713 . . . . 64.12 114.882 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.66 13.1 35.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 118.819 1.309 . . . . 74.42 112.295 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -51.47 116.54 2.13 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.132 0.573 . . . . 71.34 110.884 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.437 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 120.62 36.18 0.8 Allowed Glycine 0 N--CA 1.47 0.957 0 CA-C-N 115.931 -0.577 . . . . 44.33 112.117 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -111.79 127.25 8.03 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 110.77 -0.932 . . . . 72.44 110.77 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.08 125.82 53.96 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.282 0.541 . . . . 72.42 110.819 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -94.89 121.78 36.85 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.345 -0.983 . . . . 63.11 108.345 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD11 HD11 ' A' ' 7' ' ' LEU . 31.1 tp -103.52 108.71 20.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.53 0.681 . . . . 74.21 110.256 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.612 ' HB3' HD23 ' A' ' 71' ' ' LEU . 3.5 mm? -91.65 132.19 36.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.192 0.997 . . . . 73.22 110.357 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.65 32.07 4.63 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 116.048 -0.524 . . . . 73.41 112.966 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.3 133.99 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.976 0.511 . . . . 71.31 110.181 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.44 129.07 56.44 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.223 -1.399 . . . . 70.53 107.223 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -110.9 129.6 55.83 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.173 0.511 . . . . 73.41 111.702 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.51 54.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.287 1.035 . . . . 73.33 110.334 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.5 mm -96.2 126.76 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.292 0.637 . . . . 74.13 110.476 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 63' ' ' ASP . 30.9 p30 -87.95 -174.1 4.56 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.526 0.73 . . . . 70.02 111.61 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.92 -22.98 67.17 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.654 0.782 . . . . 75.14 112.621 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -74.11 -23.4 59.31 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.903 0.881 . . . . 75.11 112.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.74 78.64 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.625 -0.261 . . . . 75.15 112.722 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 59' ' ' ASN . 26.0 t70 -75.03 142.41 43.79 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.617 1.167 . . . . 74.12 111.278 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.3 m -93.95 108.85 20.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.693 0.797 . . . . 74.41 110.335 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.76 121.81 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.625 0.77 . . . . 70.23 109.757 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -92.08 127.34 37.52 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.404 0.682 . . . . 74.05 110.225 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -123.11 120.89 27.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.809 0.844 . . . . 75.44 110.458 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.13 90.31 0.66 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.575 2.183 . . . . 60.14 112.761 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.95 -12.18 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.289 0.636 . . . . 71.12 112.015 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.63 179.03 44.36 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.234 -0.439 . . . . 64.12 113.627 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 52' ' ' LEU . 3.5 mp -105.18 139.94 20.62 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 109.686 -0.487 . . . . 74.11 109.686 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.25 -30.17 25.1 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.137 1.891 . . . . 64.42 112.056 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.62 71.1 81.27 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.856 0.863 . . . . 75.24 110.226 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.69 -24.94 17.83 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.914 2.409 . . . . 74.21 112.764 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.17 -45.3 77.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 74.13 110.044 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 76' ' ' LYS . 7.9 mtpm? -61.39 -53.89 50.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.708 -0.678 . . . . 73.44 111.198 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.2 -35.32 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.571 0.749 . . . . 73.31 112.103 -172.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.493 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 54.2 tt0 -63.81 -46.09 86.68 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 120.99 0.424 . . . . 74.23 111.5 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -70.29 -47.61 60.45 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.566 0.746 . . . . 73.22 112.07 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.195 0.998 . . . . 60.51 111.409 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HB2' ' HE3' ' A' ' 28' ' ' MET . 19.4 tp -71.32 -41.47 69.81 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.647 0.379 . . . . 72.55 111.276 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.2 86.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.192 0.597 . . . . 74.23 111.297 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 -52.19 55.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.938 0.895 . . . . 75.41 111.191 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -68.32 -29.57 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.731 0.412 . . . . 73.52 111.596 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 45.5 t -60.27 -27.4 67.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.74 -0.6 . . . . 74.11 112.043 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.11 -49.61 6.3 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.161 0.584 . . . . 60.23 111.825 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 t -68.7 -32.14 71.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.372 0.879 . . . . 43.21 113.372 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.7 mmt -78.93 -48.15 15.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.368 0.667 . . . . 64.11 111.366 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 33' ' ' MET . 31.0 mt -88.39 151.4 22.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.688 0.625 . . . . 71.23 112.688 -166.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -55.27 -58.62 6.96 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.138 1.375 . . . . 71.34 112.369 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG21 ' HB3' ' A' ' 119' ' ' HIS . 43.1 t -102.36 146.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.621 0.769 . . . . 75.33 109.535 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.27 97.23 0.71 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.41 0.624 . . . . 63.15 110.822 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.5 tt -81.75 136.72 35.43 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.146 -1.057 . . . . 71.51 108.146 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -107.16 91.16 6.28 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.246 0.619 . . . . 73.22 109.948 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.551 ' HG2' ' HE1' ' A' ' 97' ' ' MET . 61.5 Cg_endo -78.71 118.61 4.21 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.135 1.89 . . . . 75.14 111.583 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 37.5 tt0 -73.44 109.24 6.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 75.42 109.084 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.551 ' HE1' ' HG2' ' A' ' 95' ' ' PRO . 66.7 mtt -116.39 133.21 56.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.132 0.573 . . . . 74.43 111.747 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 15.1 mm100 -134.75 139.61 45.3 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.251 1.021 . . . . 75.44 110.471 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.7 mt -104.85 113.05 26.41 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.175 0.99 . . . . 73.22 110.946 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -118.01 136.48 53.5 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.224 1.009 . . . . 54.51 110.147 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -92.44 118.7 31.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.557 0.343 . . . . 73.32 110.313 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.16 113.99 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 74.5 108.925 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.8 29.49 67.53 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 114.804 0.682 . . . . 70.0 114.804 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.69 79.95 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.507 0.563 . . . . 73.13 114.507 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.34 136.43 49.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.995 0.918 . . . . 74.24 110.19 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.3 m -87.77 120.97 29.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.701 0.682 . . . . 75.33 110.903 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.5 mp -116.36 156.46 26.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.856 0.862 . . . . 64.42 109.813 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 52.5 tp -115.75 121.57 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.097 0.559 . . . . 74.22 110.117 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 7' ' ' LEU . 51.3 t -99.05 121.79 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.532 0.733 . . . . 73.24 109.153 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.39 101.38 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.957 0.503 . . . . 73.52 110.36 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.645 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 77.6 t80 -73.33 122.7 22.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.321 0.648 . . . . 74.34 109.826 170.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.65 110.51 63.3 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.371 0.668 . . . . 63.04 109.771 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.13 145.84 24.88 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.308 2.005 . . . . 74.22 112.235 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 42.7 tt0 -74.27 145.0 44.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.159 -0.682 . . . . 75.51 109.159 169.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' HIS . . . -84.96 173.83 10.25 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 123.239 0.616 . . . . 64.1 111.691 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.97 176.87 0.64 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 124.829 1.251 . . . . 75.15 111.044 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.89 -56.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.714 -1.241 . . . . 63.25 114.117 167.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -82.72 -41.45 19.26 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.354 0.525 . . . . 74.22 111.379 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.634 ' HB3' HG21 ' A' ' 91' ' ' VAL . 19.1 m-70 -104.7 73.65 1.1 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 103.734 -2.691 . . . . 74.01 103.734 162.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.5 mttt -46.87 -139.08 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.8 1 C-N-CA 133.526 4.73 . . . . 73.02 121.301 53.163 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo 6.43 67.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 124.592 3.528 . . . . 63.1 116.225 -122.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 120' ' ' LYS . 23.5 mm -76.72 80.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-N 115.287 -0.87 . . . . 75.04 109.595 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -82.95 152.97 25.26 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.923 0.392 . . . . 75.54 110.224 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 CA--C 1.554 1.122 0 N-CA-C 109.439 -0.578 . . . . 72.4 109.439 172.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HB ' ' A' ' 109' ' ' VAL . 56.6 ttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.221 0.452 . . . . 72.1 112.221 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -47.26 145.65 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.827 0.676 . . . . 74.04 112.827 158.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -64.11 151.65 42.64 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 75.11 111.268 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.12 -26.69 68.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.953 -0.567 . . . . 74.31 111.993 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.616 HG21 HG12 ' A' ' 102' ' ' VAL . 2.0 m -66.53 -47.37 73.1 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.152 0.981 . . . . 75.44 111.131 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.83 -44.06 97.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.987 0.915 . . . . 75.12 111.502 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.04 -30.81 69.25 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.074 -0.966 . . . . 74.32 112.246 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -66.03 -43.43 87.64 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.129 0.571 . . . . 74.52 109.962 171.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.8 -37.71 85.39 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.49 0.716 . . . . 71.4 111.591 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.71 -41.97 99.41 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.074 0.95 . . . . 72.13 110.925 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.03 -44.68 94.48 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.142 0.977 . . . . 72.34 112.113 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -76.99 -16.13 59.42 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.645 0.609 . . . . 74.4 112.645 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.43 43.38 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.239 0.616 . . . . 75.32 111.147 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 17' ' ' SER . 17.1 m -115.82 119.16 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.863 0.865 . . . . 71.33 110.02 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.21 -47.48 83.33 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.774 0.83 . . . . 72.13 111.27 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.95 95.96 9.81 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 72.41 108.656 165.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 14' ' ' VAL . 35.8 t -58.57 122.08 12.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.123 -0.489 . . . . 64.42 111.929 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.96 76.95 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.698 0.629 . . . . 65.21 112.698 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -150.88 15.48 0.75 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.089 0.774 . . . . 73.32 113.089 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.0 mm -102.21 106.47 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.342 -0.984 . . . . 72.41 108.342 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 35' ' ' THR . 10.6 tp10 -94.8 114.35 26.23 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.323 0.649 . . . . 75.24 111.504 -169.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.53 35.38 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.651 0.781 . . . . 70.42 112.136 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.763 ' HZ1' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.19 156.24 38.18 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.906 0.86 . . . . 65.1 112.235 176.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -81.37 163.19 23.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.42 -1.264 . . . . 75.34 110.362 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.05 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.787 0.435 . . . . 74.12 112.078 173.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 m -64.52 -29.97 71.01 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.866 0.867 . . . . 72.34 112.572 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 63.8 m-20 -82.53 -16.08 49.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.263 0.625 . . . . 75.35 112.337 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.522 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.8 tmm? -63.64 120.1 11.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.976 0.511 . . . . 73.24 111.822 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.19 -139.46 6.13 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.147 -0.478 . . . . 74.55 112.324 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -58.64 -41.65 86.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.988 1.107 . . . . 74.33 113.988 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -64.61 -41.12 96.43 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.583 0.753 . . . . 71.31 112.225 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.542 HG23 ' HE3' ' A' ' 23' ' ' LYS . 84.5 t -67.08 -43.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.581 0.752 . . . . 71.22 110.517 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.4 tpp -56.45 -40.92 75.61 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.965 1.306 . . . . 65.2 112.479 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.71 -39.23 90.77 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.47 0.708 . . . . 72.4 110.432 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.507 HG21 ' HG2' ' A' ' 21' ' ' GLU . 23.4 m -75.51 -30.74 59.91 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.06 0.544 . . . . 75.32 111.416 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 112' ' ' VAL . 69.2 t -59.39 -41.82 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.343 0.657 . . . . 73.12 110.657 174.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mt -59.86 -36.55 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 122.843 0.457 . . . . 73.24 111.326 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.38 97.27 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.827 1.047 . . . . 74.34 113.827 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' HD21 ' A' ' 45' ' ' LEU . 87.9 m-85 -70.76 -35.41 72.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.931 0.492 . . . . 74.12 111.206 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -22.7 46.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.693 0.797 . . . . 72.12 112.397 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -74.59 -50.09 19.23 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 54.21 111.754 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.06 142.18 72.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.175 0.59 . . . . 73.53 112.076 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.53 123.0 7.8 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.584 2.19 . . . . 74.22 113.107 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.39 34.71 85.76 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.83 -0.623 . . . . 52.5 114.551 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 39' ' ' PHE . 16.4 tp -97.97 18.79 15.15 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 117.738 0.769 . . . . 63.34 111.143 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -45.55 122.62 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.898 1.073 . . . . 72.11 113.898 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.1 51.12 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.421 -0.655 . . . . 53.12 114.554 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.66 137.27 9.2 Favored Glycine 0 C--N 1.364 2.094 0 CA-C-N 118.847 1.323 . . . . 71.23 111.9 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -121.27 138.68 54.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.462 0.705 . . . . 74.02 111.623 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 121.27 44.07 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.896 0.878 . . . . 72.51 109.392 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.84 109.56 21.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.501 0.72 . . . . 72.5 110.103 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.573 HD23 HD23 ' A' ' 108' ' ' LEU . 9.5 mp -95.53 136.47 35.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.304 1.041 . . . . 74.24 109.989 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.33 31.55 8.91 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.894 -0.594 . . . . 72.11 112.372 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.3 t -112.18 139.68 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.597 0.759 . . . . 75.53 109.481 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -114.16 159.13 20.42 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.835 -1.172 . . . . 53.43 107.835 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.463 ' HH2' ' HA ' ' A' ' 23' ' ' LYS . 41.3 p90 -150.65 137.16 18.81 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 73.35 111.296 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.91 49.14 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.583 0.753 . . . . 72.52 110.701 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -88.91 130.89 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.362 0.665 . . . . 71.21 110.666 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.427 HD22 ' HB2' ' A' ' 63' ' ' ASP . 31.9 p30 -82.13 -172.49 3.99 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.631 0.772 . . . . 75.0 112.486 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.07 -33.12 75.04 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.745 0.818 . . . . 75.14 112.433 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -83.04 -12.61 57.05 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.246 0.618 . . . . 73.53 112.335 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.08 37.02 6.11 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.228 0.451 . . . . 45.33 114.228 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB2' HD22 ' A' ' 59' ' ' ASN . 8.7 m-20 -116.77 134.72 54.44 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.479 0.711 . . . . 72.54 110.413 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -86.68 118.5 26.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.415 0.686 . . . . 75.14 110.548 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.39 118.34 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.126 0.57 . . . . 74.32 109.885 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.06 120.39 34.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.575 0.75 . . . . 73.34 109.821 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -124.02 151.02 64.57 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.847 0.859 . . . . 73.3 112.088 -170.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.47 121.7 5.28 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.606 2.204 . . . . 74.31 112.823 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.41 -40.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.9 -1.045 . . . . 71.42 110.557 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.44 170.28 46.76 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.695 -0.684 . . . . 74.14 113.362 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.09 139.76 22.18 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 109.619 -0.512 . . . . 72.21 109.619 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 -29.92 31.35 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.569 2.179 . . . . 74.42 111.954 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -133.19 83.06 51.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 108.328 -0.99 . . . . 61.35 108.328 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.21 -36.65 56.18 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.904 2.403 . . . . 74.21 113.564 -172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.8 -43.01 60.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.191 0.596 . . . . 64.01 110.969 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.1 -45.57 94.15 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.407 0.283 . . . . 73.35 111.39 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG13 ' HE3' ' A' ' 28' ' ' MET . 80.2 t -65.33 -43.64 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.479 0.712 . . . . 71.22 111.352 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.48 -48.42 81.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.523 0.729 . . . . 64.15 111.953 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -66.76 -40.93 88.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.171 -0.922 . . . . 65.44 111.474 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.83 -35.81 82.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.232 0.613 . . . . 74.01 110.91 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.34 -37.05 71.73 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.624 0.769 . . . . 74.31 111.329 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.56 86.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.439 0.696 . . . . 72.43 111.399 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.2 t -65.07 -52.55 55.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.839 0.855 . . . . 73.43 111.503 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.39 -31.82 73.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.21 0.604 . . . . 75.31 111.922 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 44.8 t -60.05 -35.3 74.83 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.163 0.506 . . . . 72.34 112.153 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.78 37.2 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.615 -0.721 . . . . 74.23 112.187 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.8 p -95.35 -2.59 48.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.593 0.961 . . . . 73.51 113.593 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.3 mmt -93.16 -55.45 3.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.371 0.605 . . . . 74.14 109.955 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.94 146.82 26.01 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.36 -0.836 . . . . 72.53 110.548 -171.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.511 HD22 ' HA ' ' A' ' 122' ' ' ILE . 4.8 p30 -52.75 -33.1 46.75 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.59 1.156 . . . . 74.13 113.161 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.25 162.57 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.25 1.02 . . . . 72.45 110.773 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.28 101.75 6.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.657 -0.701 . . . . 74.51 110.427 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.4 tt -83.24 124.12 30.25 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.57 -1.27 . . . . 74.55 107.57 172.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -102.89 98.75 12.04 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 122.76 0.424 . . . . 71.02 110.856 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.406 ' HG2' ' HE2' ' A' ' 97' ' ' MET . 64.3 Cg_endo -87.82 163.06 7.63 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.284 1.99 . . . . 64.54 112.433 171.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 60.4 tt0 -88.23 121.69 30.92 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.406 ' HE2' ' HG2' ' A' ' 95' ' ' PRO . 64.9 mtt -124.4 117.78 25.22 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.241 0.617 . . . . 75.41 110.799 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 28.6 mm-40 -131.38 138.78 49.29 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.686 0.794 . . . . 64.13 110.615 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.31 117.27 29.52 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.504 0.721 . . . . 74.13 109.439 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.7 133.53 53.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.394 1.078 . . . . 73.23 110.297 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -89.86 129.9 36.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.988 0.515 . . . . 75.33 111.095 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.616 HG12 HG21 ' A' ' 5' ' ' THR . 23.9 t -128.13 107.74 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.97 0.908 . . . . 73.05 108.828 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.6 28.95 57.11 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.727 0.651 . . . . 53.55 114.727 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.75 0.93 83.42 Favored Glycine 0 CA--C 1.543 1.794 0 N-CA-C 114.82 0.688 . . . . 74.12 114.82 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.7 133.05 41.74 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.611 0.706 . . . . 73.35 109.303 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -86.74 102.72 14.51 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.418 0.554 . . . . 74.53 110.796 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.2 154.42 18.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.52 0.728 . . . . 74.22 110.26 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.573 HD23 HD23 ' A' ' 52' ' ' LEU . 52.0 tp -116.69 120.1 37.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.401 0.681 . . . . 74.34 109.288 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 17.3 t -95.87 132.63 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.105 -0.702 . . . . 74.12 109.105 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.06 99.22 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.862 -0.792 . . . . 74.52 108.862 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.692 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 54.1 t80 -83.67 131.65 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.08 0.552 . . . . 65.21 110.107 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 36' ' ' VAL . 36.6 t -121.92 116.26 30.23 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 109.434 -0.58 . . . . 73.04 109.434 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.23 -176.15 1.76 Allowed 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.708 2.272 . . . . 74.13 112.832 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HG3' ' HZ2' ' A' ' 120' ' ' LYS . 35.8 tt0 -70.81 131.68 44.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.93 0.492 . . . . 70.2 109.85 166.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.08 157.02 23.02 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.038 0.535 . . . . 55.23 111.339 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.93 150.99 46.91 Favored 'General case' 0 C--O 1.186 -2.24 0 C-N-CA 123.963 0.905 . . . . 72.45 111.417 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -38.01 -52.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 N-CA-C 115.738 1.755 . . . . 64.03 115.738 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -69.59 -37.86 77.11 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.124 0.787 . . . . 74.53 113.124 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.8 m-70 -125.73 66.66 1.17 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 105.273 -2.121 . . . . 75.51 105.273 171.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 62.8 mttm -44.14 -153.0 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.207 1 C-N-CA 132.863 4.465 . . . . 74.43 121.316 60.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -1.85 71.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.584 2.19 . . . . 72.14 116.244 -117.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' HD22 ' A' ' 90' ' ' ASN . 59.5 mt -85.88 111.0 20.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.805 -1.089 . . . . 71.32 110.248 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -113.14 139.53 48.67 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.836 -1.075 . . . . 73.22 110.401 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.322 0.649 . . . . 74.52 109.443 173.2 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.353 -0.239 . . . . 73.31 110.353 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.88 153.53 18.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.13 0.572 . . . . 72.44 111.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.3 t -74.41 156.82 36.61 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.442 0.697 . . . . 62.24 111.249 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.89 -27.73 67.75 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.934 0.493 . . . . 64.21 111.355 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 102' ' ' VAL . 3.8 m -70.18 -41.75 73.34 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.658 0.783 . . . . 74.35 110.395 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.18 -51.04 67.96 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.622 1.169 . . . . 72.14 110.952 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.461 ' HB3' HD23 ' A' ' 51' ' ' LEU . 85.3 mt -69.67 -33.25 72.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.1 0.96 . . . . 75.21 113.081 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.93 -44.8 88.32 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.013 0.435 . . . . 73.55 110.404 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.33 -37.61 86.31 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.519 -0.764 . . . . 63.24 111.096 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.29 -43.12 98.8 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.885 0.874 . . . . 74.41 110.703 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 22' ' ' ALA . 71.4 mt -67.09 -38.56 85.92 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.518 1.127 . . . . 71.52 111.96 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -72.61 -23.8 60.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.118 0.567 . . . . 65.42 111.942 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.2 17.59 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.475 0.71 . . . . 65.03 110.965 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.33 116.54 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.179 0.514 . . . . 74.31 110.77 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.17 -43.21 87.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.67 0.388 . . . . 72.21 110.629 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.24 101.2 1.44 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.232 0.539 . . . . 73.22 109.931 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.521 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 25.3 m -80.89 78.64 7.67 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.589 0.756 . . . . 75.22 110.161 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.07 40.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.955 1.095 . . . . 73.52 113.955 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -123.72 -9.35 7.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 113.047 0.758 . . . . 74.25 113.047 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 17' ' ' SER . 42.3 mt -131.92 133.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.684 0.794 . . . . 75.23 109.301 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -125.7 129.4 49.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.826 0.739 . . . . 74.42 111.316 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -89.02 131.74 35.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.705 0.802 . . . . 71.52 110.612 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.34 151.94 51.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.834 0.854 . . . . 73.43 111.046 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -92.39 165.63 12.97 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.705 . . . . 75.23 112.474 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -24.54 67.31 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.141 0.976 . . . . 72.23 112.276 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.1 -36.02 82.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.865 0.466 . . . . 72.41 111.982 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -86.04 -2.48 58.35 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.466 0.706 . . . . 70.14 112.238 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.4 tpt -52.59 105.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.346 1.059 . . . . 72.34 111.909 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.465 ' HA2' ' OE1' ' A' ' 84' ' ' GLN . . . 138.05 -124.72 3.03 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.802 -0.635 . . . . 61.13 112.83 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.31 -36.85 76.38 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.461 1.105 . . . . 74.15 112.157 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.0 m -72.53 -18.85 61.61 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.264 -0.88 . . . . 73.31 112.991 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -34.34 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.659 0 C-N-CA 122.902 0.481 . . . . 64.51 111.709 167.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 24.7 mmt -74.69 -37.52 62.61 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.367 1.618 . . . . 74.2 115.367 -158.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.44 70.52 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.38 0.537 . . . . 75.43 112.19 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 50' ' ' LEU . 31.8 m -77.31 -30.76 54.25 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.186 0.594 . . . . 65.04 111.28 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.53 -39.93 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 122.837 0.455 . . . . 74.44 110.266 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 124' ' ' LYS . 68.6 mt -57.2 -35.61 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.533 0.733 . . . . 73.03 111.637 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.3 1.61 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.47 0.308 . . . . 73.44 110.891 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -65.46 -30.51 71.31 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.498 0.719 . . . . 73.43 112.359 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.81 -24.85 55.93 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.782 0.66 . . . . 63.21 112.782 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -115.95 -4.69 12.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.149 1.166 . . . . 63.44 114.149 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -92.52 107.15 21.75 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.0 0.818 . . . . 74.41 110.773 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.52 126.74 8.47 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.464 2.11 . . . . 75.42 112.997 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.21 -7.05 32.48 Favored Glycine 0 N--CA 1.474 1.216 0 CA-C-N 116.002 -0.544 . . . . 73.3 113.734 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.07 -37.93 9.95 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.986 0.893 . . . . 72.54 108.935 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 114' ' ' GLU . 11.0 m-20 39.6 71.81 0.16 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.309 1.844 . . . . 64.53 115.401 171.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.41 74.45 0.43 Allowed Glycine 0 C--N 1.352 1.425 0 N-CA-C 115.362 0.905 . . . . 64.04 115.362 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.13 44.45 Favored Glycine 0 N--CA 1.482 1.72 0 CA-C-N 117.237 0.518 . . . . 53.33 113.234 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -129.26 142.43 50.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.575 0.954 . . . . 75.12 113.575 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.8 mt -132.28 125.44 31.02 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.24 1.416 . . . . 63.11 109.891 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 7' ' ' LEU . 3.7 mm? -103.56 108.81 20.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.743 0.417 . . . . 70.31 110.851 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.71 124.93 38.04 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 75.11 109.857 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.98 33.15 4.13 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.158 -0.474 . . . . 73.13 112.94 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.88 146.33 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.545 0.738 . . . . 73.13 109.875 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -130.55 134.3 46.91 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.997 -0.742 . . . . 74.31 108.997 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -117.44 129.65 55.97 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.291 1.036 . . . . 74.3 110.881 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.76 135.22 54.19 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.604 0.762 . . . . 75.44 110.813 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -80.54 129.68 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.606 0.762 . . . . 73.41 110.487 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 40.7 p30 -90.89 -168.17 2.01 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.88 0.696 . . . . 65.32 112.88 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.17 -44.6 68.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.755 1.222 . . . . 74.13 113.48 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -26.8 27.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.013 0.525 . . . . 75.11 111.635 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.16 7.39 14.69 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 119.913 -0.382 . . . . 71.42 114.023 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 8.3 m-20 -74.48 143.1 44.77 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.471 0.636 . . . . 75.02 111.013 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.1 m -90.11 114.28 26.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.871 0.869 . . . . 71.53 110.156 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.55 117.28 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.437 0.695 . . . . 74.21 110.443 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -92.66 116.39 28.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.088 0.955 . . . . 74.45 110.422 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -118.46 149.76 46.67 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 123.885 0.874 . . . . 75.53 111.383 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.63 104.92 1.78 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.66 2.24 . . . . 74.44 112.014 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.94 -29.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 116.052 -0.522 . . . . 74.34 110.397 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -174.16 55.11 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.615 -0.721 . . . . 73.23 113.57 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 77' ' ' VAL . 82.0 mt -104.51 133.14 20.34 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.718 0.807 . . . . 75.1 110.542 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.43 -31.34 42.77 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.521 2.148 . . . . 74.53 111.763 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 5.8 m-20 -122.52 75.43 44.53 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 124.077 0.951 . . . . 73.25 109.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.83 -60.26 0.62 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.24 2.627 . . . . 75.14 114.223 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 5.2 p-10 -66.28 -39.36 89.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.263 -0.426 . . . . 73.23 110.65 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 57.4 tptt -60.96 -40.77 94.59 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.627 0.771 . . . . 74.24 112.089 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 71' ' ' LEU . 79.2 t -62.84 -44.92 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.037 0.535 . . . . 72.51 110.888 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.49 -50.34 73.93 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.586 0.754 . . . . 71.22 112.313 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 16.5 mmt85 -68.51 -43.96 75.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.495 0.718 . . . . 75.44 111.521 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.72 -33.54 72.63 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.541 -0.754 . . . . 74.33 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.551 HD22 ' SD ' ' A' ' 97' ' ' MET . 21.6 tp -66.98 -40.19 87.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.688 0.395 . . . . 72.32 110.936 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.424 ' HB3' ' HE2' ' A' ' 97' ' ' MET . . . -63.24 -39.2 93.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.97 0.508 . . . . 70.41 111.695 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -66.52 -52.47 45.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.813 0.845 . . . . 64.14 112.016 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.465 ' OE1' ' HA2' ' A' ' 29' ' ' GLY . 11.7 pt20 -71.13 -31.17 67.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.003 0.521 . . . . 72.24 112.321 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 42.4 t -60.89 -26.92 67.78 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.435 0.636 . . . . 73.25 111.373 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -76.48 -25.15 53.98 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 113.721 1.008 . . . . 64.41 113.721 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.5 p -110.44 -37.24 5.55 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.288 0.847 . . . . 71.52 113.288 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 92.1 mmm -68.29 -46.89 69.11 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.393 1.077 . . . . 70.53 111.542 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.9 mt -85.89 161.91 18.84 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.718 -0.674 . . . . 73.11 111.374 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -37.33 -53.05 1.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.873 1.669 . . . . 75.41 114.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.64 174.33 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.507 0.723 . . . . 74.11 111.441 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -68.73 97.4 0.81 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.202 -0.666 . . . . 64.52 109.202 163.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.684 HD13 HG23 ' A' ' 122' ' ' ILE . 4.9 tt -98.84 130.84 45.27 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.47 0.708 . . . . 63.34 109.465 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -106.62 98.55 20.92 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 124.061 0.944 . . . . 73.14 110.985 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.4 149.93 15.03 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.238 1.959 . . . . 72.54 111.407 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.21 102.68 14.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.097 -0.705 . . . . 64.12 109.097 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.576 ' HB3' HD12 ' A' ' 108' ' ' LEU . 51.9 mtm -112.43 140.25 47.32 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.536 0.735 . . . . 74.05 110.679 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -149.88 150.86 32.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.352 0.661 . . . . 74.13 110.46 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.73 119.28 38.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.295 1.038 . . . . 63.42 110.59 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -127.23 133.54 50.22 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.085 0.954 . . . . 75.32 109.711 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.85 122.16 40.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.073 0.463 . . . . 70.32 110.879 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 5' ' ' THR . 9.2 t -119.95 113.44 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.502 1.121 . . . . 73.32 108.41 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.29 28.67 55.25 Favored Glycine 0 CA--C 1.547 2.064 0 N-CA-C 115.169 0.828 . . . . 60.53 115.169 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.12 1.92 66.69 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 115.088 0.795 . . . . 65.23 115.088 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -109.96 130.51 55.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.993 0.897 . . . . 75.44 109.685 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 102.41 14.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.484 0.583 . . . . 74.11 111.685 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.39 166.45 14.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.895 0.878 . . . . 75.45 111.046 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 97' ' ' MET . 49.3 tp -119.21 121.84 40.62 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.56 0.744 . . . . 75.52 110.782 175.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' MET . 52.6 t -86.93 113.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.299 0.639 . . . . 74.02 109.576 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 55.3 t -100.22 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.37 0.605 . . . . 75.22 109.691 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.6 119.28 24.54 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.929 0.892 . . . . 75.34 109.252 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.87 100.34 39.17 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.488 0.715 . . . . 73.22 109.55 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.25 157.29 41.78 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.5 2.133 . . . . 74.43 112.175 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.5 tm-20 -75.94 115.94 16.15 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.23 -0.655 . . . . 71.42 109.23 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.47 152.22 35.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.346 1.058 . . . . 65.35 112.425 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 118' ' ' THR . 14.9 t70 -77.55 156.93 30.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.049 -0.523 . . . . 73.43 111.238 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -64.99 -19.92 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.412 0.685 . . . . 73.55 112.426 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 116' ' ' ASP . 14.9 t -58.01 -18.31 23.22 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 123.534 0.733 . . . . 73.1 112.277 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 83.8 m-70 -79.88 -76.65 0.21 Allowed 'General case' 0 CA--C 1.591 2.548 0 N-CA-C 106.979 -1.489 . . . . 74.5 106.979 166.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 5.8 tmtp? -79.92 -142.57 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.414 0 C-N-CA 129.519 3.127 . . . . 72.43 110.742 -49.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' CD ' ' HB3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 1.24 112.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.592 1 C-N-CA 125.611 4.207 . . . . 65.54 119.424 -133.832 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 93' ' ' LEU . 36.8 mm -95.52 102.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 115.312 -0.858 . . . . 75.02 109.634 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -101.6 167.5 10.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.769 0.828 . . . . 65.42 110.714 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.564 ' HB2' HD12 ' A' ' 37' ' ' ILE . 37.8 ttpt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.41 -0.959 . . . . 73.3 108.41 171.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 98' ' ' GLN . 14.9 ptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 111.383 0.142 . . . . 73.23 111.383 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.09 149.22 21.9 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.681 0.392 . . . . 72.52 111.143 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -74.03 157.31 36.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.943 0.897 . . . . 74.33 112.453 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB2' HG23 ' A' ' 102' ' ' VAL . . . -61.27 -43.68 98.47 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.034 0.534 . . . . 64.54 112.208 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -65.0 -35.09 80.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.229 0.612 . . . . 73.21 112.154 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.284 0.634 . . . . 71.42 111.262 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 20' ' ' ILE . 60.2 mt -68.76 -39.56 80.21 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.541 0.736 . . . . 73.52 111.456 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 ' HA ' HD11 ' A' ' 11' ' ' LEU . 31.7 tp -65.12 -29.07 69.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.94 0.896 . . . . 75.23 111.276 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.28 -35.09 71.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.638 0.775 . . . . 75.43 111.525 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.89 -50.09 32.29 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 110.232 -0.285 . . . . 75.13 110.232 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 8' ' ' LEU . 69.6 mt -55.31 -46.86 76.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.489 1.116 . . . . 73.53 113.65 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -87.76 -4.08 58.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.486 0.921 . . . . 55.42 113.486 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.59 -59.84 2.16 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.383 0.611 . . . . 73.54 110.3 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.26 139.09 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 73.43 110.775 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -64.92 -47.24 78.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.633 0.773 . . . . 74.43 112.408 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.85 148.15 24.74 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -93.33 143.58 26.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.748 0.309 . . . . 71.54 110.721 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.58 3.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.361 0.664 . . . . 61.23 111.485 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -137.11 1.59 2.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.043 0.756 . . . . 71.4 113.043 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.556 HD12 HD21 ' A' ' 7' ' ' LEU . 11.0 mm -108.7 107.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 118.78 0.718 . . . . 74.31 110.483 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -94.2 113.81 25.81 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.46 -0.775 . . . . 75.04 110.881 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.09 129.12 35.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.277 0.631 . . . . 73.14 109.919 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -133.82 164.59 26.91 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.721 0.772 . . . . 74.23 111.892 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -101.42 177.73 4.84 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.662 -1.154 . . . . 75.12 110.945 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.06 62.65 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 74.21 111.467 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 p -65.67 -29.9 70.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 54.22 112.274 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.08 -17.01 62.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.164 0.801 . . . . 72.54 113.164 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.404 ' SD ' HG12 ' A' ' 77' ' ' VAL . 92.0 mmm -55.52 107.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.706 0.802 . . . . 74.32 112.111 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.92 -125.38 2.94 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.279 -0.873 . . . . 72.4 111.158 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.294 0.638 . . . . 74.13 112.371 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 m -68.18 -45.32 73.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.48 0.712 . . . . 54.42 111.884 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.47 -52.71 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.822 0.449 . . . . 73.32 110.222 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.473 ' SD ' HD23 ' A' ' 89' ' ' LEU . 39.8 tpp -52.66 -46.52 67.2 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.283 1.033 . . . . 74.03 113.745 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.54 -27.87 64.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.163 0.585 . . . . 74.0 111.914 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.6 m -69.48 -39.3 77.74 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.133 0.573 . . . . 61.15 111.029 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.39 -35.51 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 123.001 0.521 . . . . 73.31 110.756 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 33' ' ' MET . 47.9 mm -57.56 -39.1 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.629 0.772 . . . . 75.44 110.929 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.98 82.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.77 -0.65 . . . . 75.51 112.035 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.4 -38.87 40.62 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.113 0.565 . . . . 72.4 112.204 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.434 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . -63.76 -42.41 97.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.298 0.639 . . . . 65.32 111.939 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -90.61 7.22 40.34 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.203 0.601 . . . . 55.01 112.154 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.51 116.05 65.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.416 -0.587 . . . . 73.35 109.416 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.5 111.19 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.264 2.643 . . . . 74.4 115.412 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 25.39 64.59 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.855 1.502 . . . . 52.04 116.855 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -101.06 23.37 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.816 1.308 . . . . 74.2 111.604 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.8 p-10 -46.64 124.85 6.43 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.314 0.645 . . . . 73.41 111.535 167.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.3 -12.68 7.97 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.949 -0.569 . . . . 74.54 112.176 -165.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.15 104.54 0.17 Allowed Glycine 0 CA--C 1.548 2.114 0 N-CA-C 112.259 -0.336 . . . . 72.24 112.259 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.31 132.53 51.39 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.696 0.798 . . . . 74.03 111.405 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.3 mp -106.32 118.84 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.952 0.901 . . . . 74.24 108.634 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.42 106.74 17.33 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.956 -0.387 . . . . 75.34 109.956 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 4.2 mm? -93.01 133.41 36.18 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.736 0.814 . . . . 74.21 111.535 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 33.85 4.71 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 115.697 -0.683 . . . . 62.03 112.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.19 139.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.199 0.6 . . . . 74.3 109.859 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 19.7 t70 -105.63 159.25 16.11 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.128 -1.434 . . . . 74.14 107.128 171.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -148.02 141.11 24.96 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.283 0.563 . . . . 73.32 111.331 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.5 142.03 46.91 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.703 0.801 . . . . 74.03 110.934 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mm -80.31 123.89 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.728 0.811 . . . . 74.1 110.402 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 63' ' ' ASP . 37.6 p30 -82.53 -175.95 5.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.494 0.318 . . . . 72.43 111.642 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.27 -31.42 69.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.877 0.871 . . . . 72.31 113.267 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -81.04 -31.21 34.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.186 0.594 . . . . 73.14 111.483 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.03 9.94 11.54 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 114.389 0.515 . . . . 75.22 114.389 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' HD22 ' A' ' 59' ' ' ASN . 27.8 m-20 -85.74 147.66 26.23 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.533 0.733 . . . . 75.32 112.298 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -86.64 109.83 19.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.669 0.787 . . . . 74.31 110.868 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.98 123.56 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.465 0.706 . . . . 72.23 110.144 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.33 114.32 26.36 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.585 0.707 . . . . 73.13 111.651 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.423 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -117.05 109.95 42.13 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.146 1.379 . . . . 74.21 110.32 -177.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.83 106.42 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.268 1.979 . . . . 75.12 112.359 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.43 -8.47 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.099 0.559 . . . . 74.2 112.505 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.9 -174.14 53.77 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.687 0.635 . . . . 73.43 114.687 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 56.0 mt -119.92 124.59 27.81 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.778 1.231 . . . . 72.42 109.069 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.17 -39.1 71.86 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.601 2.2 . . . . 74.43 112.867 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.18 77.0 42.47 Favored Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 123.511 0.724 . . . . 62.34 109.605 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 99' ' ' LEU . 71.8 Cg_endo -73.43 -37.8 2.98 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.76 2.306 . . . . 74.11 114.347 -168.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HA ' HD13 ' A' ' 99' ' ' LEU . 20.3 t70 -66.36 -37.77 86.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.724 0.41 . . . . 74.23 109.915 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.28 -39.02 92.01 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 116.087 -0.506 . . . . 72.24 111.798 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG12 ' SD ' ' A' ' 28' ' ' MET . 76.6 t -57.05 -40.72 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.727 0.411 . . . . 73.31 110.612 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -64.35 -43.11 95.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.734 0.814 . . . . 63.31 112.567 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 22.8 mmt180 -69.77 -48.29 59.8 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.711 0.405 . . . . 75.14 111.479 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.53 -33.75 75.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.664 1.186 . . . . 74.13 111.788 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 97' ' ' MET . 14.5 tp -71.5 -42.99 67.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.58 0.352 . . . . 71.52 111.272 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.46 78.46 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.849 0.46 . . . . 74.21 111.568 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 t -66.22 -52.24 49.8 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.641 0.776 . . . . 74.01 111.156 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' MET . 10.8 pt20 -67.71 -34.63 77.26 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 116.459 -0.337 . . . . 75.15 111.797 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.436 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 69.6 m -65.37 -19.6 66.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.993 -1.067 . . . . 73.42 112.78 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.94 -42.67 11.67 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.524 0.73 . . . . 63.11 112.111 169.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 t -85.06 -21.08 29.52 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.802 1.038 . . . . 71.41 113.802 -170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -90.52 -36.6 14.4 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.473 1.109 . . . . 75.24 110.102 -173.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.473 HD23 ' SD ' ' A' ' 33' ' ' MET . 68.0 mt -95.72 147.28 23.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.421 -1.263 . . . . 73.44 110.281 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -56.17 -28.35 57.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.943 0.897 . . . . 74.13 112.781 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 119' ' ' HIS . 27.7 m -124.28 159.87 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.879 0.872 . . . . 74.35 110.91 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.11 99.4 3.93 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.052 0.541 . . . . 71.02 111.449 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tt -94.38 123.38 37.75 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.733 -1.21 . . . . 75.13 107.733 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -108.43 96.03 17.83 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 123.191 0.597 . . . . 72.53 110.51 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.84 158.05 59.42 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.529 2.153 . . . . 74.41 112.761 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.1 tp10 -85.53 107.35 17.43 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.09 -0.707 . . . . 73.34 109.09 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.54 ' HB3' HD12 ' A' ' 108' ' ' LEU . 65.0 mtm -122.24 130.95 53.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.309 0.644 . . . . 73.31 111.321 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.419 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 14.1 tm0? -146.04 143.83 29.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.481 0.712 . . . . 73.44 110.904 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 75' ' ' ASP . 94.6 mt -92.04 114.08 26.53 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.327 1.051 . . . . 60.04 112.031 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -102.16 124.86 48.5 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.399 1.08 . . . . 71.22 112.173 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.491 HE21 HG22 ' A' ' 106' ' ' THR . 1.8 mp0 -91.58 104.06 16.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.003 0.43 . . . . 74.32 110.105 172.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 4' ' ' ALA . 56.3 t -137.31 131.58 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.521 1.129 . . . . 72.5 110.244 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.73 65.36 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 115.456 0.943 . . . . 72.55 115.456 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.52 4.77 90.32 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 117.091 0.445 . . . . 74.3 113.137 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -115.18 165.76 12.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.299 1.04 . . . . 71.31 110.358 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.491 HG22 HE21 ' A' ' 101' ' ' GLN . 91.7 m -120.43 131.22 54.68 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 120.857 0.36 . . . . 75.33 110.585 171.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.39 170.44 10.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.405 1.082 . . . . 72.21 109.474 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 97' ' ' MET . 46.6 tp -120.06 111.31 17.72 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.975 -0.38 . . . . 74.44 109.975 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.55 HG12 HD13 ' A' ' 7' ' ' LEU . 92.6 t -83.95 120.1 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.332 -0.618 . . . . 70.22 109.332 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' HG2' ' A' ' 97' ' ' MET . 60.8 t -114.04 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.401 0.619 . . . . 72.23 110.948 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 75.7 t80 -78.12 125.83 29.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.979 0.912 . . . . 73.3 109.591 168.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.68 106.5 33.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.478 -0.934 . . . . 74.21 108.478 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.12 148.63 27.62 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.01 1.806 . . . . 72.23 110.852 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 36.8 tt0 -75.45 133.91 41.0 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.282 -1.007 . . . . 71.51 108.282 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.66 178.8 8.02 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.278 0.631 . . . . 74.32 110.89 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.2 176.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 122.967 0.507 . . . . 74.52 111.214 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.28 -41.92 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 O-C-N 121.004 -1.06 . . . . 73.35 113.349 166.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -69.3 -44.03 72.6 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 118.492 0.587 . . . . 73.55 111.193 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 21.2 m-70 -118.32 90.15 3.27 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 101.751 -3.426 . . . . 75.11 101.751 163.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 91.6 mttt -51.93 -144.49 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.048 2 C-N-CA 133.335 4.654 . . . . 74.43 122.017 45.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo 10.02 70.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 123.448 2.765 . . . . 75.3 116.805 -119.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.646 HG13 ' HA ' ' A' ' 120' ' ' LYS . 57.6 mt -102.32 131.73 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.015 -1.448 . . . . 73.45 109.492 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -155.74 162.56 40.51 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.015 0.926 . . . . 72.43 110.954 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt . . . . . 0 CA--C 1.554 1.116 0 CA-C-N 115.146 -0.934 . . . . 74.35 110.587 174.053 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.53 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 19.4 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 119.595 -0.24 . . . . 72.54 110.509 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -40.31 118.86 0.97 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.019 0.928 . . . . 73.15 112.66 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.5 m -58.1 157.63 7.88 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.105 1.362 . . . . 75.12 114.544 -171.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -61.01 -44.95 96.66 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.546 0.738 . . . . 51.22 111.817 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 102' ' ' VAL . 2.6 m -62.88 -35.55 80.37 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-N 114.711 -1.131 . . . . 75.21 110.601 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.22 -48.23 71.27 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.025 0.93 . . . . 74.53 111.753 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.569 HD23 HD11 ' A' ' 20' ' ' ILE . 35.6 mt -65.01 -36.51 84.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.624 0.37 . . . . 74.4 111.039 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.265 0.626 . . . . 74.4 110.795 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.91 -33.92 76.95 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.504 0.722 . . . . 73.23 111.277 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.11 -41.94 85.36 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.44 0.696 . . . . 71.23 110.504 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 72.9 mt -64.47 -34.69 78.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.894 0.878 . . . . 75.43 111.363 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -80.35 -20.86 43.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.56 0.744 . . . . 74.23 112.253 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.78 -55.26 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.247 0.619 . . . . 72.34 110.46 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.4 141.73 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.738 -0.665 . . . . 72.12 110.059 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.54 -45.99 64.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.826 -0.546 . . . . 74.21 111.184 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.62 128.0 56.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.033 0.933 . . . . 73.41 109.896 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 m -36.13 108.64 0.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.411 1.484 . . . . 74.02 114.085 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.46 -7.93 59.46 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.159 0.8 . . . . 63.54 113.159 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -165.9 -34.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.011 0.524 . . . . 75.32 111.35 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.569 HD11 HD23 ' A' ' 7' ' ' LEU . 55.5 mt -97.15 105.4 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.935 -0.765 . . . . 70.22 108.935 -167.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.03 113.15 24.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.083 -1.08 . . . . 64.41 108.083 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.81 145.83 40.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.808 0.843 . . . . 72.0 110.41 -171.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 160.96 42.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.798 0.808 . . . . 74.22 113.124 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -75.77 166.21 23.87 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 114.194 -1.366 . . . . 71.54 111.717 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.47 -33.3 43.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.224 1.01 . . . . 75.41 113.604 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.6 m -66.68 -30.48 70.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.936 0.894 . . . . 73.51 113.126 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.78 -6.23 58.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.888 0.699 . . . . 74.25 112.888 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mmm -52.79 108.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.14 0.576 . . . . 75.31 112.142 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.66 -123.62 1.53 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.51 -0.768 . . . . 73.53 112.417 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -57.58 -55.33 36.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.991 1.108 . . . . 75.32 113.991 -168.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -60.61 -40.47 91.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.149 0.579 . . . . 72.55 112.462 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.39 -42.22 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.045 0.538 . . . . 74.4 111.417 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.433 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 54.6 mmm -78.63 -33.83 46.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.112 -0.495 . . . . 75.23 111.713 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.002 0.921 . . . . 73.32 111.387 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.469 ' HB ' HD23 ' A' ' 50' ' ' LEU . 43.7 m -72.97 -36.45 67.11 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.692 0.797 . . . . 73.34 111.699 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.96 -37.58 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.331 0.652 . . . . 73.44 111.184 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 122' ' ' ILE . 84.7 mt -57.2 -41.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.83 0.852 . . . . 54.4 111.383 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -64.74 -48.55 74.17 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.451 0.7 . . . . 60.35 112.033 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -67.05 -37.59 84.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.187 0.595 . . . . 62.25 111.868 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . . . -67.5 -34.77 77.81 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.117 0.567 . . . . 72.3 111.553 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -71.59 -41.76 68.58 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.827 0.851 . . . . 72.21 111.716 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 13.6 mm-40 -72.91 128.7 87.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 123.157 0.583 . . . . 75.31 112.148 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -87.73 118.98 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.11 2.54 . . . . 75.22 112.929 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.09 14.99 58.31 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 115.066 0.786 . . . . 72.01 115.066 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.27 23.55 13.54 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 118.774 1.287 . . . . 74.31 110.966 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -40.37 132.81 1.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.827 0.851 . . . . 72.14 112.613 165.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.35 14.44 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.447 -0.661 . . . . 53.24 111.447 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.74 100.25 0.11 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.052 0.834 . . . . 40.25 113.835 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -116.88 144.71 44.2 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.54 0.686 . . . . 74.22 112.532 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.469 HD23 ' HB ' ' A' ' 35' ' ' THR . 5.7 mp -119.25 131.3 55.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.926 1.291 . . . . 72.34 108.167 165.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 7' ' ' LEU . 29.7 tp -110.9 111.99 23.51 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.027 0.442 . . . . 74.44 110.878 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 3.9 mm? -89.12 133.43 34.39 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.927 0.891 . . . . 73.23 111.416 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 34.11 5.37 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.9 -0.591 . . . . 51.25 112.609 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.1 137.21 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.29 0.636 . . . . 75.32 110.47 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -130.03 130.65 45.23 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.503 -0.925 . . . . 73.55 108.503 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -116.77 138.27 51.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.538 0.735 . . . . 73.01 110.892 -174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.37 141.84 47.0 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.358 0.663 . . . . 75.11 110.891 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.52 133.8 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.994 0.918 . . . . 74.21 111.072 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -87.15 -173.73 4.56 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.019 0.527 . . . . 75.13 111.889 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.99 -25.58 67.92 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 113.45 0.907 . . . . 72.42 113.45 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -82.64 -30.43 29.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.212 0.46 . . . . 65.42 110.942 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.36 11.98 8.46 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 114.675 0.63 . . . . 55.14 114.675 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.85 117.69 19.45 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.342 0.657 . . . . 70.5 111.654 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -79.62 107.97 12.8 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.555 0.742 . . . . 74.42 109.852 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.21 123.59 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.491 0.716 . . . . 74.22 110.301 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.1 124.15 37.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.984 0.914 . . . . 74.32 110.517 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -121.93 149.26 53.35 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 124.227 1.011 . . . . 74.31 111.755 -172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.01 102.81 1.4 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.504 2.136 . . . . 74.12 112.748 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.24 -24.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.816 -0.629 . . . . 74.51 110.901 170.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.23 -169.23 54.87 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.716 -0.674 . . . . 65.43 114.216 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.0 mt -115.53 124.38 30.1 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.074 0.95 . . . . 75.55 109.464 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.83 -27.53 80.54 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.787 2.324 . . . . 75.43 113.125 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.1 p-10 -131.45 63.05 68.28 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 123.834 0.854 . . . . 73.23 111.501 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.84 -31.14 32.35 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.699 2.266 . . . . 65.42 113.345 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.38 -37.27 85.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.249 1.019 . . . . 75.44 111.157 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HZ3' ' HB3' ' A' ' 76' ' ' LYS . 8.4 mtpm? -72.31 -54.77 8.54 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.82 -0.627 . . . . 73.51 110.723 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 73' ' ' ASP . 87.4 t -52.24 -38.13 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.395 1.078 . . . . 74.11 112.838 -167.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.431 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 53.1 tt0 -62.41 -47.26 84.88 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.472 0.709 . . . . 74.22 111.961 174.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.02 -48.28 53.97 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.964 0.905 . . . . 75.22 112.529 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.34 -37.08 66.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.527 1.131 . . . . 73.12 111.461 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.9 -41.83 86.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.398 0.679 . . . . 73.11 111.553 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.08 75.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.185 0.594 . . . . 73.23 112.122 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.4 t -69.92 -52.92 20.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.433 0.693 . . . . 75.23 111.447 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.63 -27.98 69.3 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.937 0.495 . . . . 73.23 111.553 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 93' ' ' LEU . 17.2 t -61.04 -30.1 70.12 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.322 0.649 . . . . 62.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.21 -25.56 29.39 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 113.259 0.837 . . . . 74.05 113.259 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -98.68 -33.91 10.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.627 0.973 . . . . 75.1 113.627 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.0 mmm -88.12 -35.79 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.945 0.898 . . . . 75.43 111.781 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -95.76 148.72 22.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.316 0.647 . . . . 75.53 111.048 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -42.18 -51.19 4.75 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 125.292 1.437 . . . . 72.01 112.766 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 122' ' ' ILE . 32.8 m -111.0 156.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.019 -0.537 . . . . 73.53 110.613 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.82 117.57 14.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.02 -0.536 . . . . 73.05 109.611 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.9 mt -111.0 142.66 42.84 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.581 0.753 . . . . 62.53 110.895 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.1 82.25 11.08 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.031 0.932 . . . . 74.22 108.825 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.22 161.54 42.49 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.423 2.082 . . . . 73.25 113.28 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.0 tp10 -77.31 127.91 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.416 -0.811 . . . . 74.21 109.031 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.431 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 65.7 mtt -136.14 140.25 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.075 0.55 . . . . 73.33 111.407 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -144.65 151.9 39.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.522 0.729 . . . . 73.23 110.786 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.8 mt -115.13 132.75 56.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.777 0.831 . . . . 73.53 110.695 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.31 149.52 47.12 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.394 0.678 . . . . 71.22 111.102 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -94.97 124.91 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.172 -0.677 . . . . 73.53 109.172 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 5' ' ' THR . 21.4 t -121.34 114.37 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 107.581 -1.266 . . . . 72.23 107.581 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.36 26.63 51.56 Favored Glycine 0 CA--C 1.548 2.108 0 N-CA-C 114.614 0.606 . . . . 75.15 114.614 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.94 60.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 114.681 0.632 . . . . 70.0 114.681 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -119.74 129.58 54.57 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.748 0.774 . . . . 74.32 109.73 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 m -85.27 104.35 15.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.746 0.703 . . . . 71.3 112.37 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.6 mp -86.98 160.53 18.62 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.298 1.039 . . . . 74.15 111.456 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 62.0 tp -114.96 131.32 56.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.474 0.71 . . . . 75.25 110.303 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.454 HG13 ' HE1' ' A' ' 1' ' ' MET . 2.5 t -98.58 122.41 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.464 1.105 . . . . 74.34 108.719 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.92 110.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 118.084 0.402 . . . . 72.22 110.927 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 60.2 t80 -94.54 132.43 39.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.222 -0.659 . . . . 75.34 109.222 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.51 105.12 23.8 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.487 -0.931 . . . . 75.33 108.487 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.78 122.3 9.88 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.033 1.822 . . . . 64.34 109.27 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -64.76 134.61 54.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.445 0.698 . . . . 73.31 111.102 -168.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 40' ' ' ALA . . . -55.86 129.63 40.3 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.226 0.61 . . . . 75.3 112.38 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.576 ' HB3' HG23 ' A' ' 118' ' ' THR . 36.2 t70 -86.85 168.84 13.07 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.072 0.949 . . . . 73.11 110.314 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.503 ' HA ' ' HG2' ' A' ' 120' ' ' LYS . 22.8 t -56.44 -22.19 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 124.401 1.081 . . . . 74.33 112.507 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 116' ' ' ASP . 9.2 t -55.87 -23.86 33.52 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.745 0.818 . . . . 74.23 111.723 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 56.1 m-70 -87.24 -89.28 0.13 Allowed 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 106.206 -1.775 . . . . 73.5 106.206 166.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 29.0 mmmt -59.46 -148.62 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.164 0 CA-C-N 124.838 3.472 . . . . 74.53 113.035 -49.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -0.68 120.94 0.0 OUTLIER 'Trans proline' 1 C--N 1.416 4.093 1 C-N-CA 126.182 4.588 . . . . 74.44 119.917 -139.132 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 91' ' ' VAL . 41.1 mm -96.62 91.91 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.299 -0.864 . . . . 73.1 108.86 171.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -81.82 162.22 22.93 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.726 0.298 . . . . 74.22 111.33 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? . . . . . 0 CA--C 1.557 1.225 0 N-CA-C 108.384 -0.969 . . . . 71.03 108.384 173.106 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 111.508 0.188 . . . . 73.43 111.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HG3' ' HH ' ' A' ' 49' ' ' TYR . 91.5 mtt180 -86.89 -169.48 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.512 0.725 . . . . 71.35 110.431 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -82.95 150.49 26.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 122.047 -0.408 . . . . 73.12 109.908 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.53 70.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.344 0.498 . . . . 75.41 112.344 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.6 p -62.38 -47.72 82.91 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.606 0.762 . . . . 75.11 111.172 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.14 -42.18 98.07 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 121.716 0.769 . . . . 75.31 111.07 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.19 -39.79 93.33 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.651 -1.159 . . . . 72.31 111.628 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.64 -34.57 78.13 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.41 -0.813 . . . . 70.25 111.124 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.23 -41.65 85.35 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.062 0.545 . . . . 74.14 111.414 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.36 -39.69 94.39 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 122.517 0.327 . . . . 71.55 110.642 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.46 -50.96 69.38 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.157 0.983 . . . . 73.04 112.739 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.01 -12.53 61.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.016 0.747 . . . . 74.21 113.016 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.13 -42.76 30.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.489 0.716 . . . . 73.13 111.021 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -98.01 161.17 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.025 0.917 . . . . 70.43 112.602 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -106.52 0.85 24.97 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.88 -1.055 . . . . 74.05 110.788 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.39 130.18 22.96 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.202 1.001 . . . . 71.01 110.113 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m -80.29 85.91 5.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.1 0.56 . . . . 75.41 110.775 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.24 -63.95 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.343 1.057 . . . . 64.12 112.731 -174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtp-105 -102.09 -5.12 24.87 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.645 0.778 . . . . 75.31 111.478 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.9 mm -104.53 167.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.62 115.02 3.89 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.293 -1.002 . . . . 70.34 108.293 167.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.42 32.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.17 0.588 . . . . 63.21 111.442 -171.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.744 ' HZ1' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -152.46 158.21 42.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.041 0.924 . . . . 61.05 112.774 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -77.06 163.77 26.34 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 113.806 -1.543 . . . . 73.53 111.331 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.64 74.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.495 0.554 . . . . 75.4 112.495 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -76.66 -13.75 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.374 0.67 . . . . 71.21 112.559 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 18.8 t70 -85.24 -5.69 59.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.234 0.613 . . . . 64.53 111.957 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.587 ' SD ' HG13 ' A' ' 77' ' ' VAL . 82.8 mtp -57.08 113.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 72.31 112.0 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.4 -155.23 10.52 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.225 -0.443 . . . . 64.15 113.531 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -73.9 -25.32 59.95 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.383 1.073 . . . . 75.12 111.442 -174.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.4 p -65.17 -48.1 74.66 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.078 0.951 . . . . 74.24 111.699 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG23 ' HE3' ' A' ' 23' ' ' LYS . 60.0 t -58.2 -40.58 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.845 0.858 . . . . 75.04 110.819 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 89' ' ' LEU . 40.1 tpp -71.46 -32.56 68.45 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.92 -1.036 . . . . 74.45 112.253 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.93 -37.73 84.86 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.535 0.734 . . . . 72.12 111.285 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 21' ' ' GLU . 17.8 m -69.8 -32.43 70.89 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 73.42 112.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.39 -37.14 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.023 0.929 . . . . 74.53 112.075 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.16 -41.06 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.028 0.931 . . . . 64.41 111.911 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.92 68.03 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.901 0.881 . . . . 72.24 112.217 -171.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -61.46 -22.23 64.87 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.806 0.842 . . . . 75.1 112.999 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.99 -26.49 59.61 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.238 0.615 . . . . 65.42 112.055 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -117.65 5.38 12.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.945 1.091 . . . . 74.22 113.945 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -58.58 117.15 18.36 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 118.748 0.704 . . . . 71.45 112.507 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.3 102.07 0.18 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.293 2.662 . . . . 75.21 113.802 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.5 9.93 59.34 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.134 1.214 . . . . 62.13 116.134 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.0 tp -115.62 -64.6 1.29 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.383 1.092 . . . . 74.52 110.965 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 37.71 -157.47 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 125.931 1.692 . . . . 74.43 114.919 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.81 58.71 7.92 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.69 -0.232 . . . . 61.1 113.501 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.21 157.39 17.8 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 112.375 -0.29 . . . . 64.12 112.375 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.404 ' HH ' ' HG3' ' A' ' 2' ' ' ARG . 90.5 m-85 -124.36 126.13 45.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.824 0.45 . . . . 74.45 111.064 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -98.92 118.17 35.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.596 -0.89 . . . . 73.11 108.596 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.42 109.01 21.15 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.719 -0.474 . . . . 75.34 109.719 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.4 128.5 46.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.254 1.022 . . . . 72.3 109.777 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.9 28.27 7.89 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 115.959 -0.564 . . . . 65.12 112.401 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.1 t -113.27 145.65 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.726 0.81 . . . . 60.13 110.699 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -121.89 151.62 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.451 1.1 . . . . 74.42 108.375 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.6 p90 -126.39 125.76 42.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.261 0.624 . . . . 75.23 109.611 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.22 140.51 51.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.655 0.782 . . . . 72.44 111.144 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.49 129.6 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.553 0.741 . . . . 71.03 111.087 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 87.3 m-20 -78.97 176.56 9.53 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.706 0.802 . . . . 71.52 112.407 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.5 -31.08 69.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.021 0.528 . . . . 74.05 111.789 170.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.73 -17.69 40.4 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.557 0.743 . . . . 71.42 111.089 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.26 34.72 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 114.818 0.687 . . . . 71.02 114.818 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.9 m-20 -79.81 147.35 31.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 117.604 0.702 . . . . 75.1 111.878 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 117.16 29.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.315 0.646 . . . . 73.22 110.528 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 59.8 t -110.86 122.26 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.725 0.81 . . . . 72.24 110.532 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -92.47 124.85 36.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.357 0.663 . . . . 73.22 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -132.35 141.0 39.7 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.995 0.918 . . . . 75.54 111.011 -171.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.35 76.92 4.28 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.916 2.41 . . . . 71.33 113.138 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.61 -18.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 115.923 -0.58 . . . . 74.12 112.399 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.81 49.35 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.427 0.531 . . . . 70.04 114.427 168.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 77' ' ' VAL . 83.0 mt -97.71 132.02 25.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.425 1.09 . . . . 72.43 110.189 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.0 -36.14 23.38 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.074 1.849 . . . . 75.13 111.535 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -123.13 81.3 51.6 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 123.754 0.822 . . . . 71.22 109.876 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.89 -57.23 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.416 2.744 . . . . 70.41 114.57 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.7 -42.53 95.23 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.96 0.504 . . . . 64.24 111.224 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -59.26 -40.88 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.428 0.455 . . . . 73.43 111.656 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.587 HG13 ' SD ' ' A' ' 28' ' ' MET . 46.7 t -60.98 -43.29 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.23 0.612 . . . . 74.55 111.549 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.45 -42.58 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.274 0.472 . . . . 73.3 112.274 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -75.85 -42.57 49.1 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 112.69 0.626 . . . . 64.43 112.69 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 -37.36 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.594 0.757 . . . . 65.54 111.709 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.31 -40.2 74.34 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.559 0.344 . . . . 72.11 110.955 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.09 73.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.483 0.713 . . . . 75.04 112.294 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 t -73.75 -53.23 10.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.255 0.622 . . . . 73.42 111.611 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.44 -31.56 72.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 112.722 0.638 . . . . 75.53 112.722 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.8 p -67.22 -29.72 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.512 0.325 . . . . 74.33 111.711 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.71 -25.66 59.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.277 0.631 . . . . 75.3 111.999 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.9 m -90.58 -44.85 9.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.364 0.666 . . . . 55.14 112.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.93 -34.73 19.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.544 0.737 . . . . 74.21 112.727 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 33' ' ' MET . 70.7 mt -88.96 142.7 27.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 122.162 -0.336 . . . . 74.33 110.769 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -36.1 -58.96 0.64 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.88 1.672 . . . . 75.14 113.583 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 119' ' ' HIS . 13.9 m -102.31 168.75 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.334 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.87 1.47 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.609 -0.885 . . . . 73.52 108.609 168.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 122' ' ' ILE . 1.5 tt -102.17 106.67 17.56 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.799 -0.815 . . . . 75.21 108.799 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -96.2 103.71 14.67 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 108.798 -0.815 . . . . 72.13 108.798 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -68.45 172.95 10.47 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 121.531 1.487 . . . . 75.54 111.492 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 86.1 tt0 -86.86 107.49 18.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.732 -1.581 . . . . 74.12 106.732 172.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.598 ' HB3' HD12 ' A' ' 108' ' ' LEU . 76.8 mtm -119.29 117.33 28.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.771 0.428 . . . . 71.53 111.234 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -120.17 131.82 55.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.878 0.871 . . . . 74.53 110.805 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.26 112.02 20.99 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.683 0.793 . . . . 74.01 109.446 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.38 128.64 55.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.494 1.118 . . . . 74.43 111.427 -167.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.66 110.22 22.34 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.879 0.472 . . . . 72.43 110.813 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.7 116.29 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.828 1.251 . . . . 72.25 108.42 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.89 30.19 62.89 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 114.768 0.667 . . . . 70.42 114.768 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.95 89.32 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 114.254 0.462 . . . . 54.21 114.254 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -102.8 129.76 49.57 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.708 0.803 . . . . 72.53 109.709 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.7 m -94.34 126.73 39.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.891 0.769 . . . . 75.53 110.76 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.57 170.47 9.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.393 1.077 . . . . 72.41 109.259 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 97' ' ' MET . 43.9 tp -115.95 118.9 34.23 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.089 -0.338 . . . . 73.14 110.089 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.18 124.71 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.009 -0.737 . . . . 72.42 109.009 169.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 42.8 t -109.76 99.86 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.186 0.517 . . . . 75.35 109.67 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 25.9 t80 -85.5 119.75 26.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.571 . . . . 74.35 109.88 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.21 95.32 45.87 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 108.357 -0.979 . . . . 73.43 108.357 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.51 -177.33 3.56 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.294 1.996 . . . . 73.23 111.766 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.15 137.82 33.91 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.098 -0.705 . . . . 75.34 109.098 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.87 179.92 4.64 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.829 0.852 . . . . 73.32 111.257 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.69 135.95 43.72 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-O 118.314 -0.85 . . . . 75.4 108.95 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.9 t -46.88 -26.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.402 1.63 . . . . 75.23 115.402 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -66.43 -49.47 66.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.685 -0.634 . . . . 74.24 111.039 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.588 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 1.6 m-70 -128.43 68.76 1.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.925 -2.621 . . . . 72.34 103.925 168.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 57.3 mtpt -46.82 -153.03 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.428 1 C-N-CA 133.332 4.653 . . . . 74.52 121.155 55.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo 4.77 67.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 123.277 2.652 . . . . 72.42 117.142 -124.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.589 HG21 HD13 ' A' ' 93' ' ' LEU . 53.0 mt -98.35 127.9 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.981 -1.009 . . . . 73.02 109.258 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.49 146.43 38.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 74.24 109.498 -175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.66 ' HZ3' ' HB3' ' A' ' 124' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 108.533 -0.914 . . . . 73.12 108.533 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.179 -1.045 . . . . 73.45 108.179 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -82.98 159.61 22.19 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.336 0.655 . . . . 75.41 112.183 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m -81.43 156.5 25.35 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.817 0.673 . . . . 74.14 112.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.88 94.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.782 0.833 . . . . 62.43 112.078 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -62.09 -46.87 87.15 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.576 -0.738 . . . . 75.33 110.639 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.21 -47.2 87.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.918 -1.037 . . . . 72.21 111.911 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.35 -36.79 85.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.172 0.589 . . . . 72.45 111.755 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.589 HD23 ' HD3' ' A' ' 68' ' ' PRO . 28.1 tp -65.05 -48.49 73.63 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.017 0.527 . . . . 74.42 111.212 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -63.7 -35.69 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.091 0.556 . . . . 62.52 111.846 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -63.32 -45.87 89.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.487 0.715 . . . . 75.22 111.229 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 22' ' ' ALA . 41.8 mt -59.8 -39.63 85.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.955 0.902 . . . . 75.33 111.069 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -65.26 -34.45 78.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.809 0.844 . . . . 73.21 112.133 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.46 -41.91 72.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.629 0.771 . . . . 73.32 112.187 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -114.84 118.35 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-O 121.653 0.74 . . . . 75.24 112.37 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.64 -9.9 16.09 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.73 1.212 . . . . 73.24 113.574 172.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.32 117.07 23.68 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.7 -0.625 . . . . 74.5 110.36 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.9 p -78.17 91.72 4.37 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.631 0.773 . . . . 70.31 111.493 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.67 -59.52 5.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.633 0.773 . . . . 73.33 111.732 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.564 HH21 ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.42 26.04 1.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.043 0.537 . . . . 70.13 111.693 170.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.24 109.61 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.407 -0.96 . . . . 73.04 108.407 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.07 130.07 49.22 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 120.93 0.395 . . . . 74.25 111.129 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -84.69 143.3 29.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.595 0.758 . . . . 63.35 111.773 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 74.5 mmtt -129.26 145.76 51.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.965 0.906 . . . . 74.52 109.565 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.95 161.49 24.29 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.239 0.616 . . . . 75.33 111.084 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 -36.95 85.55 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.091 0.556 . . . . 72.53 111.703 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 -18.99 61.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.605 0.762 . . . . 71.11 112.584 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.82 -7.12 57.56 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.38 0.672 . . . . 73.43 112.712 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.528 ' SD ' HG13 ' A' ' 77' ' ' VAL . 34.3 mtp -55.9 124.27 17.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.446 0.906 . . . . 54.41 113.446 -176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.23 -144.91 15.16 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.366 -0.833 . . . . 75.32 111.758 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -59.57 -26.85 65.74 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.137 0.975 . . . . 73.11 113.544 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.0 m -73.52 -27.23 61.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.303 0.641 . . . . 74.35 112.26 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 46.3 t -74.66 -48.94 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 121.244 0.545 . . . . 74.14 110.436 166.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.73 -34.45 67.52 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.322 1.23 . . . . 75.51 114.322 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.63 -41.76 82.01 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.14 0.576 . . . . 73.35 111.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -78.14 -27.67 48.24 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.289 0.636 . . . . 75.32 111.712 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.64 -45.54 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.626 0.77 . . . . 74.32 110.604 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -51.85 -44.02 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.778 1.231 . . . . 71.43 112.111 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.54 89.47 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.341 0.656 . . . . 71.45 112.75 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.63 -35.64 70.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.904 0.705 . . . . 73.13 112.904 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.2 55.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.163 0.585 . . . . 75.11 112.444 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -103.99 -48.33 3.93 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.733 1.012 . . . . 73.31 113.733 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.1 121.09 76.72 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.39 111.73 0.91 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.294 2.662 . . . . 75.31 113.626 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.89 -11.16 29.68 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.34 -0.845 . . . . 71.45 114.633 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.564 ' HG ' HH21 ' A' ' 19' ' ' ARG . 6.5 mp -94.64 -1.18 53.65 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.574 1.687 . . . . 75.0 110.991 173.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.71 ' HB3' ' HB3' ' A' ' 114' ' ' GLU . 10.0 m-20 -34.53 102.31 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.527 1.931 . . . . 73.13 114.371 174.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.95 0.82 Allowed Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.87 -0.605 . . . . 73.51 112.866 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.94 172.52 47.96 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 113.981 0.352 . . . . 65.54 113.981 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.38 147.16 52.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.765 0.826 . . . . 75.14 112.635 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.1 mt -129.4 124.7 34.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 74.4 108.552 172.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.59 109.21 20.8 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 122.111 -0.368 . . . . 74.04 110.138 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.628 HD12 HD22 ' A' ' 108' ' ' LEU . 56.6 mt -88.96 129.44 35.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.151 0.58 . . . . 64.41 110.964 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.48 30.36 5.0 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.195 -0.457 . . . . 73.53 112.482 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 48.3 t -116.3 139.52 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.374 0.67 . . . . 65.25 110.631 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.66 131.71 31.88 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.302 -1.369 . . . . 75.55 107.302 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -115.68 140.62 49.02 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.128 0.49 . . . . 75.34 112.282 -171.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.48 141.63 48.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 75.11 110.404 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.8 mt -101.91 133.67 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.595 0.758 . . . . 72.35 111.422 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -74.81 169.37 18.03 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.186 0.994 . . . . 64.45 111.882 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.91 -33.98 75.23 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.393 0.677 . . . . 75.15 111.231 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -71.03 -27.64 63.82 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.483 0.713 . . . . 73.4 111.683 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.47 41.14 2.24 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 116.302 -0.408 . . . . 72.41 113.08 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -100.29 121.63 41.79 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.325 0.65 . . . . 71.21 109.876 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -84.7 108.48 17.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.139 0.575 . . . . 73.53 110.574 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -100.43 112.61 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.492 1.117 . . . . 75.31 109.76 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -89.22 115.0 26.39 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.583 -0.525 . . . . 75.12 109.583 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -115.85 134.49 22.71 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.783 0.833 . . . . 73.43 111.19 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.589 ' HD3' HD23 ' A' ' 8' ' ' LEU . 88.3 Cg_endo -75.8 86.86 1.45 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.779 2.319 . . . . 75.12 112.634 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.33 -26.21 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.997 -0.547 . . . . 63.4 111.422 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 82.54 -176.16 53.52 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.115 0.806 . . . . 73.31 115.115 172.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -113.91 116.2 45.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.404 1.082 . . . . 75.52 109.988 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.56 -33.33 96.36 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.711 2.274 . . . . 75.04 112.665 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.57 75.82 78.37 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.852 0.861 . . . . 72.23 109.137 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.84 -39.46 61.9 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.064 2.509 . . . . 73.53 114.522 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.6 p-10 -72.99 -40.4 65.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.512 0.725 . . . . 74.35 111.102 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.31 -37.92 89.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.965 0.506 . . . . 74.45 111.328 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.528 HG13 ' SD ' ' A' ' 28' ' ' MET . 42.5 t -58.93 -47.55 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.045 0.938 . . . . 74.2 111.071 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.534 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 51.9 tt0 -59.84 -45.59 91.93 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.854 0.862 . . . . 71.25 112.199 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 20.8 mmm-85 -74.86 -40.04 61.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.72 -0.673 . . . . 71.51 112.085 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.39 -44.49 92.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.916 0.886 . . . . 71.04 110.778 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.624 HD21 HD13 ' A' ' 52' ' ' LEU . 22.8 tp -66.76 -40.46 88.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.423 -0.808 . . . . 74.32 111.795 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.91 82.51 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.183 0.593 . . . . 72.15 112.176 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -66.99 -52.0 48.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.386 0.674 . . . . 71.44 111.5 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 81' ' ' LEU . 29.7 pt20 -67.74 -28.48 67.67 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.508 0.558 . . . . 71.41 112.508 176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.2 -33.23 69.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.187 0.439 . . . . 63.12 112.187 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.17 -38.05 13.76 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.559 0.743 . . . . 74.54 112.183 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.3 m -74.29 -33.21 63.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.51 0.929 . . . . 71.23 113.51 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.8 mmm -88.33 -55.48 3.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.152 0.581 . . . . 70.11 111.203 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.34 148.65 43.27 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.312 0.645 . . . . 73.21 112.573 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.47 ' HB3' HG22 ' A' ' 122' ' ' ILE . 41.7 t30 -41.98 -63.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.019 1.727 . . . . 71.54 112.85 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.08 167.68 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.744 -0.662 . . . . 73.44 110.861 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.7 97.48 2.19 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.136 0.493 . . . . 72.41 110.323 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.79 123.68 35.35 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.529 -0.915 . . . . 75.4 108.529 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -104.52 106.04 52.63 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 122.934 0.494 . . . . 72.34 110.941 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HG2' ' HE3' ' A' ' 97' ' ' MET . 93.8 Cg_endo -87.99 170.56 6.06 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.403 2.069 . . . . 75.11 112.928 166.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.0 tp10 -104.06 136.87 42.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.829 0.852 . . . . 71.0 109.324 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.714 ' HB3' HD11 ' A' ' 108' ' ' LEU . 66.1 mtt -134.53 122.11 21.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.155 0.582 . . . . 74.43 110.917 -172.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -124.93 134.42 52.66 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.306 0.642 . . . . 75.52 112.135 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.17 123.19 45.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.813 0.845 . . . . 74.24 111.701 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -142.24 147.05 35.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.24 1.016 . . . . 61.0 110.443 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -97.73 123.4 41.65 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.968 0.413 . . . . 71.41 110.649 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.51 114.12 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.902 1.281 . . . . 73.14 108.511 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.15 29.57 59.87 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 115.439 0.936 . . . . 63.12 115.439 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.94 3.72 73.15 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.062 0.785 . . . . 74.25 115.062 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.523 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 11.6 mptt -117.58 132.91 56.44 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.6 0.76 . . . . 74.15 109.444 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 m -83.15 131.28 35.14 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.593 0.633 . . . . 74.43 111.087 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.25 159.44 24.06 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.602 1.161 . . . . 75.53 109.225 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 97' ' ' MET . 36.8 tp -116.74 118.19 31.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.82 0.448 . . . . 75.24 109.988 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.74 105.63 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.804 -0.813 . . . . 75.41 108.804 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 38.7 t -95.35 98.69 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.489 0.661 . . . . 74.11 109.764 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 17.1 t80 -80.58 115.76 20.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.209 -0.905 . . . . 65.43 108.705 171.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.27 94.49 3.37 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 108.462 -0.94 . . . . 74.31 108.462 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.99 166.91 27.12 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.593 2.195 . . . . 74.04 112.571 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . 12.4 pt-20 -59.97 119.78 8.4 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 113.864 1.061 . . . . 74.5 113.864 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 141.25 51.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 162.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.617 ' HB3' HG23 ' A' ' 118' ' ' THR . 38.6 t70 -75.98 161.94 28.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.909 0.483 . . . . 63.12 112.17 -174.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.05 -21.11 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 C-N-CA 124.791 1.236 . . . . 71.1 112.603 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.617 HG23 ' HB3' ' A' ' 116' ' ' ASP . 15.1 t -54.23 -21.94 10.32 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.647 0.779 . . . . 75.4 112.03 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 39.8 m-70 -90.54 -98.08 0.11 Allowed 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 104.724 -2.325 . . . . 73.31 104.724 164.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 55.3 mttm -68.14 -146.14 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.476 0 CA-C-N 125.902 3.955 . . . . 72.01 110.556 -45.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo 7.62 89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 124.721 3.614 . . . . 72.55 118.364 -138.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 90' ' ' ASN . 60.5 mt -74.59 101.54 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.516 -1.22 . . . . 75.3 109.507 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -92.18 168.89 11.03 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.686 -1.143 . . . . 73.34 109.535 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.825 -0.547 . . . . 75.41 109.58 173.76 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' HB2' ' A' ' 111' ' ' TYR . 5.0 ttm . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.106 -0.331 . . . . 63.04 110.106 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -85.69 152.51 23.03 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.447 0.699 . . . . 73.51 110.561 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.23 152.17 32.73 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.096 0.558 . . . . 75.14 111.566 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.02 66.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.154 0.581 . . . . 73.53 112.47 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -63.77 -36.31 83.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.137 0.791 . . . . 73.11 113.137 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.78 -35.44 80.72 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.039 0.447 . . . . 73.32 111.058 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.63 -36.44 80.79 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.401 0.68 . . . . 74.34 111.795 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.58 -37.22 79.67 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.602 0.361 . . . . 74.32 111.266 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.61 -38.91 92.02 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.804 0.442 . . . . 71.32 110.02 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.09 -37.14 78.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.732 0.813 . . . . 55.04 111.634 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 mt -61.83 -45.26 94.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.747 0.819 . . . . 74.35 111.708 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -77.17 -19.82 56.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.184 0.594 . . . . 74.14 112.128 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.51 -51.97 17.74 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.031 0.533 . . . . 72.15 111.097 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.95 159.14 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.213 0.53 . . . . 62.52 111.216 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.92 -21.86 24.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.371 0.668 . . . . 62.21 112.055 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -145.69 144.63 30.5 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.992 0.917 . . . . 73.14 111.097 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 t -75.13 116.2 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.664 0.786 . . . . 74.52 112.352 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.63 -58.83 1.8 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.154 0.982 . . . . 75.3 111.983 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -115.15 -13.17 11.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 123.822 0.849 . . . . 73.34 112.892 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -129.6 121.8 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.776 0.83 . . . . 75.15 110.244 -167.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -127.52 138.95 53.05 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.626 0.37 . . . . 72.43 110.768 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . . . -93.26 151.98 19.47 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.77 0.828 . . . . 74.12 111.288 175.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' HD23 ' A' ' 52' ' ' LEU . 69.6 mmtt -140.01 141.36 36.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.444 1.097 . . . . 74.41 110.454 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -84.87 160.53 20.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.391 0.676 . . . . 74.31 110.657 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.89 64.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.82 1.044 . . . . 75.33 113.82 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 m -81.86 -11.98 58.69 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 113.137 0.791 . . . . 70.52 113.137 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.5 -9.03 59.79 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.425 0.69 . . . . 73.12 112.148 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mmm -52.09 115.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.222 1.009 . . . . 74.32 112.905 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.93 -131.35 5.69 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 116.217 -0.447 . . . . 72.33 113.615 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.41 -38.31 68.78 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.699 1.2 . . . . 75.23 113.857 -168.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.12 -32.98 69.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.346 0.658 . . . . 74.32 112.093 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.74 -48.68 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.177 0.591 . . . . 75.33 110.059 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -41.44 59.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.246 1.419 . . . . 74.53 113.797 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.6 -43.48 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.207 0.527 . . . . 75.44 111.531 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 m -76.59 -30.7 57.09 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.349 0.659 . . . . 74.44 111.439 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.47 -45.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.197 0.599 . . . . 62.21 110.302 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.65 -38.39 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.301 0.64 . . . . 73.42 110.921 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.01 91.41 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.425 0.69 . . . . 72.11 112.284 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -70.01 -38.98 76.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.153 0.581 . . . . 74.42 111.917 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.9 73.14 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.061 0.544 . . . . 54.4 111.714 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.88 -17.14 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.848 0.859 . . . . 72.42 111.148 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.98 109.82 9.26 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.016 0.526 . . . . 73.41 110.459 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.44 117.05 4.95 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.222 1.948 . . . . 75.32 112.095 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 2.48 90.52 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.944 0.738 . . . . 71.21 114.944 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 tp -113.33 18.64 17.65 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.598 1.199 . . . . 74.32 109.918 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 114' ' ' GLU . 8.6 p-10 -43.51 114.03 0.58 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.22 1.408 . . . . 64.22 113.771 168.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.42 59.21 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.927 -0.579 . . . . 73.43 113.591 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.36 156.29 24.02 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 112.507 -0.237 . . . . 65.02 112.507 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.94 128.06 55.46 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.247 0.524 . . . . 64.52 112.041 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.2 mt -121.15 123.82 43.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.973 0.909 . . . . 70.3 110.121 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.42 109.3 20.88 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.314 0.646 . . . . 74.04 110.287 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 108' ' ' LEU . 57.0 mt -94.56 122.73 37.45 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.888 0.475 . . . . 73.04 109.874 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.24 3.76 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 116.503 -0.317 . . . . 75.11 112.919 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 45.0 t -115.38 139.52 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.515 0.726 . . . . 75.33 110.134 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.66 133.29 49.63 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.958 -1.497 . . . . 72.34 106.958 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -110.37 138.41 46.8 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.029 0.532 . . . . 75.2 111.404 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.33 141.32 48.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.083 0.953 . . . . 74.51 110.544 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -92.0 134.75 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.801 0.84 . . . . 72.25 110.902 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.643 HD22 HG23 ' A' ' 65' ' ' VAL . 21.4 m-80 -85.81 -179.13 6.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.464 0.706 . . . . 75.53 112.194 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.58 -38.09 80.26 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.039 0.936 . . . . 72.21 111.758 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -82.79 7.13 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.273 0.842 . . . . 72.2 113.273 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.13 85.96 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 114.885 0.714 . . . . 75.04 114.885 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.28 157.58 37.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.799 0.84 . . . . 61.22 112.423 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -103.92 124.65 49.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.053 0.941 . . . . 71.24 111.274 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.643 HG23 HD22 ' A' ' 59' ' ' ASN . 78.2 t -116.49 130.28 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.854 0.862 . . . . 73.15 109.892 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -93.82 119.63 33.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.931 0.893 . . . . 71.01 111.166 -173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -112.41 133.7 21.73 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.58 0.752 . . . . 72.52 111.644 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.28 88.4 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.286 1.991 . . . . 73.2 112.212 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -81.37 -19.03 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 122.994 0.517 . . . . 73.41 111.604 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.15 -173.41 54.92 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 121.881 0.712 . . . . 64.44 114.378 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.447 HD23 HG21 ' A' ' 77' ' ' VAL . 55.0 mt -115.2 127.65 26.63 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.643 1.177 . . . . 74.1 108.765 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.15 -23.57 52.75 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.284 1.989 . . . . 74.5 112.485 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.3 73.58 36.75 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 125.219 1.407 . . . . 64.54 110.208 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.18 -42.77 12.76 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.613 2.875 . . . . 75.21 114.821 -165.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.72 -31.31 66.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.57 0.748 . . . . 71.33 111.967 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -72.27 -34.17 68.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 120.603 0.239 . . . . 75.0 110.412 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 71' ' ' LEU . 98.7 t -59.26 -40.76 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.707 0.803 . . . . 74.43 110.918 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -63.99 -49.26 73.15 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.375 1.07 . . . . 73.55 113.173 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -34.66 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 112.614 0.598 . . . . 75.22 112.614 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 3.9 m-20 -62.11 -45.06 95.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.378 0.271 . . . . 71.4 110.573 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.645 HD22 ' SD ' ' A' ' 97' ' ' MET . 35.1 tp -63.07 -38.58 91.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.967 0.507 . . . . 73.5 112.163 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.68 72.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.626 . . . . 65.02 111.47 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 t -73.6 -44.69 56.54 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.682 0.793 . . . . 71.24 111.676 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 80.7 mt-30 -58.06 -44.87 87.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.649 0.78 . . . . 74.25 111.553 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.72 ' HG ' ' HB3' ' A' ' 93' ' ' LEU . 14.5 t -74.93 -18.42 60.4 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.183 0.993 . . . . 31.12 111.986 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -82.81 -43.63 16.46 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.294 0.638 . . . . 73.14 112.367 171.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -83.91 -52.43 6.36 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.8 0.84 . . . . 73.43 113.038 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.0 mmm -67.86 -17.62 64.55 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.852 0.861 . . . . 73.35 112.89 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 mt -108.73 148.5 30.38 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 73.13 110.166 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -39.07 -53.67 1.79 Allowed 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.741 1.216 . . . . 75.31 113.532 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.04 157.92 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 114.903 -1.044 . . . . 75.44 109.564 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.71 97.2 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.847 0.832 . . . . 73.22 109.453 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.72 ' HB3' ' HG ' ' A' ' 85' ' ' CYS . 3.4 tt -94.15 117.38 30.03 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.065 -1.457 . . . . 73.31 107.065 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -110.71 92.56 14.64 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.914 0.885 . . . . 74.5 110.167 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.32 165.59 24.16 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.742 2.295 . . . . 74.34 113.671 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 13.2 tp10 -85.13 107.57 17.27 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.645 ' SD ' HD22 ' A' ' 81' ' ' LEU . 76.2 mtm -119.1 122.53 42.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.781 0.433 . . . . 71.33 111.64 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -129.09 123.75 33.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.122 0.969 . . . . 75.23 110.741 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.67 114.79 12.32 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.73 0.812 . . . . 73.31 110.737 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.74 125.63 53.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.879 0.872 . . . . 75.12 111.211 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -97.16 117.75 32.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.348 0.659 . . . . 70.32 111.382 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.52 118.8 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.085 1.354 . . . . 75.11 110.034 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.06 52.67 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 115.817 1.087 . . . . 71.44 115.817 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.26 -3.12 85.71 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 117.05 0.425 . . . . 75.33 114.119 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.17 137.57 37.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.492 1.117 . . . . 74.4 109.078 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -107.77 131.1 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.273 0.942 . . . . 54.45 111.305 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.42 168.67 11.43 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.253 1.021 . . . . 73.3 109.267 -174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.616 HD23 HD13 ' A' ' 52' ' ' LEU . 34.7 tp -121.89 116.68 24.82 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.894 -0.41 . . . . 71.21 109.894 173.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.419 HG13 ' SD ' ' A' ' 1' ' ' MET . 38.2 t -87.8 120.81 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.92 -0.77 . . . . 75.42 108.92 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 46.2 t -110.69 104.82 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 75.5 110.394 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.622 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 74.3 t80 -90.47 113.28 25.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.136 0.974 . . . . 74.51 110.222 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.53 100.82 46.72 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.568 0.747 . . . . 74.33 110.495 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -86.31 -173.27 1.2 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.716 2.277 . . . . 73.22 113.309 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 36.4 tt0 -93.64 153.18 18.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.866 0.866 . . . . 72.12 109.71 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.08 155.2 40.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.41 0.624 . . . . 72.0 112.323 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.18 158.76 35.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.952 0.901 . . . . 73.42 110.997 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.4 t -56.46 -22.21 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.525 0.935 . . . . 74.22 113.525 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -52.08 -22.13 3.86 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 123.766 0.827 . . . . 71.23 112.366 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 81.3 m-70 -104.23 -84.29 0.48 Allowed 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 106.354 -1.721 . . . . 74.33 106.354 162.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.672 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 16.1 ptpt -79.81 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.665 0 CA-C-N 125.655 3.843 . . . . 74.23 110.909 -34.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 3.3 Cg_exo 7.52 116.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.305 1 C-N-CA 125.489 4.126 . . . . 74.44 120.102 -137.259 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.48 93.8 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.317 -1.311 . . . . 73.41 109.039 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -79.49 170.74 16.14 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.34 0.656 . . . . 72.14 111.017 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 109.065 -0.717 . . . . 74.34 109.065 179.162 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 16.6 ptm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 110.784 -0.08 . . . . 74.5 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -83.87 156.71 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.508 0.723 . . . . 74.31 111.893 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -82.16 161.23 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.781 0.832 . . . . 72.14 112.046 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 107' ' ' LEU . . . -62.25 -44.63 96.1 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.338 0.655 . . . . 75.03 112.018 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -72.22 -31.13 65.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.954 0.724 . . . . 74.24 112.954 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.23 -49.36 77.92 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 121.786 0.803 . . . . 72.53 111.447 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.404 HD23 HD12 ' A' ' 20' ' ' ILE . 50.4 mt -72.73 -26.36 61.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.768 -1.106 . . . . 72.15 112.654 176.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.93 -43.69 98.27 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.008 0.523 . . . . 71.51 110.353 169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.51 -36.33 75.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.482 1.113 . . . . 75.43 111.333 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.697 ' HG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp10 -65.02 -52.36 56.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.616 0.766 . . . . 71.22 111.267 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -56.57 -37.61 70.81 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.463 1.105 . . . . 73.41 113.503 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -78.09 -24.06 47.71 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.057 0.543 . . . . 73.43 111.501 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.67 -38.97 53.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.506 0.722 . . . . 65.53 112.314 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.35 146.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 121.296 0.57 . . . . 65.31 111.919 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.96 -39.55 82.05 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.677 1.191 . . . . 74.24 111.596 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.29 167.79 29.29 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.779 0.832 . . . . 74.13 111.623 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -66.8 89.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.471 0.709 . . . . 72.22 112.445 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.38 10.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.645 0.778 . . . . 70.04 112.017 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -121.67 -28.8 4.48 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.449 0.7 . . . . 75.41 111.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.697 HG13 ' HG2' ' A' ' 10' ' ' GLU . 33.9 mm -112.22 119.19 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 70.33 110.046 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 143.6 42.3 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.101 0.56 . . . . 62.3 109.76 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.9 27.41 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.458 0.703 . . . . 73.42 110.638 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 54.6 mtmt -141.0 152.94 45.31 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.828 0.851 . . . . 75.24 112.245 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 mtm-85 -80.58 170.4 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.676 0.79 . . . . 73.34 112.681 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 28' ' ' MET . . . -60.83 -26.7 67.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.346 0.869 . . . . 71.22 113.346 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -64.59 -1.22 1.7 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.429 1.27 . . . . 74.31 114.429 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -111.88 -9.29 14.06 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.974 0.51 . . . . 72.34 112.185 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.425 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 26.9 ptm -60.76 104.39 0.35 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.663 0.744 . . . . 74.33 111.519 -173.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.26 -122.37 1.21 Allowed Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.669 -0.696 . . . . 71.14 112.388 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -52.78 -58.18 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.292 1.037 . . . . 75.34 113.797 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.5 m -76.2 -32.06 58.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.404 0.52 . . . . 74.3 112.404 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 23' ' ' LYS . 85.3 t -64.75 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.178 0.444 . . . . 72.23 110.314 174.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.504 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 39.0 tpp -58.85 -43.62 90.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.622 0.769 . . . . 75.25 111.611 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -59.7 -39.32 84.2 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.779 . . . . 71.52 111.991 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -70.12 -35.52 74.16 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 122.847 0.459 . . . . 70.4 110.996 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.14 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.462 0.705 . . . . 71.31 110.474 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.27 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 74.15 110.585 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -62.38 -47.17 85.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.428 0.691 . . . . 65.33 112.045 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -67.42 -40.84 85.53 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 122.71 0.404 . . . . 74.55 111.501 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.07 67.15 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.287 0.635 . . . . 75.12 111.89 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -80.87 -37.43 29.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.892 0.877 . . . . 71.54 110.719 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 32.3 mm-40 -56.97 109.32 1.64 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.505 0.722 . . . . 75.24 111.944 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.68 111.07 2.9 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.25 1.966 . . . . 70.04 112.712 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.93 22.49 65.94 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 114.486 0.554 . . . . 63.03 114.486 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 26.69 10.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 117.702 0.751 . . . . 73.13 110.135 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 31.7 t70 -48.76 119.06 2.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.523 0.729 . . . . 64.31 111.777 168.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.485 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 114.41 48.04 0.57 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.101 -0.5 . . . . 60.23 112.899 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.72 137.25 13.39 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 110.613 -0.995 . . . . 54.1 110.613 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -118.43 152.68 35.42 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.325 0.861 . . . . 74.52 113.325 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.4 mt -123.06 122.32 38.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.171 1.389 . . . . 74.21 109.953 175.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.27 108.43 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.721 -0.474 . . . . 73.0 109.721 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 7.5 mp -95.19 120.71 35.89 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.114 -0.698 . . . . 70.21 109.114 176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.48 25.99 5.28 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.312 -0.404 . . . . 62.25 113.232 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.71 133.06 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.34 -0.615 . . . . 74.45 109.34 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -109.72 154.18 23.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.25 -1.018 . . . . 74.4 108.25 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.54 139.69 38.79 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.058 0.456 . . . . 61.24 111.124 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.68 140.31 52.82 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.87 0.868 . . . . 60.44 110.536 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.39 127.33 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.248 0.619 . . . . 75.41 110.809 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -71.98 171.38 11.92 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.854 0.462 . . . . 72.3 111.435 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.37 -31.03 69.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.067 0.547 . . . . 74.1 111.725 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -98.32 11.0 39.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.911 0.708 . . . . 75.23 112.911 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.3 -3.67 59.96 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 116.859 1.503 . . . . 73.41 116.859 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 128.07 34.59 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 118.905 1.353 . . . . 74.25 112.97 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -80.09 106.54 12.19 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.876 -0.787 . . . . 72.54 108.876 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -103.11 119.95 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.405 0.682 . . . . 74.22 109.589 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.93 142.47 27.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.136 0.574 . . . . 74.1 110.407 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -147.99 137.25 11.96 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.155 0.582 . . . . 74.35 111.414 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -82.18 89.53 1.18 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.907 2.405 . . . . 73.14 112.428 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.61 -13.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.865 0.466 . . . . 74.12 111.747 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.37 172.19 46.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 121.616 0.565 . . . . 72.33 114.309 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -95.44 140.16 22.26 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.202 1.001 . . . . 73.31 109.762 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.86 -37.18 98.75 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.631 2.221 . . . . 73.51 112.274 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -140.58 101.55 6.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.806 -1.183 . . . . 65.43 107.806 166.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HB2' HD23 ' A' ' 99' ' ' LEU . 90.4 Cg_endo -74.13 -22.99 16.29 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.635 2.223 . . . . 74.22 113.838 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.55 -43.29 66.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.509 0.724 . . . . 64.13 110.591 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -40.02 87.48 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.549 -0.296 . . . . 71.04 111.275 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' HA ' ' HE2' ' A' ' 28' ' ' MET . 97.6 t -60.49 -43.64 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.347 0.659 . . . . 74.23 111.748 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.21 -41.91 99.22 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.876 0.47 . . . . 75.52 111.978 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -72.86 -46.94 50.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.362 0.665 . . . . 74.11 111.915 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.35 -30.54 70.38 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.141 0.576 . . . . 71.53 112.01 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.87 -37.96 67.18 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.406 0.283 . . . . 75.04 111.027 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.55 76.19 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.19 0.596 . . . . 75.43 111.763 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.6 m -66.07 -51.5 57.56 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.364 0.666 . . . . 74.02 111.347 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -65.62 -29.68 70.29 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.74 0.416 . . . . 74.05 111.419 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.504 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 41.8 t -60.35 -32.28 71.12 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.377 0.51 . . . . 72.11 112.377 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.87 16.76 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.982 0.513 . . . . 64.45 111.381 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 64.7 m -74.22 -32.05 62.86 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.847 0.859 . . . . 74.21 113.207 -174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.5 mmm -94.87 -42.97 8.42 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.435 0.694 . . . . 71.54 112.013 -175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.01 132.19 37.7 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.45 -0.204 . . . . 75.23 110.45 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -58.16 -40.28 80.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.829 0.851 . . . . 72.21 112.223 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -97.36 155.56 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.294 0.638 . . . . 74.21 109.824 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 96.15 2.33 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.667 -0.494 . . . . 74.11 109.667 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.56 123.47 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.038 -1.097 . . . . 72.42 108.038 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -103.39 95.15 6.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.82 0.848 . . . . 74.13 110.062 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' A' ' 97' ' ' MET . 68.6 Cg_endo -86.44 156.28 9.32 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.545 2.163 . . . . 74.14 112.054 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.5 tp10 -83.44 122.56 28.67 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.967 -0.753 . . . . 64.45 108.967 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.581 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.4 mtt -128.39 124.27 35.91 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.07 0.548 . . . . 70.43 110.391 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.516 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -135.68 133.76 38.45 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.985 0.421 . . . . 74.15 110.309 175.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 74' ' ' PRO . 94.5 mt -81.72 111.06 17.63 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.196 0.999 . . . . 65.31 110.641 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.36 130.13 55.22 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.954 0.902 . . . . 72.21 111.936 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -96.78 118.91 34.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.364 0.665 . . . . 72.03 111.282 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.83 121.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.658 1.183 . . . . 75.12 109.59 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 29.09 57.63 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.795 1.078 . . . . 44.2 115.795 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.86 81.39 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.035 0.774 . . . . 71.54 115.035 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -107.59 137.25 45.96 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.558 0.743 . . . . 74.2 109.681 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.9 m -102.01 134.88 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.684 0.675 . . . . 74.22 110.751 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 4' ' ' ALA . 6.0 mp -124.48 170.18 11.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.393 1.077 . . . . 74.43 108.737 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 97' ' ' MET . 60.9 tp -117.31 116.54 27.42 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 172.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t -94.42 128.58 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.512 -0.921 . . . . 72.22 108.512 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 56.6 t -121.92 106.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.087 0.555 . . . . 62.52 111.006 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 92.3 t80 -82.52 123.95 29.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.026 0.93 . . . . 75.33 110.148 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.39 114.19 62.43 Favored Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 109.456 -0.572 . . . . 73.12 109.456 173.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.84 161.82 38.51 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.273 . . . . 75.21 112.602 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -75.02 150.15 39.02 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.94 -0.393 . . . . 75.34 109.94 176.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 119' ' ' HIS . . . -74.02 145.76 44.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.281 0.562 . . . . 72.23 111.776 169.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.68 -179.95 1.95 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.452 1.101 . . . . 63.23 110.736 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.86 -49.69 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 63.45 112.974 167.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -73.2 -49.17 29.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.16 0.505 . . . . 75.12 110.708 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.7 m-70 -103.92 83.05 2.06 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 102.199 -3.26 . . . . 74.3 102.199 159.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 31.6 mmtp -43.5 -152.9 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.521 1 C-N-CA 132.562 4.345 . . . . 72.25 121.263 61.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo 4.14 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.007 2.471 . . . . 74.22 116.046 -126.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.74 125.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.754 0.822 . . . . 75.21 109.503 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -156.44 -176.86 6.2 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.539 0.736 . . . . 74.4 111.264 -174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt . . . . . 0 N--CA 1.482 1.173 0 C-N-CA 123.524 0.729 . . . . 73.41 111.908 177.016 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.598 ' HG2' ' HB2' ' A' ' 111' ' ' TYR . 3.0 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 111.208 0.077 . . . . 71.43 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -41.52 132.19 2.84 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.338 1.055 . . . . 73.21 112.668 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -62.84 159.36 16.79 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.348 0.659 . . . . 61.54 112.154 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.38 81.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.09 0.556 . . . . 61.31 112.049 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -68.93 -36.77 78.36 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.318 0.647 . . . . 53.14 112.481 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.42 -53.68 54.65 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.113 0.565 . . . . 73.14 111.152 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 109' ' ' VAL . 93.3 mt -59.64 -38.92 82.7 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.634 0.773 . . . . 72.02 112.029 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.5 tm? -62.55 -42.34 99.47 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.717 0.807 . . . . 75.43 110.862 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.73 -37.48 87.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.031 0.533 . . . . 71.53 110.56 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -66.09 -40.14 90.56 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.679 -0.691 . . . . 74.13 111.474 173.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 8' ' ' LEU . 87.2 mt -61.03 -39.02 88.18 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.569 0.747 . . . . 73.41 111.79 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -78.51 -22.75 46.93 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.142 0.577 . . . . 74.14 111.851 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.81 -44.46 49.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.263 0.625 . . . . 73.41 111.226 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 10' ' ' GLU . 31.5 m -86.82 151.63 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 74.42 110.994 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.36 -18.46 38.78 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.566 0.747 . . . . 75.42 110.977 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.68 150.81 36.14 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.326 0.65 . . . . 72.4 111.013 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 57.4 p -83.88 80.44 9.15 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.434 0.635 . . . . 74.43 110.717 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.62 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.68 -0.691 . . . . 74.33 112.0 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -120.44 -11.83 9.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 73.2 110.926 175.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mt -115.04 106.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.294 -1.002 . . . . 74.32 108.294 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 10.2 tp10 -96.04 151.81 19.1 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.299 1.44 . . . . 74.25 111.713 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.76 28.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.919 . . . . 72.22 110.162 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HE2' ' HG2' ' A' ' 21' ' ' GLU . 62.5 mttm -136.23 166.42 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 75.41 112.167 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -105.36 167.24 9.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.577 1.151 . . . . 75.14 112.042 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.57 -26.01 67.67 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.64 0.776 . . . . 75.41 112.448 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.6 t -56.4 -37.12 69.71 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.294 0.85 . . . . 74.2 113.294 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.33 18.35 16.12 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.555 0.946 . . . . 62.14 113.555 -170.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.1 ptm -63.74 103.19 0.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.049 0.928 . . . . 75.41 110.736 166.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.08 -130.97 2.7 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.307 -0.86 . . . . 75.45 111.939 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.605 ' HZ2' ' HB3' ' A' ' 30' ' ' LYS . 5.0 ttpm? -55.14 -34.4 63.73 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.213 1.005 . . . . 74.41 112.862 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -67.39 -40.72 85.68 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.473 0.709 . . . . 71.41 111.89 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.49 -53.29 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.829 0.451 . . . . 74.22 110.033 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -48.22 -40.69 25.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.901 1.281 . . . . 72.25 113.34 175.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.07 -47.14 65.32 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.836 0.854 . . . . 73.13 111.927 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 m -77.62 -37.73 49.55 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.652 0.781 . . . . 72.01 111.912 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.24 -42.32 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.215 1.006 . . . . 62.31 112.254 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -54.14 -34.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.341 1.056 . . . . 62.21 112.379 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.78 92.55 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.249 0.62 . . . . 61.24 111.784 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -72.68 -30.22 64.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.961 0.504 . . . . 74.51 111.721 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.88 19.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.199 0.6 . . . . 75.51 112.23 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -85.16 -43.09 14.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.228 0.825 . . . . 73.43 113.228 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.63 108.23 5.49 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 122.92 0.488 . . . . 73.04 111.373 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 116.36 4.63 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.462 2.108 . . . . 65.12 111.683 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.74 3.31 40.01 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.243 -0.754 . . . . 63.14 114.24 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.53 -23.89 11.27 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 118.88 1.34 . . . . 75.45 108.401 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -44.94 155.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.246 1.819 . . . . 73.53 115.699 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 39.0 4.95 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.546 -0.752 . . . . 75.54 113.06 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.95 165.4 29.31 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 113.547 0.179 . . . . 71.0 113.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -123.22 126.75 47.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.318 0.647 . . . . 72.51 110.278 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.6 mp -112.32 118.08 34.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 75.43 108.438 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.5 tp -102.33 111.82 24.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.666 -0.494 . . . . 74.5 109.666 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.598 HD12 HD23 ' A' ' 108' ' ' LEU . 71.7 mt -92.35 138.95 31.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.213 0.605 . . . . 74.12 111.149 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.12 41.07 5.65 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.548 -0.751 . . . . 64.41 112.634 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.92 141.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.122 0.569 . . . . 74.43 110.728 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -104.73 158.6 16.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.228 . . . . 64.12 108.322 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -143.87 126.73 16.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.203 0.525 . . . . 74.12 110.295 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.13 137.34 53.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.354 1.062 . . . . 73.12 110.707 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.56 122.86 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.53 0.732 . . . . 62.32 111.54 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -72.21 177.63 4.35 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.465 1.106 . . . . 74.33 111.986 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.17 -28.61 66.57 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.003 0.521 . . . . 64.32 110.821 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.107 0.963 . . . . 75.53 112.273 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.12 10.88 70.78 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 116.786 -0.188 . . . . 74.44 112.852 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.31 158.72 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.124 0.97 . . . . 72.43 111.969 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -109.71 113.03 25.45 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.361 0.665 . . . . 63.53 110.906 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.62 124.3 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.651 0.781 . . . . 64.13 109.586 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.479 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 66.9 m-85 -93.17 127.17 38.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.262 0.625 . . . . 73.23 110.206 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -117.28 131.78 23.85 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.847 0.859 . . . . 75.0 110.601 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.03 97.3 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.268 1.979 . . . . 62.54 111.573 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.48 -20.63 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.405 0.682 . . . . 71.3 112.309 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.61 178.08 51.24 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 121.56 0.533 . . . . 60.24 114.267 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.12 138.75 20.63 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.226 1.011 . . . . 73.42 110.854 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.52 -38.37 19.52 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.481 2.121 . . . . 75.51 112.592 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -124.78 67.23 50.6 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 123.701 0.801 . . . . 72.4 109.627 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HB2' HD23 ' A' ' 99' ' ' LEU . 39.2 Cg_endo -60.22 -42.65 40.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.106 2.537 . . . . 75.55 114.638 -164.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.92 -38.0 87.55 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.133 0.573 . . . . 73.04 110.979 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -71.95 -37.23 69.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.258 0.623 . . . . 74.42 111.515 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -60.91 -39.61 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.665 0.386 . . . . 74.42 110.058 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.52 -47.92 79.67 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.24 0.616 . . . . 73.52 112.208 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -63.63 -50.06 70.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.823 0.849 . . . . 75.11 112.238 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.74 -30.31 69.76 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.895 0.878 . . . . 74.33 111.328 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.7 tp -67.56 -42.06 83.22 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.929 0.492 . . . . 74.54 111.122 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.44 98.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.445 0.698 . . . . 75.4 111.382 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -61.65 -52.61 63.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 60.24 111.668 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.94 -30.77 70.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.055 0.391 . . . . 75.24 112.055 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.19 -32.19 71.94 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.431 0.56 . . . . 74.55 112.071 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.3 -29.71 28.13 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.701 -0.681 . . . . 72.53 112.447 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -94.35 -24.41 17.4 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.549 1.314 . . . . 74.14 114.549 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.412 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 48.1 mmm -91.09 -27.1 18.79 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.46 0.704 . . . . 72.34 111.861 -173.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.6 162.0 13.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.139 0.576 . . . . 74.25 112.536 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -39.54 -63.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.083 1.753 . . . . 72.32 112.835 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.439 HG23 ' ND1' ' A' ' 119' ' ' HIS . 30.3 m -116.61 172.03 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.69 0.796 . . . . 71.54 110.16 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.17 99.66 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.197 0.523 . . . . 72.23 110.661 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.16 134.05 35.57 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.999 -1.112 . . . . 73.25 107.999 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -110.39 91.6 12.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.123 0.569 . . . . 75.21 111.462 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -90.62 169.07 3.9 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.831 2.354 . . . . 75.02 112.531 171.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.85 135.13 53.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.191 0.596 . . . . 75.23 109.838 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.652 ' HB3' HD13 ' A' ' 108' ' ' LEU . 46.9 mtt -130.03 132.57 46.27 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.203 0.601 . . . . 73.54 111.156 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -135.37 144.31 46.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.481 0.712 . . . . 73.4 111.741 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 74' ' ' PRO . 74.1 mt -104.23 117.12 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.092 0.957 . . . . 74.23 110.098 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -117.49 133.23 56.2 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.492 1.117 . . . . 75.35 111.651 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -94.21 114.36 26.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.822 0.849 . . . . 72.05 110.527 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.95 113.95 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.788 1.235 . . . . 64.54 109.149 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 51.42 28.49 20.73 Favored Glycine 0 CA--C 1.543 1.803 0 N-CA-C 115.642 1.017 . . . . 74.55 115.642 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.23 -5.71 78.23 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.546 0.578 . . . . 62.4 114.546 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -98.92 137.57 37.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 72.53 110.699 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 m -102.39 104.73 15.23 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.191 0.451 . . . . 74.44 111.461 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.09 163.7 12.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.663 0.785 . . . . 70.13 111.623 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.652 HD13 ' HB3' ' A' ' 97' ' ' MET . 39.4 tp -115.4 114.14 24.68 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.146 0.578 . . . . 73.22 110.962 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 7' ' ' LEU . 90.8 t -83.29 112.53 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.711 0.804 . . . . 71.12 109.506 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 25.1 t -108.49 100.05 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.637 0.732 . . . . 72.2 110.602 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.598 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 51.9 t80 -84.6 124.47 31.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.433 1.093 . . . . 74.14 110.535 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.07 103.02 48.66 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 122.655 0.382 . . . . 74.43 110.44 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.65 166.18 28.91 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.736 2.291 . . . . 75.34 112.011 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.51 161.74 24.82 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.915 1.079 . . . . 74.25 113.915 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.38 47.17 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.739 -1.119 . . . . 64.52 109.18 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.14 163.43 24.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 122.737 0.415 . . . . 71.13 111.058 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.0 -22.18 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.305 1.042 . . . . 74.44 112.467 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.3 p -58.28 -27.39 64.01 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.191 0.597 . . . . 75.33 111.448 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 5.4 m170 -75.84 -86.07 0.05 OUTLIER 'General case' 0 CA--C 1.591 2.53 0 N-CA-C 105.512 -2.033 . . . . 65.13 105.512 166.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 45.1 tttp -82.49 -145.04 0.0 OUTLIER Pre-proline 0 CA--C 1.591 2.538 0 C-N-CA 129.298 3.039 . . . . 71.23 109.636 -49.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo 5.47 102.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 124.884 3.723 . . . . 75.15 119.326 -136.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.2 mt -88.85 115.11 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 114.735 -1.12 . . . . 75.43 109.48 168.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -108.38 166.5 10.71 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.555 0.742 . . . . 75.23 111.458 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 26.5 tptp . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 122.937 0.495 . . . . 74.51 109.871 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.539 0.685 . . . . 75.05 112.789 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.39 179.53 4.12 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.944 -1.026 . . . . 74.13 110.189 165.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -71.76 157.25 38.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.656 -0.702 . . . . 70.45 112.063 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.22 84.47 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.402 0.681 . . . . 62.13 111.543 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -65.6 -33.95 77.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.447 0.699 . . . . 73.3 112.593 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -43.74 80.9 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 120.847 0.356 . . . . 73.42 111.092 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.72 -29.12 69.03 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.074 0.55 . . . . 72.23 111.646 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HA ' HD11 ' A' ' 11' ' ' LEU . 17.9 tp -63.73 -29.77 70.95 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.647 0.779 . . . . 73.22 111.324 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.49 -34.2 75.08 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.176 0.59 . . . . 64.02 111.821 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.0 tt0 -67.66 -52.11 41.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.595 0.634 . . . . 75.22 109.659 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 8' ' ' LEU . 77.5 mt -49.38 -45.63 46.22 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.489 1.116 . . . . 73.01 112.762 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.46 -26.38 38.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.501 0.926 . . . . 74.32 113.501 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.33 -53.41 16.82 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.339 0.518 . . . . 72.02 111.427 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.2 m -81.79 139.89 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.927 0.491 . . . . 73.33 110.379 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.79 -45.06 90.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.522 0.729 . . . . 72.42 111.605 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -123.53 138.21 54.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.922 0.889 . . . . 72.42 110.487 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -44.17 124.62 4.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 71.01 113.669 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.94 -65.08 1.01 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.167 0.587 . . . . 64.5 112.328 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -119.82 -6.61 10.08 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.819 0.848 . . . . 75.11 111.406 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' A' ' 49' ' ' TYR . 45.5 mt -128.96 121.84 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.872 0.869 . . . . 71.33 108.806 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.55 129.06 46.44 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.949 -0.389 . . . . 75.45 109.949 169.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . . . -81.38 133.86 35.48 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.517 0.727 . . . . 73.03 109.067 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -130.86 151.13 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.41 0.624 . . . . 74.24 111.438 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -97.85 159.67 14.79 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.008 -0.997 . . . . 72.02 110.241 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.627 0.771 . . . . 74.23 112.302 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -59.88 -36.42 76.88 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.93 0.892 . . . . 73.24 113.041 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.53 -10.55 55.83 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.12 0.568 . . . . 74.13 112.094 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.2 ttt -59.43 104.28 0.25 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.171 0.51 . . . . 71.24 111.239 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 170.65 -150.35 14.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.241 -0.744 . . . . 71.24 111.241 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.13 -27.14 52.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.12 1.156 . . . . 74.3 114.12 -175.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -65.44 -43.62 89.87 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.938 0.495 . . . . 64.21 111.26 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.26 -42.86 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.81 0.844 . . . . 74.11 110.773 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 84.6 mmm -64.34 -33.27 75.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.82 0.848 . . . . 74.21 112.038 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.63 -36.58 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.187 0.595 . . . . 75.43 110.936 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.404 HG21 HD22 ' A' ' 50' ' ' LEU . 3.0 m -70.64 -29.85 66.32 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 116.258 -0.428 . . . . 74.24 110.899 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.1 -38.41 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.511 0.725 . . . . 74.33 110.146 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.78 -36.55 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.42 0.288 . . . . 72.23 110.898 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.18 -57.86 7.45 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 120.965 0.412 . . . . 60.13 111.192 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -67.43 -20.79 65.55 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.447 0.906 . . . . 75.45 113.447 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.98 -33.45 19.61 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.209 0.818 . . . . 74.5 113.209 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -101.08 -27.82 13.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.761 1.023 . . . . 75.02 113.761 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.46 115.45 56.72 Favored Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 118.079 0.4 . . . . 72.13 111.739 -176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.99 160.24 38.59 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.485 2.124 . . . . 75.55 111.785 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.31 -41.15 3.07 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 114.031 0.373 . . . . 75.31 114.031 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -94.55 -34.44 12.66 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.065 0.933 . . . . 72.45 110.716 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 2.71 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.649 2.38 . . . . 75.05 116.284 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.44 0.57 Allowed Glycine 0 CA--C 1.537 1.432 0 CA-C-N 116.324 -0.398 . . . . 63.41 113.405 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.07 173.48 43.0 Favored Glycine 0 N--CA 1.478 1.45 0 O-C-N 122.833 -0.216 . . . . 71.23 112.971 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.624 ' HB2' HG12 ' A' ' 20' ' ' ILE . 76.7 m-85 -121.02 155.67 33.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.433 0.635 . . . . 74.14 111.907 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 60.8 mt -128.31 118.47 23.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.623 1.169 . . . . 73.43 108.585 170.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.3 tp -103.52 109.07 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 75.32 109.788 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.576 HD11 HD21 ' A' ' 108' ' ' LEU . 25.1 mt -99.74 126.32 45.78 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.265 0.626 . . . . 75.35 110.67 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-N 116.6 -0.273 . . . . 42.1 113.058 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 58.4 t -112.65 137.52 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.207 0.603 . . . . 73.44 109.943 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -109.89 157.41 19.25 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.05 -1.093 . . . . 75.3 108.05 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -144.02 136.11 26.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.875 0.369 . . . . 74.15 111.662 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.15 135.33 47.36 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.767 0.827 . . . . 72.4 110.669 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.3 mt -96.83 134.89 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.416 0.686 . . . . 73.44 110.996 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -84.7 -177.19 6.53 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.426 0.69 . . . . 75.21 111.665 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.3 -25.05 66.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.934 0.716 . . . . 72.12 112.934 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 61' ' ' LYS . 9.7 mtpm? -78.28 -22.94 47.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.774 0.83 . . . . 73.51 112.555 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.96 -0.96 31.64 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 114.585 0.594 . . . . 53.13 114.585 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -75.51 120.79 21.42 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.475 0.637 . . . . 71.3 110.935 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -80.94 118.95 22.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.122 0.569 . . . . 72.55 109.811 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.51 114.89 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.682 0.793 . . . . 74.04 109.326 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.85 130.25 41.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.079 -0.711 . . . . 74.21 109.079 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -143.57 131.11 10.79 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.048 0.539 . . . . 64.54 111.169 -172.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HD3' HD23 ' A' ' 8' ' ' LEU . 98.8 Cg_endo -77.53 101.43 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.759 2.306 . . . . 75.03 112.571 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.12 -6.45 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.127 0.571 . . . . 72.34 112.062 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.47 175.18 50.29 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 114.601 0.6 . . . . 74.11 114.601 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -105.48 137.77 19.38 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.854 1.262 . . . . 71.42 109.889 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.31 -30.5 19.62 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.071 1.847 . . . . 72.3 112.291 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 6.2 m-20 -125.98 66.43 58.66 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.871 0.868 . . . . 55.41 110.617 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -43.55 23.97 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.707 2.271 . . . . 75.2 114.27 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -71.04 -39.38 72.33 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.999 -0.546 . . . . 74.52 110.654 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 14.1 ttmm -60.41 -44.42 95.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.445 0.698 . . . . 74.12 111.15 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.85 -43.41 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 122.632 0.373 . . . . 73.15 110.691 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.94 -50.2 67.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.541 0.571 . . . . 71.14 112.541 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -68.82 -49.59 57.25 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.865 0.466 . . . . 74.03 111.766 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.28 -28.54 67.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.512 0.725 . . . . 63.21 112.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.8 tp -72.65 -41.52 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.385 0.539 . . . . 73.41 111.432 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.28 84.22 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.12 0.568 . . . . 73.33 112.189 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 p -73.87 -41.39 62.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 63.51 112.071 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -65.34 -30.15 70.96 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 117.665 0.211 . . . . 73.55 111.228 173.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.7 t -59.35 -21.07 59.28 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 112.923 0.712 . . . . 73.22 112.923 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.01 -35.15 17.75 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.824 0.85 . . . . 72.23 111.587 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 -14.46 31.13 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.585 0.958 . . . . 74.12 113.585 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.3 mmm -90.05 -47.51 7.79 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.82 0.848 . . . . 71.14 110.081 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.82 154.23 17.36 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.047 -0.979 . . . . 75.13 110.627 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 122' ' ' ILE . 8.0 p30 -48.29 -47.56 36.33 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.2 1.0 . . . . 74.44 112.705 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.66 173.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.244 1.018 . . . . 75.35 110.138 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.29 100.54 3.17 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.811 -0.631 . . . . 75.4 110.462 169.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.542 HD13 HG22 ' A' ' 122' ' ' ILE . 5.9 tt -75.7 131.41 39.86 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.263 -1.755 . . . . 74.01 106.263 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -106.28 95.71 11.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 122.866 0.466 . . . . 74.12 111.869 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.19 161.65 5.72 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.105 1.87 . . . . 73.04 111.928 166.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 111' ' ' TYR . 37.9 mm-40 -92.04 141.13 28.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.44 -0.8 . . . . 65.31 108.935 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.628 ' HB3' HD13 ' A' ' 108' ' ' LEU . 67.3 mtt -137.8 122.74 18.97 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.53 111.121 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -130.87 136.84 49.0 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.811 0.844 . . . . 75.33 110.13 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.91 109.82 20.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.72 -0.845 . . . . 74.33 108.72 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.96 128.53 55.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.012 0.525 . . . . 74.5 110.848 -166.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -101.2 123.85 45.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.534 0.734 . . . . 72.3 111.765 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.93 122.45 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.677 1.191 . . . . 73.21 109.881 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.75 28.85 48.11 Favored Glycine 0 CA--C 1.544 1.89 0 N-CA-C 115.733 1.053 . . . . 71.32 115.733 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.15 5.37 76.62 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.015 0.766 . . . . 74.42 115.015 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.08 134.88 50.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 74.22 109.963 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.7 m -97.7 129.18 44.77 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.751 0.705 . . . . 72.02 110.603 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.05 171.41 8.69 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.402 1.081 . . . . 75.43 109.047 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 97' ' ' MET . 47.2 tp -117.49 114.81 24.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.918 0.389 . . . . 74.15 110.155 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.55 113.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 39.5 t -107.46 101.09 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.756 -0.461 . . . . 74.21 109.756 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.527 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 62.8 t80 -85.79 119.93 26.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.756 -0.831 . . . . 74.32 108.756 172.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.61 98.39 28.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.042 0.537 . . . . 75.32 109.64 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.38 162.43 22.38 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.767 2.312 . . . . 74.14 113.381 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.461 ' HG3' ' HE3' ' A' ' 120' ' ' LYS . 10.8 tt0 -73.29 128.37 35.3 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.239 0.616 . . . . 73.33 111.679 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.76 171.51 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.184 0.994 . . . . 50.43 112.059 -175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.16 132.88 34.64 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 123.63 0.772 . . . . 71.31 110.574 -169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -38.49 -38.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.876 0 N-CA-C 116.79 2.144 . . . . 74.2 116.79 -160.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.9 t -63.98 -42.93 97.08 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.021 0.528 . . . . 72.3 111.675 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 23.1 m-70 -128.97 70.89 1.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 104.822 -2.288 . . . . 75.04 104.822 167.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.1 mttt -48.17 -156.95 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.744 0 C-N-CA 131.647 3.979 . . . . 74.21 121.59 57.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo 4.57 70.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.908 2.405 . . . . 71.31 116.04 -127.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.542 HG22 HD13 ' A' ' 93' ' ' LEU . 34.0 mm -73.92 89.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.726 -0.67 . . . . 71.53 110.032 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -89.67 150.45 22.34 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.955 -0.566 . . . . 71.11 109.921 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 109.85 -0.426 . . . . 74.31 109.85 171.407 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptm . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.489 0.185 . . . . 73.44 111.293 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -105.54 154.29 20.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.707 0.803 . . . . 73.42 111.366 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -75.73 160.24 30.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.834 0.453 . . . . 73.23 111.768 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 -27.99 69.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.641 -0.709 . . . . 63.22 112.268 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.602 HG23 HG12 ' A' ' 102' ' ' VAL . 5.8 m -71.47 -45.88 61.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.149 0.58 . . . . 72.21 110.864 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.74 -46.42 90.48 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.511 -0.768 . . . . 74.51 111.759 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.72 -34.57 67.2 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.638 0.775 . . . . 75.3 112.242 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.37 -47.7 72.56 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.129 0.571 . . . . 72.55 110.515 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.85 -35.29 79.46 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.293 -0.867 . . . . 73.02 111.128 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.62 -37.75 88.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.476 0.71 . . . . 73.33 111.171 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 HD12 ' HB1' ' A' ' 22' ' ' ALA . 59.2 mt -60.74 -37.06 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.964 0.906 . . . . 72.51 111.768 174.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.405 HD22 ' HB2' ' A' ' 66' ' ' TYR . 53.3 m-80 -80.69 -21.75 41.0 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.299 0.639 . . . . 74.05 112.186 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.24 -47.61 12.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.506 0.722 . . . . 75.45 112.567 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.34 163.71 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.573 0.702 . . . . 72.23 112.829 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.23 -33.83 22.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.271 -0.877 . . . . 74.41 110.48 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -139.81 136.77 34.39 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.133 0.973 . . . . 74.44 109.766 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 m -75.21 90.88 2.59 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.315 0.578 . . . . 64.31 110.144 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.19 82.86 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.731 1.212 . . . . 70.42 113.263 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -160.57 14.9 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.499 0.72 . . . . 75.13 111.731 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.86 117.1 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.794 -1.187 . . . . 74.13 107.794 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 150.17 38.49 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.224 0.61 . . . . 63.34 111.053 -173.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 11' ' ' LEU . . . -121.59 124.38 44.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.734 0.814 . . . . 72.44 110.411 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 32' ' ' VAL . 31.2 mmtp -122.87 144.68 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.551 0.74 . . . . 73.14 110.303 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -75.89 158.26 32.27 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.316 0.646 . . . . 72.44 111.386 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -24.51 63.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.582 0.956 . . . . 73.44 113.582 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.0 t -84.16 -11.93 55.76 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.647 0.61 . . . . 74.44 112.647 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.3 -18.87 34.92 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.595 0.758 . . . . 71.02 111.515 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.78 131.26 50.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.19 0.519 . . . . 75.25 112.309 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.56 -122.6 2.81 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.159 -0.473 . . . . 75.32 112.081 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -68.24 -38.44 81.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.81 0.844 . . . . 75.11 111.748 -173.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.3 m -69.2 -42.03 76.33 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.667 0.787 . . . . 74.53 111.732 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG22 ' HG3' ' A' ' 23' ' ' LYS . 88.0 t -70.44 -41.84 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.693 0.397 . . . . 72.22 110.825 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.442 ' SD ' HD21 ' A' ' 89' ' ' LEU . 35.0 tpp -56.28 -44.4 79.74 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.813 0.845 . . . . 75.31 111.847 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.97 -30.57 71.02 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.722 0.809 . . . . 72.01 110.953 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -76.39 -36.35 58.15 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.745 0.818 . . . . 74.42 111.321 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 32' ' ' VAL . 97.1 t -60.97 -38.73 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 123.767 0.827 . . . . 73.21 111.129 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -57.4 -33.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.941 0.896 . . . . 71.33 111.071 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.63 71.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.146 0.578 . . . . 65.42 111.759 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -67.98 -18.17 64.65 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.377 0.51 . . . . 65.34 112.377 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.06 -37.41 18.91 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.581 0.752 . . . . 73.51 112.603 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.531 HD22 ' HB ' ' A' ' 122' ' ' ILE . 58.6 m-80 -104.52 -46.06 4.47 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.102 0.778 . . . . 73.52 113.102 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.21 121.82 78.34 Favored Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 123.813 0.845 . . . . 75.23 111.721 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.96 -178.46 2.82 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.199 2.599 . . . . 73.41 113.503 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.13 -40.46 2.92 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 114.869 0.708 . . . . 75.01 114.869 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.92 -48.24 25.62 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.798 0.799 . . . . 74.41 112.876 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t70 41.21 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.249 1.203 . . . . 65.24 114.249 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 113' ' ' PRO . . . 78.01 72.21 1.17 Allowed Glycine 0 CA--C 1.535 1.294 0 C-N-CA 121.155 -0.545 . . . . 71.35 114.051 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.74 168.35 27.67 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 116.665 0.233 . . . . 74.54 113.143 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -121.36 144.23 48.77 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.83 0.678 . . . . 65.01 112.83 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 76.2 mt -122.55 123.13 40.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.702 1.201 . . . . 74.44 109.302 171.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.18 108.98 20.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.365 -0.605 . . . . 71.21 109.365 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.608 HD11 HD22 ' A' ' 108' ' ' LEU . 80.2 mt -94.76 129.91 41.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.181 0.592 . . . . 75.22 110.21 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 34.59 4.85 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.296 -0.411 . . . . 62.31 112.622 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -112.37 140.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.826 0.85 . . . . 72.22 109.964 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -124.04 154.88 39.26 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.102 -1.073 . . . . 61.04 108.102 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -136.16 128.99 31.05 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.914 0.485 . . . . 65.12 110.828 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.764 0.825 . . . . 62.13 110.63 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -100.01 128.63 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.727 0.811 . . . . 70.33 111.646 -170.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 73.8 m-20 -76.63 178.05 7.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.208 0.603 . . . . 73.51 112.181 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.23 -37.53 87.55 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.11 0.564 . . . . 72.22 111.252 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -68.17 -29.91 68.89 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.307 0.643 . . . . 73.31 111.47 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.26 6.0 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.024 -0.535 . . . . 60.32 113.924 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.431 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.7 m-20 -78.67 138.32 38.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.978 0.511 . . . . 73.13 111.663 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.6 m -89.54 102.76 15.44 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.47 0.708 . . . . 73.11 109.975 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HB ' HH12 ' A' ' 67' ' ' ARG . 57.6 t -109.96 129.26 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.552 0.741 . . . . 72.42 110.396 -176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' HB2' HD22 ' A' ' 12' ' ' ASN . 75.9 m-85 -95.76 120.81 36.68 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.73 0.812 . . . . 75.42 111.96 -171.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.409 HH12 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.69 150.91 45.61 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.128 0.971 . . . . 72.11 111.427 174.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.53 108.89 2.53 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.477 2.118 . . . . 73.25 113.229 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 m -91.86 -28.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 116.112 -0.494 . . . . 72.42 110.647 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 -176.73 53.97 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.734 -0.666 . . . . 72.43 113.83 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.4 mt -102.66 143.25 26.22 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.94 0.896 . . . . 75.34 110.856 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.0 -56.58 1.32 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.64 2.226 . . . . 71.54 111.743 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.51 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 12.1 m-20 -120.34 89.22 43.38 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.897 0.879 . . . . 70.44 108.656 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -54.98 -44.9 45.29 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.483 2.789 . . . . 73.34 114.664 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.22 -41.65 85.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.213 0.605 . . . . 74.0 110.634 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 36.9 ttpt -61.32 -43.4 98.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.795 0.438 . . . . 75.33 111.172 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.37 -43.69 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.821 0.849 . . . . 73.54 111.289 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.68 -39.67 94.9 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.838 0.855 . . . . 65.35 111.735 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -67.39 -46.2 74.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.673 0.789 . . . . 74.42 112.128 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.51 -41.17 96.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.919 0.888 . . . . 63.55 111.185 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.05 -44.23 80.69 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.025 -0.534 . . . . 72.32 111.487 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.69 97.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 73.1 111.369 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -60.89 -52.01 66.84 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.266 1.026 . . . . 72.41 111.887 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.45 -29.81 68.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.19 0.596 . . . . 74.32 112.052 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 33' ' ' MET . 31.3 t -61.57 -23.89 66.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.785 -0.572 . . . . 75.42 112.206 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.03 -48.74 7.0 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.639 0.776 . . . . 74.53 111.414 170.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 t -74.55 -22.69 58.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.387 1.255 . . . . 71.22 114.387 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.8 mmm -88.51 -51.89 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.218 0.607 . . . . 74.42 111.602 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.442 HD21 ' SD ' ' A' ' 33' ' ' MET . 88.6 mt -70.01 -103.26 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 113.847 1.054 . . . . 62.31 113.847 -165.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 123' ' ' TYR . 3.7 p30 -170.01 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.662 0.664 . . . . 73.44 110.123 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.566 HG12 ' ND1' ' A' ' 119' ' ' HIS . 23.9 m -114.59 157.22 15.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.078 0.951 . . . . 72.2 109.055 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 96.06 1.16 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.258 -0.645 . . . . 63.03 109.258 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.75 122.02 34.73 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.263 -1.384 . . . . 74.51 107.263 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -104.41 100.44 22.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 122.619 0.368 . . . . 75.31 110.473 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.18 161.62 26.12 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.981 1.787 . . . . 72.22 110.948 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.7 tp10 -104.03 101.89 11.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.356 -0.609 . . . . 75.25 109.356 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.669 ' HB3' HD13 ' A' ' 108' ' ' LEU . 5.3 mpp? -101.71 135.06 43.87 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 112.501 0.556 . . . . 62.32 112.501 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -136.03 127.01 27.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.539 0.735 . . . . 74.33 111.242 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.0 112.01 9.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.209 1.003 . . . . 73.41 110.892 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -126.38 129.59 49.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.781 0.832 . . . . 75.45 111.179 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.35 126.67 39.75 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.533 0.733 . . . . 74.44 111.405 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.602 HG12 HG23 ' A' ' 5' ' ' THR . 13.1 t -119.33 118.4 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.256 1.022 . . . . 73.33 108.877 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 28.59 63.63 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.718 0.647 . . . . 75.3 114.718 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.07 10.61 78.03 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.419 0.527 . . . . 74.41 114.419 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.6 133.03 55.51 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.019 0.928 . . . . 74.34 108.961 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 m -89.88 123.74 34.09 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.059 0.845 . . . . 72.43 111.584 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.68 170.92 8.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.513 1.125 . . . . 72.31 109.078 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -122.28 120.11 33.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.581 0.353 . . . . 64.11 110.863 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 97' ' ' MET . 38.4 t -88.54 120.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.143 -0.688 . . . . 71.11 109.143 170.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 21.5 t -108.51 101.51 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.262 -0.644 . . . . 61.24 109.262 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.5 t80 -85.4 116.16 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.189 0.596 . . . . 73.21 109.733 175.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.77 96.89 50.19 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 108.011 -1.107 . . . . 73.31 108.011 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 72.8 Cg_endo -70.49 171.13 15.85 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.656 2.237 . . . . 52.01 112.753 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.29 121.36 19.3 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.357 -0.979 . . . . 73.05 108.357 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -79.55 166.87 21.48 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.566 0.746 . . . . 75.25 112.103 -173.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 38.2 t70 -62.48 165.77 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 124.001 0.921 . . . . 75.11 112.471 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -52.88 -51.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.094 -1.004 . . . . 72.2 113.542 168.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.7 p -84.68 6.44 24.15 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.583 0.586 . . . . 72.14 112.583 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.566 ' ND1' HG12 ' A' ' 91' ' ' VAL . 52.0 m-70 -170.96 64.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 103.026 -2.953 . . . . 74.44 103.026 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.69 ' HA ' HG12 ' A' ' 122' ' ' ILE . 9.4 ptpp? -48.04 -156.67 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.399 2 C-N-CA 133.584 4.754 . . . . 63.11 122.096 42.256 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 10.9 Cg_exo 14.13 73.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.983 1.788 . . . . 73.14 115.204 -118.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 120' ' ' LYS . 49.7 mm -90.2 125.34 43.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 114.006 -1.452 . . . . 63.11 108.654 172.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.475 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 36.7 p90 -149.97 155.53 40.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.196 0.998 . . . . 74.53 108.893 -174.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 122.601 0.36 . . . . 75.43 110.784 175.803 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.716 ' HE2' ' HG3' ' A' ' 96' ' ' GLU . 11.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.555 0.217 . . . . 64.2 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -62.73 156.77 22.77 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.462 0.648 . . . . 72.5 112.494 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 m -67.2 160.6 26.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.775 -1.102 . . . . 73.02 112.973 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.97 -27.67 67.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.956 0.502 . . . . 65.33 111.211 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.57 HG23 HG11 ' A' ' 102' ' ' VAL . 39.4 p -57.15 -51.29 69.9 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.407 0.683 . . . . 73.23 111.055 168.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.23 -36.59 74.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.596 -1.184 . . . . 73.0 111.394 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 mt -70.46 -30.23 67.0 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.52 1.128 . . . . 74.44 113.008 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.41 -31.6 72.8 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.997 -0.547 . . . . 73.35 110.161 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.32 -37.72 86.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.734 0.814 . . . . 74.24 112.465 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.45 -46.99 74.58 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.308 0.504 . . . . 72.12 110.721 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.1 mt -60.18 -42.97 96.14 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 124.132 0.973 . . . . 73.43 112.25 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -80.76 -13.95 58.53 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.692 0.797 . . . . 71.42 112.915 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.85 -62.12 1.8 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.001 0.52 . . . . 55.43 110.761 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -100.14 143.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.817 -0.629 . . . . 72.33 110.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.67 -46.76 89.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.872 0.869 . . . . 62.44 111.84 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.32 111.7 15.49 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.944 0.897 . . . . 71.02 109.706 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 66.5 m -74.72 126.86 31.77 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.423 0.689 . . . . 74.54 111.716 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.71 22.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.567 0.951 . . . . 64.34 113.567 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -108.76 -2.73 18.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.408 0.683 . . . . 74.05 111.764 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 17' ' ' SER . 29.3 mm -111.17 145.24 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.917 -0.771 . . . . 65.11 108.917 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -139.7 152.12 46.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.758 0.423 . . . . 73.31 110.7 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.95 125.02 42.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.746 0.818 . . . . 71.42 109.988 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HD2' HG22 ' A' ' 32' ' ' VAL . 37.8 mttp -125.18 153.65 42.75 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.584 0.754 . . . . 73.32 111.263 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.34 155.15 24.91 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.756 -1.111 . . . . 75.21 111.356 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.03 -30.64 62.19 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.096 0.958 . . . . 64.23 113.523 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.0 p -65.89 -35.41 80.56 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.657 0.783 . . . . 75.43 112.816 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.62 13.49 6.96 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.505 0.928 . . . . 65.32 113.505 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.598 ' SD ' HD12 ' A' ' 52' ' ' LEU . 85.6 mmm -57.1 104.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.258 0.466 . . . . 53.42 112.258 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.69 -148.4 12.37 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.009 -0.541 . . . . 74.1 112.557 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -55.83 -31.53 62.79 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.552 1.141 . . . . 75.23 113.934 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -68.74 -42.62 77.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.058 0.543 . . . . 75.02 111.583 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG22 ' HD2' ' A' ' 23' ' ' LYS . 52.3 t -60.96 -53.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.255 0.55 . . . . 75.32 109.9 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.52 ' SD ' ' HG3' ' A' ' 84' ' ' GLN . 81.0 mmm -49.2 -44.12 42.91 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.449 -1.251 . . . . 73.44 113.993 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.53 -31.25 69.36 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.614 0.598 . . . . 70.51 112.614 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.572 ' HB ' HD21 ' A' ' 50' ' ' LEU . 28.2 m -70.4 -37.41 74.47 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.541 0.336 . . . . 73.11 110.573 174.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.51 -44.17 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.375 0.67 . . . . 73.51 110.419 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.91 -40.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.319 1.048 . . . . 73.34 111.257 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.15 90.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 75.33 111.832 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -81.19 -35.7 31.05 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.959 0.504 . . . . 75.3 111.386 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.14 73.21 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.659 0.784 . . . . 74.15 112.497 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -76.99 -24.58 52.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.172 0.589 . . . . 75.22 112.191 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.21 110.6 11.67 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 123.023 0.529 . . . . 72.52 110.047 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.84 118.15 4.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.509 2.806 . . . . 64.12 114.992 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.28 26.73 74.06 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.44 -0.8 . . . . 74.13 114.777 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.78 8.83 37.2 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.978 0.889 . . . . 63.33 110.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -51.49 141.48 15.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.815 0.846 . . . . 72.21 112.25 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 122.21 -29.77 5.42 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 111.347 -0.701 . . . . 64.12 111.347 -166.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.53 121.93 9.8 Favored Glycine 0 CA--C 1.548 2.117 0 N-CA-C 114.483 0.553 . . . . 73.34 114.483 175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -114.05 142.39 46.25 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.916 0.886 . . . . 74.1 112.416 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.1 mp -117.33 128.36 54.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.238 1.015 . . . . 75.11 109.022 170.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.86 109.65 21.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.238 0.615 . . . . 74.23 109.864 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.641 HD13 HD23 ' A' ' 108' ' ' LEU . 82.0 mt -97.8 125.67 42.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.561 0.744 . . . . 72.35 110.649 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 35.08 4.13 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.046 -0.524 . . . . 71.44 112.52 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.53 144.02 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.285 0.634 . . . . 74.54 110.34 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 131.76 44.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.132 0.973 . . . . 63.51 108.56 172.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 p90 -111.08 131.36 55.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.738 0.815 . . . . 75.43 111.197 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.36 129.9 56.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.545 1.138 . . . . 71.51 110.172 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.95 123.84 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 74.52 111.721 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.46 170.7 13.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.952 0.901 . . . . 63.5 111.9 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.36 -25.89 68.23 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.036 0.534 . . . . 74.42 111.618 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.85 -1.53 35.42 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.453 0.701 . . . . 75.44 112.107 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.18 32.57 51.95 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 122.656 0.17 . . . . 64.14 113.124 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.75 134.76 40.49 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.481 0.712 . . . . 71.22 111.176 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -92.82 106.32 18.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.579 0.752 . . . . 75.43 110.854 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.51 112.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.846 0.859 . . . . 74.21 109.843 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.18 115.55 27.5 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 74.01 109.536 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -116.48 136.39 23.1 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.121 0.969 . . . . 73.0 111.066 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.75 96.48 1.0 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.873 2.382 . . . . 73.2 112.793 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.72 -20.39 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 116.091 -0.504 . . . . 64.0 111.065 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.57 -169.47 53.53 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.989 0.756 . . . . 73.15 114.989 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 77' ' ' VAL . 62.7 mt -117.95 130.63 24.6 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.97 1.308 . . . . 75.45 109.11 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.04 -27.49 29.85 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.204 1.936 . . . . 72.31 111.94 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -137.97 77.71 36.95 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.341 1.456 . . . . 74.5 108.991 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.48 -35.52 29.99 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.956 2.437 . . . . 74.24 114.268 -167.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.93 -39.89 83.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.232 0.613 . . . . 75.35 110.428 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.45 -49.81 75.33 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.972 -0.558 . . . . 75.51 110.676 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 71' ' ' LEU . 81.9 t -55.93 -43.91 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.332 1.053 . . . . 74.04 111.919 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -62.84 -41.82 99.5 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.473 0.709 . . . . 74.43 112.113 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.43 -32.88 64.64 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.296 0.639 . . . . 72.24 112.359 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.22 -38.86 88.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.067 0.547 . . . . 72.31 110.107 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.99 -39.01 87.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.332 0.653 . . . . 70.15 110.877 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.47 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.706 0.802 . . . . 74.31 112.101 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 t -73.95 -53.13 10.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.166 0.586 . . . . 70.44 111.253 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.52 ' HG3' ' SD ' ' A' ' 33' ' ' MET . 9.9 pt20 -67.68 -28.93 68.1 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.711 0.804 . . . . 74.41 112.664 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.7 p -64.02 -26.57 68.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.291 0.478 . . . . 64.31 112.291 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -90.43 -41.79 11.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.572 0.749 . . . . 54.2 112.27 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -77.81 -43.97 28.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.784 1.031 . . . . 74.14 113.784 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 mmt -69.1 -44.07 73.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.766 0.826 . . . . 71.52 112.571 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.87 150.14 20.79 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.418 0.687 . . . . 73.52 111.097 -165.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.597 HD22 ' HA ' ' A' ' 122' ' ' ILE . 8.8 p30 -52.76 -34.47 53.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.307 0.854 . . . . 75.23 113.307 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 119' ' ' HIS . 26.2 m -120.48 170.83 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.719 0.808 . . . . 64.35 110.224 169.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -78.69 102.04 7.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 120.987 0.422 . . . . 64.2 110.129 170.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.74 116.97 27.4 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.183 -1.414 . . . . 73.2 107.183 174.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -103.76 98.32 12.84 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 122.858 0.463 . . . . 74.33 110.476 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.56 165.53 18.22 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.178 1.919 . . . . 74.24 112.294 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 9.5 tp10 -84.69 129.45 34.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.494 0.718 . . . . 75.4 109.418 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.545 ' HB3' HD13 ' A' ' 108' ' ' LEU . 53.4 mtt -132.84 120.62 21.79 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.49 0.716 . . . . 71.21 110.862 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.598 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.4 mm-40 -128.49 137.97 52.05 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.198 0.599 . . . . 73.52 110.446 173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.44 112.66 24.66 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.537 0.735 . . . . 74.23 110.348 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -114.9 127.16 55.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.885 0.874 . . . . 65.25 111.757 -170.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -88.38 118.72 28.2 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.384 0.674 . . . . 74.22 110.689 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.57 HG11 HG23 ' A' ' 5' ' ' THR . 15.0 t -124.68 113.52 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.631 1.172 . . . . 74.25 108.885 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.21 65.64 Favored Glycine 0 CA--C 1.543 1.84 0 N-CA-C 115.495 0.958 . . . . 51.31 115.495 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.63 6.05 70.88 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.348 0.499 . . . . 72.21 114.348 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -114.36 136.55 52.87 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.884 0.873 . . . . 74.05 108.73 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 m -93.37 132.33 37.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.569 0.622 . . . . 74.23 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.77 169.14 11.4 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.382 1.073 . . . . 75.31 109.002 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.641 HD23 HD13 ' A' ' 52' ' ' LEU . 55.1 tp -120.0 116.39 25.66 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.733 0.302 . . . . 75.0 110.446 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.423 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 51.6 t -87.78 130.89 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.297 -0.631 . . . . 71.53 109.297 173.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 24.0 t -116.19 100.92 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 122.959 0.504 . . . . 71.04 110.062 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.721 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 81.8 t80 -83.74 126.61 33.07 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.13 -0.693 . . . . 73.44 109.13 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 38.7 t -99.61 112.66 64.02 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.907 -0.405 . . . . 73.02 109.907 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.29 152.08 15.83 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.721 2.28 . . . . 71.13 111.941 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -65.99 111.57 3.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.979 0.912 . . . . 74.41 111.365 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -68.73 156.01 39.06 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.353 0.661 . . . . 75.32 112.364 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.98 141.43 51.03 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 123.717 0.807 . . . . 74.12 109.631 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.45 -40.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 115.664 1.727 . . . . 75.22 115.664 -171.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -72.48 -35.02 68.09 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.973 0.731 . . . . 74.41 112.973 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -139.03 79.17 1.71 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.936 -1.505 . . . . 71.5 106.936 169.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 17.5 ptpt -47.98 -155.2 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.733 2 N-CA-C 123.596 4.665 . . . . 73.25 123.596 43.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo 13.98 67.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.214 1.943 . . . . 75.42 116.085 -121.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.617 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.7 mm -77.63 102.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 114.467 -1.242 . . . . 72.44 110.048 175.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.425 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.0 p90 -108.94 147.65 31.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.739 0.815 . . . . 74.14 110.329 169.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm . . . . . 0 N--CA 1.477 0.914 0 C-N-CA 123.345 0.658 . . . . 74.45 110.232 173.081 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.681 ' SD ' ' HG2' ' A' ' 96' ' ' GLU . 17.2 ptm . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 112.471 0.545 . . . . 75.14 112.471 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -98.41 168.12 10.4 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.891 0.876 . . . . 74.52 111.668 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 t -76.99 155.82 32.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.757 0.823 . . . . 75.34 112.119 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.02 -34.13 77.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.357 0.663 . . . . 75.22 111.797 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.509 HG22 HG11 ' A' ' 102' ' ' VAL . 2.4 m -66.7 -44.06 82.72 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.472 0.653 . . . . 75.11 110.557 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.55 -50.57 73.37 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 125.246 1.418 . . . . 74.44 111.962 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.415 ' HB2' HD21 ' A' ' 51' ' ' LEU . 86.7 mt -62.92 -44.37 96.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.644 0.778 . . . . 75.14 111.871 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.653 ' HA ' HD11 ' A' ' 11' ' ' LEU . 51.9 tp -59.36 -40.36 86.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.224 1.01 . . . . 71.53 111.601 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.41 -41.95 99.07 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.007 -0.997 . . . . 72.35 110.875 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 14' ' ' VAL . 13.2 mm-40 -72.57 -30.3 64.29 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.572 -0.74 . . . . 75.23 112.308 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 8' ' ' LEU . 78.5 mt -57.36 -44.82 84.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.348 0.659 . . . . 75.24 112.244 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -88.49 -5.12 58.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.922 0.489 . . . . 75.25 112.313 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.24 -55.84 3.51 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.226 0.61 . . . . 72.14 111.671 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 10' ' ' GLU . 33.1 m -90.55 118.79 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.185 0.517 . . . . 75.03 111.541 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -43.85 -25.53 0.2 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.493 1.664 . . . . 71.34 115.493 172.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -127.78 122.54 33.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.862 0.465 . . . . 73.43 110.841 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.5 m -74.5 92.08 2.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.532 0.733 . . . . 74.34 110.496 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.92 -63.31 1.16 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.394 0.678 . . . . 73.14 111.769 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -119.82 -1.08 10.56 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 119.247 -0.406 . . . . 74.1 112.049 175.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.5 105.84 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.021 0.828 . . . . 64.25 109.085 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -121.57 130.21 53.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.055 0.542 . . . . 71.31 110.816 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.65 134.93 45.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.05 112.45 -172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 151.53 46.42 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.045 0.938 . . . . 74.23 111.076 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -84.08 154.05 23.42 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.97 0.908 . . . . 75.41 110.288 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.37 70.08 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 112.99 0.737 . . . . 74.42 112.99 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.1 p -81.22 13.41 2.88 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.786 1.032 . . . . 74.51 113.786 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.05 4.52 19.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.054 0.542 . . . . 63.21 112.118 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mtp -53.69 104.56 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.533 0.568 . . . . 73.55 112.533 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.74 -142.83 7.95 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.395 -0.366 . . . . 60.54 113.188 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -70.9 -21.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.238 1.015 . . . . 74.24 113.039 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 m -75.12 -43.39 53.01 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.95 0.5 . . . . 74.51 110.941 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -37.92 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.239 0.615 . . . . 74.42 110.607 168.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.527 ' HA ' HG23 ' A' ' 36' ' ' VAL . 20.7 mmt -71.19 -31.86 68.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.773 -0.649 . . . . 73.32 112.592 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.29 -32.75 74.47 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.398 0.618 . . . . 65.44 110.054 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -78.05 -46.38 21.03 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.699 0.8 . . . . 73.42 112.171 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 33' ' ' MET . 19.8 m -59.58 -39.01 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 118.11 0.414 . . . . 71.44 112.116 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.15 -35.75 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.287 0.635 . . . . 74.52 110.996 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.1 -38.41 91.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.849 0.46 . . . . 70.23 112.102 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -73.87 -47.68 36.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.172 0.589 . . . . 70.43 111.481 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.77 -21.85 60.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.585 0.957 . . . . 73.05 113.585 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -93.37 -42.75 9.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.21 0.604 . . . . 75.11 111.442 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.44 111.58 4.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.666 0.786 . . . . 74.21 112.019 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.08 105.3 0.67 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.791 2.327 . . . . 72.34 112.831 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.19 19.63 11.38 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.674 -0.694 . . . . 73.52 114.749 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.9 tp -106.84 5.49 28.52 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.764 1.282 . . . . 75.53 112.205 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -40.91 124.47 2.15 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 125.11 1.364 . . . . 73.02 113.711 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 105.57 51.52 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.896 -0.593 . . . . 71.11 112.627 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -112.55 149.27 18.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 111.673 -0.571 . . . . 62.41 111.673 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -123.47 126.84 47.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.648 0.779 . . . . 71.01 111.354 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -104.73 116.68 32.45 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.471 -1.307 . . . . 73.25 107.471 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' A' ' 7' ' ' LEU . 31.2 tp -103.4 112.35 25.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.724 0.409 . . . . 74.44 111.021 -173.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.638 HD13 HD22 ' A' ' 108' ' ' LEU . 93.1 mt -92.88 140.16 29.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.601 0.76 . . . . 75.21 111.65 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.21 7.04 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.926 -0.579 . . . . 60.3 112.739 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.08 144.37 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.507 0.723 . . . . 55.14 110.672 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -124.6 163.85 21.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 75.41 108.002 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -154.77 138.69 16.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.423 0.527 . . . . 71.15 112.423 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 151.97 47.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.799 0.84 . . . . 74.22 111.279 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -91.62 131.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.592 0.757 . . . . 73.25 111.467 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -84.89 -172.09 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.912 0.485 . . . . 72.44 111.659 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.06 -37.71 80.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.268 0.627 . . . . 71.44 112.562 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -77.33 -29.35 53.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 72.01 112.264 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.12 9.55 15.46 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.626 0.61 . . . . 63.5 114.626 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.05 138.7 37.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.283 0.633 . . . . 71.34 111.378 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -83.87 111.2 19.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.306 0.642 . . . . 62.55 109.584 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.45 115.32 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.786 . . . . 72.14 109.863 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -93.3 115.27 27.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.205 0.602 . . . . 74.43 111.095 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -110.67 153.34 43.66 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.131 0.972 . . . . 74.44 111.405 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.42 116.55 2.99 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.305 2.004 . . . . 74.02 113.032 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.01 -30.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 122.824 0.449 . . . . 72.24 110.745 168.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.58 -175.91 53.97 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.729 -0.668 . . . . 73.23 112.613 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.69 138.7 23.38 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 122.358 -0.496 . . . . 75.4 110.37 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.38 -33.9 28.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.698 2.265 . . . . 74.33 112.618 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -127.37 66.49 69.07 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.015 0.926 . . . . 61.14 109.648 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HB2' HD22 ' A' ' 99' ' ' LEU . 60.5 Cg_endo -65.34 -36.04 37.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.863 2.375 . . . . 72.25 113.725 -164.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.19 -40.59 82.17 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.645 0.778 . . . . 65.33 110.41 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -70.34 -35.69 73.75 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.2 -0.909 . . . . 64.32 111.551 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.35 -43.07 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.655 0.782 . . . . 72.25 110.815 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.505 ' HG2' HH21 ' A' ' 79' ' ' ARG . 53.2 tt0 -56.59 -45.04 81.59 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.578 0.751 . . . . 72.13 111.85 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.505 HH21 ' HG2' ' A' ' 78' ' ' GLN . 4.0 mmp_? -75.45 -36.95 60.61 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.668 -0.697 . . . . 63.34 112.626 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.33 -35.15 75.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.243 0.617 . . . . 73.54 110.42 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 26.8 tp -70.68 -39.62 73.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.613 0.765 . . . . 75.01 110.739 176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.12 77.3 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.152 0.581 . . . . 74.33 111.817 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -72.14 -53.2 13.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.289 0.635 . . . . 73.35 111.436 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.417 ' HG2' ' HA ' ' A' ' 81' ' ' LEU . 11.9 pt20 -71.05 -32.46 69.17 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.056 0.762 . . . . 71.3 113.056 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 p -64.85 -31.3 72.46 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 118.877 0.762 . . . . 75.23 112.228 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -81.45 -27.1 34.81 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 116.033 -0.531 . . . . 74.11 112.381 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -92.14 -33.89 14.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.694 0.628 . . . . 74.21 112.694 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -79.86 -48.04 14.14 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.09 0.556 . . . . 75.01 111.294 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -81.63 157.61 24.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.849 -0.614 . . . . 74.34 111.294 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -45.96 -35.39 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.358 1.463 . . . . 70.31 114.16 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.62 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.458 0.703 . . . . 75.32 111.093 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -71.72 97.53 1.78 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.725 -0.67 . . . . 62.41 110.216 170.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.89 123.89 28.17 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.944 -1.132 . . . . 75.33 107.944 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -104.01 96.02 8.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.398 0.679 . . . . 75.0 110.694 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.524 ' HG2' ' HE1' ' A' ' 97' ' ' MET . 68.9 Cg_endo -87.91 166.63 7.14 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.09 1.86 . . . . 74.43 111.977 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.681 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 40.9 tt0 -101.23 115.71 31.13 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.924 -0.769 . . . . 71.12 108.924 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.524 ' HE1' ' HG2' ' A' ' 95' ' ' PRO . 61.5 mtt -115.07 131.14 57.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.326 0.65 . . . . 75.43 112.006 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -142.02 146.71 35.84 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.813 0.845 . . . . 75.03 110.964 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 74' ' ' PRO . 42.6 mt -102.37 119.35 38.66 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.984 0.913 . . . . 65.53 110.329 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -124.87 130.32 52.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.695 1.198 . . . . 72.01 109.584 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -94.49 121.76 36.37 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.955 0.407 . . . . 74.11 111.643 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 5' ' ' THR . 12.4 t -126.4 127.08 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.285 1.034 . . . . 64.24 109.46 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.89 30.87 57.75 Favored Glycine 0 CA--C 1.548 2.124 0 N-CA-C 115.265 0.866 . . . . 71.21 115.265 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.98 81.78 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.905 0.352 . . . . 74.22 113.938 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -116.38 146.18 42.67 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.088 0.955 . . . . 75.42 109.803 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -95.34 104.58 16.47 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.969 0.804 . . . . 74.25 111.105 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.0 162.01 14.56 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.829 0.851 . . . . 72.35 111.497 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 52' ' ' LEU . 61.9 tp -120.28 118.36 30.22 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.738 0.815 . . . . 73.33 110.366 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.56 119.91 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.273 -0.64 . . . . 73.02 109.273 171.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.33 101.1 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.126 -0.694 . . . . 53.43 109.126 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.582 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.2 t80 -76.83 113.81 14.91 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.36 -0.607 . . . . 74.25 109.36 174.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.11 99.29 42.63 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 108.903 -0.777 . . . . 63.21 108.903 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.38 -176.44 1.55 Allowed 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.733 2.288 . . . . 72.34 113.093 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 44.4 mt-10 -84.92 148.33 26.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.825 -0.625 . . . . 72.33 109.748 165.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.11 178.81 4.45 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.668 0.787 . . . . 62.15 110.481 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.61 124.35 24.51 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 118.282 -0.866 . . . . 75.15 110.368 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -38.06 -37.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 116.54 2.052 . . . . 75.43 116.54 -157.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -57.01 -40.53 76.8 Favored 'General case' 0 N--CA 1.509 2.483 0 CA-C-N 118.963 0.802 . . . . 74.05 112.003 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.64 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 14.5 m-70 -133.58 77.92 1.75 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 103.986 -2.598 . . . . 70.35 103.986 165.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.5 mtmt -46.86 -149.78 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 2 C-N-CA 133.016 4.526 . . . . 75.14 122.456 46.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo 12.06 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.808 2.339 . . . . 61.44 115.112 -120.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 120' ' ' LYS . 51.1 mm -86.31 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 115.158 -0.928 . . . . 72.11 110.56 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -156.37 165.38 36.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.807 0.843 . . . . 75.34 110.386 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 122.458 0.303 . . . . 72.22 110.59 178.845 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.652 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 46.5 ttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.499 0.19 . . . . 74.2 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HB2' HD13 ' A' ' 7' ' ' LEU . 19.4 mmt180 -79.07 162.87 25.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.89 0.876 . . . . 75.2 110.783 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.8 t -80.73 155.09 26.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.183 0.593 . . . . 64.21 110.203 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.39 67.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.86 0.464 . . . . 63.32 112.103 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -70.0 -44.27 69.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.128 0.571 . . . . 74.1 110.602 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.8 -48.99 79.47 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.041 0.936 . . . . 61.52 111.398 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 20' ' ' ILE . 80.8 mt -74.43 -31.67 62.37 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.039 -0.982 . . . . 70.31 112.867 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.34 -46.83 81.76 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.937 0.495 . . . . 75.05 110.264 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.26 -33.34 73.38 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.195 -0.911 . . . . 73.35 110.789 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.1 tp10 -70.49 -41.92 72.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.594 0.758 . . . . 75.12 110.933 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.2 mt -59.13 -43.16 91.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.983 0.913 . . . . 74.32 111.918 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -68.56 -32.37 72.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.193 0.597 . . . . 75.03 111.274 176.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.79 68.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.718 0.807 . . . . 73.11 112.072 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.79 148.39 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.377 0.608 . . . . 72.33 111.389 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.72 -14.89 55.94 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 75.44 111.635 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.07 153.46 25.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.648 0.779 . . . . 63.54 110.582 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.5 m -73.99 92.13 2.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.742 0.417 . . . . 75.11 111.101 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.48 -65.43 1.01 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.382 0.673 . . . . 62.31 112.264 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -119.11 -15.59 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.356 1.062 . . . . 75.43 110.001 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.551 HD11 HD23 ' A' ' 7' ' ' LEU . 31.5 mm -111.53 119.14 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.603 1.161 . . . . 65.02 108.023 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.45 141.1 48.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.486 0.714 . . . . 71.43 110.792 -171.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.57 127.26 52.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.667 0.787 . . . . 51.15 110.151 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 25.2 mmmt -132.24 136.5 47.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.977 0.911 . . . . 64.41 109.407 -176.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -81.99 168.01 18.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.255 0.55 . . . . 73.43 111.76 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.55 69.38 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.713 0.805 . . . . 72.21 112.507 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -65.72 -37.27 85.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 64.4 111.004 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -76.99 -6.82 54.14 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.379 1.072 . . . . 75.53 113.411 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -69.58 120.29 15.13 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.286 0.565 . . . . 70.11 110.287 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.11 -129.16 5.0 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.853 -0.612 . . . . 65.0 112.436 -172.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -59.33 -39.11 82.08 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.669 0.787 . . . . 73.41 112.097 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 m -65.45 -29.2 69.85 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.086 0.955 . . . . 73.31 112.61 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.514 HG11 HD11 ' A' ' 81' ' ' LEU . 54.3 t -71.12 -51.08 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.726 0.41 . . . . 74.42 110.275 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.468 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -33.74 69.54 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.007 0.923 . . . . 72.01 112.924 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.35 -44.98 72.63 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.128 0.971 . . . . 73.23 111.159 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.3 m -76.89 -39.2 51.81 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.89 . . . . 73.24 112.461 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.25 -34.74 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 124.237 1.015 . . . . 74.25 112.444 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.599 HG12 ' HZ1' ' A' ' 124' ' ' LYS . 58.5 mt -45.14 -45.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 124.087 0.955 . . . . 73.33 112.931 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.44 -60.07 4.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.106 0.562 . . . . 75.01 112.303 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.44 -24.43 62.9 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.622 0.601 . . . . 74.34 112.622 -169.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.82 -48.33 9.47 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.506 0.722 . . . . 70.11 112.353 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -93.3 -27.11 17.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.876 1.065 . . . . 75.22 113.876 -169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.33 121.76 74.16 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 118.283 0.492 . . . . 74.21 111.731 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.15 110.48 1.36 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.598 2.199 . . . . 75.41 112.549 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.73 59.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.058 -0.857 . . . . 74.32 115.207 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.91 20.82 13.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.104 1.452 . . . . 72.45 110.831 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -41.45 114.2 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.218 1.007 . . . . 74.33 112.332 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.15 68.33 0.64 Allowed Glycine 0 N--CA 1.471 0.994 0 N-CA-C 113.738 0.255 . . . . 73.21 113.738 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.63 142.0 17.29 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.925 -0.87 . . . . 74.14 110.925 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.652 ' HE1' ' HG3' ' A' ' 1' ' ' MET . 94.6 m-85 -118.12 129.76 55.72 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.511 0.655 . . . . 75.55 112.11 -170.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 32' ' ' VAL . 5.6 mp -112.07 124.96 53.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.955 0.902 . . . . 74.21 109.329 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 7' ' ' LEU . 3.2 mm? -104.61 109.11 20.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.065 0.546 . . . . 71.53 109.707 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 8.4 mp -92.95 122.32 35.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.409 0.684 . . . . 73.45 109.196 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.14 26.34 3.81 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.571 -0.286 . . . . 63.44 113.374 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.21 133.96 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.409 -0.589 . . . . 72.31 109.409 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -119.12 137.07 53.84 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.457 -0.942 . . . . 72.21 108.457 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -122.88 139.63 53.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.046 0.539 . . . . 73.11 111.58 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.92 151.95 35.55 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.925 0.89 . . . . 75.22 111.177 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.04 122.67 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.356 0.662 . . . . 75.14 110.413 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -96.79 -168.43 1.71 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.629 0.772 . . . . 63.52 112.088 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.89 -32.37 67.65 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.57 1.148 . . . . 73.42 112.925 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -79.54 -11.77 59.88 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.48 0.712 . . . . 74.45 111.561 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.92 84.92 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 116.487 -0.324 . . . . 62.41 112.792 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.43 149.21 30.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.507 1.123 . . . . 65.24 111.914 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -104.62 115.52 30.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.253 1.021 . . . . 75.23 110.404 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.92 128.91 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.42 0.688 . . . . 74.31 109.603 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.77 119.1 32.3 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.177 0.591 . . . . 74.24 110.233 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -129.91 129.17 22.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 123.325 0.65 . . . . 74.45 110.601 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 67.5 Cg_endo -78.68 109.84 2.69 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 73.43 112.421 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.21 -14.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.678 -0.639 . . . . 74.35 111.356 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.82 53.6 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.011 -0.541 . . . . 74.24 113.929 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.34 131.07 23.55 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.055 0.942 . . . . 74.24 110.809 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -32.03 87.9 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.054 2.503 . . . . 75.45 113.009 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -138.74 87.14 15.0 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 108.221 -1.029 . . . . 75.44 108.221 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.1 -28.42 34.68 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.661 2.241 . . . . 71.43 113.505 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -47.63 66.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.082 0.953 . . . . 72.15 111.268 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.61 ' HZ2' ' HB2' ' A' ' 76' ' ' LYS . 4.9 ttmp? -69.65 -44.43 70.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.631 -0.713 . . . . 74.35 111.443 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -58.9 -37.25 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 122.908 0.483 . . . . 75.35 111.47 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.05 -52.38 49.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.842 0.682 . . . . 75.13 112.842 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -75.77 -33.86 60.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 112.434 0.531 . . . . 74.01 112.434 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.56 -33.29 73.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.413 0.685 . . . . 73.25 110.343 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD11 HG11 ' A' ' 32' ' ' VAL . 41.2 tp -63.46 -42.93 98.61 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.53 0.732 . . . . 74.54 111.415 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.25 95.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.286 0.634 . . . . 73.32 111.728 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -63.52 -52.32 61.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.983 0.913 . . . . 65.53 112.036 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.74 -32.52 74.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.101 0.56 . . . . 71.52 112.244 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.178 0.513 . . . . 73.53 112.223 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.51 -20.7 36.21 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.464 0.706 . . . . 65.13 112.016 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -112.31 -2.78 14.72 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.792 1.034 . . . . 72.23 113.792 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.7 mmm -99.6 -26.91 13.93 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.44 0.696 . . . . 72.12 111.327 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -108.32 142.79 38.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.561 0.745 . . . . 74.03 109.212 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' ND2' HG12 ' A' ' 91' ' ' VAL . 7.6 p-10 -57.66 -26.19 61.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.325 0.861 . . . . 72.24 113.325 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 ' ND2' ' A' ' 90' ' ' ASN . 6.6 m -122.22 163.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.479 1.112 . . . . 74.0 111.499 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.28 98.25 7.33 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.273 0.559 . . . . 74.45 110.935 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD13 HG12 ' A' ' 122' ' ' ILE . 4.7 tt -96.24 138.57 33.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.143 0.977 . . . . 73.03 108.686 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -106.77 95.34 12.06 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.004 0.521 . . . . 74.01 111.766 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.75 155.46 15.61 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.783 1.655 . . . . 74.42 111.198 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.714 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 41.7 tt0 -108.12 120.53 42.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.529 0.732 . . . . 75.34 110.906 -171.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.71 ' HB3' HD12 ' A' ' 108' ' ' LEU . 1.8 mpt? -111.7 141.74 44.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.73 0.812 . . . . 61.14 111.413 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 133.53 15.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.681 -0.489 . . . . 75.3 109.681 167.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.0 mt -81.46 116.21 21.15 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.571 0.748 . . . . 74.42 110.74 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -123.25 130.77 53.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.799 1.24 . . . . 64.14 110.221 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -94.61 125.45 39.27 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.168 0.587 . . . . 73.44 111.281 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.45 119.15 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.913 0.885 . . . . 75.52 109.225 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.43 41.53 63.51 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.453 0.941 . . . . 74.2 115.453 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.98 88.66 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.883 0.713 . . . . 70.31 114.883 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.7 mmtt -110.0 139.85 44.66 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.791 0.837 . . . . 74.34 109.292 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.9 m -100.3 124.57 45.94 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.777 0.717 . . . . 74.4 111.024 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.49 164.9 14.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.127 0.971 . . . . 74.4 108.981 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 97' ' ' MET . 43.5 tp -115.64 116.52 28.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.58 0.352 . . . . 65.2 110.11 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.38 121.88 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 109.21 -0.663 . . . . 71.11 109.21 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.88 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.002 0.521 . . . . 72.0 110.623 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.714 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 63.4 t80 -80.49 114.77 19.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.12 109.715 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.23 102.13 34.88 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.516 -0.92 . . . . 74.22 108.516 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.42 169.8 15.25 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.396 2.064 . . . . 74.2 112.481 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -80.79 128.09 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.547 -0.751 . . . . 74.52 109.286 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.93 173.91 9.05 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.185 0.594 . . . . 72.11 111.669 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.59 155.97 37.89 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.679 0.792 . . . . 75.45 110.677 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.8 t -47.41 -42.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 114.85 1.426 . . . . 73.31 114.85 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 123.515 0.726 . . . . 70.12 112.471 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -129.37 78.21 1.84 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 103.605 -2.739 . . . . 62.33 103.605 169.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 32.2 mmtp -44.16 -159.01 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.781 1 C-N-CA 132.04 4.136 . . . . 72.24 120.861 66.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo 5.03 71.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.265 2.644 . . . . 73.15 118.059 -132.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.461 HG12 HD13 ' A' ' 93' ' ' LEU . 1.8 mp -76.6 101.28 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.13 -1.063 . . . . 75.44 108.13 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -105.67 154.68 20.11 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.338 0.655 . . . . 73.24 109.813 168.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HZ1' HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 122.809 0.443 . . . . 75.21 110.603 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.99 -0.374 . . . . 74.31 109.99 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -40.08 134.67 1.5 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.85 1.26 . . . . 75.15 114.328 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -69.38 159.86 32.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.048 0.939 . . . . 73.32 112.007 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.08 70.37 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.26 0.624 . . . . 75.53 112.596 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -65.87 -43.79 87.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.13 110.641 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.61 -43.29 76.71 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 115.199 -0.91 . . . . 73.21 111.566 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.432 HD23 HD11 ' A' ' 20' ' ' ILE . 86.1 mt -65.94 -42.14 90.42 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.533 0.733 . . . . 72.45 111.406 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 11' ' ' LEU . 25.9 tp -52.04 -48.68 64.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.628 1.171 . . . . 74.51 111.075 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.9 -46.22 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.814 -1.084 . . . . 74.32 111.878 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.34 -30.18 61.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.412 -0.358 . . . . 74.2 111.726 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 8' ' ' LEU . 79.7 mt -57.82 -52.88 63.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.518 0.727 . . . . 73.1 111.596 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.57 -1.1 49.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.563 0.579 . . . . 70.34 112.563 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.6 -50.06 8.01 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.051 0.54 . . . . 72.34 110.611 170.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 m -80.24 150.51 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.101 0.56 . . . . 71.32 111.191 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -72.76 -27.76 62.21 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.482 0.713 . . . . 75.14 112.478 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.57 134.1 24.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.814 0.845 . . . . 73.25 109.389 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.637 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 50.9 p -72.91 80.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.483 0.713 . . . . 75.54 111.234 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.71 -64.28 1.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.611 0.765 . . . . 71.43 112.272 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.6 -26.97 14.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.008 0.523 . . . . 74.5 110.739 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.432 HD11 HD23 ' A' ' 7' ' ' LEU . 36.4 mt -116.18 109.0 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.502 -0.925 . . . . 74.22 108.502 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 8.9 tp10 -100.73 151.57 21.51 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.076 1.351 . . . . 74.32 111.307 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.44 134.25 53.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.562 0.745 . . . . 72.11 110.987 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HG2' HG21 ' A' ' 32' ' ' VAL . 13.8 mptt -130.87 149.8 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.753 0.821 . . . . 75.41 110.338 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.46 169.24 13.03 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.801 0.841 . . . . 74.54 111.653 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.61 88.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.951 0.501 . . . . 73.2 111.03 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -60.28 -35.66 76.05 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.336 1.054 . . . . 64.3 112.166 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.74 3.64 50.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.903 0.881 . . . . 62.04 112.416 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.492 ' HE2' HD13 ' A' ' 81' ' ' LEU . 83.8 mmm -65.93 128.29 35.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.324 0.649 . . . . 73.41 111.73 170.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.4 -146.84 15.84 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.098 -0.501 . . . . 73.13 112.573 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.4 -18.34 65.3 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.292 0.637 . . . . 74.43 112.568 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -73.72 -37.08 65.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.207 0.603 . . . . 61.35 111.44 176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG21 ' HG2' ' A' ' 23' ' ' LYS . 58.7 t -65.72 -47.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.12 0.486 . . . . 72.35 109.792 172.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.516 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 86.4 mmm -62.71 -35.19 78.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.962 -1.017 . . . . 63.24 112.662 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -40.08 91.5 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.817 0.847 . . . . 75.34 111.012 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -71.01 -35.6 72.1 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.708 -0.678 . . . . 75.22 111.11 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.09 -46.23 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.635 0.774 . . . . 74.11 110.785 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.4 -36.81 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.908 0.883 . . . . 74.3 110.931 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.35 62.65 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.919 0.888 . . . . 63.35 113.045 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -91.47 -42.25 10.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 122.103 -0.373 . . . . 63.01 111.011 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.81 -55.29 10.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.831 1.049 . . . . 73.12 113.831 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.27 -16.32 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.441 0.696 . . . . 73.25 112.668 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 54.1 mm-40 -79.78 132.59 60.61 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.152 0.581 . . . . 74.4 112.124 -177.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 21.4 Cg_exo -65.34 101.84 0.44 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.176 2.584 . . . . 72.45 113.218 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.75 74.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.075 1.19 . . . . 73.43 116.075 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.38 22.11 8.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.532 1.166 . . . . 74.32 110.905 173.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 16.9 t70 -50.41 153.77 1.46 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.208 1.403 . . . . 73.51 112.686 165.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 92.59 36.58 6.1 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.715 -0.675 . . . . 75.44 112.936 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.3 141.11 15.29 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 117.503 0.651 . . . . 73.42 112.661 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -118.49 127.32 53.52 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.269 0.627 . . . . 74.35 112.02 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.675 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 64.6 mt -100.73 109.5 21.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.013 1.325 . . . . 74.32 109.529 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 HD11 HG22 ' A' ' 109' ' ' VAL . 21.1 tp -101.67 109.95 21.84 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.406 0.622 . . . . 72.25 109.762 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.67 HD13 HD22 ' A' ' 108' ' ' LEU . 47.2 mt -99.35 136.32 39.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 72.43 110.416 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.23 5.93 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-O 121.224 0.347 . . . . 71.24 112.723 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.5 t -111.54 138.17 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.486 0.715 . . . . 73.22 109.636 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 18.0 t70 -103.64 148.42 26.04 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.146 -1.057 . . . . 75.22 108.146 174.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -145.29 143.01 29.96 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.152 0.501 . . . . 75.52 111.608 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.68 152.73 37.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.746 0.818 . . . . 74.44 110.428 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.08 126.87 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.927 0.491 . . . . 75.04 110.555 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -87.77 -179.29 6.24 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.359 0.663 . . . . 75.32 111.514 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -61.17 -19.17 61.25 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.962 1.097 . . . . 74.45 113.962 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -80.95 -14.87 57.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.228 0.611 . . . . 72.42 112.498 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.05 41.54 17.91 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.737 -0.545 . . . . 75.24 111.737 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.39 139.03 51.81 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.774 1.23 . . . . 71.05 110.32 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -84.87 119.89 25.85 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.201 0.601 . . . . 71.13 110.592 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.89 124.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.144 0.578 . . . . 73.33 110.056 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.05 122.05 41.78 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.459 0.703 . . . . 75.51 110.597 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 9.0 ptm180 -127.06 139.1 34.15 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.605 1.162 . . . . 74.11 110.76 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HD3' HD21 ' A' ' 8' ' ' LEU . 77.2 Cg_endo -86.3 98.47 0.55 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.714 2.276 . . . . 72.44 112.837 -176.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.5 -17.93 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 71.34 111.687 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.41 46.52 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 116.302 -0.408 . . . . 63.41 113.561 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.14 136.74 21.89 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-O 118.868 -0.587 . . . . 72.44 110.064 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.62 -36.29 92.82 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.609 2.206 . . . . 73.41 112.473 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -130.35 87.52 50.38 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.416 0.687 . . . . 70.42 109.342 168.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.69 -26.71 9.59 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.84 2.36 . . . . 75.24 114.047 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 6.3 m-20 -72.22 -47.21 52.17 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.444 0.698 . . . . 74.14 111.163 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -61.56 -36.49 80.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.262 0.351 . . . . 63.03 110.762 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.445 HG11 ' HE1' ' A' ' 28' ' ' MET . 47.3 t -60.99 -43.69 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.013 0.925 . . . . 64.31 111.221 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.99 -45.98 90.97 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.624 0.769 . . . . 71.33 111.962 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 28.8 mmm180 -70.67 -45.33 65.25 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.716 -0.675 . . . . 75.21 111.875 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.36 -28.07 64.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.759 0.824 . . . . 74.52 111.884 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.492 HD13 ' HE2' ' A' ' 28' ' ' MET . 31.9 tp -69.76 -40.01 76.38 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.588 0.355 . . . . 74.4 110.748 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.53 91.03 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.057 0.543 . . . . 63.31 111.252 173.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -64.93 -52.64 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.873 0.869 . . . . 73.53 111.712 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -64.78 -31.69 73.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.878 0.471 . . . . 73.42 111.901 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.7 t -69.73 -25.42 63.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 64.42 112.048 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.05 -33.58 20.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.428 0.691 . . . . 70.43 112.267 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 p -92.21 -37.28 12.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.667 0.988 . . . . 75.24 113.667 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.516 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 82.4 mtp -76.28 -47.48 23.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.031 0.532 . . . . 72.33 112.059 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.75 148.3 36.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.304 0.642 . . . . 75.13 112.11 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -53.78 -32.27 51.83 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.825 1.25 . . . . 73.53 112.864 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.7 m -129.41 172.37 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.281 1.032 . . . . 73.33 111.338 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.82 104.4 13.88 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.912 -0.586 . . . . 54.23 110.986 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 tt -93.02 133.23 36.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.791 -1.189 . . . . 75.54 107.791 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -109.61 95.3 19.08 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 122.808 0.443 . . . . 74.14 111.633 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.73 158.93 10.54 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.563 2.175 . . . . 73.23 112.405 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 tp10 -100.77 131.8 46.49 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.535 0.734 . . . . 74.21 109.483 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.574 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.9 mtt -125.71 116.66 22.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.08 0.552 . . . . 75.52 111.324 -172.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -114.99 133.28 56.17 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 75.42 111.05 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.68 109.73 21.15 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.122 0.569 . . . . 71.4 109.538 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -109.43 128.1 54.89 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.724 1.209 . . . . 61.42 112.309 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -97.97 109.33 22.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.341 0.591 . . . . 64.12 110.718 174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -121.17 112.73 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.624 1.17 . . . . 64.34 108.63 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.36 29.68 66.59 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 113.886 0.314 . . . . 74.3 113.886 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.03 0.44 90.3 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.197 0.439 . . . . 74.05 114.197 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -100.81 137.2 39.52 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.511 0.724 . . . . 74.24 109.301 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -98.56 121.38 40.43 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 119.047 0.84 . . . . 73.4 111.997 -174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.78 166.98 11.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.124 1.37 . . . . 74.2 108.864 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.67 HD22 HD13 ' A' ' 52' ' ' LEU . 26.4 tp -123.72 109.84 14.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.086 -0.384 . . . . 73.04 110.513 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 51' ' ' LEU . 59.0 t -84.3 123.24 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.938 -0.764 . . . . 65.55 108.938 171.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 40.9 t -118.41 99.84 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.394 0.678 . . . . 72.03 109.607 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.422 ' HE1' ' HA2' ' A' ' 47' ' ' GLY . 87.5 t80 -79.88 122.5 26.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.78 -0.646 . . . . 64.43 110.021 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.29 112.08 65.12 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 109.085 -0.709 . . . . 74.33 109.085 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.49 172.78 15.6 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.612 2.208 . . . . 74.33 113.044 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -58.24 160.59 4.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.485 0.714 . . . . 74.22 112.366 172.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -110.46 135.15 51.58 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 115.851 -0.613 . . . . 72.51 110.063 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 18.5 t70 -65.57 160.66 21.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.669 1.187 . . . . 73.52 112.001 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -47.3 -38.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.188 1.181 . . . . 74.51 114.188 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -75.21 -39.46 60.08 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.309 0.485 . . . . 64.42 112.309 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 4.3 p-80 -142.75 94.98 2.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.821 -1.548 . . . . 74.31 106.821 171.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 22.2 pttp -47.14 -163.77 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.39 2 C-N-CA 133.965 4.906 . . . . 62.34 123.298 43.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo 7.69 77.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.603 2.202 . . . . 71.24 116.566 -113.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 120' ' ' LYS . 60.0 mt -94.65 113.59 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.781 -1.1 . . . . 73.24 109.267 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -131.3 141.27 49.93 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.568 0.699 . . . . 75.3 111.508 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tttm . . . . . 0 CA--C 1.558 1.265 0 CA-C-N 114.52 -1.218 . . . . 74.4 110.523 169.506 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.322 -0.251 . . . . 74.31 110.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 174.43 144.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.744 . . . . 75.22 109.882 -154.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.34 154.43 30.83 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.431 0.293 . . . . 54.24 111.401 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.99 74.61 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.467 0.707 . . . . 72.55 112.423 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.611 HG22 HG11 ' A' ' 102' ' ' VAL . 3.7 m -65.3 -41.72 93.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.708 0.803 . . . . 71.32 110.71 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.0 -38.81 69.58 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.19 -0.914 . . . . 70.53 110.857 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 HD13 HG12 ' A' ' 109' ' ' VAL . 61.4 mt -65.03 -40.42 94.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.034 0.534 . . . . 60.3 111.301 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HA ' HD12 ' A' ' 11' ' ' LEU . 33.6 tp -62.42 -46.5 88.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.636 0.774 . . . . 74.44 110.559 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.0 -41.01 86.62 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.744 -1.116 . . . . 72.25 111.514 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.71 -38.48 83.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.472 0.709 . . . . 75.22 111.545 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 8' ' ' LEU . 44.6 mt -60.29 -39.79 88.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.191 0.996 . . . . 73.1 111.155 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.93 -32.28 69.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.765 0.826 . . . . 74.53 111.903 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.07 -46.02 58.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.876 0.87 . . . . 75.52 112.012 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.22 151.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.352 0.596 . . . . 73.54 112.121 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.22 -33.33 61.35 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.853 0.861 . . . . 75.43 111.113 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -147.95 156.52 42.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 73.01 109.958 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -66.44 76.07 0.1 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.865 0.866 . . . . 63.15 111.552 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -61.87 2.29 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.209 1.004 . . . . 74.42 111.996 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -133.98 8.38 3.78 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.024 0.93 . . . . 72.53 110.717 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.62 107.67 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.924 0.89 . . . . 72.13 110.347 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -92.33 148.65 21.96 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.35 1.06 . . . . 70.55 111.24 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.1 54.18 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.314 1.045 . . . . 73.54 109.882 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 65.0 mttm -139.62 141.02 37.13 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 73.01 111.74 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -84.92 164.21 18.49 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 115.308 -0.86 . . . . 74.44 110.449 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' MET . . . -62.65 -31.99 72.95 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.589 0.589 . . . . 75.04 112.589 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -69.61 -21.97 63.53 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.094 0.775 . . . . 71.04 113.094 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.87 -8.45 48.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.701 0.8 . . . . 63.21 111.937 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -55.03 119.95 6.2 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.108 1.363 . . . . 74.01 112.035 -176.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.98 -147.07 18.95 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.95 -0.46 . . . . 53.01 111.95 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -64.07 -25.01 67.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.239 0.616 . . . . 74.31 112.547 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -59.63 -36.92 77.31 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.232 0.613 . . . . 71.44 111.898 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 34.8 t -71.97 -43.62 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.311 0.577 . . . . 71.23 111.105 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.619 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 80.0 mmm -69.65 -40.9 76.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.118 1.155 . . . . 73.25 114.118 -166.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.73 -31.04 71.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.813 0.34 . . . . 73.11 110.909 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 m -67.75 -37.56 82.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.387 0.675 . . . . 75.43 111.004 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.07 -41.09 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.29 0.636 . . . . 72.42 110.86 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.76 -35.07 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.256 0.622 . . . . 64.43 110.39 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.24 63.45 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.807 0.843 . . . . 75.45 112.636 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -99.07 -29.49 12.86 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.307 0.643 . . . . 73.42 111.921 170.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.82 -34.69 75.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 61.5 112.377 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -8.08 58.81 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.545 0.738 . . . . 74.35 112.79 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -81.81 116.42 63.12 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.768 0.827 . . . . 72.41 112.275 -173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.49 111.74 3.39 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.662 2.241 . . . . 73.2 112.438 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.79 19.56 57.7 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.326 0.89 . . . . 72.2 115.326 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.25 21.62 14.53 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 118.716 1.258 . . . . 74.52 111.908 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -40.95 123.05 1.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.637 0.977 . . . . 74.43 113.637 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.64 53.75 0.91 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 116.343 -0.39 . . . . 52.1 113.007 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.81 135.57 12.29 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.423 -1.071 . . . . 70.55 110.423 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.21 128.53 56.27 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.936 0.868 . . . . 73.31 111.914 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.0 mp -112.54 117.81 33.37 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.78 -1.193 . . . . 73.35 107.78 167.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.24 109.83 21.57 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.924 -0.485 . . . . 74.11 109.976 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.7 134.37 40.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.885 0.874 . . . . 74.45 110.575 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.94 28.54 6.16 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 116.293 -0.412 . . . . 64.44 112.13 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.25 138.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.199 0.999 . . . . 75.54 110.252 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -116.71 165.6 13.1 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.864 -1.162 . . . . 63.0 107.864 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -148.58 141.84 25.11 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.387 0.613 . . . . 74.44 111.537 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.04 135.55 53.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.282 1.033 . . . . 74.21 110.536 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 49.6 mm -99.82 118.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.187 0.518 . . . . 73.13 111.515 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 78.6 m-20 -75.99 172.23 13.1 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.846 0.858 . . . . 74.51 111.419 176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.52 -21.45 66.62 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.006 0.522 . . . . 73.51 112.144 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HB3' ' HZ3' ' A' ' 61' ' ' LYS . 7.4 mtpm? -71.61 -14.37 62.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.149 0.98 . . . . 73.42 112.168 173.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.84 35.22 25.42 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.317 -0.713 . . . . 70.53 111.317 -168.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 25.3 t0 -99.86 140.26 34.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.972 0.909 . . . . 74.22 111.395 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -105.76 107.24 18.13 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.392 0.677 . . . . 74.14 110.633 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.54 120.17 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.833 0.853 . . . . 75.33 109.78 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.77 119.42 32.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.188 0.595 . . . . 62.54 110.422 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -121.85 153.52 60.36 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.52 1.128 . . . . 74.41 110.912 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HD3' HD22 ' A' ' 8' ' ' LEU . 89.8 Cg_endo -82.67 141.44 10.96 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.202 1.935 . . . . 71.14 112.738 177.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.87 -26.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.859 0.864 . . . . 73.53 110.681 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 -178.22 53.88 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 121.852 0.696 . . . . 71.14 114.736 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 108' ' ' LEU . 51.4 mt -101.28 142.35 24.43 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.44 110.904 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.79 -27.98 67.93 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.842 2.361 . . . . 75.34 112.424 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -145.49 97.57 4.67 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 107.817 -1.179 . . . . 74.34 107.817 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.34 -51.47 10.94 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.975 3.117 . . . . 72.31 114.689 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 23.1 t70 -64.58 -51.46 62.64 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.325 -0.852 . . . . 53.32 110.551 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.674 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 4.3 ttmp? -59.84 -36.93 77.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.582 0.753 . . . . 73.54 112.839 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.91 -41.82 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.043 0.537 . . . . 74.41 111.249 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.15 -33.35 75.23 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.528 0.731 . . . . 74.25 111.528 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 44.3 mmm-85 -72.41 -51.19 21.46 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.546 0.738 . . . . 74.15 110.886 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.22 -44.49 92.29 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.197 0.999 . . . . 75.12 111.821 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.487 HD22 ' SD ' ' A' ' 97' ' ' MET . 14.7 tp -67.22 -32.81 74.1 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 111.79 0.293 . . . . 64.24 111.79 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.37 96.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.018 0.527 . . . . 75.53 111.212 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 -45.96 90.55 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.412 0.685 . . . . 74.44 111.524 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -53.92 -53.2 55.94 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.994 0.918 . . . . 74.51 111.24 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 10.6 t -72.61 -18.37 61.6 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.865 0.691 . . . . 74.15 112.865 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -88.41 -39.6 14.15 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.386 0.675 . . . . 73.1 112.197 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -92.85 -39.86 10.95 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.371 0.878 . . . . 75.41 113.371 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.619 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 66.8 mtp -68.85 -40.95 79.09 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.13 0.49 . . . . 72.34 111.913 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.4 mt -84.12 151.46 24.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.946 0.898 . . . . 73.35 110.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.491 HD22 ' HA ' ' A' ' 122' ' ' ILE . 8.2 p30 -57.33 -32.27 66.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.382 0.882 . . . . 73.24 113.382 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.38 160.01 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.871 0.868 . . . . 73.24 110.413 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -77.12 103.6 7.14 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.109 -0.496 . . . . 74.3 110.513 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.668 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.8 tt -99.04 128.83 45.26 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.486 -0.931 . . . . 73.21 108.486 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.9 ttt85 -98.49 109.61 53.42 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 75.03 110.611 172.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.88 126.77 5.94 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 121.874 1.716 . . . . 74.24 110.311 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.88 100.8 4.92 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.047 -0.524 . . . . 62.31 109.777 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.607 ' HB3' HD13 ' A' ' 108' ' ' LEU . 70.0 mtm -110.15 133.51 53.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.427 0.691 . . . . 74.04 112.228 -171.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.27 136.5 39.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.098 0.959 . . . . 75.1 111.111 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 69.9 mt -88.29 116.02 26.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.404 1.082 . . . . 74.13 111.153 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -125.87 131.54 52.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.598 1.159 . . . . 74.31 110.63 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -92.09 125.66 36.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.26 0.624 . . . . 74.1 111.85 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.611 HG11 HG22 ' A' ' 5' ' ' THR . 12.1 t -121.18 114.04 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.584 1.154 . . . . 74.32 109.38 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.32 30.88 61.91 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.561 0.985 . . . . 72.14 115.561 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.14 8.84 83.22 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 114.219 0.448 . . . . 63.42 114.219 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -107.44 137.62 45.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 72.05 108.896 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.0 m -98.43 117.71 33.47 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.278 0.944 . . . . 75.03 111.854 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.66 163.59 13.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.357 1.063 . . . . 72.04 109.452 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -117.33 115.61 25.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.051 0.54 . . . . 74.24 110.538 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.412 HG12 HD13 ' A' ' 7' ' ' LEU . 78.8 t -82.53 106.43 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.885 -0.783 . . . . 73.13 108.885 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 60.7 t -92.88 100.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.503 -0.925 . . . . 74.53 108.503 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -85.02 115.2 22.71 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.869 -1.06 . . . . 73.45 108.872 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 63.6 t -106.52 98.39 20.05 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.359 0.663 . . . . 75.45 109.273 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.94 162.72 40.3 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.09 1.86 . . . . 74.4 110.519 167.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -70.34 132.97 46.47 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.053 -0.351 . . . . 75.12 110.053 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.34 158.03 24.63 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 122.987 0.515 . . . . 65.51 111.041 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.38 178.92 0.49 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.118 0.967 . . . . 72.03 111.2 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.84 -52.29 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.264 -1.522 . . . . 74.51 113.602 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.1 p -67.66 -48.15 67.5 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 123.711 0.805 . . . . 65.44 111.614 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.686 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -115.22 83.49 1.92 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 103.919 -2.623 . . . . 74.54 103.919 163.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.686 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.0 mttp -50.58 -143.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.131 1 C-N-CA 133.734 4.814 . . . . 75.25 120.989 49.077 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo 7.15 71.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.253 2.635 . . . . 75.4 115.797 -122.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.594 HG12 ' HA ' ' A' ' 120' ' ' LYS . 35.4 mm -81.54 77.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 114.909 -1.041 . . . . 75.25 108.936 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -88.51 146.87 24.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.646 -0.707 . . . . 75.43 110.955 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.65 135.72 36.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.946 -1.024 . . . . 73.32 110.102 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 90' ' ' ASN . 50.5 mtmt -86.05 26.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.284 0.634 . . . . 73.24 111.925 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.99 19.88 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.765 1.226 . . . . 64.21 109.714 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 63.3 m -64.55 115.75 5.49 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.943 0.497 . . . . 74.43 110.47 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.96 95.99 0.11 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 116.194 -0.457 . . . . 71.01 112.088 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.415 HD11 ' HD2' ' A' ' 130' ' ' PRO . 51.5 tp -85.83 116.89 67.46 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.392 0.677 . . . . 74.32 110.781 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HD2' HD11 ' A' ' 129' ' ' LEU . 60.0 Cg_endo -70.72 114.95 4.02 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.572 2.182 . . . . 72.52 112.534 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -94.78 139.07 14.32 Favored Glycine 0 N--CA 1.477 1.419 0 CA-C-N 116.494 -0.321 . . . . 70.32 113.622 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 142.55 171.18 13.11 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 116.818 0.309 . . . . 63.41 113.52 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.76 -62.34 1.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.3 1.04 . . . . 74.11 109.519 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -168.79 153.13 5.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.102 0.961 . . . . 73.44 110.137 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -112.34 132.22 55.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.823 0.449 . . . . 74.34 109.804 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -59.25 123.57 17.13 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.185 0.594 . . . . 74.2 111.146 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.0 tt -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.128 0.571 . . . . 74.15 110.935 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.19 -78.82 1.31 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.46 -0.656 . . . . 72.04 111.46 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.5 p -90.39 141.96 28.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.892 0.877 . . . . 72.02 110.789 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 44.2 t -108.96 152.32 25.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.675 0.79 . . . . 73.13 111.727 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.41 138.17 16.16 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.845 0.858 . . . . 71.04 110.303 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.56 20.69 1.68 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.703 0.801 . . . . 75.45 109.733 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.55 79.74 2.56 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.667 0.746 . . . . 74.13 109.194 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.81 118.49 36.99 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.759 0.823 . . . . 75.22 111.28 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 141.39 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.823 0.849 . . . . 72.54 109.772 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -114.08 150.78 33.51 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.503 0.721 . . . . 75.22 111.057 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -159.49 128.71 5.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.898 0.879 . . . . 74.24 109.722 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -88.74 46.8 1.42 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.285 0.634 . . . . 74.23 111.449 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -59.13 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.015 0.926 . . . . 74.11 111.706 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -105.89 121.24 43.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.335 1.054 . . . . 72.11 111.012 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -95.86 145.27 25.5 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.584 -0.524 . . . . 74.41 109.584 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -142.5 148.51 37.79 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.195 0.598 . . . . 70.21 111.462 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 N--CA 1.481 1.075 0 C-N-CA 124.427 1.091 . . . . 74.01 110.754 178.231 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.799 -0.445 . . . . 70.41 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 11.6 ptm180 -99.04 151.66 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.822 0.449 . . . . 75.12 110.572 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.5 p -75.3 159.98 30.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.119 0.967 . . . . 72.34 113.285 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.63 69.65 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.191 0.996 . . . . 75.05 112.132 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -66.74 -48.73 68.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.816 0.846 . . . . 73.13 111.145 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.23 -34.3 74.61 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.007 -0.997 . . . . 75.24 111.358 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.31 -36.5 81.61 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.239 1.016 . . . . 74.41 112.373 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.05 -44.94 94.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.682 0.393 . . . . 74.11 110.393 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.43 -36.34 82.1 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.215 0.606 . . . . 75.24 112.325 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.545 ' HG2' HG13 ' A' ' 20' ' ' ILE . 4.6 tp10 -66.54 -41.35 88.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.846 0.458 . . . . 73.33 111.246 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.4 mt -57.81 -47.77 81.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.118 0.967 . . . . 74.34 112.163 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.295 0.479 . . . . 64.51 112.295 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.87 -39.52 61.49 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.311 0.644 . . . . 72.5 112.142 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -91.36 143.81 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.543 0.687 . . . . 73.24 111.894 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.51 -13.79 39.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.097 0.959 . . . . 73.34 110.934 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -141.21 136.68 31.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.262 1.025 . . . . 75.25 109.989 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.6 m -74.33 77.25 1.86 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.508 0.671 . . . . 71.34 111.021 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -60.67 2.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.041 -0.982 . . . . 73.21 111.166 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -111.95 -23.23 10.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.718 0.807 . . . . 74.12 111.567 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.545 HG13 ' HG2' ' A' ' 10' ' ' GLU . 21.6 mm -115.4 107.26 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 109.526 -0.546 . . . . 75.23 109.526 -170.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.2 114.52 24.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.884 0.473 . . . . 73.23 110.187 -171.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.97 116.59 23.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.544 0.738 . . . . 70.33 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.44 153.34 33.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.179 0.514 . . . . 70.21 111.638 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -93.54 170.77 9.34 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.351 1.06 . . . . 74.1 111.593 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.74 88.42 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.967 -0.56 . . . . 73.24 110.937 169.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.4 p -57.61 -30.78 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.893 0.877 . . . . 71.51 112.455 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -84.74 -0.25 52.99 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.028 0.751 . . . . 62.44 113.028 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 88.3 mmm -68.49 131.65 45.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.004 0.521 . . . . 74.45 111.421 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.14 -132.76 6.25 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.684 -0.689 . . . . 65.44 111.746 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -39.72 89.46 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.17 0.588 . . . . 75.31 111.409 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 m -53.22 -33.6 53.54 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.564 1.145 . . . . 73.23 113.509 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.46 -35.31 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.152 0.581 . . . . 72.0 111.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.4 mmm -73.91 -41.49 62.03 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.263 0.838 . . . . 73.44 113.263 -164.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -65.34 -26.41 68.02 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 111.746 0.276 . . . . 73.11 111.746 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.0 m -72.24 -41.01 67.3 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 122.316 0.246 . . . . 62.33 111.115 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.4 0.68 . . . . 63.14 111.955 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 pt -63.27 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.651 0.38 . . . . 74.41 111.62 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.89 77.61 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.119 0.568 . . . . 73.43 111.687 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.586 ' HA ' HD21 ' A' ' 45' ' ' LEU . 32.2 m-85 -82.4 -37.29 25.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.474 0.71 . . . . 71.44 111.338 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.7 -23.48 62.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.933 1.086 . . . . 70.41 113.933 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -108.08 -8.51 15.81 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.737 1.014 . . . . 74.34 113.737 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.89 107.06 25.17 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.232 0.469 . . . . 62.22 110.563 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.96 123.68 11.62 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.933 2.422 . . . . 74.15 112.732 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.51 60.7 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-O 119.912 -0.382 . . . . 73.1 114.033 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.586 HD21 ' HA ' ' A' ' 39' ' ' PHE . 19.1 tp -89.86 13.44 14.51 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 117.713 0.756 . . . . 74.55 111.214 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -32.22 112.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.183 1.793 . . . . 71.21 114.158 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.629 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 103.78 68.63 0.77 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.395 -0.366 . . . . 52.34 112.779 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.06 124.61 5.4 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 109.618 -1.393 . . . . 54.45 109.618 171.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 56.0 m-85 -120.86 127.77 52.21 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.386 0.593 . . . . 61.52 111.819 -169.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -93.3 118.27 31.07 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.33 110.43 22.42 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.666 0.667 . . . . 75.22 109.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 9.3 mp -99.0 132.16 44.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.979 0.912 . . . . 74.42 110.793 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.5 33.15 4.91 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.247 -0.433 . . . . 73.21 112.429 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.6 138.6 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.116 0.566 . . . . 74.25 110.692 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.76 146.99 31.42 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.462 -1.31 . . . . 63.41 107.462 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -128.97 126.47 39.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.024 0.44 . . . . 74.52 110.399 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 123.4 46.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 74.34 109.969 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.52 131.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.578 0.751 . . . . 75.14 111.355 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -87.26 -178.5 6.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.608 0.763 . . . . 73.12 112.394 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.24 -28.55 69.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.584 0.754 . . . . 74.22 111.846 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -82.73 2.11 35.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.308 0.643 . . . . 74.52 112.274 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.36 32.34 58.07 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 120.933 0.185 . . . . 62.22 112.732 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.94 111.54 23.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.756 0.823 . . . . 75.13 110.631 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 m -82.8 115.05 21.53 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.604 0.762 . . . . 75.53 111.046 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.56 122.78 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.873 0.869 . . . . 75.42 110.293 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -95.7 129.04 43.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.483 0.713 . . . . 71.53 110.44 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -137.36 142.41 37.41 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.139 0.976 . . . . 71.51 111.054 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.64 80.19 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.029 2.486 . . . . 75.31 113.931 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.86 -23.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 112.703 0.631 . . . . 73.21 112.703 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.61 -173.46 53.28 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 121.313 0.396 . . . . 72.34 113.886 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 61.1 mt -115.98 124.59 29.57 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.032 0.933 . . . . 74.2 109.78 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.64 -27.02 39.03 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.473 2.115 . . . . 74.3 112.631 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.81 73.82 75.67 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.452 0.701 . . . . 74.33 109.485 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 83.4 Cg_endo -81.03 -28.3 2.56 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.78 2.32 . . . . 74.23 114.483 -170.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.39 -42.9 87.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 74.22 110.771 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.45 -33.86 76.01 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.558 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.14 -47.83 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.034 0.533 . . . . 74.41 110.784 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.455 ' OE1' ' HG ' ' A' ' 99' ' ' LEU . 41.6 tt0 -62.7 -50.28 71.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.873 0.694 . . . . 64.2 112.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -33.96 62.43 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 112.6 0.592 . . . . 74.15 112.6 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.54 -31.2 65.11 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.922 0.489 . . . . 73.01 110.895 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.78 -41.39 83.31 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.68 0.392 . . . . 75.22 111.248 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.83 92.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.896 0.479 . . . . 64.31 111.31 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -52.62 64.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.799 0.84 . . . . 71.13 112.007 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.04 -34.72 77.0 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 111.995 0.368 . . . . 62.54 111.995 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 36.8 t -67.81 -25.99 65.85 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.338 0.517 . . . . 73.43 112.102 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -78.42 -27.37 46.59 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.958 0.725 . . . . 70.31 112.958 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.7 t -106.59 -29.38 9.67 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.32 0.859 . . . . 64.2 113.32 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.1 mmt -67.3 -52.86 35.35 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.037 0.935 . . . . 74.52 111.405 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 mt -90.04 162.0 15.57 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.684 -1.144 . . . . 74.23 110.717 -169.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -29.65 -58.09 0.16 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 126.135 1.774 . . . . 73.42 114.804 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 122' ' ' ILE . 16.9 m -124.16 176.77 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.389 0.675 . . . . 64.33 110.182 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.1 98.77 0.61 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.287 0.565 . . . . 73.44 111.039 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.72 HD13 HG21 ' A' ' 122' ' ' ILE . 2.5 tt -92.02 121.65 33.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 73.35 108.017 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -101.62 99.36 11.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.154 0.582 . . . . 74.55 109.644 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.642 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 4.3 Cg_exo -76.58 168.19 24.16 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.838 1.692 . . . . 74.22 110.787 168.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 43.5 tt0 -105.12 96.99 6.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.066 0.546 . . . . 75.32 109.589 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD11 ' A' ' 108' ' ' LEU . 4.4 mpp? -105.13 134.89 47.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 72.42 111.458 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -139.61 133.79 31.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.074 0.55 . . . . 72.15 111.197 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.455 ' HG ' ' OE1' ' A' ' 78' ' ' GLN . 91.6 mt -84.26 133.29 34.57 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.897 0.879 . . . . 71.53 110.752 174.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -138.17 145.75 41.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.466 1.106 . . . . 73.4 110.595 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.9 119.97 38.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.963 0.505 . . . . 73.43 109.803 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.32 111.73 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.703 -1.221 . . . . 74.13 107.703 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.73 27.59 61.8 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 114.548 0.579 . . . . 71.13 114.548 -168.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.64 -1.02 88.86 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 114.987 0.755 . . . . 72.32 114.987 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 131.9 46.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.612 0.765 . . . . 75.34 109.964 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.6 m -92.4 106.09 18.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.318 0.858 . . . . 74.51 113.318 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.98 156.26 17.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.325 1.05 . . . . 72.21 111.126 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 97' ' ' MET . 50.4 tp -112.93 116.41 29.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.466 0.707 . . . . 62.01 110.78 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.4 113.35 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.389 0.676 . . . . 74.55 109.831 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 45.4 t -105.65 101.37 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 122.898 0.479 . . . . 65.03 110.263 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 40.4 t80 -84.46 128.51 34.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.627 0.771 . . . . 71.52 110.19 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.29 102.61 14.68 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 109.441 -0.578 . . . . 74.45 109.441 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.79 147.66 21.88 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.607 2.204 . . . . 64.41 112.163 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -75.61 134.49 40.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.853 0.358 . . . . 73.41 111.259 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -93.39 172.87 8.01 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.746 0.818 . . . . 74.44 112.968 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.62 139.31 36.31 Favored 'General case' 0 C--O 1.193 -1.914 0 C-N-CA 123.707 0.803 . . . . 65.1 110.617 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.74 -38.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 115.945 1.831 . . . . 74.33 115.945 -170.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.7 p -65.43 -49.41 69.26 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.864 0.466 . . . . 74.43 111.745 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.623 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 9.0 m-70 -127.93 69.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.88 -2.267 . . . . 71.44 104.88 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 27.8 mtpp -45.06 -152.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.386 1 C-N-CA 132.91 4.484 . . . . 70.2 120.844 58.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo 7.68 65.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.113 2.542 . . . . 70.54 116.153 -126.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.72 HG21 HD13 ' A' ' 93' ' ' LEU . 30.5 mm -80.0 77.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.094 0 CA-C-N 115.361 -0.836 . . . . 65.11 109.184 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -80.76 141.96 34.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.246 -0.433 . . . . 73.04 110.938 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -62.86 117.84 6.92 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.704 -0.68 . . . . 73.44 109.527 171.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.456 ' HZ1' ' HB2' ' A' ' 125' ' ' LYS . 10.5 mtmp? -79.12 66.12 4.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.848 0.832 . . . . 75.2 110.31 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 167.99 -162.49 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.429 2.292 . . . . 70.53 108.46 -170.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -71.05 127.02 31.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.908 -0.495 . . . . 75.42 110.602 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -151.43 112.65 0.55 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.074 -0.411 . . . . 42.45 112.074 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.0 pp -77.84 156.06 80.21 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 123.733 0.813 . . . . 72.54 112.768 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.68 152.31 74.42 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.576 2.184 . . . . 73.2 112.5 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.62 155.32 32.04 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-O 120.219 -0.212 . . . . 71.55 113.228 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.7 104.2 1.94 Allowed Glycine 0 N--CA 1.475 1.265 0 CA-C-N 116.793 0.297 . . . . 75.1 112.873 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.5 79.98 3.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.982 0.513 . . . . 71.51 111.482 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -98.81 117.19 32.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.788 0.835 . . . . 72.41 110.703 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -80.46 115.94 20.25 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.442 0.697 . . . . 73.11 111.343 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.36 160.92 14.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.768 0.827 . . . . 75.25 111.345 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.33 117.48 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 122.629 0.372 . . . . 73.24 110.834 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.82 -173.36 49.4 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 116.11 -0.496 . . . . 74.33 112.893 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.0 p -156.29 170.93 21.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.301 0.572 . . . . 64.55 112.116 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -135.25 94.55 3.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.776 0.83 . . . . 75.25 109.472 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.22 123.75 22.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.857 0.863 . . . . 72.14 111.808 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -131.63 134.55 46.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.489 0.715 . . . . 72.32 109.681 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -147.73 126.54 12.67 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.273 0.629 . . . . 75.14 109.957 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.35 147.98 27.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.781 0.832 . . . . 71.34 112.118 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.57 146.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.51 0.724 . . . . 63.3 110.329 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -124.18 106.16 10.09 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.628 0.728 . . . . 72.23 111.159 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 171.67 13.98 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.213 1.005 . . . . 72.02 110.392 171.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -59.19 -45.13 91.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.897 1.443 . . . . 73.51 114.897 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.0 m80 70.9 -27.53 0.17 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 125.115 1.366 . . . . 73.51 114.575 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -55.12 132.57 47.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.411 1.084 . . . . 75.24 112.929 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -107.82 179.15 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.275 1.03 . . . . 74.55 111.59 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -77.47 108.33 10.56 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.251 0.62 . . . . 73.41 110.548 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.803 0.811 . . . . 74.21 111.83 177.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.089 -0.338 . . . . 64.32 110.089 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -88.09 146.43 25.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.429 0.692 . . . . 74.44 110.742 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -70.24 166.71 19.48 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 122.997 0.519 . . . . 73.45 111.76 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 100' ' ' GLU . . . -62.42 -50.27 72.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.639 0.607 . . . . 64.35 112.639 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -70.47 -28.78 65.26 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 112.009 0.374 . . . . 72.13 112.009 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.55 -46.37 86.26 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.89 0.876 . . . . 70.15 111.256 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.509 HD13 HG12 ' A' ' 109' ' ' VAL . 60.5 mt -65.95 -38.46 88.67 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.722 0.809 . . . . 75.25 112.166 172.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.545 HD23 ' HD3' ' A' ' 68' ' ' PRO . 24.3 tp -59.17 -50.09 75.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.036 0.934 . . . . 75.22 110.399 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.47 -40.31 78.28 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.759 -1.109 . . . . 63.22 111.064 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.83 -41.75 95.49 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.988 0.915 . . . . 75.03 111.843 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 8' ' ' LEU . 29.3 mt -60.3 -38.62 84.23 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.659 1.184 . . . . 72.52 112.149 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -80.17 -28.95 38.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.029 0.531 . . . . 71.15 111.864 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -47.19 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.452 0.701 . . . . 54.13 111.949 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.3 154.8 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.131 0.572 . . . . 73.34 111.115 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.22 -20.61 21.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.011 0.924 . . . . 72.32 111.124 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 9.6 tp10 -140.85 134.75 30.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.604 1.162 . . . . 75.33 109.688 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -69.6 87.13 0.48 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.88 0.872 . . . . 64.3 110.456 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.06 -64.59 1.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.45 0.7 . . . . 73.21 112.488 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -107.38 -14.05 14.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.43 0.692 . . . . 72.21 110.207 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 mm -109.49 155.17 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.216 -1.031 . . . . 72.32 108.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.46 150.13 10.41 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.87 46.13 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.029 0.532 . . . . 72.15 112.005 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HG3' HG23 ' A' ' 32' ' ' VAL . 74.9 mmtt -130.61 150.37 51.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.182 0.993 . . . . 75.21 110.076 175.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -85.63 165.16 17.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.734 0.814 . . . . 75.22 110.157 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.46 -30.85 68.81 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 120.879 0.371 . . . . 72.24 111.526 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -71.97 -19.25 61.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.649 0.78 . . . . 74.25 112.803 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -84.38 -4.99 59.22 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.527 0.565 . . . . 61.22 112.527 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.681 ' SD ' HD12 ' A' ' 52' ' ' LEU . 83.6 mmm -59.5 108.45 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.315 0.579 . . . . 72.05 111.313 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 142.14 -143.53 12.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 114.878 -1.055 . . . . 71.05 110.863 -171.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -52.57 -39.24 61.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.233 1.013 . . . . 71.33 113.253 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -36.51 75.34 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.065 0.765 . . . . 63.41 113.065 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 23' ' ' LYS . 44.2 t -72.52 -50.34 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 120.968 0.413 . . . . 75.05 110.385 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.55 ' HG3' ' HG3' ' A' ' 88' ' ' MET . 91.3 mmm -57.45 -41.2 80.09 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.57 1.322 . . . . 75.43 114.57 -170.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.18 -34.24 77.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.157 0.583 . . . . 72.04 111.611 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -79.32 -28.48 42.13 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.758 0.823 . . . . 51.41 111.242 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.82 -40.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 123.48 0.712 . . . . 74.54 110.511 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.96 -31.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.507 -0.769 . . . . 73.11 111.134 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' GLU . . . -60.08 -49.96 75.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.228 0.611 . . . . 74.32 112.178 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.28 -27.56 35.06 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.681 . . . . 72.1 111.657 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.66 -32.26 60.1 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.363 0.665 . . . . 64.15 112.275 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -92.57 -17.11 24.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.163 0.585 . . . . 72.52 111.525 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.1 tp10 -75.43 106.88 3.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 123.578 0.751 . . . . 73.23 112.367 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.07 106.12 2.21 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.142 2.561 . . . . 75.42 113.201 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.08 -7.1 40.63 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 114.87 0.708 . . . . 71.34 114.87 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -92.78 -52.43 4.62 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.203 1.002 . . . . 74.14 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 36.93 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 126.296 1.839 . . . . 75.45 115.378 -170.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.09 48.09 64.51 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 116.012 1.165 . . . . 71.23 116.012 166.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.72 152.59 22.56 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.53 -0.628 . . . . 74.14 111.53 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.89 127.1 51.56 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.844 0.822 . . . . 74.33 112.074 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 97.2 mt -115.21 114.04 24.72 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.879 1.271 . . . . 75.11 108.59 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.14 109.06 20.66 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.508 -0.552 . . . . 71.12 109.508 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.718 HD13 HD23 ' A' ' 108' ' ' LEU . 29.9 mt -93.03 132.17 37.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.494 0.718 . . . . 75.02 110.533 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 36.64 4.43 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 121.298 0.388 . . . . 75.23 112.371 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.53 143.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.537 0.735 . . . . 75.4 109.813 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -113.47 154.1 27.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.765 -1.198 . . . . 63.42 107.765 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.407 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 41.7 p90 -145.73 129.03 16.78 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.408 0.623 . . . . 75.31 112.005 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.74 135.61 51.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.835 0.854 . . . . 61.22 110.933 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.6 mt -83.7 123.52 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.737 0.815 . . . . 73.22 110.582 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.408 HD22 ' HB3' ' A' ' 63' ' ' ASP . 29.5 p30 -82.5 -176.3 6.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.795 0.838 . . . . 74.15 112.08 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.77 -14.16 57.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.737 1.014 . . . . 64.12 113.737 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -86.8 -22.89 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.151 0.58 . . . . 64.22 112.021 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.4 16.05 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 116.576 -0.284 . . . . 61.22 112.512 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.408 ' HB3' HD22 ' A' ' 59' ' ' ASN . 23.4 t70 -107.74 132.71 53.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.263 1.025 . . . . 74.32 110.915 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -89.09 119.03 29.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.806 0.842 . . . . 75.42 111.509 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 67.5 t -103.44 120.8 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.169 0.988 . . . . 75.22 110.704 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -94.19 130.69 40.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.271 1.028 . . . . 73.31 110.387 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.87 147.44 48.24 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.877 0.871 . . . . 74.54 110.485 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.545 ' HD3' HD23 ' A' ' 8' ' ' LEU . 83.2 Cg_endo -78.31 108.16 2.43 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.251 1.967 . . . . 64.32 114.534 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 m -91.1 -24.42 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 122.968 0.507 . . . . 74.11 111.199 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 76.58 -170.12 54.95 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 114.81 0.684 . . . . 65.23 114.81 174.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -121.57 124.24 27.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.97 0.908 . . . . 73.43 109.979 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.97 -17.04 22.71 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.457 2.105 . . . . 65.42 113.023 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -134.38 59.77 38.97 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.404 1.081 . . . . 75.21 110.223 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' HD22 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -62.06 -36.81 68.39 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.905 2.403 . . . . 73.34 114.265 -162.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.31 -39.27 74.92 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.472 0.709 . . . . 74.22 110.58 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.47 -36.3 80.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.979 0.511 . . . . 73.21 111.205 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.35 -45.6 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 123.474 0.71 . . . . 74.01 110.813 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.9 -49.77 74.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.808 0.843 . . . . 72.42 112.043 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -67.32 -40.67 85.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.279 0.632 . . . . 70.01 111.578 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.9 -36.57 84.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.552 0.741 . . . . 74.53 110.389 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.552 HD21 ' SD ' ' A' ' 97' ' ' MET . 24.3 tp -67.78 -38.27 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.969 0.508 . . . . 74.31 111.282 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.67 90.58 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.99 0.516 . . . . 55.33 111.553 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.8 m -65.76 -48.31 72.28 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.639 0.776 . . . . 74.12 111.721 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.98 -30.36 69.61 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.797 0.439 . . . . 74.42 111.478 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 16.1 t -65.98 -19.91 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.899 -0.5 . . . . 65.33 112.292 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -39.2 17.73 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.455 0.702 . . . . 74.15 112.016 170.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -85.93 -25.67 25.98 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.153 1.168 . . . . 71.32 114.153 -173.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.55 ' HG3' ' HG3' ' A' ' 33' ' ' MET . 85.7 mmm -81.91 -58.08 3.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.815 0.846 . . . . 74.34 110.085 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.98 146.55 37.39 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.352 -0.84 . . . . 74.22 111.138 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -50.84 -37.57 43.92 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.997 0.919 . . . . 63.33 113.051 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.2 m -121.1 160.03 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.053 0.941 . . . . 75.1 110.713 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.29 105.34 7.29 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.085 0.554 . . . . 74.51 111.85 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.5 tt -93.24 137.19 32.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.28 -1.378 . . . . 73.44 107.28 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -98.83 104.73 26.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 122.692 0.397 . . . . 74.41 110.131 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.68 119.38 5.69 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.303 1.335 . . . . 63.04 110.667 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 14.3 tp10 -71.65 98.74 1.97 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.373 -0.83 . . . . 74.41 109.826 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD13 ' A' ' 108' ' ' LEU . 60.1 mtm -116.73 127.16 54.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.311 0.644 . . . . 74.14 112.198 -169.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -132.9 128.67 37.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.303 1.041 . . . . 75.1 110.2 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 74' ' ' PRO . 53.6 mt -81.91 132.14 35.26 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.167 0.987 . . . . 72.22 111.408 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 11.4 mm-40 -128.38 128.46 44.55 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.162 0.985 . . . . 73.23 111.1 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.2 117.27 29.7 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.857 0.863 . . . . 74.23 110.986 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.2 t -132.98 117.42 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.565 1.146 . . . . 74.25 110.577 -172.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.3 28.54 27.66 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 116.443 1.337 . . . . 74.22 116.443 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -4.48 67.91 Favored Glycine 0 N--CA 1.484 1.852 0 CA-C-N 117.472 0.636 . . . . 72.15 114.179 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -110.88 119.2 38.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.377 1.071 . . . . 74.13 110.074 -177.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -88.55 103.53 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.982 0.81 . . . . 75.2 110.576 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.44 168.77 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.858 0.863 . . . . 72.32 110.717 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.719 HD13 ' HB3' ' A' ' 97' ' ' MET . 60.1 tp -119.2 119.07 33.04 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.994 0.517 . . . . 73.43 110.577 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.509 HG12 HD13 ' A' ' 7' ' ' LEU . 93.1 t -83.63 111.01 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.135 -0.691 . . . . 70.14 109.135 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 48.1 t -103.5 99.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.527 0.679 . . . . 75.53 110.177 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 58.2 t80 -79.05 119.16 21.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.145 0.978 . . . . 73.13 109.026 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.79 102.49 53.66 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.079 0.952 . . . . 64.1 108.774 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.96 165.48 31.98 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.942 1.761 . . . . 74.2 111.607 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -72.14 136.56 46.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.781 -0.822 . . . . 75.31 108.781 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -71.51 156.35 39.53 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.451 0.7 . . . . 73.24 111.522 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.4 -175.61 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 124.926 1.29 . . . . 72.42 111.601 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.94 -51.56 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 O-C-N 119.756 -1.84 . . . . 74.42 113.614 162.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 t -68.39 -49.94 56.49 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.363 0.529 . . . . 75.32 111.468 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.611 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 8.5 m-70 -117.94 84.65 2.21 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 101.341 -3.577 . . . . 73.11 101.341 165.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.695 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.256 36.2 mtmm -48.79 -140.77 0.0 OUTLIER Pre-proline 0 CA--C 1.577 1.986 1 C-N-CA 133.664 4.786 . . . . 72.32 121.204 50.908 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo 10.16 62.93 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 124.207 3.272 . . . . 65.15 116.136 -121.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.695 HG12 ' HA ' ' A' ' 120' ' ' LYS . 48.5 mm -76.78 116.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.994 0.918 . . . . 73.24 110.344 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -150.52 144.19 25.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.906 0.483 . . . . 73.24 110.16 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -77.07 128.14 33.93 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.912 0.387 . . . . 73.41 110.288 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.01 -7.71 48.23 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.924 0.89 . . . . 75.22 111.827 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.96 169.73 16.85 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.076 0.95 . . . . 61.21 111.41 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.7 p -70.3 151.62 45.08 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.336 0.655 . . . . 64.32 112.672 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.15 164.83 29.88 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.587 -0.733 . . . . 64.04 114.151 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.12 159.77 84.56 Favored Pre-proline 0 CA--C 1.574 1.898 0 C-N-CA 124.426 1.09 . . . . 75.41 112.384 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.33 -171.17 1.09 Allowed 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.74 2.293 . . . . 71.2 112.973 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.61 161.06 12.87 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.662 -0.245 . . . . 72.13 113.696 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -144.74 134.73 5.76 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.706 0.67 . . . . 75.4 111.596 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.96 157.35 15.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.229 0.612 . . . . 73.44 111.678 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -91.63 142.68 27.36 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 120.863 0.363 . . . . 74.42 111.423 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -102.74 112.28 24.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.041 0.936 . . . . 75.32 110.417 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 67.3 mtt180 -108.81 159.87 16.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.686 0.794 . . . . 74.2 112.456 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -103.63 131.13 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.927 0.891 . . . . 75.2 109.901 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.19 157.82 15.13 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 113.86 0.304 . . . . 61.11 113.86 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.8 m -92.2 115.7 28.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.876 0.87 . . . . 74.41 111.09 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.1 p -96.78 12.72 31.05 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.33 0.652 . . . . 75.45 112.464 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.85 114.75 10.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.957 0.503 . . . . 61.55 111.42 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.45 121.93 39.59 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.367 1.067 . . . . 73.11 109.425 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.77 161.68 27.92 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.468 0.544 . . . . 74.5 112.468 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 147' ' ' GLU . 45.3 t -79.18 138.45 37.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.336 0.655 . . . . 73.02 112.326 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.42 162.99 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.414 1.085 . . . . 74.33 110.173 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt 57.64 28.69 16.09 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.244 1.017 . . . . 75.54 112.564 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.513 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . 8.3 pt-20 -79.79 89.58 5.23 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.091 0.957 . . . . 74.11 112.216 -174.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.2 p80 34.78 79.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.164 1.786 . . . . 73.32 114.525 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -86.07 12.59 9.24 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.215 0.606 . . . . 73.1 111.215 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.33 116.92 5.46 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.75 1.22 . . . . 75.3 111.976 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -125.02 130.66 52.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.228 1.011 . . . . 73.24 109.761 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -129.94 120.31 24.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.637 0.775 . . . . 74.23 109.921 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.663 0.744 . . . . 65.2 111.973 178.47 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 46.0 ttm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.788 0.328 . . . . 74.41 111.565 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.609 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.0 mmm180 -95.44 157.57 15.84 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.402 1.081 . . . . 71.31 111.037 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -77.45 152.35 34.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.908 0.707 . . . . 62.32 112.908 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.88 -53.05 54.67 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.505 1.122 . . . . 73.12 113.183 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.594 ' HB ' HG11 ' A' ' 102' ' ' VAL . 2.9 t -62.35 -41.5 98.65 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.234 0.613 . . . . 74.31 112.621 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -55.16 -45.31 75.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.495 1.118 . . . . 63.32 111.68 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' A' ' 2' ' ' ARG . 47.3 mt -73.68 -33.27 64.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.306 1.042 . . . . 75.54 112.749 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.36 -31.36 71.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.271 0.628 . . . . 73.02 110.587 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.49 -30.68 69.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.863 0.865 . . . . 75.2 112.802 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.414 ' O ' HG21 ' A' ' 14' ' ' VAL . 29.2 tt0 -60.85 -52.94 62.95 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.875 -0.417 . . . . 74.23 109.875 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.71 -27.46 62.08 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.836 0.854 . . . . 74.14 112.914 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.66 -11.1 60.67 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.214 0.605 . . . . 74.45 111.847 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 -36.11 8.24 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.839 0.856 . . . . 73.21 111.948 172.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 10' ' ' GLU . 29.5 m -117.54 117.54 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.616 0.767 . . . . 75.43 111.241 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.84 -44.49 82.16 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.684 1.193 . . . . 74.23 111.1 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.77 149.57 25.66 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.982 0.913 . . . . 61.35 110.601 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.1 m -87.24 129.64 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.867 0.467 . . . . 75.53 111.982 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.46 -64.94 1.0 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.833 0.453 . . . . 73.23 111.32 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -14.68 9.08 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.569 0.747 . . . . 73.34 112.013 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 49' ' ' TYR . 18.8 mm -113.87 142.99 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 118.193 0.452 . . . . 73.01 110.649 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -128.27 112.6 14.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.365 0.666 . . . . 61.32 110.632 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.29 118.2 30.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.314 0.645 . . . . 64.11 109.843 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HG3' HG22 ' A' ' 32' ' ' VAL . 73.6 mmtt -124.11 142.95 50.76 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.848 0.859 . . . . 65.24 110.632 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -89.56 174.76 7.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.548 0.739 . . . . 74.25 110.714 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -37.85 71.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.131 0.572 . . . . 71.3 112.21 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -60.45 -23.56 64.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.162 1.171 . . . . 74.23 114.162 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -88.13 -13.72 40.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.381 0.882 . . . . 72.42 113.381 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.497 ' SD ' HG13 ' A' ' 77' ' ' VAL . 84.4 mtp -58.3 109.16 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.056 0.542 . . . . 75.23 112.24 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.01 -122.46 1.18 Allowed Glycine 0 C--N 1.344 0.988 0 CA-C-N 116.136 -0.483 . . . . 60.3 112.326 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.47 -46.55 63.55 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.518 0.727 . . . . 75.04 111.57 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.6 m -63.86 -37.4 87.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.611 0.764 . . . . 63.41 112.369 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.468 HG22 ' HG3' ' A' ' 23' ' ' LYS . 87.5 t -67.69 -42.33 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.847 0.459 . . . . 74.14 111.192 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.524 ' HE2' ' HG3' ' A' ' 88' ' ' MET . 36.2 tpp -67.6 -47.31 70.07 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.75 0.648 . . . . 73.24 112.75 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.31 -27.24 66.13 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 75.42 113.041 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.456 HG23 HD23 ' A' ' 50' ' ' LEU . 14.7 t -78.22 -29.13 48.16 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 121.615 -0.678 . . . . 73.03 111.91 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.08 -43.21 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 123.055 0.542 . . . . 74.43 109.569 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 122' ' ' ILE . 48.4 mt -53.73 -45.21 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.203 1.001 . . . . 75.42 111.078 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.35 90.72 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.855 0.462 . . . . 54.42 111.611 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.07 -38.88 89.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.923 0.489 . . . . 73.2 111.726 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.53 -30.76 69.64 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.543 0.737 . . . . 64.31 112.721 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -105.63 17.13 24.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.024 0.75 . . . . 72.04 113.024 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -108.25 89.19 5.53 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 122.821 0.449 . . . . 75.12 110.53 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.07 118.92 5.96 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.302 2.001 . . . . 73.04 112.132 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.82 -12.52 32.29 Favored Glycine 0 N--CA 1.477 1.406 0 CA-C-N 115.547 -0.751 . . . . 73.1 113.216 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.25 -7.56 14.83 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.474 0.71 . . . . 75.53 109.754 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -42.87 132.08 3.96 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.923 1.289 . . . . 63.32 113.845 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.89 37.64 2.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.831 -0.622 . . . . 74.02 111.747 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.82 152.67 20.38 Favored Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.698 -0.561 . . . . 71.12 111.698 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.51 ' HB2' HD11 ' A' ' 20' ' ' ILE . 98.2 m-85 -120.69 148.74 43.54 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.768 0.784 . . . . 73.34 112.303 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.2 mp -119.93 130.96 55.05 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.893 0.877 . . . . 75.51 109.69 170.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.05 109.47 21.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.568 0.747 . . . . 71.13 109.752 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.519 HD11 HD23 ' A' ' 108' ' ' LEU . 63.5 mt -92.07 127.56 37.58 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.938 -0.393 . . . . 72.42 109.938 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.93 30.86 4.07 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 115.9 -0.591 . . . . 63.04 112.604 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.25 133.35 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.252 0.621 . . . . 74.31 110.365 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.81 176.84 5.04 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.688 -1.227 . . . . 74.43 107.688 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -157.05 144.67 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.566 -0.709 . . . . 75.0 112.454 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.71 128.29 53.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.281 1.032 . . . . 72.03 110.294 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.6 mm -82.62 123.14 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 122.9 0.48 . . . . 73.22 111.049 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.28 154.54 37.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.897 0.879 . . . . 73.54 110.185 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.37 0.26 20.16 Favored 'General case' 0 CA--C 1.559 1.289 0 O-C-N 121.997 -0.44 . . . . 70.51 111.8 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -96.71 3.51 52.37 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.87 0.868 . . . . 73.42 111.494 166.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.56 57.88 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 115.576 0.991 . . . . 71.24 115.576 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.61 148.38 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.105 0.779 . . . . 73.12 113.105 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -96.72 128.29 43.52 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.354 0.662 . . . . 63.11 111.088 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.1 119.15 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 108.781 -0.822 . . . . 75.32 108.781 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.74 113.43 25.49 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.679 0.752 . . . . 75.22 110.382 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.17 145.1 31.8 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.541 1.136 . . . . 73.23 110.143 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 88.6 Cg_endo -96.2 109.31 0.11 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.371 2.047 . . . . 73.43 113.869 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.8 -11.65 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.66 -0.65 . . . . 73.31 111.142 161.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.6 -167.54 54.34 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.466 0.481 . . . . 73.42 113.61 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 77' ' ' VAL . 95.2 mt -99.74 131.43 24.65 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.113 0.965 . . . . 73.13 110.838 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.24 -37.51 61.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.329 2.019 . . . . 74.21 111.218 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 10.8 m-20 -130.52 86.05 54.34 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.004 0.921 . . . . 74.42 109.374 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 -37.34 89.92 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.562 2.841 . . . . 75.22 114.319 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.97 -53.42 46.57 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.009 -0.996 . . . . 65.02 110.92 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 73' ' ' ASP . 67.4 mmtt -64.46 -49.08 72.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 62.1 112.064 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.497 HG13 ' SD ' ' A' ' 28' ' ' MET . 95.3 t -56.51 -40.94 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.709 0.803 . . . . 64.04 112.329 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.41 -46.12 90.02 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.414 0.686 . . . . 72.3 112.004 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.66 -44.7 61.51 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.738 0.815 . . . . 74.32 112.212 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.02 -33.25 75.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.604 0.762 . . . . 71.45 111.926 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -66.76 -45.11 79.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.656 0.265 . . . . 74.42 110.973 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.09 89.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.335 0.654 . . . . 73.42 111.86 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -64.34 -53.04 54.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.107 0.963 . . . . 70.24 111.028 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.29 -33.42 75.26 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.072 -0.513 . . . . 74.03 112.017 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.4 -29.22 63.92 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.486 0.585 . . . . 74.45 112.412 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.26 -42.65 13.59 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.679 0.792 . . . . 65.03 111.341 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -69.33 -28.52 66.31 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.975 1.102 . . . . 73.14 113.975 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.524 ' HG3' ' HE2' ' A' ' 33' ' ' MET . 14.0 mmt -80.25 -60.94 2.14 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.313 0.645 . . . . 63.34 111.769 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.495 HD23 ' SD ' ' A' ' 33' ' ' MET . 22.7 mt -81.93 159.9 23.5 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.388 -0.823 . . . . 71.13 112.796 -161.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.58 HD22 ' HA ' ' A' ' 122' ' ' ILE . 6.1 p30 -50.65 -52.26 41.46 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.036 0.754 . . . . 75.33 113.036 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.426 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.5 m -107.47 171.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.303 0.573 . . . . 73.41 111.441 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.65 99.6 5.09 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.496 -0.775 . . . . 73.23 110.062 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.439 HD11 HG23 ' A' ' 122' ' ' ILE . 3.9 tt -84.53 127.05 33.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.593 -1.262 . . . . 73.3 107.593 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 94.29 15.91 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.391 0.677 . . . . 75.41 110.583 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.01 162.09 23.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.531 2.154 . . . . 74.3 111.692 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.68 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.6 tp10 -95.75 128.81 42.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.624 ' HB3' HD13 ' A' ' 108' ' ' LEU . 62.5 mtt -126.29 114.12 17.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.017 0.527 . . . . 72.41 110.277 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -124.15 133.69 53.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.568 0.747 . . . . 75.21 111.008 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.13 125.06 41.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.007 0.923 . . . . 75.5 110.41 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -135.27 146.09 48.21 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.481 0.713 . . . . 63.04 111.156 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -101.21 117.38 34.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.23 0.538 . . . . 72.34 110.739 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.594 HG11 ' HB ' ' A' ' 5' ' ' THR . 88.3 t -126.63 120.08 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.149 1.38 . . . . 74.23 108.375 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.19 60.57 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.109 0.404 . . . . 75.1 114.109 -170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.92 88.03 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 114.152 0.421 . . . . 70.52 114.152 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.2 mmtt -103.01 134.88 45.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.918 0.887 . . . . 74.23 109.928 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.2 m -96.98 123.27 40.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.779 0.718 . . . . 74.42 111.289 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.58 161.5 17.34 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.52 0.728 . . . . 74.21 109.198 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 97' ' ' MET . 35.9 tp -114.89 111.51 21.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.469 -0.567 . . . . 72.3 109.469 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.2 t -84.76 122.27 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.219 -0.66 . . . . 75.13 109.219 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 37.3 t -113.2 99.97 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.458 0.703 . . . . 75.1 110.039 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.68 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 56.8 t80 -84.08 119.61 25.17 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 72.41 110.555 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.42 100.97 28.85 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.931 0.893 . . . . 70.41 109.175 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 176.28 10.17 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.603 2.202 . . . . 73.44 112.356 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.22 156.78 24.38 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.679 0.752 . . . . 73.52 112.934 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' HIS . . . -124.34 141.48 52.04 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.145 0.978 . . . . 74.23 109.898 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.24 150.51 37.03 Favored 'General case' 0 C--O 1.183 -2.4 0 C-N-CA 124.27 1.028 . . . . 63.11 110.933 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.0 t -38.72 -37.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 N-CA-C 115.933 1.827 . . . . 75.13 115.933 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 t -78.36 -39.57 38.89 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 112.909 0.707 . . . . 72.42 112.909 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.644 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 p-80 -136.88 77.31 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.745 -1.576 . . . . 75.23 106.745 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.682 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.263 14.1 ptmm? -51.48 -152.48 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.35 2 C-N-CA 132.81 4.444 . . . . 72.32 122.097 46.338 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo 14.4 62.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 O-C-N 117.239 -2.032 . . . . 73.41 115.844 -123.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.682 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.9 mm -75.67 95.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 114.401 -1.272 . . . . 73.33 109.451 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.3 p90 -110.53 155.18 22.65 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.928 0.491 . . . . 74.55 109.876 169.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HD2' ' SD ' ' A' ' 88' ' ' MET . 5.7 ttpm? -75.31 136.67 40.86 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -56.1 -40.95 74.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.038 0.535 . . . . 75.04 111.002 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . . . -77.19 141.83 39.9 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.031 0.533 . . . . 74.34 109.863 165.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -58.63 145.44 39.67 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.488 0.922 . . . . 74.43 113.488 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -142.18 -106.82 0.61 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 116.333 -0.394 . . . . 74.4 113.301 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.79 130.41 67.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.208 0.603 . . . . 74.41 111.568 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.69 138.59 64.9 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.761 2.307 . . . . 72.3 112.819 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.3 84.62 0.61 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 116.799 -0.182 . . . . 65.32 112.656 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.43 -113.84 0.37 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 113.939 0.335 . . . . 70.33 113.939 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -145.36 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.532 0.733 . . . . 72.15 111.798 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.21 136.41 33.96 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.653 0.781 . . . . 75.14 111.041 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.54 129.14 34.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.138 0.975 . . . . 73.2 110.982 -173.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -93.33 96.12 9.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.589 0.756 . . . . 73.42 110.555 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tt -158.58 116.98 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.516 0.726 . . . . 62.51 111.11 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.17 105.47 1.58 Allowed Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.315 -0.402 . . . . 73.03 112.767 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.2 t -127.89 117.72 22.3 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.639 0.776 . . . . 74.52 110.852 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 87.7 p -83.97 156.59 22.23 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.064 0.546 . . . . 73.03 110.829 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -146.51 161.87 39.53 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.407 0.622 . . . . 72.41 111.967 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -96.99 43.03 1.08 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.614 0.766 . . . . 74.4 111.486 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -75.53 135.04 40.62 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 73.3 110.907 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 25.7 p -120.88 154.47 35.81 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.589 0.756 . . . . 70.42 110.547 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.6 143.69 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.27 0.628 . . . . 74.31 111.402 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.84 119.41 11.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.276 1.031 . . . . 71.43 109.024 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.1 123.31 20.3 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.993 0.517 . . . . 75.45 111.603 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -76.86 94.77 3.95 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.956 -1.498 . . . . 71.12 106.956 164.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -66.07 100.64 0.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.329 0.652 . . . . 62.33 112.181 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -68.02 123.66 21.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.456 1.103 . . . . 71.23 110.652 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -65.06 125.12 23.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.569 0.348 . . . . 72.25 110.986 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -110.59 137.06 48.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.214 0.606 . . . . 72.23 111.054 -170.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.3 m80 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.895 0.878 . . . . 74.13 111.346 178.529 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HG2' ' HG3' ' A' ' 98' ' ' GLN . 10.3 tpt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.919 -0.4 . . . . 64.03 109.919 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -85.73 123.43 31.1 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.149 0.58 . . . . 75.53 110.607 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -59.47 153.71 18.78 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.103 0.961 . . . . 75.2 112.718 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.82 74.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.653 0.781 . . . . 62.3 112.642 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -65.11 -40.76 94.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.615 0.766 . . . . 73.02 110.931 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.78 -37.53 87.92 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.002 0.921 . . . . 73.21 112.239 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.6 HD12 HG12 ' A' ' 109' ' ' VAL . 68.8 mt -63.0 -41.66 99.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.124 0.569 . . . . 74.52 111.829 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.89 -32.38 69.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 73.23 112.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.14 -40.61 94.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.072 0.549 . . . . 72.03 111.553 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' O ' HG21 ' A' ' 14' ' ' VAL . 34.6 tt0 -72.61 -50.16 27.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 110.319 -0.252 . . . . 73.35 110.319 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -49.44 -55.78 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.505 1.122 . . . . 71.21 113.119 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -68.49 -20.78 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.445 0.906 . . . . 75.13 113.445 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.32 -29.0 15.87 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.232 0.827 . . . . 73.25 113.232 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 10' ' ' GLU . 23.0 m -111.76 128.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 112.59 0.589 . . . . 75.44 112.59 -172.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.82 -20.93 54.85 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.963 0.905 . . . . 75.31 113.334 164.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -124.49 98.83 5.91 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.547 0.739 . . . . 75.12 110.392 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 p -75.7 94.66 3.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.563 0.745 . . . . 75.54 109.831 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 -63.81 0.99 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.373 0.879 . . . . 53.44 113.373 -167.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -121.55 6.96 10.03 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.11 0.564 . . . . 75.04 112.1 179.35 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mt -116.6 112.81 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.155 -0.683 . . . . 71.52 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.99 115.97 22.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.969 -0.382 . . . . 72.54 109.969 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.75 131.61 37.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.652 0.781 . . . . 72.53 111.97 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 62.3 mttm -130.0 151.64 50.33 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.097 0.959 . . . . 71.01 110.678 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -90.06 170.73 10.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.085 0.554 . . . . 74.03 111.085 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.38 70.7 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.406 0.682 . . . . 64.44 111.659 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -60.6 -30.16 69.65 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.902 0.881 . . . . 74.23 112.88 171.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -86.89 -2.5 58.64 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.272 0.629 . . . . 75.54 112.646 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.514 ' HE3' ' HB2' ' A' ' 81' ' ' LEU . 12.2 tpt -63.83 123.06 17.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.795 0.838 . . . . 75.43 112.293 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.75 -135.76 5.73 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.644 -0.253 . . . . 71.34 113.116 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -31.19 70.57 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.579 0.752 . . . . 71.54 111.337 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.4 m -62.8 -31.21 72.14 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.499 0.72 . . . . 72.25 111.955 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.593 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 25.9 t -73.36 -44.06 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 120.909 0.385 . . . . 72.14 110.996 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 89' ' ' LEU . 38.1 tpp -62.51 -50.47 71.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.212 -0.903 . . . . 74.23 113.076 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -27.4 69.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.924 0.49 . . . . 72.4 112.287 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.9 m -70.54 -40.32 73.48 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.002 0.521 . . . . 63.34 110.858 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.16 -43.79 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 123.497 0.719 . . . . 74.22 110.665 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.97 -37.54 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.363 0.665 . . . . 74.44 110.735 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.35 -48.41 79.9 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.546 0.738 . . . . 62.44 112.456 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -71.95 -32.45 67.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 120.698 0.285 . . . . 75.13 111.566 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . . . -76.07 -25.68 55.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.317 0.647 . . . . 74.43 112.563 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.75 -33.46 12.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.304 0.642 . . . . 74.1 112.161 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -67.52 127.16 93.37 Favored Pre-proline 0 CA--C 1.563 1.479 0 O-C-N 122.07 -0.394 . . . . 74.14 111.927 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -58.03 109.94 0.56 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.639 2.893 . . . . 75.23 114.747 -173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.79 26.23 67.64 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.882 0.713 . . . . 64.12 114.882 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.66 13.1 35.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 118.819 1.309 . . . . 74.42 112.295 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -51.47 116.54 2.13 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.132 0.573 . . . . 71.34 110.884 167.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.437 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 120.62 36.18 0.8 Allowed Glycine 0 N--CA 1.47 0.957 0 CA-C-N 115.931 -0.577 . . . . 44.33 112.117 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -111.79 127.25 8.03 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 110.77 -0.932 . . . . 72.44 110.77 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.08 125.82 53.96 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.282 0.541 . . . . 72.42 110.819 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -94.89 121.78 36.85 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.345 -0.983 . . . . 63.11 108.345 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD11 HD11 ' A' ' 7' ' ' LEU . 31.1 tp -103.52 108.71 20.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.53 0.681 . . . . 74.21 110.256 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.612 ' HB3' HD23 ' A' ' 71' ' ' LEU . 3.5 mm? -91.65 132.19 36.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.192 0.997 . . . . 73.22 110.357 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.65 32.07 4.63 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 116.048 -0.524 . . . . 73.41 112.966 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.3 133.99 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.976 0.511 . . . . 71.31 110.181 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.44 129.07 56.44 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.223 -1.399 . . . . 70.53 107.223 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -110.9 129.6 55.83 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.173 0.511 . . . . 73.41 111.702 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.51 54.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.287 1.035 . . . . 73.33 110.334 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.5 mm -96.2 126.76 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.292 0.637 . . . . 74.13 110.476 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.437 HD22 ' HB3' ' A' ' 63' ' ' ASP . 30.9 p30 -87.95 -174.1 4.56 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.526 0.73 . . . . 70.02 111.61 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.92 -22.98 67.17 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.654 0.782 . . . . 75.14 112.621 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HE3' ' N ' ' A' ' 142' ' ' GLN . 14.3 mmmm -74.11 -23.4 59.31 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.903 0.881 . . . . 75.11 112.535 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.74 78.64 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.625 -0.261 . . . . 75.15 112.722 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' HB3' HD22 ' A' ' 59' ' ' ASN . 26.0 t70 -75.03 142.41 43.79 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.617 1.167 . . . . 74.12 111.278 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.3 m -93.95 108.85 20.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.693 0.797 . . . . 74.41 110.335 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.76 121.81 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.625 0.77 . . . . 70.23 109.757 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -92.08 127.34 37.52 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.404 0.682 . . . . 74.05 110.225 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -123.11 120.89 27.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.809 0.844 . . . . 75.44 110.458 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.13 90.31 0.66 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.575 2.183 . . . . 60.14 112.761 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.95 -12.18 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.289 0.636 . . . . 71.12 112.015 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.63 179.03 44.36 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.234 -0.439 . . . . 64.12 113.627 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' A' ' 52' ' ' LEU . 3.5 mp -105.18 139.94 20.62 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 109.686 -0.487 . . . . 74.11 109.686 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.25 -30.17 25.1 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.137 1.891 . . . . 64.42 112.056 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.62 71.1 81.27 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.856 0.863 . . . . 75.24 110.226 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.69 -24.94 17.83 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.914 2.409 . . . . 74.21 112.764 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.17 -45.3 77.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 74.13 110.044 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.479 ' HZ3' ' HB3' ' A' ' 76' ' ' LYS . 7.9 mtpm? -61.39 -53.89 50.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.708 -0.678 . . . . 73.44 111.198 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.2 -35.32 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.571 0.749 . . . . 73.31 112.103 -172.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.493 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 54.2 tt0 -63.81 -46.09 86.68 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 120.99 0.424 . . . . 74.23 111.5 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -70.29 -47.61 60.45 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.566 0.746 . . . . 73.22 112.07 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.195 0.998 . . . . 60.51 111.409 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HB2' ' HE3' ' A' ' 28' ' ' MET . 19.4 tp -71.32 -41.47 69.81 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.647 0.379 . . . . 72.55 111.276 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.2 86.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.192 0.597 . . . . 74.23 111.297 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 -52.19 55.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.938 0.895 . . . . 75.41 111.191 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -68.32 -29.57 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.731 0.412 . . . . 73.52 111.596 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 45.5 t -60.27 -27.4 67.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.74 -0.6 . . . . 74.11 112.043 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.11 -49.61 6.3 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.161 0.584 . . . . 60.23 111.825 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 t -68.7 -32.14 71.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.372 0.879 . . . . 43.21 113.372 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 5.7 mmt -78.93 -48.15 15.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.368 0.667 . . . . 64.11 111.366 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 33' ' ' MET . 31.0 mt -88.39 151.4 22.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.688 0.625 . . . . 71.23 112.688 -166.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -55.27 -58.62 6.96 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.138 1.375 . . . . 71.34 112.369 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG21 ' HB3' ' A' ' 119' ' ' HIS . 43.1 t -102.36 146.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.621 0.769 . . . . 75.33 109.535 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.27 97.23 0.71 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.41 0.624 . . . . 63.15 110.822 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.5 tt -81.75 136.72 35.43 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.146 -1.057 . . . . 71.51 108.146 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -107.16 91.16 6.28 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.246 0.619 . . . . 73.22 109.948 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.551 ' HG2' ' HE1' ' A' ' 97' ' ' MET . 61.5 Cg_endo -78.71 118.61 4.21 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.135 1.89 . . . . 75.14 111.583 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 37.5 tt0 -73.44 109.24 6.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 75.42 109.084 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.551 ' HE1' ' HG2' ' A' ' 95' ' ' PRO . 66.7 mtt -116.39 133.21 56.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.132 0.573 . . . . 74.43 111.747 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 15.1 mm100 -134.75 139.61 45.3 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.251 1.021 . . . . 75.44 110.471 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.7 mt -104.85 113.05 26.41 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.175 0.99 . . . . 73.22 110.946 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -118.01 136.48 53.5 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.224 1.009 . . . . 54.51 110.147 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -92.44 118.7 31.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.557 0.343 . . . . 73.32 110.313 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.16 113.99 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 74.5 108.925 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.8 29.49 67.53 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 114.804 0.682 . . . . 70.0 114.804 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.69 79.95 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.507 0.563 . . . . 73.13 114.507 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.34 136.43 49.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.995 0.918 . . . . 74.24 110.19 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.3 m -87.77 120.97 29.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.701 0.682 . . . . 75.33 110.903 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.5 mp -116.36 156.46 26.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.856 0.862 . . . . 64.42 109.813 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 52.5 tp -115.75 121.57 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.097 0.559 . . . . 74.22 110.117 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.6 HG12 HD12 ' A' ' 7' ' ' LEU . 51.3 t -99.05 121.79 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.532 0.733 . . . . 73.24 109.153 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.39 101.38 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.957 0.503 . . . . 73.52 110.36 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.645 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 77.6 t80 -73.33 122.7 22.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.321 0.648 . . . . 74.34 109.826 170.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.65 110.51 63.3 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.371 0.668 . . . . 63.04 109.771 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.13 145.84 24.88 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.308 2.005 . . . . 74.22 112.235 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 42.7 tt0 -74.27 145.0 44.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.159 -0.682 . . . . 75.51 109.159 169.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' HIS . . . -84.96 173.83 10.25 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 123.239 0.616 . . . . 64.1 111.691 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.97 176.87 0.64 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 124.829 1.251 . . . . 75.15 111.044 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.89 -56.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.714 -1.241 . . . . 63.25 114.117 167.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -82.72 -41.45 19.26 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.354 0.525 . . . . 74.22 111.379 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.634 ' HB3' HG21 ' A' ' 91' ' ' VAL . 19.1 m-70 -104.7 73.65 1.1 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 103.734 -2.691 . . . . 74.01 103.734 162.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.5 mttt -46.87 -139.08 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.8 1 C-N-CA 133.526 4.73 . . . . 73.02 121.301 53.163 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo 6.43 67.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 124.592 3.528 . . . . 63.1 116.225 -122.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.486 HG12 ' HA ' ' A' ' 120' ' ' LYS . 23.5 mm -76.72 80.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-N 115.287 -0.87 . . . . 75.04 109.595 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -82.95 152.97 25.26 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.923 0.392 . . . . 75.54 110.224 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -89.89 155.72 18.95 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 109.439 -0.578 . . . . 72.4 109.439 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 88' ' ' MET . 73.8 mmtt -73.02 -2.0 19.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.863 0.865 . . . . 74.21 112.44 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.7 -178.3 5.46 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.399 1.08 . . . . 35.01 111.111 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 158.06 33.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.638 0.775 . . . . 64.03 112.012 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.08 -82.84 1.25 Allowed Glycine 0 N--CA 1.477 1.37 0 CA-C-O 120.153 -0.248 . . . . 75.22 113.459 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt 59.4 82.12 0.24 Allowed Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 124.757 1.223 . . . . 73.51 110.393 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -76.88 168.92 22.64 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.847 2.364 . . . . 73.54 112.799 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.56 162.33 30.4 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 116.043 -0.526 . . . . 73.32 113.751 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.67 -172.65 37.9 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.662 0.172 . . . . 72.22 113.087 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.6 169.23 18.21 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.133 0.492 . . . . 70.43 111.967 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -125.91 172.74 9.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.73 0.812 . . . . 74.13 109.74 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -62.03 108.78 1.11 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.273 0.559 . . . . 73.43 110.835 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -96.38 8.09 44.85 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.215 1.006 . . . . 73.22 111.194 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.43 132.6 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.517 1.127 . . . . 74.34 111.02 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.41 170.32 33.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.478 -0.328 . . . . 61.44 113.304 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 p -93.05 -61.52 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.526 0.731 . . . . 72.22 111.546 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -154.59 134.63 13.08 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.219 0.608 . . . . 75.44 111.426 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.82 92.42 8.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.375 0.67 . . . . 74.31 111.001 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.464 ' N ' ' HE3' ' A' ' 61' ' ' LYS . 13.2 mm100 -74.14 155.72 38.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.552 -0.749 . . . . 75.15 110.871 171.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.75 143.79 26.16 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.486 0.314 . . . . 75.44 110.826 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 80.4 m -73.16 86.75 1.4 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.28 0.562 . . . . 71.21 110.615 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.5 p -80.63 139.95 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.484 0.714 . . . . 75.51 111.246 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -140.86 157.01 45.98 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.691 0.796 . . . . 71.23 110.113 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.29 153.93 31.36 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.009 0.524 . . . . 72.44 110.977 174.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -154.42 107.7 2.88 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.659 0.784 . . . . 75.4 108.906 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -70.66 85.44 0.64 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.937 0.875 . . . . 64.52 112.216 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -73.07 129.9 39.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.175 -1.375 . . . . 75.41 110.034 174.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -80.08 178.86 7.94 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.525 0.73 . . . . 73.33 111.278 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -103.9 146.83 28.1 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.005 0.522 . . . . 75.42 111.867 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.9 p80 . . . . . 0 N--CA 1.488 1.457 0 C-N-CA 124.39 1.076 . . . . 73.2 112.621 176.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HB ' ' A' ' 109' ' ' VAL . 56.6 ttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.221 0.452 . . . . 72.1 112.221 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -47.26 145.65 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.827 0.676 . . . . 74.04 112.827 158.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -64.11 151.65 42.64 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 75.11 111.268 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.12 -26.69 68.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.953 -0.567 . . . . 74.31 111.993 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.616 HG21 HG12 ' A' ' 102' ' ' VAL . 2.0 m -66.53 -47.37 73.1 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.152 0.981 . . . . 75.44 111.131 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.83 -44.06 97.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.987 0.915 . . . . 75.12 111.502 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.04 -30.81 69.25 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.074 -0.966 . . . . 74.32 112.246 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -66.03 -43.43 87.64 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.129 0.571 . . . . 74.52 109.962 171.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.8 -37.71 85.39 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.49 0.716 . . . . 71.4 111.591 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.71 -41.97 99.41 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.074 0.95 . . . . 72.13 110.925 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.03 -44.68 94.48 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.142 0.977 . . . . 72.34 112.113 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -76.99 -16.13 59.42 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.645 0.609 . . . . 74.4 112.645 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.43 43.38 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.239 0.616 . . . . 75.32 111.147 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 17' ' ' SER . 17.1 m -115.82 119.16 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.863 0.865 . . . . 71.33 110.02 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.21 -47.48 83.33 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.774 0.83 . . . . 72.13 111.27 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.95 95.96 9.81 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 72.41 108.656 165.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.47 ' HA ' HG22 ' A' ' 14' ' ' VAL . 35.8 t -58.57 122.08 12.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.123 -0.489 . . . . 64.42 111.929 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.96 76.95 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.698 0.629 . . . . 65.21 112.698 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -150.88 15.48 0.75 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.089 0.774 . . . . 73.32 113.089 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.0 mm -102.21 106.47 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.342 -0.984 . . . . 72.41 108.342 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.507 ' HG2' HG21 ' A' ' 35' ' ' THR . 10.6 tp10 -94.8 114.35 26.23 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.323 0.649 . . . . 75.24 111.504 -169.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.53 35.38 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.651 0.781 . . . . 70.42 112.136 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.763 ' HZ1' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.19 156.24 38.18 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.906 0.86 . . . . 65.1 112.235 176.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -81.37 163.19 23.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.42 -1.264 . . . . 75.34 110.362 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.05 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.787 0.435 . . . . 74.12 112.078 173.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 m -64.52 -29.97 71.01 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.866 0.867 . . . . 72.34 112.572 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 63.8 m-20 -82.53 -16.08 49.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.263 0.625 . . . . 75.35 112.337 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.522 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.8 tmm? -63.64 120.1 11.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.976 0.511 . . . . 73.24 111.822 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.19 -139.46 6.13 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.147 -0.478 . . . . 74.55 112.324 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -58.64 -41.65 86.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.988 1.107 . . . . 74.33 113.988 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -64.61 -41.12 96.43 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.583 0.753 . . . . 71.31 112.225 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.542 HG23 ' HE3' ' A' ' 23' ' ' LYS . 84.5 t -67.08 -43.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.581 0.752 . . . . 71.22 110.517 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.4 tpp -56.45 -40.92 75.61 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.965 1.306 . . . . 65.2 112.479 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.71 -39.23 90.77 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.47 0.708 . . . . 72.4 110.432 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.507 HG21 ' HG2' ' A' ' 21' ' ' GLU . 23.4 m -75.51 -30.74 59.91 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.06 0.544 . . . . 75.32 111.416 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 112' ' ' VAL . 69.2 t -59.39 -41.82 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.343 0.657 . . . . 73.12 110.657 174.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mt -59.86 -36.55 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 122.843 0.457 . . . . 73.24 111.326 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.38 97.27 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.827 1.047 . . . . 74.34 113.827 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.553 ' HA ' HD21 ' A' ' 45' ' ' LEU . 87.9 m-85 -70.76 -35.41 72.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.931 0.492 . . . . 74.12 111.206 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -22.7 46.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.693 0.797 . . . . 72.12 112.397 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -74.59 -50.09 19.23 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 54.21 111.754 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.06 142.18 72.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.175 0.59 . . . . 73.53 112.076 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.53 123.0 7.8 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.584 2.19 . . . . 74.22 113.107 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.39 34.71 85.76 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.83 -0.623 . . . . 52.5 114.551 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 39' ' ' PHE . 16.4 tp -97.97 18.79 15.15 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 117.738 0.769 . . . . 63.34 111.143 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -45.55 122.62 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.898 1.073 . . . . 72.11 113.898 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.1 51.12 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.421 -0.655 . . . . 53.12 114.554 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.66 137.27 9.2 Favored Glycine 0 C--N 1.364 2.094 0 CA-C-N 118.847 1.323 . . . . 71.23 111.9 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -121.27 138.68 54.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.462 0.705 . . . . 74.02 111.623 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 121.27 44.07 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.896 0.878 . . . . 72.51 109.392 172.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.84 109.56 21.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.501 0.72 . . . . 72.5 110.103 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.573 HD23 HD23 ' A' ' 108' ' ' LEU . 9.5 mp -95.53 136.47 35.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.304 1.041 . . . . 74.24 109.989 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.33 31.55 8.91 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.894 -0.594 . . . . 72.11 112.372 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.3 t -112.18 139.68 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.597 0.759 . . . . 75.53 109.481 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -114.16 159.13 20.42 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.835 -1.172 . . . . 53.43 107.835 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.463 ' HH2' ' HA ' ' A' ' 23' ' ' LYS . 41.3 p90 -150.65 137.16 18.81 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 73.35 111.296 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.91 49.14 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.583 0.753 . . . . 72.52 110.701 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -88.91 130.89 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.362 0.665 . . . . 71.21 110.666 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.427 HD22 ' HB2' ' A' ' 63' ' ' ASP . 31.9 p30 -82.13 -172.49 3.99 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.631 0.772 . . . . 75.0 112.486 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.07 -33.12 75.04 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.745 0.818 . . . . 75.14 112.433 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -83.04 -12.61 57.05 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.246 0.618 . . . . 73.53 112.335 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.08 37.02 6.11 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.228 0.451 . . . . 45.33 114.228 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB2' HD22 ' A' ' 59' ' ' ASN . 8.7 m-20 -116.77 134.72 54.44 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.479 0.711 . . . . 72.54 110.413 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -86.68 118.5 26.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.415 0.686 . . . . 75.14 110.548 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.39 118.34 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.126 0.57 . . . . 74.32 109.885 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.06 120.39 34.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.575 0.75 . . . . 73.34 109.821 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -124.02 151.02 64.57 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.847 0.859 . . . . 73.3 112.088 -170.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.47 121.7 5.28 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.606 2.204 . . . . 74.31 112.823 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.41 -40.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.9 -1.045 . . . . 71.42 110.557 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.44 170.28 46.76 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.695 -0.684 . . . . 74.14 113.362 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.09 139.76 22.18 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 109.619 -0.512 . . . . 72.21 109.619 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 -29.92 31.35 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.569 2.179 . . . . 74.42 111.954 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -133.19 83.06 51.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 108.328 -0.99 . . . . 61.35 108.328 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.21 -36.65 56.18 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.904 2.403 . . . . 74.21 113.564 -172.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.8 -43.01 60.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.191 0.596 . . . . 64.01 110.969 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.1 -45.57 94.15 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.407 0.283 . . . . 73.35 111.39 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG13 ' HE3' ' A' ' 28' ' ' MET . 80.2 t -65.33 -43.64 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.479 0.712 . . . . 71.22 111.352 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.48 -48.42 81.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.523 0.729 . . . . 64.15 111.953 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -66.76 -40.93 88.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.171 -0.922 . . . . 65.44 111.474 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.83 -35.81 82.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.232 0.613 . . . . 74.01 110.91 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.34 -37.05 71.73 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.624 0.769 . . . . 74.31 111.329 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.56 86.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.439 0.696 . . . . 72.43 111.399 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.2 t -65.07 -52.55 55.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.839 0.855 . . . . 73.43 111.503 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.39 -31.82 73.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.21 0.604 . . . . 75.31 111.922 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 44.8 t -60.05 -35.3 74.83 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.163 0.506 . . . . 72.34 112.153 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.78 37.2 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.615 -0.721 . . . . 74.23 112.187 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.8 p -95.35 -2.59 48.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.593 0.961 . . . . 73.51 113.593 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.3 mmt -93.16 -55.45 3.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.371 0.605 . . . . 74.14 109.955 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.94 146.82 26.01 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.36 -0.836 . . . . 72.53 110.548 -171.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.511 HD22 ' HA ' ' A' ' 122' ' ' ILE . 4.8 p30 -52.75 -33.1 46.75 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.59 1.156 . . . . 74.13 113.161 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.25 162.57 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.25 1.02 . . . . 72.45 110.773 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.28 101.75 6.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.657 -0.701 . . . . 74.51 110.427 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.4 tt -83.24 124.12 30.25 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.57 -1.27 . . . . 74.55 107.57 172.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -102.89 98.75 12.04 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 122.76 0.424 . . . . 71.02 110.856 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' HG2' ' HE2' ' A' ' 97' ' ' MET . 64.3 Cg_endo -87.82 163.06 7.63 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.284 1.99 . . . . 64.54 112.433 171.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.692 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 60.4 tt0 -88.23 121.69 30.92 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.406 ' HE2' ' HG2' ' A' ' 95' ' ' PRO . 64.9 mtt -124.4 117.78 25.22 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.241 0.617 . . . . 75.41 110.799 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.695 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 28.6 mm-40 -131.38 138.78 49.29 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.686 0.794 . . . . 64.13 110.615 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.31 117.27 29.52 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.504 0.721 . . . . 74.13 109.439 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.7 133.53 53.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.394 1.078 . . . . 73.23 110.297 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -89.86 129.9 36.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.988 0.515 . . . . 75.33 111.095 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG12 HG21 ' A' ' 5' ' ' THR . 23.9 t -128.13 107.74 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.97 0.908 . . . . 73.05 108.828 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.6 28.95 57.11 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.727 0.651 . . . . 53.55 114.727 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.75 0.93 83.42 Favored Glycine 0 CA--C 1.543 1.794 0 N-CA-C 114.82 0.688 . . . . 74.12 114.82 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.7 133.05 41.74 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.611 0.706 . . . . 73.35 109.303 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -86.74 102.72 14.51 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.418 0.554 . . . . 74.53 110.796 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.2 154.42 18.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.52 0.728 . . . . 74.22 110.26 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.573 HD23 HD23 ' A' ' 52' ' ' LEU . 52.0 tp -116.69 120.1 37.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.401 0.681 . . . . 74.34 109.288 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 17.3 t -95.87 132.63 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.105 -0.702 . . . . 74.12 109.105 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.06 99.22 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.862 -0.792 . . . . 74.52 108.862 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.692 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 54.1 t80 -83.67 131.65 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.08 0.552 . . . . 65.21 110.107 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 36' ' ' VAL . 36.6 t -121.92 116.26 30.23 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 109.434 -0.58 . . . . 73.04 109.434 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.23 -176.15 1.76 Allowed 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.708 2.272 . . . . 74.13 112.832 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.48 ' HG3' ' HZ2' ' A' ' 120' ' ' LYS . 35.8 tt0 -70.81 131.68 44.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.93 0.492 . . . . 70.2 109.85 166.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.08 157.02 23.02 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.038 0.535 . . . . 55.23 111.339 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.93 150.99 46.91 Favored 'General case' 0 C--O 1.186 -2.24 0 C-N-CA 123.963 0.905 . . . . 72.45 111.417 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -38.01 -52.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 N-CA-C 115.738 1.755 . . . . 64.03 115.738 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -69.59 -37.86 77.11 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.124 0.787 . . . . 74.53 113.124 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.8 m-70 -125.73 66.66 1.17 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 105.273 -2.121 . . . . 75.51 105.273 171.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 62.8 mttm -44.14 -153.0 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.207 1 C-N-CA 132.863 4.465 . . . . 74.43 121.316 60.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -1.85 71.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.584 2.19 . . . . 72.14 116.244 -117.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.511 ' HA ' HD22 ' A' ' 90' ' ' ASN . 59.5 mt -85.88 111.0 20.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.805 -1.089 . . . . 71.32 110.248 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -113.14 139.53 48.67 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.836 -1.075 . . . . 73.22 110.401 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.0 120.0 13.55 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.322 0.649 . . . . 74.52 109.443 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.454 ' HZ1' ' HB2' ' A' ' 125' ' ' LYS . 10.9 mtmp? -60.1 -33.79 72.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 112.547 0.573 . . . . 74.4 112.547 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.7 105.89 14.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.265 0.626 . . . . 74.44 109.571 171.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.5 p -57.3 105.48 0.24 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.45 112.501 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.68 -147.44 3.59 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 115.897 -0.592 . . . . 72.23 113.986 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.3 pp -145.7 143.85 20.88 Favored Pre-proline 0 N--CA 1.485 1.286 0 N-CA-C 112.547 0.573 . . . . 75.21 112.547 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -73.69 151.68 46.82 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.991 2.461 . . . . 72.01 112.548 169.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.7 107.4 3.2 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-N 116.704 -0.226 . . . . 64.43 113.09 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.49 -145.65 9.69 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.153 0.406 . . . . 70.33 112.818 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.32 150.83 51.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.25 0.62 . . . . 65.53 111.329 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -134.31 145.4 49.01 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.504 0.722 . . . . 74.1 110.403 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -97.54 178.44 5.18 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.775 0.83 . . . . 73.54 112.205 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 133.95 47.18 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.377 -0.374 . . . . 73.31 110.099 167.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.19 109.98 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 123.724 0.81 . . . . 74.21 112.187 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.4 149.27 19.21 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.639 -0.709 . . . . 70.33 111.771 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.8 p -76.99 138.29 39.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.274 0.63 . . . . 70.1 111.676 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -84.77 85.97 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.107 0.563 . . . . 71.21 109.695 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.64 155.21 41.04 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.996 0.739 . . . . 74.35 112.996 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.54 11.93 11.59 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.297 1.039 . . . . 73.22 111.537 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -79.24 27.21 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.641 0.978 . . . . 73.03 113.641 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 24.6 p -78.71 79.18 5.14 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.487 0.715 . . . . 65.51 110.94 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.36 94.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.555 0.742 . . . . 73.53 111.235 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.8 102.55 14.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.038 0.535 . . . . 73.53 109.786 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -168.02 1.5 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 122.989 0.516 . . . . 74.44 111.526 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -135.87 127.34 28.65 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.896 0.478 . . . . 72.41 111.588 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -152.23 137.19 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.473 0.709 . . . . 71.22 110.352 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -96.39 144.22 26.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.434 0.693 . . . . 74.21 110.922 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -94.35 139.49 31.02 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 72.23 110.891 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 67.42 -69.19 0.14 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.26 1.424 . . . . 75.31 111.662 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.452 0.644 . . . . 72.45 110.673 174.494 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.353 -0.239 . . . . 73.31 110.353 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.88 153.53 18.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.13 0.572 . . . . 72.44 111.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.3 t -74.41 156.82 36.61 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.442 0.697 . . . . 62.24 111.249 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.89 -27.73 67.75 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.934 0.493 . . . . 64.21 111.355 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.574 HG22 HG13 ' A' ' 102' ' ' VAL . 3.8 m -70.18 -41.75 73.34 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.658 0.783 . . . . 74.35 110.395 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.18 -51.04 67.96 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.622 1.169 . . . . 72.14 110.952 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.461 ' HB3' HD23 ' A' ' 51' ' ' LEU . 85.3 mt -69.67 -33.25 72.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.1 0.96 . . . . 75.21 113.081 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.93 -44.8 88.32 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.013 0.435 . . . . 73.55 110.404 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.33 -37.61 86.31 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.519 -0.764 . . . . 63.24 111.096 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.29 -43.12 98.8 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.885 0.874 . . . . 74.41 110.703 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 22' ' ' ALA . 71.4 mt -67.09 -38.56 85.92 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.518 1.127 . . . . 71.52 111.96 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -72.61 -23.8 60.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.118 0.567 . . . . 65.42 111.942 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.2 17.59 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.475 0.71 . . . . 65.03 110.965 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.33 116.54 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.179 0.514 . . . . 74.31 110.77 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.17 -43.21 87.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.67 0.388 . . . . 72.21 110.629 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.24 101.2 1.44 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.232 0.539 . . . . 73.22 109.931 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.521 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 25.3 m -80.89 78.64 7.67 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.589 0.756 . . . . 75.22 110.161 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.07 40.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.955 1.095 . . . . 73.52 113.955 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -123.72 -9.35 7.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 113.047 0.758 . . . . 74.25 113.047 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.521 ' O ' ' HB3' ' A' ' 17' ' ' SER . 42.3 mt -131.92 133.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.684 0.794 . . . . 75.23 109.301 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -125.7 129.4 49.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.826 0.739 . . . . 74.42 111.316 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 11' ' ' LEU . . . -89.02 131.74 35.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.705 0.802 . . . . 71.52 110.612 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.34 151.94 51.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.834 0.854 . . . . 73.43 111.046 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -92.39 165.63 12.97 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.705 . . . . 75.23 112.474 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -24.54 67.31 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.141 0.976 . . . . 72.23 112.276 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.1 -36.02 82.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.865 0.466 . . . . 72.41 111.982 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -86.04 -2.48 58.35 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.466 0.706 . . . . 70.14 112.238 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.4 tpt -52.59 105.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.346 1.059 . . . . 72.34 111.909 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.465 ' HA2' ' OE1' ' A' ' 84' ' ' GLN . . . 138.05 -124.72 3.03 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.802 -0.635 . . . . 61.13 112.83 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.31 -36.85 76.38 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.461 1.105 . . . . 74.15 112.157 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.0 m -72.53 -18.85 61.61 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.264 -0.88 . . . . 73.31 112.991 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -34.34 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.659 0 C-N-CA 122.902 0.481 . . . . 64.51 111.709 167.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 24.7 mmt -74.69 -37.52 62.61 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.367 1.618 . . . . 74.2 115.367 -158.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.44 70.52 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.38 0.537 . . . . 75.43 112.19 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 50' ' ' LEU . 31.8 m -77.31 -30.76 54.25 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.186 0.594 . . . . 65.04 111.28 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.53 -39.93 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 122.837 0.455 . . . . 74.44 110.266 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 124' ' ' LYS . 68.6 mt -57.2 -35.61 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.533 0.733 . . . . 73.03 111.637 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.3 1.61 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.47 0.308 . . . . 73.44 110.891 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -65.46 -30.51 71.31 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.498 0.719 . . . . 73.43 112.359 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.81 -24.85 55.93 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.782 0.66 . . . . 63.21 112.782 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -115.95 -4.69 12.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.149 1.166 . . . . 63.44 114.149 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -92.52 107.15 21.75 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.0 0.818 . . . . 74.41 110.773 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.52 126.74 8.47 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.464 2.11 . . . . 75.42 112.997 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.21 -7.05 32.48 Favored Glycine 0 N--CA 1.474 1.216 0 CA-C-N 116.002 -0.544 . . . . 73.3 113.734 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.07 -37.93 9.95 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.986 0.893 . . . . 72.54 108.935 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.433 ' HA ' ' HB2' ' A' ' 114' ' ' GLU . 11.0 m-20 39.6 71.81 0.16 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.309 1.844 . . . . 64.53 115.401 171.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.41 74.45 0.43 Allowed Glycine 0 C--N 1.352 1.425 0 N-CA-C 115.362 0.905 . . . . 64.04 115.362 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.13 44.45 Favored Glycine 0 N--CA 1.482 1.72 0 CA-C-N 117.237 0.518 . . . . 53.33 113.234 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -129.26 142.43 50.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.575 0.954 . . . . 75.12 113.575 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.8 mt -132.28 125.44 31.02 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.24 1.416 . . . . 63.11 109.891 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.461 HD23 ' HB3' ' A' ' 7' ' ' LEU . 3.7 mm? -103.56 108.81 20.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.743 0.417 . . . . 70.31 110.851 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.71 124.93 38.04 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 75.11 109.857 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.98 33.15 4.13 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.158 -0.474 . . . . 73.13 112.94 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.88 146.33 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.545 0.738 . . . . 73.13 109.875 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -130.55 134.3 46.91 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.997 -0.742 . . . . 74.31 108.997 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -117.44 129.65 55.97 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.291 1.036 . . . . 74.3 110.881 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.76 135.22 54.19 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.604 0.762 . . . . 75.44 110.813 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -80.54 129.68 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.606 0.762 . . . . 73.41 110.487 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.467 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 40.7 p30 -90.89 -168.17 2.01 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.88 0.696 . . . . 65.32 112.88 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.17 -44.6 68.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.755 1.222 . . . . 74.13 113.48 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -26.8 27.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.013 0.525 . . . . 75.11 111.635 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.16 7.39 14.69 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 119.913 -0.382 . . . . 71.42 114.023 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 8.3 m-20 -74.48 143.1 44.77 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.471 0.636 . . . . 75.02 111.013 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.1 m -90.11 114.28 26.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.871 0.869 . . . . 71.53 110.156 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.55 117.28 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.437 0.695 . . . . 74.21 110.443 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -92.66 116.39 28.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.088 0.955 . . . . 74.45 110.422 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -118.46 149.76 46.67 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 123.885 0.874 . . . . 75.53 111.383 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.63 104.92 1.78 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.66 2.24 . . . . 74.44 112.014 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.94 -29.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 116.052 -0.522 . . . . 74.34 110.397 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -174.16 55.11 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.615 -0.721 . . . . 73.23 113.57 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 77' ' ' VAL . 82.0 mt -104.51 133.14 20.34 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.718 0.807 . . . . 75.1 110.542 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.43 -31.34 42.77 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.521 2.148 . . . . 74.53 111.763 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 5.8 m-20 -122.52 75.43 44.53 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 124.077 0.951 . . . . 73.25 109.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.83 -60.26 0.62 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.24 2.627 . . . . 75.14 114.223 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 5.2 p-10 -66.28 -39.36 89.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.263 -0.426 . . . . 73.23 110.65 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 57.4 tptt -60.96 -40.77 94.59 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.627 0.771 . . . . 74.24 112.089 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 71' ' ' LEU . 79.2 t -62.84 -44.92 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.037 0.535 . . . . 72.51 110.888 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.49 -50.34 73.93 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.586 0.754 . . . . 71.22 112.313 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 16.5 mmt85 -68.51 -43.96 75.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.495 0.718 . . . . 75.44 111.521 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.72 -33.54 72.63 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.541 -0.754 . . . . 74.33 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.551 HD22 ' SD ' ' A' ' 97' ' ' MET . 21.6 tp -66.98 -40.19 87.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.688 0.395 . . . . 72.32 110.936 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.424 ' HB3' ' HE2' ' A' ' 97' ' ' MET . . . -63.24 -39.2 93.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.97 0.508 . . . . 70.41 111.695 174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -66.52 -52.47 45.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.813 0.845 . . . . 64.14 112.016 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.465 ' OE1' ' HA2' ' A' ' 29' ' ' GLY . 11.7 pt20 -71.13 -31.17 67.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.003 0.521 . . . . 72.24 112.321 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 42.4 t -60.89 -26.92 67.78 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.435 0.636 . . . . 73.25 111.373 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -76.48 -25.15 53.98 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 113.721 1.008 . . . . 64.41 113.721 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.5 p -110.44 -37.24 5.55 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.288 0.847 . . . . 71.52 113.288 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 92.1 mmm -68.29 -46.89 69.11 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.393 1.077 . . . . 70.53 111.542 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.9 mt -85.89 161.91 18.84 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.718 -0.674 . . . . 73.11 111.374 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -37.33 -53.05 1.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.873 1.669 . . . . 75.41 114.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.7 m -119.64 174.33 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.507 0.723 . . . . 74.11 111.441 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -68.73 97.4 0.81 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.202 -0.666 . . . . 64.52 109.202 163.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.684 HD13 HG23 ' A' ' 122' ' ' ILE . 4.9 tt -98.84 130.84 45.27 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.47 0.708 . . . . 63.34 109.465 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -106.62 98.55 20.92 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 124.061 0.944 . . . . 73.14 110.985 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.4 149.93 15.03 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.238 1.959 . . . . 72.54 111.407 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.21 102.68 14.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.097 -0.705 . . . . 64.12 109.097 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.576 ' HB3' HD12 ' A' ' 108' ' ' LEU . 51.9 mtm -112.43 140.25 47.32 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.536 0.735 . . . . 74.05 110.679 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -149.88 150.86 32.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.352 0.661 . . . . 74.13 110.46 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.73 119.28 38.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.295 1.038 . . . . 63.42 110.59 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -127.23 133.54 50.22 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.085 0.954 . . . . 75.32 109.711 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.85 122.16 40.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.073 0.463 . . . . 70.32 110.879 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 5' ' ' THR . 9.2 t -119.95 113.44 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.502 1.121 . . . . 73.32 108.41 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.29 28.67 55.25 Favored Glycine 0 CA--C 1.547 2.064 0 N-CA-C 115.169 0.828 . . . . 60.53 115.169 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.12 1.92 66.69 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 115.088 0.795 . . . . 65.23 115.088 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -109.96 130.51 55.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.993 0.897 . . . . 75.44 109.685 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 102.41 14.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.484 0.583 . . . . 74.11 111.685 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.39 166.45 14.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.895 0.878 . . . . 75.45 111.046 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 97' ' ' MET . 49.3 tp -119.21 121.84 40.62 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.56 0.744 . . . . 75.52 110.782 175.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' MET . 52.6 t -86.93 113.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.299 0.639 . . . . 74.02 109.576 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 55.3 t -100.22 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.37 0.605 . . . . 75.22 109.691 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.6 119.28 24.54 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.929 0.892 . . . . 75.34 109.252 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.87 100.34 39.17 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.488 0.715 . . . . 73.22 109.55 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.25 157.29 41.78 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.5 2.133 . . . . 74.43 112.175 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.5 tm-20 -75.94 115.94 16.15 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.23 -0.655 . . . . 71.42 109.23 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.47 152.22 35.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.346 1.058 . . . . 65.35 112.425 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' HB3' HG23 ' A' ' 118' ' ' THR . 14.9 t70 -77.55 156.93 30.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.049 -0.523 . . . . 73.43 111.238 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -64.99 -19.92 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.412 0.685 . . . . 73.55 112.426 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 116' ' ' ASP . 14.9 t -58.01 -18.31 23.22 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 123.534 0.733 . . . . 73.1 112.277 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 83.8 m-70 -79.88 -76.65 0.21 Allowed 'General case' 0 CA--C 1.591 2.548 0 N-CA-C 106.979 -1.489 . . . . 74.5 106.979 166.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.694 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 5.8 tmtp? -79.92 -142.57 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.414 0 C-N-CA 129.519 3.127 . . . . 72.43 110.742 -49.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' CD ' ' HB3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 1.24 112.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.592 1 C-N-CA 125.611 4.207 . . . . 65.54 119.424 -133.832 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.684 HG23 HD13 ' A' ' 93' ' ' LEU . 36.8 mm -95.52 102.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 115.312 -0.858 . . . . 75.02 109.634 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -101.6 167.5 10.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.769 0.828 . . . . 65.42 110.714 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.564 ' HB2' HD12 ' A' ' 37' ' ' ILE . 37.8 ttpt -85.95 119.13 25.92 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.41 -0.959 . . . . 73.3 108.41 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -66.7 -11.84 55.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.646 0.98 . . . . 74.44 113.646 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.31 67.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.036 0.534 . . . . 74.45 111.42 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m 76.22 -52.14 0.61 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.97 1.708 . . . . 74.11 113.245 173.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -57.19 116.26 7.69 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 113.914 0.326 . . . . 75.25 113.914 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 mp 65.83 78.84 0.25 Allowed Pre-proline 0 CA--C 1.565 1.55 0 C-N-CA 124.82 1.248 . . . . 75.41 112.261 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -90.81 168.63 3.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.095 2.53 . . . . 71.54 113.282 170.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.75 77.72 0.62 Allowed Glycine 0 CA--C 1.54 1.602 0 CA-C-N 116.599 -0.273 . . . . 70.51 113.023 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -105.74 79.94 0.28 Allowed Glycine 0 C--N 1.351 1.397 0 C-N-CA 122.826 0.251 . . . . 63.42 113.654 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.15 125.82 41.91 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.31 0.644 . . . . 71.52 110.562 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -86.8 147.12 25.96 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.245 0.618 . . . . 75.32 112.452 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.15 146.75 9.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.11 0.964 . . . . 74.14 109.968 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -77.57 90.01 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.198 0.523 . . . . 75.24 110.151 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.527 ' H ' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -101.57 174.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.959 0.904 . . . . 72.35 112.418 -173.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.02 144.62 15.12 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.192 -0.458 . . . . 74.51 112.362 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.3 t -147.4 -72.66 0.21 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.034 0.417 . . . . 72.33 111.451 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.2 p -105.63 175.41 5.51 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.207 0.603 . . . . 70.34 111.674 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.28 -0.32 31.84 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.952 1.093 . . . . 74.23 113.952 -172.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.1 -2.87 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.154 1.168 . . . . 74.3 114.154 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -69.24 -11.68 61.02 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.496 0.718 . . . . 73.5 112.638 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 75.8 m -69.43 139.0 53.99 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.621 0.768 . . . . 55.51 112.491 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.98 145.21 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.209 1.003 . . . . 73.14 110.251 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.05 142.71 57.71 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 122.782 0.433 . . . . 75.21 110.768 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -74.46 121.74 21.93 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.387 0.675 . . . . 61.43 109.922 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -148.66 102.2 3.28 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.304 0.641 . . . . 72.12 109.579 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -74.31 77.14 1.85 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.59 0.756 . . . . 75.22 110.799 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 t60 47.74 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.909 1.683 . . . . 72.44 113.176 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -68.17 131.81 46.07 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.112 0.565 . . . . 63.11 109.756 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.1 m80 69.16 85.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.104 1.361 . . . . 75.34 109.69 -163.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 124.15 0.98 . . . . 75.11 111.457 -175.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' HB3' ' A' ' 98' ' ' GLN . 14.9 ptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 111.383 0.142 . . . . 73.23 111.383 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.09 149.22 21.9 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.681 0.392 . . . . 72.52 111.143 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -74.03 157.31 36.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.943 0.897 . . . . 74.33 112.453 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB2' HG23 ' A' ' 102' ' ' VAL . . . -61.27 -43.68 98.47 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.034 0.534 . . . . 64.54 112.208 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -65.0 -35.09 80.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.229 0.612 . . . . 73.21 112.154 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.284 0.634 . . . . 71.42 111.262 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 20' ' ' ILE . 60.2 mt -68.76 -39.56 80.21 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.541 0.736 . . . . 73.52 111.456 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' HA ' HD11 ' A' ' 11' ' ' LEU . 31.7 tp -65.12 -29.07 69.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.94 0.896 . . . . 75.23 111.276 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.28 -35.09 71.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.638 0.775 . . . . 75.43 111.525 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.89 -50.09 32.29 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 110.232 -0.285 . . . . 75.13 110.232 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 8' ' ' LEU . 69.6 mt -55.31 -46.86 76.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.489 1.116 . . . . 73.53 113.65 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -87.76 -4.08 58.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.486 0.921 . . . . 55.42 113.486 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.59 -59.84 2.16 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.383 0.611 . . . . 73.54 110.3 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.26 139.09 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 73.43 110.775 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -64.92 -47.24 78.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.633 0.773 . . . . 74.43 112.408 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.85 148.15 24.74 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -93.33 143.58 26.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.748 0.309 . . . . 71.54 110.721 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.58 3.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.361 0.664 . . . . 61.23 111.485 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -137.11 1.59 2.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.043 0.756 . . . . 71.4 113.043 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.556 HD12 HD21 ' A' ' 7' ' ' LEU . 11.0 mm -108.7 107.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 118.78 0.718 . . . . 74.31 110.483 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -94.2 113.81 25.81 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.46 -0.775 . . . . 75.04 110.881 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.09 129.12 35.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.277 0.631 . . . . 73.14 109.919 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -133.82 164.59 26.91 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.721 0.772 . . . . 74.23 111.892 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -101.42 177.73 4.84 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.662 -1.154 . . . . 75.12 110.945 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.06 62.65 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 74.21 111.467 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 p -65.67 -29.9 70.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 54.22 112.274 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.08 -17.01 62.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.164 0.801 . . . . 72.54 113.164 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.404 ' SD ' HG12 ' A' ' 77' ' ' VAL . 92.0 mmm -55.52 107.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.706 0.802 . . . . 74.32 112.111 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.92 -125.38 2.94 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.279 -0.873 . . . . 72.4 111.158 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.294 0.638 . . . . 74.13 112.371 -174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 m -68.18 -45.32 73.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.48 0.712 . . . . 54.42 111.884 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.47 -52.71 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.822 0.449 . . . . 73.32 110.222 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.473 ' SD ' HD23 ' A' ' 89' ' ' LEU . 39.8 tpp -52.66 -46.52 67.2 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.283 1.033 . . . . 74.03 113.745 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.54 -27.87 64.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.163 0.585 . . . . 74.0 111.914 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.6 m -69.48 -39.3 77.74 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.133 0.573 . . . . 61.15 111.029 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.39 -35.51 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 123.001 0.521 . . . . 73.31 110.756 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 33' ' ' MET . 47.9 mm -57.56 -39.1 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.629 0.772 . . . . 75.44 110.929 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.98 82.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.77 -0.65 . . . . 75.51 112.035 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.4 -38.87 40.62 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.113 0.565 . . . . 72.4 112.204 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . -63.76 -42.41 97.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.298 0.639 . . . . 65.32 111.939 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -90.61 7.22 40.34 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.203 0.601 . . . . 55.01 112.154 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.51 116.05 65.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.416 -0.587 . . . . 73.35 109.416 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.5 111.19 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.264 2.643 . . . . 74.4 115.412 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 25.39 64.59 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.855 1.502 . . . . 52.04 116.855 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -101.06 23.37 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.816 1.308 . . . . 74.2 111.604 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.8 p-10 -46.64 124.85 6.43 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.314 0.645 . . . . 73.41 111.535 167.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.3 -12.68 7.97 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.949 -0.569 . . . . 74.54 112.176 -165.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.15 104.54 0.17 Allowed Glycine 0 CA--C 1.548 2.114 0 N-CA-C 112.259 -0.336 . . . . 72.24 112.259 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.31 132.53 51.39 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.696 0.798 . . . . 74.03 111.405 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.3 mp -106.32 118.84 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.952 0.901 . . . . 74.24 108.634 169.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.42 106.74 17.33 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.956 -0.387 . . . . 75.34 109.956 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 4.2 mm? -93.01 133.41 36.18 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.736 0.814 . . . . 74.21 111.535 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 33.85 4.71 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 115.697 -0.683 . . . . 62.03 112.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.19 139.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.199 0.6 . . . . 74.3 109.859 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 19.7 t70 -105.63 159.25 16.11 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.128 -1.434 . . . . 74.14 107.128 171.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -148.02 141.11 24.96 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.283 0.563 . . . . 73.32 111.331 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.5 142.03 46.91 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.703 0.801 . . . . 74.03 110.934 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mm -80.31 123.89 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.728 0.811 . . . . 74.1 110.402 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.422 HD22 ' HB2' ' A' ' 63' ' ' ASP . 37.6 p30 -82.53 -175.95 5.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.494 0.318 . . . . 72.43 111.642 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.27 -31.42 69.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.877 0.871 . . . . 72.31 113.267 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -81.04 -31.21 34.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.186 0.594 . . . . 73.14 111.483 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.03 9.94 11.54 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 114.389 0.515 . . . . 75.22 114.389 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' HD22 ' A' ' 59' ' ' ASN . 27.8 m-20 -85.74 147.66 26.23 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.533 0.733 . . . . 75.32 112.298 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -86.64 109.83 19.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.669 0.787 . . . . 74.31 110.868 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.98 123.56 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.465 0.706 . . . . 72.23 110.144 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.33 114.32 26.36 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.585 0.707 . . . . 73.13 111.651 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.423 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -117.05 109.95 42.13 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.146 1.379 . . . . 74.21 110.32 -177.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.83 106.42 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.268 1.979 . . . . 75.12 112.359 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.43 -8.47 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.099 0.559 . . . . 74.2 112.505 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.9 -174.14 53.77 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.687 0.635 . . . . 73.43 114.687 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 56.0 mt -119.92 124.59 27.81 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.778 1.231 . . . . 72.42 109.069 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.17 -39.1 71.86 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.601 2.2 . . . . 74.43 112.867 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.18 77.0 42.47 Favored Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 123.511 0.724 . . . . 62.34 109.605 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 99' ' ' LEU . 71.8 Cg_endo -73.43 -37.8 2.98 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.76 2.306 . . . . 74.11 114.347 -168.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HA ' HD13 ' A' ' 99' ' ' LEU . 20.3 t70 -66.36 -37.77 86.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.724 0.41 . . . . 74.23 109.915 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.28 -39.02 92.01 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 116.087 -0.506 . . . . 72.24 111.798 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG12 ' SD ' ' A' ' 28' ' ' MET . 76.6 t -57.05 -40.72 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.727 0.411 . . . . 73.31 110.612 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -64.35 -43.11 95.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.734 0.814 . . . . 63.31 112.567 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 22.8 mmt180 -69.77 -48.29 59.8 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.711 0.405 . . . . 75.14 111.479 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.53 -33.75 75.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.664 1.186 . . . . 74.13 111.788 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 97' ' ' MET . 14.5 tp -71.5 -42.99 67.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.58 0.352 . . . . 71.52 111.272 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.46 78.46 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.849 0.46 . . . . 74.21 111.568 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 t -66.22 -52.24 49.8 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.641 0.776 . . . . 74.01 111.156 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' MET . 10.8 pt20 -67.71 -34.63 77.26 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 116.459 -0.337 . . . . 75.15 111.797 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.436 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 69.6 m -65.37 -19.6 66.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.993 -1.067 . . . . 73.42 112.78 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.94 -42.67 11.67 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.524 0.73 . . . . 63.11 112.111 169.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 t -85.06 -21.08 29.52 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.802 1.038 . . . . 71.41 113.802 -170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -90.52 -36.6 14.4 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.473 1.109 . . . . 75.24 110.102 -173.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.473 HD23 ' SD ' ' A' ' 33' ' ' MET . 68.0 mt -95.72 147.28 23.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.421 -1.263 . . . . 73.44 110.281 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -56.17 -28.35 57.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.943 0.897 . . . . 74.13 112.781 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 119' ' ' HIS . 27.7 m -124.28 159.87 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.879 0.872 . . . . 74.35 110.91 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.11 99.4 3.93 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.052 0.541 . . . . 71.02 111.449 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tt -94.38 123.38 37.75 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.733 -1.21 . . . . 75.13 107.733 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -108.43 96.03 17.83 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 123.191 0.597 . . . . 72.53 110.51 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.84 158.05 59.42 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.529 2.153 . . . . 74.41 112.761 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.1 tp10 -85.53 107.35 17.43 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.09 -0.707 . . . . 73.34 109.09 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.54 ' HB3' HD12 ' A' ' 108' ' ' LEU . 65.0 mtm -122.24 130.95 53.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.309 0.644 . . . . 73.31 111.321 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.419 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 14.1 tm0? -146.04 143.83 29.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.481 0.712 . . . . 73.44 110.904 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 75' ' ' ASP . 94.6 mt -92.04 114.08 26.53 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.327 1.051 . . . . 60.04 112.031 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -102.16 124.86 48.5 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.399 1.08 . . . . 71.22 112.173 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.491 HE21 HG22 ' A' ' 106' ' ' THR . 1.8 mp0 -91.58 104.06 16.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.003 0.43 . . . . 74.32 110.105 172.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 4' ' ' ALA . 56.3 t -137.31 131.58 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.521 1.129 . . . . 72.5 110.244 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.73 65.36 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 115.456 0.943 . . . . 72.55 115.456 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.52 4.77 90.32 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 117.091 0.445 . . . . 74.3 113.137 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -115.18 165.76 12.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.299 1.04 . . . . 71.31 110.358 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.491 HG22 HE21 ' A' ' 101' ' ' GLN . 91.7 m -120.43 131.22 54.68 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 120.857 0.36 . . . . 75.33 110.585 171.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.39 170.44 10.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.405 1.082 . . . . 72.21 109.474 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.54 HD12 ' HB3' ' A' ' 97' ' ' MET . 46.6 tp -120.06 111.31 17.72 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.975 -0.38 . . . . 74.44 109.975 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.55 HG12 HD13 ' A' ' 7' ' ' LEU . 92.6 t -83.95 120.1 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.332 -0.618 . . . . 70.22 109.332 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG23 ' HG2' ' A' ' 97' ' ' MET . 60.8 t -114.04 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.401 0.619 . . . . 72.23 110.948 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 75.7 t80 -78.12 125.83 29.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.979 0.912 . . . . 73.3 109.591 168.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.68 106.5 33.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.478 -0.934 . . . . 74.21 108.478 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.12 148.63 27.62 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.01 1.806 . . . . 72.23 110.852 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 36.8 tt0 -75.45 133.91 41.0 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.282 -1.007 . . . . 71.51 108.282 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.66 178.8 8.02 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.278 0.631 . . . . 74.32 110.89 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.2 176.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 122.967 0.507 . . . . 74.52 111.214 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.28 -41.92 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 O-C-N 121.004 -1.06 . . . . 73.35 113.349 166.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -69.3 -44.03 72.6 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 118.492 0.587 . . . . 73.55 111.193 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.657 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 21.2 m-70 -118.32 90.15 3.27 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 101.751 -3.426 . . . . 75.11 101.751 163.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 91.6 mttt -51.93 -144.49 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.048 2 C-N-CA 133.335 4.654 . . . . 74.43 122.017 45.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo 10.02 70.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 123.448 2.765 . . . . 75.3 116.805 -119.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.646 HG13 ' HA ' ' A' ' 120' ' ' LYS . 57.6 mt -102.32 131.73 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.015 -1.448 . . . . 73.45 109.492 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -155.74 162.56 40.51 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.015 0.926 . . . . 72.43 110.954 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -70.07 144.43 52.15 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.146 -0.934 . . . . 74.35 110.587 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.25 17.32 0.82 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.88 0.696 . . . . 75.34 112.88 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.84 41.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.385 1.074 . . . . 53.03 110.05 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.1 m -64.44 101.84 0.48 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.991 0.917 . . . . 75.24 111.071 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -137.99 163.19 25.63 Favored Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.896 -0.593 . . . . 73.22 112.922 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.03 123.53 1.79 Allowed Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.756 0.823 . . . . 74.43 110.071 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.77 -33.59 32.98 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.195 2.596 . . . . 74.22 113.821 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.01 -112.68 4.88 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 115.475 -0.784 . . . . 54.24 114.048 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.83 101.64 0.16 Allowed Glycine 0 C--N 1.354 1.54 0 N-CA-C 112.088 -0.405 . . . . 74.42 112.088 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.73 -52.1 65.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.024 0.53 . . . . 70.55 111.102 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -103.87 -179.97 4.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.876 0.87 . . . . 72.43 110.629 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -149.3 99.21 2.9 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.881 -0.785 . . . . 75.33 108.881 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.29 152.35 25.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.847 0.859 . . . . 73.21 112.642 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.4 tt -129.44 127.73 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.623 0.769 . . . . 74.12 109.739 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.5 -143.74 14.16 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.492 -0.643 . . . . 70.13 111.492 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 44.8 t -162.14 136.05 6.5 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.353 0.576 . . . . 72.1 111.166 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.4 t -74.09 142.66 45.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.271 0.629 . . . . 73.43 110.381 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.59 156.15 27.82 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.148 0.579 . . . . 65.45 111.517 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.28 147.33 28.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.458 0.703 . . . . 71.2 109.951 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -108.38 115.74 30.66 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.961 -0.385 . . . . 74.24 109.961 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 15.0 p -65.61 124.06 21.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.785 0.434 . . . . 71.13 109.893 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.33 100.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.353 0.597 . . . . 71.32 111.495 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.07 92.6 0.54 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.228 -0.897 . . . . 74.32 110.15 171.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -81.12 162.8 23.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.399 -0.819 . . . . 70.11 111.556 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -115.2 79.66 1.31 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.326 0.584 . . . . 74.32 111.184 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -69.52 138.0 52.96 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 116.138 -0.483 . . . . 74.15 110.67 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -104.19 171.52 7.3 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 73.43 111.872 -172.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -63.0 138.96 58.72 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 115.672 -0.694 . . . . 63.22 111.336 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -84.88 -22.28 29.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.282 0.633 . . . . 75.45 112.181 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.691 . . . . 71.33 111.465 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 19.4 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 119.595 -0.24 . . . . 72.54 110.509 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -40.31 118.86 0.97 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.019 0.928 . . . . 73.15 112.66 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.5 m -58.1 157.63 7.88 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.105 1.362 . . . . 75.12 114.544 -171.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -61.01 -44.95 96.66 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.546 0.738 . . . . 51.22 111.817 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 102' ' ' VAL . 2.6 m -62.88 -35.55 80.37 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-N 114.711 -1.131 . . . . 75.21 110.601 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.22 -48.23 71.27 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.025 0.93 . . . . 74.53 111.753 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.569 HD23 HD11 ' A' ' 20' ' ' ILE . 35.6 mt -65.01 -36.51 84.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.624 0.37 . . . . 74.4 111.039 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.265 0.626 . . . . 74.4 110.795 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.91 -33.92 76.95 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.504 0.722 . . . . 73.23 111.277 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -67.11 -41.94 85.36 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.44 0.696 . . . . 71.23 110.504 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 72.9 mt -64.47 -34.69 78.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.894 0.878 . . . . 75.43 111.363 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -80.35 -20.86 43.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.56 0.744 . . . . 74.23 112.253 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.78 -55.26 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.247 0.619 . . . . 72.34 110.46 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.4 141.73 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.738 -0.665 . . . . 72.12 110.059 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.54 -45.99 64.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.826 -0.546 . . . . 74.21 111.184 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.62 128.0 56.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.033 0.933 . . . . 73.41 109.896 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 m -36.13 108.64 0.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.411 1.484 . . . . 74.02 114.085 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.46 -7.93 59.46 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.159 0.8 . . . . 63.54 113.159 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -165.9 -34.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.011 0.524 . . . . 75.32 111.35 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.569 HD11 HD23 ' A' ' 7' ' ' LEU . 55.5 mt -97.15 105.4 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.935 -0.765 . . . . 70.22 108.935 -167.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.03 113.15 24.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.083 -1.08 . . . . 64.41 108.083 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.81 145.83 40.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.808 0.843 . . . . 72.0 110.41 -171.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 160.96 42.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.798 0.808 . . . . 74.22 113.124 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -75.77 166.21 23.87 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 114.194 -1.366 . . . . 71.54 111.717 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.47 -33.3 43.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.224 1.01 . . . . 75.41 113.604 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.6 m -66.68 -30.48 70.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.936 0.894 . . . . 73.51 113.126 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.78 -6.23 58.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.888 0.699 . . . . 74.25 112.888 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mmm -52.79 108.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.14 0.576 . . . . 75.31 112.142 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.66 -123.62 1.53 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.51 -0.768 . . . . 73.53 112.417 -177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -57.58 -55.33 36.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.991 1.108 . . . . 75.32 113.991 -168.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -60.61 -40.47 91.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.149 0.579 . . . . 72.55 112.462 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.39 -42.22 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.045 0.538 . . . . 74.4 111.417 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.433 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 54.6 mmm -78.63 -33.83 46.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.112 -0.495 . . . . 75.23 111.713 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.002 0.921 . . . . 73.32 111.387 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.469 ' HB ' HD23 ' A' ' 50' ' ' LEU . 43.7 m -72.97 -36.45 67.11 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.692 0.797 . . . . 73.34 111.699 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.96 -37.58 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.331 0.652 . . . . 73.44 111.184 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 122' ' ' ILE . 84.7 mt -57.2 -41.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.83 0.852 . . . . 54.4 111.383 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.409 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -64.74 -48.55 74.17 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.451 0.7 . . . . 60.35 112.033 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -67.05 -37.59 84.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.187 0.595 . . . . 62.25 111.868 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . . . -67.5 -34.77 77.81 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.117 0.567 . . . . 72.3 111.553 176.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -71.59 -41.76 68.58 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.827 0.851 . . . . 72.21 111.716 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 13.6 mm-40 -72.91 128.7 87.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 123.157 0.583 . . . . 75.31 112.148 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -87.73 118.98 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.11 2.54 . . . . 75.22 112.929 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.09 14.99 58.31 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 115.066 0.786 . . . . 72.01 115.066 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.27 23.55 13.54 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 118.774 1.287 . . . . 74.31 110.966 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -40.37 132.81 1.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.827 0.851 . . . . 72.14 112.613 165.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.25 -0.35 14.44 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.447 -0.661 . . . . 53.24 111.447 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.74 100.25 0.11 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.052 0.834 . . . . 40.25 113.835 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -116.88 144.71 44.2 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.54 0.686 . . . . 74.22 112.532 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.469 HD23 ' HB ' ' A' ' 35' ' ' THR . 5.7 mp -119.25 131.3 55.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.926 1.291 . . . . 72.34 108.167 165.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 7' ' ' LEU . 29.7 tp -110.9 111.99 23.51 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.027 0.442 . . . . 74.44 110.878 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.639 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 3.9 mm? -89.12 133.43 34.39 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.927 0.891 . . . . 73.23 111.416 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 34.11 5.37 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.9 -0.591 . . . . 51.25 112.609 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.1 137.21 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.29 0.636 . . . . 75.32 110.47 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -130.03 130.65 45.23 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.503 -0.925 . . . . 73.55 108.503 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -116.77 138.27 51.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.538 0.735 . . . . 73.01 110.892 -174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.37 141.84 47.0 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.358 0.663 . . . . 75.11 110.891 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.52 133.8 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.994 0.918 . . . . 74.21 111.072 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -87.15 -173.73 4.56 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.019 0.527 . . . . 75.13 111.889 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.99 -25.58 67.92 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 113.45 0.907 . . . . 72.42 113.45 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -82.64 -30.43 29.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.212 0.46 . . . . 65.42 110.942 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.36 11.98 8.46 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 114.675 0.63 . . . . 55.14 114.675 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.85 117.69 19.45 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.342 0.657 . . . . 70.5 111.654 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -79.62 107.97 12.8 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.555 0.742 . . . . 74.42 109.852 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.21 123.59 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.491 0.716 . . . . 74.22 110.301 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.1 124.15 37.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.984 0.914 . . . . 74.32 110.517 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -121.93 149.26 53.35 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 124.227 1.011 . . . . 74.31 111.755 -172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.01 102.81 1.4 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.504 2.136 . . . . 74.12 112.748 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.24 -24.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.816 -0.629 . . . . 74.51 110.901 170.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.23 -169.23 54.87 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.716 -0.674 . . . . 65.43 114.216 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.0 mt -115.53 124.38 30.1 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.074 0.95 . . . . 75.55 109.464 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.83 -27.53 80.54 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.787 2.324 . . . . 75.43 113.125 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.1 p-10 -131.45 63.05 68.28 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 123.834 0.854 . . . . 73.23 111.501 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.84 -31.14 32.35 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.699 2.266 . . . . 65.42 113.345 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.38 -37.27 85.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.249 1.019 . . . . 75.44 111.157 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HZ3' ' HB3' ' A' ' 76' ' ' LYS . 8.4 mtpm? -72.31 -54.77 8.54 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.82 -0.627 . . . . 73.51 110.723 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 73' ' ' ASP . 87.4 t -52.24 -38.13 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.395 1.078 . . . . 74.11 112.838 -167.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 53.1 tt0 -62.41 -47.26 84.88 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.472 0.709 . . . . 74.22 111.961 174.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.02 -48.28 53.97 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.964 0.905 . . . . 75.22 112.529 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.34 -37.08 66.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.527 1.131 . . . . 73.12 111.461 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.9 -41.83 86.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.398 0.679 . . . . 73.11 111.553 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.08 75.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.185 0.594 . . . . 73.23 112.122 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.4 t -69.92 -52.92 20.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.433 0.693 . . . . 75.23 111.447 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.63 -27.98 69.3 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.937 0.495 . . . . 73.23 111.553 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 93' ' ' LEU . 17.2 t -61.04 -30.1 70.12 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.322 0.649 . . . . 62.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.21 -25.56 29.39 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 113.259 0.837 . . . . 74.05 113.259 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -98.68 -33.91 10.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.627 0.973 . . . . 75.1 113.627 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.0 mmm -88.12 -35.79 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.945 0.898 . . . . 75.43 111.781 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -95.76 148.72 22.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.316 0.647 . . . . 75.53 111.048 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -42.18 -51.19 4.75 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 125.292 1.437 . . . . 72.01 112.766 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 122' ' ' ILE . 32.8 m -111.0 156.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.019 -0.537 . . . . 73.53 110.613 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.82 117.57 14.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.02 -0.536 . . . . 73.05 109.611 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.9 mt -111.0 142.66 42.84 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.581 0.753 . . . . 62.53 110.895 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.1 82.25 11.08 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.031 0.932 . . . . 74.22 108.825 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.22 161.54 42.49 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.423 2.082 . . . . 73.25 113.28 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.728 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.0 tp10 -77.31 127.91 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.416 -0.811 . . . . 74.21 109.031 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.431 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 65.7 mtt -136.14 140.25 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.075 0.55 . . . . 73.33 111.407 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -144.65 151.9 39.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.522 0.729 . . . . 73.23 110.786 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.8 mt -115.13 132.75 56.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.777 0.831 . . . . 73.53 110.695 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.31 149.52 47.12 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.394 0.678 . . . . 71.22 111.102 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -94.97 124.91 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.172 -0.677 . . . . 73.53 109.172 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 5' ' ' THR . 21.4 t -121.34 114.37 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 107.581 -1.266 . . . . 72.23 107.581 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.36 26.63 51.56 Favored Glycine 0 CA--C 1.548 2.108 0 N-CA-C 114.614 0.606 . . . . 75.15 114.614 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.94 60.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 114.681 0.632 . . . . 70.0 114.681 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -119.74 129.58 54.57 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.748 0.774 . . . . 74.32 109.73 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 m -85.27 104.35 15.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.746 0.703 . . . . 71.3 112.37 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.6 mp -86.98 160.53 18.62 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.298 1.039 . . . . 74.15 111.456 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 62.0 tp -114.96 131.32 56.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.474 0.71 . . . . 75.25 110.303 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.454 HG13 ' HE1' ' A' ' 1' ' ' MET . 2.5 t -98.58 122.41 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.464 1.105 . . . . 74.34 108.719 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.92 110.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 118.084 0.402 . . . . 72.22 110.927 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.728 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 60.2 t80 -94.54 132.43 39.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.222 -0.659 . . . . 75.34 109.222 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.51 105.12 23.8 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.487 -0.931 . . . . 75.33 108.487 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.78 122.3 9.88 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.033 1.822 . . . . 64.34 109.27 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -64.76 134.61 54.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.445 0.698 . . . . 73.31 111.102 -168.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 40' ' ' ALA . . . -55.86 129.63 40.3 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.226 0.61 . . . . 75.3 112.38 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.576 ' HB3' HG23 ' A' ' 118' ' ' THR . 36.2 t70 -86.85 168.84 13.07 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.072 0.949 . . . . 73.11 110.314 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.503 ' HA ' ' HG2' ' A' ' 120' ' ' LYS . 22.8 t -56.44 -22.19 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 124.401 1.081 . . . . 74.33 112.507 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.576 HG23 ' HB3' ' A' ' 116' ' ' ASP . 9.2 t -55.87 -23.86 33.52 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.745 0.818 . . . . 74.23 111.723 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 56.1 m-70 -87.24 -89.28 0.13 Allowed 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 106.206 -1.775 . . . . 73.5 106.206 166.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.529 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 29.0 mmmt -59.46 -148.62 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.164 0 CA-C-N 124.838 3.472 . . . . 74.53 113.035 -49.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -0.68 120.94 0.0 OUTLIER 'Trans proline' 1 C--N 1.416 4.093 1 C-N-CA 126.182 4.588 . . . . 74.44 119.917 -139.132 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 91' ' ' VAL . 41.1 mm -96.62 91.91 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.299 -0.864 . . . . 73.1 108.86 171.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -81.82 162.22 22.93 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.726 0.298 . . . . 74.22 111.33 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -78.99 131.94 36.48 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.384 -0.969 . . . . 71.03 108.384 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.44 74.54 0.54 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.934 0.894 . . . . 75.23 111.555 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 168.8 -171.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.227 1.811 . . . . 75.45 109.67 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -80.44 -176.77 5.87 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.113 0.565 . . . . 72.33 110.51 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.66 -87.67 1.39 Allowed Glycine 0 N--CA 1.47 0.948 0 CA-C-O 119.718 -0.49 . . . . 54.5 112.085 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 tt 67.59 114.71 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.775 0 C-N-CA 125.003 1.321 . . . . 74.52 111.167 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.81 176.85 9.29 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.852 2.368 . . . . 72.12 114.437 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.97 178.19 45.08 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 115.518 -0.764 . . . . 70.34 112.654 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 122.18 175.72 14.89 Favored Glycine 0 N--CA 1.48 1.618 0 CA-C-N 116.807 0.303 . . . . 65.24 113.291 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -156.47 112.97 3.07 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.456 0.702 . . . . 65.33 110.999 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -80.96 141.46 34.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.517 0.727 . . . . 74.31 109.75 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 80.72 4.0 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.372 0.606 . . . . 71.35 109.845 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.613 ' HD3' ' H ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -53.15 131.4 36.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.032 1.333 . . . . 74.52 112.986 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 pt -102.36 146.46 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.411 0.685 . . . . 75.14 111.271 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.4 125.22 7.28 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 116.09 -0.505 . . . . 63.1 112.854 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -120.09 136.19 54.68 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.619 0.768 . . . . 74.15 110.854 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.2 p -164.43 173.78 11.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.468 0.707 . . . . 62.44 111.576 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -127.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.59 0.756 . . . . 70.24 111.352 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.9 38.45 1.2 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.432 0.693 . . . . 73.25 110.912 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -54.02 131.23 40.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.573 0.749 . . . . 75.3 112.758 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 30.3 p -109.26 -177.29 3.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.996 0.918 . . . . 75.41 111.648 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.93 129.55 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.179 0.592 . . . . 73.34 111.184 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -119.03 166.73 12.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.932 0.893 . . . . 72.42 110.171 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -150.44 124.66 9.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.663 0.268 . . . . 71.1 110.578 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -110.77 97.87 7.17 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.286 1.034 . . . . 75.22 109.892 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -95.4 143.62 26.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.304 0.573 . . . . 73.32 112.47 -176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -104.4 124.68 49.65 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.496 1.118 . . . . 74.55 111.034 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -134.78 160.15 39.11 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.831 0.853 . . . . 74.11 110.656 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 m80 63.48 87.61 0.11 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.5 1.12 . . . . 75.14 112.599 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.5 t60 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 63.21 110.24 179.281 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 111.508 0.188 . . . . 73.43 111.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' HG3' ' HH ' ' A' ' 49' ' ' TYR . 91.5 mtt180 -86.89 -169.48 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.512 0.725 . . . . 71.35 110.431 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -82.95 150.49 26.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 122.047 -0.408 . . . . 73.12 109.908 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.53 70.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.344 0.498 . . . . 75.41 112.344 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.6 p -62.38 -47.72 82.91 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.606 0.762 . . . . 75.11 111.172 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.14 -42.18 98.07 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 121.716 0.769 . . . . 75.31 111.07 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.19 -39.79 93.33 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.651 -1.159 . . . . 72.31 111.628 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.64 -34.57 78.13 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.41 -0.813 . . . . 70.25 111.124 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.23 -41.65 85.35 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.062 0.545 . . . . 74.14 111.414 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.36 -39.69 94.39 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 122.517 0.327 . . . . 71.55 110.642 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.46 -50.96 69.38 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.157 0.983 . . . . 73.04 112.739 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.01 -12.53 61.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.016 0.747 . . . . 74.21 113.016 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.13 -42.76 30.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.489 0.716 . . . . 73.13 111.021 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -98.01 161.17 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.025 0.917 . . . . 70.43 112.602 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -106.52 0.85 24.97 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.88 -1.055 . . . . 74.05 110.788 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.39 130.18 22.96 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.202 1.001 . . . . 71.01 110.113 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m -80.29 85.91 5.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.1 0.56 . . . . 75.41 110.775 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.24 -63.95 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.343 1.057 . . . . 64.12 112.731 -174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtp-105 -102.09 -5.12 24.87 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.645 0.778 . . . . 75.31 111.478 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.9 mm -104.53 167.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.557 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.62 115.02 3.89 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.293 -1.002 . . . . 70.34 108.293 167.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.42 32.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.17 0.588 . . . . 63.21 111.442 -171.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.744 ' HZ1' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -152.46 158.21 42.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.041 0.924 . . . . 61.05 112.774 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -77.06 163.77 26.34 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 113.806 -1.543 . . . . 73.53 111.331 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.64 74.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.495 0.554 . . . . 75.4 112.495 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -76.66 -13.75 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.374 0.67 . . . . 71.21 112.559 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 18.8 t70 -85.24 -5.69 59.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.234 0.613 . . . . 64.53 111.957 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.587 ' SD ' HG13 ' A' ' 77' ' ' VAL . 82.8 mtp -57.08 113.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 72.31 112.0 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.4 -155.23 10.52 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.225 -0.443 . . . . 64.15 113.531 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -73.9 -25.32 59.95 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.383 1.073 . . . . 75.12 111.442 -174.618 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.4 p -65.17 -48.1 74.66 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.078 0.951 . . . . 74.24 111.699 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG23 ' HE3' ' A' ' 23' ' ' LYS . 60.0 t -58.2 -40.58 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.845 0.858 . . . . 75.04 110.819 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.431 ' SD ' HD21 ' A' ' 89' ' ' LEU . 40.1 tpp -71.46 -32.56 68.45 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.92 -1.036 . . . . 74.45 112.253 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 130' ' ' PRO . 7.3 tp10 -66.93 -37.73 84.86 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.535 0.734 . . . . 72.12 111.285 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 21' ' ' GLU . 17.8 m -69.8 -32.43 70.89 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 73.42 112.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.39 -37.14 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.023 0.929 . . . . 74.53 112.075 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.16 -41.06 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.028 0.931 . . . . 64.41 111.911 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.92 68.03 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.901 0.881 . . . . 72.24 112.217 -171.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -61.46 -22.23 64.87 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.806 0.842 . . . . 75.1 112.999 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.99 -26.49 59.61 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.238 0.615 . . . . 65.42 112.055 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -117.65 5.38 12.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.945 1.091 . . . . 74.22 113.945 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -58.58 117.15 18.36 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 118.748 0.704 . . . . 71.45 112.507 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.3 102.07 0.18 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.293 2.662 . . . . 75.21 113.802 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.5 9.93 59.34 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.134 1.214 . . . . 62.13 116.134 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.0 tp -115.62 -64.6 1.29 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.383 1.092 . . . . 74.52 110.965 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 37.71 -157.47 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 125.931 1.692 . . . . 74.43 114.919 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.81 58.71 7.92 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.69 -0.232 . . . . 61.1 113.501 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.21 157.39 17.8 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 112.375 -0.29 . . . . 64.12 112.375 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.404 ' HH ' ' HG3' ' A' ' 2' ' ' ARG . 90.5 m-85 -124.36 126.13 45.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.824 0.45 . . . . 74.45 111.064 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -98.92 118.17 35.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.596 -0.89 . . . . 73.11 108.596 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.42 109.01 21.15 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.719 -0.474 . . . . 75.34 109.719 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.4 128.5 46.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.254 1.022 . . . . 72.3 109.777 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.9 28.27 7.89 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 115.959 -0.564 . . . . 65.12 112.401 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.1 t -113.27 145.65 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.726 0.81 . . . . 60.13 110.699 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -121.89 151.62 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.451 1.1 . . . . 74.42 108.375 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.462 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.6 p90 -126.39 125.76 42.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.261 0.624 . . . . 75.23 109.611 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.22 140.51 51.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.655 0.782 . . . . 72.44 111.144 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.49 129.6 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.553 0.741 . . . . 71.03 111.087 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 87.3 m-20 -78.97 176.56 9.53 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.706 0.802 . . . . 71.52 112.407 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.5 -31.08 69.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.021 0.528 . . . . 74.05 111.789 170.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.73 -17.69 40.4 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.557 0.743 . . . . 71.42 111.089 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.26 34.72 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 114.818 0.687 . . . . 71.02 114.818 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.9 m-20 -79.81 147.35 31.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 117.604 0.702 . . . . 75.1 111.878 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 117.16 29.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.315 0.646 . . . . 73.22 110.528 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 59.8 t -110.86 122.26 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.725 0.81 . . . . 72.24 110.532 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -92.47 124.85 36.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.357 0.663 . . . . 73.22 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -132.35 141.0 39.7 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.995 0.918 . . . . 75.54 111.011 -171.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.35 76.92 4.28 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.916 2.41 . . . . 71.33 113.138 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.61 -18.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 115.923 -0.58 . . . . 74.12 112.399 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.81 49.35 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.427 0.531 . . . . 70.04 114.427 168.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 77' ' ' VAL . 83.0 mt -97.71 132.02 25.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.425 1.09 . . . . 72.43 110.189 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.0 -36.14 23.38 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.074 1.849 . . . . 75.13 111.535 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -123.13 81.3 51.6 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 123.754 0.822 . . . . 71.22 109.876 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.89 -57.23 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.416 2.744 . . . . 70.41 114.57 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.7 -42.53 95.23 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.96 0.504 . . . . 64.24 111.224 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -59.26 -40.88 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.428 0.455 . . . . 73.43 111.656 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.587 HG13 ' SD ' ' A' ' 28' ' ' MET . 46.7 t -60.98 -43.29 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.23 0.612 . . . . 74.55 111.549 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.45 -42.58 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.274 0.472 . . . . 73.3 112.274 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -75.85 -42.57 49.1 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 112.69 0.626 . . . . 64.43 112.69 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 -37.36 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.594 0.757 . . . . 65.54 111.709 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.31 -40.2 74.34 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.559 0.344 . . . . 72.11 110.955 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.09 73.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.483 0.713 . . . . 75.04 112.294 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 t -73.75 -53.23 10.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.255 0.622 . . . . 73.42 111.611 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.44 -31.56 72.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 112.722 0.638 . . . . 75.53 112.722 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.8 p -67.22 -29.72 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.512 0.325 . . . . 74.33 111.711 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.71 -25.66 59.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.277 0.631 . . . . 75.3 111.999 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.9 m -90.58 -44.85 9.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.364 0.666 . . . . 55.14 112.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.93 -34.73 19.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.544 0.737 . . . . 74.21 112.727 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.431 HD21 ' SD ' ' A' ' 33' ' ' MET . 70.7 mt -88.96 142.7 27.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 122.162 -0.336 . . . . 74.33 110.769 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -36.1 -58.96 0.64 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.88 1.672 . . . . 75.14 113.583 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 119' ' ' HIS . 13.9 m -102.31 168.75 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.334 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.87 1.47 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.609 -0.885 . . . . 73.52 108.609 168.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 122' ' ' ILE . 1.5 tt -102.17 106.67 17.56 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.799 -0.815 . . . . 75.21 108.799 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -96.2 103.71 14.67 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 108.798 -0.815 . . . . 72.13 108.798 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -68.45 172.95 10.47 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 121.531 1.487 . . . . 75.54 111.492 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 86.1 tt0 -86.86 107.49 18.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.732 -1.581 . . . . 74.12 106.732 172.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.598 ' HB3' HD12 ' A' ' 108' ' ' LEU . 76.8 mtm -119.29 117.33 28.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.771 0.428 . . . . 71.53 111.234 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -120.17 131.82 55.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.878 0.871 . . . . 74.53 110.805 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.26 112.02 20.99 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.683 0.793 . . . . 74.01 109.446 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.38 128.64 55.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.494 1.118 . . . . 74.43 111.427 -167.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.66 110.22 22.34 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.879 0.472 . . . . 72.43 110.813 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.7 116.29 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.828 1.251 . . . . 72.25 108.42 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.89 30.19 62.89 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 114.768 0.667 . . . . 70.42 114.768 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.95 89.32 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 114.254 0.462 . . . . 54.21 114.254 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -102.8 129.76 49.57 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.708 0.803 . . . . 72.53 109.709 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.7 m -94.34 126.73 39.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.891 0.769 . . . . 75.53 110.76 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.57 170.47 9.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.393 1.077 . . . . 72.41 109.259 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 97' ' ' MET . 43.9 tp -115.95 118.9 34.23 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.089 -0.338 . . . . 73.14 110.089 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.18 124.71 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.009 -0.737 . . . . 72.42 109.009 169.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 42.8 t -109.76 99.86 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.186 0.517 . . . . 75.35 109.67 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 25.9 t80 -85.5 119.75 26.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.571 . . . . 74.35 109.88 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.21 95.32 45.87 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 108.357 -0.979 . . . . 73.43 108.357 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.51 -177.33 3.56 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.294 1.996 . . . . 73.23 111.766 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.15 137.82 33.91 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.098 -0.705 . . . . 75.34 109.098 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.87 179.92 4.64 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.829 0.852 . . . . 73.32 111.257 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.69 135.95 43.72 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-O 118.314 -0.85 . . . . 75.4 108.95 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.9 t -46.88 -26.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.402 1.63 . . . . 75.23 115.402 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -66.43 -49.47 66.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.685 -0.634 . . . . 74.24 111.039 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.588 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 1.6 m-70 -128.43 68.76 1.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.925 -2.621 . . . . 72.34 103.925 168.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 57.3 mtpt -46.82 -153.03 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.428 1 C-N-CA 133.332 4.653 . . . . 74.52 121.155 55.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo 4.77 67.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 123.277 2.652 . . . . 72.42 117.142 -124.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.589 HG21 HD13 ' A' ' 93' ' ' LEU . 53.0 mt -98.35 127.9 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.981 -1.009 . . . . 73.02 109.258 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.49 146.43 38.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 74.24 109.498 -175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.66 ' HZ3' ' HB3' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -78.36 124.19 27.83 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.533 -0.914 . . . . 73.12 108.533 173.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.65 -68.57 0.29 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.937 1.295 . . . . 74.04 113.924 -163.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.01 111.79 7.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.68 0.392 . . . . 73.12 110.687 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p 64.09 174.96 0.18 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.952 1.701 . . . . 74.43 112.44 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -155.11 -146.19 4.37 Favored Glycine 0 N--CA 1.477 1.369 0 O-C-N 121.863 -0.523 . . . . 65.45 113.922 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.6 tp 65.0 90.16 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 125.14 1.376 . . . . 74.43 111.406 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.562 ' HA ' ' HG3' ' A' ' 34' ' ' GLU . 63.2 Cg_endo -86.92 167.97 8.12 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.763 2.309 . . . . 74.52 113.741 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.89 109.74 3.47 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.744 -0.662 . . . . 75.34 111.517 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.02 136.78 6.14 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-N 117.055 0.428 . . . . 72.54 113.246 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.07 4.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.544 0.738 . . . . 72.11 110.405 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -70.72 80.91 0.61 Allowed 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 122.103 0.954 . . . . 75.14 111.609 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -108.53 139.43 43.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.988 0.915 . . . . 73.12 110.749 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -134.12 137.84 44.83 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.686 0.795 . . . . 74.5 110.328 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -151.7 115.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 C-N-CA 123.456 0.702 . . . . 75.12 110.497 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.16 116.41 5.15 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.894 -0.594 . . . . 64.03 112.001 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.0 m -78.53 -64.41 1.18 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.089 0.556 . . . . 74.42 110.721 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -165.16 152.5 10.93 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.614 0.766 . . . . 75.42 111.196 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -102.92 119.62 39.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.985 0.914 . . . . 71.55 109.93 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.26 109.74 18.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.24 0.616 . . . . 71.04 110.831 -173.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -122.03 157.64 30.92 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.89 0.876 . . . . 72.41 110.413 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.3 t -159.62 117.7 2.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.369 0.667 . . . . 65.15 111.034 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.78 144.81 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 74.11 110.538 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -123.53 133.72 53.96 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.695 0.798 . . . . 74.21 110.333 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.86 146.56 24.88 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.104 0.478 . . . . 75.33 111.547 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -80.75 145.06 31.7 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.585 0.754 . . . . 74.34 110.943 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -82.22 107.8 15.18 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.186 -0.672 . . . . 74.32 109.186 167.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -66.76 123.35 19.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.805 0.442 . . . . 64.14 110.578 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -54.41 98.28 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.687 0.795 . . . . 71.12 112.329 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -79.45 124.35 28.38 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 108.609 -0.885 . . . . 75.11 108.609 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 . . . . . 0 N--CA 1.496 1.874 0 C-N-CA 125.056 1.342 . . . . 75.24 110.771 -168.129 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.179 -1.045 . . . . 73.45 108.179 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -82.98 159.61 22.19 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.336 0.655 . . . . 75.41 112.183 -171.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m -81.43 156.5 25.35 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.817 0.673 . . . . 74.14 112.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.88 94.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.782 0.833 . . . . 62.43 112.078 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -62.09 -46.87 87.15 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.576 -0.738 . . . . 75.33 110.639 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.21 -47.2 87.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.918 -1.037 . . . . 72.21 111.911 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.35 -36.79 85.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.172 0.589 . . . . 72.45 111.755 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.589 HD23 ' HD3' ' A' ' 68' ' ' PRO . 28.1 tp -65.05 -48.49 73.63 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.017 0.527 . . . . 74.42 111.212 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -63.7 -35.69 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.091 0.556 . . . . 62.52 111.846 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -63.32 -45.87 89.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.487 0.715 . . . . 75.22 111.229 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 22' ' ' ALA . 41.8 mt -59.8 -39.63 85.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.955 0.902 . . . . 75.33 111.069 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -65.26 -34.45 78.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.809 0.844 . . . . 73.21 112.133 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.46 -41.91 72.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.629 0.771 . . . . 73.32 112.187 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -114.84 118.35 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-O 121.653 0.74 . . . . 75.24 112.37 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.64 -9.9 16.09 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.73 1.212 . . . . 73.24 113.574 172.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.32 117.07 23.68 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.7 -0.625 . . . . 74.5 110.36 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.9 p -78.17 91.72 4.37 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.631 0.773 . . . . 70.31 111.493 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.67 -59.52 5.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.633 0.773 . . . . 73.33 111.732 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.564 HH21 ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.42 26.04 1.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.043 0.537 . . . . 70.13 111.693 170.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.24 109.61 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.407 -0.96 . . . . 73.04 108.407 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.07 130.07 49.22 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 120.93 0.395 . . . . 74.25 111.129 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -84.69 143.3 29.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.595 0.758 . . . . 63.35 111.773 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 74.5 mmtt -129.26 145.76 51.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.965 0.906 . . . . 74.52 109.565 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.95 161.49 24.29 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.239 0.616 . . . . 75.33 111.084 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 -36.95 85.55 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.091 0.556 . . . . 72.53 111.703 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 -18.99 61.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.605 0.762 . . . . 71.11 112.584 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.82 -7.12 57.56 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.38 0.672 . . . . 73.43 112.712 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.528 ' SD ' HG13 ' A' ' 77' ' ' VAL . 34.3 mtp -55.9 124.27 17.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.446 0.906 . . . . 54.41 113.446 -176.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.23 -144.91 15.16 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.366 -0.833 . . . . 75.32 111.758 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -59.57 -26.85 65.74 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.137 0.975 . . . . 73.11 113.544 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.0 m -73.52 -27.23 61.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.303 0.641 . . . . 74.35 112.26 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 46.3 t -74.66 -48.94 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 121.244 0.545 . . . . 74.14 110.436 166.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.73 -34.45 67.52 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.322 1.23 . . . . 75.51 114.322 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.63 -41.76 82.01 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.14 0.576 . . . . 73.35 111.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -78.14 -27.67 48.24 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.289 0.636 . . . . 75.32 111.712 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.64 -45.54 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.626 0.77 . . . . 74.32 110.604 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -51.85 -44.02 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.778 1.231 . . . . 71.43 112.111 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.54 89.47 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.341 0.656 . . . . 71.45 112.75 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.63 -35.64 70.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.904 0.705 . . . . 73.13 112.904 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.2 55.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.163 0.585 . . . . 75.11 112.444 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -103.99 -48.33 3.93 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.733 1.012 . . . . 73.31 113.733 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.1 121.09 76.72 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.39 111.73 0.91 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.294 2.662 . . . . 75.31 113.626 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.89 -11.16 29.68 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.34 -0.845 . . . . 71.45 114.633 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.564 ' HG ' HH21 ' A' ' 19' ' ' ARG . 6.5 mp -94.64 -1.18 53.65 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.574 1.687 . . . . 75.0 110.991 173.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.71 ' HB3' ' HB3' ' A' ' 114' ' ' GLU . 10.0 m-20 -34.53 102.31 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.527 1.931 . . . . 73.13 114.371 174.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.95 0.82 Allowed Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.87 -0.605 . . . . 73.51 112.866 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.94 172.52 47.96 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 113.981 0.352 . . . . 65.54 113.981 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.38 147.16 52.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.765 0.826 . . . . 75.14 112.635 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.1 mt -129.4 124.7 34.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 74.4 108.552 172.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.59 109.21 20.8 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 122.111 -0.368 . . . . 74.04 110.138 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.628 HD12 HD22 ' A' ' 108' ' ' LEU . 56.6 mt -88.96 129.44 35.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.151 0.58 . . . . 64.41 110.964 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.48 30.36 5.0 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.195 -0.457 . . . . 73.53 112.482 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 22' ' ' ALA . 48.3 t -116.3 139.52 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.374 0.67 . . . . 65.25 110.631 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.66 131.71 31.88 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.302 -1.369 . . . . 75.55 107.302 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -115.68 140.62 49.02 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.128 0.49 . . . . 75.34 112.282 -171.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.48 141.63 48.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 75.11 110.404 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.8 mt -101.91 133.67 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.595 0.758 . . . . 72.35 111.422 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -74.81 169.37 18.03 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.186 0.994 . . . . 64.45 111.882 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.91 -33.98 75.23 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.393 0.677 . . . . 75.15 111.231 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -71.03 -27.64 63.82 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.483 0.713 . . . . 73.4 111.683 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.47 41.14 2.24 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 116.302 -0.408 . . . . 72.41 113.08 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -100.29 121.63 41.79 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.325 0.65 . . . . 71.21 109.876 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -84.7 108.48 17.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.139 0.575 . . . . 73.53 110.574 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -100.43 112.61 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.492 1.117 . . . . 75.31 109.76 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -89.22 115.0 26.39 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.583 -0.525 . . . . 75.12 109.583 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -115.85 134.49 22.71 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.783 0.833 . . . . 73.43 111.19 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.589 ' HD3' HD23 ' A' ' 8' ' ' LEU . 88.3 Cg_endo -75.8 86.86 1.45 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.779 2.319 . . . . 75.12 112.634 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.33 -26.21 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.997 -0.547 . . . . 63.4 111.422 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.523 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 82.54 -176.16 53.52 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.115 0.806 . . . . 73.31 115.115 172.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -113.91 116.2 45.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.404 1.082 . . . . 75.52 109.988 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.56 -33.33 96.36 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.711 2.274 . . . . 75.04 112.665 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.57 75.82 78.37 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.852 0.861 . . . . 72.23 109.137 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.84 -39.46 61.9 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.064 2.509 . . . . 73.53 114.522 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.6 p-10 -72.99 -40.4 65.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.512 0.725 . . . . 74.35 111.102 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.31 -37.92 89.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.965 0.506 . . . . 74.45 111.328 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.528 HG13 ' SD ' ' A' ' 28' ' ' MET . 42.5 t -58.93 -47.55 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.045 0.938 . . . . 74.2 111.071 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.534 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 51.9 tt0 -59.84 -45.59 91.93 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.854 0.862 . . . . 71.25 112.199 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 20.8 mmm-85 -74.86 -40.04 61.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.72 -0.673 . . . . 71.51 112.085 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.39 -44.49 92.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.916 0.886 . . . . 71.04 110.778 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD21 HD13 ' A' ' 52' ' ' LEU . 22.8 tp -66.76 -40.46 88.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.423 -0.808 . . . . 74.32 111.795 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.91 82.51 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.183 0.593 . . . . 72.15 112.176 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -66.99 -52.0 48.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.386 0.674 . . . . 71.44 111.5 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 81' ' ' LEU . 29.7 pt20 -67.74 -28.48 67.67 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.508 0.558 . . . . 71.41 112.508 176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.2 -33.23 69.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.187 0.439 . . . . 63.12 112.187 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.17 -38.05 13.76 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.559 0.743 . . . . 74.54 112.183 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.3 m -74.29 -33.21 63.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.51 0.929 . . . . 71.23 113.51 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.8 mmm -88.33 -55.48 3.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.152 0.581 . . . . 70.11 111.203 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.34 148.65 43.27 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.312 0.645 . . . . 73.21 112.573 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.47 ' HB3' HG22 ' A' ' 122' ' ' ILE . 41.7 t30 -41.98 -63.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.019 1.727 . . . . 71.54 112.85 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.08 167.68 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.744 -0.662 . . . . 73.44 110.861 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.7 97.48 2.19 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.136 0.493 . . . . 72.41 110.323 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.79 123.68 35.35 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.529 -0.915 . . . . 75.4 108.529 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -104.52 106.04 52.63 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 122.934 0.494 . . . . 72.34 110.941 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.413 ' HG2' ' HE3' ' A' ' 97' ' ' MET . 93.8 Cg_endo -87.99 170.56 6.06 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.403 2.069 . . . . 75.11 112.928 166.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.0 tp10 -104.06 136.87 42.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.829 0.852 . . . . 71.0 109.324 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.714 ' HB3' HD11 ' A' ' 108' ' ' LEU . 66.1 mtt -134.53 122.11 21.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.155 0.582 . . . . 74.43 110.917 -172.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -124.93 134.42 52.66 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.306 0.642 . . . . 75.52 112.135 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.17 123.19 45.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.813 0.845 . . . . 74.24 111.701 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -142.24 147.05 35.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.24 1.016 . . . . 61.0 110.443 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -97.73 123.4 41.65 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.968 0.413 . . . . 71.41 110.649 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.51 114.12 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.902 1.281 . . . . 73.14 108.511 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.15 29.57 59.87 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 115.439 0.936 . . . . 63.12 115.439 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.94 3.72 73.15 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.062 0.785 . . . . 74.25 115.062 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.523 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 11.6 mptt -117.58 132.91 56.44 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.6 0.76 . . . . 74.15 109.444 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 m -83.15 131.28 35.14 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.593 0.633 . . . . 74.43 111.087 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.25 159.44 24.06 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.602 1.161 . . . . 75.53 109.225 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.714 HD11 ' HB3' ' A' ' 97' ' ' MET . 36.8 tp -116.74 118.19 31.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.82 0.448 . . . . 75.24 109.988 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.74 105.63 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.804 -0.813 . . . . 75.41 108.804 172.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.405 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 38.7 t -95.35 98.69 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.489 0.661 . . . . 74.11 109.764 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.478 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 17.1 t80 -80.58 115.76 20.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.209 -0.905 . . . . 65.43 108.705 171.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.27 94.49 3.37 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 108.462 -0.94 . . . . 74.31 108.462 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.99 166.91 27.12 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.593 2.195 . . . . 74.04 112.571 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.71 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . 12.4 pt-20 -59.97 119.78 8.4 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 113.864 1.061 . . . . 74.5 113.864 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 141.25 51.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 162.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.617 ' HB3' HG23 ' A' ' 118' ' ' THR . 38.6 t70 -75.98 161.94 28.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.909 0.483 . . . . 63.12 112.17 -174.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.05 -21.11 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 C-N-CA 124.791 1.236 . . . . 71.1 112.603 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.617 HG23 ' HB3' ' A' ' 116' ' ' ASP . 15.1 t -54.23 -21.94 10.32 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.647 0.779 . . . . 75.4 112.03 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.533 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 39.8 m-70 -90.54 -98.08 0.11 Allowed 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 104.724 -2.325 . . . . 73.31 104.724 164.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 55.3 mttm -68.14 -146.14 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.476 0 CA-C-N 125.902 3.955 . . . . 72.01 110.556 -45.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo 7.62 89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 124.721 3.614 . . . . 72.55 118.364 -138.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 90' ' ' ASN . 60.5 mt -74.59 101.54 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.516 -1.22 . . . . 75.3 109.507 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -92.18 168.89 11.03 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.686 -1.143 . . . . 73.34 109.535 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -84.53 155.48 22.11 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.825 -0.547 . . . . 75.41 109.58 173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -64.48 -25.88 68.19 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.146 0.498 . . . . 72.31 110.682 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.0 100.49 3.58 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.2 0.6 . . . . 75.34 109.382 163.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -63.49 144.74 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 113.74 1.015 . . . . 63.2 113.74 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -173.37 135.32 3.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.456 -0.793 . . . . 65.41 111.15 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.3 tp -116.71 94.64 44.31 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.239 0.616 . . . . 71.24 111.272 -174.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -70.0 -45.24 1.53 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.903 2.402 . . . . 73.2 112.87 172.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.47 105.32 0.57 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 116.315 -0.402 . . . . 73.02 112.749 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.75 -179.06 37.8 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.918 0.327 . . . . 75.32 113.918 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.44 118.23 20.4 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.328 0.651 . . . . 70.43 110.357 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -74.98 138.59 42.37 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.742 0.817 . . . . 65.12 112.541 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.35 141.79 32.56 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.433 0.693 . . . . 73.14 109.159 171.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -56.8 170.66 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.084 1.354 . . . . 73.43 114.252 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 pt -61.98 149.33 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 75.34 112.189 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.2 64.08 0.09 OUTLIER Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.237 -0.745 . . . . 53.21 111.237 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.4 t -164.38 -64.21 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.831 0.852 . . . . 71.43 110.436 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -166.26 148.07 6.76 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.238 1.015 . . . . 73.4 109.865 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.11 122.1 18.77 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.078 0.466 . . . . 64.53 112.101 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.68 -22.28 60.94 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.502 -0.772 . . . . 71.34 110.213 168.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -68.52 99.87 1.03 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.345 1.058 . . . . 72.35 111.454 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.4 124.31 39.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.151 0.58 . . . . 52.34 110.09 173.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.19 156.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.207 0.527 . . . . 74.51 111.933 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.62 -21.95 62.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.426 0.69 . . . . 71.41 111.637 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.69 111.63 18.14 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.442 0.697 . . . . 75.33 110.624 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -158.73 141.45 14.4 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.857 0.863 . . . . 73.45 110.56 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -63.49 110.92 2.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.522 0.729 . . . . 73.33 111.9 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -129.24 135.66 49.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.803 0.841 . . . . 74.52 109.188 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -69.08 142.74 54.41 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.254 0.622 . . . . 74.04 111.653 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -151.07 -178.19 6.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 75.52 110.905 -177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 N--CA 1.482 1.175 0 C-N-CA 123.352 0.661 . . . . 73.24 111.544 179.679 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' HB2' ' A' ' 111' ' ' TYR . 5.0 ttm . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.106 -0.331 . . . . 63.04 110.106 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -85.69 152.51 23.03 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.447 0.699 . . . . 73.51 110.561 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.23 152.17 32.73 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.096 0.558 . . . . 75.14 111.566 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.02 66.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.154 0.581 . . . . 73.53 112.47 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -63.77 -36.31 83.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.137 0.791 . . . . 73.11 113.137 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.78 -35.44 80.72 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.039 0.447 . . . . 73.32 111.058 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.63 -36.44 80.79 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.401 0.68 . . . . 74.34 111.795 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.58 -37.22 79.67 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.602 0.361 . . . . 74.32 111.266 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.61 -38.91 92.02 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.804 0.442 . . . . 71.32 110.02 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.09 -37.14 78.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.732 0.813 . . . . 55.04 111.634 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 mt -61.83 -45.26 94.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.747 0.819 . . . . 74.35 111.708 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -77.17 -19.82 56.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.184 0.594 . . . . 74.14 112.128 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.51 -51.97 17.74 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.031 0.533 . . . . 72.15 111.097 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.95 159.14 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.213 0.53 . . . . 62.52 111.216 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.92 -21.86 24.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.371 0.668 . . . . 62.21 112.055 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -145.69 144.63 30.5 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.992 0.917 . . . . 73.14 111.097 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 t -75.13 116.2 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.664 0.786 . . . . 74.52 112.352 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.63 -58.83 1.8 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.154 0.982 . . . . 75.3 111.983 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -115.15 -13.17 11.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 123.822 0.849 . . . . 73.34 112.892 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -129.6 121.8 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.776 0.83 . . . . 75.15 110.244 -167.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -127.52 138.95 53.05 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.626 0.37 . . . . 72.43 110.768 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . . . -93.26 151.98 19.47 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.77 0.828 . . . . 74.12 111.288 175.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' HD23 ' A' ' 52' ' ' LEU . 69.6 mmtt -140.01 141.36 36.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.444 1.097 . . . . 74.41 110.454 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -84.87 160.53 20.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.391 0.676 . . . . 74.31 110.657 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.89 64.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.82 1.044 . . . . 75.33 113.82 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 m -81.86 -11.98 58.69 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 113.137 0.791 . . . . 70.52 113.137 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.5 -9.03 59.79 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.425 0.69 . . . . 73.12 112.148 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mmm -52.09 115.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.222 1.009 . . . . 74.32 112.905 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.93 -131.35 5.69 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 116.217 -0.447 . . . . 72.33 113.615 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.41 -38.31 68.78 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.699 1.2 . . . . 75.23 113.857 -168.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.12 -32.98 69.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.346 0.658 . . . . 74.32 112.093 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.74 -48.68 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.177 0.591 . . . . 75.33 110.059 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -41.44 59.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.246 1.419 . . . . 74.53 113.797 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.6 -43.48 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.207 0.527 . . . . 75.44 111.531 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 m -76.59 -30.7 57.09 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.349 0.659 . . . . 74.44 111.439 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.47 -45.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.197 0.599 . . . . 62.21 110.302 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.65 -38.39 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.301 0.64 . . . . 73.42 110.921 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.01 91.41 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.425 0.69 . . . . 72.11 112.284 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -70.01 -38.98 76.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.153 0.581 . . . . 74.42 111.917 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.9 73.14 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.061 0.544 . . . . 54.4 111.714 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.88 -17.14 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.848 0.859 . . . . 72.42 111.148 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.98 109.82 9.26 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.016 0.526 . . . . 73.41 110.459 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.44 117.05 4.95 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.222 1.948 . . . . 75.32 112.095 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 2.48 90.52 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.944 0.738 . . . . 71.21 114.944 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 tp -113.33 18.64 17.65 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.598 1.199 . . . . 74.32 109.918 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 114' ' ' GLU . 8.6 p-10 -43.51 114.03 0.58 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.22 1.408 . . . . 64.22 113.771 168.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.42 59.21 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.927 -0.579 . . . . 73.43 113.591 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.36 156.29 24.02 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 112.507 -0.237 . . . . 65.02 112.507 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.94 128.06 55.46 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.247 0.524 . . . . 64.52 112.041 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.2 mt -121.15 123.82 43.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.973 0.909 . . . . 70.3 110.121 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.42 109.3 20.88 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.314 0.646 . . . . 74.04 110.287 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 108' ' ' LEU . 57.0 mt -94.56 122.73 37.45 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.888 0.475 . . . . 73.04 109.874 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.24 3.76 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 116.503 -0.317 . . . . 75.11 112.919 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 45.0 t -115.38 139.52 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.515 0.726 . . . . 75.33 110.134 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.66 133.29 49.63 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.958 -1.497 . . . . 72.34 106.958 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -110.37 138.41 46.8 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.029 0.532 . . . . 75.2 111.404 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.33 141.32 48.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.083 0.953 . . . . 74.51 110.544 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -92.0 134.75 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.801 0.84 . . . . 72.25 110.902 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.643 HD22 HG23 ' A' ' 65' ' ' VAL . 21.4 m-80 -85.81 -179.13 6.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.464 0.706 . . . . 75.53 112.194 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.58 -38.09 80.26 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.039 0.936 . . . . 72.21 111.758 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -82.79 7.13 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.273 0.842 . . . . 72.2 113.273 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.13 85.96 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 114.885 0.714 . . . . 75.04 114.885 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.28 157.58 37.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.799 0.84 . . . . 61.22 112.423 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -103.92 124.65 49.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.053 0.941 . . . . 71.24 111.274 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.643 HG23 HD22 ' A' ' 59' ' ' ASN . 78.2 t -116.49 130.28 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.854 0.862 . . . . 73.15 109.892 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -93.82 119.63 33.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.931 0.893 . . . . 71.01 111.166 -173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -112.41 133.7 21.73 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.58 0.752 . . . . 72.52 111.644 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.28 88.4 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.286 1.991 . . . . 73.2 112.212 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -81.37 -19.03 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 122.994 0.517 . . . . 73.41 111.604 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.15 -173.41 54.92 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 121.881 0.712 . . . . 64.44 114.378 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.447 HD23 HG21 ' A' ' 77' ' ' VAL . 55.0 mt -115.2 127.65 26.63 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.643 1.177 . . . . 74.1 108.765 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.15 -23.57 52.75 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.284 1.989 . . . . 74.5 112.485 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.3 73.58 36.75 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 125.219 1.407 . . . . 64.54 110.208 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.18 -42.77 12.76 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.613 2.875 . . . . 75.21 114.821 -165.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.72 -31.31 66.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.57 0.748 . . . . 71.33 111.967 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -72.27 -34.17 68.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 120.603 0.239 . . . . 75.0 110.412 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 71' ' ' LEU . 98.7 t -59.26 -40.76 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.707 0.803 . . . . 74.43 110.918 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -63.99 -49.26 73.15 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.375 1.07 . . . . 73.55 113.173 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -34.66 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 112.614 0.598 . . . . 75.22 112.614 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 3.9 m-20 -62.11 -45.06 95.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.378 0.271 . . . . 71.4 110.573 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.645 HD22 ' SD ' ' A' ' 97' ' ' MET . 35.1 tp -63.07 -38.58 91.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.967 0.507 . . . . 73.5 112.163 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.68 72.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.626 . . . . 65.02 111.47 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 t -73.6 -44.69 56.54 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.682 0.793 . . . . 71.24 111.676 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 80.7 mt-30 -58.06 -44.87 87.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.649 0.78 . . . . 74.25 111.553 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.72 ' HG ' ' HB3' ' A' ' 93' ' ' LEU . 14.5 t -74.93 -18.42 60.4 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.183 0.993 . . . . 31.12 111.986 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -82.81 -43.63 16.46 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.294 0.638 . . . . 73.14 112.367 171.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -83.91 -52.43 6.36 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.8 0.84 . . . . 73.43 113.038 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.0 mmm -67.86 -17.62 64.55 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.852 0.861 . . . . 73.35 112.89 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 mt -108.73 148.5 30.38 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 73.13 110.166 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -39.07 -53.67 1.79 Allowed 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.741 1.216 . . . . 75.31 113.532 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.04 157.92 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 114.903 -1.044 . . . . 75.44 109.564 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.71 97.2 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.847 0.832 . . . . 73.22 109.453 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.72 ' HB3' ' HG ' ' A' ' 85' ' ' CYS . 3.4 tt -94.15 117.38 30.03 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.065 -1.457 . . . . 73.31 107.065 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -110.71 92.56 14.64 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.914 0.885 . . . . 74.5 110.167 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.32 165.59 24.16 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.742 2.295 . . . . 74.34 113.671 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 13.2 tp10 -85.13 107.57 17.27 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.645 ' SD ' HD22 ' A' ' 81' ' ' LEU . 76.2 mtm -119.1 122.53 42.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.781 0.433 . . . . 71.33 111.64 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -129.09 123.75 33.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.122 0.969 . . . . 75.23 110.741 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.67 114.79 12.32 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.73 0.812 . . . . 73.31 110.737 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.74 125.63 53.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.879 0.872 . . . . 75.12 111.211 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -97.16 117.75 32.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.348 0.659 . . . . 70.32 111.382 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.52 118.8 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.085 1.354 . . . . 75.11 110.034 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.06 52.67 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 115.817 1.087 . . . . 71.44 115.817 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.26 -3.12 85.71 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 117.05 0.425 . . . . 75.33 114.119 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -99.17 137.57 37.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.492 1.117 . . . . 74.4 109.078 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -107.77 131.1 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.273 0.942 . . . . 54.45 111.305 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.42 168.67 11.43 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.253 1.021 . . . . 73.3 109.267 -174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.616 HD23 HD13 ' A' ' 52' ' ' LEU . 34.7 tp -121.89 116.68 24.82 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.894 -0.41 . . . . 71.21 109.894 173.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.419 HG13 ' SD ' ' A' ' 1' ' ' MET . 38.2 t -87.8 120.81 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.92 -0.77 . . . . 75.42 108.92 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 46.2 t -110.69 104.82 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 75.5 110.394 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.622 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 74.3 t80 -90.47 113.28 25.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.136 0.974 . . . . 74.51 110.222 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.53 100.82 46.72 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.568 0.747 . . . . 74.33 110.495 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -86.31 -173.27 1.2 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.716 2.277 . . . . 73.22 113.309 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 36.4 tt0 -93.64 153.18 18.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.866 0.866 . . . . 72.12 109.71 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.08 155.2 40.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.41 0.624 . . . . 72.0 112.323 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.18 158.76 35.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.952 0.901 . . . . 73.42 110.997 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.445 HG12 ' HD2' ' A' ' 134' ' ' TYR . 16.4 t -56.46 -22.21 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.525 0.935 . . . . 74.22 113.525 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -52.08 -22.13 3.86 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 123.766 0.827 . . . . 71.23 112.366 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.672 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 81.3 m-70 -104.23 -84.29 0.48 Allowed 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 106.354 -1.721 . . . . 74.33 106.354 162.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.672 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 16.1 ptpt -79.81 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.665 0 CA-C-N 125.655 3.843 . . . . 74.23 110.909 -34.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 3.3 Cg_exo 7.52 116.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.305 1 C-N-CA 125.489 4.126 . . . . 74.44 120.102 -137.259 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.48 93.8 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.317 -1.311 . . . . 73.41 109.039 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -79.49 170.74 16.14 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.34 0.656 . . . . 72.14 111.017 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -90.67 90.74 8.09 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 109.065 -0.717 . . . . 74.34 109.065 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.473 ' HZ3' ' HB2' ' A' ' 125' ' ' LYS . 0.1 OUTLIER 18.29 101.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 127.005 2.122 . . . . 74.2 115.503 -174.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.54 167.9 18.59 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.329 0.652 . . . . 73.03 112.058 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.4 m -68.66 -29.23 67.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.904 0.882 . . . . 74.23 111.992 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.07 163.84 54.93 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.492 -0.322 . . . . 72.25 113.264 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.507 HD21 ' H ' ' A' ' 129' ' ' LEU . 2.5 pt? -117.49 154.08 50.49 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.111 0.964 . . . . 74.23 109.96 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -70.29 -166.08 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.688 2.259 . . . . 75.21 112.987 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.99 -87.78 0.02 OUTLIER Glycine 0 CA--C 1.541 1.679 0 N-CA-C 114.621 0.609 . . . . 72.52 114.621 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.43 -28.3 3.89 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 114.631 0.613 . . . . 73.44 114.631 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.51 64.26 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.781 0.832 . . . . 71.23 112.954 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . 0.445 ' HD2' HG12 ' A' ' 117' ' ' VAL . 16.4 t80 -126.43 44.42 2.88 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.589 0.755 . . . . 62.53 109.731 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -67.96 87.2 0.25 Allowed 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.84 0.829 . . . . 74.31 111.738 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -77.04 143.61 39.2 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.812 0.845 . . . . 75.24 111.495 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.32 94.2 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.084 0.469 . . . . 64.14 110.06 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.24 -57.16 3.04 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.557 -0.617 . . . . 74.4 111.557 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.7 p 57.56 2.94 0.16 Allowed 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 125.916 1.686 . . . . 53.42 114.842 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t -89.45 91.51 8.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.772 0.829 . . . . 71.21 109.484 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.57 135.66 42.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.462 0.705 . . . . 71.43 110.029 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -97.35 134.9 40.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.268 0.627 . . . . 62.43 111.148 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -78.28 125.87 29.97 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.039 0.535 . . . . 73.34 110.123 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.9 m -74.75 84.98 2.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.327 0.651 . . . . 74.43 110.12 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.59 -36.3 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 115.211 -0.904 . . . . 65.54 110.6 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.95 102.51 0.8 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.691 0.796 . . . . 72.02 110.966 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -85.81 142.75 28.7 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 109.101 -0.703 . . . . 74.02 109.101 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -93.89 128.78 40.37 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.875 0.87 . . . . 72.01 111.215 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -63.48 87.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.532 0.733 . . . . 74.32 111.013 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -89.72 125.42 35.27 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.018 0.927 . . . . 74.52 110.918 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -111.69 129.57 56.06 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.119 0.485 . . . . 63.33 111.48 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -132.78 166.94 21.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.343 1.057 . . . . 74.15 109.845 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.279 0.561 . . . . 74.32 110.701 177.53 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 16.6 ptm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 110.784 -0.08 . . . . 74.5 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -83.87 156.71 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.508 0.723 . . . . 74.31 111.893 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -82.16 161.23 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.781 0.832 . . . . 72.14 112.046 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HB3' HD22 ' A' ' 107' ' ' LEU . . . -62.25 -44.63 96.1 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.338 0.655 . . . . 75.03 112.018 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -72.22 -31.13 65.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.954 0.724 . . . . 74.24 112.954 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.23 -49.36 77.92 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 121.786 0.803 . . . . 72.53 111.447 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.404 HD23 HD12 ' A' ' 20' ' ' ILE . 50.4 mt -72.73 -26.36 61.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.768 -1.106 . . . . 72.15 112.654 176.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.93 -43.69 98.27 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.008 0.523 . . . . 71.51 110.353 169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.51 -36.33 75.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.482 1.113 . . . . 75.43 111.333 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.697 ' HG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp10 -65.02 -52.36 56.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.616 0.766 . . . . 71.22 111.267 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -56.57 -37.61 70.81 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.463 1.105 . . . . 73.41 113.503 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -78.09 -24.06 47.71 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.057 0.543 . . . . 73.43 111.501 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.67 -38.97 53.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.506 0.722 . . . . 65.53 112.314 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.35 146.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 121.296 0.57 . . . . 65.31 111.919 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.96 -39.55 82.05 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.677 1.191 . . . . 74.24 111.596 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.29 167.79 29.29 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.779 0.832 . . . . 74.13 111.623 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -66.8 89.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.471 0.709 . . . . 72.22 112.445 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.38 10.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.645 0.778 . . . . 70.04 112.017 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -121.67 -28.8 4.48 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.449 0.7 . . . . 75.41 111.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.697 HG13 ' HG2' ' A' ' 10' ' ' GLU . 33.9 mm -112.22 119.19 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 70.33 110.046 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 143.6 42.3 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.101 0.56 . . . . 62.3 109.76 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.9 27.41 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.458 0.703 . . . . 73.42 110.638 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 54.6 mtmt -141.0 152.94 45.31 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.828 0.851 . . . . 75.24 112.245 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 mtm-85 -80.58 170.4 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.676 0.79 . . . . 73.34 112.681 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 28' ' ' MET . . . -60.83 -26.7 67.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.346 0.869 . . . . 71.22 113.346 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -64.59 -1.22 1.7 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.429 1.27 . . . . 74.31 114.429 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -111.88 -9.29 14.06 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.974 0.51 . . . . 72.34 112.185 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.425 ' HE2' ' HA ' ' A' ' 77' ' ' VAL . 26.9 ptm -60.76 104.39 0.35 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.663 0.744 . . . . 74.33 111.519 -173.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.26 -122.37 1.21 Allowed Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.669 -0.696 . . . . 71.14 112.388 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -52.78 -58.18 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.292 1.037 . . . . 75.34 113.797 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.5 m -76.2 -32.06 58.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.404 0.52 . . . . 74.3 112.404 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' HA ' ' HZ2' ' A' ' 23' ' ' LYS . 85.3 t -64.75 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.178 0.444 . . . . 72.23 110.314 174.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.504 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 39.0 tpp -58.85 -43.62 90.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.622 0.769 . . . . 75.25 111.611 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -59.7 -39.32 84.2 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.779 . . . . 71.52 111.991 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -70.12 -35.52 74.16 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 122.847 0.459 . . . . 70.4 110.996 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.14 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.462 0.705 . . . . 71.31 110.474 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.27 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 74.15 110.585 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.461 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -62.38 -47.17 85.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.428 0.691 . . . . 65.33 112.045 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -67.42 -40.84 85.53 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 122.71 0.404 . . . . 74.55 111.501 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.07 67.15 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.287 0.635 . . . . 75.12 111.89 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -80.87 -37.43 29.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.892 0.877 . . . . 71.54 110.719 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 32.3 mm-40 -56.97 109.32 1.64 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.505 0.722 . . . . 75.24 111.944 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 141' ' ' ASP . 72.9 Cg_endo -70.68 111.07 2.9 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.25 1.966 . . . . 70.04 112.712 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.93 22.49 65.94 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 114.486 0.554 . . . . 63.03 114.486 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 26.69 10.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 117.702 0.751 . . . . 73.13 110.135 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 31.7 t70 -48.76 119.06 2.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.523 0.729 . . . . 64.31 111.777 168.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.485 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 114.41 48.04 0.57 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.101 -0.5 . . . . 60.23 112.899 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.72 137.25 13.39 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 110.613 -0.995 . . . . 54.1 110.613 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -118.43 152.68 35.42 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.325 0.861 . . . . 74.52 113.325 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.4 mt -123.06 122.32 38.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.171 1.389 . . . . 74.21 109.953 175.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.27 108.43 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.721 -0.474 . . . . 73.0 109.721 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 7.5 mp -95.19 120.71 35.89 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.114 -0.698 . . . . 70.21 109.114 176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.48 25.99 5.28 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.312 -0.404 . . . . 62.25 113.232 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.71 133.06 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.34 -0.615 . . . . 74.45 109.34 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -109.72 154.18 23.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.25 -1.018 . . . . 74.4 108.25 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.54 139.69 38.79 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.058 0.456 . . . . 61.24 111.124 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.68 140.31 52.82 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.87 0.868 . . . . 60.44 110.536 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.39 127.33 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.248 0.619 . . . . 75.41 110.809 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -71.98 171.38 11.92 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.854 0.462 . . . . 72.3 111.435 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.37 -31.03 69.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.067 0.547 . . . . 74.1 111.725 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -98.32 11.0 39.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.911 0.708 . . . . 75.23 112.911 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.3 -3.67 59.96 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 116.859 1.503 . . . . 73.41 116.859 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 128.07 34.59 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 118.905 1.353 . . . . 74.25 112.97 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -80.09 106.54 12.19 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.876 -0.787 . . . . 72.54 108.876 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -103.11 119.95 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.405 0.682 . . . . 74.22 109.589 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.93 142.47 27.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.136 0.574 . . . . 74.1 110.407 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -147.99 137.25 11.96 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.155 0.582 . . . . 74.35 111.414 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -82.18 89.53 1.18 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.907 2.405 . . . . 73.14 112.428 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.61 -13.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.865 0.466 . . . . 74.12 111.747 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.37 172.19 46.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 121.616 0.565 . . . . 72.33 114.309 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -95.44 140.16 22.26 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.202 1.001 . . . . 73.31 109.762 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.86 -37.18 98.75 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.631 2.221 . . . . 73.51 112.274 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -140.58 101.55 6.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.806 -1.183 . . . . 65.43 107.806 166.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HB2' HD23 ' A' ' 99' ' ' LEU . 90.4 Cg_endo -74.13 -22.99 16.29 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.635 2.223 . . . . 74.22 113.838 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.55 -43.29 66.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.509 0.724 . . . . 64.13 110.591 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -40.02 87.48 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.549 -0.296 . . . . 71.04 111.275 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' HA ' ' HE2' ' A' ' 28' ' ' MET . 97.6 t -60.49 -43.64 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.347 0.659 . . . . 74.23 111.748 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.21 -41.91 99.22 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.876 0.47 . . . . 75.52 111.978 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -72.86 -46.94 50.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.362 0.665 . . . . 74.11 111.915 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.35 -30.54 70.38 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.141 0.576 . . . . 71.53 112.01 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.87 -37.96 67.18 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.406 0.283 . . . . 75.04 111.027 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.55 76.19 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.19 0.596 . . . . 75.43 111.763 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.6 m -66.07 -51.5 57.56 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.364 0.666 . . . . 74.02 111.347 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -65.62 -29.68 70.29 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.74 0.416 . . . . 74.05 111.419 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.504 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 41.8 t -60.35 -32.28 71.12 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.377 0.51 . . . . 72.11 112.377 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.87 16.76 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.982 0.513 . . . . 64.45 111.381 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 64.7 m -74.22 -32.05 62.86 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.847 0.859 . . . . 74.21 113.207 -174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.5 mmm -94.87 -42.97 8.42 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.435 0.694 . . . . 71.54 112.013 -175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.01 132.19 37.7 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.45 -0.204 . . . . 75.23 110.45 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -58.16 -40.28 80.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.829 0.851 . . . . 72.21 112.223 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -97.36 155.56 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.294 0.638 . . . . 74.21 109.824 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 96.15 2.33 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.667 -0.494 . . . . 74.11 109.667 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.56 123.47 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.038 -1.097 . . . . 72.42 108.038 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -103.39 95.15 6.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.82 0.848 . . . . 74.13 110.062 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' A' ' 97' ' ' MET . 68.6 Cg_endo -86.44 156.28 9.32 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.545 2.163 . . . . 74.14 112.054 174.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.5 tp10 -83.44 122.56 28.67 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.967 -0.753 . . . . 64.45 108.967 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.581 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.4 mtt -128.39 124.27 35.91 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.07 0.548 . . . . 70.43 110.391 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.516 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -135.68 133.76 38.45 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.985 0.421 . . . . 74.15 110.309 175.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 74' ' ' PRO . 94.5 mt -81.72 111.06 17.63 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.196 0.999 . . . . 65.31 110.641 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.36 130.13 55.22 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.954 0.902 . . . . 72.21 111.936 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -96.78 118.91 34.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.364 0.665 . . . . 72.03 111.282 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.83 121.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.658 1.183 . . . . 75.12 109.59 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 29.09 57.63 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.795 1.078 . . . . 44.2 115.795 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.86 81.39 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.035 0.774 . . . . 71.54 115.035 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -107.59 137.25 45.96 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.558 0.743 . . . . 74.2 109.681 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.9 m -102.01 134.88 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.684 0.675 . . . . 74.22 110.751 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 4' ' ' ALA . 6.0 mp -124.48 170.18 11.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.393 1.077 . . . . 74.43 108.737 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 97' ' ' MET . 60.9 tp -117.31 116.54 27.42 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.671 -0.492 . . . . 74.34 109.671 172.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t -94.42 128.58 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.512 -0.921 . . . . 72.22 108.512 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 56.6 t -121.92 106.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.087 0.555 . . . . 62.52 111.006 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 92.3 t80 -82.52 123.95 29.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.026 0.93 . . . . 75.33 110.148 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.39 114.19 62.43 Favored Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 109.456 -0.572 . . . . 73.12 109.456 173.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.84 161.82 38.51 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.273 . . . . 75.21 112.602 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -75.02 150.15 39.02 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.94 -0.393 . . . . 75.34 109.94 176.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 119' ' ' HIS . . . -74.02 145.76 44.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.281 0.562 . . . . 72.23 111.776 169.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.68 -179.95 1.95 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.452 1.101 . . . . 63.23 110.736 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.86 -49.69 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 63.45 112.974 167.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -73.2 -49.17 29.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.16 0.505 . . . . 75.12 110.708 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.7 m-70 -103.92 83.05 2.06 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 102.199 -3.26 . . . . 74.3 102.199 159.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.619 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 31.6 mmtp -43.5 -152.9 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.521 1 C-N-CA 132.562 4.345 . . . . 72.25 121.263 61.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo 4.14 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.007 2.471 . . . . 74.22 116.046 -126.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.0 mm -100.74 125.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.754 0.822 . . . . 75.21 109.503 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -156.44 -176.86 6.2 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.539 0.736 . . . . 74.4 111.264 -174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -72.44 157.27 37.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.524 0.729 . . . . 73.41 111.908 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -64.46 -38.17 90.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.176 0.59 . . . . 71.51 110.884 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.11 142.72 30.24 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.055 0.942 . . . . 73.02 109.97 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.4 m -66.14 120.96 14.12 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.467 0.707 . . . . 71.42 111.934 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.61 71.19 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 N-CA-C 113.779 0.272 . . . . 75.41 113.779 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 52.6 tp -118.71 105.23 46.01 Favored Pre-proline 0 CA--C 1.564 1.489 0 C-N-CA 123.606 0.763 . . . . 74.42 109.868 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.79 -46.96 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.156 2.571 . . . . 73.05 114.0 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.9 92.32 0.94 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 111.618 -0.593 . . . . 73.41 111.618 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.09 0.43 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 123.118 0.389 . . . . 71.52 113.902 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.21 83.66 7.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.564 0.746 . . . . 73.03 110.774 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -93.21 -48.17 6.58 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.696 0.799 . . . . 74.13 110.311 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -94.64 154.09 17.51 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.624 0.77 . . . . 74.12 110.071 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -72.96 84.16 1.25 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.086 0.946 . . . . 72.35 112.036 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.7 pt -95.3 136.81 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.362 0.665 . . . . 74.41 110.755 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.9 -135.48 4.74 Favored Glycine 0 N--CA 1.478 1.497 0 C-N-CA 123.04 0.352 . . . . 71.34 112.801 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.4 t -148.21 107.46 3.9 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.347 0.659 . . . . 70.25 110.83 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.9 t -103.84 1.81 31.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.774 0.829 . . . . 73.32 111.217 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 43' ' ' PRO . 18.5 t70 -153.46 141.92 20.73 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.377 0.671 . . . . 73.31 110.517 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -154.45 120.61 5.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.195 0.998 . . . . 73.32 110.09 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -104.97 79.13 1.47 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.236 0.615 . . . . 70.41 111.795 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.27 74.85 0.06 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 126.496 1.918 . . . . 64.44 116.126 168.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.01 136.96 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.873 -0.417 . . . . 72.33 109.873 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -116.76 178.65 4.26 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.116 0.566 . . . . 73.3 112.354 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.36 130.15 44.05 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.504 0.722 . . . . 75.32 110.335 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -63.18 118.25 7.68 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.531 0.732 . . . . 74.23 111.604 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -76.08 157.11 33.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.121 0.968 . . . . 72.12 112.42 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -93.76 -174.18 3.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.535 0.734 . . . . 75.01 110.184 171.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -126.27 142.28 51.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.751 0.82 . . . . 73.14 110.039 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -83.33 131.66 35.05 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.795 0.438 . . . . 74.25 110.26 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.0 m170 . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 123.555 0.742 . . . . 73.21 111.299 -175.176 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.598 ' HG2' ' HB2' ' A' ' 111' ' ' TYR . 3.0 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 111.208 0.077 . . . . 71.43 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -41.52 132.19 2.84 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.338 1.055 . . . . 73.21 112.668 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -62.84 159.36 16.79 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.348 0.659 . . . . 61.54 112.154 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.38 81.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.09 0.556 . . . . 61.31 112.049 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -68.93 -36.77 78.36 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.318 0.647 . . . . 53.14 112.481 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.42 -53.68 54.65 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.113 0.565 . . . . 73.14 111.152 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 109' ' ' VAL . 93.3 mt -59.64 -38.92 82.7 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.634 0.773 . . . . 72.02 112.029 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HA ' HD13 ' A' ' 11' ' ' LEU . 2.5 tm? -62.55 -42.34 99.47 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.717 0.807 . . . . 75.43 110.862 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.73 -37.48 87.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.031 0.533 . . . . 71.53 110.56 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' HG21 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -66.09 -40.14 90.56 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.679 -0.691 . . . . 74.13 111.474 173.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 8' ' ' LEU . 87.2 mt -61.03 -39.02 88.18 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.569 0.747 . . . . 73.41 111.79 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -78.51 -22.75 46.93 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.142 0.577 . . . . 74.14 111.851 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.81 -44.46 49.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.263 0.625 . . . . 73.41 111.226 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 10' ' ' GLU . 31.5 m -86.82 151.63 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 74.42 110.994 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.36 -18.46 38.78 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.566 0.747 . . . . 75.42 110.977 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.68 150.81 36.14 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.326 0.65 . . . . 72.4 111.013 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 57.4 p -83.88 80.44 9.15 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.434 0.635 . . . . 74.43 110.717 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.62 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.68 -0.691 . . . . 74.33 112.0 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -120.44 -11.83 9.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 73.2 110.926 175.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mt -115.04 106.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.294 -1.002 . . . . 74.32 108.294 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.624 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 10.2 tp10 -96.04 151.81 19.1 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.299 1.44 . . . . 74.25 111.713 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.76 28.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.919 . . . . 72.22 110.162 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HE2' ' HG2' ' A' ' 21' ' ' GLU . 62.5 mttm -136.23 166.42 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 75.41 112.167 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -105.36 167.24 9.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.577 1.151 . . . . 75.14 112.042 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.57 -26.01 67.67 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.64 0.776 . . . . 75.41 112.448 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.6 t -56.4 -37.12 69.71 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.294 0.85 . . . . 74.2 113.294 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.33 18.35 16.12 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.555 0.946 . . . . 62.14 113.555 -170.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.1 ptm -63.74 103.19 0.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.049 0.928 . . . . 75.41 110.736 166.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.08 -130.97 2.7 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.307 -0.86 . . . . 75.45 111.939 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.605 ' HZ2' ' HB3' ' A' ' 30' ' ' LYS . 5.0 ttpm? -55.14 -34.4 63.73 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.213 1.005 . . . . 74.41 112.862 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -67.39 -40.72 85.68 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.473 0.709 . . . . 71.41 111.89 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.49 -53.29 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.829 0.451 . . . . 74.22 110.033 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -48.22 -40.69 25.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.901 1.281 . . . . 72.25 113.34 175.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.07 -47.14 65.32 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.836 0.854 . . . . 73.13 111.927 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 m -77.62 -37.73 49.55 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.652 0.781 . . . . 72.01 111.912 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.24 -42.32 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.215 1.006 . . . . 62.31 112.254 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -54.14 -34.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.341 1.056 . . . . 62.21 112.379 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.78 92.55 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.249 0.62 . . . . 61.24 111.784 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -72.68 -30.22 64.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.961 0.504 . . . . 74.51 111.721 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.88 19.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.199 0.6 . . . . 75.51 112.23 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -85.16 -43.09 14.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.228 0.825 . . . . 73.43 113.228 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.63 108.23 5.49 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 122.92 0.488 . . . . 73.04 111.373 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 116.36 4.63 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.462 2.108 . . . . 65.12 111.683 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.74 3.31 40.01 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.243 -0.754 . . . . 63.14 114.24 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.53 -23.89 11.27 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 118.88 1.34 . . . . 75.45 108.401 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -44.94 155.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.246 1.819 . . . . 73.53 115.699 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 39.0 4.95 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.546 -0.752 . . . . 75.54 113.06 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.95 165.4 29.31 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 113.547 0.179 . . . . 71.0 113.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -123.22 126.75 47.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.318 0.647 . . . . 72.51 110.278 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.6 mp -112.32 118.08 34.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 75.43 108.438 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.5 tp -102.33 111.82 24.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.666 -0.494 . . . . 74.5 109.666 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.598 HD12 HD23 ' A' ' 108' ' ' LEU . 71.7 mt -92.35 138.95 31.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.213 0.605 . . . . 74.12 111.149 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.12 41.07 5.65 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.548 -0.751 . . . . 64.41 112.634 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.92 141.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.122 0.569 . . . . 74.43 110.728 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -104.73 158.6 16.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.228 . . . . 64.12 108.322 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -143.87 126.73 16.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.203 0.525 . . . . 74.12 110.295 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.13 137.34 53.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.354 1.062 . . . . 73.12 110.707 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.56 122.86 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.53 0.732 . . . . 62.32 111.54 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -72.21 177.63 4.35 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.465 1.106 . . . . 74.33 111.986 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.17 -28.61 66.57 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.003 0.521 . . . . 64.32 110.821 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.107 0.963 . . . . 75.53 112.273 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.12 10.88 70.78 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 116.786 -0.188 . . . . 74.44 112.852 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.31 158.72 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.124 0.97 . . . . 72.43 111.969 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -109.71 113.03 25.45 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.361 0.665 . . . . 63.53 110.906 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.62 124.3 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.651 0.781 . . . . 64.13 109.586 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.479 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 66.9 m-85 -93.17 127.17 38.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.262 0.625 . . . . 73.23 110.206 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -117.28 131.78 23.85 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.847 0.859 . . . . 75.0 110.601 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.03 97.3 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.268 1.979 . . . . 62.54 111.573 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.48 -20.63 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.405 0.682 . . . . 71.3 112.309 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.61 178.08 51.24 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 121.56 0.533 . . . . 60.24 114.267 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.12 138.75 20.63 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.226 1.011 . . . . 73.42 110.854 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.52 -38.37 19.52 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.481 2.121 . . . . 75.51 112.592 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -124.78 67.23 50.6 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 123.701 0.801 . . . . 72.4 109.627 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.417 ' HB2' HD23 ' A' ' 99' ' ' LEU . 39.2 Cg_endo -60.22 -42.65 40.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.106 2.537 . . . . 75.55 114.638 -164.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.92 -38.0 87.55 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.133 0.573 . . . . 73.04 110.979 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -71.95 -37.23 69.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.258 0.623 . . . . 74.42 111.515 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -60.91 -39.61 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.665 0.386 . . . . 74.42 110.058 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.52 -47.92 79.67 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.24 0.616 . . . . 73.52 112.208 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -63.63 -50.06 70.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.823 0.849 . . . . 75.11 112.238 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.74 -30.31 69.76 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.895 0.878 . . . . 74.33 111.328 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.7 tp -67.56 -42.06 83.22 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.929 0.492 . . . . 74.54 111.122 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.44 98.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.445 0.698 . . . . 75.4 111.382 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -61.65 -52.61 63.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 60.24 111.668 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.94 -30.77 70.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.055 0.391 . . . . 75.24 112.055 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.19 -32.19 71.94 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.431 0.56 . . . . 74.55 112.071 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.3 -29.71 28.13 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.701 -0.681 . . . . 72.53 112.447 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -94.35 -24.41 17.4 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.549 1.314 . . . . 74.14 114.549 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.412 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 48.1 mmm -91.09 -27.1 18.79 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.46 0.704 . . . . 72.34 111.861 -173.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.6 162.0 13.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.139 0.576 . . . . 74.25 112.536 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -39.54 -63.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.083 1.753 . . . . 72.32 112.835 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.439 HG23 ' ND1' ' A' ' 119' ' ' HIS . 30.3 m -116.61 172.03 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.69 0.796 . . . . 71.54 110.16 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.17 99.66 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.197 0.523 . . . . 72.23 110.661 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.16 134.05 35.57 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.999 -1.112 . . . . 73.25 107.999 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -110.39 91.6 12.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.123 0.569 . . . . 75.21 111.462 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -90.62 169.07 3.9 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.831 2.354 . . . . 75.02 112.531 171.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.85 135.13 53.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.191 0.596 . . . . 75.23 109.838 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.652 ' HB3' HD13 ' A' ' 108' ' ' LEU . 46.9 mtt -130.03 132.57 46.27 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.203 0.601 . . . . 73.54 111.156 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -135.37 144.31 46.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.481 0.712 . . . . 73.4 111.741 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 74' ' ' PRO . 74.1 mt -104.23 117.12 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.092 0.957 . . . . 74.23 110.098 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -117.49 133.23 56.2 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.492 1.117 . . . . 75.35 111.651 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -94.21 114.36 26.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.822 0.849 . . . . 72.05 110.527 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.95 113.95 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.788 1.235 . . . . 64.54 109.149 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 51.42 28.49 20.73 Favored Glycine 0 CA--C 1.543 1.803 0 N-CA-C 115.642 1.017 . . . . 74.55 115.642 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.23 -5.71 78.23 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.546 0.578 . . . . 62.4 114.546 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -98.92 137.57 37.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 72.53 110.699 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 m -102.39 104.73 15.23 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.191 0.451 . . . . 74.44 111.461 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.09 163.7 12.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.663 0.785 . . . . 70.13 111.623 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.652 HD13 ' HB3' ' A' ' 97' ' ' MET . 39.4 tp -115.4 114.14 24.68 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.146 0.578 . . . . 73.22 110.962 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 7' ' ' LEU . 90.8 t -83.29 112.53 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.711 0.804 . . . . 71.12 109.506 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 25.1 t -108.49 100.05 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.637 0.732 . . . . 72.2 110.602 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.598 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 51.9 t80 -84.6 124.47 31.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.433 1.093 . . . . 74.14 110.535 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.07 103.02 48.66 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 122.655 0.382 . . . . 74.43 110.44 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.65 166.18 28.91 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.736 2.291 . . . . 75.34 112.011 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.51 161.74 24.82 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.915 1.079 . . . . 74.25 113.915 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.38 47.17 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.739 -1.119 . . . . 64.52 109.18 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.14 163.43 24.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 122.737 0.415 . . . . 71.13 111.058 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.0 -22.18 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.305 1.042 . . . . 74.44 112.467 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.3 p -58.28 -27.39 64.01 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.191 0.597 . . . . 75.33 111.448 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 5.4 m170 -75.84 -86.07 0.05 OUTLIER 'General case' 0 CA--C 1.591 2.53 0 N-CA-C 105.512 -2.033 . . . . 65.13 105.512 166.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 45.1 tttp -82.49 -145.04 0.0 OUTLIER Pre-proline 0 CA--C 1.591 2.538 0 C-N-CA 129.298 3.039 . . . . 71.23 109.636 -49.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo 5.47 102.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 124.884 3.723 . . . . 75.15 119.326 -136.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.2 mt -88.85 115.11 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 114.735 -1.12 . . . . 75.43 109.48 168.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -108.38 166.5 10.71 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.555 0.742 . . . . 75.23 111.458 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 26.5 tptp -79.75 130.68 35.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.937 0.495 . . . . 74.51 109.871 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.64 76.63 3.31 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.305 0.574 . . . . 75.44 110.439 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -172.48 98.28 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.971 1.308 . . . . 70.51 109.094 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -70.41 149.93 46.77 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.268 0.627 . . . . 74.1 112.568 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.64 -39.08 0.32 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.901 -0.59 . . . . 73.1 112.377 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.83 106.51 37.83 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.108 0.963 . . . . 65.51 110.123 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 115.4 4.32 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.161 2.574 . . . . 72.34 113.131 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.55 -77.35 2.06 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.364 -0.38 . . . . 64.3 113.38 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.11 -106.21 1.77 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.97 -0.452 . . . . 74.31 111.97 -173.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.62 67.38 9.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.588 0.708 . . . . 65.01 110.108 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -70.39 -34.72 72.89 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.173 0.989 . . . . 74.54 112.014 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -78.42 154.29 30.78 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.624 0.77 . . . . 73.21 111.653 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.82 103.72 0.6 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.694 0.798 . . . . 75.23 112.465 -170.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.79 115.18 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.189 0.996 . . . . 72.42 109.188 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.38 160.96 34.66 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 113.927 0.331 . . . . 62.44 113.927 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.5 t -92.56 58.14 3.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.002 0.921 . . . . 71.1 110.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 51.1 m 53.29 72.86 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.629 1.172 . . . . 72.24 111.883 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.43 89.17 0.09 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.964 0.906 . . . . 61.24 112.853 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.66 -26.89 5.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.805 1.242 . . . . 72.33 110.534 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -86.36 87.56 7.46 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.306 0.642 . . . . 74.32 110.262 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.4 t -97.03 142.83 28.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.933 0.493 . . . . 74.2 111.431 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.75 147.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.219 0.608 . . . . 74.03 111.088 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.92 123.67 27.99 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.236 -0.653 . . . . 55.11 109.236 173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -126.45 121.35 32.16 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.5 0.667 . . . . 71.41 112.68 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -148.42 117.5 6.8 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 75.44 108.124 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -98.06 106.39 18.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.211 -0.663 . . . . 74.01 109.211 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -62.31 144.01 56.2 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.907 0.483 . . . . 74.4 111.597 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -139.75 136.69 34.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.516 0.726 . . . . 73.13 110.211 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -124.0 -170.72 2.18 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.609 0.763 . . . . 73.5 110.653 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 65.0 t60 . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 123.259 0.623 . . . . 74.03 111.06 177.402 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.539 0.685 . . . . 75.05 112.789 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.39 179.53 4.12 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.944 -1.026 . . . . 74.13 110.189 165.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -71.76 157.25 38.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.656 -0.702 . . . . 70.45 112.063 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.22 84.47 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.402 0.681 . . . . 62.13 111.543 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -65.6 -33.95 77.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.447 0.699 . . . . 73.3 112.593 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -43.74 80.9 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 120.847 0.356 . . . . 73.42 111.092 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.72 -29.12 69.03 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.074 0.55 . . . . 72.23 111.646 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' HA ' HD11 ' A' ' 11' ' ' LEU . 17.9 tp -63.73 -29.77 70.95 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.647 0.779 . . . . 73.22 111.324 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.49 -34.2 75.08 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.176 0.59 . . . . 64.02 111.821 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.426 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.0 tt0 -67.66 -52.11 41.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.595 0.634 . . . . 75.22 109.659 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.483 HD11 ' HA ' ' A' ' 8' ' ' LEU . 77.5 mt -49.38 -45.63 46.22 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.489 1.116 . . . . 73.01 112.762 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.46 -26.38 38.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.501 0.926 . . . . 74.32 113.501 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.33 -53.41 16.82 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.339 0.518 . . . . 72.02 111.427 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.2 m -81.79 139.89 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.927 0.491 . . . . 73.33 110.379 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.79 -45.06 90.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.522 0.729 . . . . 72.42 111.605 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -123.53 138.21 54.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.922 0.889 . . . . 72.42 110.487 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -44.17 124.62 4.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 71.01 113.669 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.94 -65.08 1.01 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.167 0.587 . . . . 64.5 112.328 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -119.82 -6.61 10.08 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.819 0.848 . . . . 75.11 111.406 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' A' ' 49' ' ' TYR . 45.5 mt -128.96 121.84 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.872 0.869 . . . . 71.33 108.806 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.55 129.06 46.44 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.949 -0.389 . . . . 75.45 109.949 169.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' A' ' 54' ' ' VAL . . . -81.38 133.86 35.48 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.517 0.727 . . . . 73.03 109.067 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -130.86 151.13 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.41 0.624 . . . . 74.24 111.438 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -97.85 159.67 14.79 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.008 -0.997 . . . . 72.02 110.241 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.627 0.771 . . . . 74.23 112.302 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -59.88 -36.42 76.88 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.93 0.892 . . . . 73.24 113.041 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.53 -10.55 55.83 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.12 0.568 . . . . 74.13 112.094 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.2 ttt -59.43 104.28 0.25 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.171 0.51 . . . . 71.24 111.239 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 170.65 -150.35 14.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.241 -0.744 . . . . 71.24 111.241 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.13 -27.14 52.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.12 1.156 . . . . 74.3 114.12 -175.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -65.44 -43.62 89.87 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.938 0.495 . . . . 64.21 111.26 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.26 -42.86 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.81 0.844 . . . . 74.11 110.773 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 84.6 mmm -64.34 -33.27 75.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.82 0.848 . . . . 74.21 112.038 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.63 -36.58 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.187 0.595 . . . . 75.43 110.936 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.404 HG21 HD22 ' A' ' 50' ' ' LEU . 3.0 m -70.64 -29.85 66.32 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 116.258 -0.428 . . . . 74.24 110.899 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.1 -38.41 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.511 0.725 . . . . 74.33 110.146 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.78 -36.55 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.42 0.288 . . . . 72.23 110.898 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.18 -57.86 7.45 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 120.965 0.412 . . . . 60.13 111.192 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -67.43 -20.79 65.55 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.447 0.906 . . . . 75.45 113.447 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.98 -33.45 19.61 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.209 0.818 . . . . 74.5 113.209 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -101.08 -27.82 13.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.761 1.023 . . . . 75.02 113.761 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.46 115.45 56.72 Favored Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 118.079 0.4 . . . . 72.13 111.739 -176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.99 160.24 38.59 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.485 2.124 . . . . 75.55 111.785 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.31 -41.15 3.07 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 114.031 0.373 . . . . 75.31 114.031 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -94.55 -34.44 12.66 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.065 0.933 . . . . 72.45 110.716 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 2.71 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.649 2.38 . . . . 75.05 116.284 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.44 0.57 Allowed Glycine 0 CA--C 1.537 1.432 0 CA-C-N 116.324 -0.398 . . . . 63.41 113.405 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.07 173.48 43.0 Favored Glycine 0 N--CA 1.478 1.45 0 O-C-N 122.833 -0.216 . . . . 71.23 112.971 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.624 ' HB2' HG12 ' A' ' 20' ' ' ILE . 76.7 m-85 -121.02 155.67 33.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.433 0.635 . . . . 74.14 111.907 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 60.8 mt -128.31 118.47 23.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.623 1.169 . . . . 73.43 108.585 170.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.3 tp -103.52 109.07 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 75.32 109.788 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.576 HD11 HD21 ' A' ' 108' ' ' LEU . 25.1 mt -99.74 126.32 45.78 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.265 0.626 . . . . 75.35 110.67 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-N 116.6 -0.273 . . . . 42.1 113.058 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 58.4 t -112.65 137.52 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.207 0.603 . . . . 73.44 109.943 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -109.89 157.41 19.25 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.05 -1.093 . . . . 75.3 108.05 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -144.02 136.11 26.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.875 0.369 . . . . 74.15 111.662 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.15 135.33 47.36 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.767 0.827 . . . . 72.4 110.669 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.3 mt -96.83 134.89 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.416 0.686 . . . . 73.44 110.996 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -84.7 -177.19 6.53 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.426 0.69 . . . . 75.21 111.665 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.3 -25.05 66.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.934 0.716 . . . . 72.12 112.934 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 61' ' ' LYS . 9.7 mtpm? -78.28 -22.94 47.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.774 0.83 . . . . 73.51 112.555 178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.96 -0.96 31.64 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 114.585 0.594 . . . . 53.13 114.585 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -75.51 120.79 21.42 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.475 0.637 . . . . 71.3 110.935 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -80.94 118.95 22.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.122 0.569 . . . . 72.55 109.811 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.51 114.89 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.682 0.793 . . . . 74.04 109.326 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.85 130.25 41.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.079 -0.711 . . . . 74.21 109.079 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -143.57 131.11 10.79 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.048 0.539 . . . . 64.54 111.169 -172.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.401 ' HD3' HD23 ' A' ' 8' ' ' LEU . 98.8 Cg_endo -77.53 101.43 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.759 2.306 . . . . 75.03 112.571 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.12 -6.45 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.127 0.571 . . . . 72.34 112.062 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.47 175.18 50.29 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 114.601 0.6 . . . . 74.11 114.601 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -105.48 137.77 19.38 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.854 1.262 . . . . 71.42 109.889 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.31 -30.5 19.62 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.071 1.847 . . . . 72.3 112.291 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 6.2 m-20 -125.98 66.43 58.66 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.871 0.868 . . . . 55.41 110.617 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -43.55 23.97 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.707 2.271 . . . . 75.2 114.27 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -71.04 -39.38 72.33 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.999 -0.546 . . . . 74.52 110.654 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 14.1 ttmm -60.41 -44.42 95.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.445 0.698 . . . . 74.12 111.15 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.85 -43.41 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 122.632 0.373 . . . . 73.15 110.691 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.94 -50.2 67.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.541 0.571 . . . . 71.14 112.541 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -68.82 -49.59 57.25 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.865 0.466 . . . . 74.03 111.766 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.28 -28.54 67.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.512 0.725 . . . . 63.21 112.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.8 tp -72.65 -41.52 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.385 0.539 . . . . 73.41 111.432 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.28 84.22 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.12 0.568 . . . . 73.33 112.189 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 p -73.87 -41.39 62.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 63.51 112.071 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -65.34 -30.15 70.96 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 117.665 0.211 . . . . 73.55 111.228 173.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.7 t -59.35 -21.07 59.28 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 112.923 0.712 . . . . 73.22 112.923 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.01 -35.15 17.75 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.824 0.85 . . . . 72.23 111.587 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 -14.46 31.13 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.585 0.958 . . . . 74.12 113.585 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.3 mmm -90.05 -47.51 7.79 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.82 0.848 . . . . 71.14 110.081 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.82 154.23 17.36 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.047 -0.979 . . . . 75.13 110.627 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 122' ' ' ILE . 8.0 p30 -48.29 -47.56 36.33 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.2 1.0 . . . . 74.44 112.705 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.66 173.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.244 1.018 . . . . 75.35 110.138 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.29 100.54 3.17 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.811 -0.631 . . . . 75.4 110.462 169.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.542 HD13 HG22 ' A' ' 122' ' ' ILE . 5.9 tt -75.7 131.41 39.86 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.263 -1.755 . . . . 74.01 106.263 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -106.28 95.71 11.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 122.866 0.466 . . . . 74.12 111.869 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.19 161.65 5.72 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.105 1.87 . . . . 73.04 111.928 166.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 111' ' ' TYR . 37.9 mm-40 -92.04 141.13 28.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.44 -0.8 . . . . 65.31 108.935 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.628 ' HB3' HD13 ' A' ' 108' ' ' LEU . 67.3 mtt -137.8 122.74 18.97 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.53 111.121 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -130.87 136.84 49.0 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.811 0.844 . . . . 75.33 110.13 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.91 109.82 20.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.72 -0.845 . . . . 74.33 108.72 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.96 128.53 55.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.012 0.525 . . . . 74.5 110.848 -166.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -101.2 123.85 45.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.534 0.734 . . . . 72.3 111.765 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.93 122.45 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.677 1.191 . . . . 73.21 109.881 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.75 28.85 48.11 Favored Glycine 0 CA--C 1.544 1.89 0 N-CA-C 115.733 1.053 . . . . 71.32 115.733 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.15 5.37 76.62 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.015 0.766 . . . . 74.42 115.015 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.08 134.88 50.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 74.22 109.963 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.7 m -97.7 129.18 44.77 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.751 0.705 . . . . 72.02 110.603 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.05 171.41 8.69 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.402 1.081 . . . . 75.43 109.047 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 97' ' ' MET . 47.2 tp -117.49 114.81 24.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.918 0.389 . . . . 74.15 110.155 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.55 113.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 39.5 t -107.46 101.09 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.756 -0.461 . . . . 74.21 109.756 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.527 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 62.8 t80 -85.79 119.93 26.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.756 -0.831 . . . . 74.32 108.756 172.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.61 98.39 28.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.042 0.537 . . . . 75.32 109.64 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.38 162.43 22.38 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.767 2.312 . . . . 74.14 113.381 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.461 ' HG3' ' HE3' ' A' ' 120' ' ' LYS . 10.8 tt0 -73.29 128.37 35.3 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.239 0.616 . . . . 73.33 111.679 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.76 171.51 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.184 0.994 . . . . 50.43 112.059 -175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.16 132.88 34.64 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 123.63 0.772 . . . . 71.31 110.574 -169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -38.49 -38.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.876 0 N-CA-C 116.79 2.144 . . . . 74.2 116.79 -160.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.9 t -63.98 -42.93 97.08 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.021 0.528 . . . . 72.3 111.675 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.639 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 23.1 m-70 -128.97 70.89 1.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 104.822 -2.288 . . . . 75.04 104.822 167.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.1 mttt -48.17 -156.95 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.744 0 C-N-CA 131.647 3.979 . . . . 74.21 121.59 57.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo 4.57 70.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.908 2.405 . . . . 71.31 116.04 -127.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.542 HG22 HD13 ' A' ' 93' ' ' LEU . 34.0 mm -73.92 89.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.726 -0.67 . . . . 71.53 110.032 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -89.67 150.45 22.34 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.955 -0.566 . . . . 71.11 109.921 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -69.85 149.38 47.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 109.85 -0.426 . . . . 74.31 109.85 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -53.11 97.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.592 0.757 . . . . 75.22 111.976 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.55 136.76 38.33 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.652 0.982 . . . . 74.34 113.652 -165.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.7 m -94.75 113.8 25.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.728 0.811 . . . . 73.13 109.735 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.33 -90.63 0.09 OUTLIER Glycine 0 CA--C 1.533 1.171 0 N-CA-C 112.499 -0.24 . . . . 74.14 112.499 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.65 152.74 53.51 Favored Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 123.515 0.726 . . . . 64.43 110.898 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.99 -34.32 91.86 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.945 2.43 . . . . 73.25 113.287 169.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.66 54.59 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.981 -0.554 . . . . 61.23 113.264 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -93.7 153.17 21.13 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 112.456 -0.257 . . . . 61.15 112.456 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.08 77.67 5.56 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 117.221 0.511 . . . . 65.34 110.631 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.43 -49.34 27.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.501 0.72 . . . . 73.22 110.328 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -107.22 106.69 17.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.658 0.783 . . . . 73.45 110.065 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -75.34 165.16 25.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.065 0.546 . . . . 75.43 110.726 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.62 92.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.372 0.606 . . . . 72.23 109.651 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.26 1.15 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 115.576 -0.738 . . . . 73.43 111.75 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 44.1 t -159.24 151.92 21.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.872 0.869 . . . . 62.23 110.627 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.5 t -90.03 113.82 25.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 74.01 110.996 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.84 95.12 4.65 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.644 0.735 . . . . 75.13 112.479 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.29 156.41 35.65 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.872 -1.058 . . . . 72.12 110.72 167.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -74.2 78.46 1.79 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.424 0.69 . . . . 71.23 111.488 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.86 94.23 6.2 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.55 -0.908 . . . . 71.44 108.55 172.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 79.2 t -68.1 99.08 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.327 0.585 . . . . 73.51 111.411 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.9 mt -80.92 93.07 6.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.626 -0.879 . . . . 71.14 108.626 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -41.25 94.17 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.437 1.095 . . . . 74.53 112.977 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 38.54 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.6 1.96 . . . . 73.22 114.635 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -80.57 104.51 11.15 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.753 -0.592 . . . . 72.43 109.47 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -60.78 -48.23 82.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.024 1.49 . . . . 74.32 115.024 -166.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 67.1 m80 56.21 30.43 16.55 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 124.055 0.942 . . . . 74.54 112.966 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -62.7 100.76 0.21 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 122.898 0.479 . . . . 74.4 111.076 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 124.05 0.94 . . . . 71.3 111.576 -177.105 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptm . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.489 0.185 . . . . 73.44 111.293 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -105.54 154.29 20.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.707 0.803 . . . . 73.42 111.366 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -75.73 160.24 30.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.834 0.453 . . . . 73.23 111.768 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 -27.99 69.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.641 -0.709 . . . . 63.22 112.268 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.602 HG23 HG12 ' A' ' 102' ' ' VAL . 5.8 m -71.47 -45.88 61.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.149 0.58 . . . . 72.21 110.864 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.74 -46.42 90.48 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.511 -0.768 . . . . 74.51 111.759 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.72 -34.57 67.2 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.638 0.775 . . . . 75.3 112.242 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.37 -47.7 72.56 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.129 0.571 . . . . 72.55 110.515 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.85 -35.29 79.46 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.293 -0.867 . . . . 73.02 111.128 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.62 -37.75 88.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.476 0.71 . . . . 73.33 111.171 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 HD12 ' HB1' ' A' ' 22' ' ' ALA . 59.2 mt -60.74 -37.06 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.964 0.906 . . . . 72.51 111.768 174.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.405 HD22 ' HB2' ' A' ' 66' ' ' TYR . 53.3 m-80 -80.69 -21.75 41.0 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.299 0.639 . . . . 74.05 112.186 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.24 -47.61 12.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.506 0.722 . . . . 75.45 112.567 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.34 163.71 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.573 0.702 . . . . 72.23 112.829 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.23 -33.83 22.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.271 -0.877 . . . . 74.41 110.48 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -139.81 136.77 34.39 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.133 0.973 . . . . 74.44 109.766 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 m -75.21 90.88 2.59 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.315 0.578 . . . . 64.31 110.144 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.19 82.86 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.731 1.212 . . . . 70.42 113.263 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -160.57 14.9 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.499 0.72 . . . . 75.13 111.731 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.86 117.1 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.794 -1.187 . . . . 74.13 107.794 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 150.17 38.49 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.224 0.61 . . . . 63.34 111.053 -173.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.438 ' HB1' HD12 ' A' ' 11' ' ' LEU . . . -121.59 124.38 44.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.734 0.814 . . . . 72.44 110.411 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HG3' HG22 ' A' ' 32' ' ' VAL . 31.2 mmtp -122.87 144.68 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.551 0.74 . . . . 73.14 110.303 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -75.89 158.26 32.27 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.316 0.646 . . . . 72.44 111.386 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -24.51 63.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.582 0.956 . . . . 73.44 113.582 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.0 t -84.16 -11.93 55.76 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.647 0.61 . . . . 74.44 112.647 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.3 -18.87 34.92 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.595 0.758 . . . . 71.02 111.515 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.78 131.26 50.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.19 0.519 . . . . 75.25 112.309 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.56 -122.6 2.81 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.159 -0.473 . . . . 75.32 112.081 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -68.24 -38.44 81.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.81 0.844 . . . . 75.11 111.748 -173.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.3 m -69.2 -42.03 76.33 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.667 0.787 . . . . 74.53 111.732 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG22 ' HG3' ' A' ' 23' ' ' LYS . 88.0 t -70.44 -41.84 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.693 0.397 . . . . 72.22 110.825 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.442 ' SD ' HD21 ' A' ' 89' ' ' LEU . 35.0 tpp -56.28 -44.4 79.74 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.813 0.845 . . . . 75.31 111.847 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.97 -30.57 71.02 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.722 0.809 . . . . 72.01 110.953 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -76.39 -36.35 58.15 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.745 0.818 . . . . 74.42 111.321 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 32' ' ' VAL . 97.1 t -60.97 -38.73 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 123.767 0.827 . . . . 73.21 111.129 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -57.4 -33.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.941 0.896 . . . . 71.33 111.071 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.63 71.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.146 0.578 . . . . 65.42 111.759 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -67.98 -18.17 64.65 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.377 0.51 . . . . 65.34 112.377 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.06 -37.41 18.91 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.581 0.752 . . . . 73.51 112.603 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.531 HD22 ' HB ' ' A' ' 122' ' ' ILE . 58.6 m-80 -104.52 -46.06 4.47 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.102 0.778 . . . . 73.52 113.102 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.21 121.82 78.34 Favored Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 123.813 0.845 . . . . 75.23 111.721 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.96 -178.46 2.82 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.199 2.599 . . . . 73.41 113.503 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.13 -40.46 2.92 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 114.869 0.708 . . . . 75.01 114.869 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.92 -48.24 25.62 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.798 0.799 . . . . 74.41 112.876 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t70 41.21 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.249 1.203 . . . . 65.24 114.249 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.564 ' HA2' ' HA ' ' A' ' 113' ' ' PRO . . . 78.01 72.21 1.17 Allowed Glycine 0 CA--C 1.535 1.294 0 C-N-CA 121.155 -0.545 . . . . 71.35 114.051 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.74 168.35 27.67 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 116.665 0.233 . . . . 74.54 113.143 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -121.36 144.23 48.77 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.83 0.678 . . . . 65.01 112.83 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 76.2 mt -122.55 123.13 40.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.702 1.201 . . . . 74.44 109.302 171.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.18 108.98 20.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.365 -0.605 . . . . 71.21 109.365 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.608 HD11 HD22 ' A' ' 108' ' ' LEU . 80.2 mt -94.76 129.91 41.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.181 0.592 . . . . 75.22 110.21 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 34.59 4.85 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.296 -0.411 . . . . 62.31 112.622 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -112.37 140.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.826 0.85 . . . . 72.22 109.964 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -124.04 154.88 39.26 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.102 -1.073 . . . . 61.04 108.102 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -136.16 128.99 31.05 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.914 0.485 . . . . 65.12 110.828 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.764 0.825 . . . . 62.13 110.63 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -100.01 128.63 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.727 0.811 . . . . 70.33 111.646 -170.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 73.8 m-20 -76.63 178.05 7.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.208 0.603 . . . . 73.51 112.181 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.23 -37.53 87.55 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.11 0.564 . . . . 72.22 111.252 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -68.17 -29.91 68.89 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.307 0.643 . . . . 73.31 111.47 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.26 6.0 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.024 -0.535 . . . . 60.32 113.924 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.431 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.7 m-20 -78.67 138.32 38.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.978 0.511 . . . . 73.13 111.663 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.6 m -89.54 102.76 15.44 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.47 0.708 . . . . 73.11 109.975 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HB ' HH12 ' A' ' 67' ' ' ARG . 57.6 t -109.96 129.26 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.552 0.741 . . . . 72.42 110.396 -176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' HB2' HD22 ' A' ' 12' ' ' ASN . 75.9 m-85 -95.76 120.81 36.68 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.73 0.812 . . . . 75.42 111.96 -171.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.409 HH12 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.69 150.91 45.61 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.128 0.971 . . . . 72.11 111.427 174.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.53 108.89 2.53 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.477 2.118 . . . . 73.25 113.229 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 m -91.86 -28.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 116.112 -0.494 . . . . 72.42 110.647 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 -176.73 53.97 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.734 -0.666 . . . . 72.43 113.83 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.4 mt -102.66 143.25 26.22 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.94 0.896 . . . . 75.34 110.856 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.0 -56.58 1.32 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.64 2.226 . . . . 71.54 111.743 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.51 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 12.1 m-20 -120.34 89.22 43.38 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.897 0.879 . . . . 70.44 108.656 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -54.98 -44.9 45.29 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.483 2.789 . . . . 73.34 114.664 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.22 -41.65 85.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.213 0.605 . . . . 74.0 110.634 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 36.9 ttpt -61.32 -43.4 98.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.795 0.438 . . . . 75.33 111.172 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.37 -43.69 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.821 0.849 . . . . 73.54 111.289 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.68 -39.67 94.9 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.838 0.855 . . . . 65.35 111.735 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -67.39 -46.2 74.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.673 0.789 . . . . 74.42 112.128 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.51 -41.17 96.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.919 0.888 . . . . 63.55 111.185 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.05 -44.23 80.69 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.025 -0.534 . . . . 72.32 111.487 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.69 97.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 73.1 111.369 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -60.89 -52.01 66.84 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.266 1.026 . . . . 72.41 111.887 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.45 -29.81 68.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.19 0.596 . . . . 74.32 112.052 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 33' ' ' MET . 31.3 t -61.57 -23.89 66.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.785 -0.572 . . . . 75.42 112.206 177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.03 -48.74 7.0 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.639 0.776 . . . . 74.53 111.414 170.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 t -74.55 -22.69 58.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.387 1.255 . . . . 71.22 114.387 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.8 mmm -88.51 -51.89 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.218 0.607 . . . . 74.42 111.602 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 ' O ' ' HD3' ' A' ' 125' ' ' LYS . 88.6 mt -70.01 -103.26 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 113.847 1.054 . . . . 62.31 113.847 -165.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 123' ' ' TYR . 3.7 p30 -170.01 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.662 0.664 . . . . 73.44 110.123 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.566 HG12 ' ND1' ' A' ' 119' ' ' HIS . 23.9 m -114.59 157.22 15.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.078 0.951 . . . . 72.2 109.055 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 96.06 1.16 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.258 -0.645 . . . . 63.03 109.258 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.75 122.02 34.73 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.263 -1.384 . . . . 74.51 107.263 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -104.41 100.44 22.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 122.619 0.368 . . . . 75.31 110.473 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.18 161.62 26.12 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.981 1.787 . . . . 72.22 110.948 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.7 tp10 -104.03 101.89 11.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.356 -0.609 . . . . 75.25 109.356 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.669 ' HB3' HD13 ' A' ' 108' ' ' LEU . 5.3 mpp? -101.71 135.06 43.87 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 112.501 0.556 . . . . 62.32 112.501 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -136.03 127.01 27.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.539 0.735 . . . . 74.33 111.242 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.0 112.01 9.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.209 1.003 . . . . 73.41 110.892 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -126.38 129.59 49.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.781 0.832 . . . . 75.45 111.179 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.35 126.67 39.75 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.533 0.733 . . . . 74.44 111.405 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.602 HG12 HG23 ' A' ' 5' ' ' THR . 13.1 t -119.33 118.4 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.256 1.022 . . . . 73.33 108.877 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 28.59 63.63 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.718 0.647 . . . . 75.3 114.718 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.07 10.61 78.03 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.419 0.527 . . . . 74.41 114.419 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.6 133.03 55.51 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.019 0.928 . . . . 74.34 108.961 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 m -89.88 123.74 34.09 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.059 0.845 . . . . 72.43 111.584 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.68 170.92 8.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.513 1.125 . . . . 72.31 109.078 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.669 HD13 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -122.28 120.11 33.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.581 0.353 . . . . 64.11 110.863 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 97' ' ' MET . 38.4 t -88.54 120.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.143 -0.688 . . . . 71.11 109.143 170.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.682 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 21.5 t -108.51 101.51 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.262 -0.644 . . . . 61.24 109.262 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.424 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.5 t80 -85.4 116.16 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.189 0.596 . . . . 73.21 109.733 175.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.77 96.89 50.19 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 108.011 -1.107 . . . . 73.31 108.011 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.564 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 72.8 Cg_endo -70.49 171.13 15.85 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.656 2.237 . . . . 52.01 112.753 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.29 121.36 19.3 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.357 -0.979 . . . . 73.05 108.357 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -79.55 166.87 21.48 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.566 0.746 . . . . 75.25 112.103 -173.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 38.2 t70 -62.48 165.77 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 124.001 0.921 . . . . 75.11 112.471 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -52.88 -51.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.094 -1.004 . . . . 72.2 113.542 168.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.7 p -84.68 6.44 24.15 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.583 0.586 . . . . 72.14 112.583 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.566 ' ND1' HG12 ' A' ' 91' ' ' VAL . 52.0 m-70 -170.96 64.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 103.026 -2.953 . . . . 74.44 103.026 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.69 ' HA ' HG12 ' A' ' 122' ' ' ILE . 9.4 ptpp? -48.04 -156.67 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.399 2 C-N-CA 133.584 4.754 . . . . 63.11 122.096 42.256 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 10.9 Cg_exo 14.13 73.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.983 1.788 . . . . 73.14 115.204 -118.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 120' ' ' LYS . 49.7 mm -90.2 125.34 43.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 114.006 -1.452 . . . . 63.11 108.654 172.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.475 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 36.7 p90 -149.97 155.53 40.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.196 0.998 . . . . 74.53 108.893 -174.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -81.85 147.83 29.13 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.601 0.36 . . . . 75.43 110.784 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER -62.62 -37.68 87.27 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.499 -0.556 . . . . 73.34 109.499 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.76 90.75 2.89 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.793 -0.64 . . . . 60.22 110.067 170.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.7 m -62.69 113.35 2.96 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.203 0.601 . . . . 73.01 110.354 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.92 -155.76 49.77 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 116.204 -0.453 . . . . 73.22 112.483 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.27 138.42 8.16 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.1 0.56 . . . . 74.5 111.193 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -88.39 161.64 6.79 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.723 2.282 . . . . 73.21 112.83 170.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.03 162.94 35.2 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 113.978 0.351 . . . . 53.41 113.978 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 167.09 108.85 0.21 Allowed Glycine 0 CA--C 1.541 1.657 0 CA-C-O 120.179 -0.234 . . . . 75.11 112.757 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.85 117.99 26.11 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.903 0.881 . . . . 72.04 110.884 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -128.21 140.33 51.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.94 0.896 . . . . 63.24 110.749 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 87.35 0.97 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.139 0.495 . . . . 65.55 110.275 172.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -95.65 -18.92 20.14 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 74.34 111.877 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.7 -39.23 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 122.772 0.429 . . . . 75.45 111.069 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.87 24.01 77.44 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 114.806 0.682 . . . . 72.15 114.806 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.6 p -111.08 118.04 34.92 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.418 0.687 . . . . 63.32 110.75 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 44.1 t -115.52 144.98 43.05 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.82 0.848 . . . . 73.23 110.484 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.49 91.56 1.4 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.476 0.655 . . . . 72.22 111.863 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -119.42 124.34 46.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.856 -1.165 . . . . 74.42 107.856 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -66.74 108.35 2.47 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.292 0.567 . . . . 65.21 111.906 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 57.8 m -102.74 131.28 49.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.673 1.189 . . . . 70.54 110.057 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.38 126.34 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 123.486 0.715 . . . . 75.24 109.807 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.21 166.29 23.44 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.761 0.825 . . . . 74.12 111.065 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -146.64 150.07 34.73 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.31 0.644 . . . . 73.52 110.012 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -140.1 153.85 46.85 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.71 0.804 . . . . 65.42 110.398 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -135.85 119.57 17.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.264 0.626 . . . . 74.31 111.625 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -84.03 175.83 9.26 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.36 0.664 . . . . 62.2 110.796 169.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -130.99 37.88 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.489 0.715 . . . . 64.43 111.707 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.53 96.73 0.54 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.582 0.753 . . . . 74.33 110.826 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.617 0.767 . . . . 72.41 110.723 -179.077 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.716 ' HE2' ' HG3' ' A' ' 96' ' ' GLU . 11.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.555 0.217 . . . . 64.2 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -62.73 156.77 22.77 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.462 0.648 . . . . 72.5 112.494 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 m -67.2 160.6 26.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.775 -1.102 . . . . 73.02 112.973 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.97 -27.67 67.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.956 0.502 . . . . 65.33 111.211 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.57 HG23 HG11 ' A' ' 102' ' ' VAL . 39.4 p -57.15 -51.29 69.9 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.407 0.683 . . . . 73.23 111.055 168.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.23 -36.59 74.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.596 -1.184 . . . . 73.0 111.394 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 mt -70.46 -30.23 67.0 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.52 1.128 . . . . 74.44 113.008 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.41 -31.6 72.8 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.997 -0.547 . . . . 73.35 110.161 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.32 -37.72 86.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.734 0.814 . . . . 74.24 112.465 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.45 -46.99 74.58 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.308 0.504 . . . . 72.12 110.721 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.1 mt -60.18 -42.97 96.14 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 124.132 0.973 . . . . 73.43 112.25 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -80.76 -13.95 58.53 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.692 0.797 . . . . 71.42 112.915 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.85 -62.12 1.8 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.001 0.52 . . . . 55.43 110.761 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -100.14 143.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.817 -0.629 . . . . 72.33 110.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.67 -46.76 89.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.872 0.869 . . . . 62.44 111.84 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.32 111.7 15.49 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.944 0.897 . . . . 71.02 109.706 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 66.5 m -74.72 126.86 31.77 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.423 0.689 . . . . 74.54 111.716 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.71 22.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.567 0.951 . . . . 64.34 113.567 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -108.76 -2.73 18.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.408 0.683 . . . . 74.05 111.764 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 17' ' ' SER . 29.3 mm -111.17 145.24 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.917 -0.771 . . . . 65.11 108.917 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -139.7 152.12 46.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.758 0.423 . . . . 73.31 110.7 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.95 125.02 42.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.746 0.818 . . . . 71.42 109.988 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.443 ' HD2' HG22 ' A' ' 32' ' ' VAL . 37.8 mttp -125.18 153.65 42.75 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.584 0.754 . . . . 73.32 111.263 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.34 155.15 24.91 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.756 -1.111 . . . . 75.21 111.356 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.03 -30.64 62.19 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.096 0.958 . . . . 64.23 113.523 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.0 p -65.89 -35.41 80.56 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.657 0.783 . . . . 75.43 112.816 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.62 13.49 6.96 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.505 0.928 . . . . 65.32 113.505 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.598 ' SD ' HD12 ' A' ' 52' ' ' LEU . 85.6 mmm -57.1 104.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.258 0.466 . . . . 53.42 112.258 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.69 -148.4 12.37 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.009 -0.541 . . . . 74.1 112.557 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -55.83 -31.53 62.79 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.552 1.141 . . . . 75.23 113.934 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -68.74 -42.62 77.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.058 0.543 . . . . 75.02 111.583 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG22 ' HD2' ' A' ' 23' ' ' LYS . 52.3 t -60.96 -53.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.255 0.55 . . . . 75.32 109.9 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.52 ' SD ' ' HG3' ' A' ' 84' ' ' GLN . 81.0 mmm -49.2 -44.12 42.91 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.449 -1.251 . . . . 73.44 113.993 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.53 -31.25 69.36 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.614 0.598 . . . . 70.51 112.614 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.572 ' HB ' HD21 ' A' ' 50' ' ' LEU . 28.2 m -70.4 -37.41 74.47 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.541 0.336 . . . . 73.11 110.573 174.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.51 -44.17 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.375 0.67 . . . . 73.51 110.419 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.91 -40.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.319 1.048 . . . . 73.34 111.257 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.15 90.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 75.33 111.832 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -81.19 -35.7 31.05 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.959 0.504 . . . . 75.3 111.386 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.14 73.21 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.659 0.784 . . . . 74.15 112.497 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -76.99 -24.58 52.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.172 0.589 . . . . 75.22 112.191 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.21 110.6 11.67 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 123.023 0.529 . . . . 72.52 110.047 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.84 118.15 4.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.509 2.806 . . . . 64.12 114.992 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.28 26.73 74.06 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.44 -0.8 . . . . 74.13 114.777 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.78 8.83 37.2 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.978 0.889 . . . . 63.33 110.196 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -51.49 141.48 15.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.815 0.846 . . . . 72.21 112.25 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 122.21 -29.77 5.42 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 111.347 -0.701 . . . . 64.12 111.347 -166.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.53 121.93 9.8 Favored Glycine 0 CA--C 1.548 2.117 0 N-CA-C 114.483 0.553 . . . . 73.34 114.483 175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -114.05 142.39 46.25 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.916 0.886 . . . . 74.1 112.416 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.1 mp -117.33 128.36 54.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.238 1.015 . . . . 75.11 109.022 170.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.86 109.65 21.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.238 0.615 . . . . 74.23 109.864 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.641 HD13 HD23 ' A' ' 108' ' ' LEU . 82.0 mt -97.8 125.67 42.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.561 0.744 . . . . 72.35 110.649 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 35.08 4.13 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.046 -0.524 . . . . 71.44 112.52 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.53 144.02 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.285 0.634 . . . . 74.54 110.34 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 131.76 44.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.132 0.973 . . . . 63.51 108.56 172.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 p90 -111.08 131.36 55.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.738 0.815 . . . . 75.43 111.197 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.36 129.9 56.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.545 1.138 . . . . 71.51 110.172 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.95 123.84 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 74.52 111.721 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.46 170.7 13.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.952 0.901 . . . . 63.5 111.9 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.36 -25.89 68.23 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.036 0.534 . . . . 74.42 111.618 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.85 -1.53 35.42 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.453 0.701 . . . . 75.44 112.107 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.18 32.57 51.95 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 122.656 0.17 . . . . 64.14 113.124 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.75 134.76 40.49 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.481 0.712 . . . . 71.22 111.176 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -92.82 106.32 18.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.579 0.752 . . . . 75.43 110.854 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.51 112.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.846 0.859 . . . . 74.21 109.843 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.18 115.55 27.5 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 74.01 109.536 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -116.48 136.39 23.1 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.121 0.969 . . . . 73.0 111.066 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.75 96.48 1.0 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.873 2.382 . . . . 73.2 112.793 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.72 -20.39 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 116.091 -0.504 . . . . 64.0 111.065 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.57 -169.47 53.53 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.989 0.756 . . . . 73.15 114.989 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 77' ' ' VAL . 62.7 mt -117.95 130.63 24.6 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.97 1.308 . . . . 75.45 109.11 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.04 -27.49 29.85 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.204 1.936 . . . . 72.31 111.94 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -137.97 77.71 36.95 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.341 1.456 . . . . 74.5 108.991 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.48 -35.52 29.99 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.956 2.437 . . . . 74.24 114.268 -167.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.93 -39.89 83.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.232 0.613 . . . . 75.35 110.428 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.45 -49.81 75.33 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.972 -0.558 . . . . 75.51 110.676 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.426 HG21 HD21 ' A' ' 71' ' ' LEU . 81.9 t -55.93 -43.91 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.332 1.053 . . . . 74.04 111.919 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -62.84 -41.82 99.5 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.473 0.709 . . . . 74.43 112.113 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.43 -32.88 64.64 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.296 0.639 . . . . 72.24 112.359 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.22 -38.86 88.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.067 0.547 . . . . 72.31 110.107 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.99 -39.01 87.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.332 0.653 . . . . 70.15 110.877 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.47 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.706 0.802 . . . . 74.31 112.101 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 t -73.95 -53.13 10.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.166 0.586 . . . . 70.44 111.253 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.52 ' HG3' ' SD ' ' A' ' 33' ' ' MET . 9.9 pt20 -67.68 -28.93 68.1 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.711 0.804 . . . . 74.41 112.664 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.7 p -64.02 -26.57 68.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.291 0.478 . . . . 64.31 112.291 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -90.43 -41.79 11.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.572 0.749 . . . . 54.2 112.27 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -77.81 -43.97 28.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.784 1.031 . . . . 74.14 113.784 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 mmt -69.1 -44.07 73.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.766 0.826 . . . . 71.52 112.571 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.87 150.14 20.79 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.418 0.687 . . . . 73.52 111.097 -165.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.597 HD22 ' HA ' ' A' ' 122' ' ' ILE . 8.8 p30 -52.76 -34.47 53.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.307 0.854 . . . . 75.23 113.307 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 119' ' ' HIS . 26.2 m -120.48 170.83 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.719 0.808 . . . . 64.35 110.224 169.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -78.69 102.04 7.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 120.987 0.422 . . . . 64.2 110.129 170.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.74 116.97 27.4 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.183 -1.414 . . . . 73.2 107.183 174.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -103.76 98.32 12.84 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 122.858 0.463 . . . . 74.33 110.476 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.56 165.53 18.22 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.178 1.919 . . . . 74.24 112.294 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 9.5 tp10 -84.69 129.45 34.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.494 0.718 . . . . 75.4 109.418 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.545 ' HB3' HD13 ' A' ' 108' ' ' LEU . 53.4 mtt -132.84 120.62 21.79 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.49 0.716 . . . . 71.21 110.862 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.598 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.4 mm-40 -128.49 137.97 52.05 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.198 0.599 . . . . 73.52 110.446 173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.44 112.66 24.66 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.537 0.735 . . . . 74.23 110.348 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -114.9 127.16 55.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.885 0.874 . . . . 65.25 111.757 -170.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -88.38 118.72 28.2 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.384 0.674 . . . . 74.22 110.689 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.57 HG11 HG23 ' A' ' 5' ' ' THR . 15.0 t -124.68 113.52 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.631 1.172 . . . . 74.25 108.885 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.21 65.64 Favored Glycine 0 CA--C 1.543 1.84 0 N-CA-C 115.495 0.958 . . . . 51.31 115.495 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.63 6.05 70.88 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.348 0.499 . . . . 72.21 114.348 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -114.36 136.55 52.87 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.884 0.873 . . . . 74.05 108.73 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 m -93.37 132.33 37.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.569 0.622 . . . . 74.23 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.77 169.14 11.4 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.382 1.073 . . . . 75.31 109.002 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.641 HD23 HD13 ' A' ' 52' ' ' LEU . 55.1 tp -120.0 116.39 25.66 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.733 0.302 . . . . 75.0 110.446 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.423 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 51.6 t -87.78 130.89 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.297 -0.631 . . . . 71.53 109.297 173.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 24.0 t -116.19 100.92 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 122.959 0.504 . . . . 71.04 110.062 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.721 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 81.8 t80 -83.74 126.61 33.07 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.13 -0.693 . . . . 73.44 109.13 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 38.7 t -99.61 112.66 64.02 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.907 -0.405 . . . . 73.02 109.907 176.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.29 152.08 15.83 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.721 2.28 . . . . 71.13 111.941 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -65.99 111.57 3.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.979 0.912 . . . . 74.41 111.365 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -68.73 156.01 39.06 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.353 0.661 . . . . 75.32 112.364 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.98 141.43 51.03 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 123.717 0.807 . . . . 74.12 109.631 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.45 -40.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 115.664 1.727 . . . . 75.22 115.664 -171.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -72.48 -35.02 68.09 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.973 0.731 . . . . 74.41 112.973 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -139.03 79.17 1.71 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.936 -1.505 . . . . 71.5 106.936 169.081 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 17.5 ptpt -47.98 -155.2 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.733 2 N-CA-C 123.596 4.665 . . . . 73.25 123.596 43.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo 13.98 67.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.214 1.943 . . . . 75.42 116.085 -121.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.617 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.7 mm -77.63 102.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 114.467 -1.242 . . . . 72.44 110.048 175.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.425 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.0 p90 -108.94 147.65 31.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.739 0.815 . . . . 74.14 110.329 169.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -78.75 142.3 37.13 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.345 0.658 . . . . 74.45 110.232 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -28.53 69.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.808 0.337 . . . . 73.25 110.107 168.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.11 101.04 1.08 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.74 0.816 . . . . 62.11 110.161 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 p -85.46 176.76 8.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.926 0.89 . . . . 72.43 112.534 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 155.0 -15.12 0.51 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 115.685 -0.688 . . . . 74.54 112.512 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.5 tp 51.14 67.76 3.97 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 125.403 1.481 . . . . 75.13 111.543 -171.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.97 -143.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.839 3.026 . . . . 75.32 111.246 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.8 123.87 1.2 Allowed Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.248 0.477 . . . . 73.12 113.062 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.81 92.78 0.54 Allowed Glycine 0 N--CA 1.477 1.41 0 CA-C-N 116.92 0.36 . . . . 72.11 113.682 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.5 -36.51 65.77 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.379 0.671 . . . . 74.01 111.644 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -96.84 136.74 36.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.441 0.697 . . . . 73.02 110.582 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -138.05 -179.14 5.6 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.585 0.754 . . . . 73.51 111.636 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -128.29 179.08 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.855 0.862 . . . . 74.5 111.882 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.8 pt -117.36 170.32 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.803 0.841 . . . . 74.52 110.823 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.83 177.39 48.08 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 116.439 -0.346 . . . . 71.13 113.609 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.6 t 69.46 151.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.409 1.483 . . . . 73.2 113.441 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.1 p -161.94 -67.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.254 0.622 . . . . 73.44 111.016 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.2 27.25 2.57 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.749 0.82 . . . . 75.55 112.211 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -70.93 103.0 2.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 74.2 110.753 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.58 172.76 12.54 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 75.52 111.078 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 27.7 p -141.28 174.16 10.8 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.495 0.718 . . . . 50.53 111.004 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 137.85 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.505 0.722 . . . . 74.21 110.576 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.0 tp -118.64 129.22 55.18 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.062 0.945 . . . . 61.41 109.598 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -159.64 121.87 3.4 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.737 0.415 . . . . 63.01 111.858 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -133.72 104.58 6.4 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.143 0.977 . . . . 74.13 109.213 172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.09 114.79 22.5 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.843 0.457 . . . . 74.14 110.494 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -91.48 166.44 12.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.451 0.7 . . . . 73.04 112.268 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.59 111.68 11.95 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.924 0.89 . . . . 64.4 109.672 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -104.89 131.89 51.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.836 0.855 . . . . 74.32 111.054 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.787 0.803 . . . . 73.31 110.288 176.034 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.681 ' SD ' ' HG2' ' A' ' 96' ' ' GLU . 17.2 ptm . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 112.471 0.545 . . . . 75.14 112.471 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -98.41 168.12 10.4 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.891 0.876 . . . . 74.52 111.668 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 t -76.99 155.82 32.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.757 0.823 . . . . 75.34 112.119 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.02 -34.13 77.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.357 0.663 . . . . 75.22 111.797 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.509 HG22 HG11 ' A' ' 102' ' ' VAL . 2.4 m -66.7 -44.06 82.72 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.472 0.653 . . . . 75.11 110.557 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.55 -50.57 73.37 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 125.246 1.418 . . . . 74.44 111.962 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.415 ' HB2' HD21 ' A' ' 51' ' ' LEU . 86.7 mt -62.92 -44.37 96.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.644 0.778 . . . . 75.14 111.871 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.653 ' HA ' HD11 ' A' ' 11' ' ' LEU . 51.9 tp -59.36 -40.36 86.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.224 1.01 . . . . 71.53 111.601 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.41 -41.95 99.07 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.007 -0.997 . . . . 72.35 110.875 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 14' ' ' VAL . 13.2 mm-40 -72.57 -30.3 64.29 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.572 -0.74 . . . . 75.23 112.308 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 8' ' ' LEU . 78.5 mt -57.36 -44.82 84.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.348 0.659 . . . . 75.24 112.244 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -88.49 -5.12 58.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.922 0.489 . . . . 75.25 112.313 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.24 -55.84 3.51 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.226 0.61 . . . . 72.14 111.671 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 10' ' ' GLU . 33.1 m -90.55 118.79 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.185 0.517 . . . . 75.03 111.541 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -43.85 -25.53 0.2 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.493 1.664 . . . . 71.34 115.493 172.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -127.78 122.54 33.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.862 0.465 . . . . 73.43 110.841 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.5 m -74.5 92.08 2.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.532 0.733 . . . . 74.34 110.496 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.92 -63.31 1.16 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.394 0.678 . . . . 73.14 111.769 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -119.82 -1.08 10.56 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 119.247 -0.406 . . . . 74.1 112.049 175.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.5 105.84 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.021 0.828 . . . . 64.25 109.085 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -121.57 130.21 53.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.055 0.542 . . . . 71.31 110.816 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.65 134.93 45.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.05 112.45 -172.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 151.53 46.42 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.045 0.938 . . . . 74.23 111.076 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -84.08 154.05 23.42 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.97 0.908 . . . . 75.41 110.288 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.37 70.08 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 112.99 0.737 . . . . 74.42 112.99 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.1 p -81.22 13.41 2.88 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.786 1.032 . . . . 74.51 113.786 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.05 4.52 19.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.054 0.542 . . . . 63.21 112.118 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mtp -53.69 104.56 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.533 0.568 . . . . 73.55 112.533 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.74 -142.83 7.95 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.395 -0.366 . . . . 60.54 113.188 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -70.9 -21.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.238 1.015 . . . . 74.24 113.039 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 m -75.12 -43.39 53.01 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.95 0.5 . . . . 74.51 110.941 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -37.92 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.239 0.615 . . . . 74.42 110.607 168.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.527 ' HA ' HG23 ' A' ' 36' ' ' VAL . 20.7 mmt -71.19 -31.86 68.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.773 -0.649 . . . . 73.32 112.592 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.29 -32.75 74.47 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.398 0.618 . . . . 65.44 110.054 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -78.05 -46.38 21.03 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.699 0.8 . . . . 73.42 112.171 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 33' ' ' MET . 19.8 m -59.58 -39.01 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 118.11 0.414 . . . . 71.44 112.116 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.15 -35.75 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.287 0.635 . . . . 74.52 110.996 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.1 -38.41 91.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.849 0.46 . . . . 70.23 112.102 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -73.87 -47.68 36.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.172 0.589 . . . . 70.43 111.481 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.77 -21.85 60.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.585 0.957 . . . . 73.05 113.585 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -93.37 -42.75 9.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.21 0.604 . . . . 75.11 111.442 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.44 111.58 4.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.666 0.786 . . . . 74.21 112.019 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.08 105.3 0.67 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.791 2.327 . . . . 72.34 112.831 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.19 19.63 11.38 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.674 -0.694 . . . . 73.52 114.749 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.9 tp -106.84 5.49 28.52 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.764 1.282 . . . . 75.53 112.205 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -40.91 124.47 2.15 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 125.11 1.364 . . . . 73.02 113.711 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 105.57 51.52 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.896 -0.593 . . . . 71.11 112.627 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -112.55 149.27 18.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 111.673 -0.571 . . . . 62.41 111.673 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -123.47 126.84 47.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.648 0.779 . . . . 71.01 111.354 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -104.73 116.68 32.45 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.471 -1.307 . . . . 73.25 107.471 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.415 HD21 ' HB2' ' A' ' 7' ' ' LEU . 31.2 tp -103.4 112.35 25.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.724 0.409 . . . . 74.44 111.021 -173.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.638 HD13 HD22 ' A' ' 108' ' ' LEU . 93.1 mt -92.88 140.16 29.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.601 0.76 . . . . 75.21 111.65 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.21 7.04 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.926 -0.579 . . . . 60.3 112.739 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.08 144.37 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.507 0.723 . . . . 55.14 110.672 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -124.6 163.85 21.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 75.41 108.002 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -154.77 138.69 16.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.423 0.527 . . . . 71.15 112.423 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 151.97 47.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.799 0.84 . . . . 74.22 111.279 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -91.62 131.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.592 0.757 . . . . 73.25 111.467 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -84.89 -172.09 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.912 0.485 . . . . 72.44 111.659 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.06 -37.71 80.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.268 0.627 . . . . 71.44 112.562 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -77.33 -29.35 53.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 72.01 112.264 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.12 9.55 15.46 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.626 0.61 . . . . 63.5 114.626 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.05 138.7 37.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.283 0.633 . . . . 71.34 111.378 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -83.87 111.2 19.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.306 0.642 . . . . 62.55 109.584 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.45 115.32 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.786 . . . . 72.14 109.863 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -93.3 115.27 27.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.205 0.602 . . . . 74.43 111.095 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -110.67 153.34 43.66 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.131 0.972 . . . . 74.44 111.405 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.42 116.55 2.99 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.305 2.004 . . . . 74.02 113.032 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.01 -30.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 122.824 0.449 . . . . 72.24 110.745 168.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.58 -175.91 53.97 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.729 -0.668 . . . . 73.23 112.613 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.69 138.7 23.38 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 122.358 -0.496 . . . . 75.4 110.37 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.38 -33.9 28.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.698 2.265 . . . . 74.33 112.618 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -127.37 66.49 69.07 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.015 0.926 . . . . 61.14 109.648 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.544 ' HB2' HD22 ' A' ' 99' ' ' LEU . 60.5 Cg_endo -65.34 -36.04 37.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.863 2.375 . . . . 72.25 113.725 -164.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.19 -40.59 82.17 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.645 0.778 . . . . 65.33 110.41 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -70.34 -35.69 73.75 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.2 -0.909 . . . . 64.32 111.551 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.35 -43.07 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.655 0.782 . . . . 72.25 110.815 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.505 ' HG2' HH21 ' A' ' 79' ' ' ARG . 53.2 tt0 -56.59 -45.04 81.59 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.578 0.751 . . . . 72.13 111.85 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.505 HH21 ' HG2' ' A' ' 78' ' ' GLN . 4.0 mmp_? -75.45 -36.95 60.61 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.668 -0.697 . . . . 63.34 112.626 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.33 -35.15 75.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.243 0.617 . . . . 73.54 110.42 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 26.8 tp -70.68 -39.62 73.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.613 0.765 . . . . 75.01 110.739 176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.12 77.3 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.152 0.581 . . . . 74.33 111.817 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -72.14 -53.2 13.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.289 0.635 . . . . 73.35 111.436 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.417 ' HG2' ' HA ' ' A' ' 81' ' ' LEU . 11.9 pt20 -71.05 -32.46 69.17 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.056 0.762 . . . . 71.3 113.056 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 p -64.85 -31.3 72.46 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 118.877 0.762 . . . . 75.23 112.228 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -81.45 -27.1 34.81 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 116.033 -0.531 . . . . 74.11 112.381 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -92.14 -33.89 14.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.694 0.628 . . . . 74.21 112.694 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -79.86 -48.04 14.14 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.09 0.556 . . . . 75.01 111.294 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -81.63 157.61 24.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.849 -0.614 . . . . 74.34 111.294 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -45.96 -35.39 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.358 1.463 . . . . 70.31 114.16 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.62 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.458 0.703 . . . . 75.32 111.093 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -71.72 97.53 1.78 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.725 -0.67 . . . . 62.41 110.216 170.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.89 123.89 28.17 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.944 -1.132 . . . . 75.33 107.944 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -104.01 96.02 8.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.398 0.679 . . . . 75.0 110.694 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.524 ' HG2' ' HE1' ' A' ' 97' ' ' MET . 68.9 Cg_endo -87.91 166.63 7.14 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.09 1.86 . . . . 74.43 111.977 172.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.681 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 40.9 tt0 -101.23 115.71 31.13 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.924 -0.769 . . . . 71.12 108.924 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.524 ' HE1' ' HG2' ' A' ' 95' ' ' PRO . 61.5 mtt -115.07 131.14 57.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.326 0.65 . . . . 75.43 112.006 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -142.02 146.71 35.84 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.813 0.845 . . . . 75.03 110.964 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 74' ' ' PRO . 42.6 mt -102.37 119.35 38.66 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.984 0.913 . . . . 65.53 110.329 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -124.87 130.32 52.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.695 1.198 . . . . 72.01 109.584 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -94.49 121.76 36.37 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.955 0.407 . . . . 74.11 111.643 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.509 HG11 HG22 ' A' ' 5' ' ' THR . 12.4 t -126.4 127.08 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.285 1.034 . . . . 64.24 109.46 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.89 30.87 57.75 Favored Glycine 0 CA--C 1.548 2.124 0 N-CA-C 115.265 0.866 . . . . 71.21 115.265 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.98 81.78 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.905 0.352 . . . . 74.22 113.938 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -116.38 146.18 42.67 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.088 0.955 . . . . 75.42 109.803 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -95.34 104.58 16.47 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.969 0.804 . . . . 74.25 111.105 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.0 162.01 14.56 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.829 0.851 . . . . 72.35 111.497 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 52' ' ' LEU . 61.9 tp -120.28 118.36 30.22 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.738 0.815 . . . . 73.33 110.366 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.56 119.91 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.273 -0.64 . . . . 73.02 109.273 171.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.33 101.1 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.126 -0.694 . . . . 53.43 109.126 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.582 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.2 t80 -76.83 113.81 14.91 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.36 -0.607 . . . . 74.25 109.36 174.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.11 99.29 42.63 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 108.903 -0.777 . . . . 63.21 108.903 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.38 -176.44 1.55 Allowed 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.733 2.288 . . . . 72.34 113.093 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.432 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 44.4 mt-10 -84.92 148.33 26.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.825 -0.625 . . . . 72.33 109.748 165.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.11 178.81 4.45 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.668 0.787 . . . . 62.15 110.481 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.61 124.35 24.51 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 118.282 -0.866 . . . . 75.15 110.368 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -38.06 -37.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 116.54 2.052 . . . . 75.43 116.54 -157.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -57.01 -40.53 76.8 Favored 'General case' 0 N--CA 1.509 2.483 0 CA-C-N 118.963 0.802 . . . . 74.05 112.003 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.64 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 14.5 m-70 -133.58 77.92 1.75 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 103.986 -2.598 . . . . 70.35 103.986 165.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.5 mtmt -46.86 -149.78 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 2 C-N-CA 133.016 4.526 . . . . 75.14 122.456 46.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo 12.06 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.808 2.339 . . . . 61.44 115.112 -120.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 120' ' ' LYS . 51.1 mm -86.31 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 115.158 -0.928 . . . . 72.11 110.56 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -156.37 165.38 36.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.807 0.843 . . . . 75.34 110.386 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' HZ2' HD12 ' A' ' 129' ' ' LEU . 14.2 ptpt -79.41 139.82 37.59 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.458 0.303 . . . . 72.22 110.59 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 10.2 mtmp? -79.96 -10.17 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.76 0.424 . . . . 75.43 111.297 172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.28 85.0 1.42 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.606 0.762 . . . . 75.34 111.114 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.8 m -78.08 121.02 23.73 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.636 0.774 . . . . 74.32 110.076 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.09 72.12 0.3 Allowed Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.742 -0.543 . . . . 62.21 111.742 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.464 HD12 ' HZ2' ' A' ' 124' ' ' LYS . 0.9 OUTLIER -127.76 92.46 42.55 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.586 0.755 . . . . 74.14 111.056 -177.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.21 102.28 1.52 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 122.497 2.131 . . . . 73.01 112.464 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.36 109.77 3.01 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 116.229 -0.441 . . . . 74.12 112.958 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.48 -130.68 0.39 Allowed Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.203 0.441 . . . . 64.03 114.203 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.83 95.03 2.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.062 0.545 . . . . 73.02 111.785 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -75.89 -54.47 6.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.947 -0.569 . . . . 74.54 110.07 171.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -75.07 108.82 8.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.803 0.841 . . . . 70.33 110.501 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.83 124.56 26.33 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.858 0.361 . . . . 73.24 110.194 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.0 tt -90.08 -41.45 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.981 0.513 . . . . 73.05 111.658 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.21 158.93 34.87 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.418 -0.355 . . . . 73.23 113.401 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.9 m -131.04 -166.65 1.73 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.224 1.01 . . . . 65.35 109.503 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -68.58 93.06 0.48 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.762 0.315 . . . . 63.42 110.258 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.65 123.76 19.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.61 0.764 . . . . 74.33 110.745 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -65.24 111.86 3.18 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.312 0.645 . . . . 75.21 111.877 -169.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -66.47 103.94 1.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.298 -0.864 . . . . 74.33 108.988 168.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 29.1 p -61.92 153.14 30.06 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.702 0.801 . . . . 65.34 111.635 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.4 m -61.57 142.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.264 0.625 . . . . 63.53 111.493 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -73.81 164.07 27.12 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.979 0.512 . . . . 74.13 111.197 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.94 120.18 14.43 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 122.496 0.319 . . . . 72.12 110.626 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -84.91 91.29 8.0 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.589 0.356 . . . . 70.44 110.933 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.5 p80 36.64 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 126.02 1.728 . . . . 74.43 115.271 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -70.15 148.07 49.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.093 0.557 . . . . 73.23 112.273 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.2 t60 69.25 133.9 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.38 1.472 . . . . 73.1 113.413 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -138.94 176.36 8.76 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.221 1.009 . . . . 74.54 110.835 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.239 0.542 . . . . 73.44 110.302 169.74 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.652 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 46.5 ttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.499 0.19 . . . . 74.2 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HB2' HD13 ' A' ' 7' ' ' LEU . 19.4 mmt180 -79.07 162.87 25.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.89 0.876 . . . . 75.2 110.783 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.8 t -80.73 155.09 26.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.183 0.593 . . . . 64.21 110.203 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.39 67.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.86 0.464 . . . . 63.32 112.103 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -70.0 -44.27 69.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.128 0.571 . . . . 74.1 110.602 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.8 -48.99 79.47 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.041 0.936 . . . . 61.52 111.398 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 20' ' ' ILE . 80.8 mt -74.43 -31.67 62.37 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.039 -0.982 . . . . 70.31 112.867 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.34 -46.83 81.76 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.937 0.495 . . . . 75.05 110.264 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.26 -33.34 73.38 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.195 -0.911 . . . . 73.35 110.789 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.1 tp10 -70.49 -41.92 72.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.594 0.758 . . . . 75.12 110.933 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.2 mt -59.13 -43.16 91.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.983 0.913 . . . . 74.32 111.918 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -68.56 -32.37 72.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.193 0.597 . . . . 75.03 111.274 176.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.79 68.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.718 0.807 . . . . 73.11 112.072 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.79 148.39 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.377 0.608 . . . . 72.33 111.389 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.72 -14.89 55.94 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 75.44 111.635 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.07 153.46 25.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.648 0.779 . . . . 63.54 110.582 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.5 m -73.99 92.13 2.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.742 0.417 . . . . 75.11 111.101 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.48 -65.43 1.01 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.382 0.673 . . . . 62.31 112.264 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -119.11 -15.59 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.356 1.062 . . . . 75.43 110.001 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.551 HD11 HD23 ' A' ' 7' ' ' LEU . 31.5 mm -111.53 119.14 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.603 1.161 . . . . 65.02 108.023 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.45 141.1 48.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.486 0.714 . . . . 71.43 110.792 -171.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.57 127.26 52.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.667 0.787 . . . . 51.15 110.151 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 25.2 mmmt -132.24 136.5 47.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.977 0.911 . . . . 64.41 109.407 -176.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -81.99 168.01 18.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.255 0.55 . . . . 73.43 111.76 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.55 69.38 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.713 0.805 . . . . 72.21 112.507 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -65.72 -37.27 85.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 64.4 111.004 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -76.99 -6.82 54.14 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.379 1.072 . . . . 75.53 113.411 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -69.58 120.29 15.13 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.286 0.565 . . . . 70.11 110.287 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.11 -129.16 5.0 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.853 -0.612 . . . . 65.0 112.436 -172.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -59.33 -39.11 82.08 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.669 0.787 . . . . 73.41 112.097 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 m -65.45 -29.2 69.85 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.086 0.955 . . . . 73.31 112.61 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.514 HG11 HD11 ' A' ' 81' ' ' LEU . 54.3 t -71.12 -51.08 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.726 0.41 . . . . 74.42 110.275 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.468 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -33.74 69.54 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.007 0.923 . . . . 72.01 112.924 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.35 -44.98 72.63 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.128 0.971 . . . . 73.23 111.159 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.3 m -76.89 -39.2 51.81 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.89 . . . . 73.24 112.461 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.25 -34.74 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 124.237 1.015 . . . . 74.25 112.444 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.599 HG12 ' HZ1' ' A' ' 124' ' ' LYS . 58.5 mt -45.14 -45.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 124.087 0.955 . . . . 73.33 112.931 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.44 -60.07 4.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.106 0.562 . . . . 75.01 112.303 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.44 -24.43 62.9 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.622 0.601 . . . . 74.34 112.622 -169.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.82 -48.33 9.47 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.506 0.722 . . . . 70.11 112.353 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -93.3 -27.11 17.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.876 1.065 . . . . 75.22 113.876 -169.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.33 121.76 74.16 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 118.283 0.492 . . . . 74.21 111.731 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.15 110.48 1.36 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.598 2.199 . . . . 75.41 112.549 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.73 59.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.058 -0.857 . . . . 74.32 115.207 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.91 20.82 13.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.104 1.452 . . . . 72.45 110.831 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -41.45 114.2 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.218 1.007 . . . . 74.33 112.332 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.15 68.33 0.64 Allowed Glycine 0 N--CA 1.471 0.994 0 N-CA-C 113.738 0.255 . . . . 73.21 113.738 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.63 142.0 17.29 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.925 -0.87 . . . . 74.14 110.925 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.652 ' HE1' ' HG3' ' A' ' 1' ' ' MET . 94.6 m-85 -118.12 129.76 55.72 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.511 0.655 . . . . 75.55 112.11 -170.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 32' ' ' VAL . 5.6 mp -112.07 124.96 53.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.955 0.902 . . . . 74.21 109.329 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 7' ' ' LEU . 3.2 mm? -104.61 109.11 20.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.065 0.546 . . . . 71.53 109.707 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 8.4 mp -92.95 122.32 35.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.409 0.684 . . . . 73.45 109.196 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.14 26.34 3.81 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.571 -0.286 . . . . 63.44 113.374 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.21 133.96 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.409 -0.589 . . . . 72.31 109.409 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -119.12 137.07 53.84 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.457 -0.942 . . . . 72.21 108.457 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -122.88 139.63 53.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.046 0.539 . . . . 73.11 111.58 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.92 151.95 35.55 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.925 0.89 . . . . 75.22 111.177 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.04 122.67 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.356 0.662 . . . . 75.14 110.413 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -96.79 -168.43 1.71 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.629 0.772 . . . . 63.52 112.088 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.89 -32.37 67.65 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.57 1.148 . . . . 73.42 112.925 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -79.54 -11.77 59.88 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.48 0.712 . . . . 74.45 111.561 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.92 84.92 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 116.487 -0.324 . . . . 62.41 112.792 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.43 149.21 30.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.507 1.123 . . . . 65.24 111.914 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -104.62 115.52 30.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.253 1.021 . . . . 75.23 110.404 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.92 128.91 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.42 0.688 . . . . 74.31 109.603 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.77 119.1 32.3 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.177 0.591 . . . . 74.24 110.233 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -129.91 129.17 22.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 123.325 0.65 . . . . 74.45 110.601 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 67.5 Cg_endo -78.68 109.84 2.69 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 73.43 112.421 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.21 -14.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.678 -0.639 . . . . 74.35 111.356 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.82 53.6 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.011 -0.541 . . . . 74.24 113.929 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.34 131.07 23.55 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.055 0.942 . . . . 74.24 110.809 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -32.03 87.9 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.054 2.503 . . . . 75.45 113.009 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -138.74 87.14 15.0 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 108.221 -1.029 . . . . 75.44 108.221 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.1 -28.42 34.68 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.661 2.241 . . . . 71.43 113.505 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -47.63 66.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.082 0.953 . . . . 72.15 111.268 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.61 ' HZ2' ' HB2' ' A' ' 76' ' ' LYS . 4.9 ttmp? -69.65 -44.43 70.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.631 -0.713 . . . . 74.35 111.443 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -58.9 -37.25 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 122.908 0.483 . . . . 75.35 111.47 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.05 -52.38 49.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.842 0.682 . . . . 75.13 112.842 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -75.77 -33.86 60.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 112.434 0.531 . . . . 74.01 112.434 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.56 -33.29 73.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.413 0.685 . . . . 73.25 110.343 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD11 HG11 ' A' ' 32' ' ' VAL . 41.2 tp -63.46 -42.93 98.61 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.53 0.732 . . . . 74.54 111.415 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.25 95.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.286 0.634 . . . . 73.32 111.728 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -63.52 -52.32 61.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.983 0.913 . . . . 65.53 112.036 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.74 -32.52 74.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.101 0.56 . . . . 71.52 112.244 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.178 0.513 . . . . 73.53 112.223 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.51 -20.7 36.21 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.464 0.706 . . . . 65.13 112.016 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -112.31 -2.78 14.72 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.792 1.034 . . . . 72.23 113.792 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.7 mmm -99.6 -26.91 13.93 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.44 0.696 . . . . 72.12 111.327 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -108.32 142.79 38.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.561 0.745 . . . . 74.03 109.212 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' ND2' HG12 ' A' ' 91' ' ' VAL . 7.6 p-10 -57.66 -26.19 61.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.325 0.861 . . . . 72.24 113.325 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG12 ' ND2' ' A' ' 90' ' ' ASN . 6.6 m -122.22 163.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.479 1.112 . . . . 74.0 111.499 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.28 98.25 7.33 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.273 0.559 . . . . 74.45 110.935 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD13 HG12 ' A' ' 122' ' ' ILE . 4.7 tt -96.24 138.57 33.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.143 0.977 . . . . 73.03 108.686 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -106.77 95.34 12.06 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.004 0.521 . . . . 74.01 111.766 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.75 155.46 15.61 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.783 1.655 . . . . 74.42 111.198 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.714 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 41.7 tt0 -108.12 120.53 42.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.529 0.732 . . . . 75.34 110.906 -171.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.71 ' HB3' HD12 ' A' ' 108' ' ' LEU . 1.8 mpt? -111.7 141.74 44.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.73 0.812 . . . . 61.14 111.413 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 133.53 15.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.681 -0.489 . . . . 75.3 109.681 167.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.0 mt -81.46 116.21 21.15 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.571 0.748 . . . . 74.42 110.74 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -123.25 130.77 53.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.799 1.24 . . . . 64.14 110.221 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -94.61 125.45 39.27 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.168 0.587 . . . . 73.44 111.281 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.45 119.15 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.913 0.885 . . . . 75.52 109.225 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.43 41.53 63.51 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.453 0.941 . . . . 74.2 115.453 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.98 88.66 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.883 0.713 . . . . 70.31 114.883 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.7 mmtt -110.0 139.85 44.66 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.791 0.837 . . . . 74.34 109.292 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.9 m -100.3 124.57 45.94 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.777 0.717 . . . . 74.4 111.024 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.49 164.9 14.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.127 0.971 . . . . 74.4 108.981 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.71 HD12 ' HB3' ' A' ' 97' ' ' MET . 43.5 tp -115.64 116.52 28.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.58 0.352 . . . . 65.2 110.11 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.38 121.88 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 109.21 -0.663 . . . . 71.11 109.21 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.88 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.002 0.521 . . . . 72.0 110.623 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.714 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 63.4 t80 -80.49 114.77 19.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.12 109.715 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.23 102.13 34.88 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.516 -0.92 . . . . 74.22 108.516 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.42 169.8 15.25 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.396 2.064 . . . . 74.2 112.481 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -80.79 128.09 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.547 -0.751 . . . . 74.52 109.286 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.93 173.91 9.05 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.185 0.594 . . . . 72.11 111.669 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.59 155.97 37.89 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.679 0.792 . . . . 75.45 110.677 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.8 t -47.41 -42.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 114.85 1.426 . . . . 73.31 114.85 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 123.515 0.726 . . . . 70.12 112.471 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.626 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -129.37 78.21 1.84 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 103.605 -2.739 . . . . 62.33 103.605 169.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.626 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 32.2 mmtp -44.16 -159.01 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.781 1 C-N-CA 132.04 4.136 . . . . 72.24 120.861 66.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo 5.03 71.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.265 2.644 . . . . 73.15 118.059 -132.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.461 HG12 HD13 ' A' ' 93' ' ' LEU . 1.8 mp -76.6 101.28 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.13 -1.063 . . . . 75.44 108.13 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -105.67 154.68 20.11 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.338 0.655 . . . . 73.24 109.813 168.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HZ1' HG12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -78.81 151.56 31.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.809 0.443 . . . . 75.21 110.603 -176.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.9 -10.32 58.07 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.664 0.786 . . . . 74.12 110.97 172.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.83 168.15 9.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.62 1.168 . . . . 72.43 111.107 173.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -150.22 139.59 21.38 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.624 0.77 . . . . 75.21 110.268 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.82 76.46 1.08 Allowed Glycine 0 C--N 1.349 1.295 0 O-C-N 123.014 0.196 . . . . 73.3 112.651 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.15 91.41 36.56 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.639 0.775 . . . . 74.14 110.739 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -94.85 13.8 1.35 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.184 2.589 . . . . 74.24 113.774 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.95 -172.31 54.22 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 116.94 -0.118 . . . . 74.01 112.96 -171.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.38 54.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.227 0 O-C-N 122.766 -0.256 . . . . 62.31 112.73 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.09 158.76 43.88 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.604 0.762 . . . . 60.41 111.981 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.55 143.97 29.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.956 0.902 . . . . 73.12 110.192 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -80.25 115.02 19.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.328 0.651 . . . . 74.11 111.764 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -77.75 99.91 6.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.08 0.552 . . . . 75.24 110.084 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 35.6 mt -91.1 124.4 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.945 0.898 . . . . 73.13 109.654 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.12 158.12 29.93 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 113.939 0.335 . . . . 72.53 113.939 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -153.07 158.79 42.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.457 0.703 . . . . 73.01 111.715 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.4 p -163.57 -155.09 0.3 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.493 1.117 . . . . 75.15 109.718 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t70 76.22 -8.1 1.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.079 1.14 . . . . 73.31 114.079 163.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -79.73 76.05 6.39 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.741 0.781 . . . . 72.24 112.866 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -164.36 96.71 0.78 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.312 -0.995 . . . . 75.14 108.312 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 47.9 t -104.38 156.42 17.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.16 0.584 . . . . 73.15 111.908 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.33 171.91 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.931 0.892 . . . . 70.23 110.389 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.52 154.09 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.008 0.523 . . . . 73.42 111.393 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -136.12 135.62 39.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.783 0.833 . . . . 71.32 110.05 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -142.82 166.29 25.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.703 0.801 . . . . 75.33 110.942 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -144.64 131.06 19.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.292 0.637 . . . . 73.31 109.697 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -99.03 128.62 45.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.301 0.641 . . . . 75.44 110.258 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -75.6 145.47 41.13 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.834 0.35 . . . . 74.05 110.821 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -136.89 107.27 6.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.521 0.729 . . . . 72.32 110.54 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 p80 . . . . . 0 N--CA 1.487 1.417 0 C-N-CA 123.07 0.548 . . . . 72.15 111.705 178.042 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.99 -0.374 . . . . 74.31 109.99 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -40.08 134.67 1.5 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.85 1.26 . . . . 75.15 114.328 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -69.38 159.86 32.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.048 0.939 . . . . 73.32 112.007 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.08 70.37 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.26 0.624 . . . . 75.53 112.596 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -65.87 -43.79 87.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.13 110.641 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.61 -43.29 76.71 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 115.199 -0.91 . . . . 73.21 111.566 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.432 HD23 HD11 ' A' ' 20' ' ' ILE . 86.1 mt -65.94 -42.14 90.42 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.533 0.733 . . . . 72.45 111.406 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' HA ' HD11 ' A' ' 11' ' ' LEU . 25.9 tp -52.04 -48.68 64.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.628 1.171 . . . . 74.51 111.075 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.9 -46.22 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.814 -1.084 . . . . 74.32 111.878 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.34 -30.18 61.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.412 -0.358 . . . . 74.2 111.726 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.525 HD11 ' HA ' ' A' ' 8' ' ' LEU . 79.7 mt -57.82 -52.88 63.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.518 0.727 . . . . 73.1 111.596 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.57 -1.1 49.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.563 0.579 . . . . 70.34 112.563 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.6 -50.06 8.01 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.051 0.54 . . . . 72.34 110.611 170.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 m -80.24 150.51 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.101 0.56 . . . . 71.32 111.191 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -72.76 -27.76 62.21 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.482 0.713 . . . . 75.14 112.478 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.57 134.1 24.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.814 0.845 . . . . 73.25 109.389 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.637 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 50.9 p -72.91 80.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.483 0.713 . . . . 75.54 111.234 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.71 -64.28 1.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.611 0.765 . . . . 71.43 112.272 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.6 -26.97 14.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.008 0.523 . . . . 74.5 110.739 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.432 HD11 HD23 ' A' ' 7' ' ' LEU . 36.4 mt -116.18 109.0 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.502 -0.925 . . . . 74.22 108.502 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 8.9 tp10 -100.73 151.57 21.51 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.076 1.351 . . . . 74.32 111.307 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.44 134.25 53.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.562 0.745 . . . . 72.11 110.987 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HG2' HG21 ' A' ' 32' ' ' VAL . 13.8 mptt -130.87 149.8 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.753 0.821 . . . . 75.41 110.338 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.46 169.24 13.03 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.801 0.841 . . . . 74.54 111.653 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.61 88.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.951 0.501 . . . . 73.2 111.03 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -60.28 -35.66 76.05 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.336 1.054 . . . . 64.3 112.166 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.74 3.64 50.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.903 0.881 . . . . 62.04 112.416 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.492 ' HE2' HD13 ' A' ' 81' ' ' LEU . 83.8 mmm -65.93 128.29 35.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.324 0.649 . . . . 73.41 111.73 170.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.4 -146.84 15.84 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.098 -0.501 . . . . 73.13 112.573 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.4 -18.34 65.3 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.292 0.637 . . . . 74.43 112.568 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -73.72 -37.08 65.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.207 0.603 . . . . 61.35 111.44 176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG21 ' HG2' ' A' ' 23' ' ' LYS . 58.7 t -65.72 -47.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.12 0.486 . . . . 72.35 109.792 172.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.516 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 86.4 mmm -62.71 -35.19 78.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.962 -1.017 . . . . 63.24 112.662 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -40.08 91.5 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.817 0.847 . . . . 75.34 111.012 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -71.01 -35.6 72.1 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.708 -0.678 . . . . 75.22 111.11 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.09 -46.23 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.635 0.774 . . . . 74.11 110.785 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.4 -36.81 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.908 0.883 . . . . 74.3 110.931 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.35 62.65 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.919 0.888 . . . . 63.35 113.045 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -91.47 -42.25 10.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 122.103 -0.373 . . . . 63.01 111.011 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.81 -55.29 10.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.831 1.049 . . . . 73.12 113.831 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.27 -16.32 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.441 0.696 . . . . 73.25 112.668 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 54.1 mm-40 -79.78 132.59 60.61 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.152 0.581 . . . . 74.4 112.124 -177.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 21.4 Cg_exo -65.34 101.84 0.44 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.176 2.584 . . . . 72.45 113.218 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.75 74.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.075 1.19 . . . . 73.43 116.075 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.38 22.11 8.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.532 1.166 . . . . 74.32 110.905 173.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.466 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 16.9 t70 -50.41 153.77 1.46 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.208 1.403 . . . . 73.51 112.686 165.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 92.59 36.58 6.1 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.715 -0.675 . . . . 75.44 112.936 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.3 141.11 15.29 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 117.503 0.651 . . . . 73.42 112.661 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -118.49 127.32 53.52 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.269 0.627 . . . . 74.35 112.02 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.675 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 64.6 mt -100.73 109.5 21.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.013 1.325 . . . . 74.32 109.529 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 HD11 HG22 ' A' ' 109' ' ' VAL . 21.1 tp -101.67 109.95 21.84 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.406 0.622 . . . . 72.25 109.762 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.67 HD13 HD22 ' A' ' 108' ' ' LEU . 47.2 mt -99.35 136.32 39.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 72.43 110.416 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.23 5.93 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-O 121.224 0.347 . . . . 71.24 112.723 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.5 t -111.54 138.17 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.486 0.715 . . . . 73.22 109.636 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 18.0 t70 -103.64 148.42 26.04 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.146 -1.057 . . . . 75.22 108.146 174.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -145.29 143.01 29.96 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.152 0.501 . . . . 75.52 111.608 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.68 152.73 37.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.746 0.818 . . . . 74.44 110.428 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.08 126.87 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.927 0.491 . . . . 75.04 110.555 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -87.77 -179.29 6.24 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.359 0.663 . . . . 75.32 111.514 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -61.17 -19.17 61.25 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.962 1.097 . . . . 74.45 113.962 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -80.95 -14.87 57.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.228 0.611 . . . . 72.42 112.498 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.05 41.54 17.91 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.737 -0.545 . . . . 75.24 111.737 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.39 139.03 51.81 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.774 1.23 . . . . 71.05 110.32 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -84.87 119.89 25.85 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.201 0.601 . . . . 71.13 110.592 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.89 124.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.144 0.578 . . . . 73.33 110.056 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.05 122.05 41.78 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.459 0.703 . . . . 75.51 110.597 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 9.0 ptm180 -127.06 139.1 34.15 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.605 1.162 . . . . 74.11 110.76 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HD3' HD21 ' A' ' 8' ' ' LEU . 77.2 Cg_endo -86.3 98.47 0.55 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.714 2.276 . . . . 72.44 112.837 -176.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.5 -17.93 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 71.34 111.687 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.41 46.52 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 116.302 -0.408 . . . . 63.41 113.561 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.14 136.74 21.89 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-O 118.868 -0.587 . . . . 72.44 110.064 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.62 -36.29 92.82 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.609 2.206 . . . . 73.41 112.473 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -130.35 87.52 50.38 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.416 0.687 . . . . 70.42 109.342 168.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.69 -26.71 9.59 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.84 2.36 . . . . 75.24 114.047 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 6.3 m-20 -72.22 -47.21 52.17 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.444 0.698 . . . . 74.14 111.163 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -61.56 -36.49 80.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.262 0.351 . . . . 63.03 110.762 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.445 HG11 ' HE1' ' A' ' 28' ' ' MET . 47.3 t -60.99 -43.69 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.013 0.925 . . . . 64.31 111.221 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.99 -45.98 90.97 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.624 0.769 . . . . 71.33 111.962 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 28.8 mmm180 -70.67 -45.33 65.25 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.716 -0.675 . . . . 75.21 111.875 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.36 -28.07 64.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.759 0.824 . . . . 74.52 111.884 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.492 HD13 ' HE2' ' A' ' 28' ' ' MET . 31.9 tp -69.76 -40.01 76.38 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.588 0.355 . . . . 74.4 110.748 174.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.53 91.03 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.057 0.543 . . . . 63.31 111.252 173.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -64.93 -52.64 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.873 0.869 . . . . 73.53 111.712 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -64.78 -31.69 73.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.878 0.471 . . . . 73.42 111.901 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.7 t -69.73 -25.42 63.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 64.42 112.048 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.05 -33.58 20.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.428 0.691 . . . . 70.43 112.267 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 p -92.21 -37.28 12.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.667 0.988 . . . . 75.24 113.667 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.516 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 82.4 mtp -76.28 -47.48 23.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.031 0.532 . . . . 72.33 112.059 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.75 148.3 36.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.304 0.642 . . . . 75.13 112.11 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -53.78 -32.27 51.83 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.825 1.25 . . . . 73.53 112.864 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.7 m -129.41 172.37 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.281 1.032 . . . . 73.33 111.338 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.82 104.4 13.88 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.912 -0.586 . . . . 54.23 110.986 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 tt -93.02 133.23 36.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.791 -1.189 . . . . 75.54 107.791 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -109.61 95.3 19.08 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 122.808 0.443 . . . . 74.14 111.633 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.73 158.93 10.54 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.563 2.175 . . . . 73.23 112.405 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 tp10 -100.77 131.8 46.49 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.535 0.734 . . . . 74.21 109.483 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.574 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.9 mtt -125.71 116.66 22.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.08 0.552 . . . . 75.52 111.324 -172.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -114.99 133.28 56.17 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 75.42 111.05 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.68 109.73 21.15 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.122 0.569 . . . . 71.4 109.538 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -109.43 128.1 54.89 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.724 1.209 . . . . 61.42 112.309 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -97.97 109.33 22.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.341 0.591 . . . . 64.12 110.718 174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -121.17 112.73 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.624 1.17 . . . . 64.34 108.63 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.36 29.68 66.59 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 113.886 0.314 . . . . 74.3 113.886 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.03 0.44 90.3 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.197 0.439 . . . . 74.05 114.197 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -100.81 137.2 39.52 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.511 0.724 . . . . 74.24 109.301 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -98.56 121.38 40.43 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 119.047 0.84 . . . . 73.4 111.997 -174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.78 166.98 11.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.124 1.37 . . . . 74.2 108.864 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.67 HD22 HD13 ' A' ' 52' ' ' LEU . 26.4 tp -123.72 109.84 14.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.086 -0.384 . . . . 73.04 110.513 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 51' ' ' LEU . 59.0 t -84.3 123.24 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.938 -0.764 . . . . 65.55 108.938 171.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 40.9 t -118.41 99.84 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.394 0.678 . . . . 72.03 109.607 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.422 ' HE1' ' HA2' ' A' ' 47' ' ' GLY . 87.5 t80 -79.88 122.5 26.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.78 -0.646 . . . . 64.43 110.021 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.29 112.08 65.12 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 109.085 -0.709 . . . . 74.33 109.085 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.49 172.78 15.6 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.612 2.208 . . . . 74.33 113.044 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -58.24 160.59 4.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.485 0.714 . . . . 74.22 112.366 172.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -110.46 135.15 51.58 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 115.851 -0.613 . . . . 72.51 110.063 175.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 18.5 t70 -65.57 160.66 21.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.669 1.187 . . . . 73.52 112.001 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -47.3 -38.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.188 1.181 . . . . 74.51 114.188 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -75.21 -39.46 60.08 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.309 0.485 . . . . 64.42 112.309 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 4.3 p-80 -142.75 94.98 2.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.821 -1.548 . . . . 74.31 106.821 171.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 22.2 pttp -47.14 -163.77 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.39 2 C-N-CA 133.965 4.906 . . . . 62.34 123.298 43.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo 7.69 77.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.603 2.202 . . . . 71.24 116.566 -113.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 120' ' ' LYS . 60.0 mt -94.65 113.59 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.781 -1.1 . . . . 73.24 109.267 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -131.3 141.27 49.93 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.568 0.699 . . . . 75.3 111.508 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -61.86 134.93 57.31 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.52 -1.218 . . . . 74.4 110.523 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.9 153.03 44.6 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 120.545 0.212 . . . . 74.04 110.93 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 67.07 18.84 10.52 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.47 1.108 . . . . 71.44 111.744 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.7 m -140.59 105.36 4.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.333 1.053 . . . . 74.11 109.361 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.61 -76.97 0.8 Allowed Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.22 -0.445 . . . . 51.44 113.209 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 1.6 pp -137.07 140.32 30.98 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.603 0.761 . . . . 75.42 111.185 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 129' ' ' LEU . 21.9 Cg_exo -67.11 -57.92 0.16 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.832 2.355 . . . . 45.12 112.897 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.02 71.44 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 115.895 -0.593 . . . . 71.42 113.114 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.79 78.87 Favored Glycine 0 CA--C 1.546 2.007 0 N-CA-C 115.032 0.773 . . . . 60.41 115.032 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 72.47 -59.46 0.56 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.799 1.64 . . . . 75.24 113.948 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.64 153.04 17.26 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.733 1.213 . . . . 65.44 113.315 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -79.23 34.96 0.26 Allowed 'General case' 0 CA--C 1.577 2.004 0 C-N-CA 124.862 1.265 . . . . 73.44 112.754 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -74.55 99.8 3.71 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.352 -0.842 . . . . 72.25 110.229 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.5 mt -83.02 77.06 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.596 0.712 . . . . 73.04 110.315 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.94 -34.3 5.22 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 115.545 -0.752 . . . . 52.32 112.904 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -72.7 121.4 19.75 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.725 0.81 . . . . 74.13 111.659 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.2 t -74.58 126.64 31.24 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.06 0.544 . . . . 71.31 110.405 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.97 128.03 33.78 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.569 0.699 . . . . 64.11 111.997 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -82.36 -178.4 7.03 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.186 0.995 . . . . 75.34 111.446 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -67.82 85.06 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.37 0.668 . . . . 70.14 110.847 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 28.2 p -167.37 162.15 14.55 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.907 0.883 . . . . 72.15 111.549 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -81.75 129.92 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.935 0.494 . . . . 74.24 110.98 173.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.64 -175.12 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.443 0.697 . . . . 73.04 110.398 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -88.24 95.05 10.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.195 0.598 . . . . 74.44 110.004 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -146.89 117.44 7.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.862 0.865 . . . . 72.15 109.987 173.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -70.99 103.29 2.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.684 -0.858 . . . . 71.34 108.684 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -57.23 112.69 1.45 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.238 0.615 . . . . 73.41 112.104 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -74.15 98.8 3.22 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.482 0.713 . . . . 71.04 109.94 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -110.16 -59.54 1.92 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.424 0.69 . . . . 64.0 111.332 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 . . . . . 0 N--CA 1.491 1.576 0 C-N-CA 123.858 0.863 . . . . 74.3 111.682 -174.781 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' H ' ' A' ' 2' ' ' ARG . 10.8 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.322 -0.251 . . . . 73.42 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.0 ttt180 174.43 144.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.744 . . . . 72.13 109.882 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.34 154.43 30.83 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.431 0.293 . . . . 44.22 111.401 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.99 74.61 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.467 0.707 . . . . 72.55 112.423 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.621 HG23 HG13 ' A' ' 102' ' ' VAL . 3.7 m -65.3 -41.72 93.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.708 0.803 . . . . 71.15 110.71 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.0 -38.81 69.58 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.19 -0.914 . . . . 65.4 110.857 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD11 HG13 ' A' ' 109' ' ' VAL . 61.4 mt -65.03 -40.42 94.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.034 0.534 . . . . 60.3 111.301 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 11' ' ' LEU . 33.6 tp -62.42 -46.5 88.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.636 0.774 . . . . 74.44 110.559 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.0 -41.01 86.62 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.744 -1.116 . . . . 72.25 111.514 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.71 -38.48 83.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.472 0.709 . . . . 72.03 111.545 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 8' ' ' LEU . 44.6 mt -60.29 -39.79 88.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.191 0.996 . . . . 72.14 111.155 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.93 -32.28 69.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.765 0.826 . . . . 74.13 111.903 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.07 -46.02 58.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.876 0.87 . . . . 75.52 112.012 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.22 151.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.352 0.596 . . . . 63.52 112.121 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.22 -33.33 61.35 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.853 0.861 . . . . 75.43 111.113 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -147.95 156.52 42.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 72.24 109.958 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -66.44 76.07 0.1 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.865 0.866 . . . . 63.15 111.552 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -61.87 2.29 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.209 1.004 . . . . 51.12 111.996 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -133.98 8.38 3.78 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.024 0.93 . . . . 71.34 110.717 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.62 107.67 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.924 0.89 . . . . 72.13 110.347 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -92.33 148.65 21.96 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.35 1.06 . . . . 70.55 111.24 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.1 54.18 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.314 1.045 . . . . 73.54 109.882 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 65.0 mttm -139.62 141.02 37.13 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 71.42 111.74 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -84.92 164.21 18.49 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 115.308 -0.86 . . . . 73.54 110.449 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' MET . . . -62.65 -31.99 72.95 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.589 0.589 . . . . 75.04 112.589 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -69.61 -21.97 63.53 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.094 0.775 . . . . 71.04 113.094 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.87 -8.45 48.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.701 0.8 . . . . 63.21 111.937 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -55.03 119.95 6.2 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.108 1.363 . . . . 74.01 112.035 -176.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.98 -147.07 18.95 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.95 -0.46 . . . . 53.01 111.95 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -64.07 -25.01 67.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.239 0.616 . . . . 73.45 112.547 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -59.63 -36.92 77.31 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.232 0.613 . . . . 71.44 111.898 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 34.8 t -71.97 -43.62 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.311 0.577 . . . . 71.23 111.105 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.632 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 80.0 mmm -69.65 -40.9 76.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.118 1.155 . . . . 71.51 114.118 -166.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.73 -31.04 71.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.813 0.34 . . . . 72.22 110.909 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 m -67.75 -37.56 82.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.387 0.675 . . . . 75.43 111.004 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.07 -41.09 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.29 0.636 . . . . 61.24 110.86 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.76 -35.07 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.256 0.622 . . . . 54.22 110.39 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.24 63.45 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.807 0.843 . . . . 61.21 112.636 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -99.07 -29.49 12.86 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.307 0.643 . . . . 73.34 111.921 170.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.82 -34.69 75.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 55.2 112.377 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -79.34 -8.08 58.81 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.545 0.738 . . . . 74.35 112.79 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -81.81 116.42 63.12 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.768 0.827 . . . . 72.41 112.275 -173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.49 111.74 3.39 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.662 2.241 . . . . 64.12 112.438 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.79 19.56 57.7 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.326 0.89 . . . . 72.2 115.326 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.25 21.62 14.53 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 118.716 1.258 . . . . 74.52 111.908 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -40.95 123.05 1.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.637 0.977 . . . . 74.43 113.637 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.64 53.75 0.91 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 116.343 -0.39 . . . . 44.12 113.007 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.81 135.57 12.29 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.423 -1.071 . . . . 70.55 110.423 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.21 128.53 56.27 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.936 0.868 . . . . 73.31 111.914 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.0 mp -112.54 117.81 33.37 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.78 -1.193 . . . . 64.24 107.78 167.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.24 109.83 21.57 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.924 -0.485 . . . . 64.53 109.976 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.7 134.37 40.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.885 0.874 . . . . 73.42 110.575 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.94 28.54 6.16 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 116.293 -0.412 . . . . 60.33 112.13 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.25 138.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.199 0.999 . . . . 74.32 110.252 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -116.71 165.6 13.1 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.864 -1.162 . . . . 63.0 107.864 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -148.58 141.84 25.11 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.387 0.613 . . . . 74.44 111.537 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.04 135.55 53.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.282 1.033 . . . . 65.1 110.536 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 49.6 mm -99.82 118.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.187 0.518 . . . . 62.33 111.515 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -75.99 172.23 13.1 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.846 0.858 . . . . 71.41 111.419 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.52 -21.45 66.62 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.006 0.522 . . . . 62.25 112.144 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -71.61 -14.37 62.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.149 0.98 . . . . 71.33 112.168 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.84 35.22 25.42 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.317 -0.713 . . . . 70.53 111.317 -168.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 25.3 t0 -99.86 140.26 34.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.972 0.909 . . . . 74.04 111.395 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -105.76 107.24 18.13 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.392 0.677 . . . . 74.14 110.633 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.54 120.17 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.833 0.853 . . . . 74.43 109.78 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.77 119.42 32.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.188 0.595 . . . . 54.5 110.422 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -121.85 153.52 60.36 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.52 1.128 . . . . 62.31 110.912 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' HD21 ' A' ' 8' ' ' LEU . 89.8 Cg_endo -82.67 141.44 10.96 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.202 1.935 . . . . 71.14 112.738 177.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.87 -26.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.859 0.864 . . . . 70.31 110.681 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 -178.22 53.88 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 121.852 0.696 . . . . 71.03 114.736 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 108' ' ' LEU . 51.4 mt -101.28 142.35 24.43 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.44 110.904 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.79 -27.98 67.93 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.842 2.361 . . . . 75.34 112.424 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -145.49 97.57 4.67 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 107.817 -1.179 . . . . 62.5 107.817 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.34 -51.47 10.94 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.975 3.117 . . . . 72.31 114.689 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 23.1 t70 -64.58 -51.46 62.64 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.325 -0.852 . . . . 53.32 110.551 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 ttmp? -59.84 -36.93 77.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.582 0.753 . . . . 73.54 112.839 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.91 -41.82 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.043 0.537 . . . . 71.54 111.249 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.15 -33.35 75.23 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.528 0.731 . . . . 74.25 111.528 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 44.3 mmm-85 -72.41 -51.19 21.46 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.546 0.738 . . . . 71.24 110.886 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.22 -44.49 92.29 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.197 0.999 . . . . 75.12 111.821 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.7 tp -67.22 -32.81 74.1 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 111.79 0.293 . . . . 64.24 111.79 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.37 96.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.018 0.527 . . . . 75.53 111.212 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 -45.96 90.55 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.412 0.685 . . . . 74.44 111.524 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -53.2 55.94 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.994 0.918 . . . . 74.44 111.24 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 10.6 t -72.61 -18.37 61.6 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.865 0.691 . . . . 64.03 112.865 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -88.41 -39.6 14.15 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.386 0.675 . . . . 71.42 112.197 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -92.85 -39.86 10.95 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.371 0.878 . . . . 75.41 113.371 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.632 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 66.8 mtp -68.85 -40.95 79.09 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.13 0.49 . . . . 71.34 111.913 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.4 mt -84.12 151.46 24.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.946 0.898 . . . . 73.35 110.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' ND2' HG13 ' A' ' 91' ' ' VAL . 4.0 p-10 -57.33 -32.27 66.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.382 0.882 . . . . 73.04 113.382 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG13 ' ND2' ' A' ' 90' ' ' ASN . 24.9 m -115.38 160.01 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.871 0.868 . . . . 73.24 110.413 172.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -77.12 103.6 7.14 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.109 -0.496 . . . . 65.25 110.513 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.674 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.8 tt -99.04 128.83 45.26 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.486 -0.931 . . . . 64.44 108.486 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.9 ttt85 -98.49 109.61 53.42 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 75.03 110.611 172.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.88 126.77 5.94 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 121.874 1.716 . . . . 74.24 110.311 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.88 100.8 4.92 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.047 -0.524 . . . . 62.11 109.777 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.616 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.0 mtm -110.15 133.51 53.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.427 0.691 . . . . 65.33 112.228 -171.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.27 136.5 39.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.098 0.959 . . . . 71.41 111.111 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 69.9 mt -88.29 116.02 26.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.404 1.082 . . . . 72.23 111.153 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -125.87 131.54 52.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.598 1.159 . . . . 73.4 110.63 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -92.09 125.66 36.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.26 0.624 . . . . 64.51 111.85 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.621 HG13 HG23 ' A' ' 5' ' ' THR . 12.1 t -121.18 114.04 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.584 1.154 . . . . 74.32 109.38 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.32 30.88 61.91 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.561 0.985 . . . . 72.14 115.561 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.14 8.84 83.22 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 114.219 0.448 . . . . 63.42 114.219 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -107.44 137.62 45.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 72.05 108.896 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.0 m -98.43 117.71 33.47 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.278 0.944 . . . . 73.45 111.854 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.66 163.59 13.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.357 1.063 . . . . 72.04 109.452 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -117.33 115.61 25.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.051 0.54 . . . . 71.24 110.538 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.419 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -82.53 106.43 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.885 -0.783 . . . . 73.13 108.885 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 60.7 t -92.88 100.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.503 -0.925 . . . . 70.31 108.503 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -85.02 115.2 22.71 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.869 -1.06 . . . . 73.45 108.872 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 63.6 t -106.52 98.39 20.05 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.359 0.663 . . . . 75.45 109.273 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.94 162.72 40.3 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.09 1.86 . . . . 74.4 110.519 167.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -70.34 132.97 46.47 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.053 -0.351 . . . . 65.21 110.053 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -64.34 158.03 24.63 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 122.987 0.515 . . . . 65.51 111.041 172.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.38 178.92 0.49 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.118 0.967 . . . . 64.14 111.2 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.84 -52.29 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.264 -1.522 . . . . 72.44 113.602 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.1 p -67.66 -48.15 67.5 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 123.711 0.805 . . . . 65.44 111.614 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -115.22 83.49 1.92 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 103.919 -2.623 . . . . 74.21 103.919 163.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.0 mttp -50.58 -143.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.131 1 C-N-CA 133.734 4.814 . . . . 65.41 120.989 49.077 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo 7.15 71.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.253 2.635 . . . . 75.4 115.797 -122.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 120' ' ' LYS . 35.4 mm -81.54 77.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 114.909 -1.041 . . . . 75.25 108.936 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -88.51 146.87 24.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.646 -0.707 . . . . 75.43 110.955 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? . . . . . 0 CA--C 1.549 0.932 0 CA-C-N 114.946 -1.024 . . . . 60.33 110.102 177.425 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.799 -0.445 . . . . 50.24 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 11.6 ptm180 -99.04 151.66 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.822 0.449 . . . . 74.22 110.572 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.5 p -75.3 159.98 30.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.119 0.967 . . . . 72.34 113.285 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.63 69.65 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.191 0.996 . . . . 75.05 112.132 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -66.74 -48.73 68.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.816 0.846 . . . . 72.33 111.145 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.23 -34.3 74.61 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.007 -0.997 . . . . 75.24 111.358 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.31 -36.5 81.61 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.239 1.016 . . . . 62.32 112.373 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.05 -44.94 94.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.682 0.393 . . . . 71.22 110.393 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.43 -36.34 82.1 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.215 0.606 . . . . 41.13 112.325 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.559 ' HG2' HG13 ' A' ' 20' ' ' ILE . 4.6 tp10 -66.54 -41.35 88.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.846 0.458 . . . . 73.33 111.246 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.4 mt -57.81 -47.77 81.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.118 0.967 . . . . 65.05 112.163 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.295 0.479 . . . . 64.51 112.295 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.87 -39.52 61.49 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.311 0.644 . . . . 72.5 112.142 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -91.36 143.81 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.543 0.687 . . . . 73.24 111.894 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.51 -13.79 39.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.097 0.959 . . . . 73.34 110.934 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -141.21 136.68 31.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.262 1.025 . . . . 73.31 109.989 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.6 m -74.33 77.25 1.86 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.508 0.671 . . . . 65.54 111.021 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -60.67 2.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.041 -0.982 . . . . 70.32 111.166 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -111.95 -23.23 10.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.718 0.807 . . . . 70.15 111.567 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.559 HG13 ' HG2' ' A' ' 10' ' ' GLU . 21.6 mm -115.4 107.26 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 -170.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.2 114.52 24.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.884 0.473 . . . . 73.23 110.187 -171.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.97 116.59 23.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.544 0.738 . . . . 70.33 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.44 153.34 33.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.179 0.514 . . . . 63.51 111.638 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -93.54 170.77 9.34 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.351 1.06 . . . . 74.1 111.593 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.74 88.42 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.967 -0.56 . . . . 54.32 110.937 169.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.4 p -57.61 -30.78 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.893 0.877 . . . . 71.51 112.455 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -84.74 -0.25 52.99 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.028 0.751 . . . . 62.44 113.028 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 88.3 mmm -68.49 131.65 45.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.004 0.521 . . . . 61.32 111.421 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.14 -132.76 6.25 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.684 -0.689 . . . . 54.55 111.746 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -39.72 89.46 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.17 0.588 . . . . 74.42 111.409 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 m -53.22 -33.6 53.54 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.564 1.145 . . . . 54.43 113.509 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.46 -35.31 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.152 0.581 . . . . 60.55 111.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.4 mmm -73.91 -41.49 62.03 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.263 0.838 . . . . 73.35 113.263 -164.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -65.34 -26.41 68.02 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 111.746 0.276 . . . . 54.32 111.746 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.0 m -72.24 -41.01 67.3 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 122.316 0.246 . . . . 53.2 111.115 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.4 0.68 . . . . 42.22 111.955 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 pt -63.27 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.651 0.38 . . . . 74.41 111.62 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.89 77.61 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.119 0.568 . . . . 73.43 111.687 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' HD23 ' A' ' 45' ' ' LEU . 32.2 m-85 -82.4 -37.29 25.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.474 0.71 . . . . 71.44 111.338 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.7 -23.48 62.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.933 1.086 . . . . 70.41 113.933 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -108.08 -8.51 15.81 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.737 1.014 . . . . 74.32 113.737 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.89 107.06 25.17 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.232 0.469 . . . . 62.22 110.563 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.96 123.68 11.62 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.933 2.422 . . . . 53.13 112.732 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.51 60.7 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-O 119.912 -0.382 . . . . 63.11 114.033 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' PHE . 19.1 tp -89.86 13.44 14.51 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 117.713 0.756 . . . . 54.14 111.214 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -32.22 112.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.183 1.793 . . . . 71.21 114.158 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.632 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 103.78 68.63 0.77 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.395 -0.366 . . . . 45.31 112.779 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.06 124.61 5.4 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 109.618 -1.393 . . . . 43.41 109.618 171.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 2' ' ' ARG . 56.0 m-85 -120.86 127.77 52.21 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.386 0.593 . . . . 61.52 111.819 -169.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -93.3 118.27 31.07 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.33 110.43 22.42 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.666 0.667 . . . . 62.43 109.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 9.3 mp -99.0 132.16 44.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.979 0.912 . . . . 64.11 110.793 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.5 33.15 4.91 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.247 -0.433 . . . . 73.21 112.429 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.6 138.6 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.116 0.566 . . . . 61.31 110.692 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.76 146.99 31.42 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.462 -1.31 . . . . 60.52 107.462 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -128.97 126.47 39.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.024 0.44 . . . . 74.52 110.399 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 123.4 46.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 54.03 109.969 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.52 131.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.578 0.751 . . . . 63.1 111.355 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.26 -178.5 6.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.608 0.763 . . . . 71.31 112.394 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.24 -28.55 69.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.584 0.754 . . . . 74.22 111.846 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -82.73 2.11 35.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.308 0.643 . . . . 74.52 112.274 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.36 32.34 58.07 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 120.933 0.185 . . . . 62.22 112.732 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.94 111.54 23.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.756 0.823 . . . . 75.13 110.631 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 m -82.8 115.05 21.53 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.604 0.762 . . . . 75.53 111.046 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.56 122.78 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.873 0.869 . . . . 75.42 110.293 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -95.7 129.04 43.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.483 0.713 . . . . 71.53 110.44 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -137.36 142.41 37.41 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.139 0.976 . . . . 71.32 111.054 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.64 80.19 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.029 2.486 . . . . 75.31 113.931 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.86 -23.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 112.703 0.631 . . . . 64.32 112.703 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.61 -173.46 53.28 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 121.313 0.396 . . . . 72.15 113.886 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 61.1 mt -115.98 124.59 29.57 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.032 0.933 . . . . 41.43 109.78 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.64 -27.02 39.03 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.473 2.115 . . . . 74.3 112.631 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.81 73.82 75.67 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.452 0.701 . . . . 74.33 109.485 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 83.4 Cg_endo -81.03 -28.3 2.56 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.78 2.32 . . . . 71.21 114.483 -170.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.39 -42.9 87.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 74.22 110.771 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.45 -33.86 76.01 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.558 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.14 -47.83 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.034 0.533 . . . . 74.41 110.784 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.456 ' OE1' ' HG ' ' A' ' 99' ' ' LEU . 41.6 tt0 -62.7 -50.28 71.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.873 0.694 . . . . 61.22 112.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -33.96 62.43 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 112.6 0.592 . . . . 72.21 112.6 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.54 -31.2 65.11 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.922 0.489 . . . . 65.04 110.895 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.78 -41.39 83.31 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.68 0.392 . . . . 35.33 111.248 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.83 92.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.896 0.479 . . . . 53.53 111.31 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -52.62 64.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.799 0.84 . . . . 62.21 112.007 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -68.04 -34.72 77.0 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 111.995 0.368 . . . . 62.54 111.995 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 36.8 t -67.81 -25.99 65.85 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.338 0.517 . . . . 73.43 112.102 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -78.42 -27.37 46.59 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.958 0.725 . . . . 33.03 112.958 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.7 t -106.59 -29.38 9.67 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.32 0.859 . . . . 64.2 113.32 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.1 mmt -67.3 -52.86 35.35 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.037 0.935 . . . . 74.52 111.405 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 mt -90.04 162.0 15.57 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.684 -1.144 . . . . 72.31 110.717 -169.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -29.65 -58.09 0.16 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 126.135 1.774 . . . . 70.2 114.804 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 122' ' ' ILE . 16.9 m -124.16 176.77 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.389 0.675 . . . . 53.41 110.182 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.1 98.77 0.61 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.287 0.565 . . . . 73.44 111.039 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 122' ' ' ILE . 2.5 tt -92.02 121.65 33.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 71.52 108.017 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -101.62 99.36 11.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.154 0.582 . . . . 74.55 109.644 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.64 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 4.3 Cg_exo -76.58 168.19 24.16 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.838 1.692 . . . . 72.3 110.787 168.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 43.5 tt0 -105.12 96.99 6.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.066 0.546 . . . . 75.32 109.589 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.734 ' HB3' HD11 ' A' ' 108' ' ' LEU . 4.4 mpp? -105.13 134.89 47.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 71.52 111.458 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -139.61 133.79 31.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.074 0.55 . . . . 72.15 111.197 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 78' ' ' GLN . 91.6 mt -84.26 133.29 34.57 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.897 0.879 . . . . 71.53 110.752 174.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -138.17 145.75 41.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.466 1.106 . . . . 73.4 110.595 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.9 119.97 38.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.963 0.505 . . . . 71.3 109.803 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.32 111.73 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.703 -1.221 . . . . 74.12 107.703 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.73 27.59 61.8 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 114.548 0.579 . . . . 50.44 114.548 -168.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.64 -1.02 88.86 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 114.987 0.755 . . . . 72.32 114.987 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 131.9 46.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.612 0.765 . . . . 75.34 109.964 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.6 m -92.4 106.09 18.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.318 0.858 . . . . 74.51 113.318 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.98 156.26 17.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.325 1.05 . . . . 72.11 111.126 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 97' ' ' MET . 50.4 tp -112.93 116.41 29.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.466 0.707 . . . . 52.3 110.78 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.4 113.35 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.389 0.676 . . . . 63.44 109.831 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 45.4 t -105.65 101.37 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 122.898 0.479 . . . . 43.51 110.263 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 40.4 t80 -84.46 128.51 34.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.627 0.771 . . . . 71.52 110.19 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.29 102.61 14.68 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 109.441 -0.578 . . . . 74.45 109.441 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.79 147.66 21.88 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.607 2.204 . . . . 64.41 112.163 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -75.61 134.49 40.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.853 0.358 . . . . 73.41 111.259 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -93.39 172.87 8.01 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.746 0.818 . . . . 74.44 112.968 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.62 139.31 36.31 Favored 'General case' 0 C--O 1.193 -1.914 0 C-N-CA 123.707 0.803 . . . . 62.31 110.617 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.74 -38.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 115.945 1.831 . . . . 74.25 115.945 -170.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.7 p -65.43 -49.41 69.26 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.864 0.466 . . . . 72.04 111.745 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 9.0 m-70 -127.93 69.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.88 -2.267 . . . . 64.14 104.88 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.62 ' HA ' HG12 ' A' ' 122' ' ' ILE . 27.8 mtpp -45.06 -152.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.386 1 C-N-CA 132.91 4.484 . . . . 70.14 120.844 58.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo 7.68 65.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.113 2.542 . . . . 70.54 116.153 -126.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 93' ' ' LEU . 30.5 mm -80.0 77.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.094 0 CA-C-N 115.361 -0.836 . . . . 61.52 109.184 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -80.76 141.96 34.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.246 -0.433 . . . . 73.04 110.938 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 CA--C 1.55 0.949 0 CA-C-N 115.704 -0.68 . . . . 73.44 109.527 171.227 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.089 -0.338 . . . . 62.23 110.089 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -88.09 146.43 25.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.429 0.692 . . . . 73.5 110.742 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -70.24 166.71 19.48 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 122.997 0.519 . . . . 73.45 111.76 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . . . -62.42 -50.27 72.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.639 0.607 . . . . 42.4 112.639 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -70.47 -28.78 65.26 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 112.009 0.374 . . . . 72.13 112.009 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.55 -46.37 86.26 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.89 0.876 . . . . 31.14 111.256 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HG13 ' A' ' 109' ' ' VAL . 60.5 mt -65.95 -38.46 88.67 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.722 0.809 . . . . 75.25 112.166 172.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 24.3 tp -59.17 -50.09 75.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.036 0.934 . . . . 75.22 110.399 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.47 -40.31 78.28 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.759 -1.109 . . . . 63.22 111.064 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.83 -41.75 95.49 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.988 0.915 . . . . 74.34 111.843 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 8' ' ' LEU . 29.3 mt -60.3 -38.62 84.23 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.659 1.184 . . . . 72.34 112.149 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -80.17 -28.95 38.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.029 0.531 . . . . 71.15 111.864 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -47.19 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.452 0.701 . . . . 54.13 111.949 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.3 154.8 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.131 0.572 . . . . 73.34 111.115 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.22 -20.61 21.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.011 0.924 . . . . 72.32 111.124 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.85 134.75 30.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.604 1.162 . . . . 62.31 109.688 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -69.6 87.13 0.48 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.88 0.872 . . . . 64.3 110.456 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.06 -64.59 1.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.45 0.7 . . . . 73.21 112.488 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -107.38 -14.05 14.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.43 0.692 . . . . 61.41 110.207 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 mm -109.49 155.17 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.216 -1.031 . . . . 72.32 108.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.46 150.13 10.41 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.005 -0.739 . . . . 62.22 109.005 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.87 46.13 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.029 0.532 . . . . 70.34 112.005 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 32' ' ' VAL . 74.9 mmtt -130.61 150.37 51.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.182 0.993 . . . . 31.44 110.076 175.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' VAL . 57.7 mtt-85 -85.63 165.16 17.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.734 0.814 . . . . 73.12 110.157 171.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.46 -30.85 68.81 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 120.879 0.371 . . . . 62.52 111.526 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -71.97 -19.25 61.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.649 0.78 . . . . 74.25 112.803 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -84.38 -4.99 59.22 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.527 0.565 . . . . 61.22 112.527 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.6 mmm -59.5 108.45 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.315 0.579 . . . . 63.3 111.313 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 142.14 -143.53 12.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 114.878 -1.055 . . . . 71.05 110.863 -171.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -52.57 -39.24 61.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.233 1.013 . . . . 71.05 113.253 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -36.51 75.34 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.065 0.765 . . . . 62.44 113.065 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' A' ' 23' ' ' LYS . 44.2 t -72.52 -50.34 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 120.968 0.413 . . . . 75.05 110.385 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 88' ' ' MET . 91.3 mmm -57.45 -41.2 80.09 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.57 1.322 . . . . 75.43 114.57 -170.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.18 -34.24 77.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.157 0.583 . . . . 72.04 111.611 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -79.32 -28.48 42.13 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.758 0.823 . . . . 42.35 111.242 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.82 -40.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 123.48 0.712 . . . . 61.22 110.511 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.96 -31.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.507 -0.769 . . . . 63.23 111.134 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 42' ' ' GLU . . . -60.08 -49.96 75.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.228 0.611 . . . . 74.32 112.178 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.28 -27.56 35.06 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.681 . . . . 72.1 111.657 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.66 -32.26 60.1 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.363 0.665 . . . . 62.32 112.275 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -92.57 -17.11 24.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.163 0.585 . . . . 72.52 111.525 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.1 tp10 -75.43 106.88 3.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 123.578 0.751 . . . . 73.23 112.367 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.07 106.12 2.21 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.142 2.561 . . . . 73.52 113.201 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.08 -7.1 40.63 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 114.87 0.708 . . . . 71.34 114.87 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -92.78 -52.43 4.62 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.203 1.002 . . . . 64.13 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 36.93 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 126.296 1.839 . . . . 75.45 115.378 -170.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.09 48.09 64.51 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 116.012 1.165 . . . . 71.23 116.012 166.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.72 152.59 22.56 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.53 -0.628 . . . . 74.14 111.53 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.89 127.1 51.56 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.844 0.822 . . . . 63.21 112.074 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 97.2 mt -115.21 114.04 24.72 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.879 1.271 . . . . 44.25 108.59 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.14 109.06 20.66 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.508 -0.552 . . . . 65.05 109.508 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 108' ' ' LEU . 29.9 mt -93.03 132.17 37.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.494 0.718 . . . . 73.01 110.533 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 36.64 4.43 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 121.298 0.388 . . . . 75.23 112.371 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 43.1 t -115.53 143.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.537 0.735 . . . . 75.4 109.813 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -113.47 154.1 27.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.765 -1.198 . . . . 63.42 107.765 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 41.7 p90 -145.73 129.03 16.78 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.408 0.623 . . . . 75.31 112.005 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.74 135.61 51.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.835 0.854 . . . . 61.22 110.933 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.6 mt -83.7 123.52 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.737 0.815 . . . . 64.24 110.582 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 63' ' ' ASP . 29.5 p30 -82.5 -176.3 6.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.795 0.838 . . . . 74.15 112.08 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.77 -14.16 57.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.737 1.014 . . . . 64.12 113.737 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -86.8 -22.89 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.151 0.58 . . . . 64.22 112.021 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.4 16.05 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 116.576 -0.284 . . . . 34.23 112.512 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HD21 ' A' ' 59' ' ' ASN . 23.4 t70 -107.74 132.71 53.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.263 1.025 . . . . 74.01 110.915 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -89.09 119.03 29.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.806 0.842 . . . . 71.11 111.509 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 67.5 t -103.44 120.8 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.169 0.988 . . . . 75.22 110.704 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -94.19 130.69 40.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.271 1.028 . . . . 73.31 110.387 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.87 147.44 48.24 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.877 0.871 . . . . 74.04 110.485 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 83.2 Cg_endo -78.31 108.16 2.43 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.251 1.967 . . . . 64.32 114.534 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 m -91.1 -24.42 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 122.968 0.507 . . . . 62.2 111.199 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 76.58 -170.12 54.95 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 114.81 0.684 . . . . 34.5 114.81 174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -121.57 124.24 27.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.97 0.908 . . . . 53.43 109.979 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.97 -17.04 22.71 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.457 2.105 . . . . 61.15 113.023 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -134.38 59.77 38.97 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.404 1.081 . . . . 70.42 110.223 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HB2' HD22 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -62.06 -36.81 68.39 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.905 2.403 . . . . 73.34 114.265 -162.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.31 -39.27 74.92 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.472 0.709 . . . . 74.22 110.58 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.47 -36.3 80.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.979 0.511 . . . . 73.21 111.205 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.35 -45.6 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 123.474 0.71 . . . . 71.35 110.813 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.9 -49.77 74.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.808 0.843 . . . . 62.53 112.043 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -67.32 -40.67 85.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.279 0.632 . . . . 64.43 111.578 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.9 -36.57 84.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.552 0.741 . . . . 65.4 110.389 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.56 HD23 ' SD ' ' A' ' 97' ' ' MET . 24.3 tp -67.78 -38.27 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.969 0.508 . . . . 72.12 111.282 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.67 90.58 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.99 0.516 . . . . 55.33 111.553 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.8 m -65.76 -48.31 72.28 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.639 0.776 . . . . 74.12 111.721 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.98 -30.36 69.61 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.797 0.439 . . . . 74.42 111.478 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 16.1 t -65.98 -19.91 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.899 -0.5 . . . . 65.33 112.292 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -39.2 17.73 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.455 0.702 . . . . 40.1 112.016 170.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -85.93 -25.67 25.98 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.153 1.168 . . . . 33.01 114.153 -173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 33' ' ' MET . 85.7 mmm -81.91 -58.08 3.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.815 0.846 . . . . 72.34 110.085 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.98 146.55 37.39 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.352 -0.84 . . . . 63.0 111.138 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -50.84 -37.57 43.92 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.997 0.919 . . . . 63.33 113.051 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.2 m -121.1 160.03 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.053 0.941 . . . . 71.32 110.713 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.29 105.34 7.29 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.085 0.554 . . . . 72.45 111.85 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.5 tt -93.24 137.19 32.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.28 -1.378 . . . . 63.45 107.28 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -98.83 104.73 26.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 122.692 0.397 . . . . 62.33 110.131 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.68 119.38 5.69 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.303 1.335 . . . . 50.22 110.667 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 14.3 tp10 -71.65 98.74 1.97 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.373 -0.83 . . . . 72.14 109.826 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.1 mtm -116.73 127.16 54.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.311 0.644 . . . . 72.1 112.198 -169.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -132.9 128.67 37.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.303 1.041 . . . . 75.1 110.2 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 74' ' ' PRO . 53.6 mt -81.91 132.14 35.26 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.167 0.987 . . . . 71.4 111.408 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 11.4 mm-40 -128.38 128.46 44.55 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.162 0.985 . . . . 73.23 111.1 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.2 117.27 29.7 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.857 0.863 . . . . 73.44 110.986 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.2 t -132.98 117.42 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.565 1.146 . . . . 74.25 110.577 -172.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.3 28.54 27.66 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 116.443 1.337 . . . . 74.22 116.443 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -4.48 67.91 Favored Glycine 0 N--CA 1.484 1.852 0 CA-C-N 117.472 0.636 . . . . 53.22 114.179 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.483 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -110.88 119.2 38.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.377 1.071 . . . . 52.52 110.074 -177.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -88.55 103.53 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.982 0.81 . . . . 53.13 110.576 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.44 168.77 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.858 0.863 . . . . 72.32 110.717 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 52' ' ' LEU . 60.1 tp -119.2 119.07 33.04 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.994 0.517 . . . . 73.43 110.577 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.507 HG13 HD11 ' A' ' 7' ' ' LEU . 93.1 t -83.63 111.01 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.135 -0.691 . . . . 52.3 109.135 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 48.1 t -103.5 99.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.527 0.679 . . . . 75.53 110.177 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 58.2 t80 -79.05 119.16 21.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.145 0.978 . . . . 70.3 109.026 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.79 102.49 53.66 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.079 0.952 . . . . 64.1 108.774 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.96 165.48 31.98 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.942 1.761 . . . . 74.2 111.607 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -72.14 136.56 46.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.781 -0.822 . . . . 54.13 108.781 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -71.51 156.35 39.53 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.451 0.7 . . . . 73.24 111.522 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.4 -175.61 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 124.926 1.29 . . . . 63.3 111.601 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.94 -51.56 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 O-C-N 119.756 -1.84 . . . . 74.42 113.614 162.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 t -68.39 -49.94 56.49 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.363 0.529 . . . . 53.5 111.468 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 8.5 m-70 -117.94 84.65 2.21 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 101.341 -3.577 . . . . 73.11 101.341 165.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.686 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.256 36.2 mtmm -48.79 -140.77 0.0 OUTLIER Pre-proline 0 CA--C 1.577 1.986 1 C-N-CA 133.664 4.786 . . . . 70.14 121.204 50.908 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo 10.16 62.93 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 124.207 3.272 . . . . 51.1 116.136 -121.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.686 HG12 ' HA ' ' A' ' 120' ' ' LYS . 48.5 mm -76.78 116.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.994 0.918 . . . . 73.24 110.344 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -150.52 144.19 25.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.906 0.483 . . . . 73.24 110.16 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 120.912 0.387 . . . . 73.41 110.288 171.782 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 46.0 ttm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.788 0.328 . . . . 74.41 111.565 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.0 mmm180 -95.44 157.57 15.84 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.402 1.081 . . . . 71.31 111.037 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -77.45 152.35 34.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.908 0.707 . . . . 62.32 112.908 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.88 -53.05 54.67 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.505 1.122 . . . . 73.12 113.183 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HG11 ' A' ' 102' ' ' VAL . 2.9 t -62.35 -41.5 98.65 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.234 0.613 . . . . 74.31 112.621 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -55.16 -45.31 75.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.495 1.118 . . . . 33.53 111.68 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 2' ' ' ARG . 47.3 mt -73.68 -33.27 64.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.306 1.042 . . . . 72.01 112.749 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.36 -31.36 71.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.271 0.628 . . . . 63.53 110.587 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.49 -30.68 69.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.863 0.865 . . . . 44.2 112.802 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.2 tt0 -60.85 -52.94 62.95 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.875 -0.417 . . . . 74.23 109.875 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.71 -27.46 62.08 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.836 0.854 . . . . 73.35 112.914 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.66 -11.1 60.67 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.214 0.605 . . . . 74.45 111.847 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 -36.11 8.24 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.839 0.856 . . . . 73.21 111.948 172.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 10' ' ' GLU . 29.5 m -117.54 117.54 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.616 0.767 . . . . 75.43 111.241 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.84 -44.49 82.16 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.684 1.193 . . . . 74.23 111.1 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.77 149.57 25.66 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.982 0.913 . . . . 61.35 110.601 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.1 m -87.24 129.64 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.867 0.467 . . . . 75.53 111.982 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.46 -64.94 1.0 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.833 0.453 . . . . 71.45 111.32 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -14.68 9.08 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.569 0.747 . . . . 73.21 112.013 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 49' ' ' TYR . 18.8 mm -113.87 142.99 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 118.193 0.452 . . . . 73.01 110.649 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 3.7 mm-40 -128.27 112.6 14.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.365 0.666 . . . . 61.14 110.632 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.29 118.2 30.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.314 0.645 . . . . 51.41 109.843 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' A' ' 32' ' ' VAL . 73.6 mmtt -124.11 142.95 50.76 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.848 0.859 . . . . 64.23 110.632 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -89.56 174.76 7.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.548 0.739 . . . . 71.01 110.714 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -37.85 71.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.131 0.572 . . . . 63.45 112.21 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -60.45 -23.56 64.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.162 1.171 . . . . 74.23 114.162 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -88.13 -13.72 40.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.381 0.882 . . . . 72.01 113.381 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.512 ' SD ' HG13 ' A' ' 77' ' ' VAL . 84.4 mtp -58.3 109.16 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.056 0.542 . . . . 75.23 112.24 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.01 -122.46 1.18 Allowed Glycine 0 C--N 1.344 0.988 0 CA-C-N 116.136 -0.483 . . . . 43.01 112.326 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.47 -46.55 63.55 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.518 0.727 . . . . 75.04 111.57 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.6 m -63.86 -37.4 87.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.611 0.764 . . . . 61.21 112.369 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' A' ' 23' ' ' LYS . 87.5 t -67.69 -42.33 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.847 0.459 . . . . 74.01 111.192 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.491 ' SD ' HD21 ' A' ' 89' ' ' LEU . 36.2 tpp -67.6 -47.31 70.07 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.75 0.648 . . . . 73.24 112.75 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.31 -27.24 66.13 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 62.11 113.041 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.46 HG23 HD21 ' A' ' 50' ' ' LEU . 14.7 t -78.22 -29.13 48.16 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 121.615 -0.678 . . . . 73.03 111.91 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.08 -43.21 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 123.055 0.542 . . . . 74.21 109.569 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 122' ' ' ILE . 48.4 mt -53.73 -45.21 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.203 1.001 . . . . 75.42 111.078 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.35 90.72 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.855 0.462 . . . . 50.3 111.611 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.07 -38.88 89.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.923 0.489 . . . . 71.25 111.726 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.53 -30.76 69.64 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.543 0.737 . . . . 64.31 112.721 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -105.63 17.13 24.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.024 0.75 . . . . 54.43 113.024 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -108.25 89.19 5.53 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 122.821 0.449 . . . . 73.33 110.53 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.07 118.92 5.96 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.302 2.001 . . . . 71.35 112.132 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.82 -12.52 32.29 Favored Glycine 0 N--CA 1.477 1.406 0 CA-C-N 115.547 -0.751 . . . . 71.4 113.216 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.25 -7.56 14.83 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.474 0.71 . . . . 75.4 109.754 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -42.87 132.08 3.96 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.923 1.289 . . . . 63.32 113.845 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.89 37.64 2.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.831 -0.622 . . . . 41.32 111.747 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.82 152.67 20.38 Favored Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.698 -0.561 . . . . 71.12 111.698 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' HB2' HD12 ' A' ' 20' ' ' ILE . 98.2 m-85 -120.69 148.74 43.54 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.768 0.784 . . . . 72.32 112.303 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.2 mp -119.93 130.96 55.05 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.893 0.877 . . . . 75.14 109.69 170.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.05 109.47 21.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.568 0.747 . . . . 70.33 109.752 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD12 HD23 ' A' ' 108' ' ' LEU . 63.5 mt -92.07 127.56 37.58 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.938 -0.393 . . . . 72.42 109.938 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.93 30.86 4.07 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 115.9 -0.591 . . . . 63.04 112.604 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.25 133.35 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.252 0.621 . . . . 74.31 110.365 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.81 176.84 5.04 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.688 -1.227 . . . . 74.43 107.688 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -157.05 144.67 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.566 -0.709 . . . . 64.41 112.454 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.71 128.29 53.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.281 1.032 . . . . 72.03 110.294 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.6 mm -82.62 123.14 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 122.9 0.48 . . . . 64.22 111.049 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -65.28 154.54 37.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.897 0.879 . . . . 72.25 110.185 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.37 0.26 20.16 Favored 'General case' 0 CA--C 1.559 1.289 0 O-C-N 121.997 -0.44 . . . . 70.51 111.8 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -96.71 3.51 52.37 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.87 0.868 . . . . 53.45 111.494 166.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.56 57.88 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 115.576 0.991 . . . . 71.24 115.576 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.61 148.38 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.105 0.779 . . . . 73.12 113.105 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -96.72 128.29 43.52 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.354 0.662 . . . . 60.12 111.088 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.1 119.15 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 108.781 -0.822 . . . . 75.32 108.781 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.74 113.43 25.49 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.679 0.752 . . . . 72.25 110.382 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.17 145.1 31.8 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.541 1.136 . . . . 72.31 110.143 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 88.6 Cg_endo -96.2 109.31 0.11 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.371 2.047 . . . . 63.44 113.869 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.8 -11.65 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.66 -0.65 . . . . 71.25 111.142 161.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.6 -167.54 54.34 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.466 0.481 . . . . 64.12 113.61 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 77' ' ' VAL . 95.2 mt -99.74 131.43 24.65 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.113 0.965 . . . . 72.24 110.838 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.24 -37.51 61.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.329 2.019 . . . . 74.21 111.218 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 10.8 m-20 -130.52 86.05 54.34 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.004 0.921 . . . . 74.42 109.374 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 -37.34 89.92 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.562 2.841 . . . . 74.04 114.319 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.97 -53.42 46.57 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.009 -0.996 . . . . 65.02 110.92 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 73' ' ' ASP . 67.4 mmtt -64.46 -49.08 72.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 54.55 112.064 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.512 HG13 ' SD ' ' A' ' 28' ' ' MET . 95.3 t -56.51 -40.94 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.709 0.803 . . . . 61.33 112.329 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.41 -46.12 90.02 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.414 0.686 . . . . 71.5 112.004 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.66 -44.7 61.51 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.738 0.815 . . . . 73.35 112.212 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.02 -33.25 75.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.604 0.762 . . . . 71.45 111.926 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -66.76 -45.11 79.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.656 0.265 . . . . 72.23 110.973 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.09 89.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.335 0.654 . . . . 71.22 111.86 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -64.34 -53.04 54.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.107 0.963 . . . . 70.24 111.028 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.29 -33.42 75.26 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.072 -0.513 . . . . 74.03 112.017 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.4 -29.22 63.92 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.486 0.585 . . . . 74.45 112.412 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.26 -42.65 13.59 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.679 0.792 . . . . 65.03 111.341 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -69.33 -28.52 66.31 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.975 1.102 . . . . 71.14 113.975 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.489 ' SD ' ' HD2' ' A' ' 124' ' ' LYS . 14.0 mmt -80.25 -60.94 2.14 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.313 0.645 . . . . 53.53 111.769 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.491 HD21 ' SD ' ' A' ' 33' ' ' MET . 22.7 mt -81.93 159.9 23.5 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.388 -0.823 . . . . 61.13 112.796 -161.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.718 HD21 HG13 ' A' ' 91' ' ' VAL . 2.5 p-10 -50.65 -52.26 41.46 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.036 0.754 . . . . 75.33 113.036 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.718 HG13 HD21 ' A' ' 90' ' ' ASN . 34.5 m -107.47 171.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.303 0.573 . . . . 73.41 111.441 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.65 99.6 5.09 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.496 -0.775 . . . . 65.43 110.062 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 122' ' ' ILE . 3.9 tt -84.53 127.05 33.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.593 -1.262 . . . . 73.3 107.593 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 94.29 15.91 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.391 0.677 . . . . 74.44 110.583 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.01 162.09 23.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.531 2.154 . . . . 74.3 111.692 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.693 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.6 tp10 -95.75 128.81 42.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 108' ' ' LEU . 62.5 mtt -126.29 114.12 17.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.017 0.527 . . . . 72.41 110.277 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -124.15 133.69 53.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.568 0.747 . . . . 72.23 111.008 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.13 125.06 41.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.007 0.923 . . . . 75.5 110.41 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -135.27 146.09 48.21 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.481 0.713 . . . . 63.04 111.156 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -101.21 117.38 34.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.23 0.538 . . . . 71.23 110.739 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 5' ' ' THR . 88.3 t -126.63 120.08 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.149 1.38 . . . . 73.4 108.375 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.19 60.57 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.109 0.404 . . . . 33.04 114.109 -170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.92 88.03 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 114.152 0.421 . . . . 70.52 114.152 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.2 mmtt -103.01 134.88 45.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.918 0.887 . . . . 74.23 109.928 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.2 m -96.98 123.27 40.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.779 0.718 . . . . 64.42 111.289 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 68' ' ' PRO . 6.7 mp -113.58 161.5 17.34 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.52 0.728 . . . . 72.04 109.198 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 35.9 tp -114.89 111.51 21.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.469 -0.567 . . . . 72.3 109.469 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.2 t -84.76 122.27 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.219 -0.66 . . . . 75.13 109.219 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 37.3 t -113.2 99.97 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.458 0.703 . . . . 73.02 110.039 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 56.8 t80 -84.08 119.61 25.17 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 71.35 110.555 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.42 100.97 28.85 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.931 0.893 . . . . 70.41 109.175 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 176.28 10.17 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.603 2.202 . . . . 71.41 112.356 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.22 156.78 24.38 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.679 0.752 . . . . 73.52 112.934 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -124.34 141.48 52.04 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.145 0.978 . . . . 71.25 109.898 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.24 150.51 37.03 Favored 'General case' 0 C--O 1.183 -2.4 0 C-N-CA 124.27 1.028 . . . . 63.11 110.933 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.0 t -38.72 -37.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 N-CA-C 115.933 1.827 . . . . 72.22 115.933 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 t -78.36 -39.57 38.89 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 112.909 0.707 . . . . 72.42 112.909 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 p-80 -136.88 77.31 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.745 -1.576 . . . . 54.22 106.745 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.727 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.263 14.1 ptmm? -51.48 -152.48 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.35 2 C-N-CA 132.81 4.444 . . . . 72.32 122.097 46.338 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo 14.4 62.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 O-C-N 117.239 -2.032 . . . . 72.05 115.844 -123.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.727 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.9 mm -75.67 95.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 114.401 -1.272 . . . . 72.53 109.451 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -110.53 155.18 22.65 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.928 0.491 . . . . 74.55 109.876 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD2' ' SD ' ' A' ' 88' ' ' MET . 5.7 ttpm? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' HG3' ' A' ' 98' ' ' GLN . 10.3 tpt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.919 -0.4 . . . . 63.32 109.919 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -85.73 123.43 31.1 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.149 0.58 . . . . 75.53 110.607 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -59.47 153.71 18.78 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.103 0.961 . . . . 75.2 112.718 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.82 74.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.653 0.781 . . . . 62.3 112.642 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -65.11 -40.76 94.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.615 0.766 . . . . 70.22 110.931 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.78 -37.53 87.92 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.002 0.921 . . . . 70.43 112.239 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 109' ' ' VAL . 68.8 mt -63.0 -41.66 99.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.124 0.569 . . . . 74.52 111.829 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.89 -32.38 69.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 61.02 112.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.14 -40.61 94.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.072 0.549 . . . . 72.03 111.553 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 14' ' ' VAL . 34.6 tt0 -72.61 -50.16 27.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 110.319 -0.252 . . . . 72.13 110.319 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -49.44 -55.78 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.505 1.122 . . . . 55.33 113.119 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -68.49 -20.78 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.445 0.906 . . . . 75.13 113.445 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.32 -29.0 15.87 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.232 0.827 . . . . 73.25 113.232 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 10' ' ' GLU . 23.0 m -111.76 128.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 112.59 0.589 . . . . 72.51 112.59 -172.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.82 -20.93 54.85 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.963 0.905 . . . . 75.31 113.334 164.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -124.49 98.83 5.91 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.547 0.739 . . . . 64.52 110.392 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 p -75.7 94.66 3.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.563 0.745 . . . . 75.54 109.831 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 -63.81 0.99 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.373 0.879 . . . . 42.02 113.373 -167.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -121.55 6.96 10.03 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.11 0.564 . . . . 72.13 112.1 179.35 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mt -116.6 112.81 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.155 -0.683 . . . . 53.23 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.99 115.97 22.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.969 -0.382 . . . . 72.54 109.969 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.75 131.61 37.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.652 0.781 . . . . 72.53 111.97 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 62.3 mttm -130.0 151.64 50.33 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.097 0.959 . . . . 71.01 110.678 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -90.06 170.73 10.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.085 0.554 . . . . 74.03 111.085 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.38 70.7 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.406 0.682 . . . . 64.44 111.659 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -60.6 -30.16 69.65 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.902 0.881 . . . . 63.35 112.88 171.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -86.89 -2.5 58.64 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.272 0.629 . . . . 73.13 112.646 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.2 tpt -63.83 123.06 17.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.795 0.838 . . . . 75.43 112.293 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.75 -135.76 5.73 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.644 -0.253 . . . . 64.51 113.116 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -31.19 70.57 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.579 0.752 . . . . 63.54 111.337 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.4 m -62.8 -31.21 72.14 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.499 0.72 . . . . 64.2 111.955 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.594 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 25.9 t -73.36 -44.06 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 120.909 0.385 . . . . 72.14 110.996 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.566 ' SD ' HD21 ' A' ' 89' ' ' LEU . 38.1 tpp -62.51 -50.47 71.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.212 -0.903 . . . . 72.25 113.076 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -27.4 69.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.924 0.49 . . . . 72.4 112.287 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.9 m -70.54 -40.32 73.48 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.002 0.521 . . . . 52.43 110.858 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.16 -43.79 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 123.497 0.719 . . . . 72.31 110.665 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.97 -37.54 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.363 0.665 . . . . 74.44 110.735 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.35 -48.41 79.9 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.546 0.738 . . . . 62.43 112.456 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -71.95 -32.45 67.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 120.698 0.285 . . . . 75.13 111.566 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . . . -76.07 -25.68 55.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.317 0.647 . . . . 64.03 112.563 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.75 -33.46 12.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.304 0.642 . . . . 74.1 112.161 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.5 mm-40 -67.52 127.16 93.37 Favored Pre-proline 0 CA--C 1.563 1.479 0 O-C-N 122.07 -0.394 . . . . 72.01 111.927 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 40.7 Cg_exo -58.03 109.94 0.56 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.639 2.893 . . . . 75.23 114.747 -173.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.79 26.23 67.64 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.882 0.713 . . . . 64.12 114.882 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.66 13.1 35.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 118.819 1.309 . . . . 74.42 112.295 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 8.0 p-10 -51.47 116.54 2.13 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.132 0.573 . . . . 71.34 110.884 167.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 120.62 36.18 0.8 Allowed Glycine 0 N--CA 1.47 0.957 0 CA-C-N 115.931 -0.577 . . . . 41.32 112.117 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -111.79 127.25 8.03 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 110.77 -0.932 . . . . 52.32 110.77 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.08 125.82 53.96 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.282 0.541 . . . . 54.22 110.819 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -94.89 121.78 36.85 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.345 -0.983 . . . . 63.04 108.345 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.52 108.71 20.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.53 0.681 . . . . 63.34 110.256 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD21 ' A' ' 71' ' ' LEU . 3.5 mm? -91.65 132.19 36.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.192 0.997 . . . . 72.31 110.357 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.65 32.07 4.63 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 116.048 -0.524 . . . . 73.41 112.966 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.3 133.99 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.976 0.511 . . . . 60.31 110.181 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.44 129.07 56.44 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.223 -1.399 . . . . 70.53 107.223 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -110.9 129.6 55.83 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.173 0.511 . . . . 73.41 111.702 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.51 54.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.287 1.035 . . . . 73.33 110.334 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.5 mm -96.2 126.76 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.292 0.637 . . . . 74.11 110.476 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 63' ' ' ASP . 30.9 p30 -87.95 -174.1 4.56 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.526 0.73 . . . . 52.54 111.61 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.92 -22.98 67.17 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.654 0.782 . . . . 72.43 112.621 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -74.11 -23.4 59.31 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.903 0.881 . . . . 73.41 112.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.74 78.64 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.625 -0.261 . . . . 75.15 112.722 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' HD21 ' A' ' 59' ' ' ASN . 26.0 t70 -75.03 142.41 43.79 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.617 1.167 . . . . 71.23 111.278 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.3 m -93.95 108.85 20.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.693 0.797 . . . . 74.41 110.335 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.76 121.81 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.625 0.77 . . . . 70.23 109.757 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -92.08 127.34 37.52 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.404 0.682 . . . . 74.05 110.225 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -123.11 120.89 27.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.809 0.844 . . . . 75.44 110.458 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.13 90.31 0.66 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.575 2.183 . . . . 60.14 112.761 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.95 -12.18 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.289 0.636 . . . . 62.03 112.015 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.63 179.03 44.36 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.234 -0.439 . . . . 53.23 113.627 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 52' ' ' LEU . 3.5 mp -105.18 139.94 20.62 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 109.686 -0.487 . . . . 61.05 109.686 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.25 -30.17 25.1 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.137 1.891 . . . . 64.42 112.056 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.62 71.1 81.27 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.856 0.863 . . . . 75.24 110.226 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.69 -24.94 17.83 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.914 2.409 . . . . 74.21 112.764 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.17 -45.3 77.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 74.13 110.044 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 7.9 mtpm? -61.39 -53.89 50.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.708 -0.678 . . . . 63.22 111.198 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.2 -35.32 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.571 0.749 . . . . 52.12 112.103 -172.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 54.2 tt0 -63.81 -46.09 86.68 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 120.99 0.424 . . . . 74.23 111.5 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -70.29 -47.61 60.45 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.566 0.746 . . . . 55.2 112.07 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.195 0.998 . . . . 53.21 111.409 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 tp -71.32 -41.47 69.81 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.647 0.379 . . . . 72.55 111.276 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.2 86.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.192 0.597 . . . . 72.31 111.297 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 -52.19 55.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.938 0.895 . . . . 72.41 111.191 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -68.32 -29.57 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.731 0.412 . . . . 73.52 111.596 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 45.5 t -60.27 -27.4 67.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.74 -0.6 . . . . 74.11 112.043 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.11 -49.61 6.3 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.161 0.584 . . . . 60.23 111.825 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 t -68.7 -32.14 71.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.372 0.879 . . . . 43.21 113.372 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.7 mmt -78.93 -48.15 15.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.368 0.667 . . . . 63.41 111.366 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD21 ' SD ' ' A' ' 33' ' ' MET . 31.0 mt -88.39 151.4 22.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.688 0.625 . . . . 71.23 112.688 -166.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -55.27 -58.62 6.96 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.138 1.375 . . . . 70.11 112.369 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' HB3' ' A' ' 119' ' ' HIS . 43.1 t -102.36 146.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.621 0.769 . . . . 74.12 109.535 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.27 97.23 0.71 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.41 0.624 . . . . 63.15 110.822 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.474 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.5 tt -81.75 136.72 35.43 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.146 -1.057 . . . . 44.51 108.146 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -107.16 91.16 6.28 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.246 0.619 . . . . 73.22 109.948 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.71 118.61 4.21 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.135 1.89 . . . . 70.31 111.583 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 37.5 tt0 -73.44 109.24 6.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 74.22 109.084 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.509 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 66.7 mtt -116.39 133.21 56.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.132 0.573 . . . . 74.43 111.747 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.429 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 15.1 mm100 -134.75 139.61 45.3 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.251 1.021 . . . . 75.44 110.471 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.7 mt -104.85 113.05 26.41 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.175 0.99 . . . . 73.04 110.946 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -118.01 136.48 53.5 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.224 1.009 . . . . 54.32 110.147 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -92.44 118.7 31.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.557 0.343 . . . . 73.32 110.313 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.16 113.99 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 63.4 108.925 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.8 29.49 67.53 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 114.804 0.682 . . . . 62.45 114.804 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.69 79.95 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.507 0.563 . . . . 73.13 114.507 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.34 136.43 49.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.995 0.918 . . . . 53.1 110.19 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.3 m -87.77 120.97 29.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.701 0.682 . . . . 74.45 110.903 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.5 mp -116.36 156.46 26.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.856 0.862 . . . . 64.3 109.813 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 52.5 tp -115.75 121.57 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.097 0.559 . . . . 74.22 110.117 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HD11 ' A' ' 7' ' ' LEU . 51.3 t -99.05 121.79 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.532 0.733 . . . . 73.24 109.153 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.39 101.38 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.957 0.503 . . . . 70.51 110.36 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 77.6 t80 -73.33 122.7 22.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.321 0.648 . . . . 74.34 109.826 170.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.65 110.51 63.3 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.371 0.668 . . . . 45.45 109.771 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.13 145.84 24.88 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.308 2.005 . . . . 74.22 112.235 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 42.7 tt0 -74.27 145.0 44.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.159 -0.682 . . . . 74.33 109.159 169.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -84.96 173.83 10.25 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 123.239 0.616 . . . . 64.1 111.691 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.97 176.87 0.64 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 124.829 1.251 . . . . 75.15 111.044 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.89 -56.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.714 -1.241 . . . . 63.02 114.117 167.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -82.72 -41.45 19.26 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.354 0.525 . . . . 74.22 111.379 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.66 ' HB3' HG21 ' A' ' 91' ' ' VAL . 19.1 m-70 -104.7 73.65 1.1 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 103.734 -2.691 . . . . 74.01 103.734 162.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.5 mttt -46.87 -139.08 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.8 1 C-N-CA 133.526 4.73 . . . . 73.02 121.301 53.163 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo 6.43 67.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 124.592 3.528 . . . . 54.35 116.225 -122.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 120' ' ' LYS . 23.5 mm -76.72 80.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-N 115.287 -0.87 . . . . 51.42 109.595 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -82.95 152.97 25.26 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.923 0.392 . . . . 65.05 110.224 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 CA--C 1.554 1.122 0 N-CA-C 109.439 -0.578 . . . . 71.01 109.439 172.942 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HB ' ' A' ' 109' ' ' VAL . 56.6 ttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.221 0.452 . . . . 60.51 112.221 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 1' ' ' MET . 86.5 mtt180 -47.26 145.65 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.827 0.676 . . . . 72.23 112.827 158.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -64.11 151.65 42.64 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 71.13 111.268 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.12 -26.69 68.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.953 -0.567 . . . . 51.4 111.993 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.605 HG23 HG13 ' A' ' 102' ' ' VAL . 2.0 m -66.53 -47.37 73.1 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.152 0.981 . . . . 61.25 111.131 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.83 -44.06 97.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.987 0.915 . . . . 72.12 111.502 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.04 -30.81 69.25 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.074 -0.966 . . . . 74.32 112.246 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -66.03 -43.43 87.64 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.129 0.571 . . . . 74.52 109.962 171.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.8 -37.71 85.39 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.49 0.716 . . . . 71.4 111.591 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.71 -41.97 99.41 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.074 0.95 . . . . 72.13 110.925 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.03 -44.68 94.48 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.142 0.977 . . . . 71.12 112.113 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -76.99 -16.13 59.42 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.645 0.609 . . . . 74.4 112.645 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.43 43.38 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.239 0.616 . . . . 61.52 111.147 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 17' ' ' SER . 17.1 m -115.82 119.16 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.863 0.865 . . . . 63.03 110.02 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.21 -47.48 83.33 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.774 0.83 . . . . 65.04 111.27 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.95 95.96 9.81 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 62.34 108.656 165.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 14' ' ' VAL . 35.8 t -58.57 122.08 12.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.123 -0.489 . . . . 64.42 111.929 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.96 76.95 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.698 0.629 . . . . 65.21 112.698 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -150.88 15.48 0.75 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.089 0.774 . . . . 73.32 113.089 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.0 mm -102.21 106.47 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.342 -0.984 . . . . 72.41 108.342 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' HG2' HG21 ' A' ' 35' ' ' THR . 10.6 tp10 -94.8 114.35 26.23 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.323 0.649 . . . . 75.24 111.504 -169.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.53 35.38 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.651 0.781 . . . . 52.52 112.136 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -153.19 156.24 38.18 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.906 0.86 . . . . 64.12 112.235 176.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -81.37 163.19 23.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.42 -1.264 . . . . 75.34 110.362 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.05 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.787 0.435 . . . . 74.12 112.078 173.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 m -64.52 -29.97 71.01 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.866 0.867 . . . . 71.11 112.572 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 63.8 m-20 -82.53 -16.08 49.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.263 0.625 . . . . 75.35 112.337 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.506 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.8 tmm? -63.64 120.1 11.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.976 0.511 . . . . 73.24 111.822 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.19 -139.46 6.13 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.147 -0.478 . . . . 65.43 112.324 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -58.64 -41.65 86.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.988 1.107 . . . . 71.12 113.988 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -64.61 -41.12 96.43 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.583 0.753 . . . . 71.31 112.225 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.546 HG22 ' HE3' ' A' ' 23' ' ' LYS . 84.5 t -67.08 -43.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.581 0.752 . . . . 71.22 110.517 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.4 tpp -56.45 -40.92 75.61 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.965 1.306 . . . . 60.43 112.479 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.71 -39.23 90.77 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.47 0.708 . . . . 64.2 110.432 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.523 HG21 ' HG2' ' A' ' 21' ' ' GLU . 23.4 m -75.51 -30.74 59.91 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.06 0.544 . . . . 75.32 111.416 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 112' ' ' VAL . 69.2 t -59.39 -41.82 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.343 0.657 . . . . 73.12 110.657 174.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mt -59.86 -36.55 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 122.843 0.457 . . . . 73.24 111.326 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.38 97.27 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.827 1.047 . . . . 74.34 113.827 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' HD23 ' A' ' 45' ' ' LEU . 87.9 m-85 -70.76 -35.41 72.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.931 0.492 . . . . 73.14 111.206 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -22.7 46.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.693 0.797 . . . . 53.11 112.397 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -74.59 -50.09 19.23 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 54.21 111.754 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.06 142.18 72.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.175 0.59 . . . . 73.53 112.076 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.53 123.0 7.8 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.584 2.19 . . . . 74.22 113.107 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.39 34.71 85.76 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.83 -0.623 . . . . 52.11 114.551 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 39' ' ' PHE . 16.4 tp -97.97 18.79 15.15 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 117.738 0.769 . . . . 60.55 111.143 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -45.55 122.62 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.898 1.073 . . . . 72.11 113.898 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.1 51.12 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.421 -0.655 . . . . 34.2 114.554 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.66 137.27 9.2 Favored Glycine 0 C--N 1.364 2.094 0 CA-C-N 118.847 1.323 . . . . 71.23 111.9 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -121.27 138.68 54.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.462 0.705 . . . . 73.4 111.623 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 21' ' ' GLU . 5.4 mp -106.87 121.27 44.07 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.896 0.878 . . . . 71.44 109.392 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.84 109.56 21.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.501 0.72 . . . . 72.01 110.103 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 108' ' ' LEU . 9.5 mp -95.53 136.47 35.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.304 1.041 . . . . 74.24 109.989 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.33 31.55 8.91 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.894 -0.594 . . . . 42.02 112.372 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.3 t -112.18 139.68 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.597 0.759 . . . . 75.53 109.481 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -114.16 159.13 20.42 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.835 -1.172 . . . . 50.3 107.835 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.454 ' HH2' ' HA ' ' A' ' 23' ' ' LYS . 41.3 p90 -150.65 137.16 18.81 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 73.35 111.296 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.91 49.14 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.583 0.753 . . . . 55.14 110.701 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -88.91 130.89 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.362 0.665 . . . . 62.34 110.666 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 63' ' ' ASP . 31.9 p30 -82.13 -172.49 3.99 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.631 0.772 . . . . 72.32 112.486 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.07 -33.12 75.04 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.745 0.818 . . . . 75.14 112.433 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -83.04 -12.61 57.05 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.246 0.618 . . . . 73.53 112.335 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.08 37.02 6.11 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.228 0.451 . . . . 45.33 114.228 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' HD21 ' A' ' 59' ' ' ASN . 8.7 m-20 -116.77 134.72 54.44 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.479 0.711 . . . . 72.54 110.413 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -86.68 118.5 26.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.415 0.686 . . . . 73.44 110.548 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.39 118.34 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.126 0.57 . . . . 74.32 109.885 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.06 120.39 34.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.575 0.75 . . . . 73.34 109.821 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -124.02 151.02 64.57 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.847 0.859 . . . . 73.3 112.088 -170.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.47 121.7 5.28 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.606 2.204 . . . . 74.31 112.823 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.41 -40.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.9 -1.045 . . . . 64.54 110.557 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.44 170.28 46.76 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.695 -0.684 . . . . 53.4 113.362 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.09 139.76 22.18 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 109.619 -0.512 . . . . 70.44 109.619 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 -29.92 31.35 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.569 2.179 . . . . 53.22 111.954 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -133.19 83.06 51.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 108.328 -0.99 . . . . 61.35 108.328 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.21 -36.65 56.18 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.904 2.403 . . . . 63.5 113.564 -172.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.8 -43.01 60.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.191 0.596 . . . . 64.01 110.969 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.1 -45.57 94.15 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.407 0.283 . . . . 71.12 111.39 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.33 -43.64 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.479 0.712 . . . . 71.22 111.352 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.48 -48.42 81.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.523 0.729 . . . . 64.15 111.953 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -66.76 -40.93 88.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.171 -0.922 . . . . 61.45 111.474 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.83 -35.81 82.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.232 0.613 . . . . 74.01 110.91 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.34 -37.05 71.73 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.624 0.769 . . . . 74.31 111.329 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.56 86.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.439 0.696 . . . . 72.43 111.399 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.2 t -65.07 -52.55 55.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.839 0.855 . . . . 73.43 111.503 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.39 -31.82 73.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.21 0.604 . . . . 75.31 111.922 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 44.8 t -60.05 -35.3 74.83 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.163 0.506 . . . . 71.13 112.153 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.78 37.2 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.615 -0.721 . . . . 74.23 112.187 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.8 p -95.35 -2.59 48.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.593 0.961 . . . . 72.5 113.593 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.3 mmt -93.16 -55.45 3.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.371 0.605 . . . . 71.23 109.955 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.94 146.82 26.01 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.36 -0.836 . . . . 72.53 110.548 -171.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' A' ' 91' ' ' VAL . 8.5 p-10 -52.75 -33.1 46.75 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.59 1.156 . . . . 41.32 113.161 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG13 ' ND2' ' A' ' 90' ' ' ASN . 18.1 m -120.25 162.57 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.25 1.02 . . . . 62.42 110.773 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.28 101.75 6.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.657 -0.701 . . . . 74.51 110.427 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.421 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.4 tt -83.24 124.12 30.25 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.57 -1.27 . . . . 73.11 107.57 172.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -102.89 98.75 12.04 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 122.76 0.424 . . . . 71.02 110.856 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.82 163.06 7.63 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.284 1.99 . . . . 64.54 112.433 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 60.4 tt0 -88.23 121.69 30.92 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtt -124.4 117.78 25.22 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.241 0.617 . . . . 71.04 110.799 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.692 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 28.6 mm-40 -131.38 138.78 49.29 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.686 0.794 . . . . 54.31 110.615 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.31 117.27 29.52 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.504 0.721 . . . . 63.5 109.439 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.7 133.53 53.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.394 1.078 . . . . 64.41 110.297 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -89.86 129.9 36.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.988 0.515 . . . . 73.25 111.095 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.605 HG13 HG23 ' A' ' 5' ' ' THR . 23.9 t -128.13 107.74 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.97 0.908 . . . . 63.33 108.828 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.6 28.95 57.11 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.727 0.651 . . . . 53.11 114.727 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.75 0.93 83.42 Favored Glycine 0 CA--C 1.543 1.794 0 N-CA-C 114.82 0.688 . . . . 74.12 114.82 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.7 133.05 41.74 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.611 0.706 . . . . 71.03 109.303 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -86.74 102.72 14.51 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.418 0.554 . . . . 74.11 110.796 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.2 154.42 18.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.52 0.728 . . . . 71.02 110.26 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 52' ' ' LEU . 52.0 tp -116.69 120.1 37.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.401 0.681 . . . . 72.1 109.288 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 17.3 t -95.87 132.63 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.105 -0.702 . . . . 74.12 109.105 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.06 99.22 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.862 -0.792 . . . . 74.52 108.862 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 54.1 t80 -83.67 131.65 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.08 0.552 . . . . 55.43 110.107 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 36' ' ' VAL . 36.6 t -121.92 116.26 30.23 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 109.434 -0.58 . . . . 73.04 109.434 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.23 -176.15 1.76 Allowed 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.708 2.272 . . . . 54.44 112.832 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.81 131.68 44.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.93 0.492 . . . . 70.2 109.85 166.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.08 157.02 23.02 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.038 0.535 . . . . 53.45 111.339 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.93 150.99 46.91 Favored 'General case' 0 C--O 1.186 -2.24 0 C-N-CA 123.963 0.905 . . . . 72.45 111.417 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -38.01 -52.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 N-CA-C 115.738 1.755 . . . . 44.24 115.738 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -69.59 -37.86 77.11 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.124 0.787 . . . . 64.45 113.124 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.8 m-70 -125.73 66.66 1.17 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 105.273 -2.121 . . . . 75.4 105.273 171.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 122' ' ' ILE . 62.8 mttm -44.14 -153.0 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.207 1 C-N-CA 132.863 4.465 . . . . 70.13 121.316 60.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -1.85 71.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.584 2.19 . . . . 65.03 116.244 -117.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.612 HG13 ' HA ' ' A' ' 120' ' ' LYS . 59.5 mt -85.88 111.0 20.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.805 -1.089 . . . . 71.23 110.248 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -113.14 139.53 48.67 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.836 -1.075 . . . . 72.14 110.401 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.322 0.649 . . . . 71.52 109.443 173.2 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 23.3 ttt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.353 -0.239 . . . . 73.31 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.88 153.53 18.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.13 0.572 . . . . 72.44 111.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.3 t -74.41 156.82 36.61 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.442 0.697 . . . . 62.15 111.249 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.89 -27.73 67.75 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.934 0.493 . . . . 64.21 111.355 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.576 HG23 HG13 ' A' ' 102' ' ' VAL . 3.8 m -70.18 -41.75 73.34 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.658 0.783 . . . . 70.34 110.395 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.18 -51.04 67.96 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.622 1.169 . . . . 72.14 110.952 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 51' ' ' LEU . 85.3 mt -69.67 -33.25 72.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.1 0.96 . . . . 75.21 113.081 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.93 -44.8 88.32 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.013 0.435 . . . . 44.33 110.404 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.33 -37.61 86.31 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.519 -0.764 . . . . 63.24 111.096 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.29 -43.12 98.8 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.885 0.874 . . . . 74.41 110.703 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 22' ' ' ALA . 71.4 mt -67.09 -38.56 85.92 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.518 1.127 . . . . 71.43 111.96 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -72.61 -23.8 60.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.118 0.567 . . . . 62.1 111.942 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.2 17.59 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.475 0.71 . . . . 52.05 110.965 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.33 116.54 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.179 0.514 . . . . 64.01 110.77 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.17 -43.21 87.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.67 0.388 . . . . 72.21 110.629 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.24 101.2 1.44 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.232 0.539 . . . . 73.22 109.931 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 25.3 m -80.89 78.64 7.67 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.589 0.756 . . . . 75.22 110.161 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.07 40.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.955 1.095 . . . . 73.52 113.955 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -123.72 -9.35 7.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 113.047 0.758 . . . . 74.25 113.047 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 17' ' ' SER . 42.3 mt -131.92 133.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.684 0.794 . . . . 73.41 109.301 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -125.7 129.4 49.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.826 0.739 . . . . 72.05 111.316 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -89.02 131.74 35.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.705 0.802 . . . . 71.52 110.612 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.34 151.94 51.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.834 0.854 . . . . 72.12 111.046 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -92.39 165.63 12.97 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.705 . . . . 72.34 112.474 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -24.54 67.31 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.141 0.976 . . . . 72.23 112.276 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.1 -36.02 82.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.865 0.466 . . . . 53.43 111.982 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -86.04 -2.48 58.35 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.466 0.706 . . . . 70.14 112.238 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.4 tpt -52.59 105.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.346 1.059 . . . . 72.34 111.909 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.471 ' HA2' ' OE1' ' A' ' 84' ' ' GLN . . . 138.05 -124.72 3.03 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.802 -0.635 . . . . 61.13 112.83 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.31 -36.85 76.38 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.461 1.105 . . . . 74.15 112.157 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.0 m -72.53 -18.85 61.61 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.264 -0.88 . . . . 63.31 112.991 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -34.34 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.659 0 C-N-CA 122.902 0.481 . . . . 62.23 111.709 167.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 24.7 mmt -74.69 -37.52 62.61 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.367 1.618 . . . . 73.24 115.367 -158.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.44 70.52 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.38 0.537 . . . . 72.2 112.19 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 HD21 ' A' ' 50' ' ' LEU . 31.8 m -77.31 -30.76 54.25 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.186 0.594 . . . . 65.04 111.28 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.53 -39.93 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 122.837 0.455 . . . . 72.32 110.266 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB2' ' A' ' 124' ' ' LYS . 68.6 mt -57.2 -35.61 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.533 0.733 . . . . 73.03 111.637 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.3 1.61 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.47 0.308 . . . . 73.04 110.891 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -65.46 -30.51 71.31 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.498 0.719 . . . . 73.43 112.359 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.81 -24.85 55.93 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.782 0.66 . . . . 51.44 112.782 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 121' ' ' PRO . 49.0 m-80 -115.95 -4.69 12.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.149 1.166 . . . . 63.14 114.149 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -92.52 107.15 21.75 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.0 0.818 . . . . 73.35 110.773 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.52 126.74 8.47 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.464 2.11 . . . . 32.21 112.997 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.21 -7.05 32.48 Favored Glycine 0 N--CA 1.474 1.216 0 CA-C-N 116.002 -0.544 . . . . 73.3 113.734 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.07 -37.93 9.95 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.986 0.893 . . . . 72.54 108.935 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' GLU . 11.0 m-20 39.6 71.81 0.16 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.309 1.844 . . . . 64.53 115.401 171.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.41 74.45 0.43 Allowed Glycine 0 C--N 1.352 1.425 0 N-CA-C 115.362 0.905 . . . . 54.33 115.362 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.13 44.45 Favored Glycine 0 N--CA 1.482 1.72 0 CA-C-N 117.237 0.518 . . . . 53.33 113.234 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -129.26 142.43 50.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.575 0.954 . . . . 74.11 113.575 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 35' ' ' THR . 95.8 mt -132.28 125.44 31.02 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.24 1.416 . . . . 63.11 109.891 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.7 mm? -103.56 108.81 20.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.743 0.417 . . . . 70.31 110.851 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.71 124.93 38.04 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 61.52 109.857 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.98 33.15 4.13 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.158 -0.474 . . . . 73.13 112.94 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.88 146.33 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.545 0.738 . . . . 73.13 109.875 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -130.55 134.3 46.91 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.997 -0.742 . . . . 74.31 108.997 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -117.44 129.65 55.97 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.291 1.036 . . . . 74.3 110.881 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.76 135.22 54.19 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.604 0.762 . . . . 75.04 110.813 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -80.54 129.68 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.606 0.762 . . . . 63.35 110.487 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 40.7 p30 -90.89 -168.17 2.01 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.88 0.696 . . . . 63.55 112.88 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.17 -44.6 68.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.755 1.222 . . . . 74.13 113.48 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -26.8 27.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.013 0.525 . . . . 75.11 111.635 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.16 7.39 14.69 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 119.913 -0.382 . . . . 71.42 114.023 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 8.3 m-20 -74.48 143.1 44.77 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.471 0.636 . . . . 75.02 111.013 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.1 m -90.11 114.28 26.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.871 0.869 . . . . 71.03 110.156 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.55 117.28 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.437 0.695 . . . . 73.43 110.443 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -92.66 116.39 28.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.088 0.955 . . . . 74.45 110.422 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -118.46 149.76 46.67 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 123.885 0.874 . . . . 75.53 111.383 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.63 104.92 1.78 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.66 2.24 . . . . 74.44 112.014 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.94 -29.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 116.052 -0.522 . . . . 74.25 110.397 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -174.16 55.11 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.615 -0.721 . . . . 55.41 113.57 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 77' ' ' VAL . 82.0 mt -104.51 133.14 20.34 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.718 0.807 . . . . 73.21 110.542 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.43 -31.34 42.77 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.521 2.148 . . . . 74.53 111.763 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 5.8 m-20 -122.52 75.43 44.53 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 124.077 0.951 . . . . 64.14 109.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.83 -60.26 0.62 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.24 2.627 . . . . 73.14 114.223 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 5.2 p-10 -66.28 -39.36 89.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.263 -0.426 . . . . 54.43 110.65 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 57.4 tptt -60.96 -40.77 94.59 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.627 0.771 . . . . 62.31 112.089 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG21 HD22 ' A' ' 71' ' ' LEU . 79.2 t -62.84 -44.92 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.037 0.535 . . . . 70.44 110.888 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.49 -50.34 73.93 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.586 0.754 . . . . 71.22 112.313 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 16.5 mmt85 -68.51 -43.96 75.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.495 0.718 . . . . 75.44 111.521 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.72 -33.54 72.63 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.541 -0.754 . . . . 74.33 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.559 HD23 ' SD ' ' A' ' 97' ' ' MET . 21.6 tp -66.98 -40.19 87.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.688 0.395 . . . . 62.51 110.936 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.2 93.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.97 0.508 . . . . 40.55 111.695 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -66.52 -52.47 45.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.813 0.845 . . . . 64.14 112.016 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.471 ' OE1' ' HA2' ' A' ' 29' ' ' GLY . 11.7 pt20 -71.13 -31.17 67.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.003 0.521 . . . . 72.24 112.321 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 42.4 t -60.89 -26.92 67.78 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.435 0.636 . . . . 64.35 111.373 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -76.48 -25.15 53.98 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 113.721 1.008 . . . . 51.0 113.721 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.5 p -110.44 -37.24 5.55 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.288 0.847 . . . . 71.52 113.288 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 92.1 mmm -68.29 -46.89 69.11 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.393 1.077 . . . . 70.53 111.542 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.407 HD12 ' SG ' ' A' ' 85' ' ' CYS . 53.9 mt -85.89 161.91 18.84 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.718 -0.674 . . . . 72.2 111.374 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -37.33 -53.05 1.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.873 1.669 . . . . 75.41 114.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 122' ' ' ILE . 28.7 m -119.64 174.33 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.507 0.723 . . . . 73.41 111.441 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -68.73 97.4 0.81 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.202 -0.666 . . . . 54.32 109.202 163.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 122' ' ' ILE . 4.9 tt -98.84 130.84 45.27 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.47 0.708 . . . . 61.13 109.465 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -106.62 98.55 20.92 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 124.061 0.944 . . . . 73.14 110.985 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.4 149.93 15.03 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.238 1.959 . . . . 51.03 111.407 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 9.9 tp10 -87.21 102.68 14.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.097 -0.705 . . . . 64.12 109.097 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 108' ' ' LEU . 51.9 mtm -112.43 140.25 47.32 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.536 0.735 . . . . 70.04 110.679 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -149.88 150.86 32.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.352 0.661 . . . . 74.13 110.46 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.73 119.28 38.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.295 1.038 . . . . 63.34 110.59 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -127.23 133.54 50.22 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.085 0.954 . . . . 75.32 109.711 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.85 122.16 40.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.073 0.463 . . . . 70.32 110.879 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 5' ' ' THR . 9.2 t -119.95 113.44 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.502 1.121 . . . . 73.32 108.41 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.29 28.67 55.25 Favored Glycine 0 CA--C 1.547 2.064 0 N-CA-C 115.169 0.828 . . . . 54.32 115.169 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.12 1.92 66.69 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 115.088 0.795 . . . . 65.23 115.088 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -109.96 130.51 55.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.993 0.897 . . . . 75.44 109.685 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 102.41 14.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.484 0.583 . . . . 73.13 111.685 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.39 166.45 14.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.895 0.878 . . . . 63.33 111.046 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 97' ' ' MET . 49.3 tp -119.21 121.84 40.62 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.56 0.744 . . . . 74.03 110.782 175.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' MET . 52.6 t -86.93 113.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.299 0.639 . . . . 74.02 109.576 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 55.3 t -100.22 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.37 0.605 . . . . 74.41 109.691 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.6 119.28 24.54 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.929 0.892 . . . . 75.34 109.252 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.87 100.34 39.17 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.488 0.715 . . . . 62.14 109.55 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.25 157.29 41.78 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.5 2.133 . . . . 71.43 112.175 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.5 tm-20 -75.94 115.94 16.15 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.23 -0.655 . . . . 71.42 109.23 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.47 152.22 35.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.346 1.058 . . . . 53.2 112.425 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' HB3' HG22 ' A' ' 118' ' ' THR . 14.9 t70 -77.55 156.93 30.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.049 -0.523 . . . . 73.43 111.238 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -64.99 -19.92 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.412 0.685 . . . . 71.32 112.426 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 116' ' ' ASP . 14.9 t -58.01 -18.31 23.22 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 123.534 0.733 . . . . 51.44 112.277 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 83.8 m-70 -79.88 -76.65 0.21 Allowed 'General case' 0 CA--C 1.591 2.548 0 N-CA-C 106.979 -1.489 . . . . 71.03 106.979 166.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 5.8 tmtp? -79.92 -142.57 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.414 0 C-N-CA 129.519 3.127 . . . . 72.43 110.742 -49.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 1.24 112.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.592 1 C-N-CA 125.611 4.207 . . . . 65.54 119.424 -133.832 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.701 HG21 HD12 ' A' ' 93' ' ' LEU . 36.8 mm -95.52 102.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 115.312 -0.858 . . . . 75.02 109.634 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -101.6 167.5 10.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.769 0.828 . . . . 65.42 110.714 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.586 ' HB2' HD11 ' A' ' 37' ' ' ILE . 37.8 ttpt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.41 -0.959 . . . . 73.3 108.41 171.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 98' ' ' GLN . 14.9 ptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 111.383 0.142 . . . . 71.42 111.383 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.09 149.22 21.9 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.681 0.392 . . . . 72.52 111.143 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -74.03 157.31 36.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.943 0.897 . . . . 74.32 112.453 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 102' ' ' VAL . . . -61.27 -43.68 98.47 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.034 0.534 . . . . 64.54 112.208 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -65.0 -35.09 80.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.229 0.612 . . . . 73.21 112.154 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.284 0.634 . . . . 71.33 111.262 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 20' ' ' ILE . 60.2 mt -68.76 -39.56 80.21 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.541 0.736 . . . . 63.21 111.456 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 31.7 tp -65.12 -29.07 69.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.94 0.896 . . . . 75.23 111.276 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.28 -35.09 71.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.638 0.775 . . . . 75.43 111.525 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.89 -50.09 32.29 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 110.232 -0.285 . . . . 75.13 110.232 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 69.6 mt -55.31 -46.86 76.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.489 1.116 . . . . 73.53 113.65 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -87.76 -4.08 58.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.486 0.921 . . . . 55.42 113.486 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.59 -59.84 2.16 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.383 0.611 . . . . 65.52 110.3 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.26 139.09 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 73.43 110.775 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -64.92 -47.24 78.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.633 0.773 . . . . 74.43 112.408 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.85 148.15 24.74 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -93.33 143.58 26.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.748 0.309 . . . . 71.54 110.721 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.58 3.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.361 0.664 . . . . 61.23 111.485 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -137.11 1.59 2.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.043 0.756 . . . . 71.4 113.043 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.576 HD12 HD22 ' A' ' 7' ' ' LEU . 11.0 mm -108.7 107.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 118.78 0.718 . . . . 74.31 110.483 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -94.2 113.81 25.81 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.46 -0.775 . . . . 75.04 110.881 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.09 129.12 35.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.277 0.631 . . . . 73.14 109.919 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -133.82 164.59 26.91 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.721 0.772 . . . . 74.23 111.892 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -101.42 177.73 4.84 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.662 -1.154 . . . . 75.12 110.945 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.06 62.65 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 73.33 111.467 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 p -65.67 -29.9 70.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 53.2 112.274 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.08 -17.01 62.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.164 0.801 . . . . 70.0 113.164 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.409 ' SD ' HG13 ' A' ' 77' ' ' VAL . 92.0 mmm -55.52 107.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.706 0.802 . . . . 70.13 112.111 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.92 -125.38 2.94 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.279 -0.873 . . . . 40.44 111.158 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 2.9 mptp? -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.294 0.638 . . . . 71.43 112.371 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 m -68.18 -45.32 73.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.48 0.712 . . . . 50.4 111.884 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.47 -52.71 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.822 0.449 . . . . 64.43 110.222 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.575 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 39.8 tpp -52.66 -46.52 67.2 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.283 1.033 . . . . 74.03 113.745 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.54 -27.87 64.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.163 0.585 . . . . 74.0 111.914 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.6 m -69.48 -39.3 77.74 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.133 0.573 . . . . 54.12 111.029 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.39 -35.51 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 123.001 0.521 . . . . 73.31 110.756 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 33' ' ' MET . 47.9 mm -57.56 -39.1 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.629 0.772 . . . . 75.44 110.929 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.98 82.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.77 -0.65 . . . . 74.54 112.035 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.4 -38.87 40.62 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.113 0.565 . . . . 72.4 112.204 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . -63.76 -42.41 97.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.298 0.639 . . . . 65.32 111.939 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -90.61 7.22 40.34 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.203 0.601 . . . . 55.01 112.154 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.51 116.05 65.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.416 -0.587 . . . . 73.35 109.416 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.5 111.19 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.264 2.643 . . . . 74.4 115.412 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 25.39 64.59 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.855 1.502 . . . . 52.04 116.855 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -101.06 23.37 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.816 1.308 . . . . 72.53 111.604 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.8 p-10 -46.64 124.85 6.43 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.314 0.645 . . . . 70.31 111.535 167.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.3 -12.68 7.97 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.949 -0.569 . . . . 54.43 112.176 -165.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.15 104.54 0.17 Allowed Glycine 0 CA--C 1.548 2.114 0 N-CA-C 112.259 -0.336 . . . . 41.12 112.259 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.31 132.53 51.39 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.696 0.798 . . . . 74.03 111.405 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.32 118.84 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.952 0.901 . . . . 62.12 108.634 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.487 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.42 106.74 17.33 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.956 -0.387 . . . . 75.34 109.956 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 4.2 mm? -93.01 133.41 36.18 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.736 0.814 . . . . 52.4 111.535 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 33.85 4.71 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 115.697 -0.683 . . . . 62.03 112.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.19 139.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.199 0.6 . . . . 74.3 109.859 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 19.7 t70 -105.63 159.25 16.11 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.128 -1.434 . . . . 74.14 107.128 171.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -148.02 141.11 24.96 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.283 0.563 . . . . 53.25 111.331 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.5 142.03 46.91 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.703 0.801 . . . . 74.03 110.934 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mm -80.31 123.89 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.728 0.811 . . . . 61.4 110.402 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 63' ' ' ASP . 37.6 p30 -82.53 -175.95 5.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.494 0.318 . . . . 72.43 111.642 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.27 -31.42 69.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.877 0.871 . . . . 71.41 113.267 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -81.04 -31.21 34.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.186 0.594 . . . . 73.14 111.483 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.03 9.94 11.54 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 114.389 0.515 . . . . 75.22 114.389 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 59' ' ' ASN . 27.8 m-20 -85.74 147.66 26.23 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.533 0.733 . . . . 75.32 112.298 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -86.64 109.83 19.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.669 0.787 . . . . 70.13 110.868 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.98 123.56 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.465 0.706 . . . . 71.4 110.144 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.33 114.32 26.36 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.585 0.707 . . . . 73.13 111.651 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -117.05 109.95 42.13 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.146 1.379 . . . . 74.21 110.32 -177.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.83 106.42 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.268 1.979 . . . . 61.43 112.359 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.43 -8.47 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.099 0.559 . . . . 64.44 112.505 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.9 -174.14 53.77 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.687 0.635 . . . . 73.43 114.687 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.92 124.59 27.81 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.778 1.231 . . . . 72.42 109.069 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.17 -39.1 71.86 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.601 2.2 . . . . 74.43 112.867 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.18 77.0 42.47 Favored Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 123.511 0.724 . . . . 62.34 109.605 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 99' ' ' LEU . 71.8 Cg_endo -73.43 -37.8 2.98 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.76 2.306 . . . . 74.11 114.347 -168.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HA ' HD11 ' A' ' 99' ' ' LEU . 20.3 t70 -66.36 -37.77 86.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.724 0.41 . . . . 71.04 109.915 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.28 -39.02 92.01 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 116.087 -0.506 . . . . 54.41 111.798 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 28' ' ' MET . 76.6 t -57.05 -40.72 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.727 0.411 . . . . 73.0 110.612 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -64.35 -43.11 95.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.734 0.814 . . . . 63.31 112.567 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 22.8 mmt180 -69.77 -48.29 59.8 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.711 0.405 . . . . 75.14 111.479 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.53 -33.75 75.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.664 1.186 . . . . 65.55 111.788 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.545 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.5 tp -71.5 -42.99 67.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.58 0.352 . . . . 71.52 111.272 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.46 78.46 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.849 0.46 . . . . 74.21 111.568 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 t -66.22 -52.24 49.8 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.641 0.776 . . . . 64.14 111.156 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 88' ' ' MET . 10.8 pt20 -67.71 -34.63 77.26 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 116.459 -0.337 . . . . 71.4 111.797 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.575 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 69.6 m -65.37 -19.6 66.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.993 -1.067 . . . . 73.42 112.78 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.94 -42.67 11.67 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.524 0.73 . . . . 62.13 112.111 169.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 t -85.06 -21.08 29.52 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.802 1.038 . . . . 62.24 113.802 -170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -90.52 -36.6 14.4 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.473 1.109 . . . . 73.04 110.102 -173.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.485 HD21 ' SD ' ' A' ' 33' ' ' MET . 68.0 mt -95.72 147.28 23.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.421 -1.263 . . . . 64.25 110.281 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.413 HD22 HG13 ' A' ' 91' ' ' VAL . 2.9 p-10 -56.17 -28.35 57.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.943 0.897 . . . . 73.45 112.781 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.7 m -124.28 159.87 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.879 0.872 . . . . 74.35 110.91 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.11 99.4 3.93 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.052 0.541 . . . . 62.21 111.449 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tt -94.38 123.38 37.75 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.733 -1.21 . . . . 73.55 107.733 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -108.43 96.03 17.83 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 123.191 0.597 . . . . 72.53 110.51 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.84 158.05 59.42 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.529 2.153 . . . . 74.41 112.761 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.1 tp10 -85.53 107.35 17.43 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.09 -0.707 . . . . 73.34 109.09 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.554 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.0 mtm -122.24 130.95 53.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.309 0.644 . . . . 62.22 111.321 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 14.1 tm0? -146.04 143.83 29.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.481 0.712 . . . . 64.44 110.904 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 75' ' ' ASP . 94.6 mt -92.04 114.08 26.53 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.327 1.051 . . . . 60.04 112.031 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -102.16 124.86 48.5 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.399 1.08 . . . . 62.13 112.173 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.58 104.06 16.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.003 0.43 . . . . 74.32 110.105 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 4' ' ' ALA . 56.3 t -137.31 131.58 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.521 1.129 . . . . 64.12 110.244 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.73 65.36 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 115.456 0.943 . . . . 72.55 115.456 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.52 4.77 90.32 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 117.091 0.445 . . . . 74.02 113.137 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -115.18 165.76 12.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.299 1.04 . . . . 71.31 110.358 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.7 m -120.43 131.22 54.68 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 120.857 0.36 . . . . 65.14 110.585 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.39 170.44 10.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.405 1.082 . . . . 64.4 109.474 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 97' ' ' MET . 46.6 tp -120.06 111.31 17.72 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.975 -0.38 . . . . 74.44 109.975 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.565 HG13 HD11 ' A' ' 7' ' ' LEU . 92.6 t -83.95 120.1 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.332 -0.618 . . . . 61.15 109.332 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 97' ' ' MET . 60.8 t -114.04 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.401 0.619 . . . . 63.4 110.948 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.735 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 75.7 t80 -78.12 125.83 29.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.979 0.912 . . . . 71.31 109.591 168.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.68 106.5 33.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.478 -0.934 . . . . 74.21 108.478 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.12 148.63 27.62 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.01 1.806 . . . . 61.42 110.852 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 36.8 tt0 -75.45 133.91 41.0 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.282 -1.007 . . . . 71.51 108.282 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.66 178.8 8.02 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.278 0.631 . . . . 62.21 110.89 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.2 176.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 122.967 0.507 . . . . 64.22 111.214 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.28 -41.92 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 O-C-N 121.004 -1.06 . . . . 73.35 113.349 166.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -69.3 -44.03 72.6 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 118.492 0.587 . . . . 73.55 111.193 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 21.2 m-70 -118.32 90.15 3.27 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 101.751 -3.426 . . . . 33.13 101.751 163.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.751 ' HA ' HG13 ' A' ' 122' ' ' ILE . 91.6 mttt -51.93 -144.49 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.048 2 C-N-CA 133.335 4.654 . . . . 74.43 122.017 45.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo 10.02 70.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 123.448 2.765 . . . . 75.3 116.805 -119.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.751 HG13 ' HA ' ' A' ' 120' ' ' LYS . 57.6 mt -102.32 131.73 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.015 -1.448 . . . . 73.45 109.492 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -155.74 162.56 40.51 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.015 0.926 . . . . 72.43 110.954 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt . . . . . 0 CA--C 1.554 1.116 0 CA-C-N 115.146 -0.934 . . . . 74.22 110.587 174.053 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 19.4 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 119.595 -0.24 . . . . 55.31 110.509 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -40.31 118.86 0.97 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.019 0.928 . . . . 71.52 112.66 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.5 m -58.1 157.63 7.88 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.105 1.362 . . . . 75.12 114.544 -171.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -61.01 -44.95 96.66 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.546 0.738 . . . . 51.22 111.817 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.42 HG23 HG13 ' A' ' 102' ' ' VAL . 2.6 m -62.88 -35.55 80.37 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-N 114.711 -1.131 . . . . 75.21 110.601 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.22 -48.23 71.27 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.025 0.93 . . . . 74.53 111.753 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 20' ' ' ILE . 35.6 mt -65.01 -36.51 84.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.624 0.37 . . . . 74.4 111.039 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.265 0.626 . . . . 65.23 110.795 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.91 -33.92 76.95 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.504 0.722 . . . . 71.13 111.277 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' HG2' HD12 ' A' ' 20' ' ' ILE . 8.8 tp10 -67.11 -41.94 85.36 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.44 0.696 . . . . 71.13 110.504 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 72.9 mt -64.47 -34.69 78.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.894 0.878 . . . . 75.43 111.363 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -80.35 -20.86 43.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.56 0.744 . . . . 74.23 112.253 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.78 -55.26 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.247 0.619 . . . . 63.21 110.46 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.4 141.73 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.059 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.54 -45.99 64.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.826 -0.546 . . . . 74.21 111.184 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.62 128.0 56.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.033 0.933 . . . . 73.41 109.896 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 m -36.13 108.64 0.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.411 1.484 . . . . 74.02 114.085 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.46 -7.93 59.46 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.159 0.8 . . . . 63.54 113.159 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -165.9 -34.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.011 0.524 . . . . 71.45 111.35 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 7' ' ' LEU . 55.5 mt -97.15 105.4 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.935 -0.765 . . . . 52.34 108.935 -167.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.03 113.15 24.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.083 -1.08 . . . . 61.25 108.083 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.81 145.83 40.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.808 0.843 . . . . 72.0 110.41 -171.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 160.96 42.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.798 0.808 . . . . 73.3 113.124 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -75.77 166.21 23.87 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 114.194 -1.366 . . . . 71.54 111.717 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.47 -33.3 43.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.224 1.01 . . . . 75.41 113.604 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.6 m -66.68 -30.48 70.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.936 0.894 . . . . 65.12 113.126 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.78 -6.23 58.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.888 0.699 . . . . 72.55 112.888 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mmm -52.79 108.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.14 0.576 . . . . 75.31 112.142 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 151.66 -123.62 1.53 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.51 -0.768 . . . . 73.53 112.417 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -57.58 -55.33 36.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.991 1.108 . . . . 75.32 113.991 -168.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -60.61 -40.47 91.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.149 0.579 . . . . 72.55 112.462 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.39 -42.22 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.045 0.538 . . . . 62.42 111.417 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 54.6 mmm -78.63 -33.83 46.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.112 -0.495 . . . . 74.54 111.713 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.002 0.921 . . . . 73.32 111.387 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' HD21 ' A' ' 50' ' ' LEU . 43.7 m -72.97 -36.45 67.11 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.692 0.797 . . . . 55.41 111.699 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.96 -37.58 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.331 0.652 . . . . 70.02 111.184 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 122' ' ' ILE . 84.7 mt -57.2 -41.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.83 0.852 . . . . 54.12 111.383 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -64.74 -48.55 74.17 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.451 0.7 . . . . 41.41 112.033 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -67.05 -37.59 84.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.187 0.595 . . . . 62.25 111.868 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.77 77.81 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.117 0.567 . . . . 71.14 111.553 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -71.59 -41.76 68.58 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.827 0.851 . . . . 72.21 111.716 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 13.6 mm-40 -72.91 128.7 87.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 123.157 0.583 . . . . 54.31 112.148 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -87.73 118.98 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.11 2.54 . . . . 75.22 112.929 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.09 14.99 58.31 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 115.066 0.786 . . . . 72.01 115.066 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.27 23.55 13.54 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 118.774 1.287 . . . . 74.31 110.966 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -40.37 132.81 1.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.827 0.851 . . . . 54.13 112.613 165.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.46 ' H ' ' HE1' ' A' ' 111' ' ' TYR . . . 119.25 -0.35 14.44 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.447 -0.661 . . . . 52.02 111.447 -161.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.74 100.25 0.11 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.052 0.834 . . . . 40.25 113.835 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -116.88 144.71 44.2 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.54 0.686 . . . . 74.22 112.532 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.7 mp -119.25 131.3 55.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.926 1.291 . . . . 63.1 108.167 165.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 7' ' ' LEU . 29.7 tp -110.9 111.99 23.51 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.027 0.442 . . . . 72.34 110.878 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 3.9 mm? -89.12 133.43 34.39 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.927 0.891 . . . . 73.23 111.416 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 34.11 5.37 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.9 -0.591 . . . . 51.25 112.609 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.1 137.21 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.29 0.636 . . . . 71.03 110.47 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -130.03 130.65 45.23 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.503 -0.925 . . . . 73.55 108.503 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -116.77 138.27 51.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.538 0.735 . . . . 73.01 110.892 -174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.37 141.84 47.0 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.358 0.663 . . . . 73.42 110.891 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.52 133.8 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.994 0.918 . . . . 71.5 111.072 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -87.15 -173.73 4.56 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.019 0.527 . . . . 75.13 111.889 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.99 -25.58 67.92 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 113.45 0.907 . . . . 72.42 113.45 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -82.64 -30.43 29.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.212 0.46 . . . . 64.04 110.942 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.36 11.98 8.46 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 114.675 0.63 . . . . 55.14 114.675 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.85 117.69 19.45 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.342 0.657 . . . . 70.5 111.654 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -79.62 107.97 12.8 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.555 0.742 . . . . 74.42 109.852 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.21 123.59 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.491 0.716 . . . . 72.12 110.301 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.1 124.15 37.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.984 0.914 . . . . 74.32 110.517 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -121.93 149.26 53.35 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 124.227 1.011 . . . . 74.31 111.755 -172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.01 102.81 1.4 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.504 2.136 . . . . 74.12 112.748 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.24 -24.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.816 -0.629 . . . . 74.51 110.901 170.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.23 -169.23 54.87 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.716 -0.674 . . . . 40.52 114.216 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.0 mt -115.53 124.38 30.1 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.074 0.95 . . . . 75.55 109.464 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.83 -27.53 80.54 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.787 2.324 . . . . 75.43 113.125 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.1 p-10 -131.45 63.05 68.28 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 123.834 0.854 . . . . 72.34 111.501 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.84 -31.14 32.35 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.699 2.266 . . . . 65.42 113.345 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.38 -37.27 85.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.249 1.019 . . . . 75.44 111.157 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 8.4 mtpm? -72.31 -54.77 8.54 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.82 -0.627 . . . . 73.51 110.723 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 73' ' ' ASP . 87.4 t -52.24 -38.13 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.395 1.078 . . . . 73.21 112.838 -167.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 53.1 tt0 -62.41 -47.26 84.88 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.472 0.709 . . . . 73.33 111.961 174.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.02 -48.28 53.97 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.964 0.905 . . . . 62.03 112.529 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.34 -37.08 66.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.527 1.131 . . . . 73.12 111.461 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.9 -41.83 86.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.398 0.679 . . . . 63.01 111.553 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.08 75.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.185 0.594 . . . . 63.03 112.122 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.4 t -69.92 -52.92 20.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.433 0.693 . . . . 75.23 111.447 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.63 -27.98 69.3 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.937 0.495 . . . . 63.31 111.553 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 93' ' ' LEU . 17.2 t -61.04 -30.1 70.12 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.322 0.649 . . . . 62.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.21 -25.56 29.39 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 113.259 0.837 . . . . 74.05 113.259 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -98.68 -33.91 10.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.627 0.973 . . . . 75.1 113.627 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.0 mmm -88.12 -35.79 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.945 0.898 . . . . 75.43 111.781 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -95.76 148.72 22.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.316 0.647 . . . . 75.53 111.048 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -42.18 -51.19 4.75 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 125.292 1.437 . . . . 53.34 112.766 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 HD12 ' A' ' 122' ' ' ILE . 32.8 m -111.0 156.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.019 -0.537 . . . . 44.4 110.613 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.82 117.57 14.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.02 -0.536 . . . . 52.33 109.611 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.657 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.9 mt -111.0 142.66 42.84 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.581 0.753 . . . . 62.53 110.895 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.1 82.25 11.08 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.031 0.932 . . . . 74.22 108.825 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.22 161.54 42.49 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.423 2.082 . . . . 72.42 113.28 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.0 tp10 -77.31 127.91 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.416 -0.811 . . . . 65.21 109.031 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 65.7 mtt -136.14 140.25 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.075 0.55 . . . . 71.34 111.407 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -144.65 151.9 39.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.522 0.729 . . . . 73.23 110.786 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.8 mt -115.13 132.75 56.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.777 0.831 . . . . 73.53 110.695 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 46.8 mt-10 -137.31 149.52 47.12 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.394 0.678 . . . . 54.34 111.102 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -94.97 124.91 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.172 -0.677 . . . . 73.53 109.172 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG13 HG23 ' A' ' 5' ' ' THR . 21.4 t -121.34 114.37 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 107.581 -1.266 . . . . 72.23 107.581 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.36 26.63 51.56 Favored Glycine 0 CA--C 1.548 2.108 0 N-CA-C 114.614 0.606 . . . . 75.15 114.614 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.94 60.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 114.681 0.632 . . . . 70.0 114.681 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -119.74 129.58 54.57 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.748 0.774 . . . . 74.32 109.73 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 m -85.27 104.35 15.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.746 0.703 . . . . 63.24 112.37 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.6 mp -86.98 160.53 18.62 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.298 1.039 . . . . 63.51 111.456 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 62.0 tp -114.96 131.32 56.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.474 0.71 . . . . 75.25 110.303 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 4' ' ' ALA . 2.5 t -98.58 122.41 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.464 1.105 . . . . 72.54 108.719 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.92 110.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 118.084 0.402 . . . . 72.22 110.927 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 60.2 t80 -94.54 132.43 39.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.222 -0.659 . . . . 75.34 109.222 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.51 105.12 23.8 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.487 -0.931 . . . . 75.23 108.487 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.78 122.3 9.88 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.033 1.822 . . . . 62.32 109.27 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -64.76 134.61 54.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.445 0.698 . . . . 73.31 111.102 -168.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.86 129.63 40.3 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.226 0.61 . . . . 71.43 112.38 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.59 ' HB3' HG22 ' A' ' 118' ' ' THR . 36.2 t70 -86.85 168.84 13.07 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.072 0.949 . . . . 73.11 110.314 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 120' ' ' LYS . 22.8 t -56.44 -22.19 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 124.401 1.081 . . . . 74.33 112.507 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.59 HG22 ' HB3' ' A' ' 116' ' ' ASP . 9.2 t -55.87 -23.86 33.52 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.745 0.818 . . . . 74.23 111.723 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 56.1 m-70 -87.24 -89.28 0.13 Allowed 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 106.206 -1.775 . . . . 73.5 106.206 166.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 29.0 mmmt -59.46 -148.62 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.164 0 CA-C-N 124.838 3.472 . . . . 74.53 113.035 -49.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -0.68 120.94 0.0 OUTLIER 'Trans proline' 1 C--N 1.416 4.093 1 C-N-CA 126.182 4.588 . . . . 72.45 119.917 -139.132 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.527 HD12 HG22 ' A' ' 91' ' ' VAL . 41.1 mm -96.62 91.91 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.299 -0.864 . . . . 73.1 108.86 171.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -81.82 162.22 22.93 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.726 0.298 . . . . 65.11 111.33 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? . . . . . 0 CA--C 1.557 1.225 0 N-CA-C 108.384 -0.969 . . . . 70.13 108.384 173.106 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 51.1 ttm . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 111.508 0.188 . . . . 73.43 111.508 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 1' ' ' MET . 91.5 mtt180 -86.89 -169.48 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.512 0.725 . . . . 70.34 110.431 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -82.95 150.49 26.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 122.047 -0.408 . . . . 73.12 109.908 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.53 70.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.344 0.498 . . . . 75.04 112.344 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.6 p -62.38 -47.72 82.91 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.606 0.762 . . . . 74.24 111.172 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.14 -42.18 98.07 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 121.716 0.769 . . . . 75.31 111.07 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.19 -39.79 93.33 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.651 -1.159 . . . . 53.11 111.628 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.64 -34.57 78.13 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.41 -0.813 . . . . 51.4 111.124 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.23 -41.65 85.35 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.062 0.545 . . . . 74.14 111.414 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.36 -39.69 94.39 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 122.517 0.327 . . . . 54.31 110.642 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.46 -50.96 69.38 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.157 0.983 . . . . 73.03 112.739 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.01 -12.53 61.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.016 0.747 . . . . 74.21 113.016 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.13 -42.76 30.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.489 0.716 . . . . 73.13 111.021 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -98.01 161.17 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.025 0.917 . . . . 63.11 112.602 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -106.52 0.85 24.97 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.88 -1.055 . . . . 71.15 110.788 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.39 130.18 22.96 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.202 1.001 . . . . 71.01 110.113 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m -80.29 85.91 5.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.1 0.56 . . . . 75.41 110.775 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.24 -63.95 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.343 1.057 . . . . 63.44 112.731 -174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtp-105 -102.09 -5.12 24.87 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.645 0.778 . . . . 75.31 111.478 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.9 mm -104.53 167.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.62 115.02 3.89 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.293 -1.002 . . . . 70.34 108.293 167.216 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.42 32.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.17 0.588 . . . . 63.21 111.442 -171.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -152.46 158.21 42.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.041 0.924 . . . . 61.05 112.774 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -77.06 163.77 26.34 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 113.806 -1.543 . . . . 73.53 111.331 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.64 74.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.495 0.554 . . . . 73.22 112.495 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -76.66 -13.75 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.374 0.67 . . . . 71.21 112.559 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 18.8 t70 -85.24 -5.69 59.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.234 0.613 . . . . 64.13 111.957 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.595 ' SD ' HG13 ' A' ' 77' ' ' VAL . 82.8 mtp -57.08 113.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.01 112.0 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.4 -155.23 10.52 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.225 -0.443 . . . . 55.25 113.531 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -73.9 -25.32 59.95 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.383 1.073 . . . . 72.44 111.442 -174.618 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.4 p -65.17 -48.1 74.66 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.078 0.951 . . . . 74.24 111.699 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HE3' ' A' ' 23' ' ' LYS . 60.0 t -58.2 -40.58 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.845 0.858 . . . . 75.04 110.819 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.425 ' SD ' HD21 ' A' ' 89' ' ' LEU . 40.1 tpp -71.46 -32.56 68.45 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.92 -1.036 . . . . 65.53 112.253 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.93 -37.73 84.86 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.535 0.734 . . . . 72.12 111.285 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.558 HG21 ' HG3' ' A' ' 21' ' ' GLU . 17.8 m -69.8 -32.43 70.89 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 72.31 112.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.39 -37.14 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.023 0.929 . . . . 74.53 112.075 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.16 -41.06 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.028 0.931 . . . . 64.41 111.911 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.92 68.03 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.901 0.881 . . . . 72.24 112.217 -171.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -61.46 -22.23 64.87 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.806 0.842 . . . . 74.11 112.999 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.99 -26.49 59.61 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.238 0.615 . . . . 65.42 112.055 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -117.65 5.38 12.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.945 1.091 . . . . 74.22 113.945 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -58.58 117.15 18.36 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 118.748 0.704 . . . . 65.0 112.507 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.3 102.07 0.18 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.293 2.662 . . . . 70.21 113.802 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.5 9.93 59.34 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.134 1.214 . . . . 54.32 116.134 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.0 tp -115.62 -64.6 1.29 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.383 1.092 . . . . 71.33 110.965 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 37.71 -157.47 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 125.931 1.692 . . . . 74.11 114.919 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.81 58.71 7.92 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.69 -0.232 . . . . 54.23 113.501 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.21 157.39 17.8 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 112.375 -0.29 . . . . 23.31 112.375 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 90.5 m-85 -124.36 126.13 45.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.824 0.45 . . . . 74.45 111.064 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -98.92 118.17 35.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.596 -0.89 . . . . 72.43 108.596 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.42 109.01 21.15 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.719 -0.474 . . . . 75.34 109.719 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.4 128.5 46.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.254 1.022 . . . . 60.42 109.777 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.9 28.27 7.89 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 115.959 -0.564 . . . . 64.33 112.401 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.1 t -113.27 145.65 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.726 0.81 . . . . 60.13 110.699 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -121.89 151.62 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.451 1.1 . . . . 74.42 108.375 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.6 p90 -126.39 125.76 42.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.261 0.624 . . . . 75.23 109.611 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.22 140.51 51.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.655 0.782 . . . . 63.14 111.144 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.49 129.6 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.553 0.741 . . . . 63.35 111.087 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 87.3 m-20 -78.97 176.56 9.53 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.706 0.802 . . . . 65.21 112.407 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.5 -31.08 69.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.021 0.528 . . . . 74.05 111.789 170.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.73 -17.69 40.4 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.557 0.743 . . . . 70.25 111.089 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.26 34.72 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 114.818 0.687 . . . . 23.52 114.818 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.9 m-20 -79.81 147.35 31.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 117.604 0.702 . . . . 75.1 111.878 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 117.16 29.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.315 0.646 . . . . 63.54 110.528 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 59.8 t -110.86 122.26 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.725 0.81 . . . . 64.53 110.532 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -92.47 124.85 36.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.357 0.663 . . . . 71.41 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -132.35 141.0 39.7 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.995 0.918 . . . . 50.01 111.011 -171.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.35 76.92 4.28 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.916 2.41 . . . . 71.33 113.138 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.61 -18.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 115.923 -0.58 . . . . 71.11 112.399 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.81 49.35 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.427 0.531 . . . . 70.04 114.427 168.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 77' ' ' VAL . 83.0 mt -97.71 132.02 25.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.425 1.09 . . . . 71.55 110.189 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.0 -36.14 23.38 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.074 1.849 . . . . 75.13 111.535 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -123.13 81.3 51.6 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 123.754 0.822 . . . . 71.22 109.876 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.89 -57.23 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.416 2.744 . . . . 70.41 114.57 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.7 -42.53 95.23 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.96 0.504 . . . . 64.24 111.224 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -59.26 -40.88 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.428 0.455 . . . . 73.43 111.656 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 28' ' ' MET . 46.7 t -60.98 -43.29 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.23 0.612 . . . . 71.22 111.549 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.45 -42.58 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.274 0.472 . . . . 73.3 112.274 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -75.85 -42.57 49.1 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 112.69 0.626 . . . . 64.43 112.69 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 -37.36 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.594 0.757 . . . . 65.54 111.709 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.31 -40.2 74.34 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.559 0.344 . . . . 72.11 110.955 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.09 73.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.483 0.713 . . . . 75.04 112.294 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 t -73.75 -53.23 10.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.255 0.622 . . . . 64.54 111.611 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.44 -31.56 72.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 112.722 0.638 . . . . 75.53 112.722 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.8 p -67.22 -29.72 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.512 0.325 . . . . 74.33 111.711 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.71 -25.66 59.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.277 0.631 . . . . 61.41 111.999 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.9 m -90.58 -44.85 9.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.364 0.666 . . . . 53.53 112.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.93 -34.73 19.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.544 0.737 . . . . 73.12 112.727 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD21 ' SD ' ' A' ' 33' ' ' MET . 70.7 mt -88.96 142.7 27.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 122.162 -0.336 . . . . 42.55 110.769 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -36.1 -58.96 0.64 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.88 1.672 . . . . 70.21 113.583 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 119' ' ' HIS . 13.9 m -102.31 168.75 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.334 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.87 1.47 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.609 -0.885 . . . . 71.42 108.609 168.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 122' ' ' ILE . 1.5 tt -102.17 106.67 17.56 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.799 -0.815 . . . . 73.35 108.799 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -96.2 103.71 14.67 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 108.798 -0.815 . . . . 65.23 108.798 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -68.45 172.95 10.47 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 121.531 1.487 . . . . 75.54 111.492 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 86.1 tt0 -86.86 107.49 18.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.732 -1.581 . . . . 74.12 106.732 172.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.612 ' HB3' HD11 ' A' ' 108' ' ' LEU . 76.8 mtm -119.29 117.33 28.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.771 0.428 . . . . 71.32 111.234 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -120.17 131.82 55.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.878 0.871 . . . . 74.53 110.805 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.26 112.02 20.99 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.683 0.793 . . . . 74.01 109.446 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.38 128.64 55.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.494 1.118 . . . . 74.43 111.427 -167.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.66 110.22 22.34 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.879 0.472 . . . . 53.54 110.813 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.7 116.29 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.828 1.251 . . . . 63.11 108.42 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.89 30.19 62.89 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 114.768 0.667 . . . . 70.42 114.768 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.95 89.32 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 114.254 0.462 . . . . 54.21 114.254 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -102.8 129.76 49.57 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.708 0.803 . . . . 72.53 109.709 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.7 m -94.34 126.73 39.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.891 0.769 . . . . 74.13 110.76 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.57 170.47 9.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.393 1.077 . . . . 72.35 109.259 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.9 tp -115.95 118.9 34.23 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.089 -0.338 . . . . 72.33 110.089 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.18 124.71 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.009 -0.737 . . . . 53.51 109.009 169.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 42.8 t -109.76 99.86 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.186 0.517 . . . . 75.35 109.67 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 25.9 t80 -85.5 119.75 26.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.571 . . . . 74.35 109.88 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.21 95.32 45.87 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 108.357 -0.979 . . . . 73.43 108.357 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.51 -177.33 3.56 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.294 1.996 . . . . 71.31 111.766 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.15 137.82 33.91 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.098 -0.705 . . . . 73.24 109.098 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.87 179.92 4.64 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.829 0.852 . . . . 53.33 111.257 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.69 135.95 43.72 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-O 118.314 -0.85 . . . . 75.4 108.95 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.9 t -46.88 -26.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.402 1.63 . . . . 75.23 115.402 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -66.43 -49.47 66.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.685 -0.634 . . . . 55.43 111.039 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 1.6 m-70 -128.43 68.76 1.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.925 -2.621 . . . . 65.55 103.925 168.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 57.3 mtpt -46.82 -153.03 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.428 1 C-N-CA 133.332 4.653 . . . . 74.52 121.155 55.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo 4.77 67.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 123.277 2.652 . . . . 64.15 117.142 -124.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.608 HG21 HD12 ' A' ' 93' ' ' LEU . 53.0 mt -98.35 127.9 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.981 -1.009 . . . . 71.22 109.258 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.49 146.43 38.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 60.41 109.498 -175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 108.533 -0.914 . . . . 73.12 108.533 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.179 -1.045 . . . . 55.21 108.179 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.404 ' O ' HG11 ' A' ' 109' ' ' VAL . 26.6 mmm180 -82.98 159.61 22.19 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.336 0.655 . . . . 75.41 112.183 -171.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m -81.43 156.5 25.35 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.817 0.673 . . . . 42.22 112.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.88 94.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.782 0.833 . . . . 45.51 112.078 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -62.09 -46.87 87.15 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.576 -0.738 . . . . 75.33 110.639 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.21 -47.2 87.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.918 -1.037 . . . . 72.21 111.911 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.35 -36.79 85.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.172 0.589 . . . . 71.34 111.755 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 28.1 tp -65.05 -48.49 73.63 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.017 0.527 . . . . 74.34 111.212 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -63.7 -35.69 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.091 0.556 . . . . 62.52 111.846 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -63.32 -45.87 89.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.487 0.715 . . . . 75.22 111.229 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 22' ' ' ALA . 41.8 mt -59.8 -39.63 85.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.955 0.902 . . . . 75.33 111.069 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.26 -34.45 78.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.809 0.844 . . . . 73.21 112.133 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.46 -41.91 72.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.629 0.771 . . . . 73.32 112.187 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -114.84 118.35 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-O 121.653 0.74 . . . . 75.24 112.37 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.64 -9.9 16.09 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.73 1.212 . . . . 73.24 113.574 172.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.32 117.07 23.68 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.7 -0.625 . . . . 74.5 110.36 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.9 p -78.17 91.72 4.37 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.631 0.773 . . . . 70.31 111.493 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.67 -59.52 5.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.633 0.773 . . . . 73.33 111.732 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.6 HH21 ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.42 26.04 1.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.043 0.537 . . . . 70.13 111.693 170.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.24 109.61 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.407 -0.96 . . . . 60.04 108.407 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.07 130.07 49.22 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 120.93 0.395 . . . . 70.12 111.129 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -84.69 143.3 29.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.595 0.758 . . . . 51.43 111.773 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 74.5 mmtt -129.26 145.76 51.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.965 0.906 . . . . 74.44 109.565 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.95 161.49 24.29 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.239 0.616 . . . . 75.33 111.084 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 -36.95 85.55 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.091 0.556 . . . . 65.41 111.703 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 -18.99 61.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.605 0.762 . . . . 71.11 112.584 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.82 -7.12 57.56 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.38 0.672 . . . . 73.43 112.712 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.541 ' SD ' HG13 ' A' ' 77' ' ' VAL . 34.3 mtp -55.9 124.27 17.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.446 0.906 . . . . 51.05 113.446 -176.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.23 -144.91 15.16 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.366 -0.833 . . . . 75.32 111.758 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -59.57 -26.85 65.74 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.137 0.975 . . . . 71.32 113.544 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.0 m -73.52 -27.23 61.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.303 0.641 . . . . 71.23 112.26 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 46.3 t -74.66 -48.94 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 121.244 0.545 . . . . 73.34 110.436 166.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.73 -34.45 67.52 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.322 1.23 . . . . 75.51 114.322 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.63 -41.76 82.01 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.14 0.576 . . . . 73.35 111.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -78.14 -27.67 48.24 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.289 0.636 . . . . 75.32 111.712 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.64 -45.54 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.626 0.77 . . . . 54.53 110.604 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -51.85 -44.02 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.778 1.231 . . . . 64.31 112.111 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.54 89.47 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.341 0.656 . . . . 43.33 112.75 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.63 -35.64 70.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.904 0.705 . . . . 64.5 112.904 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.2 55.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.163 0.585 . . . . 75.11 112.444 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -103.99 -48.33 3.93 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.733 1.012 . . . . 65.01 113.733 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.1 121.09 76.72 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.39 111.73 0.91 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.294 2.662 . . . . 75.31 113.626 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.89 -11.16 29.68 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.34 -0.845 . . . . 70.11 114.633 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HG ' HH21 ' A' ' 19' ' ' ARG . 6.5 mp -94.64 -1.18 53.65 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.574 1.687 . . . . 75.0 110.991 173.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.74 ' HB3' ' HB3' ' A' ' 114' ' ' GLU . 10.0 m-20 -34.53 102.31 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.527 1.931 . . . . 55.5 114.371 174.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.95 0.82 Allowed Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.87 -0.605 . . . . 40.33 112.866 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.94 172.52 47.96 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 113.981 0.352 . . . . 65.54 113.981 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.38 147.16 52.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.765 0.826 . . . . 63.34 112.635 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.1 mt -129.4 124.7 34.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 74.4 108.552 172.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.59 109.21 20.8 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 122.111 -0.368 . . . . 74.04 110.138 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 108' ' ' LEU . 56.6 mt -88.96 129.44 35.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.151 0.58 . . . . 64.41 110.964 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.48 30.36 5.0 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.195 -0.457 . . . . 54.2 112.482 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 48.3 t -116.3 139.52 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.374 0.67 . . . . 65.25 110.631 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.66 131.71 31.88 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.302 -1.369 . . . . 75.55 107.302 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -115.68 140.62 49.02 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.128 0.49 . . . . 75.12 112.282 -171.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.48 141.63 48.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 75.11 110.404 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.8 mt -101.91 133.67 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.595 0.758 . . . . 72.23 111.422 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -74.81 169.37 18.03 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.186 0.994 . . . . 61.22 111.882 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.91 -33.98 75.23 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.393 0.677 . . . . 75.15 111.231 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -71.03 -27.64 63.82 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.483 0.713 . . . . 53.02 111.683 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.47 41.14 2.24 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 116.302 -0.408 . . . . 72.41 113.08 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -100.29 121.63 41.79 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.325 0.65 . . . . 71.21 109.876 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -84.7 108.48 17.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.139 0.575 . . . . 73.53 110.574 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -100.43 112.61 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.492 1.117 . . . . 74.12 109.76 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -89.22 115.0 26.39 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.583 -0.525 . . . . 75.12 109.583 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -115.85 134.49 22.71 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.783 0.833 . . . . 72.02 111.19 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 88.3 Cg_endo -75.8 86.86 1.45 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.779 2.319 . . . . 75.12 112.634 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.33 -26.21 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.997 -0.547 . . . . 61.52 111.422 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 82.54 -176.16 53.52 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.115 0.806 . . . . 73.31 115.115 172.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -113.91 116.2 45.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.404 1.082 . . . . 75.52 109.988 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.56 -33.33 96.36 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.711 2.274 . . . . 75.04 112.665 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.57 75.82 78.37 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.852 0.861 . . . . 71.2 109.137 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.84 -39.46 61.9 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.064 2.509 . . . . 73.53 114.522 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.6 p-10 -72.99 -40.4 65.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.512 0.725 . . . . 74.35 111.102 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.31 -37.92 89.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.965 0.506 . . . . 53.5 111.328 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.541 HG13 ' SD ' ' A' ' 28' ' ' MET . 42.5 t -58.93 -47.55 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.045 0.938 . . . . 74.2 111.071 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.549 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 51.9 tt0 -59.84 -45.59 91.93 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.854 0.862 . . . . 61.34 112.199 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 20.8 mmm-85 -74.86 -40.04 61.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.72 -0.673 . . . . 70.12 112.085 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.39 -44.49 92.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.916 0.886 . . . . 71.04 110.778 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 52' ' ' LEU . 22.8 tp -66.76 -40.46 88.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.423 -0.808 . . . . 73.22 111.795 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.91 82.51 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.183 0.593 . . . . 61.44 112.176 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -66.99 -52.0 48.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.386 0.674 . . . . 71.44 111.5 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' A' ' 81' ' ' LEU . 29.7 pt20 -67.74 -28.48 67.67 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.508 0.558 . . . . 71.34 112.508 176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.2 -33.23 69.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.187 0.439 . . . . 63.12 112.187 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.17 -38.05 13.76 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.559 0.743 . . . . 61.21 112.183 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.3 m -74.29 -33.21 63.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.51 0.929 . . . . 71.02 113.51 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.8 mmm -88.33 -55.48 3.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.152 0.581 . . . . 53.25 111.203 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.34 148.65 43.27 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.312 0.645 . . . . 73.21 112.573 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.494 ' HB3' HG23 ' A' ' 122' ' ' ILE . 41.7 t30 -41.98 -63.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.019 1.727 . . . . 64.02 112.85 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.08 167.68 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.744 -0.662 . . . . 73.44 110.861 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.7 97.48 2.19 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.136 0.493 . . . . 72.41 110.323 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.79 123.68 35.35 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.529 -0.915 . . . . 74.54 108.529 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -104.52 106.04 52.63 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 122.934 0.494 . . . . 72.34 110.941 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -87.99 170.56 6.06 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.403 2.069 . . . . 74.3 112.928 166.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.0 tp10 -104.06 136.87 42.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.829 0.852 . . . . 70.34 109.324 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 108' ' ' LEU . 66.1 mtt -134.53 122.11 21.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.155 0.582 . . . . 74.43 110.917 -172.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -124.93 134.42 52.66 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.306 0.642 . . . . 73.32 112.135 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.17 123.19 45.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.813 0.845 . . . . 73.25 111.701 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -142.24 147.05 35.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.24 1.016 . . . . 61.0 110.443 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -97.73 123.4 41.65 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.968 0.413 . . . . 43.34 110.649 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.51 114.12 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.902 1.281 . . . . 73.14 108.511 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.15 29.57 59.87 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 115.439 0.936 . . . . 62.1 115.439 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.94 3.72 73.15 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.062 0.785 . . . . 63.42 115.062 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 11.6 mptt -117.58 132.91 56.44 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.6 0.76 . . . . 63.13 109.444 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 m -83.15 131.28 35.14 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.593 0.633 . . . . 74.43 111.087 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.25 159.44 24.06 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.602 1.161 . . . . 75.53 109.225 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 97' ' ' MET . 36.8 tp -116.74 118.19 31.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.82 0.448 . . . . 72.31 109.988 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 2' ' ' ARG . 29.7 t -82.74 105.63 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.804 -0.813 . . . . 60.2 108.804 172.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 38.7 t -95.35 98.69 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.489 0.661 . . . . 74.01 109.764 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 17.1 t80 -80.58 115.76 20.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.209 -0.905 . . . . 63.11 108.705 171.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.27 94.49 3.37 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 108.462 -0.94 . . . . 71.53 108.462 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.99 166.91 27.12 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.593 2.195 . . . . 50.41 112.571 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . 12.4 pt-20 -59.97 119.78 8.4 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 113.864 1.061 . . . . 71.23 113.864 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 141.25 51.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 162.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.641 ' HB3' HG22 ' A' ' 118' ' ' THR . 38.6 t70 -75.98 161.94 28.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.909 0.483 . . . . 63.12 112.17 -174.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.05 -21.11 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 C-N-CA 124.791 1.236 . . . . 41.44 112.603 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.641 HG22 ' HB3' ' A' ' 116' ' ' ASP . 15.1 t -54.23 -21.94 10.32 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.647 0.779 . . . . 75.4 112.03 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 18.7 m80 -90.54 -98.08 0.11 Allowed 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 104.724 -2.325 . . . . 71.03 104.724 164.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 55.3 mttm -68.14 -146.14 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.476 0 CA-C-N 125.902 3.955 . . . . 72.01 110.556 -45.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo 7.62 89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 124.721 3.614 . . . . 54.14 118.364 -138.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 90' ' ' ASN . 60.5 mt -74.59 101.54 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.516 -1.22 . . . . 75.3 109.507 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -92.18 168.89 11.03 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.686 -1.143 . . . . 73.02 109.535 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.825 -0.547 . . . . 75.34 109.58 173.76 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.599 ' SD ' ' HB2' ' A' ' 111' ' ' TYR . 5.0 ttm . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.106 -0.331 . . . . 63.04 110.106 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -85.69 152.51 23.03 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.447 0.699 . . . . 73.51 110.561 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.23 152.17 32.73 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.096 0.558 . . . . 75.14 111.566 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.02 66.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.154 0.581 . . . . 73.53 112.47 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -63.77 -36.31 83.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.137 0.791 . . . . 73.11 113.137 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.78 -35.44 80.72 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.039 0.447 . . . . 73.02 111.058 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.63 -36.44 80.79 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.401 0.68 . . . . 74.34 111.795 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.58 -37.22 79.67 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.602 0.361 . . . . 61.41 111.266 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.61 -38.91 92.02 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.804 0.442 . . . . 71.32 110.02 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.09 -37.14 78.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.732 0.813 . . . . 55.04 111.634 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 mt -61.83 -45.26 94.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.747 0.819 . . . . 74.35 111.708 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -77.17 -19.82 56.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.184 0.594 . . . . 74.14 112.128 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.51 -51.97 17.74 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.031 0.533 . . . . 71.45 111.097 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.95 159.14 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.213 0.53 . . . . 62.52 111.216 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.92 -21.86 24.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.371 0.668 . . . . 62.21 112.055 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -145.69 144.63 30.5 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.992 0.917 . . . . 73.14 111.097 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 t -75.13 116.2 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.664 0.786 . . . . 62.13 112.352 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.63 -58.83 1.8 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.154 0.982 . . . . 75.3 111.983 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -115.15 -13.17 11.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 123.822 0.849 . . . . 73.34 112.892 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -129.6 121.8 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.776 0.83 . . . . 74.23 110.244 -167.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -127.52 138.95 53.05 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.626 0.37 . . . . 64.02 110.768 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -93.26 151.98 19.47 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.77 0.828 . . . . 70.42 111.288 175.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HB2' HD23 ' A' ' 52' ' ' LEU . 69.6 mmtt -140.01 141.36 36.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.444 1.097 . . . . 63.11 110.454 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -84.87 160.53 20.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.391 0.676 . . . . 71.52 110.657 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.89 64.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.82 1.044 . . . . 74.34 113.82 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 m -81.86 -11.98 58.69 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 113.137 0.791 . . . . 70.52 113.137 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.5 -9.03 59.79 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.425 0.69 . . . . 64.24 112.148 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mmm -52.09 115.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.222 1.009 . . . . 74.24 112.905 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.93 -131.35 5.69 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 116.217 -0.447 . . . . 72.33 113.615 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.41 -38.31 68.78 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.699 1.2 . . . . 71.13 113.857 -168.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.12 -32.98 69.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.346 0.658 . . . . 61.33 112.093 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.74 -48.68 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.177 0.591 . . . . 72.14 110.059 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -41.44 59.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.246 1.419 . . . . 71.31 113.797 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.6 -43.48 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.207 0.527 . . . . 75.44 111.531 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 m -76.59 -30.7 57.09 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.349 0.659 . . . . 52.24 111.439 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.47 -45.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.197 0.599 . . . . 62.05 110.302 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.65 -38.39 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.301 0.64 . . . . 72.33 110.921 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.01 91.41 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.425 0.69 . . . . 63.2 112.284 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -70.01 -38.98 76.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.153 0.581 . . . . 64.03 111.917 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.9 73.14 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.061 0.544 . . . . 51.11 111.714 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.88 -17.14 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.848 0.859 . . . . 72.42 111.148 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.98 109.82 9.26 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.016 0.526 . . . . 73.02 110.459 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.44 117.05 4.95 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.222 1.948 . . . . 75.32 112.095 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 2.48 90.52 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.944 0.738 . . . . 71.21 114.944 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 tp -113.33 18.64 17.65 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.598 1.199 . . . . 74.32 109.918 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 114' ' ' GLU . 8.6 p-10 -43.51 114.03 0.58 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.22 1.408 . . . . 64.22 113.771 168.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.42 59.21 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.927 -0.579 . . . . 73.43 113.591 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.36 156.29 24.02 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 112.507 -0.237 . . . . 54.12 112.507 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.94 128.06 55.46 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.247 0.524 . . . . 64.52 112.041 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.2 mt -121.15 123.82 43.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.973 0.909 . . . . 63.12 110.121 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.42 109.3 20.88 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.314 0.646 . . . . 72.11 110.287 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.681 HD12 HD23 ' A' ' 108' ' ' LEU . 57.0 mt -94.56 122.73 37.45 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.888 0.475 . . . . 73.04 109.874 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.24 3.76 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 116.503 -0.317 . . . . 75.11 112.919 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 45.0 t -115.38 139.52 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.515 0.726 . . . . 75.33 110.134 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.66 133.29 49.63 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.958 -1.497 . . . . 72.34 106.958 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -110.37 138.41 46.8 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.029 0.532 . . . . 75.2 111.404 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.33 141.32 48.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.083 0.953 . . . . 74.51 110.544 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -92.0 134.75 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.801 0.84 . . . . 72.25 110.902 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -85.81 -179.13 6.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.464 0.706 . . . . 75.51 112.194 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.58 -38.09 80.26 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.039 0.936 . . . . 64.45 111.758 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -82.79 7.13 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.273 0.842 . . . . 72.2 113.273 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.13 85.96 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 114.885 0.714 . . . . 75.04 114.885 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.28 157.58 37.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.799 0.84 . . . . 61.22 112.423 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -103.92 124.65 49.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.053 0.941 . . . . 71.24 111.274 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -116.49 130.28 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.854 0.862 . . . . 54.12 109.892 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -93.82 119.63 33.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.931 0.893 . . . . 70.14 111.166 -173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -112.41 133.7 21.73 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.58 0.752 . . . . 72.52 111.644 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.28 88.4 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.286 1.991 . . . . 72.41 112.212 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -81.37 -19.03 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 122.994 0.517 . . . . 60.44 111.604 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 77.15 -173.41 54.92 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 121.881 0.712 . . . . 54.12 114.378 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 77' ' ' VAL . 55.0 mt -115.2 127.65 26.63 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.643 1.177 . . . . 73.22 108.765 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.15 -23.57 52.75 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.284 1.989 . . . . 74.5 112.485 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.3 73.58 36.75 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 125.219 1.407 . . . . 64.54 110.208 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.18 -42.77 12.76 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.613 2.875 . . . . 75.21 114.821 -165.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.72 -31.31 66.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.57 0.748 . . . . 61.43 111.967 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -72.27 -34.17 68.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 120.603 0.239 . . . . 74.35 110.412 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 71' ' ' LEU . 98.7 t -59.26 -40.76 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.707 0.803 . . . . 50.21 110.918 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -63.99 -49.26 73.15 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.375 1.07 . . . . 73.43 113.173 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -34.66 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 112.614 0.598 . . . . 73.53 112.614 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 3.9 m-20 -62.11 -45.06 95.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.378 0.271 . . . . 71.4 110.573 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.665 HD23 ' SD ' ' A' ' 97' ' ' MET . 35.1 tp -63.07 -38.58 91.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.967 0.507 . . . . 73.5 112.163 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.68 72.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.626 . . . . 65.02 111.47 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 t -73.6 -44.69 56.54 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.682 0.793 . . . . 71.24 111.676 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 80.7 mt-30 -58.06 -44.87 87.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.649 0.78 . . . . 72.34 111.553 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.5 t -74.93 -18.42 60.4 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.183 0.993 . . . . 23.53 111.986 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -82.81 -43.63 16.46 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.294 0.638 . . . . 54.05 112.367 171.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -83.91 -52.43 6.36 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.8 0.84 . . . . 73.43 113.038 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.0 mmm -67.86 -17.62 64.55 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.852 0.861 . . . . 54.4 112.89 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 mt -108.73 148.5 30.38 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 71.24 110.166 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -39.07 -53.67 1.79 Allowed 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.741 1.216 . . . . 75.31 113.532 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.04 157.92 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 114.903 -1.044 . . . . 61.31 109.564 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.71 97.2 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.847 0.832 . . . . 62.14 109.453 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tt -94.15 117.38 30.03 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.065 -1.457 . . . . 73.31 107.065 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -110.71 92.56 14.64 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.914 0.885 . . . . 74.5 110.167 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.32 165.59 24.16 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.742 2.295 . . . . 74.34 113.671 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 13.2 tp10 -85.13 107.57 17.27 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.665 ' SD ' HD23 ' A' ' 81' ' ' LEU . 76.2 mtm -119.1 122.53 42.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.781 0.433 . . . . 52.32 111.64 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.09 123.75 33.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.122 0.969 . . . . 74.54 110.741 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.67 114.79 12.32 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.73 0.812 . . . . 73.31 110.737 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.74 125.63 53.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.879 0.872 . . . . 75.12 111.211 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -97.16 117.75 32.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.348 0.659 . . . . 70.32 111.382 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.52 118.8 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.085 1.354 . . . . 64.2 110.034 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.06 52.67 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 115.817 1.087 . . . . 62.53 115.817 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.26 -3.12 85.71 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 117.05 0.425 . . . . 74.11 114.119 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 74.2 mmtt -99.17 137.57 37.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.492 1.117 . . . . 60.45 109.078 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -107.77 131.1 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.273 0.942 . . . . 54.45 111.305 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.42 168.67 11.43 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.253 1.021 . . . . 73.11 109.267 -174.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD23 HD12 ' A' ' 52' ' ' LEU . 34.7 tp -121.89 116.68 24.82 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.894 -0.41 . . . . 71.21 109.894 173.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 1' ' ' MET . 38.2 t -87.8 120.81 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.92 -0.77 . . . . 70.45 108.92 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 46.2 t -110.69 104.82 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 64.0 110.394 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 74.3 t80 -90.47 113.28 25.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.136 0.974 . . . . 74.51 110.222 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.53 100.82 46.72 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.568 0.747 . . . . 74.33 110.495 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -86.31 -173.27 1.2 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.716 2.277 . . . . 64.45 113.309 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 36.4 tt0 -93.64 153.18 18.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.866 0.866 . . . . 64.41 109.71 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.08 155.2 40.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.41 0.624 . . . . 61.41 112.323 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.18 158.76 35.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.952 0.901 . . . . 73.42 110.997 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.4 t -56.46 -22.21 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.525 0.935 . . . . 74.22 113.525 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -52.08 -22.13 3.86 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 123.766 0.827 . . . . 64.33 112.366 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.659 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 81.3 m-70 -104.23 -84.29 0.48 Allowed 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 106.354 -1.721 . . . . 62.52 106.354 162.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 16.1 ptpt -79.81 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.665 0 CA-C-N 125.655 3.843 . . . . 71.33 110.909 -34.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 3.3 Cg_exo 7.52 116.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.305 1 C-N-CA 125.489 4.126 . . . . 74.44 120.102 -137.259 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.48 93.8 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.317 -1.311 . . . . 72.12 109.039 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -79.49 170.74 16.14 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.34 0.656 . . . . 72.14 111.017 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.162 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 16.6 ptm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 110.784 -0.08 . . . . 74.5 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -83.87 156.71 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.508 0.723 . . . . 61.21 111.893 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -82.16 161.23 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.781 0.832 . . . . 63.13 112.046 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB1' HD22 ' A' ' 107' ' ' LEU . . . -62.25 -44.63 96.1 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.338 0.655 . . . . 72.44 112.018 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -72.22 -31.13 65.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.954 0.724 . . . . 73.03 112.954 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.23 -49.36 77.92 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 121.786 0.803 . . . . 65.43 111.447 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.4 mt -72.73 -26.36 61.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.768 -1.106 . . . . 72.15 112.654 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.93 -43.69 98.27 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.008 0.523 . . . . 52.33 110.353 169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.51 -36.33 75.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.482 1.113 . . . . 75.43 111.333 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp10 -65.02 -52.36 56.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.616 0.766 . . . . 71.22 111.267 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -56.57 -37.61 70.81 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.463 1.105 . . . . 73.41 113.503 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -78.09 -24.06 47.71 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.057 0.543 . . . . 73.43 111.501 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.67 -38.97 53.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.506 0.722 . . . . 65.53 112.314 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.35 146.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 121.296 0.57 . . . . 65.31 111.919 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.96 -39.55 82.05 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.677 1.191 . . . . 74.24 111.596 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.29 167.79 29.29 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.779 0.832 . . . . 74.13 111.623 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -66.8 89.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.471 0.709 . . . . 14.24 112.445 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.38 10.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.645 0.778 . . . . 63.05 112.017 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -121.67 -28.8 4.48 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.449 0.7 . . . . 64.32 111.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 10' ' ' GLU . 33.9 mm -112.22 119.19 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 70.33 110.046 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 143.6 42.3 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.101 0.56 . . . . 53.52 109.76 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.9 27.41 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.458 0.703 . . . . 73.42 110.638 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 54.6 mtmt -141.0 152.94 45.31 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.828 0.851 . . . . 72.35 112.245 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 mtm-85 -80.58 170.4 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.676 0.79 . . . . 73.34 112.681 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 28' ' ' MET . . . -60.83 -26.7 67.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.346 0.869 . . . . 71.22 113.346 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -64.59 -1.22 1.7 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.429 1.27 . . . . 63.03 114.429 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -111.88 -9.29 14.06 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.974 0.51 . . . . 72.34 112.185 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.9 ptm -60.76 104.39 0.35 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.663 0.744 . . . . 74.13 111.519 -173.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.26 -122.37 1.21 Allowed Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.669 -0.696 . . . . 65.43 112.388 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -52.78 -58.18 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.292 1.037 . . . . 75.34 113.797 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.5 m -76.2 -32.06 58.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.404 0.52 . . . . 70.4 112.404 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.75 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.178 0.444 . . . . 60.22 110.314 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 39.0 tpp -58.85 -43.62 90.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.622 0.769 . . . . 75.25 111.611 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -59.7 -39.32 84.2 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.779 . . . . 71.12 111.991 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -70.12 -35.52 74.16 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 122.847 0.459 . . . . 63.33 110.996 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.14 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.462 0.705 . . . . 54.35 110.474 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.27 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 74.15 110.585 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -62.38 -47.17 85.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.428 0.691 . . . . 64.11 112.045 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -67.42 -40.84 85.53 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 122.71 0.404 . . . . 74.55 111.501 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.07 67.15 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.287 0.635 . . . . 63.45 111.89 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -80.87 -37.43 29.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.892 0.877 . . . . 32.43 110.719 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 32.3 mm-40 -56.97 109.32 1.64 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.505 0.722 . . . . 75.24 111.944 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.68 111.07 2.9 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.25 1.966 . . . . 64.25 112.712 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.93 22.49 65.94 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 114.486 0.554 . . . . 34.41 114.486 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 26.69 10.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 117.702 0.751 . . . . 55.32 110.135 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 31.7 t70 -48.76 119.06 2.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.523 0.729 . . . . 62.51 111.777 168.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.501 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 114.41 48.04 0.57 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.101 -0.5 . . . . 60.23 112.899 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.72 137.25 13.39 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 110.613 -0.995 . . . . 33.4 110.613 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -118.43 152.68 35.42 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.325 0.861 . . . . 73.34 113.325 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.4 mt -123.06 122.32 38.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.171 1.389 . . . . 74.21 109.953 175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.27 108.43 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.721 -0.474 . . . . 73.0 109.721 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 7.5 mp -95.19 120.71 35.89 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.114 -0.698 . . . . 70.21 109.114 176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.48 25.99 5.28 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.312 -0.404 . . . . 51.44 113.232 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.71 133.06 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.34 -0.615 . . . . 65.11 109.34 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -109.72 154.18 23.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.25 -1.018 . . . . 72.42 108.25 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.54 139.69 38.79 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.058 0.456 . . . . 61.24 111.124 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.68 140.31 52.82 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.87 0.868 . . . . 60.44 110.536 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.39 127.33 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.248 0.619 . . . . 73.52 110.809 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -71.98 171.38 11.92 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.854 0.462 . . . . 70.45 111.435 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.37 -31.03 69.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.067 0.547 . . . . 74.1 111.725 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -98.32 11.0 39.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.911 0.708 . . . . 75.23 112.911 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.3 -3.67 59.96 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 116.859 1.503 . . . . 73.41 116.859 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 128.07 34.59 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 118.905 1.353 . . . . 74.25 112.97 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -80.09 106.54 12.19 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.876 -0.787 . . . . 72.54 108.876 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -103.11 119.95 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.405 0.682 . . . . 64.44 109.589 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.93 142.47 27.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.136 0.574 . . . . 74.1 110.407 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -147.99 137.25 11.96 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.155 0.582 . . . . 74.35 111.414 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -82.18 89.53 1.18 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.907 2.405 . . . . 72.5 112.428 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.61 -13.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.865 0.466 . . . . 61.43 111.747 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.37 172.19 46.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 121.616 0.565 . . . . 72.33 114.309 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -95.44 140.16 22.26 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.202 1.001 . . . . 71.13 109.762 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.86 -37.18 98.75 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.631 2.221 . . . . 55.33 112.274 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -140.58 101.55 6.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.806 -1.183 . . . . 65.43 107.806 166.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HB2' HD22 ' A' ' 99' ' ' LEU . 90.4 Cg_endo -74.13 -22.99 16.29 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.635 2.223 . . . . 70.31 113.838 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.55 -43.29 66.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.509 0.724 . . . . 41.12 110.591 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -40.02 87.48 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.549 -0.296 . . . . 62.45 111.275 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.49 -43.64 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.347 0.659 . . . . 74.23 111.748 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.21 -41.91 99.22 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.876 0.47 . . . . 53.34 111.978 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -72.86 -46.94 50.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.362 0.665 . . . . 71.13 111.915 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.35 -30.54 70.38 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.141 0.576 . . . . 71.53 112.01 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.87 -37.96 67.18 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.406 0.283 . . . . 75.04 111.027 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.55 76.19 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.19 0.596 . . . . 75.43 111.763 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.6 m -66.07 -51.5 57.56 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.364 0.666 . . . . 74.02 111.347 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -65.62 -29.68 70.29 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.74 0.416 . . . . 74.05 111.419 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.35 -32.28 71.12 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.377 0.51 . . . . 63.53 112.377 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.87 16.76 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.982 0.513 . . . . 63.13 111.381 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 64.7 m -74.22 -32.05 62.86 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.847 0.859 . . . . 74.21 113.207 -174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.5 mmm -94.87 -42.97 8.42 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.435 0.694 . . . . 70.53 112.013 -175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.01 132.19 37.7 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.45 -0.204 . . . . 74.23 110.45 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -58.16 -40.28 80.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.829 0.851 . . . . 72.21 112.223 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -97.36 155.56 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.294 0.638 . . . . 42.14 109.824 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 96.15 2.33 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.667 -0.494 . . . . 74.11 109.667 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.56 123.47 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.038 -1.097 . . . . 72.42 108.038 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -103.39 95.15 6.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.82 0.848 . . . . 71.43 110.062 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.44 156.28 9.32 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.545 2.163 . . . . 74.14 112.054 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.5 tp10 -83.44 122.56 28.67 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.967 -0.753 . . . . 64.45 108.967 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.4 mtt -128.39 124.27 35.91 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.07 0.548 . . . . 70.43 110.391 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -135.68 133.76 38.45 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.985 0.421 . . . . 74.15 110.309 175.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 74' ' ' PRO . 94.5 mt -81.72 111.06 17.63 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.196 0.999 . . . . 60.32 110.641 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.36 130.13 55.22 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.954 0.902 . . . . 72.21 111.936 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -96.78 118.91 34.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.364 0.665 . . . . 72.03 111.282 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.83 121.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.658 1.183 . . . . 75.12 109.59 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 29.09 57.63 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.795 1.078 . . . . 32.52 115.795 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.86 81.39 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.035 0.774 . . . . 70.12 115.035 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -107.59 137.25 45.96 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.558 0.743 . . . . 63.25 109.681 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.9 m -102.01 134.88 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.684 0.675 . . . . 74.22 110.751 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.437 HD22 ' HB1' ' A' ' 4' ' ' ALA . 6.0 mp -124.48 170.18 11.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.393 1.077 . . . . 73.13 108.737 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 97' ' ' MET . 60.9 tp -117.31 116.54 27.42 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.671 -0.492 . . . . 62.01 109.671 172.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t -94.42 128.58 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.512 -0.921 . . . . 72.22 108.512 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 56.6 t -121.92 106.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.087 0.555 . . . . 60.42 111.006 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 92.3 t80 -82.52 123.95 29.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.026 0.93 . . . . 75.33 110.148 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.39 114.19 62.43 Favored Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 109.456 -0.572 . . . . 51.43 109.456 173.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.84 161.82 38.51 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.273 . . . . 62.43 112.602 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -75.02 150.15 39.02 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.94 -0.393 . . . . 72.43 109.94 176.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -74.02 145.76 44.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.281 0.562 . . . . 72.23 111.776 169.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.68 -179.95 1.95 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.452 1.101 . . . . 63.23 110.736 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.86 -49.69 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 62.31 112.974 167.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -73.2 -49.17 29.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.16 0.505 . . . . 75.12 110.708 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.7 m-70 -103.92 83.05 2.06 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 102.199 -3.26 . . . . 61.32 102.199 159.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 31.6 mmtp -43.5 -152.9 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.521 1 C-N-CA 132.562 4.345 . . . . 72.25 121.263 61.346 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo 4.14 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.007 2.471 . . . . 63.32 116.046 -126.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 120' ' ' LYS . 46.0 mm -100.74 125.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.754 0.822 . . . . 64.34 109.503 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -156.44 -176.86 6.2 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.539 0.736 . . . . 74.4 111.264 -174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt . . . . . 0 N--CA 1.482 1.173 0 C-N-CA 123.524 0.729 . . . . 73.41 111.908 177.016 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.607 ' HG2' ' HB2' ' A' ' 111' ' ' TYR . 3.0 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 111.208 0.077 . . . . 63.02 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -41.52 132.19 2.84 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.338 1.055 . . . . 73.21 112.668 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -62.84 159.36 16.79 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.348 0.659 . . . . 61.54 112.154 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.38 81.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.09 0.556 . . . . 61.31 112.049 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -68.93 -36.77 78.36 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.318 0.647 . . . . 53.14 112.481 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.42 -53.68 54.65 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.113 0.565 . . . . 73.14 111.152 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 109' ' ' VAL . 93.3 mt -59.64 -38.92 82.7 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.634 0.773 . . . . 62.23 112.029 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.5 tm? -62.55 -42.34 99.47 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.717 0.807 . . . . 75.43 110.862 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.73 -37.48 87.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.031 0.533 . . . . 60.55 110.56 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -66.09 -40.14 90.56 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.679 -0.691 . . . . 74.13 111.474 173.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 87.2 mt -61.03 -39.02 88.18 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.569 0.747 . . . . 73.41 111.79 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.51 -22.75 46.93 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.142 0.577 . . . . 74.14 111.851 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.81 -44.46 49.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.263 0.625 . . . . 51.21 111.226 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.5 m -86.82 151.63 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 74.42 110.994 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.36 -18.46 38.78 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.566 0.747 . . . . 74.2 110.977 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.68 150.81 36.14 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.326 0.65 . . . . 72.4 111.013 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 57.4 p -83.88 80.44 9.15 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.434 0.635 . . . . 71.5 110.717 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.62 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.68 -0.691 . . . . 65.04 112.0 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -120.44 -11.83 9.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 73.2 110.926 175.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mt -115.04 106.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.294 -1.002 . . . . 74.32 108.294 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 10.2 tp10 -96.04 151.81 19.1 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.299 1.44 . . . . 74.25 111.713 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.76 28.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.919 . . . . 72.22 110.162 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HG2' ' A' ' 21' ' ' GLU . 62.5 mttm -136.23 166.42 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 54.13 112.167 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -105.36 167.24 9.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.577 1.151 . . . . 64.14 112.042 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.57 -26.01 67.67 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.64 0.776 . . . . 75.41 112.448 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.6 t -56.4 -37.12 69.71 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.294 0.85 . . . . 23.21 113.294 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.33 18.35 16.12 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.555 0.946 . . . . 62.14 113.555 -170.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.1 ptm -63.74 103.19 0.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.049 0.928 . . . . 71.23 110.736 166.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.08 -130.97 2.7 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.307 -0.86 . . . . 75.45 111.939 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -55.14 -34.4 63.73 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.213 1.005 . . . . 74.34 112.862 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -67.39 -40.72 85.68 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.473 0.709 . . . . 65.43 111.89 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.49 -53.29 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.829 0.451 . . . . 73.44 110.033 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -48.22 -40.69 25.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.901 1.281 . . . . 72.25 113.34 175.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.07 -47.14 65.32 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.836 0.854 . . . . 73.13 111.927 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 m -77.62 -37.73 49.55 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.652 0.781 . . . . 61.34 111.912 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.24 -42.32 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.215 1.006 . . . . 62.31 112.254 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -54.14 -34.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.341 1.056 . . . . 62.21 112.379 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.78 92.55 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.249 0.62 . . . . 61.24 111.784 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -72.68 -30.22 64.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.961 0.504 . . . . 74.51 111.721 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.88 19.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.199 0.6 . . . . 75.51 112.23 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -85.16 -43.09 14.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.228 0.825 . . . . 73.43 113.228 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.63 108.23 5.49 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 122.92 0.488 . . . . 70.02 111.373 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 116.36 4.63 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.462 2.108 . . . . 65.12 111.683 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.74 3.31 40.01 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.243 -0.754 . . . . 63.14 114.24 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.53 -23.89 11.27 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 118.88 1.34 . . . . 75.45 108.401 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -44.94 155.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.246 1.819 . . . . 73.53 115.699 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 39.0 4.95 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.546 -0.752 . . . . 75.54 113.06 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.95 165.4 29.31 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 113.547 0.179 . . . . 71.0 113.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -123.22 126.75 47.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.318 0.647 . . . . 72.51 110.278 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.6 mp -112.32 118.08 34.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 75.43 108.438 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.5 tp -102.33 111.82 24.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.666 -0.494 . . . . 74.5 109.666 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 108' ' ' LEU . 71.7 mt -92.35 138.95 31.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.213 0.605 . . . . 74.12 111.149 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.12 41.07 5.65 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.548 -0.751 . . . . 64.41 112.634 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.92 141.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.122 0.569 . . . . 74.43 110.728 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -104.73 158.6 16.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.228 . . . . 62.02 108.322 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -143.87 126.73 16.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.203 0.525 . . . . 73.32 110.295 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.13 137.34 53.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.354 1.062 . . . . 73.12 110.707 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.56 122.86 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.53 0.732 . . . . 62.32 111.54 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -72.21 177.63 4.35 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.465 1.106 . . . . 74.33 111.986 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.17 -28.61 66.57 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.003 0.521 . . . . 62.22 110.821 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.107 0.963 . . . . 75.53 112.273 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.12 10.88 70.78 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 116.786 -0.188 . . . . 74.44 112.852 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.31 158.72 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.124 0.97 . . . . 72.43 111.969 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -109.71 113.03 25.45 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.361 0.665 . . . . 63.53 110.906 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.62 124.3 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.651 0.781 . . . . 64.13 109.586 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -93.17 127.17 38.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.262 0.625 . . . . 65.4 110.206 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -117.28 131.78 23.85 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.847 0.859 . . . . 74.3 110.601 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.03 97.3 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.268 1.979 . . . . 62.54 111.573 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.48 -20.63 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.405 0.682 . . . . 71.3 112.309 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.61 178.08 51.24 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 121.56 0.533 . . . . 60.24 114.267 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.12 138.75 20.63 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.226 1.011 . . . . 61.32 110.854 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.52 -38.37 19.52 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.481 2.121 . . . . 65.31 112.592 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 77' ' ' VAL . 14.5 m-20 -124.78 67.23 50.6 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 123.701 0.801 . . . . 64.44 109.627 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 99' ' ' LEU . 39.2 Cg_endo -60.22 -42.65 40.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.106 2.537 . . . . 64.22 114.638 -164.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.92 -38.0 87.55 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.133 0.573 . . . . 71.04 110.979 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -71.95 -37.23 69.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.258 0.623 . . . . 74.42 111.515 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.8 t -60.91 -39.61 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.665 0.386 . . . . 74.42 110.058 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.52 -47.92 79.67 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.24 0.616 . . . . 72.53 112.208 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -63.63 -50.06 70.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.823 0.849 . . . . 75.11 112.238 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.74 -30.31 69.76 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.895 0.878 . . . . 74.33 111.328 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.7 tp -67.56 -42.06 83.22 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.929 0.492 . . . . 74.54 111.122 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.44 98.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.445 0.698 . . . . 75.4 111.382 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -61.65 -52.61 63.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 60.2 111.668 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.94 -30.77 70.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.055 0.391 . . . . 75.24 112.055 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.19 -32.19 71.94 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.431 0.56 . . . . 70.24 112.071 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.3 -29.71 28.13 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.701 -0.681 . . . . 60.15 112.447 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -94.35 -24.41 17.4 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.549 1.314 . . . . 74.14 114.549 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.402 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 48.1 mmm -91.09 -27.1 18.79 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.46 0.704 . . . . 71.43 111.861 -173.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.6 162.0 13.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.139 0.576 . . . . 74.25 112.536 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -39.54 -63.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.083 1.753 . . . . 55.44 112.835 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.437 HG21 ' ND1' ' A' ' 119' ' ' HIS . 30.3 m -116.61 172.03 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.69 0.796 . . . . 71.54 110.16 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.17 99.66 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.197 0.523 . . . . 72.23 110.661 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.16 134.05 35.57 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.999 -1.112 . . . . 73.25 107.999 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -110.39 91.6 12.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.123 0.569 . . . . 75.21 111.462 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -90.62 169.07 3.9 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.831 2.354 . . . . 62.14 112.531 171.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.85 135.13 53.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.191 0.596 . . . . 72.41 109.838 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.661 ' HB3' HD11 ' A' ' 108' ' ' LEU . 46.9 mtt -130.03 132.57 46.27 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.203 0.601 . . . . 72.13 111.156 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -135.37 144.31 46.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.481 0.712 . . . . 71.43 111.741 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 74' ' ' PRO . 74.1 mt -104.23 117.12 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.092 0.957 . . . . 74.23 110.098 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -117.49 133.23 56.2 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.492 1.117 . . . . 75.35 111.651 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -94.21 114.36 26.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.822 0.849 . . . . 72.05 110.527 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.95 113.95 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.788 1.235 . . . . 63.44 109.149 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 51.42 28.49 20.73 Favored Glycine 0 CA--C 1.543 1.803 0 N-CA-C 115.642 1.017 . . . . 62.31 115.642 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.23 -5.71 78.23 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.546 0.578 . . . . 60.52 114.546 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -98.92 137.57 37.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 61.34 110.699 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 m -102.39 104.73 15.23 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.191 0.451 . . . . 74.44 111.461 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.09 163.7 12.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.663 0.785 . . . . 62.32 111.623 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 97' ' ' MET . 39.4 tp -115.4 114.14 24.68 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.146 0.578 . . . . 62.14 110.962 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 7' ' ' LEU . 90.8 t -83.29 112.53 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.711 0.804 . . . . 71.12 109.506 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 25.1 t -108.49 100.05 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.637 0.732 . . . . 61.2 110.602 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 51.9 t80 -84.6 124.47 31.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.433 1.093 . . . . 74.14 110.535 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.07 103.02 48.66 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 122.655 0.382 . . . . 63.43 110.44 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.65 166.18 28.91 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.736 2.291 . . . . 71.53 112.011 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.51 161.74 24.82 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.915 1.079 . . . . 74.25 113.915 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.38 47.17 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.739 -1.119 . . . . 33.13 109.18 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.14 163.43 24.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 122.737 0.415 . . . . 62.21 111.058 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.0 -22.18 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.305 1.042 . . . . 73.54 112.467 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.3 p -58.28 -27.39 64.01 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.191 0.597 . . . . 75.33 111.448 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 5.4 m170 -75.84 -86.07 0.05 OUTLIER 'General case' 0 CA--C 1.591 2.53 0 N-CA-C 105.512 -2.033 . . . . 65.13 105.512 166.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 45.1 tttp -82.49 -145.04 0.0 OUTLIER Pre-proline 0 CA--C 1.591 2.538 0 C-N-CA 129.298 3.039 . . . . 71.23 109.636 -49.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo 5.47 102.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 124.884 3.723 . . . . 53.24 119.326 -136.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.2 mt -88.85 115.11 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 114.735 -1.12 . . . . 75.43 109.48 168.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -108.38 166.5 10.71 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.555 0.742 . . . . 72.24 111.458 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 26.5 tptp . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 122.937 0.495 . . . . 72.23 109.871 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.539 0.685 . . . . 75.05 112.789 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.39 179.53 4.12 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.944 -1.026 . . . . 71.31 110.189 165.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -71.76 157.25 38.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.656 -0.702 . . . . 70.45 112.063 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.22 84.47 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.402 0.681 . . . . 62.13 111.543 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -65.6 -33.95 77.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.447 0.699 . . . . 73.3 112.593 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -43.74 80.9 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 120.847 0.356 . . . . 63.45 111.092 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.72 -29.12 69.03 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.074 0.55 . . . . 72.23 111.646 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 11' ' ' LEU . 17.9 tp -63.73 -29.77 70.95 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.647 0.779 . . . . 73.22 111.324 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.49 -34.2 75.08 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.176 0.59 . . . . 64.02 111.821 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.0 tt0 -67.66 -52.11 41.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.595 0.634 . . . . 75.22 109.659 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 8' ' ' LEU . 77.5 mt -49.38 -45.63 46.22 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.489 1.116 . . . . 73.01 112.762 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.46 -26.38 38.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.501 0.926 . . . . 61.02 113.501 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.33 -53.41 16.82 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.339 0.518 . . . . 71.04 111.427 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.2 m -81.79 139.89 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.927 0.491 . . . . 73.33 110.379 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.79 -45.06 90.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.522 0.729 . . . . 72.42 111.605 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -123.53 138.21 54.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.922 0.889 . . . . 72.42 110.487 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -44.17 124.62 4.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 71.01 113.669 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.94 -65.08 1.01 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.167 0.587 . . . . 64.31 112.328 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -119.82 -6.61 10.08 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.819 0.848 . . . . 75.11 111.406 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' A' ' 49' ' ' TYR . 45.5 mt -128.96 121.84 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.872 0.869 . . . . 55.43 108.806 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.55 129.06 46.44 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.949 -0.389 . . . . 74.12 109.949 169.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -81.38 133.86 35.48 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.517 0.727 . . . . 64.22 109.067 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -130.86 151.13 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.41 0.624 . . . . 65.24 111.438 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -97.85 159.67 14.79 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.008 -0.997 . . . . 72.02 110.241 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.627 0.771 . . . . 74.23 112.302 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -59.88 -36.42 76.88 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.93 0.892 . . . . 73.24 113.041 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.53 -10.55 55.83 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.12 0.568 . . . . 74.13 112.094 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.2 ttt -59.43 104.28 0.25 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.171 0.51 . . . . 51.13 111.239 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 170.65 -150.35 14.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.241 -0.744 . . . . 61.43 111.241 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.13 -27.14 52.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.12 1.156 . . . . 63.22 114.12 -175.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -65.44 -43.62 89.87 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.938 0.495 . . . . 63.2 111.26 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.26 -42.86 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.81 0.844 . . . . 74.11 110.773 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 84.6 mmm -64.34 -33.27 75.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.82 0.848 . . . . 71.14 112.038 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.63 -36.58 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.187 0.595 . . . . 75.43 110.936 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 50' ' ' LEU . 3.0 m -70.64 -29.85 66.32 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 116.258 -0.428 . . . . 72.14 110.899 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.1 -38.41 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.511 0.725 . . . . 74.33 110.146 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.78 -36.55 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.42 0.288 . . . . 64.3 110.898 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.18 -57.86 7.45 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 120.965 0.412 . . . . 60.04 111.192 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -67.43 -20.79 65.55 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.447 0.906 . . . . 73.34 113.447 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.98 -33.45 19.61 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.209 0.818 . . . . 72.32 113.209 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -101.08 -27.82 13.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.761 1.023 . . . . 63.42 113.761 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.46 115.45 56.72 Favored Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 118.079 0.4 . . . . 72.13 111.739 -176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.99 160.24 38.59 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.485 2.124 . . . . 75.55 111.785 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.31 -41.15 3.07 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 114.031 0.373 . . . . 75.31 114.031 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -94.55 -34.44 12.66 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.065 0.933 . . . . 51.05 110.716 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 2.71 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.649 2.38 . . . . 75.05 116.284 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.44 0.57 Allowed Glycine 0 CA--C 1.537 1.432 0 CA-C-N 116.324 -0.398 . . . . 43.25 113.405 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.07 173.48 43.0 Favored Glycine 0 N--CA 1.478 1.45 0 O-C-N 122.833 -0.216 . . . . 60.3 112.971 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.624 ' HB2' HG12 ' A' ' 20' ' ' ILE . 76.7 m-85 -121.02 155.67 33.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.433 0.635 . . . . 74.14 111.907 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 60.8 mt -128.31 118.47 23.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.623 1.169 . . . . 73.43 108.585 170.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.3 tp -103.52 109.07 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 75.32 109.788 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 108' ' ' LEU . 25.1 mt -99.74 126.32 45.78 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.265 0.626 . . . . 62.22 110.67 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-N 116.6 -0.273 . . . . 40.53 113.058 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 58.4 t -112.65 137.52 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.207 0.603 . . . . 63.24 109.943 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -109.89 157.41 19.25 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.05 -1.093 . . . . 74.3 108.05 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -144.02 136.11 26.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.875 0.369 . . . . 74.04 111.662 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.15 135.33 47.36 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.767 0.827 . . . . 42.1 110.669 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.3 mt -96.83 134.89 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.416 0.686 . . . . 73.44 110.996 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -84.7 -177.19 6.53 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.426 0.69 . . . . 75.21 111.665 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.3 -25.05 66.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.934 0.716 . . . . 72.12 112.934 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -78.28 -22.94 47.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.774 0.83 . . . . 71.14 112.555 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.96 -0.96 31.64 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 114.585 0.594 . . . . 53.13 114.585 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -75.51 120.79 21.42 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.475 0.637 . . . . 70.33 110.935 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -80.94 118.95 22.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.122 0.569 . . . . 65.33 109.811 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.51 114.89 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.682 0.793 . . . . 72.25 109.326 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.85 130.25 41.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.079 -0.711 . . . . 72.41 109.079 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -143.57 131.11 10.79 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.048 0.539 . . . . 64.54 111.169 -172.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.53 101.43 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.759 2.306 . . . . 75.03 112.571 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.12 -6.45 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.127 0.571 . . . . 71.33 112.062 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.47 175.18 50.29 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 114.601 0.6 . . . . 73.13 114.601 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -105.48 137.77 19.38 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.854 1.262 . . . . 63.4 109.889 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.31 -30.5 19.62 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.071 1.847 . . . . 71.11 112.291 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 6.2 m-20 -125.98 66.43 58.66 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.871 0.868 . . . . 55.41 110.617 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -43.55 23.97 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.707 2.271 . . . . 75.2 114.27 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -71.04 -39.38 72.33 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.999 -0.546 . . . . 74.52 110.654 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 14.1 ttmm -60.41 -44.42 95.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.445 0.698 . . . . 74.12 111.15 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 73' ' ' ASP . 78.4 t -59.85 -43.41 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 122.632 0.373 . . . . 61.44 110.691 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.94 -50.2 67.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.541 0.571 . . . . 71.14 112.541 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -68.82 -49.59 57.25 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.865 0.466 . . . . 74.03 111.766 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.28 -28.54 67.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.512 0.725 . . . . 54.13 112.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.8 tp -72.65 -41.52 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.385 0.539 . . . . 73.41 111.432 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.28 84.22 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.12 0.568 . . . . 72.12 112.189 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 p -73.87 -41.39 62.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 63.51 112.071 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -65.34 -30.15 70.96 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 117.665 0.211 . . . . 73.55 111.228 173.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.7 t -59.35 -21.07 59.28 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 112.923 0.712 . . . . 73.22 112.923 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.01 -35.15 17.75 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.824 0.85 . . . . 72.23 111.587 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 -14.46 31.13 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.585 0.958 . . . . 72.21 113.585 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.3 mmm -90.05 -47.51 7.79 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.82 0.848 . . . . 71.14 110.081 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.82 154.23 17.36 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.047 -0.979 . . . . 74.14 110.627 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.0 p30 -48.29 -47.56 36.33 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.2 1.0 . . . . 74.44 112.705 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.66 173.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.244 1.018 . . . . 75.35 110.138 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.29 100.54 3.17 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.811 -0.631 . . . . 51.35 110.462 169.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 122' ' ' ILE . 5.9 tt -75.7 131.41 39.86 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.263 -1.755 . . . . 71.15 106.263 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -106.28 95.71 11.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 122.866 0.466 . . . . 74.12 111.869 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.19 161.65 5.72 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.105 1.87 . . . . 44.32 111.928 166.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 111' ' ' TYR . 37.9 mm-40 -92.04 141.13 28.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.44 -0.8 . . . . 65.31 108.935 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.632 ' HB3' HD11 ' A' ' 108' ' ' LEU . 67.3 mtt -137.8 122.74 18.97 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.32 111.121 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -130.87 136.84 49.0 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.811 0.844 . . . . 42.15 110.13 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.91 109.82 20.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.72 -0.845 . . . . 60.2 108.72 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.96 128.53 55.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.012 0.525 . . . . 62.32 110.848 -166.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -101.2 123.85 45.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.534 0.734 . . . . 71.31 111.765 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.93 122.45 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.677 1.191 . . . . 72.31 109.881 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.75 28.85 48.11 Favored Glycine 0 CA--C 1.544 1.89 0 N-CA-C 115.733 1.053 . . . . 61.41 115.733 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.15 5.37 76.62 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.015 0.766 . . . . 71.1 115.015 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.08 134.88 50.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 74.22 109.963 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.7 m -97.7 129.18 44.77 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.751 0.705 . . . . 72.02 110.603 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.05 171.41 8.69 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.402 1.081 . . . . 72.23 109.047 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 97' ' ' MET . 47.2 tp -117.49 114.81 24.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.918 0.389 . . . . 74.15 110.155 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.55 113.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 39.5 t -107.46 101.09 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.756 -0.461 . . . . 73.54 109.756 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 62.8 t80 -85.79 119.93 26.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.756 -0.831 . . . . 74.32 108.756 172.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.61 98.39 28.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.042 0.537 . . . . 55.54 109.64 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.38 162.43 22.38 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.767 2.312 . . . . 73.3 113.381 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HG3' ' HE3' ' A' ' 120' ' ' LYS . 10.8 tt0 -73.29 128.37 35.3 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.239 0.616 . . . . 73.33 111.679 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.76 171.51 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.184 0.994 . . . . 50.43 112.059 -175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.16 132.88 34.64 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 123.63 0.772 . . . . 71.31 110.574 -169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -38.49 -38.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.876 0 N-CA-C 116.79 2.144 . . . . 70.35 116.79 -160.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.9 t -63.98 -42.93 97.08 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.021 0.528 . . . . 62.24 111.675 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 23.1 m-70 -128.97 70.89 1.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 104.822 -2.288 . . . . 75.04 104.822 167.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.1 mttt -48.17 -156.95 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.744 0 C-N-CA 131.647 3.979 . . . . 74.21 121.59 57.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo 4.57 70.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.908 2.405 . . . . 62.35 116.04 -127.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 93' ' ' LEU . 34.0 mm -73.92 89.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.726 -0.67 . . . . 71.41 110.032 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -89.67 150.45 22.34 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.955 -0.566 . . . . 70.5 109.921 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 109.85 -0.426 . . . . 72.33 109.85 171.407 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptm . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.489 0.185 . . . . 73.44 111.293 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -105.54 154.29 20.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.707 0.803 . . . . 73.42 111.366 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -75.73 160.24 30.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.834 0.453 . . . . 64.02 111.768 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 -27.99 69.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.641 -0.709 . . . . 63.22 112.268 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.61 HG23 HG13 ' A' ' 102' ' ' VAL . 5.8 m -71.47 -45.88 61.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.149 0.58 . . . . 71.41 110.864 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.74 -46.42 90.48 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.511 -0.768 . . . . 74.51 111.759 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.72 -34.57 67.2 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.638 0.775 . . . . 75.3 112.242 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.37 -47.7 72.56 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.129 0.571 . . . . 42.33 110.515 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.85 -35.29 79.46 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.293 -0.867 . . . . 71.53 111.128 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.62 -37.75 88.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.476 0.71 . . . . 73.33 111.171 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.418 HD13 ' HB2' ' A' ' 22' ' ' ALA . 59.2 mt -60.74 -37.06 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.964 0.906 . . . . 63.41 111.768 174.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 66' ' ' TYR . 53.3 m-80 -80.69 -21.75 41.0 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.299 0.639 . . . . 51.54 112.186 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.24 -47.61 12.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.506 0.722 . . . . 64.32 112.567 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.34 163.71 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.573 0.702 . . . . 72.23 112.829 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.23 -33.83 22.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.271 -0.877 . . . . 74.41 110.48 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -139.81 136.77 34.39 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.133 0.973 . . . . 74.44 109.766 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 m -75.21 90.88 2.59 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.315 0.578 . . . . 61.14 110.144 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.19 82.86 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.731 1.212 . . . . 61.32 113.263 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -160.57 14.9 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.499 0.72 . . . . 75.13 111.731 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.86 117.1 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.794 -1.187 . . . . 74.13 107.794 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 150.17 38.49 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.224 0.61 . . . . 63.34 111.053 -173.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -121.59 124.38 44.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.734 0.814 . . . . 72.44 110.411 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 32' ' ' VAL . 31.2 mmtp -122.87 144.68 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.551 0.74 . . . . 73.14 110.303 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -75.89 158.26 32.27 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.316 0.646 . . . . 70.13 111.386 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -24.51 63.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.582 0.956 . . . . 55.22 113.582 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.0 t -84.16 -11.93 55.76 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.647 0.61 . . . . 64.54 112.647 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.3 -18.87 34.92 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.595 0.758 . . . . 71.02 111.515 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.78 131.26 50.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.19 0.519 . . . . 75.25 112.309 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.56 -122.6 2.81 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.159 -0.473 . . . . 75.32 112.081 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -68.24 -38.44 81.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.81 0.844 . . . . 74.24 111.748 -173.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.3 m -69.2 -42.03 76.33 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.667 0.787 . . . . 74.53 111.732 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 23' ' ' LYS . 88.0 t -70.44 -41.84 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.693 0.397 . . . . 72.22 110.825 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 89' ' ' LEU . 35.0 tpp -56.28 -44.4 79.74 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.813 0.845 . . . . 75.31 111.847 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.97 -30.57 71.02 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.722 0.809 . . . . 62.0 110.953 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -76.39 -36.35 58.15 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.745 0.818 . . . . 54.33 111.321 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 32' ' ' VAL . 97.1 t -60.97 -38.73 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 123.767 0.827 . . . . 73.21 111.129 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -57.4 -33.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.941 0.896 . . . . 63.24 111.071 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.63 71.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.146 0.578 . . . . 65.42 111.759 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.402 ' HE2' HD21 ' A' ' 50' ' ' LEU . 89.5 m-85 -67.98 -18.17 64.65 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.377 0.51 . . . . 65.34 112.377 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.06 -37.41 18.91 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.581 0.752 . . . . 73.51 112.603 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.572 HD21 ' HB ' ' A' ' 122' ' ' ILE . 58.6 m-80 -104.52 -46.06 4.47 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.102 0.778 . . . . 52.51 113.102 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.21 121.82 78.34 Favored Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 123.813 0.845 . . . . 75.23 111.721 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.96 -178.46 2.82 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.199 2.599 . . . . 55.11 113.503 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.13 -40.46 2.92 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 114.869 0.708 . . . . 75.01 114.869 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.92 -48.24 25.62 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.798 0.799 . . . . 74.41 112.876 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t70 41.21 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.249 1.203 . . . . 65.24 114.249 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 113' ' ' PRO . . . 78.01 72.21 1.17 Allowed Glycine 0 CA--C 1.535 1.294 0 C-N-CA 121.155 -0.545 . . . . 54.32 114.051 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.74 168.35 27.67 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 116.665 0.233 . . . . 22.04 113.143 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -121.36 144.23 48.77 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.83 0.678 . . . . 65.01 112.83 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 76.2 mt -122.55 123.13 40.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.702 1.201 . . . . 51.4 109.302 171.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.18 108.98 20.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.365 -0.605 . . . . 61.11 109.365 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.631 HD12 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -94.76 129.91 41.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.181 0.592 . . . . 71.45 110.21 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 34.59 4.85 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.296 -0.411 . . . . 61.01 112.622 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -112.37 140.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.826 0.85 . . . . 72.03 109.964 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -124.04 154.88 39.26 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.102 -1.073 . . . . 61.04 108.102 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -136.16 128.99 31.05 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.914 0.485 . . . . 65.12 110.828 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.764 0.825 . . . . 62.13 110.63 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -100.01 128.63 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.727 0.811 . . . . 70.33 111.646 -170.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 73.8 m-20 -76.63 178.05 7.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.208 0.603 . . . . 62.34 112.181 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.23 -37.53 87.55 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.11 0.564 . . . . 72.22 111.252 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -68.17 -29.91 68.89 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.307 0.643 . . . . 71.2 111.47 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.26 6.0 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.024 -0.535 . . . . 42.42 113.924 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.7 m-20 -78.67 138.32 38.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.978 0.511 . . . . 73.13 111.663 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.6 m -89.54 102.76 15.44 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.47 0.708 . . . . 73.11 109.975 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' HH12 ' A' ' 67' ' ' ARG . 57.6 t -109.96 129.26 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.552 0.741 . . . . 71.21 110.396 -176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB2' HD21 ' A' ' 12' ' ' ASN . 75.9 m-85 -95.76 120.81 36.68 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.73 0.812 . . . . 74.34 111.96 -171.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.43 HH12 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.69 150.91 45.61 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.128 0.971 . . . . 72.01 111.427 174.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.53 108.89 2.53 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.477 2.118 . . . . 73.01 113.229 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 m -91.86 -28.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 116.112 -0.494 . . . . 62.14 110.647 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 -176.73 53.97 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.734 -0.666 . . . . 64.15 113.83 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.4 mt -102.66 143.25 26.22 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.94 0.896 . . . . 75.34 110.856 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.0 -56.58 1.32 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.64 2.226 . . . . 64.02 111.743 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.514 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 12.1 m-20 -120.34 89.22 43.38 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.897 0.879 . . . . 70.44 108.656 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -54.98 -44.9 45.29 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.483 2.789 . . . . 73.34 114.664 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.22 -41.65 85.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.213 0.605 . . . . 74.0 110.634 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 36.9 ttpt -61.32 -43.4 98.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.795 0.438 . . . . 71.42 111.172 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.37 -43.69 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.821 0.849 . . . . 73.54 111.289 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.68 -39.67 94.9 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.838 0.855 . . . . 50.21 111.735 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -67.39 -46.2 74.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.673 0.789 . . . . 63.03 112.128 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.51 -41.17 96.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.919 0.888 . . . . 63.55 111.185 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.05 -44.23 80.69 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.025 -0.534 . . . . 63.21 111.487 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.69 97.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 73.1 111.369 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -60.89 -52.01 66.84 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.266 1.026 . . . . 72.41 111.887 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.45 -29.81 68.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.19 0.596 . . . . 71.35 112.052 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.3 t -61.57 -23.89 66.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.785 -0.572 . . . . 74.31 112.206 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.03 -48.74 7.0 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.639 0.776 . . . . 74.53 111.414 170.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 t -74.55 -22.69 58.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.387 1.255 . . . . 71.22 114.387 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.8 mmm -88.51 -51.89 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.218 0.607 . . . . 74.42 111.602 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 33' ' ' MET . 88.6 mt -70.01 -103.26 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 113.847 1.054 . . . . 62.05 113.847 -165.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.453 ' ND2' HG13 ' A' ' 91' ' ' VAL . 9.6 p-10 -170.01 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.662 0.664 . . . . 55.2 110.123 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG11 ' ND1' ' A' ' 119' ' ' HIS . 23.9 m -114.59 157.22 15.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.078 0.951 . . . . 63.34 109.055 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 96.06 1.16 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.258 -0.645 . . . . 63.03 109.258 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.75 122.02 34.73 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.263 -1.384 . . . . 61.14 107.263 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -104.41 100.44 22.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 122.619 0.368 . . . . 75.12 110.473 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.18 161.62 26.12 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.981 1.787 . . . . 71.22 110.948 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.7 tp10 -104.03 101.89 11.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.356 -0.609 . . . . 75.25 109.356 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 108' ' ' LEU . 5.3 mpp? -101.71 135.06 43.87 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 112.501 0.556 . . . . 54.12 112.501 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -136.03 127.01 27.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.539 0.735 . . . . 74.33 111.242 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.0 112.01 9.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.209 1.003 . . . . 64.33 110.892 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -126.38 129.59 49.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.781 0.832 . . . . 75.45 111.179 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.35 126.67 39.75 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.533 0.733 . . . . 74.44 111.405 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' THR . 13.1 t -119.33 118.4 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.256 1.022 . . . . 73.33 108.877 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 28.59 63.63 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.718 0.647 . . . . 75.3 114.718 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.07 10.61 78.03 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.419 0.527 . . . . 74.41 114.419 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.6 133.03 55.51 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.019 0.928 . . . . 74.34 108.961 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 m -89.88 123.74 34.09 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.059 0.845 . . . . 72.43 111.584 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.68 170.92 8.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.513 1.125 . . . . 72.31 109.078 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -122.28 120.11 33.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.581 0.353 . . . . 64.11 110.863 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' MET . 38.4 t -88.54 120.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.143 -0.688 . . . . 64.52 109.143 170.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 21.5 t -108.51 101.51 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.262 -0.644 . . . . 51.21 109.262 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.5 t80 -85.4 116.16 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.189 0.596 . . . . 70.43 109.733 175.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.77 96.89 50.19 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 108.011 -1.107 . . . . 53.34 108.011 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 72.8 Cg_endo -70.49 171.13 15.85 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.656 2.237 . . . . 51.35 112.753 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.29 121.36 19.3 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.357 -0.979 . . . . 61.22 108.357 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -79.55 166.87 21.48 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.566 0.746 . . . . 51.55 112.103 -173.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 38.2 t70 -62.48 165.77 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 124.001 0.921 . . . . 75.11 112.471 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -52.88 -51.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.094 -1.004 . . . . 63.14 113.542 168.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.7 p -84.68 6.44 24.15 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.583 0.586 . . . . 72.14 112.583 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.572 ' ND1' HG11 ' A' ' 91' ' ' VAL . 52.0 m-70 -170.96 64.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 103.026 -2.953 . . . . 74.44 103.026 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.752 ' HA ' HG12 ' A' ' 122' ' ' ILE . 9.4 ptpp? -48.04 -156.67 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.399 2 C-N-CA 133.584 4.754 . . . . 63.11 122.096 42.256 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 10.9 Cg_exo 14.13 73.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.983 1.788 . . . . 63.43 115.204 -118.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.752 HG12 ' HA ' ' A' ' 120' ' ' LYS . 49.7 mm -90.2 125.34 43.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 114.006 -1.452 . . . . 60.44 108.654 172.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -149.97 155.53 40.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.196 0.998 . . . . 73.23 108.893 -174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 122.601 0.36 . . . . 75.43 110.784 175.803 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 11.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.555 0.217 . . . . 64.2 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -62.73 156.77 22.77 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.462 0.648 . . . . 71.01 112.494 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 m -67.2 160.6 26.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.775 -1.102 . . . . 73.02 112.973 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.97 -27.67 67.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.956 0.502 . . . . 62.25 111.211 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 102' ' ' VAL . 39.4 p -57.15 -51.29 69.9 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.407 0.683 . . . . 73.23 111.055 168.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.23 -36.59 74.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.596 -1.184 . . . . 73.0 111.394 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 mt -70.46 -30.23 67.0 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.52 1.128 . . . . 71.02 113.008 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.41 -31.6 72.8 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.997 -0.547 . . . . 73.35 110.161 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.32 -37.72 86.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.734 0.814 . . . . 74.24 112.465 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.45 -46.99 74.58 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.308 0.504 . . . . 71.44 110.721 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.1 mt -60.18 -42.97 96.14 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 124.132 0.973 . . . . 62.31 112.25 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -80.76 -13.95 58.53 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.692 0.797 . . . . 53.41 112.915 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.85 -62.12 1.8 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.001 0.52 . . . . 55.43 110.761 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -100.14 143.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.817 -0.629 . . . . 60.22 110.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.67 -46.76 89.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.872 0.869 . . . . 62.44 111.84 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.32 111.7 15.49 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.944 0.897 . . . . 60.35 109.706 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 66.5 m -74.72 126.86 31.77 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.423 0.689 . . . . 74.54 111.716 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.71 22.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.567 0.951 . . . . 64.34 113.567 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -108.76 -2.73 18.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.408 0.683 . . . . 72.23 111.764 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 17' ' ' SER . 29.3 mm -111.17 145.24 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.917 -0.771 . . . . 64.11 108.917 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -139.7 152.12 46.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.758 0.423 . . . . 73.04 110.7 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.95 125.02 42.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.746 0.818 . . . . 63.1 109.988 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HD2' HG22 ' A' ' 32' ' ' VAL . 37.8 mttp -125.18 153.65 42.75 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.584 0.754 . . . . 71.14 111.263 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.34 155.15 24.91 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.756 -1.111 . . . . 73.24 111.356 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.03 -30.64 62.19 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.096 0.958 . . . . 55.33 113.523 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.0 p -65.89 -35.41 80.56 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.657 0.783 . . . . 74.42 112.816 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.62 13.49 6.96 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.505 0.928 . . . . 60.44 113.505 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.609 ' SD ' HD13 ' A' ' 52' ' ' LEU . 85.6 mmm -57.1 104.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.258 0.466 . . . . 34.43 112.258 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.69 -148.4 12.37 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.009 -0.541 . . . . 72.41 112.557 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -55.83 -31.53 62.79 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.552 1.141 . . . . 71.32 113.934 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -68.74 -42.62 77.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.058 0.543 . . . . 75.02 111.583 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 23' ' ' LYS . 52.3 t -60.96 -53.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.255 0.55 . . . . 75.32 109.9 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.521 ' SD ' ' HG3' ' A' ' 84' ' ' GLN . 81.0 mmm -49.2 -44.12 42.91 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.449 -1.251 . . . . 63.0 113.993 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.53 -31.25 69.36 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.614 0.598 . . . . 70.51 112.614 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.598 ' HB ' HD21 ' A' ' 50' ' ' LEU . 28.2 m -70.4 -37.41 74.47 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.541 0.336 . . . . 73.11 110.573 174.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.51 -44.17 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.375 0.67 . . . . 73.51 110.419 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.91 -40.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.319 1.048 . . . . 73.34 111.257 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.15 90.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 75.33 111.832 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 112' ' ' VAL . 21.2 m-85 -81.19 -35.7 31.05 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.959 0.504 . . . . 75.3 111.386 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.14 73.21 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.659 0.784 . . . . 63.21 112.497 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -76.99 -24.58 52.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.172 0.589 . . . . 74.44 112.191 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.21 110.6 11.67 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 123.023 0.529 . . . . 72.52 110.047 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.84 118.15 4.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.509 2.806 . . . . 64.12 114.992 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.28 26.73 74.06 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.44 -0.8 . . . . 74.13 114.777 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -103.78 8.83 37.2 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.978 0.889 . . . . 63.33 110.196 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -51.49 141.48 15.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.815 0.846 . . . . 72.21 112.25 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 122.21 -29.77 5.42 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 111.347 -0.701 . . . . 64.12 111.347 -166.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.53 121.93 9.8 Favored Glycine 0 CA--C 1.548 2.117 0 N-CA-C 114.483 0.553 . . . . 73.34 114.483 175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -114.05 142.39 46.25 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.916 0.886 . . . . 74.1 112.416 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.598 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.1 mp -117.33 128.36 54.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.238 1.015 . . . . 75.11 109.022 170.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.86 109.65 21.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.238 0.615 . . . . 74.23 109.864 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.662 HD12 HD23 ' A' ' 108' ' ' LEU . 82.0 mt -97.8 125.67 42.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.561 0.744 . . . . 72.35 110.649 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 35.08 4.13 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.046 -0.524 . . . . 71.44 112.52 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.53 144.02 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.285 0.634 . . . . 71.52 110.34 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 131.76 44.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.132 0.973 . . . . 52.1 108.56 172.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 p90 -111.08 131.36 55.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.738 0.815 . . . . 72.51 111.197 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.36 129.9 56.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.545 1.138 . . . . 71.51 110.172 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.95 123.84 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 53.04 111.721 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.46 170.7 13.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.952 0.901 . . . . 62.34 111.9 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.36 -25.89 68.23 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.036 0.534 . . . . 71.4 111.618 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.85 -1.53 35.42 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.453 0.701 . . . . 75.44 112.107 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.18 32.57 51.95 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 122.656 0.17 . . . . 45.42 113.124 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.75 134.76 40.49 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.481 0.712 . . . . 71.22 111.176 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -92.82 106.32 18.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.579 0.752 . . . . 62.44 110.854 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.51 112.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.846 0.859 . . . . 73.33 109.843 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.18 115.55 27.5 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.12 109.536 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -116.48 136.39 23.1 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.121 0.969 . . . . 62.24 111.066 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.75 96.48 1.0 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.873 2.382 . . . . 73.2 112.793 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.72 -20.39 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 116.091 -0.504 . . . . 43.11 111.065 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.57 -169.47 53.53 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.989 0.756 . . . . 73.15 114.989 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 77' ' ' VAL . 62.7 mt -117.95 130.63 24.6 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.97 1.308 . . . . 75.45 109.11 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.04 -27.49 29.85 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.204 1.936 . . . . 54.43 111.94 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -137.97 77.71 36.95 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.341 1.456 . . . . 71.23 108.991 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.48 -35.52 29.99 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.956 2.437 . . . . 64.34 114.268 -167.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.93 -39.89 83.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.232 0.613 . . . . 75.35 110.428 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.45 -49.81 75.33 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.972 -0.558 . . . . 75.51 110.676 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 71' ' ' LEU . 81.9 t -55.93 -43.91 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.332 1.053 . . . . 74.04 111.919 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -62.84 -41.82 99.5 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.473 0.709 . . . . 73.01 112.113 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.43 -32.88 64.64 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.296 0.639 . . . . 71.3 112.359 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.22 -38.86 88.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.067 0.547 . . . . 65.35 110.107 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.99 -39.01 87.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.332 0.653 . . . . 70.15 110.877 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.47 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.706 0.802 . . . . 52.42 112.101 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 t -73.95 -53.13 10.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.166 0.586 . . . . 40.32 111.253 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.521 ' HG3' ' SD ' ' A' ' 33' ' ' MET . 9.9 pt20 -67.68 -28.93 68.1 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.711 0.804 . . . . 74.41 112.664 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.7 p -64.02 -26.57 68.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.291 0.478 . . . . 64.31 112.291 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -90.43 -41.79 11.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.572 0.749 . . . . 54.2 112.27 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -77.81 -43.97 28.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.784 1.031 . . . . 74.14 113.784 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 mmt -69.1 -44.07 73.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.766 0.826 . . . . 62.22 112.571 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.87 150.14 20.79 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.418 0.687 . . . . 54.44 111.097 -165.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.575 HD21 HG13 ' A' ' 91' ' ' VAL . 2.0 p-10 -52.76 -34.47 53.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.307 0.854 . . . . 73.54 113.307 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.575 HG13 HD21 ' A' ' 90' ' ' ASN . 26.2 m -120.48 170.83 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.719 0.808 . . . . 64.31 110.224 169.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -78.69 102.04 7.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 120.987 0.422 . . . . 64.2 110.129 170.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.74 116.97 27.4 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.183 -1.414 . . . . 73.2 107.183 174.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -103.76 98.32 12.84 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 122.858 0.463 . . . . 74.33 110.476 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.56 165.53 18.22 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.178 1.919 . . . . 74.24 112.294 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 9.5 tp10 -84.69 129.45 34.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.494 0.718 . . . . 75.4 109.418 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB3' HD11 ' A' ' 108' ' ' LEU . 53.4 mtt -132.84 120.62 21.79 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.49 0.716 . . . . 63.44 110.862 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.589 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.4 mm-40 -128.49 137.97 52.05 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.198 0.599 . . . . 73.52 110.446 173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.44 112.66 24.66 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.537 0.735 . . . . 74.23 110.348 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -114.9 127.16 55.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.885 0.874 . . . . 63.25 111.757 -170.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -88.38 118.72 28.2 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.384 0.674 . . . . 74.22 110.689 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 5' ' ' THR . 15.0 t -124.68 113.52 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.631 1.172 . . . . 72.43 108.885 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.21 65.64 Favored Glycine 0 CA--C 1.543 1.84 0 N-CA-C 115.495 0.958 . . . . 42.25 115.495 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.63 6.05 70.88 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.348 0.499 . . . . 72.21 114.348 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -114.36 136.55 52.87 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.884 0.873 . . . . 62.25 108.73 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 m -93.37 132.33 37.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.569 0.622 . . . . 74.23 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.77 169.14 11.4 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.382 1.073 . . . . 75.31 109.002 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 52' ' ' LEU . 55.1 tp -120.0 116.39 25.66 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.733 0.302 . . . . 74.4 110.446 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 51.6 t -87.78 130.89 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.297 -0.631 . . . . 54.32 109.297 173.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 24.0 t -116.19 100.92 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 122.959 0.504 . . . . 71.04 110.062 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.724 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 81.8 t80 -83.74 126.61 33.07 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.13 -0.693 . . . . 73.44 109.13 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 39' ' ' PHE . 38.7 t -99.61 112.66 64.02 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.907 -0.405 . . . . 73.02 109.907 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.29 152.08 15.83 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.721 2.28 . . . . 63.23 111.941 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -65.99 111.57 3.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.979 0.912 . . . . 74.41 111.365 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -68.73 156.01 39.06 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.353 0.661 . . . . 71.24 112.364 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.98 141.43 51.03 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 123.717 0.807 . . . . 62.24 109.631 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.45 -40.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 115.664 1.727 . . . . 75.22 115.664 -171.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -72.48 -35.02 68.09 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.973 0.731 . . . . 64.01 112.973 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -139.03 79.17 1.71 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.936 -1.505 . . . . 71.5 106.936 169.081 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 122' ' ' ILE . 17.5 ptpt -47.98 -155.2 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.733 2 N-CA-C 123.596 4.665 . . . . 71.21 123.596 43.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo 13.98 67.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.214 1.943 . . . . 73.42 116.085 -121.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.7 mm -77.63 102.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 114.467 -1.242 . . . . 72.44 110.048 175.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -108.94 147.65 31.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.739 0.815 . . . . 61.05 110.329 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm . . . . . 0 N--CA 1.477 0.914 0 C-N-CA 123.345 0.658 . . . . 74.1 110.232 173.081 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.683 ' SD ' ' HG2' ' A' ' 96' ' ' GLU . 17.2 ptm . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 112.471 0.545 . . . . 75.14 112.471 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -98.41 168.12 10.4 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.891 0.876 . . . . 70.4 111.668 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 t -76.99 155.82 32.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.757 0.823 . . . . 75.34 112.119 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.02 -34.13 77.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.357 0.663 . . . . 75.22 111.797 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.503 HG23 HG13 ' A' ' 102' ' ' VAL . 2.4 m -66.7 -44.06 82.72 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.472 0.653 . . . . 75.11 110.557 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.55 -50.57 73.37 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 125.246 1.418 . . . . 74.44 111.962 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' ' 51' ' ' LEU . 86.7 mt -62.92 -44.37 96.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.644 0.778 . . . . 74.14 111.871 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 11' ' ' LEU . 51.9 tp -59.36 -40.36 86.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.224 1.01 . . . . 63.34 111.601 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.41 -41.95 99.07 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.007 -0.997 . . . . 72.35 110.875 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 14' ' ' VAL . 13.2 mm-40 -72.57 -30.3 64.29 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.572 -0.74 . . . . 72.44 112.308 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 8' ' ' LEU . 78.5 mt -57.36 -44.82 84.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.348 0.659 . . . . 75.24 112.244 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.49 -5.12 58.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.922 0.489 . . . . 75.25 112.313 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.24 -55.84 3.51 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.226 0.61 . . . . 50.3 111.671 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 10' ' ' GLU . 33.1 m -90.55 118.79 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.185 0.517 . . . . 63.11 111.541 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -43.85 -25.53 0.2 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.493 1.664 . . . . 71.34 115.493 172.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -127.78 122.54 33.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.862 0.465 . . . . 65.03 110.841 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.5 m -74.5 92.08 2.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.532 0.733 . . . . 52.21 110.496 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.92 -63.31 1.16 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.394 0.678 . . . . 73.14 111.769 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -119.82 -1.08 10.56 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 119.247 -0.406 . . . . 63.43 112.049 175.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.5 105.84 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.021 0.828 . . . . 61.31 109.085 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -121.57 130.21 53.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.055 0.542 . . . . 71.31 110.816 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.65 134.93 45.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 70.54 112.45 -172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 151.53 46.42 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.045 0.938 . . . . 74.23 111.076 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -84.08 154.05 23.42 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.97 0.908 . . . . 74.22 110.288 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.37 70.08 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 112.99 0.737 . . . . 74.42 112.99 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.1 p -81.22 13.41 2.88 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.786 1.032 . . . . 74.51 113.786 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.05 4.52 19.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.054 0.542 . . . . 63.21 112.118 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mtp -53.69 104.56 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.533 0.568 . . . . 73.55 112.533 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.74 -142.83 7.95 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.395 -0.366 . . . . 60.54 113.188 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -70.9 -21.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.238 1.015 . . . . 74.24 113.039 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 m -75.12 -43.39 53.01 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.95 0.5 . . . . 63.22 110.941 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -37.92 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.239 0.615 . . . . 74.42 110.607 168.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.536 ' HA ' HG22 ' A' ' 36' ' ' VAL . 20.7 mmt -71.19 -31.86 68.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.773 -0.649 . . . . 73.22 112.592 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.29 -32.75 74.47 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.398 0.618 . . . . 53.04 110.054 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -78.05 -46.38 21.03 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.699 0.8 . . . . 65.51 112.171 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 33' ' ' MET . 19.8 m -59.58 -39.01 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 118.11 0.414 . . . . 70.42 112.116 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.15 -35.75 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.287 0.635 . . . . 74.52 110.996 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.1 -38.41 91.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.849 0.46 . . . . 70.23 112.102 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -73.87 -47.68 36.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.172 0.589 . . . . 60.32 111.481 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.77 -21.85 60.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.585 0.957 . . . . 61.53 113.585 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -93.37 -42.75 9.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.21 0.604 . . . . 71.25 111.442 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.44 111.58 4.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.666 0.786 . . . . 74.12 112.019 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.08 105.3 0.67 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.791 2.327 . . . . 72.34 112.831 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.19 19.63 11.38 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.674 -0.694 . . . . 70.52 114.749 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.9 tp -106.84 5.49 28.52 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.764 1.282 . . . . 72.23 112.205 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -40.91 124.47 2.15 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 125.11 1.364 . . . . 71.34 113.711 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 105.57 51.52 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.896 -0.593 . . . . 71.11 112.627 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -112.55 149.27 18.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 111.673 -0.571 . . . . 34.43 111.673 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -123.47 126.84 47.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.648 0.779 . . . . 71.01 111.354 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -104.73 116.68 32.45 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.471 -1.307 . . . . 65.42 107.471 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 7' ' ' LEU . 31.2 tp -103.4 112.35 25.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.724 0.409 . . . . 74.33 111.021 -173.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 108' ' ' LEU . 93.1 mt -92.88 140.16 29.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.601 0.76 . . . . 64.54 111.65 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.21 7.04 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.926 -0.579 . . . . 60.3 112.739 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.08 144.37 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.507 0.723 . . . . 43.34 110.672 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -124.6 163.85 21.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 62.54 108.002 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -154.77 138.69 16.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.423 0.527 . . . . 71.15 112.423 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 151.97 47.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.799 0.84 . . . . 72.23 111.279 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -91.62 131.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.592 0.757 . . . . 73.25 111.467 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -84.89 -172.09 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.912 0.485 . . . . 52.31 111.659 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.06 -37.71 80.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.268 0.627 . . . . 61.42 112.562 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -77.33 -29.35 53.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 63.22 112.264 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.12 9.55 15.46 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.626 0.61 . . . . 63.5 114.626 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.05 138.7 37.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.283 0.633 . . . . 53.44 111.378 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -83.87 111.2 19.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.306 0.642 . . . . 62.55 109.584 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.45 115.32 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.786 . . . . 72.14 109.863 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -93.3 115.27 27.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.205 0.602 . . . . 74.43 111.095 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -110.67 153.34 43.66 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.131 0.972 . . . . 53.34 111.405 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.42 116.55 2.99 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.305 2.004 . . . . 74.02 113.032 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.01 -30.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 122.824 0.449 . . . . 54.22 110.745 168.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.58 -175.91 53.97 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.729 -0.668 . . . . 43.14 112.613 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.69 138.7 23.38 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 122.358 -0.496 . . . . 75.4 110.37 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.38 -33.9 28.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.698 2.265 . . . . 61.22 112.618 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -127.37 66.49 69.07 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.015 0.926 . . . . 61.14 109.648 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HB2' HD22 ' A' ' 99' ' ' LEU . 60.5 Cg_endo -65.34 -36.04 37.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.863 2.375 . . . . 62.02 113.725 -164.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.19 -40.59 82.17 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.645 0.778 . . . . 61.41 110.41 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -70.34 -35.69 73.75 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.2 -0.909 . . . . 63.14 111.551 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.35 -43.07 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.655 0.782 . . . . 60.22 110.815 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.523 ' HG2' HH21 ' A' ' 79' ' ' ARG . 53.2 tt0 -56.59 -45.04 81.59 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.578 0.751 . . . . 65.41 111.85 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.523 HH21 ' HG2' ' A' ' 78' ' ' GLN . 4.0 mmp_? -75.45 -36.95 60.61 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.668 -0.697 . . . . 61.32 112.626 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.33 -35.15 75.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.243 0.617 . . . . 73.54 110.42 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 26.8 tp -70.68 -39.62 73.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.613 0.765 . . . . 75.01 110.739 176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.12 77.3 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.152 0.581 . . . . 63.43 111.817 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -72.14 -53.2 13.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.289 0.635 . . . . 64.45 111.436 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 81' ' ' LEU . 11.9 pt20 -71.05 -32.46 69.17 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.056 0.762 . . . . 71.3 113.056 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 p -64.85 -31.3 72.46 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 118.877 0.762 . . . . 75.23 112.228 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -81.45 -27.1 34.81 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 116.033 -0.531 . . . . 74.11 112.381 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -92.14 -33.89 14.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.694 0.628 . . . . 74.21 112.694 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -79.86 -48.04 14.14 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.09 0.556 . . . . 75.01 111.294 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -81.63 157.61 24.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.849 -0.614 . . . . 74.34 111.294 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -45.96 -35.39 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.358 1.463 . . . . 70.31 114.16 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.62 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.458 0.703 . . . . 74.53 111.093 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -71.72 97.53 1.78 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.725 -0.67 . . . . 53.43 110.216 170.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.89 123.89 28.17 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.944 -1.132 . . . . 75.33 107.944 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -104.01 96.02 8.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.398 0.679 . . . . 64.35 110.694 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.91 166.63 7.14 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.09 1.86 . . . . 74.43 111.977 172.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.683 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 40.9 tt0 -101.23 115.71 31.13 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.924 -0.769 . . . . 64.21 108.924 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 61.5 mtt -115.07 131.14 57.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.326 0.65 . . . . 73.24 112.006 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -142.02 146.71 35.84 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.813 0.845 . . . . 75.03 110.964 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 74' ' ' PRO . 42.6 mt -102.37 119.35 38.66 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.984 0.913 . . . . 63.01 110.329 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -124.87 130.32 52.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.695 1.198 . . . . 62.42 109.584 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -94.49 121.76 36.37 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.955 0.407 . . . . 74.11 111.643 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 5' ' ' THR . 12.4 t -126.4 127.08 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.285 1.034 . . . . 62.22 109.46 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.89 30.87 57.75 Favored Glycine 0 CA--C 1.548 2.124 0 N-CA-C 115.265 0.866 . . . . 71.21 115.265 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.98 81.78 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.905 0.352 . . . . 74.22 113.938 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -116.38 146.18 42.67 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.088 0.955 . . . . 75.42 109.803 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -95.34 104.58 16.47 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.969 0.804 . . . . 71.24 111.105 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.0 162.01 14.56 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.829 0.851 . . . . 72.35 111.497 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 52' ' ' LEU . 61.9 tp -120.28 118.36 30.22 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.738 0.815 . . . . 73.33 110.366 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.56 119.91 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.273 -0.64 . . . . 52.33 109.273 171.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.33 101.1 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.126 -0.694 . . . . 51.52 109.126 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.2 t80 -76.83 113.81 14.91 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.36 -0.607 . . . . 74.25 109.36 174.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.11 99.29 42.63 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 108.903 -0.777 . . . . 63.21 108.903 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.38 -176.44 1.55 Allowed 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.733 2.288 . . . . 72.34 113.093 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 44.4 mt-10 -84.92 148.33 26.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.825 -0.625 . . . . 72.33 109.748 165.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.11 178.81 4.45 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.668 0.787 . . . . 55.14 110.481 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.61 124.35 24.51 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 118.282 -0.866 . . . . 75.12 110.368 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -38.06 -37.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 116.54 2.052 . . . . 51.21 116.54 -157.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -57.01 -40.53 76.8 Favored 'General case' 0 N--CA 1.509 2.483 0 CA-C-N 118.963 0.802 . . . . 74.05 112.003 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 14.5 m-70 -133.58 77.92 1.75 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 103.986 -2.598 . . . . 70.35 103.986 165.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.587 ' HA ' HG12 ' A' ' 122' ' ' ILE . 47.5 mtmt -46.86 -149.78 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 2 C-N-CA 133.016 4.526 . . . . 74.1 122.456 46.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo 12.06 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.808 2.339 . . . . 61.44 115.112 -120.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 120' ' ' LYS . 51.1 mm -86.31 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 115.158 -0.928 . . . . 72.11 110.56 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -156.37 165.38 36.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.807 0.843 . . . . 73.33 110.386 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 122.458 0.303 . . . . 72.22 110.59 178.845 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.649 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 46.5 ttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.499 0.19 . . . . 64.32 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB2' HD11 ' A' ' 7' ' ' LEU . 19.4 mmt180 -79.07 162.87 25.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.89 0.876 . . . . 65.22 110.783 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.8 t -80.73 155.09 26.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.183 0.593 . . . . 64.21 110.203 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.39 67.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.86 0.464 . . . . 63.32 112.103 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -70.0 -44.27 69.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.128 0.571 . . . . 64.41 110.602 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.8 -48.99 79.47 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.041 0.936 . . . . 61.52 111.398 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.568 HD22 HD12 ' A' ' 20' ' ' ILE . 80.8 mt -74.43 -31.67 62.37 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.039 -0.982 . . . . 63.02 112.867 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.34 -46.83 81.76 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.937 0.495 . . . . 75.05 110.264 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.26 -33.34 73.38 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.195 -0.911 . . . . 73.35 110.789 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.1 tp10 -70.49 -41.92 72.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.594 0.758 . . . . 73.53 110.933 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.2 mt -59.13 -43.16 91.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.983 0.913 . . . . 74.32 111.918 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.56 -32.37 72.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.193 0.597 . . . . 64.34 111.274 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.79 68.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.718 0.807 . . . . 73.11 112.072 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.79 148.39 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.377 0.608 . . . . 72.33 111.389 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.72 -14.89 55.94 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 75.44 111.635 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.07 153.46 25.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.648 0.779 . . . . 63.54 110.582 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.5 m -73.99 92.13 2.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.742 0.417 . . . . 64.52 111.101 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.48 -65.43 1.01 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.382 0.673 . . . . 61.23 112.264 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -119.11 -15.59 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.356 1.062 . . . . 60.05 110.001 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.568 HD12 HD22 ' A' ' 7' ' ' LEU . 31.5 mm -111.53 119.14 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.603 1.161 . . . . 53.41 108.023 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.45 141.1 48.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.486 0.714 . . . . 71.43 110.792 -171.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.57 127.26 52.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.667 0.787 . . . . 51.15 110.151 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 25.2 mmmt -132.24 136.5 47.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.977 0.911 . . . . 64.41 109.407 -176.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -81.99 168.01 18.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.255 0.55 . . . . 73.43 111.76 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.55 69.38 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.713 0.805 . . . . 62.41 112.507 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -65.72 -37.27 85.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 43.02 111.004 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -76.99 -6.82 54.14 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.379 1.072 . . . . 75.53 113.411 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -69.58 120.29 15.13 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.286 0.565 . . . . 70.11 110.287 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.11 -129.16 5.0 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.853 -0.612 . . . . 65.0 112.436 -172.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -59.33 -39.11 82.08 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.669 0.787 . . . . 73.21 112.097 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 m -65.45 -29.2 69.85 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.086 0.955 . . . . 34.11 112.61 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 81' ' ' LEU . 54.3 t -71.12 -51.08 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.726 0.41 . . . . 73.44 110.275 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -33.74 69.54 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.007 0.923 . . . . 72.01 112.924 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.35 -44.98 72.63 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.128 0.971 . . . . 73.23 111.159 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.3 m -76.89 -39.2 51.81 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.89 . . . . 63.52 112.461 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.25 -34.74 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 124.237 1.015 . . . . 65.33 112.444 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 33' ' ' MET . 58.5 mt -45.14 -45.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 124.087 0.955 . . . . 72.34 112.931 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.44 -60.07 4.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.106 0.562 . . . . 54.43 112.303 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.44 -24.43 62.9 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.622 0.601 . . . . 73.11 112.622 -169.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.82 -48.33 9.47 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.506 0.722 . . . . 62.32 112.353 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -93.3 -27.11 17.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.876 1.065 . . . . 74.13 113.876 -169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 68.6 mm-40 -64.33 121.76 74.16 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 118.283 0.492 . . . . 74.21 111.731 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 23.7 Cg_exo -64.15 110.48 1.36 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.598 2.199 . . . . 63.43 112.549 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.73 59.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.058 -0.857 . . . . 35.35 115.207 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.91 20.82 13.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.104 1.452 . . . . 72.45 110.831 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -41.45 114.2 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.218 1.007 . . . . 74.33 112.332 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.15 68.33 0.64 Allowed Glycine 0 N--CA 1.471 0.994 0 N-CA-C 113.738 0.255 . . . . 61.52 113.738 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.63 142.0 17.29 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.925 -0.87 . . . . 50.12 110.925 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.649 ' HE1' ' HG3' ' A' ' 1' ' ' MET . 94.6 m-85 -118.12 129.76 55.72 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.511 0.655 . . . . 75.55 112.11 -170.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 32' ' ' VAL . 5.6 mp -112.07 124.96 53.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.955 0.902 . . . . 74.21 109.329 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.2 mm? -104.61 109.11 20.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.065 0.546 . . . . 71.53 109.707 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 8.4 mp -92.95 122.32 35.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.409 0.684 . . . . 73.45 109.196 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.14 26.34 3.81 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.571 -0.286 . . . . 63.44 113.374 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.21 133.96 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.409 -0.589 . . . . 50.33 109.409 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -119.12 137.07 53.84 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.457 -0.942 . . . . 72.21 108.457 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -122.88 139.63 53.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.046 0.539 . . . . 72.52 111.58 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.92 151.95 35.55 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.925 0.89 . . . . 75.22 111.177 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.04 122.67 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.356 0.662 . . . . 74.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -96.79 -168.43 1.71 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.629 0.772 . . . . 63.52 112.088 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.89 -32.37 67.65 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.57 1.148 . . . . 64.54 112.925 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -79.54 -11.77 59.88 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.48 0.712 . . . . 74.45 111.561 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.92 84.92 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 116.487 -0.324 . . . . 62.41 112.792 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.43 149.21 30.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.507 1.123 . . . . 64.13 111.914 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -104.62 115.52 30.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.253 1.021 . . . . 75.23 110.404 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.92 128.91 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.42 0.688 . . . . 61.33 109.603 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.77 119.1 32.3 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.177 0.591 . . . . 74.24 110.233 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -129.91 129.17 22.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 123.325 0.65 . . . . 74.45 110.601 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 67.5 Cg_endo -78.68 109.84 2.69 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 72.4 112.421 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.21 -14.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.678 -0.639 . . . . 71.11 111.356 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.82 53.6 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.011 -0.541 . . . . 74.24 113.929 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.34 131.07 23.55 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.055 0.942 . . . . 74.24 110.809 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -32.03 87.9 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.054 2.503 . . . . 53.45 113.009 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -138.74 87.14 15.0 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 108.221 -1.029 . . . . 74.43 108.221 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.1 -28.42 34.68 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.661 2.241 . . . . 71.43 113.505 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -47.63 66.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.082 0.953 . . . . 72.15 111.268 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.65 -44.43 70.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.631 -0.713 . . . . 72.34 111.443 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -58.9 -37.25 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 122.908 0.483 . . . . 75.35 111.47 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.05 -52.38 49.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.842 0.682 . . . . 75.13 112.842 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -75.77 -33.86 60.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 112.434 0.531 . . . . 70.12 112.434 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.56 -33.29 73.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.413 0.685 . . . . 73.25 110.343 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 HG11 ' A' ' 32' ' ' VAL . 41.2 tp -63.46 -42.93 98.61 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.53 0.732 . . . . 54.53 111.415 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.25 95.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.286 0.634 . . . . 53.53 111.728 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -63.52 -52.32 61.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.983 0.913 . . . . 62.55 112.036 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.74 -32.52 74.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.101 0.56 . . . . 53.32 112.244 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.178 0.513 . . . . 73.53 112.223 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.51 -20.7 36.21 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.464 0.706 . . . . 34.43 112.016 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -112.31 -2.78 14.72 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.792 1.034 . . . . 42.4 113.792 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.7 mmm -99.6 -26.91 13.93 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.44 0.696 . . . . 72.12 111.327 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -108.32 142.79 38.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.561 0.745 . . . . 63.13 109.212 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' A' ' 91' ' ' VAL . 7.6 p-10 -57.66 -26.19 61.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.325 0.861 . . . . 63.44 113.325 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 119' ' ' HIS . 6.6 m -122.22 163.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.479 1.112 . . . . 64.43 111.499 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.28 98.25 7.33 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.273 0.559 . . . . 74.45 110.935 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 122' ' ' ILE . 4.7 tt -96.24 138.57 33.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.143 0.977 . . . . 72.23 108.686 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -106.77 95.34 12.06 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.004 0.521 . . . . 72.24 111.766 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.75 155.46 15.61 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.783 1.655 . . . . 62.24 111.198 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 41.7 tt0 -108.12 120.53 42.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.529 0.732 . . . . 61.13 110.906 -171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD11 ' A' ' 108' ' ' LEU . 1.8 mpt? -111.7 141.74 44.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.73 0.812 . . . . 60.11 111.413 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 133.53 15.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.681 -0.489 . . . . 75.3 109.681 167.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.0 mt -81.46 116.21 21.15 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.571 0.748 . . . . 62.02 110.74 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -123.25 130.77 53.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.799 1.24 . . . . 63.01 110.221 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -94.61 125.45 39.27 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.168 0.587 . . . . 73.44 111.281 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.45 119.15 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.913 0.885 . . . . 72.22 109.225 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.43 41.53 63.51 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.453 0.941 . . . . 74.2 115.453 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.98 88.66 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.883 0.713 . . . . 70.31 114.883 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.7 mmtt -110.0 139.85 44.66 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.791 0.837 . . . . 71.45 109.292 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.9 m -100.3 124.57 45.94 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.777 0.717 . . . . 74.4 111.024 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.49 164.9 14.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.127 0.971 . . . . 70.31 108.981 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.5 tp -115.64 116.52 28.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.58 0.352 . . . . 65.2 110.11 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.38 121.88 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 109.21 -0.663 . . . . 52.35 109.21 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.88 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.002 0.521 . . . . 72.0 110.623 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.721 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 63.4 t80 -80.49 114.77 19.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.12 109.715 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.23 102.13 34.88 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.516 -0.92 . . . . 72.24 108.516 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.42 169.8 15.25 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.396 2.064 . . . . 74.2 112.481 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -80.79 128.09 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.547 -0.751 . . . . 71.32 109.286 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.93 173.91 9.05 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.185 0.594 . . . . 72.11 111.669 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.59 155.97 37.89 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.679 0.792 . . . . 75.45 110.677 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.8 t -47.41 -42.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 114.85 1.426 . . . . 64.55 114.85 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 123.515 0.726 . . . . 64.12 112.471 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -129.37 78.21 1.84 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 103.605 -2.739 . . . . 62.33 103.605 169.454 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 32.2 mmtp -44.16 -159.01 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.781 1 C-N-CA 132.04 4.136 . . . . 64.03 120.861 66.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo 5.03 71.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.265 2.644 . . . . 71.31 118.059 -132.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 93' ' ' LEU . 1.8 mp -76.6 101.28 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.13 -1.063 . . . . 75.44 108.13 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -105.67 154.68 20.11 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.338 0.655 . . . . 73.24 109.813 168.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HD3' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 122.809 0.443 . . . . 73.03 110.603 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.99 -0.374 . . . . 74.31 109.99 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -40.08 134.67 1.5 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.85 1.26 . . . . 73.13 114.328 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -69.38 159.86 32.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.048 0.939 . . . . 61.1 112.007 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.08 70.37 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.26 0.624 . . . . 75.53 112.596 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -65.87 -43.79 87.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.13 110.641 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.61 -43.29 76.71 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 115.199 -0.91 . . . . 73.21 111.566 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 20' ' ' ILE . 86.1 mt -65.94 -42.14 90.42 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.533 0.733 . . . . 55.21 111.406 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 11' ' ' LEU . 25.9 tp -52.04 -48.68 64.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.628 1.171 . . . . 72.53 111.075 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.9 -46.22 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.814 -1.084 . . . . 74.32 111.878 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.34 -30.18 61.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.412 -0.358 . . . . 74.2 111.726 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 8' ' ' LEU . 79.7 mt -57.82 -52.88 63.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.518 0.727 . . . . 63.04 111.596 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -82.57 -1.1 49.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.563 0.579 . . . . 70.34 112.563 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.6 -50.06 8.01 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.051 0.54 . . . . 55.2 110.611 170.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 m -80.24 150.51 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.101 0.56 . . . . 30.1 111.191 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -72.76 -27.76 62.21 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.482 0.713 . . . . 63.43 112.478 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.57 134.1 24.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.814 0.845 . . . . 72.31 109.389 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.634 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 50.9 p -72.91 80.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.483 0.713 . . . . 73.14 111.234 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.71 -64.28 1.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.611 0.765 . . . . 71.43 112.272 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.6 -26.97 14.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.008 0.523 . . . . 74.5 110.739 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 HD22 ' A' ' 7' ' ' LEU . 36.4 mt -116.18 109.0 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 8.9 tp10 -100.73 151.57 21.51 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.076 1.351 . . . . 74.32 111.307 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.44 134.25 53.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.562 0.745 . . . . 72.11 110.987 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 32' ' ' VAL . 13.8 mptt -130.87 149.8 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.753 0.821 . . . . 75.41 110.338 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.46 169.24 13.03 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.801 0.841 . . . . 72.32 111.653 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.61 88.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.951 0.501 . . . . 73.2 111.03 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -60.28 -35.66 76.05 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.336 1.054 . . . . 60.44 112.166 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.74 3.64 50.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.903 0.881 . . . . 52.11 112.416 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.8 mmm -65.93 128.29 35.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.324 0.649 . . . . 51.04 111.73 170.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.4 -146.84 15.84 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.098 -0.501 . . . . 50.33 112.573 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.4 -18.34 65.3 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.292 0.637 . . . . 53.21 112.568 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -73.72 -37.08 65.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.207 0.603 . . . . 53.3 111.44 176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 23' ' ' LYS . 58.7 t -65.72 -47.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.12 0.486 . . . . 53.35 109.792 172.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.524 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 86.4 mmm -62.71 -35.19 78.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.962 -1.017 . . . . 61.02 112.662 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -40.08 91.5 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.817 0.847 . . . . 75.34 111.012 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -71.01 -35.6 72.1 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.708 -0.678 . . . . 75.22 111.11 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.09 -46.23 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.635 0.774 . . . . 74.11 110.785 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.4 -36.81 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.908 0.883 . . . . 74.04 110.931 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.35 62.65 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.919 0.888 . . . . 63.35 113.045 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -91.47 -42.25 10.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 122.103 -0.373 . . . . 63.01 111.011 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.81 -55.29 10.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.831 1.049 . . . . 73.12 113.831 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.27 -16.32 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.441 0.696 . . . . 73.25 112.668 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 54.1 mm-40 -79.78 132.59 60.61 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.152 0.581 . . . . 74.4 112.124 -177.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 21.4 Cg_exo -65.34 101.84 0.44 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.176 2.584 . . . . 72.45 113.218 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.75 74.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.075 1.19 . . . . 45.12 116.075 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 42' ' ' GLU . 10.1 mp -96.38 22.11 8.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.532 1.166 . . . . 70.14 110.905 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 16.9 t70 -50.41 153.77 1.46 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.208 1.403 . . . . 73.51 112.686 165.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 92.59 36.58 6.1 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.715 -0.675 . . . . 75.44 112.936 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.3 141.11 15.29 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 117.503 0.651 . . . . 73.42 112.661 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -118.49 127.32 53.52 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.269 0.627 . . . . 74.35 112.02 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 64.6 mt -100.73 109.5 21.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.013 1.325 . . . . 72.24 109.529 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD13 HG22 ' A' ' 109' ' ' VAL . 21.1 tp -101.67 109.95 21.84 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.406 0.622 . . . . 72.25 109.762 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 108' ' ' LEU . 47.2 mt -99.35 136.32 39.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 72.43 110.416 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.23 5.93 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-O 121.224 0.347 . . . . 71.24 112.723 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.5 t -111.54 138.17 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.486 0.715 . . . . 62.02 109.636 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 18.0 t70 -103.64 148.42 26.04 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.146 -1.057 . . . . 75.22 108.146 174.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -145.29 143.01 29.96 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.152 0.501 . . . . 74.54 111.608 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.68 152.73 37.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.746 0.818 . . . . 74.44 110.428 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.08 126.87 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.927 0.491 . . . . 75.04 110.555 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -87.77 -179.29 6.24 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.359 0.663 . . . . 75.32 111.514 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -61.17 -19.17 61.25 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.962 1.097 . . . . 74.45 113.962 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -80.95 -14.87 57.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.228 0.611 . . . . 72.42 112.498 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.05 41.54 17.91 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.737 -0.545 . . . . 64.34 111.737 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.39 139.03 51.81 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.774 1.23 . . . . 71.05 110.32 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -84.87 119.89 25.85 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.201 0.601 . . . . 71.13 110.592 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.89 124.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.144 0.578 . . . . 41.35 110.056 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.05 122.05 41.78 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.459 0.703 . . . . 75.51 110.597 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 9.0 ptm180 -127.06 139.1 34.15 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.605 1.162 . . . . 52.33 110.76 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' HD21 ' A' ' 8' ' ' LEU . 77.2 Cg_endo -86.3 98.47 0.55 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.714 2.276 . . . . 61.02 112.837 -176.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.5 -17.93 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 70.14 111.687 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.41 46.52 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 116.302 -0.408 . . . . 63.41 113.561 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.14 136.74 21.89 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-O 118.868 -0.587 . . . . 55.21 110.064 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.62 -36.29 92.82 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.609 2.206 . . . . 63.55 112.473 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -130.35 87.52 50.38 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.416 0.687 . . . . 70.42 109.342 168.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.69 -26.71 9.59 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.84 2.36 . . . . 75.24 114.047 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 6.3 m-20 -72.22 -47.21 52.17 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.444 0.698 . . . . 74.14 111.163 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -61.56 -36.49 80.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.262 0.351 . . . . 60.31 110.762 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.99 -43.69 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.013 0.925 . . . . 61.24 111.221 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -59.99 -45.98 90.97 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.624 0.769 . . . . 63.51 111.962 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 28.8 mmm180 -70.67 -45.33 65.25 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.716 -0.675 . . . . 74.01 111.875 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.36 -28.07 64.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.759 0.824 . . . . 74.52 111.884 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.9 tp -69.76 -40.01 76.38 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.588 0.355 . . . . 74.4 110.748 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.53 91.03 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.057 0.543 . . . . 63.31 111.252 173.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -64.93 -52.64 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.873 0.869 . . . . 64.01 111.712 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -64.78 -31.69 73.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.878 0.471 . . . . 73.42 111.901 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.7 t -69.73 -25.42 63.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 64.42 112.048 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.05 -33.58 20.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.428 0.691 . . . . 70.43 112.267 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 p -92.21 -37.28 12.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.667 0.988 . . . . 71.33 113.667 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.524 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 82.4 mtp -76.28 -47.48 23.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.031 0.532 . . . . 65.21 112.059 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.75 148.3 36.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.304 0.642 . . . . 74.11 112.11 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -53.78 -32.27 51.83 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.825 1.25 . . . . 72.34 112.864 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.7 m -129.41 172.37 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.281 1.032 . . . . 64.01 111.338 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.82 104.4 13.88 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.912 -0.586 . . . . 53.41 110.986 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 tt -93.02 133.23 36.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.791 -1.189 . . . . 74.22 107.791 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -109.61 95.3 19.08 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 122.808 0.443 . . . . 64.34 111.633 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.73 158.93 10.54 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.563 2.175 . . . . 73.23 112.405 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.2 tp10 -100.77 131.8 46.49 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.535 0.734 . . . . 74.21 109.483 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.9 mtt -125.71 116.66 22.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.08 0.552 . . . . 75.35 111.324 -172.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -114.99 133.28 56.17 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 75.42 111.05 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.68 109.73 21.15 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.122 0.569 . . . . 71.11 109.538 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -109.43 128.1 54.89 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.724 1.209 . . . . 61.42 112.309 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -97.97 109.33 22.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.341 0.591 . . . . 64.12 110.718 174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -121.17 112.73 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.624 1.17 . . . . 61.41 108.63 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.36 29.68 66.59 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 113.886 0.314 . . . . 71.1 113.886 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.03 0.44 90.3 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.197 0.439 . . . . 62.04 114.197 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -100.81 137.2 39.52 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.511 0.724 . . . . 74.24 109.301 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -98.56 121.38 40.43 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 119.047 0.84 . . . . 72.25 111.997 -174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.78 166.98 11.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.124 1.37 . . . . 65.24 108.864 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 52' ' ' LEU . 26.4 tp -123.72 109.84 14.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.086 -0.384 . . . . 73.04 110.513 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG22 HD13 ' A' ' 51' ' ' LEU . 59.0 t -84.3 123.24 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.938 -0.764 . . . . 63.23 108.938 171.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 40.9 t -118.41 99.84 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.394 0.678 . . . . 72.03 109.607 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HE1' ' HA2' ' A' ' 47' ' ' GLY . 87.5 t80 -79.88 122.5 26.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.78 -0.646 . . . . 63.54 110.021 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.29 112.08 65.12 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 109.085 -0.709 . . . . 60.45 109.085 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.49 172.78 15.6 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.612 2.208 . . . . 74.33 113.044 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -58.24 160.59 4.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.485 0.714 . . . . 42.1 112.366 172.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 120' ' ' LYS . . . -110.46 135.15 51.58 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 115.851 -0.613 . . . . 72.51 110.063 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 18.5 t70 -65.57 160.66 21.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.669 1.187 . . . . 73.52 112.001 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -47.3 -38.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.188 1.181 . . . . 74.31 114.188 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -75.21 -39.46 60.08 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.309 0.485 . . . . 63.53 112.309 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 4.3 p-80 -142.75 94.98 2.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.821 -1.548 . . . . 74.31 106.821 171.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 22.2 pttp -47.14 -163.77 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.39 2 C-N-CA 133.965 4.906 . . . . 61.32 123.298 43.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo 7.69 77.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.603 2.202 . . . . 65.24 116.566 -113.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' A' ' 120' ' ' LYS . 60.0 mt -94.65 113.59 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.781 -1.1 . . . . 73.24 109.267 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -131.3 141.27 49.93 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.568 0.699 . . . . 75.3 111.508 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tttm . . . . . 0 CA--C 1.558 1.265 0 CA-C-N 114.52 -1.218 . . . . 62.35 110.523 169.506 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' H ' ' A' ' 2' ' ' ARG . 10.8 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.322 -0.251 . . . . 73.42 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.0 ttt180 174.43 144.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.744 . . . . 72.13 109.882 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.34 154.43 30.83 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.431 0.293 . . . . 44.22 111.401 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.99 74.61 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.467 0.707 . . . . 72.55 112.423 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.621 HG23 HG13 ' A' ' 102' ' ' VAL . 3.7 m -65.3 -41.72 93.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.708 0.803 . . . . 71.15 110.71 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.0 -38.81 69.58 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.19 -0.914 . . . . 65.4 110.857 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD11 HG13 ' A' ' 109' ' ' VAL . 61.4 mt -65.03 -40.42 94.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.034 0.534 . . . . 60.3 111.301 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 11' ' ' LEU . 33.6 tp -62.42 -46.5 88.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.636 0.774 . . . . 74.44 110.559 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.0 -41.01 86.62 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.744 -1.116 . . . . 72.25 111.514 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.71 -38.48 83.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.472 0.709 . . . . 72.03 111.545 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 8' ' ' LEU . 44.6 mt -60.29 -39.79 88.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.191 0.996 . . . . 72.14 111.155 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.93 -32.28 69.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.765 0.826 . . . . 74.13 111.903 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.07 -46.02 58.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.876 0.87 . . . . 75.52 112.012 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.22 151.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.352 0.596 . . . . 63.52 112.121 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.22 -33.33 61.35 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.853 0.861 . . . . 75.43 111.113 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -147.95 156.52 42.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 72.24 109.958 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -66.44 76.07 0.1 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.865 0.866 . . . . 63.15 111.552 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -61.87 2.29 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.209 1.004 . . . . 51.12 111.996 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -133.98 8.38 3.78 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.024 0.93 . . . . 71.34 110.717 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.62 107.67 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.924 0.89 . . . . 72.13 110.347 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -92.33 148.65 21.96 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.35 1.06 . . . . 70.55 111.24 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.1 54.18 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.314 1.045 . . . . 73.54 109.882 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 65.0 mttm -139.62 141.02 37.13 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 71.42 111.74 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -84.92 164.21 18.49 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 115.308 -0.86 . . . . 73.54 110.449 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' MET . . . -62.65 -31.99 72.95 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.589 0.589 . . . . 75.04 112.589 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -69.61 -21.97 63.53 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.094 0.775 . . . . 71.04 113.094 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.87 -8.45 48.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.701 0.8 . . . . 63.21 111.937 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -55.03 119.95 6.2 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.108 1.363 . . . . 74.01 112.035 -176.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.98 -147.07 18.95 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.95 -0.46 . . . . 53.01 111.95 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -64.07 -25.01 67.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.239 0.616 . . . . 73.45 112.547 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -59.63 -36.92 77.31 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.232 0.613 . . . . 71.44 111.898 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 34.8 t -71.97 -43.62 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.311 0.577 . . . . 71.23 111.105 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.632 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 80.0 mmm -69.65 -40.9 76.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.118 1.155 . . . . 71.51 114.118 -166.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.73 -31.04 71.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.813 0.34 . . . . 72.22 110.909 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 m -67.75 -37.56 82.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.387 0.675 . . . . 75.43 111.004 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.07 -41.09 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.29 0.636 . . . . 61.24 110.86 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.76 -35.07 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.256 0.622 . . . . 54.22 110.39 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.24 63.45 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.807 0.843 . . . . 61.21 112.636 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -99.07 -29.49 12.86 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.307 0.643 . . . . 73.34 111.921 170.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.82 -34.69 75.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 55.2 112.377 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -79.34 -8.08 58.81 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.545 0.738 . . . . 74.35 112.79 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -81.81 116.42 63.12 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.768 0.827 . . . . 72.41 112.275 -173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.49 111.74 3.39 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.662 2.241 . . . . 64.12 112.438 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.79 19.56 57.7 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.326 0.89 . . . . 72.2 115.326 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.25 21.62 14.53 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 118.716 1.258 . . . . 74.52 111.908 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -40.95 123.05 1.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.637 0.977 . . . . 74.43 113.637 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.64 53.75 0.91 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 116.343 -0.39 . . . . 44.12 113.007 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.81 135.57 12.29 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.423 -1.071 . . . . 70.55 110.423 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.21 128.53 56.27 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.936 0.868 . . . . 73.31 111.914 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.0 mp -112.54 117.81 33.37 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.78 -1.193 . . . . 64.24 107.78 167.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.24 109.83 21.57 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.924 -0.485 . . . . 64.53 109.976 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.7 134.37 40.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.885 0.874 . . . . 73.42 110.575 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.94 28.54 6.16 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 116.293 -0.412 . . . . 60.33 112.13 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.25 138.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.199 0.999 . . . . 74.32 110.252 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -116.71 165.6 13.1 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.864 -1.162 . . . . 63.0 107.864 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -148.58 141.84 25.11 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.387 0.613 . . . . 74.44 111.537 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.04 135.55 53.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.282 1.033 . . . . 65.1 110.536 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 49.6 mm -99.82 118.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.187 0.518 . . . . 62.33 111.515 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -75.99 172.23 13.1 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.846 0.858 . . . . 71.41 111.419 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.52 -21.45 66.62 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.006 0.522 . . . . 62.25 112.144 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -71.61 -14.37 62.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.149 0.98 . . . . 71.33 112.168 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.84 35.22 25.42 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.317 -0.713 . . . . 70.53 111.317 -168.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 25.3 t0 -99.86 140.26 34.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.972 0.909 . . . . 74.04 111.395 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -105.76 107.24 18.13 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.392 0.677 . . . . 74.14 110.633 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.54 120.17 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.833 0.853 . . . . 74.43 109.78 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.77 119.42 32.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.188 0.595 . . . . 54.5 110.422 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -121.85 153.52 60.36 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.52 1.128 . . . . 62.31 110.912 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' HD21 ' A' ' 8' ' ' LEU . 89.8 Cg_endo -82.67 141.44 10.96 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.202 1.935 . . . . 71.14 112.738 177.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.87 -26.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.859 0.864 . . . . 70.31 110.681 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 -178.22 53.88 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 121.852 0.696 . . . . 71.03 114.736 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 108' ' ' LEU . 51.4 mt -101.28 142.35 24.43 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.44 110.904 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.79 -27.98 67.93 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.842 2.361 . . . . 75.34 112.424 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -145.49 97.57 4.67 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 107.817 -1.179 . . . . 62.5 107.817 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.34 -51.47 10.94 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.975 3.117 . . . . 72.31 114.689 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 23.1 t70 -64.58 -51.46 62.64 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.325 -0.852 . . . . 53.32 110.551 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 ttmp? -59.84 -36.93 77.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.582 0.753 . . . . 73.54 112.839 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.91 -41.82 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.043 0.537 . . . . 71.54 111.249 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.15 -33.35 75.23 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.528 0.731 . . . . 74.25 111.528 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 44.3 mmm-85 -72.41 -51.19 21.46 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.546 0.738 . . . . 71.24 110.886 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.22 -44.49 92.29 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.197 0.999 . . . . 75.12 111.821 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.7 tp -67.22 -32.81 74.1 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 111.79 0.293 . . . . 64.24 111.79 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.37 96.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.018 0.527 . . . . 75.53 111.212 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 -45.96 90.55 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.412 0.685 . . . . 74.44 111.524 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.92 -53.2 55.94 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.994 0.918 . . . . 74.44 111.24 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 10.6 t -72.61 -18.37 61.6 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.865 0.691 . . . . 64.03 112.865 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -88.41 -39.6 14.15 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.386 0.675 . . . . 71.42 112.197 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -92.85 -39.86 10.95 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.371 0.878 . . . . 75.41 113.371 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.632 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 66.8 mtp -68.85 -40.95 79.09 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.13 0.49 . . . . 71.34 111.913 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.4 mt -84.12 151.46 24.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.946 0.898 . . . . 73.35 110.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 125' ' ' LYS . 4.0 p-10 -57.33 -32.27 66.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.382 0.882 . . . . 73.04 113.382 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG13 ' ND2' ' A' ' 90' ' ' ASN . 24.9 m -115.38 160.01 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.871 0.868 . . . . 73.24 110.413 172.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -77.12 103.6 7.14 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.109 -0.496 . . . . 65.25 110.513 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.674 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.8 tt -99.04 128.83 45.26 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.486 -0.931 . . . . 64.44 108.486 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.9 ttt85 -98.49 109.61 53.42 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 75.03 110.611 172.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.88 126.77 5.94 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 121.874 1.716 . . . . 74.24 110.311 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.88 100.8 4.92 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.047 -0.524 . . . . 62.11 109.777 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.616 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.0 mtm -110.15 133.51 53.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.427 0.691 . . . . 65.33 112.228 -171.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.27 136.5 39.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.098 0.959 . . . . 71.41 111.111 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 69.9 mt -88.29 116.02 26.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.404 1.082 . . . . 72.23 111.153 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -125.87 131.54 52.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.598 1.159 . . . . 73.4 110.63 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -92.09 125.66 36.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.26 0.624 . . . . 64.51 111.85 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.621 HG13 HG23 ' A' ' 5' ' ' THR . 12.1 t -121.18 114.04 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.584 1.154 . . . . 74.32 109.38 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.32 30.88 61.91 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.561 0.985 . . . . 72.14 115.561 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.14 8.84 83.22 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 114.219 0.448 . . . . 63.42 114.219 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -107.44 137.62 45.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 72.05 108.896 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.0 m -98.43 117.71 33.47 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.278 0.944 . . . . 73.45 111.854 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.66 163.59 13.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.357 1.063 . . . . 72.04 109.452 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -117.33 115.61 25.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.051 0.54 . . . . 71.24 110.538 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.419 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -82.53 106.43 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.885 -0.783 . . . . 73.13 108.885 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 60.7 t -92.88 100.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.503 -0.925 . . . . 70.31 108.503 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -85.02 115.2 22.71 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.869 -1.06 . . . . 73.45 108.872 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 63.6 t -106.52 98.39 20.05 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.359 0.663 . . . . 75.45 109.273 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.94 162.72 40.3 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.09 1.86 . . . . 74.4 110.519 167.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -70.34 132.97 46.47 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.053 -0.351 . . . . 65.21 110.053 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -64.34 158.03 24.63 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 122.987 0.515 . . . . 65.51 111.041 172.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.38 178.92 0.49 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.118 0.967 . . . . 64.14 111.2 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.84 -52.29 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.264 -1.522 . . . . 72.44 113.602 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.1 p -67.66 -48.15 67.5 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 123.711 0.805 . . . . 65.44 111.614 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -115.22 83.49 1.92 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 103.919 -2.623 . . . . 74.21 103.919 163.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.0 mttp -50.58 -143.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.131 1 C-N-CA 133.734 4.814 . . . . 65.41 120.989 49.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo 7.15 71.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.253 2.635 . . . . 75.4 115.797 -122.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 120' ' ' LYS . 35.4 mm -81.54 77.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 114.909 -1.041 . . . . 75.25 108.936 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -88.51 146.87 24.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.646 -0.707 . . . . 75.43 110.955 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.65 135.72 36.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.946 -1.024 . . . . 60.33 110.102 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 90' ' ' ASN . 50.5 mtmt -86.05 26.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.284 0.634 . . . . 71.43 111.925 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.99 19.88 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.765 1.226 . . . . 64.21 109.714 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 63.3 m -64.55 115.75 5.49 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.943 0.497 . . . . 74.43 110.47 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.96 95.99 0.11 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 116.194 -0.457 . . . . 71.01 112.088 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.418 HD12 ' HD2' ' A' ' 130' ' ' PRO . 51.5 tp -85.83 116.89 67.46 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.392 0.677 . . . . 73.5 110.781 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD2' HD12 ' A' ' 129' ' ' LEU . 60.0 Cg_endo -70.72 114.95 4.02 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.572 2.182 . . . . 70.24 112.534 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -94.78 139.07 14.32 Favored Glycine 0 N--CA 1.477 1.419 0 CA-C-N 116.494 -0.321 . . . . 70.32 113.622 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 142.55 171.18 13.11 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 116.818 0.309 . . . . 63.41 113.52 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.76 -62.34 1.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.3 1.04 . . . . 65.34 109.519 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -168.79 153.13 5.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.102 0.961 . . . . 72.45 110.137 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -112.34 132.22 55.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.823 0.449 . . . . 74.34 109.804 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -59.25 123.57 17.13 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.185 0.594 . . . . 73.41 111.146 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.0 tt -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.128 0.571 . . . . 74.15 110.935 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.19 -78.82 1.31 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.46 -0.656 . . . . 70.33 111.46 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.5 p -90.39 141.96 28.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.892 0.877 . . . . 71.05 110.789 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 44.2 t -108.96 152.32 25.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.675 0.79 . . . . 61.31 111.727 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.41 138.17 16.16 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.845 0.858 . . . . 71.04 110.303 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.56 20.69 1.68 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.703 0.801 . . . . 73.22 109.733 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.55 79.74 2.56 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.667 0.746 . . . . 74.13 109.194 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.81 118.49 36.99 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.759 0.823 . . . . 64.21 111.28 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 141.39 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.823 0.849 . . . . 72.54 109.772 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -114.08 150.78 33.51 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.503 0.721 . . . . 62.1 111.057 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -159.49 128.71 5.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.898 0.879 . . . . 74.24 109.722 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -88.74 46.8 1.42 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.285 0.634 . . . . 74.23 111.449 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -59.13 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.015 0.926 . . . . 63.1 111.706 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -105.89 121.24 43.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.335 1.054 . . . . 72.11 111.012 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -95.86 145.27 25.5 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.584 -0.524 . . . . 71.52 109.584 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -142.5 148.51 37.79 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.195 0.598 . . . . 70.21 111.462 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 N--CA 1.481 1.075 0 C-N-CA 124.427 1.091 . . . . 74.01 110.754 178.231 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.799 -0.445 . . . . 50.24 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 11.6 ptm180 -99.04 151.66 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.822 0.449 . . . . 74.22 110.572 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.5 p -75.3 159.98 30.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.119 0.967 . . . . 72.34 113.285 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.63 69.65 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.191 0.996 . . . . 75.05 112.132 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -66.74 -48.73 68.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.816 0.846 . . . . 72.33 111.145 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.23 -34.3 74.61 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.007 -0.997 . . . . 75.24 111.358 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.31 -36.5 81.61 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.239 1.016 . . . . 62.32 112.373 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.05 -44.94 94.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.682 0.393 . . . . 71.22 110.393 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.43 -36.34 82.1 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.215 0.606 . . . . 41.13 112.325 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.559 ' HG2' HG13 ' A' ' 20' ' ' ILE . 4.6 tp10 -66.54 -41.35 88.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.846 0.458 . . . . 73.33 111.246 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.4 mt -57.81 -47.77 81.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.118 0.967 . . . . 65.05 112.163 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.295 0.479 . . . . 64.51 112.295 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.87 -39.52 61.49 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.311 0.644 . . . . 72.5 112.142 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -91.36 143.81 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.543 0.687 . . . . 73.24 111.894 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.51 -13.79 39.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.097 0.959 . . . . 73.34 110.934 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -141.21 136.68 31.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.262 1.025 . . . . 73.31 109.989 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.6 m -74.33 77.25 1.86 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.508 0.671 . . . . 65.54 111.021 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -60.67 2.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.041 -0.982 . . . . 70.32 111.166 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -111.95 -23.23 10.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.718 0.807 . . . . 70.15 111.567 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.559 HG13 ' HG2' ' A' ' 10' ' ' GLU . 21.6 mm -115.4 107.26 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 -170.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.2 114.52 24.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.884 0.473 . . . . 73.23 110.187 -171.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.97 116.59 23.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.544 0.738 . . . . 70.33 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.44 153.34 33.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.179 0.514 . . . . 63.51 111.638 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -93.54 170.77 9.34 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.351 1.06 . . . . 74.1 111.593 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.74 88.42 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.967 -0.56 . . . . 54.32 110.937 169.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.4 p -57.61 -30.78 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.893 0.877 . . . . 71.51 112.455 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -84.74 -0.25 52.99 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.028 0.751 . . . . 62.44 113.028 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 88.3 mmm -68.49 131.65 45.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.004 0.521 . . . . 61.32 111.421 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.14 -132.76 6.25 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.684 -0.689 . . . . 54.55 111.746 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -39.72 89.46 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.17 0.588 . . . . 74.42 111.409 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 m -53.22 -33.6 53.54 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.564 1.145 . . . . 54.43 113.509 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.46 -35.31 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.152 0.581 . . . . 60.55 111.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.4 mmm -73.91 -41.49 62.03 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.263 0.838 . . . . 73.35 113.263 -164.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -65.34 -26.41 68.02 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 111.746 0.276 . . . . 54.32 111.746 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.0 m -72.24 -41.01 67.3 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 122.316 0.246 . . . . 53.2 111.115 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.4 0.68 . . . . 42.22 111.955 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 pt -63.27 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.651 0.38 . . . . 74.41 111.62 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.89 77.61 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.119 0.568 . . . . 73.43 111.687 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' HD23 ' A' ' 45' ' ' LEU . 32.2 m-85 -82.4 -37.29 25.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.474 0.71 . . . . 71.44 111.338 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.7 -23.48 62.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.933 1.086 . . . . 70.41 113.933 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -108.08 -8.51 15.81 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.737 1.014 . . . . 74.32 113.737 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.89 107.06 25.17 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.232 0.469 . . . . 62.22 110.563 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.96 123.68 11.62 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.933 2.422 . . . . 53.13 112.732 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.51 60.7 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-O 119.912 -0.382 . . . . 63.11 114.033 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' PHE . 19.1 tp -89.86 13.44 14.51 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 117.713 0.756 . . . . 54.14 111.214 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -32.22 112.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.183 1.793 . . . . 71.21 114.158 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.632 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 103.78 68.63 0.77 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.395 -0.366 . . . . 45.31 112.779 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.06 124.61 5.4 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 109.618 -1.393 . . . . 43.41 109.618 171.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 2' ' ' ARG . 56.0 m-85 -120.86 127.77 52.21 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.386 0.593 . . . . 61.52 111.819 -169.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -93.3 118.27 31.07 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.33 110.43 22.42 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.666 0.667 . . . . 62.43 109.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 9.3 mp -99.0 132.16 44.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.979 0.912 . . . . 64.11 110.793 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.5 33.15 4.91 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.247 -0.433 . . . . 73.21 112.429 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.6 138.6 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.116 0.566 . . . . 61.31 110.692 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.76 146.99 31.42 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.462 -1.31 . . . . 60.52 107.462 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -128.97 126.47 39.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.024 0.44 . . . . 74.52 110.399 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 123.4 46.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 54.03 109.969 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.52 131.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.578 0.751 . . . . 63.1 111.355 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -87.26 -178.5 6.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.608 0.763 . . . . 71.31 112.394 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.24 -28.55 69.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.584 0.754 . . . . 74.22 111.846 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -82.73 2.11 35.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.308 0.643 . . . . 74.52 112.274 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.36 32.34 58.07 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 120.933 0.185 . . . . 62.22 112.732 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.94 111.54 23.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.756 0.823 . . . . 75.13 110.631 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 m -82.8 115.05 21.53 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.604 0.762 . . . . 75.53 111.046 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.56 122.78 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.873 0.869 . . . . 75.42 110.293 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -95.7 129.04 43.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.483 0.713 . . . . 71.53 110.44 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -137.36 142.41 37.41 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.139 0.976 . . . . 71.32 111.054 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.64 80.19 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.029 2.486 . . . . 75.31 113.931 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.86 -23.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 112.703 0.631 . . . . 64.32 112.703 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.61 -173.46 53.28 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 121.313 0.396 . . . . 72.15 113.886 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 61.1 mt -115.98 124.59 29.57 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.032 0.933 . . . . 41.43 109.78 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.64 -27.02 39.03 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.473 2.115 . . . . 74.3 112.631 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.81 73.82 75.67 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.452 0.701 . . . . 74.33 109.485 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 83.4 Cg_endo -81.03 -28.3 2.56 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.78 2.32 . . . . 71.21 114.483 -170.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.39 -42.9 87.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 74.22 110.771 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.45 -33.86 76.01 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.558 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.14 -47.83 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.034 0.533 . . . . 74.41 110.784 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.456 ' OE1' ' HG ' ' A' ' 99' ' ' LEU . 41.6 tt0 -62.7 -50.28 71.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.873 0.694 . . . . 61.22 112.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -33.96 62.43 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 112.6 0.592 . . . . 72.21 112.6 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.54 -31.2 65.11 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.922 0.489 . . . . 65.04 110.895 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.78 -41.39 83.31 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.68 0.392 . . . . 35.33 111.248 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.83 92.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.896 0.479 . . . . 53.53 111.31 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -52.62 64.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.799 0.84 . . . . 62.21 112.007 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -68.04 -34.72 77.0 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 111.995 0.368 . . . . 62.54 111.995 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 36.8 t -67.81 -25.99 65.85 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.338 0.517 . . . . 73.43 112.102 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -78.42 -27.37 46.59 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.958 0.725 . . . . 33.03 112.958 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.7 t -106.59 -29.38 9.67 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.32 0.859 . . . . 64.2 113.32 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.1 mmt -67.3 -52.86 35.35 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.037 0.935 . . . . 74.52 111.405 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 mt -90.04 162.0 15.57 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.684 -1.144 . . . . 72.31 110.717 -169.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -29.65 -58.09 0.16 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 126.135 1.774 . . . . 70.2 114.804 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 122' ' ' ILE . 16.9 m -124.16 176.77 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.389 0.675 . . . . 53.41 110.182 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.1 98.77 0.61 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.287 0.565 . . . . 73.44 111.039 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 122' ' ' ILE . 2.5 tt -92.02 121.65 33.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 71.52 108.017 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -101.62 99.36 11.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.154 0.582 . . . . 74.55 109.644 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.64 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 4.3 Cg_exo -76.58 168.19 24.16 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.838 1.692 . . . . 72.3 110.787 168.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 43.5 tt0 -105.12 96.99 6.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.066 0.546 . . . . 75.32 109.589 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.734 ' HB3' HD11 ' A' ' 108' ' ' LEU . 4.4 mpp? -105.13 134.89 47.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 71.52 111.458 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -139.61 133.79 31.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.074 0.55 . . . . 72.15 111.197 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 78' ' ' GLN . 91.6 mt -84.26 133.29 34.57 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.897 0.879 . . . . 71.53 110.752 174.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -138.17 145.75 41.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.466 1.106 . . . . 73.4 110.595 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.9 119.97 38.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.963 0.505 . . . . 71.3 109.803 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.32 111.73 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.703 -1.221 . . . . 74.12 107.703 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.73 27.59 61.8 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 114.548 0.579 . . . . 50.44 114.548 -168.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.64 -1.02 88.86 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 114.987 0.755 . . . . 72.32 114.987 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 131.9 46.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.612 0.765 . . . . 75.34 109.964 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.6 m -92.4 106.09 18.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.318 0.858 . . . . 74.51 113.318 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.98 156.26 17.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.325 1.05 . . . . 72.11 111.126 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 97' ' ' MET . 50.4 tp -112.93 116.41 29.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.466 0.707 . . . . 52.3 110.78 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.4 113.35 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.389 0.676 . . . . 63.44 109.831 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 45.4 t -105.65 101.37 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 122.898 0.479 . . . . 43.51 110.263 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 40.4 t80 -84.46 128.51 34.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.627 0.771 . . . . 71.52 110.19 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.29 102.61 14.68 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 109.441 -0.578 . . . . 74.45 109.441 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.79 147.66 21.88 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.607 2.204 . . . . 64.41 112.163 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -75.61 134.49 40.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.853 0.358 . . . . 73.41 111.259 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -93.39 172.87 8.01 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.746 0.818 . . . . 74.44 112.968 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.62 139.31 36.31 Favored 'General case' 0 C--O 1.193 -1.914 0 C-N-CA 123.707 0.803 . . . . 62.31 110.617 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.74 -38.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 115.945 1.831 . . . . 74.25 115.945 -170.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.7 p -65.43 -49.41 69.26 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.864 0.466 . . . . 72.04 111.745 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 9.0 m-70 -127.93 69.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.88 -2.267 . . . . 64.14 104.88 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.62 ' HA ' HG12 ' A' ' 122' ' ' ILE . 27.8 mtpp -45.06 -152.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.386 1 C-N-CA 132.91 4.484 . . . . 70.14 120.844 58.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo 7.68 65.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.113 2.542 . . . . 70.54 116.153 -126.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 93' ' ' LEU . 30.5 mm -80.0 77.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.094 0 CA-C-N 115.361 -0.836 . . . . 61.52 109.184 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -80.76 141.96 34.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.246 -0.433 . . . . 73.04 110.938 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -62.86 117.84 6.92 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.704 -0.68 . . . . 73.44 109.527 171.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -79.12 66.12 4.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.848 0.832 . . . . 63.04 110.31 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 167.99 -162.49 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.429 2.292 . . . . 70.53 108.46 -170.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -71.05 127.02 31.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.908 -0.495 . . . . 70.12 110.602 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -151.43 112.65 0.55 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.074 -0.411 . . . . 33.43 112.074 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 2.0 pp -77.84 156.06 80.21 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 123.733 0.813 . . . . 64.1 112.768 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.68 152.31 74.42 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.576 2.184 . . . . 73.2 112.5 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.62 155.32 32.04 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-O 120.219 -0.212 . . . . 63.35 113.228 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.7 104.2 1.94 Allowed Glycine 0 N--CA 1.475 1.265 0 CA-C-N 116.793 0.297 . . . . 75.1 112.873 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.5 79.98 3.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.982 0.513 . . . . 71.51 111.482 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -98.81 117.19 32.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.788 0.835 . . . . 72.41 110.703 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -80.46 115.94 20.25 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.442 0.697 . . . . 64.31 111.343 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.36 160.92 14.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.768 0.827 . . . . 75.25 111.345 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.33 117.48 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 122.629 0.372 . . . . 60.14 110.834 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.82 -173.36 49.4 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 116.11 -0.496 . . . . 74.14 112.893 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.0 p -156.29 170.93 21.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.301 0.572 . . . . 64.55 112.116 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -135.25 94.55 3.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.776 0.83 . . . . 74.5 109.472 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.22 123.75 22.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.857 0.863 . . . . 72.14 111.808 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -131.63 134.55 46.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.489 0.715 . . . . 72.32 109.681 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -147.73 126.54 12.67 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.273 0.629 . . . . 71.54 109.957 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.35 147.98 27.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.781 0.832 . . . . 71.34 112.118 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.57 146.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.51 0.724 . . . . 61.2 110.329 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -124.18 106.16 10.09 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.628 0.728 . . . . 71.13 111.159 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 171.67 13.98 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.213 1.005 . . . . 72.02 110.392 171.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -59.19 -45.13 91.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.897 1.443 . . . . 73.51 114.897 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.0 m80 70.9 -27.53 0.17 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 125.115 1.366 . . . . 71.53 114.575 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -55.12 132.57 47.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.411 1.084 . . . . 75.24 112.929 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -107.82 179.15 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.275 1.03 . . . . 65.25 111.59 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -77.47 108.33 10.56 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.251 0.62 . . . . 73.41 110.548 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.803 0.811 . . . . 74.21 111.83 177.636 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.089 -0.338 . . . . 62.23 110.089 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -88.09 146.43 25.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.429 0.692 . . . . 73.5 110.742 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -70.24 166.71 19.48 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 122.997 0.519 . . . . 73.45 111.76 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . . . -62.42 -50.27 72.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.639 0.607 . . . . 42.4 112.639 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -70.47 -28.78 65.26 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 112.009 0.374 . . . . 72.13 112.009 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.55 -46.37 86.26 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.89 0.876 . . . . 31.14 111.256 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HG13 ' A' ' 109' ' ' VAL . 60.5 mt -65.95 -38.46 88.67 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.722 0.809 . . . . 75.25 112.166 172.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 24.3 tp -59.17 -50.09 75.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.036 0.934 . . . . 75.22 110.399 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.47 -40.31 78.28 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.759 -1.109 . . . . 63.22 111.064 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.83 -41.75 95.49 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.988 0.915 . . . . 74.34 111.843 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 8' ' ' LEU . 29.3 mt -60.3 -38.62 84.23 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.659 1.184 . . . . 72.34 112.149 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -80.17 -28.95 38.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.029 0.531 . . . . 71.15 111.864 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -47.19 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.452 0.701 . . . . 54.13 111.949 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.3 154.8 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.131 0.572 . . . . 73.34 111.115 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.22 -20.61 21.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.011 0.924 . . . . 72.32 111.124 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 9.6 tp10 -140.85 134.75 30.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.604 1.162 . . . . 62.31 109.688 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -69.6 87.13 0.48 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.88 0.872 . . . . 64.3 110.456 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.06 -64.59 1.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.45 0.7 . . . . 73.21 112.488 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -107.38 -14.05 14.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.43 0.692 . . . . 61.41 110.207 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 mm -109.49 155.17 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.216 -1.031 . . . . 72.32 108.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.46 150.13 10.41 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.005 -0.739 . . . . 62.22 109.005 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.87 46.13 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.029 0.532 . . . . 70.34 112.005 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 32' ' ' VAL . 74.9 mmtt -130.61 150.37 51.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.182 0.993 . . . . 31.44 110.076 175.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' VAL . 57.7 mtt-85 -85.63 165.16 17.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.734 0.814 . . . . 73.12 110.157 171.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.46 -30.85 68.81 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 120.879 0.371 . . . . 62.52 111.526 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -71.97 -19.25 61.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.649 0.78 . . . . 74.25 112.803 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -84.38 -4.99 59.22 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.527 0.565 . . . . 61.22 112.527 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.6 mmm -59.5 108.45 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.315 0.579 . . . . 63.3 111.313 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 142.14 -143.53 12.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 114.878 -1.055 . . . . 71.05 110.863 -171.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -52.57 -39.24 61.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.233 1.013 . . . . 71.05 113.253 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -36.51 75.34 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.065 0.765 . . . . 62.44 113.065 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' A' ' 23' ' ' LYS . 44.2 t -72.52 -50.34 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 120.968 0.413 . . . . 75.05 110.385 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 88' ' ' MET . 91.3 mmm -57.45 -41.2 80.09 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.57 1.322 . . . . 75.43 114.57 -170.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.18 -34.24 77.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.157 0.583 . . . . 72.04 111.611 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -79.32 -28.48 42.13 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.758 0.823 . . . . 42.35 111.242 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.82 -40.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 123.48 0.712 . . . . 61.22 110.511 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.96 -31.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.507 -0.769 . . . . 63.23 111.134 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 42' ' ' GLU . . . -60.08 -49.96 75.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.228 0.611 . . . . 74.32 112.178 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.28 -27.56 35.06 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.681 . . . . 72.1 111.657 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.66 -32.26 60.1 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.363 0.665 . . . . 62.32 112.275 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -92.57 -17.11 24.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.163 0.585 . . . . 72.52 111.525 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.1 tp10 -75.43 106.88 3.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 123.578 0.751 . . . . 73.23 112.367 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.07 106.12 2.21 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.142 2.561 . . . . 73.52 113.201 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.08 -7.1 40.63 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 114.87 0.708 . . . . 71.34 114.87 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -92.78 -52.43 4.62 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.203 1.002 . . . . 64.13 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 36.93 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 126.296 1.839 . . . . 75.45 115.378 -170.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.09 48.09 64.51 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 116.012 1.165 . . . . 71.23 116.012 166.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.72 152.59 22.56 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.53 -0.628 . . . . 74.14 111.53 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.89 127.1 51.56 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.844 0.822 . . . . 63.21 112.074 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 97.2 mt -115.21 114.04 24.72 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.879 1.271 . . . . 44.25 108.59 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.14 109.06 20.66 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.508 -0.552 . . . . 65.05 109.508 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 108' ' ' LEU . 29.9 mt -93.03 132.17 37.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.494 0.718 . . . . 73.01 110.533 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 36.64 4.43 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 121.298 0.388 . . . . 75.23 112.371 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 43.1 t -115.53 143.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.537 0.735 . . . . 75.4 109.813 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -113.47 154.1 27.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.765 -1.198 . . . . 63.42 107.765 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 41.7 p90 -145.73 129.03 16.78 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.408 0.623 . . . . 75.31 112.005 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.74 135.61 51.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.835 0.854 . . . . 61.22 110.933 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.6 mt -83.7 123.52 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.737 0.815 . . . . 64.24 110.582 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 63' ' ' ASP . 29.5 p30 -82.5 -176.3 6.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.795 0.838 . . . . 74.15 112.08 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.77 -14.16 57.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.737 1.014 . . . . 64.12 113.737 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -86.8 -22.89 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.151 0.58 . . . . 64.22 112.021 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.4 16.05 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 116.576 -0.284 . . . . 34.23 112.512 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HD21 ' A' ' 59' ' ' ASN . 23.4 t70 -107.74 132.71 53.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.263 1.025 . . . . 74.01 110.915 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -89.09 119.03 29.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.806 0.842 . . . . 71.11 111.509 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 67.5 t -103.44 120.8 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.169 0.988 . . . . 75.22 110.704 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -94.19 130.69 40.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.271 1.028 . . . . 73.31 110.387 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.87 147.44 48.24 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.877 0.871 . . . . 74.04 110.485 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 83.2 Cg_endo -78.31 108.16 2.43 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.251 1.967 . . . . 64.32 114.534 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 m -91.1 -24.42 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 122.968 0.507 . . . . 62.2 111.199 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 76.58 -170.12 54.95 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 114.81 0.684 . . . . 34.5 114.81 174.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -121.57 124.24 27.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.97 0.908 . . . . 53.43 109.979 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.97 -17.04 22.71 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.457 2.105 . . . . 61.15 113.023 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -134.38 59.77 38.97 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.404 1.081 . . . . 70.42 110.223 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HB2' HD22 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -62.06 -36.81 68.39 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.905 2.403 . . . . 73.34 114.265 -162.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.31 -39.27 74.92 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.472 0.709 . . . . 74.22 110.58 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.47 -36.3 80.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.979 0.511 . . . . 73.21 111.205 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.35 -45.6 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 123.474 0.71 . . . . 71.35 110.813 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.9 -49.77 74.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.808 0.843 . . . . 62.53 112.043 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -67.32 -40.67 85.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.279 0.632 . . . . 64.43 111.578 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.9 -36.57 84.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.552 0.741 . . . . 65.4 110.389 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.56 HD23 ' SD ' ' A' ' 97' ' ' MET . 24.3 tp -67.78 -38.27 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.969 0.508 . . . . 72.12 111.282 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.67 90.58 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.99 0.516 . . . . 55.33 111.553 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.8 m -65.76 -48.31 72.28 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.639 0.776 . . . . 74.12 111.721 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.98 -30.36 69.61 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.797 0.439 . . . . 74.42 111.478 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 16.1 t -65.98 -19.91 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.899 -0.5 . . . . 65.33 112.292 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -39.2 17.73 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.455 0.702 . . . . 40.1 112.016 170.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -85.93 -25.67 25.98 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.153 1.168 . . . . 33.01 114.153 -173.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 33' ' ' MET . 85.7 mmm -81.91 -58.08 3.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.815 0.846 . . . . 72.34 110.085 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.98 146.55 37.39 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.352 -0.84 . . . . 63.0 111.138 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -50.84 -37.57 43.92 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.997 0.919 . . . . 63.33 113.051 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.2 m -121.1 160.03 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.053 0.941 . . . . 71.32 110.713 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.29 105.34 7.29 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.085 0.554 . . . . 72.45 111.85 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.5 tt -93.24 137.19 32.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.28 -1.378 . . . . 63.45 107.28 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -98.83 104.73 26.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 122.692 0.397 . . . . 62.33 110.131 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.68 119.38 5.69 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.303 1.335 . . . . 50.22 110.667 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 14.3 tp10 -71.65 98.74 1.97 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.373 -0.83 . . . . 72.14 109.826 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.1 mtm -116.73 127.16 54.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.311 0.644 . . . . 72.1 112.198 -169.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -132.9 128.67 37.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.303 1.041 . . . . 75.1 110.2 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 74' ' ' PRO . 53.6 mt -81.91 132.14 35.26 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.167 0.987 . . . . 71.4 111.408 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 11.4 mm-40 -128.38 128.46 44.55 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.162 0.985 . . . . 73.23 111.1 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.2 117.27 29.7 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.857 0.863 . . . . 73.44 110.986 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.2 t -132.98 117.42 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.565 1.146 . . . . 74.25 110.577 -172.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.3 28.54 27.66 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 116.443 1.337 . . . . 74.22 116.443 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -4.48 67.91 Favored Glycine 0 N--CA 1.484 1.852 0 CA-C-N 117.472 0.636 . . . . 53.22 114.179 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.483 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -110.88 119.2 38.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.377 1.071 . . . . 52.52 110.074 -177.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -88.55 103.53 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.982 0.81 . . . . 53.13 110.576 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.44 168.77 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.858 0.863 . . . . 72.32 110.717 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 52' ' ' LEU . 60.1 tp -119.2 119.07 33.04 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.994 0.517 . . . . 73.43 110.577 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.507 HG13 HD11 ' A' ' 7' ' ' LEU . 93.1 t -83.63 111.01 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.135 -0.691 . . . . 52.3 109.135 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 48.1 t -103.5 99.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.527 0.679 . . . . 75.53 110.177 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 58.2 t80 -79.05 119.16 21.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.145 0.978 . . . . 70.3 109.026 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.79 102.49 53.66 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.079 0.952 . . . . 64.1 108.774 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.96 165.48 31.98 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.942 1.761 . . . . 74.2 111.607 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -72.14 136.56 46.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.781 -0.822 . . . . 54.13 108.781 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -71.51 156.35 39.53 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.451 0.7 . . . . 73.24 111.522 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.4 -175.61 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 124.926 1.29 . . . . 63.3 111.601 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.94 -51.56 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 O-C-N 119.756 -1.84 . . . . 74.42 113.614 162.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 t -68.39 -49.94 56.49 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.363 0.529 . . . . 53.5 111.468 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 8.5 m-70 -117.94 84.65 2.21 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 101.341 -3.577 . . . . 73.11 101.341 165.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.686 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.256 36.2 mtmm -48.79 -140.77 0.0 OUTLIER Pre-proline 0 CA--C 1.577 1.986 1 C-N-CA 133.664 4.786 . . . . 70.14 121.204 50.908 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo 10.16 62.93 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 124.207 3.272 . . . . 51.1 116.136 -121.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.686 HG12 ' HA ' ' A' ' 120' ' ' LYS . 48.5 mm -76.78 116.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.994 0.918 . . . . 73.24 110.344 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -150.52 144.19 25.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.906 0.483 . . . . 73.24 110.16 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -77.07 128.14 33.93 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.912 0.387 . . . . 73.41 110.288 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.01 -7.71 48.23 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.924 0.89 . . . . 75.22 111.827 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.96 169.73 16.85 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.076 0.95 . . . . 61.21 111.41 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.7 p -70.3 151.62 45.08 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.336 0.655 . . . . 64.32 112.672 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.15 164.83 29.88 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.587 -0.733 . . . . 64.04 114.151 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.12 159.77 84.56 Favored Pre-proline 0 CA--C 1.574 1.898 0 C-N-CA 124.426 1.09 . . . . 75.41 112.384 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.33 -171.17 1.09 Allowed 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.74 2.293 . . . . 62.1 112.973 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.61 161.06 12.87 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.662 -0.245 . . . . 72.13 113.696 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -144.74 134.73 5.76 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.706 0.67 . . . . 75.4 111.596 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.96 157.35 15.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.229 0.612 . . . . 73.44 111.678 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -91.63 142.68 27.36 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 120.863 0.363 . . . . 73.52 111.423 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -102.74 112.28 24.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.041 0.936 . . . . 61.12 110.417 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.48 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 67.3 mtt180 -108.81 159.87 16.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.686 0.794 . . . . 72.44 112.456 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -103.63 131.13 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.927 0.891 . . . . 73.23 109.901 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.19 157.82 15.13 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 113.86 0.304 . . . . 61.01 113.86 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.8 m -92.2 115.7 28.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.876 0.87 . . . . 74.41 111.09 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.1 p -96.78 12.72 31.05 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.33 0.652 . . . . 75.45 112.464 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.85 114.75 10.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.957 0.503 . . . . 61.33 111.42 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.45 121.93 39.59 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.367 1.067 . . . . 73.11 109.425 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.77 161.68 27.92 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.468 0.544 . . . . 73.24 112.468 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 147' ' ' GLU . 45.3 t -79.18 138.45 37.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.336 0.655 . . . . 73.02 112.326 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.42 162.99 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.414 1.085 . . . . 74.33 110.173 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt 57.64 28.69 16.09 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.244 1.017 . . . . 75.54 112.564 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.518 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . 8.3 pt-20 -79.79 89.58 5.23 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.091 0.957 . . . . 74.11 112.216 -174.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.2 p80 34.78 79.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.164 1.786 . . . . 73.32 114.525 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -86.07 12.59 9.24 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.215 0.606 . . . . 72.43 111.215 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.33 116.92 5.46 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.75 1.22 . . . . 75.3 111.976 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -125.02 130.66 52.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.228 1.011 . . . . 65.42 109.761 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -129.94 120.31 24.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.637 0.775 . . . . 74.23 109.921 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.663 0.744 . . . . 65.2 111.973 178.47 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 46.0 ttm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.788 0.328 . . . . 74.41 111.565 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.0 mmm180 -95.44 157.57 15.84 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.402 1.081 . . . . 71.31 111.037 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -77.45 152.35 34.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.908 0.707 . . . . 62.32 112.908 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.88 -53.05 54.67 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.505 1.122 . . . . 73.12 113.183 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HG11 ' A' ' 102' ' ' VAL . 2.9 t -62.35 -41.5 98.65 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.234 0.613 . . . . 74.31 112.621 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -55.16 -45.31 75.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.495 1.118 . . . . 33.53 111.68 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 2' ' ' ARG . 47.3 mt -73.68 -33.27 64.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.306 1.042 . . . . 72.01 112.749 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.36 -31.36 71.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.271 0.628 . . . . 63.53 110.587 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.49 -30.68 69.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.863 0.865 . . . . 44.2 112.802 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.2 tt0 -60.85 -52.94 62.95 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.875 -0.417 . . . . 74.23 109.875 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.71 -27.46 62.08 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.836 0.854 . . . . 73.35 112.914 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.66 -11.1 60.67 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.214 0.605 . . . . 74.45 111.847 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 -36.11 8.24 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.839 0.856 . . . . 73.21 111.948 172.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 10' ' ' GLU . 29.5 m -117.54 117.54 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.616 0.767 . . . . 75.43 111.241 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.84 -44.49 82.16 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.684 1.193 . . . . 74.23 111.1 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.77 149.57 25.66 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.982 0.913 . . . . 61.35 110.601 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.1 m -87.24 129.64 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.867 0.467 . . . . 75.53 111.982 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.46 -64.94 1.0 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.833 0.453 . . . . 71.45 111.32 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -14.68 9.08 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.569 0.747 . . . . 73.21 112.013 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 49' ' ' TYR . 18.8 mm -113.87 142.99 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 118.193 0.452 . . . . 73.01 110.649 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 3.7 mm-40 -128.27 112.6 14.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.365 0.666 . . . . 61.14 110.632 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.29 118.2 30.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.314 0.645 . . . . 51.41 109.843 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' A' ' 32' ' ' VAL . 73.6 mmtt -124.11 142.95 50.76 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.848 0.859 . . . . 64.23 110.632 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -89.56 174.76 7.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.548 0.739 . . . . 71.01 110.714 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -37.85 71.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.131 0.572 . . . . 63.45 112.21 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -60.45 -23.56 64.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.162 1.171 . . . . 74.23 114.162 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -88.13 -13.72 40.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.381 0.882 . . . . 72.01 113.381 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.512 ' SD ' HG13 ' A' ' 77' ' ' VAL . 84.4 mtp -58.3 109.16 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.056 0.542 . . . . 75.23 112.24 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.01 -122.46 1.18 Allowed Glycine 0 C--N 1.344 0.988 0 CA-C-N 116.136 -0.483 . . . . 43.01 112.326 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.47 -46.55 63.55 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.518 0.727 . . . . 75.04 111.57 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.6 m -63.86 -37.4 87.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.611 0.764 . . . . 61.21 112.369 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' A' ' 23' ' ' LYS . 87.5 t -67.69 -42.33 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.847 0.459 . . . . 74.01 111.192 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.491 ' SD ' HD21 ' A' ' 89' ' ' LEU . 36.2 tpp -67.6 -47.31 70.07 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.75 0.648 . . . . 73.24 112.75 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.31 -27.24 66.13 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 62.11 113.041 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.46 HG23 HD21 ' A' ' 50' ' ' LEU . 14.7 t -78.22 -29.13 48.16 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 121.615 -0.678 . . . . 73.03 111.91 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.08 -43.21 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 123.055 0.542 . . . . 74.21 109.569 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 122' ' ' ILE . 48.4 mt -53.73 -45.21 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.203 1.001 . . . . 75.42 111.078 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.35 90.72 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.855 0.462 . . . . 50.3 111.611 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.07 -38.88 89.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.923 0.489 . . . . 71.25 111.726 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.53 -30.76 69.64 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.543 0.737 . . . . 64.31 112.721 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -105.63 17.13 24.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.024 0.75 . . . . 54.43 113.024 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -108.25 89.19 5.53 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 122.821 0.449 . . . . 73.33 110.53 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.07 118.92 5.96 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.302 2.001 . . . . 71.35 112.132 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.82 -12.52 32.29 Favored Glycine 0 N--CA 1.477 1.406 0 CA-C-N 115.547 -0.751 . . . . 71.4 113.216 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.25 -7.56 14.83 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.474 0.71 . . . . 75.4 109.754 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -42.87 132.08 3.96 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.923 1.289 . . . . 63.32 113.845 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.89 37.64 2.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.831 -0.622 . . . . 41.32 111.747 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.82 152.67 20.38 Favored Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.698 -0.561 . . . . 71.12 111.698 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' HB2' HD12 ' A' ' 20' ' ' ILE . 98.2 m-85 -120.69 148.74 43.54 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.768 0.784 . . . . 72.32 112.303 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.2 mp -119.93 130.96 55.05 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.893 0.877 . . . . 75.14 109.69 170.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.05 109.47 21.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.568 0.747 . . . . 70.33 109.752 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD12 HD23 ' A' ' 108' ' ' LEU . 63.5 mt -92.07 127.56 37.58 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.938 -0.393 . . . . 72.42 109.938 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.93 30.86 4.07 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 115.9 -0.591 . . . . 63.04 112.604 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.25 133.35 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.252 0.621 . . . . 74.31 110.365 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.81 176.84 5.04 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.688 -1.227 . . . . 74.43 107.688 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -157.05 144.67 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.566 -0.709 . . . . 64.41 112.454 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.71 128.29 53.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.281 1.032 . . . . 72.03 110.294 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.6 mm -82.62 123.14 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 122.9 0.48 . . . . 64.22 111.049 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -65.28 154.54 37.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.897 0.879 . . . . 72.25 110.185 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.37 0.26 20.16 Favored 'General case' 0 CA--C 1.559 1.289 0 O-C-N 121.997 -0.44 . . . . 70.51 111.8 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -96.71 3.51 52.37 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.87 0.868 . . . . 53.45 111.494 166.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.56 57.88 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 115.576 0.991 . . . . 71.24 115.576 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.61 148.38 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.105 0.779 . . . . 73.12 113.105 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -96.72 128.29 43.52 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.354 0.662 . . . . 60.12 111.088 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.1 119.15 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 108.781 -0.822 . . . . 75.32 108.781 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.74 113.43 25.49 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.679 0.752 . . . . 72.25 110.382 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.17 145.1 31.8 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.541 1.136 . . . . 72.31 110.143 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 88.6 Cg_endo -96.2 109.31 0.11 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.371 2.047 . . . . 63.44 113.869 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.8 -11.65 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.66 -0.65 . . . . 71.25 111.142 161.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.6 -167.54 54.34 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.466 0.481 . . . . 64.12 113.61 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 77' ' ' VAL . 95.2 mt -99.74 131.43 24.65 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.113 0.965 . . . . 72.24 110.838 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.24 -37.51 61.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.329 2.019 . . . . 74.21 111.218 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 10.8 m-20 -130.52 86.05 54.34 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.004 0.921 . . . . 74.42 109.374 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 -37.34 89.92 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.562 2.841 . . . . 74.04 114.319 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.97 -53.42 46.57 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.009 -0.996 . . . . 65.02 110.92 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 73' ' ' ASP . 67.4 mmtt -64.46 -49.08 72.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 54.55 112.064 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.512 HG13 ' SD ' ' A' ' 28' ' ' MET . 95.3 t -56.51 -40.94 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.709 0.803 . . . . 61.33 112.329 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.41 -46.12 90.02 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.414 0.686 . . . . 71.5 112.004 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.66 -44.7 61.51 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.738 0.815 . . . . 73.35 112.212 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.02 -33.25 75.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.604 0.762 . . . . 71.45 111.926 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -66.76 -45.11 79.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.656 0.265 . . . . 72.23 110.973 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.09 89.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.335 0.654 . . . . 71.22 111.86 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -64.34 -53.04 54.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.107 0.963 . . . . 70.24 111.028 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.29 -33.42 75.26 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.072 -0.513 . . . . 74.03 112.017 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.4 -29.22 63.92 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.486 0.585 . . . . 74.45 112.412 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.26 -42.65 13.59 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.679 0.792 . . . . 65.03 111.341 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -69.33 -28.52 66.31 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.975 1.102 . . . . 71.14 113.975 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.489 ' SD ' ' HD2' ' A' ' 124' ' ' LYS . 14.0 mmt -80.25 -60.94 2.14 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.313 0.645 . . . . 53.53 111.769 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.491 HD21 ' SD ' ' A' ' 33' ' ' MET . 22.7 mt -81.93 159.9 23.5 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.388 -0.823 . . . . 61.13 112.796 -161.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.718 HD21 HG13 ' A' ' 91' ' ' VAL . 2.5 p-10 -50.65 -52.26 41.46 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.036 0.754 . . . . 75.33 113.036 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.718 HG13 HD21 ' A' ' 90' ' ' ASN . 34.5 m -107.47 171.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.303 0.573 . . . . 73.41 111.441 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.65 99.6 5.09 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.496 -0.775 . . . . 65.43 110.062 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 122' ' ' ILE . 3.9 tt -84.53 127.05 33.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.593 -1.262 . . . . 73.3 107.593 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 94.29 15.91 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.391 0.677 . . . . 74.44 110.583 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.01 162.09 23.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.531 2.154 . . . . 74.3 111.692 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.693 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.6 tp10 -95.75 128.81 42.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 108' ' ' LEU . 62.5 mtt -126.29 114.12 17.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.017 0.527 . . . . 72.41 110.277 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -124.15 133.69 53.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.568 0.747 . . . . 72.23 111.008 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.13 125.06 41.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.007 0.923 . . . . 75.5 110.41 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -135.27 146.09 48.21 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.481 0.713 . . . . 63.04 111.156 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -101.21 117.38 34.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.23 0.538 . . . . 71.23 110.739 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 5' ' ' THR . 88.3 t -126.63 120.08 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.149 1.38 . . . . 73.4 108.375 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.19 60.57 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.109 0.404 . . . . 33.04 114.109 -170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.92 88.03 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 114.152 0.421 . . . . 70.52 114.152 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.2 mmtt -103.01 134.88 45.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.918 0.887 . . . . 74.23 109.928 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.2 m -96.98 123.27 40.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.779 0.718 . . . . 64.42 111.289 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 68' ' ' PRO . 6.7 mp -113.58 161.5 17.34 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.52 0.728 . . . . 72.04 109.198 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 35.9 tp -114.89 111.51 21.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.469 -0.567 . . . . 72.3 109.469 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.2 t -84.76 122.27 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.219 -0.66 . . . . 75.13 109.219 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 37.3 t -113.2 99.97 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.458 0.703 . . . . 73.02 110.039 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 56.8 t80 -84.08 119.61 25.17 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 71.35 110.555 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.42 100.97 28.85 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.931 0.893 . . . . 70.41 109.175 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 176.28 10.17 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.603 2.202 . . . . 71.41 112.356 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.22 156.78 24.38 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.679 0.752 . . . . 73.52 112.934 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -124.34 141.48 52.04 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.145 0.978 . . . . 71.25 109.898 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.24 150.51 37.03 Favored 'General case' 0 C--O 1.183 -2.4 0 C-N-CA 124.27 1.028 . . . . 63.11 110.933 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.0 t -38.72 -37.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 N-CA-C 115.933 1.827 . . . . 72.22 115.933 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 t -78.36 -39.57 38.89 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 112.909 0.707 . . . . 72.42 112.909 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 p-80 -136.88 77.31 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.745 -1.576 . . . . 54.22 106.745 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.727 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.263 14.1 ptmm? -51.48 -152.48 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.35 2 C-N-CA 132.81 4.444 . . . . 72.32 122.097 46.338 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo 14.4 62.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 O-C-N 117.239 -2.032 . . . . 72.05 115.844 -123.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.727 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.9 mm -75.67 95.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 114.401 -1.272 . . . . 72.53 109.451 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -110.53 155.18 22.65 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.928 0.491 . . . . 74.55 109.876 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD2' ' SD ' ' A' ' 88' ' ' MET . 5.7 ttpm? -75.31 136.67 40.86 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -56.1 -40.95 74.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.038 0.535 . . . . 75.04 111.002 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.418 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . . . -77.19 141.83 39.9 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.031 0.533 . . . . 54.24 109.863 165.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -58.63 145.44 39.67 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.488 0.922 . . . . 74.43 113.488 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -142.18 -106.82 0.61 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 116.333 -0.394 . . . . 74.4 113.301 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.79 130.41 67.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.208 0.603 . . . . 74.41 111.568 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.69 138.59 64.9 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.761 2.307 . . . . 61.44 112.819 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.3 84.62 0.61 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 116.799 -0.182 . . . . 65.32 112.656 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.43 -113.84 0.37 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 113.939 0.335 . . . . 70.33 113.939 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -145.36 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.532 0.733 . . . . 72.15 111.798 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.21 136.41 33.96 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.653 0.781 . . . . 75.14 111.041 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.54 129.14 34.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.138 0.975 . . . . 73.12 110.982 -173.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -93.33 96.12 9.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.589 0.756 . . . . 63.11 110.555 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tt -158.58 116.98 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.516 0.726 . . . . 42.4 111.11 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.17 105.47 1.58 Allowed Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.315 -0.402 . . . . 70.11 112.767 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.2 t -127.89 117.72 22.3 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.639 0.776 . . . . 74.52 110.852 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 87.7 p -83.97 156.59 22.23 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.064 0.546 . . . . 62.15 110.829 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -146.51 161.87 39.53 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.407 0.622 . . . . 72.32 111.967 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -96.99 43.03 1.08 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.614 0.766 . . . . 74.4 111.486 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -75.53 135.04 40.62 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 72.43 110.907 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 25.7 p -120.88 154.47 35.81 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.589 0.756 . . . . 62.24 110.547 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.6 143.69 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.27 0.628 . . . . 73.55 111.402 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.84 119.41 11.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.276 1.031 . . . . 71.43 109.024 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.1 123.31 20.3 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.993 0.517 . . . . 75.45 111.603 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -76.86 94.77 3.95 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.956 -1.498 . . . . 70.04 106.956 164.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -66.07 100.64 0.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.329 0.652 . . . . 62.33 112.181 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -68.02 123.66 21.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.456 1.103 . . . . 71.23 110.652 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -65.06 125.12 23.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.569 0.348 . . . . 72.25 110.986 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -110.59 137.06 48.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.214 0.606 . . . . 62.12 111.054 -170.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.3 m80 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.895 0.878 . . . . 74.13 111.346 178.529 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' HG3' ' A' ' 98' ' ' GLN . 10.3 tpt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.919 -0.4 . . . . 63.32 109.919 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -85.73 123.43 31.1 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.149 0.58 . . . . 75.53 110.607 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -59.47 153.71 18.78 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.103 0.961 . . . . 75.2 112.718 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.82 74.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.653 0.781 . . . . 62.3 112.642 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -65.11 -40.76 94.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.615 0.766 . . . . 70.22 110.931 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.78 -37.53 87.92 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.002 0.921 . . . . 70.43 112.239 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 109' ' ' VAL . 68.8 mt -63.0 -41.66 99.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.124 0.569 . . . . 74.52 111.829 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.89 -32.38 69.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 61.02 112.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.14 -40.61 94.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.072 0.549 . . . . 72.03 111.553 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 14' ' ' VAL . 34.6 tt0 -72.61 -50.16 27.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 110.319 -0.252 . . . . 72.13 110.319 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -49.44 -55.78 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.505 1.122 . . . . 55.33 113.119 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -68.49 -20.78 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.445 0.906 . . . . 75.13 113.445 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.32 -29.0 15.87 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.232 0.827 . . . . 73.25 113.232 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 10' ' ' GLU . 23.0 m -111.76 128.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 112.59 0.589 . . . . 72.51 112.59 -172.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.82 -20.93 54.85 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.963 0.905 . . . . 75.31 113.334 164.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -124.49 98.83 5.91 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.547 0.739 . . . . 64.52 110.392 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 p -75.7 94.66 3.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.563 0.745 . . . . 75.54 109.831 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 -63.81 0.99 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.373 0.879 . . . . 42.02 113.373 -167.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -121.55 6.96 10.03 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.11 0.564 . . . . 72.13 112.1 179.35 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mt -116.6 112.81 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.155 -0.683 . . . . 53.23 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.99 115.97 22.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.969 -0.382 . . . . 72.54 109.969 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.75 131.61 37.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.652 0.781 . . . . 72.53 111.97 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 62.3 mttm -130.0 151.64 50.33 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.097 0.959 . . . . 71.01 110.678 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -90.06 170.73 10.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.085 0.554 . . . . 74.03 111.085 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.38 70.7 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.406 0.682 . . . . 64.44 111.659 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -60.6 -30.16 69.65 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.902 0.881 . . . . 63.35 112.88 171.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -86.89 -2.5 58.64 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.272 0.629 . . . . 73.13 112.646 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.2 tpt -63.83 123.06 17.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.795 0.838 . . . . 75.43 112.293 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.75 -135.76 5.73 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.644 -0.253 . . . . 64.51 113.116 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -31.19 70.57 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.579 0.752 . . . . 63.54 111.337 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.4 m -62.8 -31.21 72.14 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.499 0.72 . . . . 64.2 111.955 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.594 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 25.9 t -73.36 -44.06 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 120.909 0.385 . . . . 72.14 110.996 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.566 ' SD ' HD21 ' A' ' 89' ' ' LEU . 38.1 tpp -62.51 -50.47 71.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.212 -0.903 . . . . 72.25 113.076 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -27.4 69.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.924 0.49 . . . . 72.4 112.287 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.9 m -70.54 -40.32 73.48 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.002 0.521 . . . . 52.43 110.858 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.16 -43.79 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 123.497 0.719 . . . . 72.31 110.665 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.97 -37.54 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.363 0.665 . . . . 74.44 110.735 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.35 -48.41 79.9 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.546 0.738 . . . . 62.43 112.456 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -71.95 -32.45 67.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 120.698 0.285 . . . . 75.13 111.566 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . . . -76.07 -25.68 55.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.317 0.647 . . . . 64.03 112.563 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.75 -33.46 12.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.304 0.642 . . . . 74.1 112.161 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.5 mm-40 -67.52 127.16 93.37 Favored Pre-proline 0 CA--C 1.563 1.479 0 O-C-N 122.07 -0.394 . . . . 72.01 111.927 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 40.7 Cg_exo -58.03 109.94 0.56 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.639 2.893 . . . . 75.23 114.747 -173.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.79 26.23 67.64 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.882 0.713 . . . . 64.12 114.882 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.66 13.1 35.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 118.819 1.309 . . . . 74.42 112.295 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 8.0 p-10 -51.47 116.54 2.13 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.132 0.573 . . . . 71.34 110.884 167.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 120.62 36.18 0.8 Allowed Glycine 0 N--CA 1.47 0.957 0 CA-C-N 115.931 -0.577 . . . . 41.32 112.117 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -111.79 127.25 8.03 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 110.77 -0.932 . . . . 52.32 110.77 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.08 125.82 53.96 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.282 0.541 . . . . 54.22 110.819 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -94.89 121.78 36.85 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.345 -0.983 . . . . 63.04 108.345 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.52 108.71 20.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.53 0.681 . . . . 63.34 110.256 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD21 ' A' ' 71' ' ' LEU . 3.5 mm? -91.65 132.19 36.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.192 0.997 . . . . 72.31 110.357 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.65 32.07 4.63 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 116.048 -0.524 . . . . 73.41 112.966 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.3 133.99 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.976 0.511 . . . . 60.31 110.181 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.44 129.07 56.44 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.223 -1.399 . . . . 70.53 107.223 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -110.9 129.6 55.83 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.173 0.511 . . . . 73.41 111.702 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.51 54.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.287 1.035 . . . . 73.33 110.334 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.5 mm -96.2 126.76 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.292 0.637 . . . . 74.11 110.476 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 63' ' ' ASP . 30.9 p30 -87.95 -174.1 4.56 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.526 0.73 . . . . 52.54 111.61 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.92 -22.98 67.17 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.654 0.782 . . . . 72.43 112.621 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HE3' ' H ' ' A' ' 142' ' ' GLN . 14.3 mmmm -74.11 -23.4 59.31 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.903 0.881 . . . . 73.41 112.535 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.74 78.64 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.625 -0.261 . . . . 75.15 112.722 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' HD21 ' A' ' 59' ' ' ASN . 26.0 t70 -75.03 142.41 43.79 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.617 1.167 . . . . 71.23 111.278 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.3 m -93.95 108.85 20.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.693 0.797 . . . . 74.41 110.335 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.76 121.81 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.625 0.77 . . . . 70.23 109.757 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -92.08 127.34 37.52 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.404 0.682 . . . . 74.05 110.225 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -123.11 120.89 27.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.809 0.844 . . . . 75.44 110.458 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.13 90.31 0.66 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.575 2.183 . . . . 60.14 112.761 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.95 -12.18 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.289 0.636 . . . . 62.03 112.015 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.63 179.03 44.36 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.234 -0.439 . . . . 53.23 113.627 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 52' ' ' LEU . 3.5 mp -105.18 139.94 20.62 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 109.686 -0.487 . . . . 61.05 109.686 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.25 -30.17 25.1 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.137 1.891 . . . . 64.42 112.056 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.62 71.1 81.27 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.856 0.863 . . . . 75.24 110.226 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.69 -24.94 17.83 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.914 2.409 . . . . 74.21 112.764 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.17 -45.3 77.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 74.13 110.044 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 7.9 mtpm? -61.39 -53.89 50.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.708 -0.678 . . . . 63.22 111.198 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.2 -35.32 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.571 0.749 . . . . 52.12 112.103 -172.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 54.2 tt0 -63.81 -46.09 86.68 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 120.99 0.424 . . . . 74.23 111.5 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -70.29 -47.61 60.45 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.566 0.746 . . . . 55.2 112.07 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.195 0.998 . . . . 53.21 111.409 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 tp -71.32 -41.47 69.81 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.647 0.379 . . . . 72.55 111.276 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.2 86.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.192 0.597 . . . . 72.31 111.297 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 -52.19 55.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.938 0.895 . . . . 72.41 111.191 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -68.32 -29.57 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.731 0.412 . . . . 73.52 111.596 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 45.5 t -60.27 -27.4 67.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.74 -0.6 . . . . 74.11 112.043 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.11 -49.61 6.3 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.161 0.584 . . . . 60.23 111.825 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 t -68.7 -32.14 71.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.372 0.879 . . . . 43.21 113.372 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.427 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 5.7 mmt -78.93 -48.15 15.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.368 0.667 . . . . 63.41 111.366 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD21 ' SD ' ' A' ' 33' ' ' MET . 31.0 mt -88.39 151.4 22.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.688 0.625 . . . . 71.23 112.688 -166.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -55.27 -58.62 6.96 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.138 1.375 . . . . 70.11 112.369 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' HB3' ' A' ' 119' ' ' HIS . 43.1 t -102.36 146.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.621 0.769 . . . . 74.12 109.535 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.27 97.23 0.71 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.41 0.624 . . . . 63.15 110.822 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.474 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.5 tt -81.75 136.72 35.43 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.146 -1.057 . . . . 44.51 108.146 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -107.16 91.16 6.28 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.246 0.619 . . . . 73.22 109.948 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.71 118.61 4.21 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.135 1.89 . . . . 70.31 111.583 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 37.5 tt0 -73.44 109.24 6.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 74.22 109.084 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.509 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 66.7 mtt -116.39 133.21 56.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.132 0.573 . . . . 74.43 111.747 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.429 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 15.1 mm100 -134.75 139.61 45.3 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.251 1.021 . . . . 75.44 110.471 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.7 mt -104.85 113.05 26.41 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.175 0.99 . . . . 73.04 110.946 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -118.01 136.48 53.5 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.224 1.009 . . . . 54.32 110.147 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -92.44 118.7 31.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.557 0.343 . . . . 73.32 110.313 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.16 113.99 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 63.4 108.925 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.8 29.49 67.53 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 114.804 0.682 . . . . 62.45 114.804 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.69 79.95 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.507 0.563 . . . . 73.13 114.507 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.34 136.43 49.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.995 0.918 . . . . 53.1 110.19 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.3 m -87.77 120.97 29.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.701 0.682 . . . . 74.45 110.903 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.5 mp -116.36 156.46 26.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.856 0.862 . . . . 64.3 109.813 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 52.5 tp -115.75 121.57 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.097 0.559 . . . . 74.22 110.117 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HD11 ' A' ' 7' ' ' LEU . 51.3 t -99.05 121.79 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.532 0.733 . . . . 73.24 109.153 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.39 101.38 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.957 0.503 . . . . 70.51 110.36 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 77.6 t80 -73.33 122.7 22.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.321 0.648 . . . . 74.34 109.826 170.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.65 110.51 63.3 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.371 0.668 . . . . 45.45 109.771 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.13 145.84 24.88 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.308 2.005 . . . . 74.22 112.235 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 42.7 tt0 -74.27 145.0 44.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.159 -0.682 . . . . 74.33 109.159 169.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -84.96 173.83 10.25 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 123.239 0.616 . . . . 64.1 111.691 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.97 176.87 0.64 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 124.829 1.251 . . . . 75.15 111.044 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.89 -56.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.714 -1.241 . . . . 63.02 114.117 167.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -82.72 -41.45 19.26 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.354 0.525 . . . . 74.22 111.379 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.66 ' HB3' HG21 ' A' ' 91' ' ' VAL . 19.1 m-70 -104.7 73.65 1.1 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 103.734 -2.691 . . . . 74.01 103.734 162.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.5 mttt -46.87 -139.08 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.8 1 C-N-CA 133.526 4.73 . . . . 73.02 121.301 53.163 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo 6.43 67.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 124.592 3.528 . . . . 54.35 116.225 -122.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 120' ' ' LYS . 23.5 mm -76.72 80.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-N 115.287 -0.87 . . . . 51.42 109.595 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -82.95 152.97 25.26 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.923 0.392 . . . . 65.05 110.224 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -89.89 155.72 18.95 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 109.439 -0.578 . . . . 71.01 109.439 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 88' ' ' MET . 73.8 mmtt -73.02 -2.0 19.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.863 0.865 . . . . 64.4 112.44 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.7 -178.3 5.46 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.399 1.08 . . . . 32.43 111.111 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 158.06 33.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.638 0.775 . . . . 54.22 112.012 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.08 -82.84 1.25 Allowed Glycine 0 N--CA 1.477 1.37 0 CA-C-O 120.153 -0.248 . . . . 75.22 113.459 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt 59.4 82.12 0.24 Allowed Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 124.757 1.223 . . . . 73.51 110.393 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -76.88 168.92 22.64 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.847 2.364 . . . . 73.54 112.799 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.56 162.33 30.4 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 116.043 -0.526 . . . . 73.32 113.751 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.67 -172.65 37.9 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.662 0.172 . . . . 71.23 113.087 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.6 169.23 18.21 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.133 0.492 . . . . 70.43 111.967 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -125.91 172.74 9.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.73 0.812 . . . . 74.13 109.74 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -62.03 108.78 1.11 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.273 0.559 . . . . 71.13 110.835 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -96.38 8.09 44.85 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.215 1.006 . . . . 73.22 111.194 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.43 132.6 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.517 1.127 . . . . 74.34 111.02 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.41 170.32 33.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.478 -0.328 . . . . 61.44 113.304 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 p -93.05 -61.52 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.526 0.731 . . . . 52.54 111.546 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -154.59 134.63 13.08 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.219 0.608 . . . . 75.44 111.426 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.82 92.42 8.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.375 0.67 . . . . 74.31 111.001 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.513 ' H ' ' HE3' ' A' ' 61' ' ' LYS . 13.2 mm100 -74.14 155.72 38.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.552 -0.749 . . . . 70.4 110.871 171.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.75 143.79 26.16 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.486 0.314 . . . . 65.44 110.826 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 80.4 m -73.16 86.75 1.4 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.28 0.562 . . . . 71.21 110.615 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.5 p -80.63 139.95 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.484 0.714 . . . . 75.11 111.246 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -140.86 157.01 45.98 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.691 0.796 . . . . 71.23 110.113 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.29 153.93 31.36 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.009 0.524 . . . . 62.25 110.977 174.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -154.42 107.7 2.88 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.659 0.784 . . . . 73.41 108.906 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -70.66 85.44 0.64 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.937 0.875 . . . . 64.52 112.216 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -73.07 129.9 39.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.175 -1.375 . . . . 61.42 110.034 174.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -80.08 178.86 7.94 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.525 0.73 . . . . 45.22 111.278 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -103.9 146.83 28.1 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.005 0.522 . . . . 75.42 111.867 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.9 p80 . . . . . 0 N--CA 1.488 1.457 0 C-N-CA 124.39 1.076 . . . . 73.2 112.621 176.285 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HB ' ' A' ' 109' ' ' VAL . 56.6 ttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.221 0.452 . . . . 60.51 112.221 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 1' ' ' MET . 86.5 mtt180 -47.26 145.65 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.827 0.676 . . . . 72.23 112.827 158.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -64.11 151.65 42.64 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 71.13 111.268 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.12 -26.69 68.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.953 -0.567 . . . . 51.4 111.993 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.605 HG23 HG13 ' A' ' 102' ' ' VAL . 2.0 m -66.53 -47.37 73.1 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.152 0.981 . . . . 61.25 111.131 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.83 -44.06 97.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.987 0.915 . . . . 72.12 111.502 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.04 -30.81 69.25 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.074 -0.966 . . . . 74.32 112.246 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -66.03 -43.43 87.64 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.129 0.571 . . . . 74.52 109.962 171.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.8 -37.71 85.39 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.49 0.716 . . . . 71.4 111.591 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.71 -41.97 99.41 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.074 0.95 . . . . 72.13 110.925 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.03 -44.68 94.48 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.142 0.977 . . . . 71.12 112.113 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -76.99 -16.13 59.42 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.645 0.609 . . . . 74.4 112.645 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.43 43.38 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.239 0.616 . . . . 61.52 111.147 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 17' ' ' SER . 17.1 m -115.82 119.16 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.863 0.865 . . . . 63.03 110.02 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.21 -47.48 83.33 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.774 0.83 . . . . 65.04 111.27 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.95 95.96 9.81 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 62.34 108.656 165.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 14' ' ' VAL . 35.8 t -58.57 122.08 12.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.123 -0.489 . . . . 64.42 111.929 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.96 76.95 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.698 0.629 . . . . 65.21 112.698 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -150.88 15.48 0.75 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.089 0.774 . . . . 73.32 113.089 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.0 mm -102.21 106.47 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.342 -0.984 . . . . 72.41 108.342 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' HG2' HG21 ' A' ' 35' ' ' THR . 10.6 tp10 -94.8 114.35 26.23 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.323 0.649 . . . . 75.24 111.504 -169.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.53 35.38 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.651 0.781 . . . . 52.52 112.136 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -153.19 156.24 38.18 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.906 0.86 . . . . 64.12 112.235 176.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -81.37 163.19 23.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.42 -1.264 . . . . 75.34 110.362 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.05 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.787 0.435 . . . . 74.12 112.078 173.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 m -64.52 -29.97 71.01 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.866 0.867 . . . . 71.11 112.572 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 63.8 m-20 -82.53 -16.08 49.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.263 0.625 . . . . 75.35 112.337 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.506 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.8 tmm? -63.64 120.1 11.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.976 0.511 . . . . 73.24 111.822 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.19 -139.46 6.13 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.147 -0.478 . . . . 65.43 112.324 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -58.64 -41.65 86.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.988 1.107 . . . . 71.12 113.988 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -64.61 -41.12 96.43 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.583 0.753 . . . . 71.31 112.225 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.546 HG22 ' HE3' ' A' ' 23' ' ' LYS . 84.5 t -67.08 -43.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.581 0.752 . . . . 71.22 110.517 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.4 tpp -56.45 -40.92 75.61 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.965 1.306 . . . . 60.43 112.479 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.71 -39.23 90.77 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.47 0.708 . . . . 64.2 110.432 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.523 HG21 ' HG2' ' A' ' 21' ' ' GLU . 23.4 m -75.51 -30.74 59.91 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.06 0.544 . . . . 75.32 111.416 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 112' ' ' VAL . 69.2 t -59.39 -41.82 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.343 0.657 . . . . 73.12 110.657 174.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mt -59.86 -36.55 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 122.843 0.457 . . . . 73.24 111.326 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.38 97.27 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.827 1.047 . . . . 74.34 113.827 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' HD23 ' A' ' 45' ' ' LEU . 87.9 m-85 -70.76 -35.41 72.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.931 0.492 . . . . 73.14 111.206 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -22.7 46.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.693 0.797 . . . . 53.11 112.397 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -74.59 -50.09 19.23 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 54.21 111.754 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.06 142.18 72.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.175 0.59 . . . . 73.53 112.076 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.53 123.0 7.8 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.584 2.19 . . . . 74.22 113.107 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.39 34.71 85.76 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.83 -0.623 . . . . 52.11 114.551 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 39' ' ' PHE . 16.4 tp -97.97 18.79 15.15 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 117.738 0.769 . . . . 60.55 111.143 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -45.55 122.62 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.898 1.073 . . . . 72.11 113.898 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.1 51.12 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.421 -0.655 . . . . 34.2 114.554 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.66 137.27 9.2 Favored Glycine 0 C--N 1.364 2.094 0 CA-C-N 118.847 1.323 . . . . 71.23 111.9 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -121.27 138.68 54.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.462 0.705 . . . . 73.4 111.623 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 21' ' ' GLU . 5.4 mp -106.87 121.27 44.07 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.896 0.878 . . . . 71.44 109.392 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.84 109.56 21.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.501 0.72 . . . . 72.01 110.103 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 108' ' ' LEU . 9.5 mp -95.53 136.47 35.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.304 1.041 . . . . 74.24 109.989 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.33 31.55 8.91 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.894 -0.594 . . . . 42.02 112.372 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.3 t -112.18 139.68 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.597 0.759 . . . . 75.53 109.481 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -114.16 159.13 20.42 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.835 -1.172 . . . . 50.3 107.835 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.454 ' HH2' ' HA ' ' A' ' 23' ' ' LYS . 41.3 p90 -150.65 137.16 18.81 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 73.35 111.296 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.91 49.14 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.583 0.753 . . . . 55.14 110.701 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -88.91 130.89 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.362 0.665 . . . . 62.34 110.666 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 63' ' ' ASP . 31.9 p30 -82.13 -172.49 3.99 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.631 0.772 . . . . 72.32 112.486 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.07 -33.12 75.04 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.745 0.818 . . . . 75.14 112.433 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -83.04 -12.61 57.05 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.246 0.618 . . . . 73.53 112.335 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.08 37.02 6.11 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.228 0.451 . . . . 45.33 114.228 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' HD21 ' A' ' 59' ' ' ASN . 8.7 m-20 -116.77 134.72 54.44 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.479 0.711 . . . . 72.54 110.413 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -86.68 118.5 26.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.415 0.686 . . . . 73.44 110.548 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.39 118.34 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.126 0.57 . . . . 74.32 109.885 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.06 120.39 34.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.575 0.75 . . . . 73.34 109.821 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -124.02 151.02 64.57 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.847 0.859 . . . . 73.3 112.088 -170.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.47 121.7 5.28 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.606 2.204 . . . . 74.31 112.823 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.41 -40.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.9 -1.045 . . . . 64.54 110.557 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.44 170.28 46.76 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.695 -0.684 . . . . 53.4 113.362 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.09 139.76 22.18 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 109.619 -0.512 . . . . 70.44 109.619 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 -29.92 31.35 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.569 2.179 . . . . 53.22 111.954 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -133.19 83.06 51.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 108.328 -0.99 . . . . 61.35 108.328 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.21 -36.65 56.18 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.904 2.403 . . . . 63.5 113.564 -172.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.8 -43.01 60.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.191 0.596 . . . . 64.01 110.969 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.1 -45.57 94.15 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.407 0.283 . . . . 71.12 111.39 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.33 -43.64 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.479 0.712 . . . . 71.22 111.352 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.48 -48.42 81.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.523 0.729 . . . . 64.15 111.953 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -66.76 -40.93 88.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.171 -0.922 . . . . 61.45 111.474 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.83 -35.81 82.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.232 0.613 . . . . 74.01 110.91 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.34 -37.05 71.73 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.624 0.769 . . . . 74.31 111.329 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.56 86.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.439 0.696 . . . . 72.43 111.399 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.2 t -65.07 -52.55 55.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.839 0.855 . . . . 73.43 111.503 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.39 -31.82 73.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.21 0.604 . . . . 75.31 111.922 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 44.8 t -60.05 -35.3 74.83 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.163 0.506 . . . . 71.13 112.153 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.78 37.2 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.615 -0.721 . . . . 74.23 112.187 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.8 p -95.35 -2.59 48.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.593 0.961 . . . . 72.5 113.593 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.3 mmt -93.16 -55.45 3.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.371 0.605 . . . . 71.23 109.955 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.94 146.82 26.01 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.36 -0.836 . . . . 72.53 110.548 -171.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' ND2' HG13 ' A' ' 91' ' ' VAL . 8.5 p-10 -52.75 -33.1 46.75 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.59 1.156 . . . . 41.32 113.161 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG13 ' ND2' ' A' ' 90' ' ' ASN . 18.1 m -120.25 162.57 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.25 1.02 . . . . 62.42 110.773 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.28 101.75 6.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.657 -0.701 . . . . 74.51 110.427 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.421 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.4 tt -83.24 124.12 30.25 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.57 -1.27 . . . . 73.11 107.57 172.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -102.89 98.75 12.04 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 122.76 0.424 . . . . 71.02 110.856 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.82 163.06 7.63 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.284 1.99 . . . . 64.54 112.433 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 60.4 tt0 -88.23 121.69 30.92 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtt -124.4 117.78 25.22 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.241 0.617 . . . . 71.04 110.799 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.692 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 28.6 mm-40 -131.38 138.78 49.29 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.686 0.794 . . . . 54.31 110.615 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.31 117.27 29.52 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.504 0.721 . . . . 63.5 109.439 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.7 133.53 53.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.394 1.078 . . . . 64.41 110.297 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -89.86 129.9 36.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.988 0.515 . . . . 73.25 111.095 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.605 HG13 HG23 ' A' ' 5' ' ' THR . 23.9 t -128.13 107.74 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.97 0.908 . . . . 63.33 108.828 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.6 28.95 57.11 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.727 0.651 . . . . 53.11 114.727 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.75 0.93 83.42 Favored Glycine 0 CA--C 1.543 1.794 0 N-CA-C 114.82 0.688 . . . . 74.12 114.82 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.7 133.05 41.74 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.611 0.706 . . . . 71.03 109.303 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -86.74 102.72 14.51 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.418 0.554 . . . . 74.11 110.796 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.2 154.42 18.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.52 0.728 . . . . 71.02 110.26 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 52' ' ' LEU . 52.0 tp -116.69 120.1 37.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.401 0.681 . . . . 72.1 109.288 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 17.3 t -95.87 132.63 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.105 -0.702 . . . . 74.12 109.105 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.06 99.22 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.862 -0.792 . . . . 74.52 108.862 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 54.1 t80 -83.67 131.65 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.08 0.552 . . . . 55.43 110.107 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 36' ' ' VAL . 36.6 t -121.92 116.26 30.23 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 109.434 -0.58 . . . . 73.04 109.434 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.23 -176.15 1.76 Allowed 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.708 2.272 . . . . 54.44 112.832 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.81 131.68 44.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.93 0.492 . . . . 70.2 109.85 166.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.08 157.02 23.02 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.038 0.535 . . . . 53.45 111.339 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.93 150.99 46.91 Favored 'General case' 0 C--O 1.186 -2.24 0 C-N-CA 123.963 0.905 . . . . 72.45 111.417 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -38.01 -52.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 N-CA-C 115.738 1.755 . . . . 44.24 115.738 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -69.59 -37.86 77.11 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.124 0.787 . . . . 64.45 113.124 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.8 m-70 -125.73 66.66 1.17 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 105.273 -2.121 . . . . 75.4 105.273 171.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 122' ' ' ILE . 62.8 mttm -44.14 -153.0 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.207 1 C-N-CA 132.863 4.465 . . . . 70.13 121.316 60.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -1.85 71.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.584 2.19 . . . . 65.03 116.244 -117.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.612 HG13 ' HA ' ' A' ' 120' ' ' LYS . 59.5 mt -85.88 111.0 20.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.805 -1.089 . . . . 71.23 110.248 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -113.14 139.53 48.67 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.836 -1.075 . . . . 72.14 110.401 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.0 120.0 13.55 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.322 0.649 . . . . 71.52 109.443 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mtmp? -60.1 -33.79 72.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 112.547 0.573 . . . . 50.33 112.547 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.7 105.89 14.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.265 0.626 . . . . 72.04 109.571 171.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.5 p -57.3 105.48 0.24 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.45 112.501 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.68 -147.44 3.59 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 115.897 -0.592 . . . . 64.51 113.986 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 1.3 pp -145.7 143.85 20.88 Favored Pre-proline 0 N--CA 1.485 1.286 0 N-CA-C 112.547 0.573 . . . . 64.31 112.547 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 129' ' ' LEU . 12.6 Cg_exo -73.69 151.68 46.82 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.991 2.461 . . . . 72.01 112.548 169.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.7 107.4 3.2 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-N 116.704 -0.226 . . . . 64.43 113.09 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.49 -145.65 9.69 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.153 0.406 . . . . 42.22 112.818 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.32 150.83 51.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.25 0.62 . . . . 65.53 111.329 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -134.31 145.4 49.01 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.504 0.722 . . . . 74.1 110.403 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -97.54 178.44 5.18 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.775 0.83 . . . . 73.54 112.205 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 133.95 47.18 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.377 -0.374 . . . . 73.31 110.099 167.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.19 109.98 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 123.724 0.81 . . . . 71.44 112.187 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.4 149.27 19.21 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.639 -0.709 . . . . 64.02 111.771 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.8 p -76.99 138.29 39.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.274 0.63 . . . . 64.51 111.676 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -84.77 85.97 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.107 0.563 . . . . 71.21 109.695 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.64 155.21 41.04 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.996 0.739 . . . . 74.35 112.996 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.54 11.93 11.59 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.297 1.039 . . . . 73.22 111.537 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -79.24 27.21 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.641 0.978 . . . . 73.03 113.641 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 24.6 p -78.71 79.18 5.14 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.487 0.715 . . . . 65.51 110.94 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.36 94.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.555 0.742 . . . . 73.53 111.235 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.8 102.55 14.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.038 0.535 . . . . 61.22 109.786 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -168.02 1.5 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 122.989 0.516 . . . . 55.1 111.526 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -135.87 127.34 28.65 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.896 0.478 . . . . 71.22 111.588 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -152.23 137.19 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.473 0.709 . . . . 71.22 110.352 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -96.39 144.22 26.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.434 0.693 . . . . 54.41 110.922 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -94.35 139.49 31.02 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 72.23 110.891 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 67.42 -69.19 0.14 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.26 1.424 . . . . 75.31 111.662 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.452 0.644 . . . . 54.25 110.673 174.494 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 23.3 ttt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.353 -0.239 . . . . 73.31 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.88 153.53 18.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.13 0.572 . . . . 72.44 111.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.3 t -74.41 156.82 36.61 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.442 0.697 . . . . 62.15 111.249 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.89 -27.73 67.75 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.934 0.493 . . . . 64.21 111.355 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.576 HG23 HG13 ' A' ' 102' ' ' VAL . 3.8 m -70.18 -41.75 73.34 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.658 0.783 . . . . 70.34 110.395 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.18 -51.04 67.96 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.622 1.169 . . . . 72.14 110.952 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 51' ' ' LEU . 85.3 mt -69.67 -33.25 72.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.1 0.96 . . . . 75.21 113.081 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.93 -44.8 88.32 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.013 0.435 . . . . 44.33 110.404 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.33 -37.61 86.31 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.519 -0.764 . . . . 63.24 111.096 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.29 -43.12 98.8 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.885 0.874 . . . . 74.41 110.703 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 22' ' ' ALA . 71.4 mt -67.09 -38.56 85.92 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.518 1.127 . . . . 71.43 111.96 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -72.61 -23.8 60.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.118 0.567 . . . . 62.1 111.942 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.2 17.59 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.475 0.71 . . . . 52.05 110.965 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.33 116.54 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.179 0.514 . . . . 64.01 110.77 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.17 -43.21 87.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.67 0.388 . . . . 72.21 110.629 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.24 101.2 1.44 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.232 0.539 . . . . 73.22 109.931 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 25.3 m -80.89 78.64 7.67 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.589 0.756 . . . . 75.22 110.161 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.07 40.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.955 1.095 . . . . 73.52 113.955 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -123.72 -9.35 7.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 113.047 0.758 . . . . 74.25 113.047 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 17' ' ' SER . 42.3 mt -131.92 133.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.684 0.794 . . . . 73.41 109.301 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -125.7 129.4 49.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.826 0.739 . . . . 72.05 111.316 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -89.02 131.74 35.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.705 0.802 . . . . 71.52 110.612 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.34 151.94 51.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.834 0.854 . . . . 72.12 111.046 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -92.39 165.63 12.97 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.705 . . . . 72.34 112.474 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -24.54 67.31 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.141 0.976 . . . . 72.23 112.276 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.1 -36.02 82.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.865 0.466 . . . . 53.43 111.982 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -86.04 -2.48 58.35 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.466 0.706 . . . . 70.14 112.238 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.4 tpt -52.59 105.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.346 1.059 . . . . 72.34 111.909 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' HA2' ' OE1' ' A' ' 84' ' ' GLN . . . 138.05 -124.72 3.03 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.802 -0.635 . . . . 61.13 112.83 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.31 -36.85 76.38 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.461 1.105 . . . . 74.15 112.157 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.0 m -72.53 -18.85 61.61 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.264 -0.88 . . . . 63.31 112.991 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -34.34 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.659 0 C-N-CA 122.902 0.481 . . . . 62.23 111.709 167.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 24.7 mmt -74.69 -37.52 62.61 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.367 1.618 . . . . 73.24 115.367 -158.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.44 70.52 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.38 0.537 . . . . 72.2 112.19 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 HD21 ' A' ' 50' ' ' LEU . 31.8 m -77.31 -30.76 54.25 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.186 0.594 . . . . 65.04 111.28 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.53 -39.93 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 122.837 0.455 . . . . 72.32 110.266 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB2' ' A' ' 124' ' ' LYS . 68.6 mt -57.2 -35.61 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.533 0.733 . . . . 73.03 111.637 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.3 1.61 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.47 0.308 . . . . 73.04 110.891 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -65.46 -30.51 71.31 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.498 0.719 . . . . 73.43 112.359 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.81 -24.85 55.93 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.782 0.66 . . . . 51.44 112.782 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 121' ' ' PRO . 49.0 m-80 -115.95 -4.69 12.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.149 1.166 . . . . 63.14 114.149 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -92.52 107.15 21.75 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.0 0.818 . . . . 73.35 110.773 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.52 126.74 8.47 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.464 2.11 . . . . 32.21 112.997 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.21 -7.05 32.48 Favored Glycine 0 N--CA 1.474 1.216 0 CA-C-N 116.002 -0.544 . . . . 73.3 113.734 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.07 -37.93 9.95 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.986 0.893 . . . . 72.54 108.935 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' GLU . 11.0 m-20 39.6 71.81 0.16 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.309 1.844 . . . . 64.53 115.401 171.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.41 74.45 0.43 Allowed Glycine 0 C--N 1.352 1.425 0 N-CA-C 115.362 0.905 . . . . 54.33 115.362 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.13 44.45 Favored Glycine 0 N--CA 1.482 1.72 0 CA-C-N 117.237 0.518 . . . . 53.33 113.234 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -129.26 142.43 50.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.575 0.954 . . . . 74.11 113.575 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 35' ' ' THR . 95.8 mt -132.28 125.44 31.02 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.24 1.416 . . . . 63.11 109.891 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.7 mm? -103.56 108.81 20.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.743 0.417 . . . . 70.31 110.851 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.71 124.93 38.04 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 61.52 109.857 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.98 33.15 4.13 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.158 -0.474 . . . . 73.13 112.94 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.88 146.33 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.545 0.738 . . . . 73.13 109.875 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -130.55 134.3 46.91 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.997 -0.742 . . . . 74.31 108.997 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -117.44 129.65 55.97 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.291 1.036 . . . . 74.3 110.881 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.76 135.22 54.19 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.604 0.762 . . . . 75.04 110.813 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -80.54 129.68 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.606 0.762 . . . . 63.35 110.487 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 40.7 p30 -90.89 -168.17 2.01 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.88 0.696 . . . . 63.55 112.88 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.17 -44.6 68.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.755 1.222 . . . . 74.13 113.48 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -26.8 27.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.013 0.525 . . . . 75.11 111.635 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.16 7.39 14.69 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 119.913 -0.382 . . . . 71.42 114.023 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 8.3 m-20 -74.48 143.1 44.77 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.471 0.636 . . . . 75.02 111.013 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.1 m -90.11 114.28 26.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.871 0.869 . . . . 71.03 110.156 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.55 117.28 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.437 0.695 . . . . 73.43 110.443 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -92.66 116.39 28.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.088 0.955 . . . . 74.45 110.422 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -118.46 149.76 46.67 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 123.885 0.874 . . . . 75.53 111.383 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.63 104.92 1.78 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.66 2.24 . . . . 74.44 112.014 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.94 -29.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 116.052 -0.522 . . . . 74.25 110.397 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -174.16 55.11 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.615 -0.721 . . . . 55.41 113.57 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 77' ' ' VAL . 82.0 mt -104.51 133.14 20.34 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.718 0.807 . . . . 73.21 110.542 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.43 -31.34 42.77 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.521 2.148 . . . . 74.53 111.763 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 5.8 m-20 -122.52 75.43 44.53 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 124.077 0.951 . . . . 64.14 109.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.83 -60.26 0.62 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.24 2.627 . . . . 73.14 114.223 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 5.2 p-10 -66.28 -39.36 89.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.263 -0.426 . . . . 54.43 110.65 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 57.4 tptt -60.96 -40.77 94.59 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.627 0.771 . . . . 62.31 112.089 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG21 HD22 ' A' ' 71' ' ' LEU . 79.2 t -62.84 -44.92 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.037 0.535 . . . . 70.44 110.888 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.49 -50.34 73.93 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.586 0.754 . . . . 71.22 112.313 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 16.5 mmt85 -68.51 -43.96 75.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.495 0.718 . . . . 75.44 111.521 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.72 -33.54 72.63 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.541 -0.754 . . . . 74.33 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.559 HD23 ' SD ' ' A' ' 97' ' ' MET . 21.6 tp -66.98 -40.19 87.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.688 0.395 . . . . 62.51 110.936 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.2 93.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.97 0.508 . . . . 40.55 111.695 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -66.52 -52.47 45.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.813 0.845 . . . . 64.14 112.016 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.471 ' OE1' ' HA2' ' A' ' 29' ' ' GLY . 11.7 pt20 -71.13 -31.17 67.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.003 0.521 . . . . 72.24 112.321 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 42.4 t -60.89 -26.92 67.78 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.435 0.636 . . . . 64.35 111.373 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -76.48 -25.15 53.98 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 113.721 1.008 . . . . 51.0 113.721 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.5 p -110.44 -37.24 5.55 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.288 0.847 . . . . 71.52 113.288 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 92.1 mmm -68.29 -46.89 69.11 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.393 1.077 . . . . 70.53 111.542 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.407 HD12 ' SG ' ' A' ' 85' ' ' CYS . 53.9 mt -85.89 161.91 18.84 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.718 -0.674 . . . . 72.2 111.374 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -37.33 -53.05 1.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.873 1.669 . . . . 75.41 114.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 122' ' ' ILE . 28.7 m -119.64 174.33 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.507 0.723 . . . . 73.41 111.441 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -68.73 97.4 0.81 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.202 -0.666 . . . . 54.32 109.202 163.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 122' ' ' ILE . 4.9 tt -98.84 130.84 45.27 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.47 0.708 . . . . 61.13 109.465 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -106.62 98.55 20.92 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 124.061 0.944 . . . . 73.14 110.985 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.4 149.93 15.03 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.238 1.959 . . . . 51.03 111.407 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 9.9 tp10 -87.21 102.68 14.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.097 -0.705 . . . . 64.12 109.097 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 108' ' ' LEU . 51.9 mtm -112.43 140.25 47.32 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.536 0.735 . . . . 70.04 110.679 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -149.88 150.86 32.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.352 0.661 . . . . 74.13 110.46 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.73 119.28 38.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.295 1.038 . . . . 63.34 110.59 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -127.23 133.54 50.22 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.085 0.954 . . . . 75.32 109.711 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.85 122.16 40.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.073 0.463 . . . . 70.32 110.879 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 5' ' ' THR . 9.2 t -119.95 113.44 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.502 1.121 . . . . 73.32 108.41 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.29 28.67 55.25 Favored Glycine 0 CA--C 1.547 2.064 0 N-CA-C 115.169 0.828 . . . . 54.32 115.169 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.12 1.92 66.69 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 115.088 0.795 . . . . 65.23 115.088 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -109.96 130.51 55.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.993 0.897 . . . . 75.44 109.685 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 102.41 14.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.484 0.583 . . . . 73.13 111.685 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.39 166.45 14.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.895 0.878 . . . . 63.33 111.046 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 97' ' ' MET . 49.3 tp -119.21 121.84 40.62 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.56 0.744 . . . . 74.03 110.782 175.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' MET . 52.6 t -86.93 113.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.299 0.639 . . . . 74.02 109.576 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 55.3 t -100.22 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.37 0.605 . . . . 74.41 109.691 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.6 119.28 24.54 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.929 0.892 . . . . 75.34 109.252 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.87 100.34 39.17 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.488 0.715 . . . . 62.14 109.55 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.25 157.29 41.78 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.5 2.133 . . . . 71.43 112.175 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.5 tm-20 -75.94 115.94 16.15 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.23 -0.655 . . . . 71.42 109.23 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.47 152.22 35.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.346 1.058 . . . . 53.2 112.425 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' HB3' HG22 ' A' ' 118' ' ' THR . 14.9 t70 -77.55 156.93 30.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.049 -0.523 . . . . 73.43 111.238 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -64.99 -19.92 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.412 0.685 . . . . 71.32 112.426 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 116' ' ' ASP . 14.9 t -58.01 -18.31 23.22 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 123.534 0.733 . . . . 51.44 112.277 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 83.8 m-70 -79.88 -76.65 0.21 Allowed 'General case' 0 CA--C 1.591 2.548 0 N-CA-C 106.979 -1.489 . . . . 71.03 106.979 166.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 5.8 tmtp? -79.92 -142.57 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.414 0 C-N-CA 129.519 3.127 . . . . 72.43 110.742 -49.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 1.24 112.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.592 1 C-N-CA 125.611 4.207 . . . . 65.54 119.424 -133.832 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.701 HG21 HD12 ' A' ' 93' ' ' LEU . 36.8 mm -95.52 102.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 115.312 -0.858 . . . . 75.02 109.634 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -101.6 167.5 10.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.769 0.828 . . . . 65.42 110.714 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.586 ' HB2' HD11 ' A' ' 37' ' ' ILE . 37.8 ttpt -85.95 119.13 25.92 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.41 -0.959 . . . . 73.3 108.41 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -66.7 -11.84 55.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.646 0.98 . . . . 74.34 113.646 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.31 67.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.036 0.534 . . . . 74.45 111.42 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m 76.22 -52.14 0.61 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.97 1.708 . . . . 73.41 113.245 173.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -57.19 116.26 7.69 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 113.914 0.326 . . . . 75.25 113.914 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 mp 65.83 78.84 0.25 Allowed Pre-proline 0 CA--C 1.565 1.55 0 C-N-CA 124.82 1.248 . . . . 75.41 112.261 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -90.81 168.63 3.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.095 2.53 . . . . 71.54 113.282 170.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.75 77.72 0.62 Allowed Glycine 0 CA--C 1.54 1.602 0 CA-C-N 116.599 -0.273 . . . . 70.51 113.023 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -105.74 79.94 0.28 Allowed Glycine 0 C--N 1.351 1.397 0 C-N-CA 122.826 0.251 . . . . 63.42 113.654 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.15 125.82 41.91 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.31 0.644 . . . . 65.25 110.562 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -86.8 147.12 25.96 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.245 0.618 . . . . 74.33 112.452 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.15 146.75 9.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.11 0.964 . . . . 64.33 109.968 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -77.57 90.01 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.198 0.523 . . . . 72.24 110.151 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.604 HD13 ' H ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -101.57 174.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.959 0.904 . . . . 72.35 112.418 -173.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.02 144.62 15.12 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.192 -0.458 . . . . 74.51 112.362 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.3 t -147.4 -72.66 0.21 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.034 0.417 . . . . 44.3 111.451 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.2 p -105.63 175.41 5.51 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.207 0.603 . . . . 70.34 111.674 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.28 -0.32 31.84 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.952 1.093 . . . . 74.23 113.952 -172.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.1 -2.87 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.154 1.168 . . . . 74.3 114.154 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -69.24 -11.68 61.02 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.496 0.718 . . . . 73.5 112.638 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 75.8 m -69.43 139.0 53.99 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.621 0.768 . . . . 55.51 112.491 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.98 145.21 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.209 1.003 . . . . 73.14 110.251 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.05 142.71 57.71 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 122.782 0.433 . . . . 73.34 110.768 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -74.46 121.74 21.93 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.387 0.675 . . . . 61.43 109.922 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -148.66 102.2 3.28 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.304 0.641 . . . . 72.03 109.579 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -74.31 77.14 1.85 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.59 0.756 . . . . 75.22 110.799 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 t60 47.74 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.909 1.683 . . . . 70.11 113.176 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -68.17 131.81 46.07 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.112 0.565 . . . . 62.31 109.756 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.1 m80 69.16 85.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.104 1.361 . . . . 75.34 109.69 -163.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 124.15 0.98 . . . . 75.11 111.457 -175.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 98' ' ' GLN . 14.9 ptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 111.383 0.142 . . . . 71.42 111.383 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.09 149.22 21.9 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.681 0.392 . . . . 72.52 111.143 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -74.03 157.31 36.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.943 0.897 . . . . 74.32 112.453 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 102' ' ' VAL . . . -61.27 -43.68 98.47 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.034 0.534 . . . . 64.54 112.208 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -65.0 -35.09 80.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.229 0.612 . . . . 73.21 112.154 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.284 0.634 . . . . 71.33 111.262 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 20' ' ' ILE . 60.2 mt -68.76 -39.56 80.21 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.541 0.736 . . . . 63.21 111.456 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 31.7 tp -65.12 -29.07 69.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.94 0.896 . . . . 75.23 111.276 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.28 -35.09 71.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.638 0.775 . . . . 75.43 111.525 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.89 -50.09 32.29 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 110.232 -0.285 . . . . 75.13 110.232 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 69.6 mt -55.31 -46.86 76.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.489 1.116 . . . . 73.53 113.65 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -87.76 -4.08 58.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.486 0.921 . . . . 55.42 113.486 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.59 -59.84 2.16 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.383 0.611 . . . . 65.52 110.3 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.26 139.09 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 73.43 110.775 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -64.92 -47.24 78.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.633 0.773 . . . . 74.43 112.408 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.85 148.15 24.74 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -93.33 143.58 26.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.748 0.309 . . . . 71.54 110.721 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.58 3.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.361 0.664 . . . . 61.23 111.485 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -137.11 1.59 2.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.043 0.756 . . . . 71.4 113.043 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.576 HD12 HD22 ' A' ' 7' ' ' LEU . 11.0 mm -108.7 107.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 118.78 0.718 . . . . 74.31 110.483 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -94.2 113.81 25.81 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.46 -0.775 . . . . 75.04 110.881 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.09 129.12 35.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.277 0.631 . . . . 73.14 109.919 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -133.82 164.59 26.91 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.721 0.772 . . . . 74.23 111.892 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -101.42 177.73 4.84 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.662 -1.154 . . . . 75.12 110.945 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.06 62.65 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 73.33 111.467 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 p -65.67 -29.9 70.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 53.2 112.274 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.08 -17.01 62.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.164 0.801 . . . . 70.0 113.164 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.409 ' SD ' HG13 ' A' ' 77' ' ' VAL . 92.0 mmm -55.52 107.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.706 0.802 . . . . 70.13 112.111 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.92 -125.38 2.94 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.279 -0.873 . . . . 40.44 111.158 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 2.9 mptp? -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.294 0.638 . . . . 71.43 112.371 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 m -68.18 -45.32 73.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.48 0.712 . . . . 50.4 111.884 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.47 -52.71 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.822 0.449 . . . . 64.43 110.222 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.575 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 39.8 tpp -52.66 -46.52 67.2 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.283 1.033 . . . . 74.03 113.745 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.54 -27.87 64.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.163 0.585 . . . . 74.0 111.914 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.6 m -69.48 -39.3 77.74 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.133 0.573 . . . . 54.12 111.029 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.39 -35.51 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 123.001 0.521 . . . . 73.31 110.756 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 33' ' ' MET . 47.9 mm -57.56 -39.1 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.629 0.772 . . . . 75.44 110.929 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.98 82.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.77 -0.65 . . . . 74.54 112.035 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.4 -38.87 40.62 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.113 0.565 . . . . 72.4 112.204 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . -63.76 -42.41 97.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.298 0.639 . . . . 65.32 111.939 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -90.61 7.22 40.34 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.203 0.601 . . . . 55.01 112.154 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.51 116.05 65.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.416 -0.587 . . . . 73.35 109.416 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.5 111.19 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.264 2.643 . . . . 74.4 115.412 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 25.39 64.59 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.855 1.502 . . . . 52.04 116.855 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -101.06 23.37 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.816 1.308 . . . . 72.53 111.604 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.8 p-10 -46.64 124.85 6.43 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.314 0.645 . . . . 70.31 111.535 167.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.3 -12.68 7.97 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.949 -0.569 . . . . 54.43 112.176 -165.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.15 104.54 0.17 Allowed Glycine 0 CA--C 1.548 2.114 0 N-CA-C 112.259 -0.336 . . . . 41.12 112.259 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.31 132.53 51.39 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.696 0.798 . . . . 74.03 111.405 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.32 118.84 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.952 0.901 . . . . 62.12 108.634 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.487 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.42 106.74 17.33 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.956 -0.387 . . . . 75.34 109.956 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 4.2 mm? -93.01 133.41 36.18 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.736 0.814 . . . . 52.4 111.535 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 33.85 4.71 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 115.697 -0.683 . . . . 62.03 112.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.19 139.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.199 0.6 . . . . 74.3 109.859 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 19.7 t70 -105.63 159.25 16.11 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.128 -1.434 . . . . 74.14 107.128 171.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -148.02 141.11 24.96 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.283 0.563 . . . . 53.25 111.331 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.5 142.03 46.91 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.703 0.801 . . . . 74.03 110.934 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mm -80.31 123.89 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.728 0.811 . . . . 61.4 110.402 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 63' ' ' ASP . 37.6 p30 -82.53 -175.95 5.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.494 0.318 . . . . 72.43 111.642 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.27 -31.42 69.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.877 0.871 . . . . 71.41 113.267 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -81.04 -31.21 34.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.186 0.594 . . . . 73.14 111.483 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.03 9.94 11.54 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 114.389 0.515 . . . . 75.22 114.389 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 59' ' ' ASN . 27.8 m-20 -85.74 147.66 26.23 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.533 0.733 . . . . 75.32 112.298 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -86.64 109.83 19.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.669 0.787 . . . . 70.13 110.868 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.98 123.56 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.465 0.706 . . . . 71.4 110.144 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.33 114.32 26.36 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.585 0.707 . . . . 73.13 111.651 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -117.05 109.95 42.13 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.146 1.379 . . . . 74.21 110.32 -177.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.83 106.42 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.268 1.979 . . . . 61.43 112.359 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.43 -8.47 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.099 0.559 . . . . 64.44 112.505 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.9 -174.14 53.77 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.687 0.635 . . . . 73.43 114.687 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.92 124.59 27.81 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.778 1.231 . . . . 72.42 109.069 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.17 -39.1 71.86 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.601 2.2 . . . . 74.43 112.867 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.18 77.0 42.47 Favored Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 123.511 0.724 . . . . 62.34 109.605 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 99' ' ' LEU . 71.8 Cg_endo -73.43 -37.8 2.98 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.76 2.306 . . . . 74.11 114.347 -168.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HA ' HD11 ' A' ' 99' ' ' LEU . 20.3 t70 -66.36 -37.77 86.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.724 0.41 . . . . 71.04 109.915 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.28 -39.02 92.01 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 116.087 -0.506 . . . . 54.41 111.798 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 28' ' ' MET . 76.6 t -57.05 -40.72 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.727 0.411 . . . . 73.0 110.612 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -64.35 -43.11 95.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.734 0.814 . . . . 63.31 112.567 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 22.8 mmt180 -69.77 -48.29 59.8 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.711 0.405 . . . . 75.14 111.479 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.53 -33.75 75.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.664 1.186 . . . . 65.55 111.788 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.545 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.5 tp -71.5 -42.99 67.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.58 0.352 . . . . 71.52 111.272 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.46 78.46 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.849 0.46 . . . . 74.21 111.568 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 t -66.22 -52.24 49.8 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.641 0.776 . . . . 64.14 111.156 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 88' ' ' MET . 10.8 pt20 -67.71 -34.63 77.26 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 116.459 -0.337 . . . . 71.4 111.797 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.575 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 69.6 m -65.37 -19.6 66.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.993 -1.067 . . . . 73.42 112.78 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.94 -42.67 11.67 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.524 0.73 . . . . 62.13 112.111 169.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 t -85.06 -21.08 29.52 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.802 1.038 . . . . 62.24 113.802 -170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -90.52 -36.6 14.4 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.473 1.109 . . . . 73.04 110.102 -173.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.485 HD21 ' SD ' ' A' ' 33' ' ' MET . 68.0 mt -95.72 147.28 23.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.421 -1.263 . . . . 64.25 110.281 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.413 HD22 HG13 ' A' ' 91' ' ' VAL . 2.9 p-10 -56.17 -28.35 57.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.943 0.897 . . . . 73.45 112.781 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.7 m -124.28 159.87 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.879 0.872 . . . . 74.35 110.91 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.11 99.4 3.93 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.052 0.541 . . . . 62.21 111.449 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tt -94.38 123.38 37.75 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.733 -1.21 . . . . 73.55 107.733 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -108.43 96.03 17.83 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 123.191 0.597 . . . . 72.53 110.51 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.84 158.05 59.42 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.529 2.153 . . . . 74.41 112.761 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.1 tp10 -85.53 107.35 17.43 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.09 -0.707 . . . . 73.34 109.09 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.554 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.0 mtm -122.24 130.95 53.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.309 0.644 . . . . 62.22 111.321 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 14.1 tm0? -146.04 143.83 29.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.481 0.712 . . . . 64.44 110.904 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 75' ' ' ASP . 94.6 mt -92.04 114.08 26.53 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.327 1.051 . . . . 60.04 112.031 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -102.16 124.86 48.5 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.399 1.08 . . . . 62.13 112.173 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -91.58 104.06 16.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.003 0.43 . . . . 74.32 110.105 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 4' ' ' ALA . 56.3 t -137.31 131.58 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.521 1.129 . . . . 64.12 110.244 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.73 65.36 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 115.456 0.943 . . . . 72.55 115.456 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.52 4.77 90.32 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 117.091 0.445 . . . . 74.02 113.137 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -115.18 165.76 12.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.299 1.04 . . . . 71.31 110.358 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.7 m -120.43 131.22 54.68 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 120.857 0.36 . . . . 65.14 110.585 171.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.39 170.44 10.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.405 1.082 . . . . 64.4 109.474 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 97' ' ' MET . 46.6 tp -120.06 111.31 17.72 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.975 -0.38 . . . . 74.44 109.975 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.565 HG13 HD11 ' A' ' 7' ' ' LEU . 92.6 t -83.95 120.1 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.332 -0.618 . . . . 61.15 109.332 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 97' ' ' MET . 60.8 t -114.04 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.401 0.619 . . . . 63.4 110.948 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.735 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 75.7 t80 -78.12 125.83 29.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.979 0.912 . . . . 71.31 109.591 168.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.68 106.5 33.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.478 -0.934 . . . . 74.21 108.478 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.12 148.63 27.62 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.01 1.806 . . . . 61.42 110.852 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 36.8 tt0 -75.45 133.91 41.0 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.282 -1.007 . . . . 71.51 108.282 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.66 178.8 8.02 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.278 0.631 . . . . 62.21 110.89 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.2 176.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 122.967 0.507 . . . . 64.22 111.214 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.28 -41.92 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 O-C-N 121.004 -1.06 . . . . 73.35 113.349 166.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -69.3 -44.03 72.6 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 118.492 0.587 . . . . 73.55 111.193 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 21.2 m-70 -118.32 90.15 3.27 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 101.751 -3.426 . . . . 33.13 101.751 163.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.751 ' HA ' HG13 ' A' ' 122' ' ' ILE . 91.6 mttt -51.93 -144.49 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.048 2 C-N-CA 133.335 4.654 . . . . 74.43 122.017 45.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo 10.02 70.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 123.448 2.765 . . . . 75.3 116.805 -119.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.751 HG13 ' HA ' ' A' ' 120' ' ' LYS . 57.6 mt -102.32 131.73 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.015 -1.448 . . . . 73.45 109.492 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -155.74 162.56 40.51 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.015 0.926 . . . . 72.43 110.954 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -70.07 144.43 52.15 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.146 -0.934 . . . . 74.22 110.587 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.25 17.32 0.82 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.88 0.696 . . . . 73.34 112.88 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.84 41.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.385 1.074 . . . . 53.03 110.05 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.1 m -64.44 101.84 0.48 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.991 0.917 . . . . 42.11 111.071 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -137.99 163.19 25.63 Favored Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.896 -0.593 . . . . 51.14 112.922 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.03 123.53 1.79 Allowed Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.756 0.823 . . . . 71.5 110.071 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.77 -33.59 32.98 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.195 2.596 . . . . 74.22 113.821 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.01 -112.68 4.88 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 115.475 -0.784 . . . . 54.24 114.048 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.83 101.64 0.16 Allowed Glycine 0 C--N 1.354 1.54 0 N-CA-C 112.088 -0.405 . . . . 74.42 112.088 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.73 -52.1 65.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.024 0.53 . . . . 70.43 111.102 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -103.87 -179.97 4.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.876 0.87 . . . . 64.05 110.629 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -149.3 99.21 2.9 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.881 -0.785 . . . . 64.5 108.881 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.29 152.35 25.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.847 0.859 . . . . 72.41 112.642 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.4 tt -129.44 127.73 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.623 0.769 . . . . 51.13 109.739 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.5 -143.74 14.16 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.492 -0.643 . . . . 62.52 111.492 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 44.8 t -162.14 136.05 6.5 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.353 0.576 . . . . 72.1 111.166 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.4 t -74.09 142.66 45.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.271 0.629 . . . . 50.14 110.381 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.59 156.15 27.82 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.148 0.579 . . . . 65.45 111.517 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.28 147.33 28.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.458 0.703 . . . . 71.2 109.951 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -108.38 115.74 30.66 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.961 -0.385 . . . . 74.24 109.961 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 15.0 p -65.61 124.06 21.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.785 0.434 . . . . 71.01 109.893 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.33 100.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.353 0.597 . . . . 70.33 111.495 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.07 92.6 0.54 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.228 -0.897 . . . . 74.32 110.15 171.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -81.12 162.8 23.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.399 -0.819 . . . . 54.23 111.556 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -115.2 79.66 1.31 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.326 0.584 . . . . 62.34 111.184 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -69.52 138.0 52.96 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 116.138 -0.483 . . . . 73.35 110.67 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -104.19 171.52 7.3 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 73.43 111.872 -172.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -63.0 138.96 58.72 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 115.672 -0.694 . . . . 62.54 111.336 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -84.88 -22.28 29.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.282 0.633 . . . . 73.13 112.181 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.691 . . . . 71.33 111.465 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 19.4 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 119.595 -0.24 . . . . 55.31 110.509 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -40.31 118.86 0.97 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.019 0.928 . . . . 71.52 112.66 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.5 m -58.1 157.63 7.88 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.105 1.362 . . . . 75.12 114.544 -171.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -61.01 -44.95 96.66 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.546 0.738 . . . . 51.22 111.817 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.42 HG23 HG13 ' A' ' 102' ' ' VAL . 2.6 m -62.88 -35.55 80.37 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-N 114.711 -1.131 . . . . 75.21 110.601 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.22 -48.23 71.27 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.025 0.93 . . . . 74.53 111.753 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 20' ' ' ILE . 35.6 mt -65.01 -36.51 84.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.624 0.37 . . . . 74.4 111.039 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.265 0.626 . . . . 65.23 110.795 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.91 -33.92 76.95 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.504 0.722 . . . . 71.13 111.277 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' HG2' HD12 ' A' ' 20' ' ' ILE . 8.8 tp10 -67.11 -41.94 85.36 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.44 0.696 . . . . 71.13 110.504 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 72.9 mt -64.47 -34.69 78.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.894 0.878 . . . . 75.43 111.363 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -80.35 -20.86 43.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.56 0.744 . . . . 74.23 112.253 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.78 -55.26 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.247 0.619 . . . . 63.21 110.46 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.4 141.73 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.059 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.54 -45.99 64.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.826 -0.546 . . . . 74.21 111.184 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.62 128.0 56.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.033 0.933 . . . . 73.41 109.896 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 m -36.13 108.64 0.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.411 1.484 . . . . 74.02 114.085 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.46 -7.93 59.46 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.159 0.8 . . . . 63.54 113.159 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -165.9 -34.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.011 0.524 . . . . 71.45 111.35 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 7' ' ' LEU . 55.5 mt -97.15 105.4 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.935 -0.765 . . . . 52.34 108.935 -167.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.03 113.15 24.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.083 -1.08 . . . . 61.25 108.083 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.81 145.83 40.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.808 0.843 . . . . 72.0 110.41 -171.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 160.96 42.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.798 0.808 . . . . 73.3 113.124 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -75.77 166.21 23.87 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 114.194 -1.366 . . . . 71.54 111.717 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.47 -33.3 43.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.224 1.01 . . . . 75.41 113.604 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.6 m -66.68 -30.48 70.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.936 0.894 . . . . 65.12 113.126 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.78 -6.23 58.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.888 0.699 . . . . 72.55 112.888 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mmm -52.79 108.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.14 0.576 . . . . 75.31 112.142 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 151.66 -123.62 1.53 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.51 -0.768 . . . . 73.53 112.417 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -57.58 -55.33 36.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.991 1.108 . . . . 75.32 113.991 -168.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -60.61 -40.47 91.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.149 0.579 . . . . 72.55 112.462 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.39 -42.22 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.045 0.538 . . . . 62.42 111.417 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 54.6 mmm -78.63 -33.83 46.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.112 -0.495 . . . . 74.54 111.713 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.002 0.921 . . . . 73.32 111.387 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' HD21 ' A' ' 50' ' ' LEU . 43.7 m -72.97 -36.45 67.11 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.692 0.797 . . . . 55.41 111.699 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.96 -37.58 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.331 0.652 . . . . 70.02 111.184 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 122' ' ' ILE . 84.7 mt -57.2 -41.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.83 0.852 . . . . 54.12 111.383 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -64.74 -48.55 74.17 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.451 0.7 . . . . 41.41 112.033 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -67.05 -37.59 84.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.187 0.595 . . . . 62.25 111.868 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.77 77.81 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.117 0.567 . . . . 71.14 111.553 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -71.59 -41.76 68.58 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.827 0.851 . . . . 72.21 111.716 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 13.6 mm-40 -72.91 128.7 87.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 123.157 0.583 . . . . 54.31 112.148 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -87.73 118.98 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.11 2.54 . . . . 75.22 112.929 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.09 14.99 58.31 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 115.066 0.786 . . . . 72.01 115.066 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.27 23.55 13.54 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 118.774 1.287 . . . . 74.31 110.966 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -40.37 132.81 1.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.827 0.851 . . . . 54.13 112.613 165.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.46 ' H ' ' HE1' ' A' ' 111' ' ' TYR . . . 119.25 -0.35 14.44 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.447 -0.661 . . . . 52.02 111.447 -161.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.74 100.25 0.11 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.052 0.834 . . . . 40.25 113.835 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -116.88 144.71 44.2 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.54 0.686 . . . . 74.22 112.532 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.7 mp -119.25 131.3 55.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.926 1.291 . . . . 63.1 108.167 165.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 7' ' ' LEU . 29.7 tp -110.9 111.99 23.51 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.027 0.442 . . . . 72.34 110.878 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 3.9 mm? -89.12 133.43 34.39 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.927 0.891 . . . . 73.23 111.416 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 34.11 5.37 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.9 -0.591 . . . . 51.25 112.609 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.1 137.21 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.29 0.636 . . . . 71.03 110.47 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -130.03 130.65 45.23 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.503 -0.925 . . . . 73.55 108.503 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -116.77 138.27 51.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.538 0.735 . . . . 73.01 110.892 -174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.37 141.84 47.0 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.358 0.663 . . . . 73.42 110.891 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.52 133.8 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.994 0.918 . . . . 71.5 111.072 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -87.15 -173.73 4.56 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.019 0.527 . . . . 75.13 111.889 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.99 -25.58 67.92 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 113.45 0.907 . . . . 72.42 113.45 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -82.64 -30.43 29.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.212 0.46 . . . . 64.04 110.942 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.36 11.98 8.46 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 114.675 0.63 . . . . 55.14 114.675 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.85 117.69 19.45 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.342 0.657 . . . . 70.5 111.654 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -79.62 107.97 12.8 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.555 0.742 . . . . 74.42 109.852 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.21 123.59 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.491 0.716 . . . . 72.12 110.301 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.1 124.15 37.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.984 0.914 . . . . 74.32 110.517 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -121.93 149.26 53.35 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 124.227 1.011 . . . . 74.31 111.755 -172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.01 102.81 1.4 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.504 2.136 . . . . 74.12 112.748 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.24 -24.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.816 -0.629 . . . . 74.51 110.901 170.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.23 -169.23 54.87 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.716 -0.674 . . . . 40.52 114.216 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.0 mt -115.53 124.38 30.1 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.074 0.95 . . . . 75.55 109.464 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.83 -27.53 80.54 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.787 2.324 . . . . 75.43 113.125 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.1 p-10 -131.45 63.05 68.28 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 123.834 0.854 . . . . 72.34 111.501 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.84 -31.14 32.35 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.699 2.266 . . . . 65.42 113.345 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.38 -37.27 85.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.249 1.019 . . . . 75.44 111.157 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 8.4 mtpm? -72.31 -54.77 8.54 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.82 -0.627 . . . . 73.51 110.723 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 73' ' ' ASP . 87.4 t -52.24 -38.13 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.395 1.078 . . . . 73.21 112.838 -167.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 53.1 tt0 -62.41 -47.26 84.88 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.472 0.709 . . . . 73.33 111.961 174.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.02 -48.28 53.97 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.964 0.905 . . . . 62.03 112.529 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.34 -37.08 66.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.527 1.131 . . . . 73.12 111.461 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.9 -41.83 86.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.398 0.679 . . . . 63.01 111.553 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.08 75.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.185 0.594 . . . . 63.03 112.122 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.4 t -69.92 -52.92 20.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.433 0.693 . . . . 75.23 111.447 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.63 -27.98 69.3 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.937 0.495 . . . . 63.31 111.553 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 93' ' ' LEU . 17.2 t -61.04 -30.1 70.12 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.322 0.649 . . . . 62.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.21 -25.56 29.39 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 113.259 0.837 . . . . 74.05 113.259 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -98.68 -33.91 10.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.627 0.973 . . . . 75.1 113.627 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.0 mmm -88.12 -35.79 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.945 0.898 . . . . 75.43 111.781 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -95.76 148.72 22.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.316 0.647 . . . . 75.53 111.048 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -42.18 -51.19 4.75 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 125.292 1.437 . . . . 53.34 112.766 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 HD12 ' A' ' 122' ' ' ILE . 32.8 m -111.0 156.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.019 -0.537 . . . . 44.4 110.613 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.82 117.57 14.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.02 -0.536 . . . . 52.33 109.611 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.657 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.9 mt -111.0 142.66 42.84 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.581 0.753 . . . . 62.53 110.895 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.1 82.25 11.08 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.031 0.932 . . . . 74.22 108.825 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.22 161.54 42.49 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.423 2.082 . . . . 72.42 113.28 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.0 tp10 -77.31 127.91 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.416 -0.811 . . . . 65.21 109.031 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 65.7 mtt -136.14 140.25 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.075 0.55 . . . . 71.34 111.407 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -144.65 151.9 39.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.522 0.729 . . . . 73.23 110.786 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.8 mt -115.13 132.75 56.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.777 0.831 . . . . 73.53 110.695 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 46.8 mt-10 -137.31 149.52 47.12 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.394 0.678 . . . . 54.34 111.102 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -94.97 124.91 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.172 -0.677 . . . . 73.53 109.172 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG13 HG23 ' A' ' 5' ' ' THR . 21.4 t -121.34 114.37 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 107.581 -1.266 . . . . 72.23 107.581 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.36 26.63 51.56 Favored Glycine 0 CA--C 1.548 2.108 0 N-CA-C 114.614 0.606 . . . . 75.15 114.614 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.94 60.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 114.681 0.632 . . . . 70.0 114.681 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -119.74 129.58 54.57 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.748 0.774 . . . . 74.32 109.73 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 m -85.27 104.35 15.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.746 0.703 . . . . 63.24 112.37 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.6 mp -86.98 160.53 18.62 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.298 1.039 . . . . 63.51 111.456 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 62.0 tp -114.96 131.32 56.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.474 0.71 . . . . 75.25 110.303 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 4' ' ' ALA . 2.5 t -98.58 122.41 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.464 1.105 . . . . 72.54 108.719 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.92 110.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 118.084 0.402 . . . . 72.22 110.927 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 60.2 t80 -94.54 132.43 39.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.222 -0.659 . . . . 75.34 109.222 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.51 105.12 23.8 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.487 -0.931 . . . . 75.23 108.487 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.78 122.3 9.88 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.033 1.822 . . . . 62.32 109.27 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -64.76 134.61 54.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.445 0.698 . . . . 73.31 111.102 -168.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.86 129.63 40.3 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.226 0.61 . . . . 71.43 112.38 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.59 ' HB3' HG22 ' A' ' 118' ' ' THR . 36.2 t70 -86.85 168.84 13.07 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.072 0.949 . . . . 73.11 110.314 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 120' ' ' LYS . 22.8 t -56.44 -22.19 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 124.401 1.081 . . . . 74.33 112.507 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.59 HG22 ' HB3' ' A' ' 116' ' ' ASP . 9.2 t -55.87 -23.86 33.52 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.745 0.818 . . . . 74.23 111.723 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 56.1 m-70 -87.24 -89.28 0.13 Allowed 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 106.206 -1.775 . . . . 73.5 106.206 166.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 29.0 mmmt -59.46 -148.62 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.164 0 CA-C-N 124.838 3.472 . . . . 74.53 113.035 -49.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -0.68 120.94 0.0 OUTLIER 'Trans proline' 1 C--N 1.416 4.093 1 C-N-CA 126.182 4.588 . . . . 72.45 119.917 -139.132 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.527 HD12 HG22 ' A' ' 91' ' ' VAL . 41.1 mm -96.62 91.91 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.299 -0.864 . . . . 73.1 108.86 171.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -81.82 162.22 22.93 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.726 0.298 . . . . 65.11 111.33 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -78.99 131.94 36.48 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.384 -0.969 . . . . 70.13 108.384 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.44 74.54 0.54 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.934 0.894 . . . . 75.23 111.555 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 168.8 -171.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.227 1.811 . . . . 43.33 109.67 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -80.44 -176.77 5.87 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.113 0.565 . . . . 72.33 110.51 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.66 -87.67 1.39 Allowed Glycine 0 N--CA 1.47 0.948 0 CA-C-O 119.718 -0.49 . . . . 50.54 112.085 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 tt 67.59 114.71 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.775 0 C-N-CA 125.003 1.321 . . . . 52.43 111.167 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.81 176.85 9.29 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.852 2.368 . . . . 53.44 114.437 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.97 178.19 45.08 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 115.518 -0.764 . . . . 70.34 112.654 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 122.18 175.72 14.89 Favored Glycine 0 N--CA 1.48 1.618 0 CA-C-N 116.807 0.303 . . . . 65.24 113.291 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -156.47 112.97 3.07 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.456 0.702 . . . . 63.23 110.999 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -80.96 141.46 34.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.517 0.727 . . . . 73.3 109.75 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 80.72 4.0 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.372 0.606 . . . . 71.25 109.845 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -53.15 131.4 36.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.032 1.333 . . . . 74.52 112.986 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 pt -102.36 146.46 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.411 0.685 . . . . 74.13 111.271 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.4 125.22 7.28 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 116.09 -0.505 . . . . 63.1 112.854 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -120.09 136.19 54.68 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.619 0.768 . . . . 74.15 110.854 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.2 p -164.43 173.78 11.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.468 0.707 . . . . 61.15 111.576 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -127.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.59 0.756 . . . . 70.24 111.352 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.9 38.45 1.2 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.432 0.693 . . . . 73.25 110.912 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -54.02 131.23 40.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.573 0.749 . . . . 63.14 112.758 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 30.3 p -109.26 -177.29 3.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.996 0.918 . . . . 64.51 111.648 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.93 129.55 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.179 0.592 . . . . 73.34 111.184 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -119.03 166.73 12.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.932 0.893 . . . . 71.12 110.171 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -150.44 124.66 9.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.663 0.268 . . . . 71.1 110.578 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -110.77 97.87 7.17 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.286 1.034 . . . . 75.22 109.892 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -95.4 143.62 26.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.304 0.573 . . . . 73.03 112.47 -176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -104.4 124.68 49.65 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.496 1.118 . . . . 74.55 111.034 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -134.78 160.15 39.11 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.831 0.853 . . . . 73.25 110.656 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 m80 63.48 87.61 0.11 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.5 1.12 . . . . 75.14 112.599 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.5 t60 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 63.21 110.24 179.281 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 51.1 ttm . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 111.508 0.188 . . . . 73.43 111.508 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 1' ' ' MET . 91.5 mtt180 -86.89 -169.48 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.512 0.725 . . . . 70.34 110.431 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -82.95 150.49 26.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 122.047 -0.408 . . . . 73.12 109.908 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.53 70.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.344 0.498 . . . . 75.04 112.344 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.6 p -62.38 -47.72 82.91 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.606 0.762 . . . . 74.24 111.172 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.14 -42.18 98.07 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 121.716 0.769 . . . . 75.31 111.07 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.19 -39.79 93.33 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.651 -1.159 . . . . 53.11 111.628 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.64 -34.57 78.13 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.41 -0.813 . . . . 51.4 111.124 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.23 -41.65 85.35 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.062 0.545 . . . . 74.14 111.414 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.36 -39.69 94.39 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 122.517 0.327 . . . . 54.31 110.642 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.46 -50.96 69.38 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.157 0.983 . . . . 73.03 112.739 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.01 -12.53 61.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.016 0.747 . . . . 74.21 113.016 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.13 -42.76 30.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.489 0.716 . . . . 73.13 111.021 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -98.01 161.17 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.025 0.917 . . . . 63.11 112.602 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -106.52 0.85 24.97 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.88 -1.055 . . . . 71.15 110.788 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.39 130.18 22.96 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.202 1.001 . . . . 71.01 110.113 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m -80.29 85.91 5.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.1 0.56 . . . . 75.41 110.775 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.24 -63.95 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.343 1.057 . . . . 63.44 112.731 -174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtp-105 -102.09 -5.12 24.87 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.645 0.778 . . . . 75.31 111.478 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.9 mm -104.53 167.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.62 115.02 3.89 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.293 -1.002 . . . . 70.34 108.293 167.216 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.42 32.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.17 0.588 . . . . 63.21 111.442 -171.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -152.46 158.21 42.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.041 0.924 . . . . 61.05 112.774 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -77.06 163.77 26.34 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 113.806 -1.543 . . . . 73.53 111.331 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.64 74.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.495 0.554 . . . . 73.22 112.495 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -76.66 -13.75 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.374 0.67 . . . . 71.21 112.559 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 18.8 t70 -85.24 -5.69 59.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.234 0.613 . . . . 64.13 111.957 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.595 ' SD ' HG13 ' A' ' 77' ' ' VAL . 82.8 mtp -57.08 113.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.01 112.0 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.4 -155.23 10.52 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.225 -0.443 . . . . 55.25 113.531 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -73.9 -25.32 59.95 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.383 1.073 . . . . 72.44 111.442 -174.618 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.4 p -65.17 -48.1 74.66 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.078 0.951 . . . . 74.24 111.699 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HE3' ' A' ' 23' ' ' LYS . 60.0 t -58.2 -40.58 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.845 0.858 . . . . 75.04 110.819 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.425 ' SD ' HD21 ' A' ' 89' ' ' LEU . 40.1 tpp -71.46 -32.56 68.45 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.92 -1.036 . . . . 65.53 112.253 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 130' ' ' PRO . 7.3 tp10 -66.93 -37.73 84.86 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.535 0.734 . . . . 72.12 111.285 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.558 HG21 ' HG3' ' A' ' 21' ' ' GLU . 17.8 m -69.8 -32.43 70.89 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 72.31 112.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.39 -37.14 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.023 0.929 . . . . 74.53 112.075 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.16 -41.06 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.028 0.931 . . . . 64.41 111.911 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.92 68.03 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.901 0.881 . . . . 72.24 112.217 -171.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -61.46 -22.23 64.87 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.806 0.842 . . . . 74.11 112.999 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.99 -26.49 59.61 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.238 0.615 . . . . 65.42 112.055 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -117.65 5.38 12.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.945 1.091 . . . . 74.22 113.945 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -58.58 117.15 18.36 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 118.748 0.704 . . . . 65.0 112.507 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.3 102.07 0.18 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.293 2.662 . . . . 70.21 113.802 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.5 9.93 59.34 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.134 1.214 . . . . 54.32 116.134 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.0 tp -115.62 -64.6 1.29 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.383 1.092 . . . . 71.33 110.965 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 37.71 -157.47 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 125.931 1.692 . . . . 74.11 114.919 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.81 58.71 7.92 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.69 -0.232 . . . . 54.23 113.501 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.21 157.39 17.8 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 112.375 -0.29 . . . . 23.31 112.375 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 90.5 m-85 -124.36 126.13 45.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.824 0.45 . . . . 74.45 111.064 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -98.92 118.17 35.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.596 -0.89 . . . . 72.43 108.596 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.42 109.01 21.15 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.719 -0.474 . . . . 75.34 109.719 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.4 128.5 46.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.254 1.022 . . . . 60.42 109.777 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.9 28.27 7.89 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 115.959 -0.564 . . . . 64.33 112.401 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.1 t -113.27 145.65 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.726 0.81 . . . . 60.13 110.699 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -121.89 151.62 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.451 1.1 . . . . 74.42 108.375 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.6 p90 -126.39 125.76 42.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.261 0.624 . . . . 75.23 109.611 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.22 140.51 51.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.655 0.782 . . . . 63.14 111.144 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.49 129.6 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.553 0.741 . . . . 63.35 111.087 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 87.3 m-20 -78.97 176.56 9.53 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.706 0.802 . . . . 65.21 112.407 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.5 -31.08 69.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.021 0.528 . . . . 74.05 111.789 170.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.73 -17.69 40.4 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.557 0.743 . . . . 70.25 111.089 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.26 34.72 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 114.818 0.687 . . . . 23.52 114.818 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.9 m-20 -79.81 147.35 31.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 117.604 0.702 . . . . 75.1 111.878 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 117.16 29.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.315 0.646 . . . . 63.54 110.528 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 59.8 t -110.86 122.26 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.725 0.81 . . . . 64.53 110.532 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -92.47 124.85 36.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.357 0.663 . . . . 71.41 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -132.35 141.0 39.7 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.995 0.918 . . . . 50.01 111.011 -171.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.35 76.92 4.28 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.916 2.41 . . . . 71.33 113.138 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.61 -18.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 115.923 -0.58 . . . . 71.11 112.399 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.81 49.35 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.427 0.531 . . . . 70.04 114.427 168.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 77' ' ' VAL . 83.0 mt -97.71 132.02 25.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.425 1.09 . . . . 71.55 110.189 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.0 -36.14 23.38 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.074 1.849 . . . . 75.13 111.535 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -123.13 81.3 51.6 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 123.754 0.822 . . . . 71.22 109.876 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.89 -57.23 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.416 2.744 . . . . 70.41 114.57 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.7 -42.53 95.23 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.96 0.504 . . . . 64.24 111.224 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -59.26 -40.88 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.428 0.455 . . . . 73.43 111.656 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 28' ' ' MET . 46.7 t -60.98 -43.29 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.23 0.612 . . . . 71.22 111.549 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.45 -42.58 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.274 0.472 . . . . 73.3 112.274 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -75.85 -42.57 49.1 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 112.69 0.626 . . . . 64.43 112.69 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 -37.36 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.594 0.757 . . . . 65.54 111.709 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.31 -40.2 74.34 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.559 0.344 . . . . 72.11 110.955 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.09 73.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.483 0.713 . . . . 75.04 112.294 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 t -73.75 -53.23 10.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.255 0.622 . . . . 64.54 111.611 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.44 -31.56 72.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 112.722 0.638 . . . . 75.53 112.722 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.8 p -67.22 -29.72 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.512 0.325 . . . . 74.33 111.711 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.71 -25.66 59.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.277 0.631 . . . . 61.41 111.999 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.9 m -90.58 -44.85 9.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.364 0.666 . . . . 53.53 112.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.93 -34.73 19.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.544 0.737 . . . . 73.12 112.727 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD21 ' SD ' ' A' ' 33' ' ' MET . 70.7 mt -88.96 142.7 27.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 122.162 -0.336 . . . . 42.55 110.769 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -36.1 -58.96 0.64 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.88 1.672 . . . . 70.21 113.583 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 119' ' ' HIS . 13.9 m -102.31 168.75 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.334 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.87 1.47 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.609 -0.885 . . . . 71.42 108.609 168.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 122' ' ' ILE . 1.5 tt -102.17 106.67 17.56 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.799 -0.815 . . . . 73.35 108.799 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -96.2 103.71 14.67 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 108.798 -0.815 . . . . 65.23 108.798 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -68.45 172.95 10.47 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 121.531 1.487 . . . . 75.54 111.492 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 86.1 tt0 -86.86 107.49 18.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.732 -1.581 . . . . 74.12 106.732 172.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.612 ' HB3' HD11 ' A' ' 108' ' ' LEU . 76.8 mtm -119.29 117.33 28.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.771 0.428 . . . . 71.32 111.234 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -120.17 131.82 55.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.878 0.871 . . . . 74.53 110.805 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.26 112.02 20.99 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.683 0.793 . . . . 74.01 109.446 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.38 128.64 55.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.494 1.118 . . . . 74.43 111.427 -167.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.66 110.22 22.34 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.879 0.472 . . . . 53.54 110.813 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.7 116.29 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.828 1.251 . . . . 63.11 108.42 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.89 30.19 62.89 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 114.768 0.667 . . . . 70.42 114.768 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.95 89.32 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 114.254 0.462 . . . . 54.21 114.254 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -102.8 129.76 49.57 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.708 0.803 . . . . 72.53 109.709 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.7 m -94.34 126.73 39.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.891 0.769 . . . . 74.13 110.76 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.57 170.47 9.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.393 1.077 . . . . 72.35 109.259 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.9 tp -115.95 118.9 34.23 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.089 -0.338 . . . . 72.33 110.089 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.18 124.71 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.009 -0.737 . . . . 53.51 109.009 169.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 42.8 t -109.76 99.86 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.186 0.517 . . . . 75.35 109.67 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 25.9 t80 -85.5 119.75 26.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.571 . . . . 74.35 109.88 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.21 95.32 45.87 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 108.357 -0.979 . . . . 73.43 108.357 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.51 -177.33 3.56 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.294 1.996 . . . . 71.31 111.766 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.15 137.82 33.91 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.098 -0.705 . . . . 73.24 109.098 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.87 179.92 4.64 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.829 0.852 . . . . 53.33 111.257 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.69 135.95 43.72 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-O 118.314 -0.85 . . . . 75.4 108.95 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.9 t -46.88 -26.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.402 1.63 . . . . 75.23 115.402 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -66.43 -49.47 66.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.685 -0.634 . . . . 55.43 111.039 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 1.6 m-70 -128.43 68.76 1.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.925 -2.621 . . . . 65.55 103.925 168.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 57.3 mtpt -46.82 -153.03 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.428 1 C-N-CA 133.332 4.653 . . . . 74.52 121.155 55.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo 4.77 67.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 123.277 2.652 . . . . 64.15 117.142 -124.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.608 HG21 HD12 ' A' ' 93' ' ' LEU . 53.0 mt -98.35 127.9 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.981 -1.009 . . . . 71.22 109.258 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.49 146.43 38.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 60.41 109.498 -175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -78.36 124.19 27.83 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.533 -0.914 . . . . 73.12 108.533 173.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.65 -68.57 0.29 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.937 1.295 . . . . 71.51 113.924 -163.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.01 111.79 7.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.68 0.392 . . . . 73.12 110.687 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p 64.09 174.96 0.18 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.952 1.701 . . . . 74.43 112.44 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -155.11 -146.19 4.37 Favored Glycine 0 N--CA 1.477 1.369 0 O-C-N 121.863 -0.523 . . . . 65.45 113.922 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.6 tp 65.0 90.16 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 125.14 1.376 . . . . 71.15 111.406 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HA ' ' HG3' ' A' ' 34' ' ' GLU . 63.2 Cg_endo -86.92 167.97 8.12 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.763 2.309 . . . . 60.55 113.741 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.89 109.74 3.47 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.744 -0.662 . . . . 75.34 111.517 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.02 136.78 6.14 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-N 117.055 0.428 . . . . 72.54 113.246 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.07 4.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.544 0.738 . . . . 65.23 110.405 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -70.72 80.91 0.61 Allowed 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 122.103 0.954 . . . . 64.42 111.609 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -108.53 139.43 43.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.988 0.915 . . . . 63.43 110.749 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -134.12 137.84 44.83 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.686 0.795 . . . . 74.5 110.328 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -151.7 115.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 C-N-CA 123.456 0.702 . . . . 54.21 110.497 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.16 116.41 5.15 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.894 -0.594 . . . . 55.41 112.001 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.0 m -78.53 -64.41 1.18 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.089 0.556 . . . . 74.42 110.721 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -165.16 152.5 10.93 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.614 0.766 . . . . 72.12 111.196 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -102.92 119.62 39.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.985 0.914 . . . . 71.55 109.93 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.26 109.74 18.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.24 0.616 . . . . 71.04 110.831 -173.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -122.03 157.64 30.92 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.89 0.876 . . . . 72.22 110.413 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.3 t -159.62 117.7 2.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.369 0.667 . . . . 62.11 111.034 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.78 144.81 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 62.44 110.538 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -123.53 133.72 53.96 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.695 0.798 . . . . 74.21 110.333 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.86 146.56 24.88 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.104 0.478 . . . . 75.33 111.547 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -80.75 145.06 31.7 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.585 0.754 . . . . 74.34 110.943 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -82.22 107.8 15.18 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.186 -0.672 . . . . 71.23 109.186 167.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -66.76 123.35 19.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.805 0.442 . . . . 64.14 110.578 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -54.41 98.28 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.687 0.795 . . . . 70.34 112.329 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -79.45 124.35 28.38 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 108.609 -0.885 . . . . 75.11 108.609 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 . . . . . 0 N--CA 1.496 1.874 0 C-N-CA 125.056 1.342 . . . . 74.25 110.771 -168.129 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.179 -1.045 . . . . 55.21 108.179 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' O ' HG11 ' A' ' 109' ' ' VAL . 26.6 mmm180 -82.98 159.61 22.19 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.336 0.655 . . . . 75.41 112.183 -171.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m -81.43 156.5 25.35 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.817 0.673 . . . . 42.22 112.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.88 94.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.782 0.833 . . . . 45.51 112.078 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -62.09 -46.87 87.15 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.576 -0.738 . . . . 75.33 110.639 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.21 -47.2 87.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.918 -1.037 . . . . 72.21 111.911 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.35 -36.79 85.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.172 0.589 . . . . 71.34 111.755 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 28.1 tp -65.05 -48.49 73.63 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.017 0.527 . . . . 74.34 111.212 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -63.7 -35.69 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.091 0.556 . . . . 62.52 111.846 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -63.32 -45.87 89.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.487 0.715 . . . . 75.22 111.229 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 22' ' ' ALA . 41.8 mt -59.8 -39.63 85.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.955 0.902 . . . . 75.33 111.069 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.26 -34.45 78.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.809 0.844 . . . . 73.21 112.133 174.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.46 -41.91 72.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.629 0.771 . . . . 73.32 112.187 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -114.84 118.35 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-O 121.653 0.74 . . . . 75.24 112.37 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.64 -9.9 16.09 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.73 1.212 . . . . 73.24 113.574 172.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.32 117.07 23.68 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.7 -0.625 . . . . 74.5 110.36 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.9 p -78.17 91.72 4.37 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.631 0.773 . . . . 70.31 111.493 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.67 -59.52 5.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.633 0.773 . . . . 73.33 111.732 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.6 HH21 ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.42 26.04 1.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.043 0.537 . . . . 70.13 111.693 170.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.24 109.61 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.407 -0.96 . . . . 60.04 108.407 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.07 130.07 49.22 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 120.93 0.395 . . . . 70.12 111.129 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -84.69 143.3 29.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.595 0.758 . . . . 51.43 111.773 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 74.5 mmtt -129.26 145.76 51.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.965 0.906 . . . . 74.44 109.565 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.95 161.49 24.29 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.239 0.616 . . . . 75.33 111.084 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 -36.95 85.55 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.091 0.556 . . . . 65.41 111.703 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 -18.99 61.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.605 0.762 . . . . 71.11 112.584 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.82 -7.12 57.56 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.38 0.672 . . . . 73.43 112.712 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.541 ' SD ' HG13 ' A' ' 77' ' ' VAL . 34.3 mtp -55.9 124.27 17.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.446 0.906 . . . . 51.05 113.446 -176.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.23 -144.91 15.16 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.366 -0.833 . . . . 75.32 111.758 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -59.57 -26.85 65.74 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.137 0.975 . . . . 71.32 113.544 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.0 m -73.52 -27.23 61.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.303 0.641 . . . . 71.23 112.26 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 46.3 t -74.66 -48.94 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 121.244 0.545 . . . . 73.34 110.436 166.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.73 -34.45 67.52 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.322 1.23 . . . . 75.51 114.322 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.63 -41.76 82.01 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.14 0.576 . . . . 73.35 111.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -78.14 -27.67 48.24 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.289 0.636 . . . . 75.32 111.712 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.64 -45.54 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.626 0.77 . . . . 54.53 110.604 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -51.85 -44.02 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.778 1.231 . . . . 64.31 112.111 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.54 89.47 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.341 0.656 . . . . 43.33 112.75 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.63 -35.64 70.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.904 0.705 . . . . 64.5 112.904 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.2 55.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.163 0.585 . . . . 75.11 112.444 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -103.99 -48.33 3.93 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.733 1.012 . . . . 65.01 113.733 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.1 121.09 76.72 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.39 111.73 0.91 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.294 2.662 . . . . 75.31 113.626 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.89 -11.16 29.68 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.34 -0.845 . . . . 70.11 114.633 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HG ' HH21 ' A' ' 19' ' ' ARG . 6.5 mp -94.64 -1.18 53.65 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.574 1.687 . . . . 75.0 110.991 173.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.74 ' HB3' ' HB3' ' A' ' 114' ' ' GLU . 10.0 m-20 -34.53 102.31 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.527 1.931 . . . . 55.5 114.371 174.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.95 0.82 Allowed Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.87 -0.605 . . . . 40.33 112.866 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.94 172.52 47.96 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 113.981 0.352 . . . . 65.54 113.981 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.38 147.16 52.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.765 0.826 . . . . 63.34 112.635 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.1 mt -129.4 124.7 34.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 74.4 108.552 172.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.59 109.21 20.8 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 122.111 -0.368 . . . . 74.04 110.138 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 108' ' ' LEU . 56.6 mt -88.96 129.44 35.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.151 0.58 . . . . 64.41 110.964 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.48 30.36 5.0 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.195 -0.457 . . . . 54.2 112.482 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 48.3 t -116.3 139.52 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.374 0.67 . . . . 65.25 110.631 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.66 131.71 31.88 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.302 -1.369 . . . . 75.55 107.302 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -115.68 140.62 49.02 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.128 0.49 . . . . 75.12 112.282 -171.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.48 141.63 48.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 75.11 110.404 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.8 mt -101.91 133.67 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.595 0.758 . . . . 72.23 111.422 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -74.81 169.37 18.03 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.186 0.994 . . . . 61.22 111.882 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.91 -33.98 75.23 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.393 0.677 . . . . 75.15 111.231 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -71.03 -27.64 63.82 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.483 0.713 . . . . 53.02 111.683 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.47 41.14 2.24 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 116.302 -0.408 . . . . 72.41 113.08 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -100.29 121.63 41.79 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.325 0.65 . . . . 71.21 109.876 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -84.7 108.48 17.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.139 0.575 . . . . 73.53 110.574 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -100.43 112.61 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.492 1.117 . . . . 74.12 109.76 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -89.22 115.0 26.39 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.583 -0.525 . . . . 75.12 109.583 -175.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -115.85 134.49 22.71 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.783 0.833 . . . . 72.02 111.19 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 88.3 Cg_endo -75.8 86.86 1.45 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.779 2.319 . . . . 75.12 112.634 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.33 -26.21 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.997 -0.547 . . . . 61.52 111.422 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 82.54 -176.16 53.52 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.115 0.806 . . . . 73.31 115.115 172.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -113.91 116.2 45.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.404 1.082 . . . . 75.52 109.988 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.56 -33.33 96.36 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.711 2.274 . . . . 75.04 112.665 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.57 75.82 78.37 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.852 0.861 . . . . 71.2 109.137 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.84 -39.46 61.9 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.064 2.509 . . . . 73.53 114.522 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.6 p-10 -72.99 -40.4 65.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.512 0.725 . . . . 74.35 111.102 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.31 -37.92 89.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.965 0.506 . . . . 53.5 111.328 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.541 HG13 ' SD ' ' A' ' 28' ' ' MET . 42.5 t -58.93 -47.55 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.045 0.938 . . . . 74.2 111.071 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.549 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 51.9 tt0 -59.84 -45.59 91.93 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.854 0.862 . . . . 61.34 112.199 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 20.8 mmm-85 -74.86 -40.04 61.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.72 -0.673 . . . . 70.12 112.085 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.39 -44.49 92.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.916 0.886 . . . . 71.04 110.778 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 52' ' ' LEU . 22.8 tp -66.76 -40.46 88.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.423 -0.808 . . . . 73.22 111.795 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.91 82.51 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.183 0.593 . . . . 61.44 112.176 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -66.99 -52.0 48.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.386 0.674 . . . . 71.44 111.5 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' A' ' 81' ' ' LEU . 29.7 pt20 -67.74 -28.48 67.67 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.508 0.558 . . . . 71.34 112.508 176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.2 -33.23 69.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.187 0.439 . . . . 63.12 112.187 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.17 -38.05 13.76 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.559 0.743 . . . . 61.21 112.183 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.3 m -74.29 -33.21 63.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.51 0.929 . . . . 71.02 113.51 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.8 mmm -88.33 -55.48 3.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.152 0.581 . . . . 53.25 111.203 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.34 148.65 43.27 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.312 0.645 . . . . 73.21 112.573 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.494 ' HB3' HG23 ' A' ' 122' ' ' ILE . 41.7 t30 -41.98 -63.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.019 1.727 . . . . 64.02 112.85 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.08 167.68 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.744 -0.662 . . . . 73.44 110.861 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.7 97.48 2.19 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.136 0.493 . . . . 72.41 110.323 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.79 123.68 35.35 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.529 -0.915 . . . . 74.54 108.529 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -104.52 106.04 52.63 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 122.934 0.494 . . . . 72.34 110.941 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -87.99 170.56 6.06 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.403 2.069 . . . . 74.3 112.928 166.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.0 tp10 -104.06 136.87 42.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.829 0.852 . . . . 70.34 109.324 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 108' ' ' LEU . 66.1 mtt -134.53 122.11 21.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.155 0.582 . . . . 74.43 110.917 -172.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -124.93 134.42 52.66 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.306 0.642 . . . . 73.32 112.135 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.17 123.19 45.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.813 0.845 . . . . 73.25 111.701 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -142.24 147.05 35.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.24 1.016 . . . . 61.0 110.443 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -97.73 123.4 41.65 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.968 0.413 . . . . 43.34 110.649 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.51 114.12 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.902 1.281 . . . . 73.14 108.511 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.15 29.57 59.87 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 115.439 0.936 . . . . 62.1 115.439 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.94 3.72 73.15 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.062 0.785 . . . . 63.42 115.062 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 11.6 mptt -117.58 132.91 56.44 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.6 0.76 . . . . 63.13 109.444 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 m -83.15 131.28 35.14 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.593 0.633 . . . . 74.43 111.087 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.25 159.44 24.06 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.602 1.161 . . . . 75.53 109.225 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 97' ' ' MET . 36.8 tp -116.74 118.19 31.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.82 0.448 . . . . 72.31 109.988 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 2' ' ' ARG . 29.7 t -82.74 105.63 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.804 -0.813 . . . . 60.2 108.804 172.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 38.7 t -95.35 98.69 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.489 0.661 . . . . 74.01 109.764 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 17.1 t80 -80.58 115.76 20.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.209 -0.905 . . . . 63.11 108.705 171.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.27 94.49 3.37 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 108.462 -0.94 . . . . 71.53 108.462 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.99 166.91 27.12 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.593 2.195 . . . . 50.41 112.571 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . 12.4 pt-20 -59.97 119.78 8.4 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 113.864 1.061 . . . . 71.23 113.864 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 141.25 51.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 162.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.641 ' HB3' HG22 ' A' ' 118' ' ' THR . 38.6 t70 -75.98 161.94 28.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.909 0.483 . . . . 63.12 112.17 -174.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.05 -21.11 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 C-N-CA 124.791 1.236 . . . . 41.44 112.603 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.641 HG22 ' HB3' ' A' ' 116' ' ' ASP . 15.1 t -54.23 -21.94 10.32 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.647 0.779 . . . . 75.4 112.03 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 18.7 m80 -90.54 -98.08 0.11 Allowed 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 104.724 -2.325 . . . . 71.03 104.724 164.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 55.3 mttm -68.14 -146.14 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.476 0 CA-C-N 125.902 3.955 . . . . 72.01 110.556 -45.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo 7.62 89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 124.721 3.614 . . . . 54.14 118.364 -138.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 90' ' ' ASN . 60.5 mt -74.59 101.54 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.516 -1.22 . . . . 75.3 109.507 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -92.18 168.89 11.03 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.686 -1.143 . . . . 73.02 109.535 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -84.53 155.48 22.11 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.825 -0.547 . . . . 75.34 109.58 173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -64.48 -25.88 68.19 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.146 0.498 . . . . 45.53 110.682 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.0 100.49 3.58 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.2 0.6 . . . . 75.34 109.382 163.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -63.49 144.74 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 113.74 1.015 . . . . 53.24 113.74 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -173.37 135.32 3.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.456 -0.793 . . . . 65.41 111.15 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.3 tp -116.71 94.64 44.31 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.239 0.616 . . . . 61.44 111.272 -174.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -70.0 -45.24 1.53 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.903 2.402 . . . . 54.34 112.87 172.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.47 105.32 0.57 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 116.315 -0.402 . . . . 60.42 112.749 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.75 -179.06 37.8 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.918 0.327 . . . . 70.25 113.918 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.44 118.23 20.4 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.328 0.651 . . . . 63.41 110.357 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -74.98 138.59 42.37 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.742 0.817 . . . . 65.12 112.541 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.35 141.79 32.56 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.433 0.693 . . . . 71.23 109.159 171.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -56.8 170.66 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.084 1.354 . . . . 73.43 114.252 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 pt -61.98 149.33 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 44.13 112.189 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.2 64.08 0.09 OUTLIER Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.237 -0.745 . . . . 42.5 111.237 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.4 t -164.38 -64.21 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.831 0.852 . . . . 71.43 110.436 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -166.26 148.07 6.76 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.238 1.015 . . . . 73.4 109.865 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.11 122.1 18.77 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.078 0.466 . . . . 64.53 112.101 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.68 -22.28 60.94 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.502 -0.772 . . . . 71.34 110.213 168.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -68.52 99.87 1.03 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.345 1.058 . . . . 60.33 111.454 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.4 124.31 39.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.151 0.58 . . . . 52.34 110.09 173.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.19 156.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.207 0.527 . . . . 74.51 111.933 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.62 -21.95 62.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.426 0.69 . . . . 64.0 111.637 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.69 111.63 18.14 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.442 0.697 . . . . 63.32 110.624 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -158.73 141.45 14.4 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.857 0.863 . . . . 73.45 110.56 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -63.49 110.92 2.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.522 0.729 . . . . 70.31 111.9 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -129.24 135.66 49.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.803 0.841 . . . . 74.52 109.188 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -69.08 142.74 54.41 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.254 0.622 . . . . 70.31 111.653 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -151.07 -178.19 6.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 65.04 110.905 -177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 N--CA 1.482 1.175 0 C-N-CA 123.352 0.661 . . . . 73.24 111.544 179.679 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.599 ' SD ' ' HB2' ' A' ' 111' ' ' TYR . 5.0 ttm . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.106 -0.331 . . . . 63.04 110.106 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -85.69 152.51 23.03 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.447 0.699 . . . . 73.51 110.561 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.23 152.17 32.73 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.096 0.558 . . . . 75.14 111.566 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.02 66.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.154 0.581 . . . . 73.53 112.47 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -63.77 -36.31 83.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.137 0.791 . . . . 73.11 113.137 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.78 -35.44 80.72 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.039 0.447 . . . . 73.02 111.058 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.63 -36.44 80.79 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.401 0.68 . . . . 74.34 111.795 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.58 -37.22 79.67 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.602 0.361 . . . . 61.41 111.266 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.61 -38.91 92.02 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.804 0.442 . . . . 71.32 110.02 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.09 -37.14 78.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.732 0.813 . . . . 55.04 111.634 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 mt -61.83 -45.26 94.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.747 0.819 . . . . 74.35 111.708 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -77.17 -19.82 56.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.184 0.594 . . . . 74.14 112.128 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.51 -51.97 17.74 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.031 0.533 . . . . 71.45 111.097 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.95 159.14 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.213 0.53 . . . . 62.52 111.216 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.92 -21.86 24.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.371 0.668 . . . . 62.21 112.055 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -145.69 144.63 30.5 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.992 0.917 . . . . 73.14 111.097 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 t -75.13 116.2 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.664 0.786 . . . . 62.13 112.352 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.63 -58.83 1.8 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.154 0.982 . . . . 75.3 111.983 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -115.15 -13.17 11.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 123.822 0.849 . . . . 73.34 112.892 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -129.6 121.8 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.776 0.83 . . . . 74.23 110.244 -167.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -127.52 138.95 53.05 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.626 0.37 . . . . 64.02 110.768 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -93.26 151.98 19.47 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.77 0.828 . . . . 70.42 111.288 175.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HB2' HD23 ' A' ' 52' ' ' LEU . 69.6 mmtt -140.01 141.36 36.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.444 1.097 . . . . 63.11 110.454 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -84.87 160.53 20.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.391 0.676 . . . . 71.52 110.657 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.89 64.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.82 1.044 . . . . 74.34 113.82 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 m -81.86 -11.98 58.69 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 113.137 0.791 . . . . 70.52 113.137 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.5 -9.03 59.79 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.425 0.69 . . . . 64.24 112.148 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mmm -52.09 115.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.222 1.009 . . . . 74.24 112.905 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.93 -131.35 5.69 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 116.217 -0.447 . . . . 72.33 113.615 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.41 -38.31 68.78 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.699 1.2 . . . . 71.13 113.857 -168.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.12 -32.98 69.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.346 0.658 . . . . 61.33 112.093 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.74 -48.68 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.177 0.591 . . . . 72.14 110.059 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -41.44 59.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.246 1.419 . . . . 71.31 113.797 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.6 -43.48 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.207 0.527 . . . . 75.44 111.531 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 m -76.59 -30.7 57.09 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.349 0.659 . . . . 52.24 111.439 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.47 -45.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.197 0.599 . . . . 62.05 110.302 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.65 -38.39 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.301 0.64 . . . . 72.33 110.921 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.01 91.41 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.425 0.69 . . . . 63.2 112.284 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -70.01 -38.98 76.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.153 0.581 . . . . 64.03 111.917 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.9 73.14 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.061 0.544 . . . . 51.11 111.714 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.88 -17.14 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.848 0.859 . . . . 72.42 111.148 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.98 109.82 9.26 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.016 0.526 . . . . 73.02 110.459 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.44 117.05 4.95 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.222 1.948 . . . . 75.32 112.095 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 2.48 90.52 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.944 0.738 . . . . 71.21 114.944 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 tp -113.33 18.64 17.65 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.598 1.199 . . . . 74.32 109.918 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 114' ' ' GLU . 8.6 p-10 -43.51 114.03 0.58 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.22 1.408 . . . . 64.22 113.771 168.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.42 59.21 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.927 -0.579 . . . . 73.43 113.591 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.36 156.29 24.02 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 112.507 -0.237 . . . . 54.12 112.507 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.94 128.06 55.46 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.247 0.524 . . . . 64.52 112.041 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.2 mt -121.15 123.82 43.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.973 0.909 . . . . 63.12 110.121 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.42 109.3 20.88 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.314 0.646 . . . . 72.11 110.287 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.681 HD12 HD23 ' A' ' 108' ' ' LEU . 57.0 mt -94.56 122.73 37.45 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.888 0.475 . . . . 73.04 109.874 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.24 3.76 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 116.503 -0.317 . . . . 75.11 112.919 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 45.0 t -115.38 139.52 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.515 0.726 . . . . 75.33 110.134 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.66 133.29 49.63 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.958 -1.497 . . . . 72.34 106.958 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -110.37 138.41 46.8 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.029 0.532 . . . . 75.2 111.404 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.33 141.32 48.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.083 0.953 . . . . 74.51 110.544 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -92.0 134.75 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.801 0.84 . . . . 72.25 110.902 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -85.81 -179.13 6.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.464 0.706 . . . . 75.51 112.194 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.58 -38.09 80.26 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.039 0.936 . . . . 64.45 111.758 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -82.79 7.13 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.273 0.842 . . . . 72.2 113.273 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.13 85.96 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 114.885 0.714 . . . . 75.04 114.885 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -71.28 157.58 37.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.799 0.84 . . . . 61.22 112.423 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -103.92 124.65 49.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.053 0.941 . . . . 71.24 111.274 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -116.49 130.28 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.854 0.862 . . . . 54.12 109.892 174.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -93.82 119.63 33.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.931 0.893 . . . . 70.14 111.166 -173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -112.41 133.7 21.73 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.58 0.752 . . . . 72.52 111.644 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.28 88.4 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.286 1.991 . . . . 72.41 112.212 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -81.37 -19.03 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 122.994 0.517 . . . . 60.44 111.604 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 77.15 -173.41 54.92 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 121.881 0.712 . . . . 54.12 114.378 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 77' ' ' VAL . 55.0 mt -115.2 127.65 26.63 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.643 1.177 . . . . 73.22 108.765 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.15 -23.57 52.75 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.284 1.989 . . . . 74.5 112.485 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.3 73.58 36.75 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 125.219 1.407 . . . . 64.54 110.208 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.18 -42.77 12.76 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.613 2.875 . . . . 75.21 114.821 -165.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.72 -31.31 66.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.57 0.748 . . . . 61.43 111.967 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -72.27 -34.17 68.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 120.603 0.239 . . . . 74.35 110.412 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 71' ' ' LEU . 98.7 t -59.26 -40.76 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.707 0.803 . . . . 50.21 110.918 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -63.99 -49.26 73.15 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.375 1.07 . . . . 73.43 113.173 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -34.66 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 112.614 0.598 . . . . 73.53 112.614 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 3.9 m-20 -62.11 -45.06 95.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.378 0.271 . . . . 71.4 110.573 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.665 HD23 ' SD ' ' A' ' 97' ' ' MET . 35.1 tp -63.07 -38.58 91.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.967 0.507 . . . . 73.5 112.163 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.68 72.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.626 . . . . 65.02 111.47 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 t -73.6 -44.69 56.54 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.682 0.793 . . . . 71.24 111.676 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 80.7 mt-30 -58.06 -44.87 87.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.649 0.78 . . . . 72.34 111.553 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.5 t -74.93 -18.42 60.4 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.183 0.993 . . . . 23.53 111.986 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -82.81 -43.63 16.46 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.294 0.638 . . . . 54.05 112.367 171.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -83.91 -52.43 6.36 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.8 0.84 . . . . 73.43 113.038 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.0 mmm -67.86 -17.62 64.55 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.852 0.861 . . . . 54.4 112.89 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 mt -108.73 148.5 30.38 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 71.24 110.166 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -39.07 -53.67 1.79 Allowed 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.741 1.216 . . . . 75.31 113.532 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.04 157.92 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 114.903 -1.044 . . . . 61.31 109.564 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.71 97.2 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.847 0.832 . . . . 62.14 109.453 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tt -94.15 117.38 30.03 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.065 -1.457 . . . . 73.31 107.065 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -110.71 92.56 14.64 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.914 0.885 . . . . 74.5 110.167 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.32 165.59 24.16 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.742 2.295 . . . . 74.34 113.671 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 13.2 tp10 -85.13 107.57 17.27 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.665 ' SD ' HD23 ' A' ' 81' ' ' LEU . 76.2 mtm -119.1 122.53 42.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.781 0.433 . . . . 52.32 111.64 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -129.09 123.75 33.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.122 0.969 . . . . 74.54 110.741 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.67 114.79 12.32 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.73 0.812 . . . . 73.31 110.737 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.74 125.63 53.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.879 0.872 . . . . 75.12 111.211 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -97.16 117.75 32.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.348 0.659 . . . . 70.32 111.382 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.52 118.8 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.085 1.354 . . . . 64.2 110.034 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.06 52.67 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 115.817 1.087 . . . . 62.53 115.817 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.26 -3.12 85.71 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 117.05 0.425 . . . . 74.11 114.119 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 74.2 mmtt -99.17 137.57 37.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.492 1.117 . . . . 60.45 109.078 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -107.77 131.1 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.273 0.942 . . . . 54.45 111.305 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.42 168.67 11.43 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.253 1.021 . . . . 73.11 109.267 -174.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD23 HD12 ' A' ' 52' ' ' LEU . 34.7 tp -121.89 116.68 24.82 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.894 -0.41 . . . . 71.21 109.894 173.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 1' ' ' MET . 38.2 t -87.8 120.81 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.92 -0.77 . . . . 70.45 108.92 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 46.2 t -110.69 104.82 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 64.0 110.394 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 74.3 t80 -90.47 113.28 25.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.136 0.974 . . . . 74.51 110.222 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.53 100.82 46.72 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.568 0.747 . . . . 74.33 110.495 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -86.31 -173.27 1.2 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.716 2.277 . . . . 64.45 113.309 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 36.4 tt0 -93.64 153.18 18.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.866 0.866 . . . . 64.41 109.71 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.08 155.2 40.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.41 0.624 . . . . 61.41 112.323 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.18 158.76 35.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.952 0.901 . . . . 73.42 110.997 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' HD2' ' A' ' 134' ' ' TYR . 16.4 t -56.46 -22.21 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.525 0.935 . . . . 74.22 113.525 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -52.08 -22.13 3.86 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 123.766 0.827 . . . . 64.33 112.366 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.659 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 81.3 m-70 -104.23 -84.29 0.48 Allowed 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 106.354 -1.721 . . . . 62.52 106.354 162.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 16.1 ptpt -79.81 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.665 0 CA-C-N 125.655 3.843 . . . . 71.33 110.909 -34.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 3.3 Cg_exo 7.52 116.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.305 1 C-N-CA 125.489 4.126 . . . . 74.44 120.102 -137.259 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.48 93.8 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.317 -1.311 . . . . 72.12 109.039 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -79.49 170.74 16.14 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.34 0.656 . . . . 72.14 111.017 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -90.67 90.74 8.09 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 18.29 101.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 127.005 2.122 . . . . 51.23 115.503 -174.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.54 167.9 18.59 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.329 0.652 . . . . 73.03 112.058 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.4 m -68.66 -29.23 67.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.904 0.882 . . . . 74.23 111.992 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.07 163.84 54.93 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.492 -0.322 . . . . 72.25 113.264 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 129' ' ' LEU . 2.5 pt? -117.49 154.08 50.49 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.111 0.964 . . . . 72.24 109.96 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -70.29 -166.08 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.688 2.259 . . . . 75.02 112.987 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.99 -87.78 0.02 OUTLIER Glycine 0 CA--C 1.541 1.679 0 N-CA-C 114.621 0.609 . . . . 72.52 114.621 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.43 -28.3 3.89 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 114.631 0.613 . . . . 53.35 114.631 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.51 64.26 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.781 0.832 . . . . 71.23 112.954 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.45 ' HD2' HG11 ' A' ' 117' ' ' VAL . 16.4 t80 -126.43 44.42 2.88 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.589 0.755 . . . . 54.21 109.731 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -67.96 87.2 0.25 Allowed 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.84 0.829 . . . . 73.24 111.738 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -77.04 143.61 39.2 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.812 0.845 . . . . 75.24 111.495 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.32 94.2 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.084 0.469 . . . . 60.15 110.06 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.24 -57.16 3.04 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.557 -0.617 . . . . 74.4 111.557 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.7 p 57.56 2.94 0.16 Allowed 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 125.916 1.686 . . . . 53.42 114.842 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t -89.45 91.51 8.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.772 0.829 . . . . 71.21 109.484 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.57 135.66 42.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.462 0.705 . . . . 71.43 110.029 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -97.35 134.9 40.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.268 0.627 . . . . 62.4 111.148 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -78.28 125.87 29.97 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.039 0.535 . . . . 73.34 110.123 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.9 m -74.75 84.98 2.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.327 0.651 . . . . 74.43 110.12 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.59 -36.3 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 115.211 -0.904 . . . . 61.32 110.6 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.95 102.51 0.8 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.691 0.796 . . . . 41.22 110.966 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -85.81 142.75 28.7 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 109.101 -0.703 . . . . 74.02 109.101 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -93.89 128.78 40.37 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.875 0.87 . . . . 72.01 111.215 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -63.48 87.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.532 0.733 . . . . 74.32 111.013 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -89.72 125.42 35.27 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.018 0.927 . . . . 73.25 110.918 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -111.69 129.57 56.06 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.119 0.485 . . . . 63.33 111.48 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -132.78 166.94 21.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.343 1.057 . . . . 63.51 109.845 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.279 0.561 . . . . 51.34 110.701 177.53 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 16.6 ptm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 110.784 -0.08 . . . . 74.5 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -83.87 156.71 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.508 0.723 . . . . 61.21 111.893 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -82.16 161.23 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.781 0.832 . . . . 63.13 112.046 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB1' HD22 ' A' ' 107' ' ' LEU . . . -62.25 -44.63 96.1 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.338 0.655 . . . . 72.44 112.018 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -72.22 -31.13 65.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.954 0.724 . . . . 73.03 112.954 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.23 -49.36 77.92 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 121.786 0.803 . . . . 65.43 111.447 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.4 mt -72.73 -26.36 61.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.768 -1.106 . . . . 72.15 112.654 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.93 -43.69 98.27 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.008 0.523 . . . . 52.33 110.353 169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.51 -36.33 75.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.482 1.113 . . . . 75.43 111.333 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp10 -65.02 -52.36 56.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.616 0.766 . . . . 71.22 111.267 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -56.57 -37.61 70.81 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.463 1.105 . . . . 73.41 113.503 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -78.09 -24.06 47.71 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.057 0.543 . . . . 73.43 111.501 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.67 -38.97 53.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.506 0.722 . . . . 65.53 112.314 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.35 146.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 121.296 0.57 . . . . 65.31 111.919 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.96 -39.55 82.05 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.677 1.191 . . . . 74.24 111.596 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.29 167.79 29.29 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.779 0.832 . . . . 74.13 111.623 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -66.8 89.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.471 0.709 . . . . 14.24 112.445 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.38 10.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.645 0.778 . . . . 63.05 112.017 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -121.67 -28.8 4.48 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.449 0.7 . . . . 64.32 111.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 10' ' ' GLU . 33.9 mm -112.22 119.19 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 70.33 110.046 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 143.6 42.3 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.101 0.56 . . . . 53.52 109.76 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.9 27.41 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.458 0.703 . . . . 73.42 110.638 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 54.6 mtmt -141.0 152.94 45.31 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.828 0.851 . . . . 72.35 112.245 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 mtm-85 -80.58 170.4 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.676 0.79 . . . . 73.34 112.681 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 28' ' ' MET . . . -60.83 -26.7 67.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.346 0.869 . . . . 71.22 113.346 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -64.59 -1.22 1.7 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.429 1.27 . . . . 63.03 114.429 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -111.88 -9.29 14.06 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.974 0.51 . . . . 72.34 112.185 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.9 ptm -60.76 104.39 0.35 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.663 0.744 . . . . 74.13 111.519 -173.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.26 -122.37 1.21 Allowed Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.669 -0.696 . . . . 65.43 112.388 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -52.78 -58.18 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.292 1.037 . . . . 75.34 113.797 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.5 m -76.2 -32.06 58.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.404 0.52 . . . . 70.4 112.404 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.75 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.178 0.444 . . . . 60.22 110.314 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 39.0 tpp -58.85 -43.62 90.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.622 0.769 . . . . 75.25 111.611 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -59.7 -39.32 84.2 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.779 . . . . 71.12 111.991 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -70.12 -35.52 74.16 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 122.847 0.459 . . . . 63.33 110.996 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.14 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.462 0.705 . . . . 54.35 110.474 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.27 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 74.15 110.585 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -62.38 -47.17 85.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.428 0.691 . . . . 64.11 112.045 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -67.42 -40.84 85.53 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 122.71 0.404 . . . . 74.55 111.501 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.07 67.15 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.287 0.635 . . . . 63.45 111.89 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -80.87 -37.43 29.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.892 0.877 . . . . 32.43 110.719 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 32.3 mm-40 -56.97 109.32 1.64 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.505 0.722 . . . . 75.24 111.944 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 141' ' ' ASP . 72.9 Cg_endo -70.68 111.07 2.9 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.25 1.966 . . . . 64.25 112.712 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.93 22.49 65.94 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 114.486 0.554 . . . . 34.41 114.486 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 26.69 10.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 117.702 0.751 . . . . 55.32 110.135 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 31.7 t70 -48.76 119.06 2.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.523 0.729 . . . . 62.51 111.777 168.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.501 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 114.41 48.04 0.57 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.101 -0.5 . . . . 60.23 112.899 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.72 137.25 13.39 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 110.613 -0.995 . . . . 33.4 110.613 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -118.43 152.68 35.42 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.325 0.861 . . . . 73.34 113.325 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.4 mt -123.06 122.32 38.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.171 1.389 . . . . 74.21 109.953 175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.27 108.43 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.721 -0.474 . . . . 73.0 109.721 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 7.5 mp -95.19 120.71 35.89 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.114 -0.698 . . . . 70.21 109.114 176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.48 25.99 5.28 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.312 -0.404 . . . . 51.44 113.232 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.71 133.06 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.34 -0.615 . . . . 65.11 109.34 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -109.72 154.18 23.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.25 -1.018 . . . . 72.42 108.25 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.54 139.69 38.79 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.058 0.456 . . . . 61.24 111.124 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.68 140.31 52.82 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.87 0.868 . . . . 60.44 110.536 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.39 127.33 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.248 0.619 . . . . 73.52 110.809 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -71.98 171.38 11.92 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.854 0.462 . . . . 70.45 111.435 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.37 -31.03 69.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.067 0.547 . . . . 74.1 111.725 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -98.32 11.0 39.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.911 0.708 . . . . 75.23 112.911 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.3 -3.67 59.96 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 116.859 1.503 . . . . 73.41 116.859 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 128.07 34.59 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 118.905 1.353 . . . . 74.25 112.97 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -80.09 106.54 12.19 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.876 -0.787 . . . . 72.54 108.876 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -103.11 119.95 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.405 0.682 . . . . 64.44 109.589 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.93 142.47 27.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.136 0.574 . . . . 74.1 110.407 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -147.99 137.25 11.96 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.155 0.582 . . . . 74.35 111.414 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -82.18 89.53 1.18 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.907 2.405 . . . . 72.5 112.428 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.61 -13.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.865 0.466 . . . . 61.43 111.747 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.37 172.19 46.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 121.616 0.565 . . . . 72.33 114.309 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -95.44 140.16 22.26 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.202 1.001 . . . . 71.13 109.762 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.86 -37.18 98.75 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.631 2.221 . . . . 55.33 112.274 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -140.58 101.55 6.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.806 -1.183 . . . . 65.43 107.806 166.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HB2' HD22 ' A' ' 99' ' ' LEU . 90.4 Cg_endo -74.13 -22.99 16.29 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.635 2.223 . . . . 70.31 113.838 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.55 -43.29 66.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.509 0.724 . . . . 41.12 110.591 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -40.02 87.48 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.549 -0.296 . . . . 62.45 111.275 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.49 -43.64 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.347 0.659 . . . . 74.23 111.748 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.21 -41.91 99.22 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.876 0.47 . . . . 53.34 111.978 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -72.86 -46.94 50.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.362 0.665 . . . . 71.13 111.915 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.35 -30.54 70.38 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.141 0.576 . . . . 71.53 112.01 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.87 -37.96 67.18 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.406 0.283 . . . . 75.04 111.027 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.55 76.19 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.19 0.596 . . . . 75.43 111.763 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.6 m -66.07 -51.5 57.56 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.364 0.666 . . . . 74.02 111.347 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -65.62 -29.68 70.29 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.74 0.416 . . . . 74.05 111.419 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.35 -32.28 71.12 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.377 0.51 . . . . 63.53 112.377 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.87 16.76 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.982 0.513 . . . . 63.13 111.381 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 64.7 m -74.22 -32.05 62.86 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.847 0.859 . . . . 74.21 113.207 -174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.5 mmm -94.87 -42.97 8.42 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.435 0.694 . . . . 70.53 112.013 -175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.01 132.19 37.7 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.45 -0.204 . . . . 74.23 110.45 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -58.16 -40.28 80.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.829 0.851 . . . . 72.21 112.223 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -97.36 155.56 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.294 0.638 . . . . 42.14 109.824 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 96.15 2.33 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.667 -0.494 . . . . 74.11 109.667 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.56 123.47 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.038 -1.097 . . . . 72.42 108.038 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -103.39 95.15 6.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.82 0.848 . . . . 71.43 110.062 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.44 156.28 9.32 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.545 2.163 . . . . 74.14 112.054 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.5 tp10 -83.44 122.56 28.67 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.967 -0.753 . . . . 64.45 108.967 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.4 mtt -128.39 124.27 35.91 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.07 0.548 . . . . 70.43 110.391 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -135.68 133.76 38.45 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.985 0.421 . . . . 74.15 110.309 175.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 74' ' ' PRO . 94.5 mt -81.72 111.06 17.63 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.196 0.999 . . . . 60.32 110.641 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.36 130.13 55.22 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.954 0.902 . . . . 72.21 111.936 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -96.78 118.91 34.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.364 0.665 . . . . 72.03 111.282 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.83 121.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.658 1.183 . . . . 75.12 109.59 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 29.09 57.63 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.795 1.078 . . . . 32.52 115.795 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.86 81.39 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.035 0.774 . . . . 70.12 115.035 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -107.59 137.25 45.96 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.558 0.743 . . . . 63.25 109.681 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.9 m -102.01 134.88 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.684 0.675 . . . . 74.22 110.751 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.437 HD22 ' HB1' ' A' ' 4' ' ' ALA . 6.0 mp -124.48 170.18 11.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.393 1.077 . . . . 73.13 108.737 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 97' ' ' MET . 60.9 tp -117.31 116.54 27.42 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.671 -0.492 . . . . 62.01 109.671 172.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t -94.42 128.58 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.512 -0.921 . . . . 72.22 108.512 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 56.6 t -121.92 106.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.087 0.555 . . . . 60.42 111.006 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 92.3 t80 -82.52 123.95 29.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.026 0.93 . . . . 75.33 110.148 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.39 114.19 62.43 Favored Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 109.456 -0.572 . . . . 51.43 109.456 173.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.84 161.82 38.51 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.273 . . . . 62.43 112.602 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -75.02 150.15 39.02 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.94 -0.393 . . . . 72.43 109.94 176.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -74.02 145.76 44.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.281 0.562 . . . . 72.23 111.776 169.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.68 -179.95 1.95 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.452 1.101 . . . . 63.23 110.736 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.86 -49.69 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 62.31 112.974 167.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -73.2 -49.17 29.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.16 0.505 . . . . 75.12 110.708 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.7 m-70 -103.92 83.05 2.06 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 102.199 -3.26 . . . . 61.32 102.199 159.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 31.6 mmtp -43.5 -152.9 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.521 1 C-N-CA 132.562 4.345 . . . . 72.25 121.263 61.346 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo 4.14 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.007 2.471 . . . . 63.32 116.046 -126.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 120' ' ' LYS . 46.0 mm -100.74 125.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.754 0.822 . . . . 64.34 109.503 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -156.44 -176.86 6.2 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.539 0.736 . . . . 74.4 111.264 -174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -72.44 157.27 37.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.524 0.729 . . . . 73.41 111.908 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -64.46 -38.17 90.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.176 0.59 . . . . 70.24 110.884 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.11 142.72 30.24 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.055 0.942 . . . . 53.32 109.97 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.4 m -66.14 120.96 14.12 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.467 0.707 . . . . 51.35 111.934 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.61 71.19 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 N-CA-C 113.779 0.272 . . . . 45.44 113.779 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 52.6 tp -118.71 105.23 46.01 Favored Pre-proline 0 CA--C 1.564 1.489 0 C-N-CA 123.606 0.763 . . . . 72.1 109.868 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.79 -46.96 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.156 2.571 . . . . 73.05 114.0 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.9 92.32 0.94 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 111.618 -0.593 . . . . 73.41 111.618 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.09 0.43 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 123.118 0.389 . . . . 71.52 113.902 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.21 83.66 7.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.564 0.746 . . . . 73.03 110.774 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -93.21 -48.17 6.58 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.696 0.799 . . . . 64.54 110.311 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -94.64 154.09 17.51 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.624 0.77 . . . . 74.12 110.071 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -72.96 84.16 1.25 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.086 0.946 . . . . 72.23 112.036 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.7 pt -95.3 136.81 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.362 0.665 . . . . 74.41 110.755 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.9 -135.48 4.74 Favored Glycine 0 N--CA 1.478 1.497 0 C-N-CA 123.04 0.352 . . . . 71.34 112.801 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.4 t -148.21 107.46 3.9 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.347 0.659 . . . . 70.25 110.83 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.9 t -103.84 1.81 31.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.774 0.829 . . . . 71.54 111.217 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 43' ' ' PRO . 18.5 t70 -153.46 141.92 20.73 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.377 0.671 . . . . 73.31 110.517 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -154.45 120.61 5.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.195 0.998 . . . . 73.32 110.09 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -104.97 79.13 1.47 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.236 0.615 . . . . 62.35 111.795 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.27 74.85 0.06 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 126.496 1.918 . . . . 64.44 116.126 168.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.01 136.96 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.873 -0.417 . . . . 64.23 109.873 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -116.76 178.65 4.26 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.116 0.566 . . . . 71.25 112.354 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.36 130.15 44.05 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.504 0.722 . . . . 74.42 110.335 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -63.18 118.25 7.68 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.531 0.732 . . . . 74.23 111.604 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -76.08 157.11 33.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.121 0.968 . . . . 72.12 112.42 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -93.76 -174.18 3.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.535 0.734 . . . . 75.01 110.184 171.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -126.27 142.28 51.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.751 0.82 . . . . 73.14 110.039 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -83.33 131.66 35.05 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.795 0.438 . . . . 74.25 110.26 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.0 m170 . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 123.555 0.742 . . . . 73.21 111.299 -175.176 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.607 ' HG2' ' HB2' ' A' ' 111' ' ' TYR . 3.0 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 111.208 0.077 . . . . 63.02 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -41.52 132.19 2.84 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.338 1.055 . . . . 73.21 112.668 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -62.84 159.36 16.79 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.348 0.659 . . . . 61.54 112.154 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.38 81.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.09 0.556 . . . . 61.31 112.049 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -68.93 -36.77 78.36 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.318 0.647 . . . . 53.14 112.481 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.42 -53.68 54.65 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.113 0.565 . . . . 73.14 111.152 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 109' ' ' VAL . 93.3 mt -59.64 -38.92 82.7 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.634 0.773 . . . . 62.23 112.029 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.5 tm? -62.55 -42.34 99.47 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.717 0.807 . . . . 75.43 110.862 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.73 -37.48 87.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.031 0.533 . . . . 60.55 110.56 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -66.09 -40.14 90.56 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.679 -0.691 . . . . 74.13 111.474 173.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 87.2 mt -61.03 -39.02 88.18 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.569 0.747 . . . . 73.41 111.79 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -78.51 -22.75 46.93 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.142 0.577 . . . . 74.14 111.851 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.81 -44.46 49.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.263 0.625 . . . . 51.21 111.226 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.5 m -86.82 151.63 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 74.42 110.994 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.36 -18.46 38.78 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.566 0.747 . . . . 74.2 110.977 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.68 150.81 36.14 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.326 0.65 . . . . 72.4 111.013 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 57.4 p -83.88 80.44 9.15 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.434 0.635 . . . . 71.5 110.717 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.62 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.68 -0.691 . . . . 65.04 112.0 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -120.44 -11.83 9.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 73.2 110.926 175.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mt -115.04 106.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.294 -1.002 . . . . 74.32 108.294 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 10.2 tp10 -96.04 151.81 19.1 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.299 1.44 . . . . 74.25 111.713 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.76 28.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.919 . . . . 72.22 110.162 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HG2' ' A' ' 21' ' ' GLU . 62.5 mttm -136.23 166.42 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 54.13 112.167 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -105.36 167.24 9.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.577 1.151 . . . . 64.14 112.042 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.57 -26.01 67.67 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.64 0.776 . . . . 75.41 112.448 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.6 t -56.4 -37.12 69.71 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.294 0.85 . . . . 23.21 113.294 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.33 18.35 16.12 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.555 0.946 . . . . 62.14 113.555 -170.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.1 ptm -63.74 103.19 0.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.049 0.928 . . . . 71.23 110.736 166.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.08 -130.97 2.7 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.307 -0.86 . . . . 75.45 111.939 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -55.14 -34.4 63.73 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.213 1.005 . . . . 74.34 112.862 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -67.39 -40.72 85.68 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.473 0.709 . . . . 65.43 111.89 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.49 -53.29 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.829 0.451 . . . . 73.44 110.033 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -48.22 -40.69 25.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.901 1.281 . . . . 72.25 113.34 175.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.07 -47.14 65.32 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.836 0.854 . . . . 73.13 111.927 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 m -77.62 -37.73 49.55 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.652 0.781 . . . . 61.34 111.912 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.24 -42.32 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.215 1.006 . . . . 62.31 112.254 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -54.14 -34.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.341 1.056 . . . . 62.21 112.379 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.78 92.55 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.249 0.62 . . . . 61.24 111.784 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -72.68 -30.22 64.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.961 0.504 . . . . 74.51 111.721 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.88 19.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.199 0.6 . . . . 75.51 112.23 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -85.16 -43.09 14.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.228 0.825 . . . . 73.43 113.228 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.63 108.23 5.49 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 122.92 0.488 . . . . 70.02 111.373 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 116.36 4.63 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.462 2.108 . . . . 65.12 111.683 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.74 3.31 40.01 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.243 -0.754 . . . . 63.14 114.24 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.53 -23.89 11.27 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 118.88 1.34 . . . . 75.45 108.401 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -44.94 155.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.246 1.819 . . . . 73.53 115.699 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 39.0 4.95 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.546 -0.752 . . . . 75.54 113.06 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.95 165.4 29.31 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 113.547 0.179 . . . . 71.0 113.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -123.22 126.75 47.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.318 0.647 . . . . 72.51 110.278 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.6 mp -112.32 118.08 34.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 75.43 108.438 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.5 tp -102.33 111.82 24.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.666 -0.494 . . . . 74.5 109.666 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 108' ' ' LEU . 71.7 mt -92.35 138.95 31.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.213 0.605 . . . . 74.12 111.149 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.12 41.07 5.65 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.548 -0.751 . . . . 64.41 112.634 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.92 141.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.122 0.569 . . . . 74.43 110.728 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -104.73 158.6 16.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.228 . . . . 62.02 108.322 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -143.87 126.73 16.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.203 0.525 . . . . 73.32 110.295 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.13 137.34 53.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.354 1.062 . . . . 73.12 110.707 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.56 122.86 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.53 0.732 . . . . 62.32 111.54 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -72.21 177.63 4.35 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.465 1.106 . . . . 74.33 111.986 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.17 -28.61 66.57 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.003 0.521 . . . . 62.22 110.821 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.107 0.963 . . . . 75.53 112.273 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.12 10.88 70.78 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 116.786 -0.188 . . . . 74.44 112.852 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.31 158.72 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.124 0.97 . . . . 72.43 111.969 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -109.71 113.03 25.45 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.361 0.665 . . . . 63.53 110.906 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.62 124.3 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.651 0.781 . . . . 64.13 109.586 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -93.17 127.17 38.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.262 0.625 . . . . 65.4 110.206 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -117.28 131.78 23.85 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.847 0.859 . . . . 74.3 110.601 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.03 97.3 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.268 1.979 . . . . 62.54 111.573 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.48 -20.63 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.405 0.682 . . . . 71.3 112.309 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.61 178.08 51.24 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 121.56 0.533 . . . . 60.24 114.267 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.12 138.75 20.63 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.226 1.011 . . . . 61.32 110.854 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.52 -38.37 19.52 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.481 2.121 . . . . 65.31 112.592 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 77' ' ' VAL . 14.5 m-20 -124.78 67.23 50.6 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 123.701 0.801 . . . . 64.44 109.627 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 99' ' ' LEU . 39.2 Cg_endo -60.22 -42.65 40.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.106 2.537 . . . . 64.22 114.638 -164.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.92 -38.0 87.55 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.133 0.573 . . . . 71.04 110.979 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -71.95 -37.23 69.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.258 0.623 . . . . 74.42 111.515 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.8 t -60.91 -39.61 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.665 0.386 . . . . 74.42 110.058 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.52 -47.92 79.67 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.24 0.616 . . . . 72.53 112.208 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -63.63 -50.06 70.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.823 0.849 . . . . 75.11 112.238 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.74 -30.31 69.76 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.895 0.878 . . . . 74.33 111.328 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.7 tp -67.56 -42.06 83.22 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.929 0.492 . . . . 74.54 111.122 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.44 98.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.445 0.698 . . . . 75.4 111.382 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -61.65 -52.61 63.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 60.2 111.668 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.94 -30.77 70.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.055 0.391 . . . . 75.24 112.055 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.19 -32.19 71.94 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.431 0.56 . . . . 70.24 112.071 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.3 -29.71 28.13 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.701 -0.681 . . . . 60.15 112.447 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -94.35 -24.41 17.4 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.549 1.314 . . . . 74.14 114.549 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.402 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 48.1 mmm -91.09 -27.1 18.79 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.46 0.704 . . . . 71.43 111.861 -173.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.6 162.0 13.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.139 0.576 . . . . 74.25 112.536 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -39.54 -63.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.083 1.753 . . . . 55.44 112.835 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.437 HG21 ' ND1' ' A' ' 119' ' ' HIS . 30.3 m -116.61 172.03 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.69 0.796 . . . . 71.54 110.16 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.17 99.66 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.197 0.523 . . . . 72.23 110.661 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.16 134.05 35.57 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.999 -1.112 . . . . 73.25 107.999 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -110.39 91.6 12.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.123 0.569 . . . . 75.21 111.462 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -90.62 169.07 3.9 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.831 2.354 . . . . 62.14 112.531 171.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.85 135.13 53.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.191 0.596 . . . . 72.41 109.838 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.661 ' HB3' HD11 ' A' ' 108' ' ' LEU . 46.9 mtt -130.03 132.57 46.27 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.203 0.601 . . . . 72.13 111.156 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -135.37 144.31 46.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.481 0.712 . . . . 71.43 111.741 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 74' ' ' PRO . 74.1 mt -104.23 117.12 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.092 0.957 . . . . 74.23 110.098 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -117.49 133.23 56.2 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.492 1.117 . . . . 75.35 111.651 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -94.21 114.36 26.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.822 0.849 . . . . 72.05 110.527 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.95 113.95 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.788 1.235 . . . . 63.44 109.149 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 51.42 28.49 20.73 Favored Glycine 0 CA--C 1.543 1.803 0 N-CA-C 115.642 1.017 . . . . 62.31 115.642 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.23 -5.71 78.23 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.546 0.578 . . . . 60.52 114.546 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -98.92 137.57 37.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 61.34 110.699 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 m -102.39 104.73 15.23 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.191 0.451 . . . . 74.44 111.461 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.09 163.7 12.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.663 0.785 . . . . 62.32 111.623 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 97' ' ' MET . 39.4 tp -115.4 114.14 24.68 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.146 0.578 . . . . 62.14 110.962 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 7' ' ' LEU . 90.8 t -83.29 112.53 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.711 0.804 . . . . 71.12 109.506 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 25.1 t -108.49 100.05 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.637 0.732 . . . . 61.2 110.602 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 51.9 t80 -84.6 124.47 31.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.433 1.093 . . . . 74.14 110.535 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.07 103.02 48.66 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 122.655 0.382 . . . . 63.43 110.44 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.65 166.18 28.91 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.736 2.291 . . . . 71.53 112.011 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.51 161.74 24.82 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.915 1.079 . . . . 74.25 113.915 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.38 47.17 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.739 -1.119 . . . . 33.13 109.18 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.14 163.43 24.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 122.737 0.415 . . . . 62.21 111.058 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.0 -22.18 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.305 1.042 . . . . 73.54 112.467 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.3 p -58.28 -27.39 64.01 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.191 0.597 . . . . 75.33 111.448 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 5.4 m170 -75.84 -86.07 0.05 OUTLIER 'General case' 0 CA--C 1.591 2.53 0 N-CA-C 105.512 -2.033 . . . . 65.13 105.512 166.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 45.1 tttp -82.49 -145.04 0.0 OUTLIER Pre-proline 0 CA--C 1.591 2.538 0 C-N-CA 129.298 3.039 . . . . 71.23 109.636 -49.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo 5.47 102.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 124.884 3.723 . . . . 53.24 119.326 -136.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.2 mt -88.85 115.11 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 114.735 -1.12 . . . . 75.43 109.48 168.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -108.38 166.5 10.71 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.555 0.742 . . . . 72.24 111.458 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 26.5 tptp -79.75 130.68 35.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.937 0.495 . . . . 72.23 109.871 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.64 76.63 3.31 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.305 0.574 . . . . 75.44 110.439 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -172.48 98.28 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.971 1.308 . . . . 61.42 109.094 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -70.41 149.93 46.77 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.268 0.627 . . . . 61.32 112.568 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.64 -39.08 0.32 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.901 -0.59 . . . . 73.1 112.377 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.83 106.51 37.83 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.108 0.963 . . . . 61.41 110.123 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 115.4 4.32 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.161 2.574 . . . . 64.0 113.131 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.55 -77.35 2.06 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.364 -0.38 . . . . 61.0 113.38 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.11 -106.21 1.77 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.97 -0.452 . . . . 74.31 111.97 -173.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.62 67.38 9.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.588 0.708 . . . . 65.01 110.108 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -70.39 -34.72 72.89 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.173 0.989 . . . . 74.33 112.014 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -78.42 154.29 30.78 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.624 0.77 . . . . 72.42 111.653 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.82 103.72 0.6 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.694 0.798 . . . . 74.42 112.465 -170.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.79 115.18 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.189 0.996 . . . . 63.24 109.188 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.38 160.96 34.66 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 113.927 0.331 . . . . 62.44 113.927 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.5 t -92.56 58.14 3.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.002 0.921 . . . . 71.1 110.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 51.1 m 53.29 72.86 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.629 1.172 . . . . 72.24 111.883 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.43 89.17 0.09 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.964 0.906 . . . . 61.24 112.853 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.66 -26.89 5.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.805 1.242 . . . . 71.22 110.534 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -86.36 87.56 7.46 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.306 0.642 . . . . 73.34 110.262 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.4 t -97.03 142.83 28.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.933 0.493 . . . . 74.2 111.431 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.75 147.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.219 0.608 . . . . 64.03 111.088 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.92 123.67 27.99 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.236 -0.653 . . . . 53.44 109.236 173.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -126.45 121.35 32.16 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.5 0.667 . . . . 71.41 112.68 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -148.42 117.5 6.8 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 63.31 108.124 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -98.06 106.39 18.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.211 -0.663 . . . . 71.23 109.211 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -62.31 144.01 56.2 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.907 0.483 . . . . 60.13 111.597 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -139.75 136.69 34.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.516 0.726 . . . . 64.35 110.211 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -124.0 -170.72 2.18 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.609 0.763 . . . . 50.4 110.653 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 65.0 t60 . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 123.259 0.623 . . . . 74.03 111.06 177.402 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.539 0.685 . . . . 75.05 112.789 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.39 179.53 4.12 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.944 -1.026 . . . . 71.31 110.189 165.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -71.76 157.25 38.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.656 -0.702 . . . . 70.45 112.063 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.22 84.47 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.402 0.681 . . . . 62.13 111.543 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -65.6 -33.95 77.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.447 0.699 . . . . 73.3 112.593 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -43.74 80.9 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 120.847 0.356 . . . . 63.45 111.092 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.72 -29.12 69.03 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.074 0.55 . . . . 72.23 111.646 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 11' ' ' LEU . 17.9 tp -63.73 -29.77 70.95 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.647 0.779 . . . . 73.22 111.324 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.49 -34.2 75.08 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.176 0.59 . . . . 64.02 111.821 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.0 tt0 -67.66 -52.11 41.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.595 0.634 . . . . 75.22 109.659 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 8' ' ' LEU . 77.5 mt -49.38 -45.63 46.22 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.489 1.116 . . . . 73.01 112.762 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.46 -26.38 38.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.501 0.926 . . . . 61.02 113.501 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.33 -53.41 16.82 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.339 0.518 . . . . 71.04 111.427 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.2 m -81.79 139.89 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.927 0.491 . . . . 73.33 110.379 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.79 -45.06 90.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.522 0.729 . . . . 72.42 111.605 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -123.53 138.21 54.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.922 0.889 . . . . 72.42 110.487 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -44.17 124.62 4.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 71.01 113.669 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.94 -65.08 1.01 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.167 0.587 . . . . 64.31 112.328 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -119.82 -6.61 10.08 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.819 0.848 . . . . 75.11 111.406 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' A' ' 49' ' ' TYR . 45.5 mt -128.96 121.84 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.872 0.869 . . . . 55.43 108.806 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.55 129.06 46.44 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.949 -0.389 . . . . 74.12 109.949 169.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -81.38 133.86 35.48 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.517 0.727 . . . . 64.22 109.067 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -130.86 151.13 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.41 0.624 . . . . 65.24 111.438 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -97.85 159.67 14.79 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.008 -0.997 . . . . 72.02 110.241 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.627 0.771 . . . . 74.23 112.302 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -59.88 -36.42 76.88 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.93 0.892 . . . . 73.24 113.041 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.53 -10.55 55.83 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.12 0.568 . . . . 74.13 112.094 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.2 ttt -59.43 104.28 0.25 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.171 0.51 . . . . 51.13 111.239 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 170.65 -150.35 14.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.241 -0.744 . . . . 61.43 111.241 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.13 -27.14 52.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.12 1.156 . . . . 63.22 114.12 -175.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -65.44 -43.62 89.87 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.938 0.495 . . . . 63.2 111.26 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.26 -42.86 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.81 0.844 . . . . 74.11 110.773 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 84.6 mmm -64.34 -33.27 75.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.82 0.848 . . . . 71.14 112.038 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.63 -36.58 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.187 0.595 . . . . 75.43 110.936 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 50' ' ' LEU . 3.0 m -70.64 -29.85 66.32 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 116.258 -0.428 . . . . 72.14 110.899 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.1 -38.41 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.511 0.725 . . . . 74.33 110.146 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.78 -36.55 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.42 0.288 . . . . 64.3 110.898 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.18 -57.86 7.45 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 120.965 0.412 . . . . 60.04 111.192 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -67.43 -20.79 65.55 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.447 0.906 . . . . 73.34 113.447 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.98 -33.45 19.61 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.209 0.818 . . . . 72.32 113.209 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -101.08 -27.82 13.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.761 1.023 . . . . 63.42 113.761 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.46 115.45 56.72 Favored Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 118.079 0.4 . . . . 72.13 111.739 -176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.99 160.24 38.59 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.485 2.124 . . . . 75.55 111.785 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.31 -41.15 3.07 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 114.031 0.373 . . . . 75.31 114.031 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -94.55 -34.44 12.66 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.065 0.933 . . . . 51.05 110.716 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 2.71 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.649 2.38 . . . . 75.05 116.284 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.44 0.57 Allowed Glycine 0 CA--C 1.537 1.432 0 CA-C-N 116.324 -0.398 . . . . 43.25 113.405 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.07 173.48 43.0 Favored Glycine 0 N--CA 1.478 1.45 0 O-C-N 122.833 -0.216 . . . . 60.3 112.971 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.624 ' HB2' HG12 ' A' ' 20' ' ' ILE . 76.7 m-85 -121.02 155.67 33.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.433 0.635 . . . . 74.14 111.907 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 60.8 mt -128.31 118.47 23.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.623 1.169 . . . . 73.43 108.585 170.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.3 tp -103.52 109.07 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 75.32 109.788 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 108' ' ' LEU . 25.1 mt -99.74 126.32 45.78 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.265 0.626 . . . . 62.22 110.67 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-N 116.6 -0.273 . . . . 40.53 113.058 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 58.4 t -112.65 137.52 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.207 0.603 . . . . 63.24 109.943 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -109.89 157.41 19.25 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.05 -1.093 . . . . 74.3 108.05 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -144.02 136.11 26.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.875 0.369 . . . . 74.04 111.662 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.15 135.33 47.36 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.767 0.827 . . . . 42.1 110.669 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.3 mt -96.83 134.89 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.416 0.686 . . . . 73.44 110.996 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -84.7 -177.19 6.53 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.426 0.69 . . . . 75.21 111.665 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.3 -25.05 66.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.934 0.716 . . . . 72.12 112.934 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -78.28 -22.94 47.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.774 0.83 . . . . 71.14 112.555 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.96 -0.96 31.64 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 114.585 0.594 . . . . 53.13 114.585 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -75.51 120.79 21.42 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.475 0.637 . . . . 70.33 110.935 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -80.94 118.95 22.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.122 0.569 . . . . 65.33 109.811 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.51 114.89 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.682 0.793 . . . . 72.25 109.326 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.85 130.25 41.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.079 -0.711 . . . . 72.41 109.079 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -143.57 131.11 10.79 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.048 0.539 . . . . 64.54 111.169 -172.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.53 101.43 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.759 2.306 . . . . 75.03 112.571 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.12 -6.45 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.127 0.571 . . . . 71.33 112.062 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.47 175.18 50.29 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 114.601 0.6 . . . . 73.13 114.601 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -105.48 137.77 19.38 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.854 1.262 . . . . 63.4 109.889 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.31 -30.5 19.62 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.071 1.847 . . . . 71.11 112.291 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 6.2 m-20 -125.98 66.43 58.66 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.871 0.868 . . . . 55.41 110.617 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -43.55 23.97 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.707 2.271 . . . . 75.2 114.27 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -71.04 -39.38 72.33 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.999 -0.546 . . . . 74.52 110.654 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 14.1 ttmm -60.41 -44.42 95.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.445 0.698 . . . . 74.12 111.15 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 73' ' ' ASP . 78.4 t -59.85 -43.41 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 122.632 0.373 . . . . 61.44 110.691 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.94 -50.2 67.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.541 0.571 . . . . 71.14 112.541 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -68.82 -49.59 57.25 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.865 0.466 . . . . 74.03 111.766 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.28 -28.54 67.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.512 0.725 . . . . 54.13 112.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.8 tp -72.65 -41.52 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.385 0.539 . . . . 73.41 111.432 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.28 84.22 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.12 0.568 . . . . 72.12 112.189 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 p -73.87 -41.39 62.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 63.51 112.071 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -65.34 -30.15 70.96 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 117.665 0.211 . . . . 73.55 111.228 173.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.7 t -59.35 -21.07 59.28 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 112.923 0.712 . . . . 73.22 112.923 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.01 -35.15 17.75 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.824 0.85 . . . . 72.23 111.587 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 -14.46 31.13 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.585 0.958 . . . . 72.21 113.585 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.3 mmm -90.05 -47.51 7.79 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.82 0.848 . . . . 71.14 110.081 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.82 154.23 17.36 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.047 -0.979 . . . . 74.14 110.627 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.0 p30 -48.29 -47.56 36.33 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.2 1.0 . . . . 74.44 112.705 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.66 173.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.244 1.018 . . . . 75.35 110.138 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.29 100.54 3.17 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.811 -0.631 . . . . 51.35 110.462 169.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 122' ' ' ILE . 5.9 tt -75.7 131.41 39.86 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.263 -1.755 . . . . 71.15 106.263 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -106.28 95.71 11.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 122.866 0.466 . . . . 74.12 111.869 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.19 161.65 5.72 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.105 1.87 . . . . 44.32 111.928 166.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 111' ' ' TYR . 37.9 mm-40 -92.04 141.13 28.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.44 -0.8 . . . . 65.31 108.935 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.632 ' HB3' HD11 ' A' ' 108' ' ' LEU . 67.3 mtt -137.8 122.74 18.97 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.32 111.121 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -130.87 136.84 49.0 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.811 0.844 . . . . 42.15 110.13 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.91 109.82 20.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.72 -0.845 . . . . 60.2 108.72 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.96 128.53 55.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.012 0.525 . . . . 62.32 110.848 -166.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -101.2 123.85 45.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.534 0.734 . . . . 71.31 111.765 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.93 122.45 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.677 1.191 . . . . 72.31 109.881 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.75 28.85 48.11 Favored Glycine 0 CA--C 1.544 1.89 0 N-CA-C 115.733 1.053 . . . . 61.41 115.733 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.15 5.37 76.62 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.015 0.766 . . . . 71.1 115.015 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.08 134.88 50.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 74.22 109.963 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.7 m -97.7 129.18 44.77 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.751 0.705 . . . . 72.02 110.603 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.05 171.41 8.69 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.402 1.081 . . . . 72.23 109.047 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 97' ' ' MET . 47.2 tp -117.49 114.81 24.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.918 0.389 . . . . 74.15 110.155 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.55 113.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 39.5 t -107.46 101.09 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.756 -0.461 . . . . 73.54 109.756 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 62.8 t80 -85.79 119.93 26.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.756 -0.831 . . . . 74.32 108.756 172.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.61 98.39 28.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.042 0.537 . . . . 55.54 109.64 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.38 162.43 22.38 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.767 2.312 . . . . 73.3 113.381 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HG3' ' HE3' ' A' ' 120' ' ' LYS . 10.8 tt0 -73.29 128.37 35.3 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.239 0.616 . . . . 73.33 111.679 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.76 171.51 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.184 0.994 . . . . 50.43 112.059 -175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.16 132.88 34.64 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 123.63 0.772 . . . . 71.31 110.574 -169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -38.49 -38.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.876 0 N-CA-C 116.79 2.144 . . . . 70.35 116.79 -160.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.9 t -63.98 -42.93 97.08 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.021 0.528 . . . . 62.24 111.675 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 23.1 m-70 -128.97 70.89 1.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 104.822 -2.288 . . . . 75.04 104.822 167.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.1 mttt -48.17 -156.95 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.744 0 C-N-CA 131.647 3.979 . . . . 74.21 121.59 57.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo 4.57 70.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.908 2.405 . . . . 62.35 116.04 -127.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 93' ' ' LEU . 34.0 mm -73.92 89.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.726 -0.67 . . . . 71.41 110.032 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -89.67 150.45 22.34 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.955 -0.566 . . . . 70.5 109.921 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -69.85 149.38 47.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 109.85 -0.426 . . . . 72.33 109.85 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -53.11 97.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.592 0.757 . . . . 75.11 111.976 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.55 136.76 38.33 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.652 0.982 . . . . 74.34 113.652 -165.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.7 m -94.75 113.8 25.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.728 0.811 . . . . 73.13 109.735 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.33 -90.63 0.09 OUTLIER Glycine 0 CA--C 1.533 1.171 0 N-CA-C 112.499 -0.24 . . . . 52.3 112.499 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.65 152.74 53.51 Favored Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 123.515 0.726 . . . . 64.35 110.898 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.99 -34.32 91.86 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.945 2.43 . . . . 63.21 113.287 169.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.66 54.59 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.981 -0.554 . . . . 51.1 113.264 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -93.7 153.17 21.13 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 112.456 -0.257 . . . . 61.15 112.456 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.08 77.67 5.56 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 117.221 0.511 . . . . 63.41 110.631 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.43 -49.34 27.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.501 0.72 . . . . 73.22 110.328 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -107.22 106.69 17.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.658 0.783 . . . . 63.24 110.065 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -75.34 165.16 25.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.065 0.546 . . . . 74.42 110.726 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.62 92.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.372 0.606 . . . . 63.32 109.651 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.26 1.15 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 115.576 -0.738 . . . . 51.04 111.75 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 44.1 t -159.24 151.92 21.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.872 0.869 . . . . 62.23 110.627 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.5 t -90.03 113.82 25.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 73.54 110.996 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.84 95.12 4.65 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.644 0.735 . . . . 74.22 112.479 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.29 156.41 35.65 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.872 -1.058 . . . . 72.12 110.72 167.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -74.2 78.46 1.79 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.424 0.69 . . . . 62.4 111.488 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.86 94.23 6.2 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.55 -0.908 . . . . 71.44 108.55 172.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 79.2 t -68.1 99.08 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.327 0.585 . . . . 73.51 111.411 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.9 mt -80.92 93.07 6.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.626 -0.879 . . . . 70.21 108.626 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -41.25 94.17 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.437 1.095 . . . . 74.44 112.977 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 38.54 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.6 1.96 . . . . 53.5 114.635 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -80.57 104.51 11.15 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.753 -0.592 . . . . 72.43 109.47 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -60.78 -48.23 82.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.024 1.49 . . . . 74.32 115.024 -166.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 67.1 m80 56.21 30.43 16.55 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 124.055 0.942 . . . . 74.54 112.966 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -62.7 100.76 0.21 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 122.898 0.479 . . . . 74.23 111.076 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 124.05 0.94 . . . . 71.3 111.576 -177.105 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptm . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.489 0.185 . . . . 73.44 111.293 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -105.54 154.29 20.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.707 0.803 . . . . 73.42 111.366 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -75.73 160.24 30.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.834 0.453 . . . . 64.02 111.768 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 -27.99 69.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.641 -0.709 . . . . 63.22 112.268 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.61 HG23 HG13 ' A' ' 102' ' ' VAL . 5.8 m -71.47 -45.88 61.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.149 0.58 . . . . 71.41 110.864 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.74 -46.42 90.48 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.511 -0.768 . . . . 74.51 111.759 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.72 -34.57 67.2 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.638 0.775 . . . . 75.3 112.242 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.37 -47.7 72.56 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.129 0.571 . . . . 42.33 110.515 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.85 -35.29 79.46 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.293 -0.867 . . . . 71.53 111.128 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.62 -37.75 88.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.476 0.71 . . . . 73.33 111.171 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.418 HD13 ' HB2' ' A' ' 22' ' ' ALA . 59.2 mt -60.74 -37.06 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.964 0.906 . . . . 63.41 111.768 174.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 66' ' ' TYR . 53.3 m-80 -80.69 -21.75 41.0 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.299 0.639 . . . . 51.54 112.186 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.24 -47.61 12.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.506 0.722 . . . . 64.32 112.567 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.34 163.71 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.573 0.702 . . . . 72.23 112.829 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.23 -33.83 22.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.271 -0.877 . . . . 74.41 110.48 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -139.81 136.77 34.39 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.133 0.973 . . . . 74.44 109.766 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 m -75.21 90.88 2.59 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.315 0.578 . . . . 61.14 110.144 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.19 82.86 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.731 1.212 . . . . 61.32 113.263 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -160.57 14.9 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.499 0.72 . . . . 75.13 111.731 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.86 117.1 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.794 -1.187 . . . . 74.13 107.794 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 150.17 38.49 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.224 0.61 . . . . 63.34 111.053 -173.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -121.59 124.38 44.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.734 0.814 . . . . 72.44 110.411 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 32' ' ' VAL . 31.2 mmtp -122.87 144.68 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.551 0.74 . . . . 73.14 110.303 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -75.89 158.26 32.27 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.316 0.646 . . . . 70.13 111.386 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -24.51 63.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.582 0.956 . . . . 55.22 113.582 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.0 t -84.16 -11.93 55.76 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.647 0.61 . . . . 64.54 112.647 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.3 -18.87 34.92 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.595 0.758 . . . . 71.02 111.515 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.78 131.26 50.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.19 0.519 . . . . 75.25 112.309 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.56 -122.6 2.81 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.159 -0.473 . . . . 75.32 112.081 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -68.24 -38.44 81.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.81 0.844 . . . . 74.24 111.748 -173.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.3 m -69.2 -42.03 76.33 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.667 0.787 . . . . 74.53 111.732 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 23' ' ' LYS . 88.0 t -70.44 -41.84 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.693 0.397 . . . . 72.22 110.825 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 89' ' ' LEU . 35.0 tpp -56.28 -44.4 79.74 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.813 0.845 . . . . 75.31 111.847 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.97 -30.57 71.02 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.722 0.809 . . . . 62.0 110.953 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -76.39 -36.35 58.15 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.745 0.818 . . . . 54.33 111.321 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 32' ' ' VAL . 97.1 t -60.97 -38.73 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 123.767 0.827 . . . . 73.21 111.129 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -57.4 -33.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.941 0.896 . . . . 63.24 111.071 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.63 71.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.146 0.578 . . . . 65.42 111.759 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.402 ' HE2' HD21 ' A' ' 50' ' ' LEU . 89.5 m-85 -67.98 -18.17 64.65 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.377 0.51 . . . . 65.34 112.377 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.06 -37.41 18.91 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.581 0.752 . . . . 73.51 112.603 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.572 HD21 ' HB ' ' A' ' 122' ' ' ILE . 58.6 m-80 -104.52 -46.06 4.47 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.102 0.778 . . . . 52.51 113.102 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.21 121.82 78.34 Favored Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 123.813 0.845 . . . . 75.23 111.721 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.96 -178.46 2.82 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.199 2.599 . . . . 55.11 113.503 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.13 -40.46 2.92 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 114.869 0.708 . . . . 75.01 114.869 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.92 -48.24 25.62 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.798 0.799 . . . . 74.41 112.876 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t70 41.21 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.249 1.203 . . . . 65.24 114.249 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 113' ' ' PRO . . . 78.01 72.21 1.17 Allowed Glycine 0 CA--C 1.535 1.294 0 C-N-CA 121.155 -0.545 . . . . 54.32 114.051 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.74 168.35 27.67 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 116.665 0.233 . . . . 22.04 113.143 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -121.36 144.23 48.77 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.83 0.678 . . . . 65.01 112.83 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 76.2 mt -122.55 123.13 40.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.702 1.201 . . . . 51.4 109.302 171.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.18 108.98 20.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.365 -0.605 . . . . 61.11 109.365 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.631 HD12 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -94.76 129.91 41.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.181 0.592 . . . . 71.45 110.21 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 34.59 4.85 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.296 -0.411 . . . . 61.01 112.622 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -112.37 140.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.826 0.85 . . . . 72.03 109.964 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -124.04 154.88 39.26 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.102 -1.073 . . . . 61.04 108.102 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -136.16 128.99 31.05 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.914 0.485 . . . . 65.12 110.828 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.764 0.825 . . . . 62.13 110.63 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -100.01 128.63 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.727 0.811 . . . . 70.33 111.646 -170.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 73.8 m-20 -76.63 178.05 7.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.208 0.603 . . . . 62.34 112.181 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.23 -37.53 87.55 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.11 0.564 . . . . 72.22 111.252 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -68.17 -29.91 68.89 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.307 0.643 . . . . 71.2 111.47 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.26 6.0 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.024 -0.535 . . . . 42.42 113.924 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.7 m-20 -78.67 138.32 38.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.978 0.511 . . . . 73.13 111.663 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.6 m -89.54 102.76 15.44 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.47 0.708 . . . . 73.11 109.975 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' HH12 ' A' ' 67' ' ' ARG . 57.6 t -109.96 129.26 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.552 0.741 . . . . 71.21 110.396 -176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB2' HD21 ' A' ' 12' ' ' ASN . 75.9 m-85 -95.76 120.81 36.68 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.73 0.812 . . . . 74.34 111.96 -171.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.43 HH12 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.69 150.91 45.61 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.128 0.971 . . . . 72.01 111.427 174.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.53 108.89 2.53 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.477 2.118 . . . . 73.01 113.229 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 m -91.86 -28.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 116.112 -0.494 . . . . 62.14 110.647 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 -176.73 53.97 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.734 -0.666 . . . . 64.15 113.83 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.4 mt -102.66 143.25 26.22 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.94 0.896 . . . . 75.34 110.856 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.0 -56.58 1.32 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.64 2.226 . . . . 64.02 111.743 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.514 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 12.1 m-20 -120.34 89.22 43.38 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.897 0.879 . . . . 70.44 108.656 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -54.98 -44.9 45.29 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.483 2.789 . . . . 73.34 114.664 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.22 -41.65 85.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.213 0.605 . . . . 74.0 110.634 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 36.9 ttpt -61.32 -43.4 98.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.795 0.438 . . . . 71.42 111.172 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.37 -43.69 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.821 0.849 . . . . 73.54 111.289 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.68 -39.67 94.9 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.838 0.855 . . . . 50.21 111.735 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -67.39 -46.2 74.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.673 0.789 . . . . 63.03 112.128 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.51 -41.17 96.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.919 0.888 . . . . 63.55 111.185 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.05 -44.23 80.69 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.025 -0.534 . . . . 63.21 111.487 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.69 97.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 73.1 111.369 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -60.89 -52.01 66.84 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.266 1.026 . . . . 72.41 111.887 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.45 -29.81 68.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.19 0.596 . . . . 71.35 112.052 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.3 t -61.57 -23.89 66.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.785 -0.572 . . . . 74.31 112.206 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.03 -48.74 7.0 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.639 0.776 . . . . 74.53 111.414 170.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 t -74.55 -22.69 58.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.387 1.255 . . . . 71.22 114.387 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.8 mmm -88.51 -51.89 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.218 0.607 . . . . 74.42 111.602 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 125' ' ' LYS . 88.6 mt -70.01 -103.26 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 113.847 1.054 . . . . 62.05 113.847 -165.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.453 ' ND2' HG13 ' A' ' 91' ' ' VAL . 9.6 p-10 -170.01 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.662 0.664 . . . . 55.2 110.123 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG11 ' ND1' ' A' ' 119' ' ' HIS . 23.9 m -114.59 157.22 15.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.078 0.951 . . . . 63.34 109.055 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 96.06 1.16 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.258 -0.645 . . . . 63.03 109.258 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.75 122.02 34.73 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.263 -1.384 . . . . 61.14 107.263 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -104.41 100.44 22.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 122.619 0.368 . . . . 75.12 110.473 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.18 161.62 26.12 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.981 1.787 . . . . 71.22 110.948 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.7 tp10 -104.03 101.89 11.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.356 -0.609 . . . . 75.25 109.356 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 108' ' ' LEU . 5.3 mpp? -101.71 135.06 43.87 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 112.501 0.556 . . . . 54.12 112.501 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -136.03 127.01 27.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.539 0.735 . . . . 74.33 111.242 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.0 112.01 9.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.209 1.003 . . . . 64.33 110.892 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -126.38 129.59 49.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.781 0.832 . . . . 75.45 111.179 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.35 126.67 39.75 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.533 0.733 . . . . 74.44 111.405 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' THR . 13.1 t -119.33 118.4 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.256 1.022 . . . . 73.33 108.877 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 28.59 63.63 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.718 0.647 . . . . 75.3 114.718 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.07 10.61 78.03 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.419 0.527 . . . . 74.41 114.419 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.6 133.03 55.51 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.019 0.928 . . . . 74.34 108.961 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 m -89.88 123.74 34.09 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.059 0.845 . . . . 72.43 111.584 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.68 170.92 8.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.513 1.125 . . . . 72.31 109.078 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -122.28 120.11 33.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.581 0.353 . . . . 64.11 110.863 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' MET . 38.4 t -88.54 120.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.143 -0.688 . . . . 64.52 109.143 170.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 21.5 t -108.51 101.51 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.262 -0.644 . . . . 51.21 109.262 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.5 t80 -85.4 116.16 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.189 0.596 . . . . 70.43 109.733 175.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.77 96.89 50.19 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 108.011 -1.107 . . . . 53.34 108.011 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 72.8 Cg_endo -70.49 171.13 15.85 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.656 2.237 . . . . 51.35 112.753 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.29 121.36 19.3 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.357 -0.979 . . . . 61.22 108.357 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -79.55 166.87 21.48 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.566 0.746 . . . . 51.55 112.103 -173.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 38.2 t70 -62.48 165.77 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 124.001 0.921 . . . . 75.11 112.471 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -52.88 -51.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.094 -1.004 . . . . 63.14 113.542 168.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.7 p -84.68 6.44 24.15 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.583 0.586 . . . . 72.14 112.583 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.572 ' ND1' HG11 ' A' ' 91' ' ' VAL . 52.0 m-70 -170.96 64.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 103.026 -2.953 . . . . 74.44 103.026 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.752 ' HA ' HG12 ' A' ' 122' ' ' ILE . 9.4 ptpp? -48.04 -156.67 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.399 2 C-N-CA 133.584 4.754 . . . . 63.11 122.096 42.256 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 10.9 Cg_exo 14.13 73.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.983 1.788 . . . . 63.43 115.204 -118.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.752 HG12 ' HA ' ' A' ' 120' ' ' LYS . 49.7 mm -90.2 125.34 43.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 114.006 -1.452 . . . . 60.44 108.654 172.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -149.97 155.53 40.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.196 0.998 . . . . 73.23 108.893 -174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -81.85 147.83 29.13 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.601 0.36 . . . . 75.43 110.784 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -62.62 -37.68 87.27 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.499 -0.556 . . . . 73.34 109.499 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.76 90.75 2.89 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.793 -0.64 . . . . 60.22 110.067 170.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.7 m -62.69 113.35 2.96 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.203 0.601 . . . . 73.01 110.354 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.92 -155.76 49.77 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 116.204 -0.453 . . . . 73.22 112.483 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.27 138.42 8.16 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.1 0.56 . . . . 74.5 111.193 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -88.39 161.64 6.79 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.723 2.282 . . . . 73.21 112.83 170.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.03 162.94 35.2 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 113.978 0.351 . . . . 53.41 113.978 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 167.09 108.85 0.21 Allowed Glycine 0 CA--C 1.541 1.657 0 CA-C-O 120.179 -0.234 . . . . 75.11 112.757 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.85 117.99 26.11 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.903 0.881 . . . . 72.04 110.884 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -128.21 140.33 51.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.94 0.896 . . . . 63.24 110.749 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 87.35 0.97 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.139 0.495 . . . . 65.23 110.275 172.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -95.65 -18.92 20.14 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 70.32 111.877 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.7 -39.23 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 122.772 0.429 . . . . 75.45 111.069 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.87 24.01 77.44 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 114.806 0.682 . . . . 72.15 114.806 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.6 p -111.08 118.04 34.92 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.418 0.687 . . . . 63.32 110.75 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 44.1 t -115.52 144.98 43.05 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.82 0.848 . . . . 73.23 110.484 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.49 91.56 1.4 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.476 0.655 . . . . 61.41 111.863 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -119.42 124.34 46.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.856 -1.165 . . . . 62.12 107.856 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -66.74 108.35 2.47 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.292 0.567 . . . . 63.41 111.906 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 57.8 m -102.74 131.28 49.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.673 1.189 . . . . 70.12 110.057 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.38 126.34 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 123.486 0.715 . . . . 72.41 109.807 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.21 166.29 23.44 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.761 0.825 . . . . 74.12 111.065 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -146.64 150.07 34.73 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.31 0.644 . . . . 73.52 110.012 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -140.1 153.85 46.85 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.71 0.804 . . . . 64.33 110.398 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -135.85 119.57 17.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.264 0.626 . . . . 74.01 111.625 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -84.03 175.83 9.26 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.36 0.664 . . . . 62.2 110.796 169.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -130.99 37.88 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.489 0.715 . . . . 64.43 111.707 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.53 96.73 0.54 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.582 0.753 . . . . 61.24 110.826 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.617 0.767 . . . . 72.41 110.723 -179.077 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 11.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.555 0.217 . . . . 64.2 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -62.73 156.77 22.77 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.462 0.648 . . . . 71.01 112.494 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 m -67.2 160.6 26.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.775 -1.102 . . . . 73.02 112.973 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.97 -27.67 67.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.956 0.502 . . . . 62.25 111.211 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 102' ' ' VAL . 39.4 p -57.15 -51.29 69.9 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.407 0.683 . . . . 73.23 111.055 168.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.23 -36.59 74.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.596 -1.184 . . . . 73.0 111.394 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 mt -70.46 -30.23 67.0 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.52 1.128 . . . . 71.02 113.008 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.41 -31.6 72.8 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.997 -0.547 . . . . 73.35 110.161 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.32 -37.72 86.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.734 0.814 . . . . 74.24 112.465 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.45 -46.99 74.58 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.308 0.504 . . . . 71.44 110.721 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.1 mt -60.18 -42.97 96.14 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 124.132 0.973 . . . . 62.31 112.25 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -80.76 -13.95 58.53 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.692 0.797 . . . . 53.41 112.915 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.85 -62.12 1.8 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.001 0.52 . . . . 55.43 110.761 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -100.14 143.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.817 -0.629 . . . . 60.22 110.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.67 -46.76 89.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.872 0.869 . . . . 62.44 111.84 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.32 111.7 15.49 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.944 0.897 . . . . 60.35 109.706 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 66.5 m -74.72 126.86 31.77 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.423 0.689 . . . . 74.54 111.716 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.71 22.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.567 0.951 . . . . 64.34 113.567 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -108.76 -2.73 18.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.408 0.683 . . . . 72.23 111.764 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 17' ' ' SER . 29.3 mm -111.17 145.24 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.917 -0.771 . . . . 64.11 108.917 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -139.7 152.12 46.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.758 0.423 . . . . 73.04 110.7 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.95 125.02 42.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.746 0.818 . . . . 63.1 109.988 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HD2' HG22 ' A' ' 32' ' ' VAL . 37.8 mttp -125.18 153.65 42.75 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.584 0.754 . . . . 71.14 111.263 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.34 155.15 24.91 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.756 -1.111 . . . . 73.24 111.356 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.03 -30.64 62.19 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.096 0.958 . . . . 55.33 113.523 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.0 p -65.89 -35.41 80.56 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.657 0.783 . . . . 74.42 112.816 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.62 13.49 6.96 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.505 0.928 . . . . 60.44 113.505 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.609 ' SD ' HD13 ' A' ' 52' ' ' LEU . 85.6 mmm -57.1 104.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.258 0.466 . . . . 34.43 112.258 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.69 -148.4 12.37 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.009 -0.541 . . . . 72.41 112.557 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -55.83 -31.53 62.79 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.552 1.141 . . . . 71.32 113.934 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -68.74 -42.62 77.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.058 0.543 . . . . 75.02 111.583 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 23' ' ' LYS . 52.3 t -60.96 -53.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.255 0.55 . . . . 75.32 109.9 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.521 ' SD ' ' HG3' ' A' ' 84' ' ' GLN . 81.0 mmm -49.2 -44.12 42.91 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.449 -1.251 . . . . 63.0 113.993 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.53 -31.25 69.36 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.614 0.598 . . . . 70.51 112.614 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.598 ' HB ' HD21 ' A' ' 50' ' ' LEU . 28.2 m -70.4 -37.41 74.47 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.541 0.336 . . . . 73.11 110.573 174.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.51 -44.17 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.375 0.67 . . . . 73.51 110.419 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.91 -40.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.319 1.048 . . . . 73.34 111.257 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.15 90.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 75.33 111.832 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 112' ' ' VAL . 21.2 m-85 -81.19 -35.7 31.05 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.959 0.504 . . . . 75.3 111.386 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.14 73.21 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.659 0.784 . . . . 63.21 112.497 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -76.99 -24.58 52.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.172 0.589 . . . . 74.44 112.191 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.21 110.6 11.67 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 123.023 0.529 . . . . 72.52 110.047 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.84 118.15 4.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.509 2.806 . . . . 64.12 114.992 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.28 26.73 74.06 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.44 -0.8 . . . . 74.13 114.777 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -103.78 8.83 37.2 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.978 0.889 . . . . 63.33 110.196 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -51.49 141.48 15.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.815 0.846 . . . . 72.21 112.25 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 122.21 -29.77 5.42 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 111.347 -0.701 . . . . 64.12 111.347 -166.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.53 121.93 9.8 Favored Glycine 0 CA--C 1.548 2.117 0 N-CA-C 114.483 0.553 . . . . 73.34 114.483 175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -114.05 142.39 46.25 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.916 0.886 . . . . 74.1 112.416 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.598 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.1 mp -117.33 128.36 54.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.238 1.015 . . . . 75.11 109.022 170.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.86 109.65 21.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.238 0.615 . . . . 74.23 109.864 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.662 HD12 HD23 ' A' ' 108' ' ' LEU . 82.0 mt -97.8 125.67 42.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.561 0.744 . . . . 72.35 110.649 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 35.08 4.13 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.046 -0.524 . . . . 71.44 112.52 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.53 144.02 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.285 0.634 . . . . 71.52 110.34 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 131.76 44.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.132 0.973 . . . . 52.1 108.56 172.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 p90 -111.08 131.36 55.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.738 0.815 . . . . 72.51 111.197 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.36 129.9 56.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.545 1.138 . . . . 71.51 110.172 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.95 123.84 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 53.04 111.721 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.46 170.7 13.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.952 0.901 . . . . 62.34 111.9 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.36 -25.89 68.23 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.036 0.534 . . . . 71.4 111.618 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.85 -1.53 35.42 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.453 0.701 . . . . 75.44 112.107 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.18 32.57 51.95 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 122.656 0.17 . . . . 45.42 113.124 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.75 134.76 40.49 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.481 0.712 . . . . 71.22 111.176 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -92.82 106.32 18.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.579 0.752 . . . . 62.44 110.854 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.51 112.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.846 0.859 . . . . 73.33 109.843 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.18 115.55 27.5 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.12 109.536 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -116.48 136.39 23.1 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.121 0.969 . . . . 62.24 111.066 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.75 96.48 1.0 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.873 2.382 . . . . 73.2 112.793 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.72 -20.39 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 116.091 -0.504 . . . . 43.11 111.065 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.57 -169.47 53.53 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.989 0.756 . . . . 73.15 114.989 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 77' ' ' VAL . 62.7 mt -117.95 130.63 24.6 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.97 1.308 . . . . 75.45 109.11 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.04 -27.49 29.85 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.204 1.936 . . . . 54.43 111.94 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -137.97 77.71 36.95 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.341 1.456 . . . . 71.23 108.991 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.48 -35.52 29.99 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.956 2.437 . . . . 64.34 114.268 -167.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.93 -39.89 83.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.232 0.613 . . . . 75.35 110.428 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.45 -49.81 75.33 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.972 -0.558 . . . . 75.51 110.676 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 71' ' ' LEU . 81.9 t -55.93 -43.91 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.332 1.053 . . . . 74.04 111.919 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -62.84 -41.82 99.5 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.473 0.709 . . . . 73.01 112.113 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.43 -32.88 64.64 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.296 0.639 . . . . 71.3 112.359 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.22 -38.86 88.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.067 0.547 . . . . 65.35 110.107 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.99 -39.01 87.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.332 0.653 . . . . 70.15 110.877 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.47 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.706 0.802 . . . . 52.42 112.101 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 t -73.95 -53.13 10.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.166 0.586 . . . . 40.32 111.253 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.521 ' HG3' ' SD ' ' A' ' 33' ' ' MET . 9.9 pt20 -67.68 -28.93 68.1 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.711 0.804 . . . . 74.41 112.664 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.7 p -64.02 -26.57 68.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.291 0.478 . . . . 64.31 112.291 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -90.43 -41.79 11.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.572 0.749 . . . . 54.2 112.27 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -77.81 -43.97 28.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.784 1.031 . . . . 74.14 113.784 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 mmt -69.1 -44.07 73.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.766 0.826 . . . . 62.22 112.571 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.87 150.14 20.79 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.418 0.687 . . . . 54.44 111.097 -165.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.575 HD21 HG13 ' A' ' 91' ' ' VAL . 2.0 p-10 -52.76 -34.47 53.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.307 0.854 . . . . 73.54 113.307 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.575 HG13 HD21 ' A' ' 90' ' ' ASN . 26.2 m -120.48 170.83 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.719 0.808 . . . . 64.31 110.224 169.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -78.69 102.04 7.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 120.987 0.422 . . . . 64.2 110.129 170.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.74 116.97 27.4 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.183 -1.414 . . . . 73.2 107.183 174.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -103.76 98.32 12.84 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 122.858 0.463 . . . . 74.33 110.476 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.56 165.53 18.22 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.178 1.919 . . . . 74.24 112.294 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 9.5 tp10 -84.69 129.45 34.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.494 0.718 . . . . 75.4 109.418 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB3' HD11 ' A' ' 108' ' ' LEU . 53.4 mtt -132.84 120.62 21.79 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.49 0.716 . . . . 63.44 110.862 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.589 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.4 mm-40 -128.49 137.97 52.05 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.198 0.599 . . . . 73.52 110.446 173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.44 112.66 24.66 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.537 0.735 . . . . 74.23 110.348 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -114.9 127.16 55.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.885 0.874 . . . . 63.25 111.757 -170.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -88.38 118.72 28.2 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.384 0.674 . . . . 74.22 110.689 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 5' ' ' THR . 15.0 t -124.68 113.52 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.631 1.172 . . . . 72.43 108.885 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.21 65.64 Favored Glycine 0 CA--C 1.543 1.84 0 N-CA-C 115.495 0.958 . . . . 42.25 115.495 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.63 6.05 70.88 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.348 0.499 . . . . 72.21 114.348 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -114.36 136.55 52.87 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.884 0.873 . . . . 62.25 108.73 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 m -93.37 132.33 37.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.569 0.622 . . . . 74.23 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.77 169.14 11.4 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.382 1.073 . . . . 75.31 109.002 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 52' ' ' LEU . 55.1 tp -120.0 116.39 25.66 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.733 0.302 . . . . 74.4 110.446 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 51.6 t -87.78 130.89 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.297 -0.631 . . . . 54.32 109.297 173.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 24.0 t -116.19 100.92 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 122.959 0.504 . . . . 71.04 110.062 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.724 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 81.8 t80 -83.74 126.61 33.07 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.13 -0.693 . . . . 73.44 109.13 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 39' ' ' PHE . 38.7 t -99.61 112.66 64.02 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.907 -0.405 . . . . 73.02 109.907 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.29 152.08 15.83 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.721 2.28 . . . . 63.23 111.941 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -65.99 111.57 3.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.979 0.912 . . . . 74.41 111.365 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -68.73 156.01 39.06 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.353 0.661 . . . . 71.24 112.364 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.98 141.43 51.03 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 123.717 0.807 . . . . 62.24 109.631 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.45 -40.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 115.664 1.727 . . . . 75.22 115.664 -171.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -72.48 -35.02 68.09 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.973 0.731 . . . . 64.01 112.973 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -139.03 79.17 1.71 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.936 -1.505 . . . . 71.5 106.936 169.081 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 122' ' ' ILE . 17.5 ptpt -47.98 -155.2 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.733 2 N-CA-C 123.596 4.665 . . . . 71.21 123.596 43.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo 13.98 67.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.214 1.943 . . . . 73.42 116.085 -121.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.7 mm -77.63 102.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 114.467 -1.242 . . . . 72.44 110.048 175.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -108.94 147.65 31.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.739 0.815 . . . . 61.05 110.329 169.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -78.75 142.3 37.13 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.345 0.658 . . . . 74.1 110.232 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -28.53 69.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.808 0.337 . . . . 73.25 110.107 168.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.11 101.04 1.08 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.74 0.816 . . . . 62.11 110.161 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 p -85.46 176.76 8.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.926 0.89 . . . . 45.25 112.534 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 155.0 -15.12 0.51 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 115.685 -0.688 . . . . 74.54 112.512 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.5 tp 51.14 67.76 3.97 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 125.403 1.481 . . . . 75.13 111.543 -171.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.97 -143.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.839 3.026 . . . . 75.32 111.246 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.8 123.87 1.2 Allowed Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.248 0.477 . . . . 73.12 113.062 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.81 92.78 0.54 Allowed Glycine 0 N--CA 1.477 1.41 0 CA-C-N 116.92 0.36 . . . . 72.11 113.682 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.5 -36.51 65.77 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.379 0.671 . . . . 71.11 111.644 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -96.84 136.74 36.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.441 0.697 . . . . 52.23 110.582 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -138.05 -179.14 5.6 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.585 0.754 . . . . 70.33 111.636 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -128.29 179.08 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.855 0.862 . . . . 70.23 111.882 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.8 pt -117.36 170.32 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.803 0.841 . . . . 71.52 110.823 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.83 177.39 48.08 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 116.439 -0.346 . . . . 63.13 113.609 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.6 t 69.46 151.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.409 1.483 . . . . 73.2 113.441 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.1 p -161.94 -67.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.254 0.622 . . . . 64.34 111.016 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.2 27.25 2.57 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.749 0.82 . . . . 75.55 112.211 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -70.93 103.0 2.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 63.14 110.753 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.58 172.76 12.54 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 74.3 111.078 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 27.7 p -141.28 174.16 10.8 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.495 0.718 . . . . 50.53 111.004 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 137.85 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.505 0.722 . . . . 64.35 110.576 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.0 tp -118.64 129.22 55.18 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.062 0.945 . . . . 54.2 109.598 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -159.64 121.87 3.4 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.737 0.415 . . . . 63.01 111.858 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -133.72 104.58 6.4 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.143 0.977 . . . . 73.31 109.213 172.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.09 114.79 22.5 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.843 0.457 . . . . 74.14 110.494 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -91.48 166.44 12.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.451 0.7 . . . . 73.04 112.268 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.59 111.68 11.95 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.924 0.89 . . . . 44.3 109.672 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -104.89 131.89 51.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.836 0.855 . . . . 74.32 111.054 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.787 0.803 . . . . 73.12 110.288 176.034 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.683 ' SD ' ' HG2' ' A' ' 96' ' ' GLU . 17.2 ptm . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 112.471 0.545 . . . . 75.14 112.471 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -98.41 168.12 10.4 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.891 0.876 . . . . 70.4 111.668 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 t -76.99 155.82 32.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.757 0.823 . . . . 75.34 112.119 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.02 -34.13 77.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.357 0.663 . . . . 75.22 111.797 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.503 HG23 HG13 ' A' ' 102' ' ' VAL . 2.4 m -66.7 -44.06 82.72 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.472 0.653 . . . . 75.11 110.557 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.55 -50.57 73.37 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 125.246 1.418 . . . . 74.44 111.962 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' ' 51' ' ' LEU . 86.7 mt -62.92 -44.37 96.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.644 0.778 . . . . 74.14 111.871 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 11' ' ' LEU . 51.9 tp -59.36 -40.36 86.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.224 1.01 . . . . 63.34 111.601 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.41 -41.95 99.07 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.007 -0.997 . . . . 72.35 110.875 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 14' ' ' VAL . 13.2 mm-40 -72.57 -30.3 64.29 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.572 -0.74 . . . . 72.44 112.308 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 8' ' ' LEU . 78.5 mt -57.36 -44.82 84.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.348 0.659 . . . . 75.24 112.244 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -88.49 -5.12 58.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.922 0.489 . . . . 75.25 112.313 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.24 -55.84 3.51 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.226 0.61 . . . . 50.3 111.671 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 10' ' ' GLU . 33.1 m -90.55 118.79 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.185 0.517 . . . . 63.11 111.541 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -43.85 -25.53 0.2 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.493 1.664 . . . . 71.34 115.493 172.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -127.78 122.54 33.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.862 0.465 . . . . 65.03 110.841 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.5 m -74.5 92.08 2.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.532 0.733 . . . . 52.21 110.496 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.92 -63.31 1.16 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.394 0.678 . . . . 73.14 111.769 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -119.82 -1.08 10.56 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 119.247 -0.406 . . . . 63.43 112.049 175.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.5 105.84 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.021 0.828 . . . . 61.31 109.085 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -121.57 130.21 53.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.055 0.542 . . . . 71.31 110.816 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.65 134.93 45.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 70.54 112.45 -172.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 151.53 46.42 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.045 0.938 . . . . 74.23 111.076 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -84.08 154.05 23.42 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.97 0.908 . . . . 74.22 110.288 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.37 70.08 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 112.99 0.737 . . . . 74.42 112.99 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.1 p -81.22 13.41 2.88 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.786 1.032 . . . . 74.51 113.786 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.05 4.52 19.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.054 0.542 . . . . 63.21 112.118 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mtp -53.69 104.56 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.533 0.568 . . . . 73.55 112.533 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.74 -142.83 7.95 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.395 -0.366 . . . . 60.54 113.188 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -70.9 -21.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.238 1.015 . . . . 74.24 113.039 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 m -75.12 -43.39 53.01 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.95 0.5 . . . . 63.22 110.941 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -37.92 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.239 0.615 . . . . 74.42 110.607 168.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.536 ' HA ' HG22 ' A' ' 36' ' ' VAL . 20.7 mmt -71.19 -31.86 68.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.773 -0.649 . . . . 73.22 112.592 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.29 -32.75 74.47 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.398 0.618 . . . . 53.04 110.054 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -78.05 -46.38 21.03 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.699 0.8 . . . . 65.51 112.171 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 33' ' ' MET . 19.8 m -59.58 -39.01 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 118.11 0.414 . . . . 70.42 112.116 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.15 -35.75 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.287 0.635 . . . . 74.52 110.996 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.1 -38.41 91.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.849 0.46 . . . . 70.23 112.102 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -73.87 -47.68 36.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.172 0.589 . . . . 60.32 111.481 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.77 -21.85 60.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.585 0.957 . . . . 61.53 113.585 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -93.37 -42.75 9.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.21 0.604 . . . . 71.25 111.442 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.44 111.58 4.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.666 0.786 . . . . 74.12 112.019 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.08 105.3 0.67 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.791 2.327 . . . . 72.34 112.831 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.19 19.63 11.38 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.674 -0.694 . . . . 70.52 114.749 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.9 tp -106.84 5.49 28.52 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.764 1.282 . . . . 72.23 112.205 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -40.91 124.47 2.15 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 125.11 1.364 . . . . 71.34 113.711 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 105.57 51.52 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.896 -0.593 . . . . 71.11 112.627 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -112.55 149.27 18.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 111.673 -0.571 . . . . 34.43 111.673 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -123.47 126.84 47.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.648 0.779 . . . . 71.01 111.354 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -104.73 116.68 32.45 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.471 -1.307 . . . . 65.42 107.471 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 7' ' ' LEU . 31.2 tp -103.4 112.35 25.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.724 0.409 . . . . 74.33 111.021 -173.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 108' ' ' LEU . 93.1 mt -92.88 140.16 29.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.601 0.76 . . . . 64.54 111.65 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.21 7.04 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.926 -0.579 . . . . 60.3 112.739 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.08 144.37 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.507 0.723 . . . . 43.34 110.672 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -124.6 163.85 21.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 62.54 108.002 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -154.77 138.69 16.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.423 0.527 . . . . 71.15 112.423 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 151.97 47.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.799 0.84 . . . . 72.23 111.279 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -91.62 131.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.592 0.757 . . . . 73.25 111.467 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -84.89 -172.09 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.912 0.485 . . . . 52.31 111.659 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.06 -37.71 80.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.268 0.627 . . . . 61.42 112.562 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -77.33 -29.35 53.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 63.22 112.264 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.12 9.55 15.46 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.626 0.61 . . . . 63.5 114.626 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.05 138.7 37.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.283 0.633 . . . . 53.44 111.378 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -83.87 111.2 19.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.306 0.642 . . . . 62.55 109.584 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.45 115.32 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.786 . . . . 72.14 109.863 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -93.3 115.27 27.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.205 0.602 . . . . 74.43 111.095 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -110.67 153.34 43.66 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.131 0.972 . . . . 53.34 111.405 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.42 116.55 2.99 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.305 2.004 . . . . 74.02 113.032 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.01 -30.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 122.824 0.449 . . . . 54.22 110.745 168.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.58 -175.91 53.97 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.729 -0.668 . . . . 43.14 112.613 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.69 138.7 23.38 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 122.358 -0.496 . . . . 75.4 110.37 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.38 -33.9 28.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.698 2.265 . . . . 61.22 112.618 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -127.37 66.49 69.07 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.015 0.926 . . . . 61.14 109.648 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HB2' HD22 ' A' ' 99' ' ' LEU . 60.5 Cg_endo -65.34 -36.04 37.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.863 2.375 . . . . 62.02 113.725 -164.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.19 -40.59 82.17 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.645 0.778 . . . . 61.41 110.41 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -70.34 -35.69 73.75 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.2 -0.909 . . . . 63.14 111.551 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.35 -43.07 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.655 0.782 . . . . 60.22 110.815 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.523 ' HG2' HH21 ' A' ' 79' ' ' ARG . 53.2 tt0 -56.59 -45.04 81.59 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.578 0.751 . . . . 65.41 111.85 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.523 HH21 ' HG2' ' A' ' 78' ' ' GLN . 4.0 mmp_? -75.45 -36.95 60.61 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.668 -0.697 . . . . 61.32 112.626 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.33 -35.15 75.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.243 0.617 . . . . 73.54 110.42 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 26.8 tp -70.68 -39.62 73.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.613 0.765 . . . . 75.01 110.739 176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.12 77.3 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.152 0.581 . . . . 63.43 111.817 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -72.14 -53.2 13.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.289 0.635 . . . . 64.45 111.436 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 81' ' ' LEU . 11.9 pt20 -71.05 -32.46 69.17 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.056 0.762 . . . . 71.3 113.056 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 p -64.85 -31.3 72.46 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 118.877 0.762 . . . . 75.23 112.228 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -81.45 -27.1 34.81 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 116.033 -0.531 . . . . 74.11 112.381 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -92.14 -33.89 14.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.694 0.628 . . . . 74.21 112.694 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -79.86 -48.04 14.14 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.09 0.556 . . . . 75.01 111.294 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -81.63 157.61 24.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.849 -0.614 . . . . 74.34 111.294 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -45.96 -35.39 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.358 1.463 . . . . 70.31 114.16 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.62 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.458 0.703 . . . . 74.53 111.093 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -71.72 97.53 1.78 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.725 -0.67 . . . . 53.43 110.216 170.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.89 123.89 28.17 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.944 -1.132 . . . . 75.33 107.944 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -104.01 96.02 8.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.398 0.679 . . . . 64.35 110.694 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.91 166.63 7.14 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.09 1.86 . . . . 74.43 111.977 172.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.683 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 40.9 tt0 -101.23 115.71 31.13 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.924 -0.769 . . . . 64.21 108.924 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 61.5 mtt -115.07 131.14 57.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.326 0.65 . . . . 73.24 112.006 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -142.02 146.71 35.84 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.813 0.845 . . . . 75.03 110.964 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 74' ' ' PRO . 42.6 mt -102.37 119.35 38.66 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.984 0.913 . . . . 63.01 110.329 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -124.87 130.32 52.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.695 1.198 . . . . 62.42 109.584 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -94.49 121.76 36.37 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.955 0.407 . . . . 74.11 111.643 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 5' ' ' THR . 12.4 t -126.4 127.08 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.285 1.034 . . . . 62.22 109.46 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.89 30.87 57.75 Favored Glycine 0 CA--C 1.548 2.124 0 N-CA-C 115.265 0.866 . . . . 71.21 115.265 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.98 81.78 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.905 0.352 . . . . 74.22 113.938 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -116.38 146.18 42.67 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.088 0.955 . . . . 75.42 109.803 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -95.34 104.58 16.47 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.969 0.804 . . . . 71.24 111.105 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.0 162.01 14.56 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.829 0.851 . . . . 72.35 111.497 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 52' ' ' LEU . 61.9 tp -120.28 118.36 30.22 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.738 0.815 . . . . 73.33 110.366 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.56 119.91 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.273 -0.64 . . . . 52.33 109.273 171.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.33 101.1 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.126 -0.694 . . . . 51.52 109.126 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.2 t80 -76.83 113.81 14.91 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.36 -0.607 . . . . 74.25 109.36 174.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.11 99.29 42.63 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 108.903 -0.777 . . . . 63.21 108.903 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.38 -176.44 1.55 Allowed 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.733 2.288 . . . . 72.34 113.093 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 44.4 mt-10 -84.92 148.33 26.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.825 -0.625 . . . . 72.33 109.748 165.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.11 178.81 4.45 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.668 0.787 . . . . 55.14 110.481 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.61 124.35 24.51 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 118.282 -0.866 . . . . 75.12 110.368 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -38.06 -37.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 116.54 2.052 . . . . 51.21 116.54 -157.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -57.01 -40.53 76.8 Favored 'General case' 0 N--CA 1.509 2.483 0 CA-C-N 118.963 0.802 . . . . 74.05 112.003 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 14.5 m-70 -133.58 77.92 1.75 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 103.986 -2.598 . . . . 70.35 103.986 165.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.587 ' HA ' HG12 ' A' ' 122' ' ' ILE . 47.5 mtmt -46.86 -149.78 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 2 C-N-CA 133.016 4.526 . . . . 74.1 122.456 46.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo 12.06 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.808 2.339 . . . . 61.44 115.112 -120.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 120' ' ' LYS . 51.1 mm -86.31 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 115.158 -0.928 . . . . 72.11 110.56 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -156.37 165.38 36.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.807 0.843 . . . . 73.33 110.386 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -79.41 139.82 37.59 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.458 0.303 . . . . 72.22 110.59 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -79.96 -10.17 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.76 0.424 . . . . 74.34 111.297 172.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.28 85.0 1.42 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.606 0.762 . . . . 65.01 111.114 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.8 m -78.08 121.02 23.73 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.636 0.774 . . . . 74.13 110.076 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.09 72.12 0.3 Allowed Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.742 -0.543 . . . . 61.54 111.742 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.76 92.46 42.55 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.586 0.755 . . . . 74.14 111.056 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.21 102.28 1.52 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 122.497 2.131 . . . . 73.01 112.464 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.36 109.77 3.01 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 116.229 -0.441 . . . . 74.12 112.958 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.48 -130.68 0.39 Allowed Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.203 0.441 . . . . 60.33 114.203 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.83 95.03 2.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.062 0.545 . . . . 62.33 111.785 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -75.89 -54.47 6.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.947 -0.569 . . . . 74.54 110.07 171.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -75.07 108.82 8.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.803 0.841 . . . . 53.31 110.501 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.83 124.56 26.33 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.858 0.361 . . . . 53.53 110.194 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.0 tt -90.08 -41.45 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.981 0.513 . . . . 72.12 111.658 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.21 158.93 34.87 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.418 -0.355 . . . . 22.0 113.401 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.9 m -131.04 -166.65 1.73 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.224 1.01 . . . . 35.54 109.503 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -68.58 93.06 0.48 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.762 0.315 . . . . 61.41 110.258 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.65 123.76 19.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.61 0.764 . . . . 74.33 110.745 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -65.24 111.86 3.18 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.312 0.645 . . . . 75.21 111.877 -169.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -66.47 103.94 1.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.298 -0.864 . . . . 70.11 108.988 168.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 29.1 p -61.92 153.14 30.06 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.702 0.801 . . . . 63.4 111.635 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.4 m -61.57 142.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.264 0.625 . . . . 63.53 111.493 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -73.81 164.07 27.12 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.979 0.512 . . . . 63.51 111.197 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.94 120.18 14.43 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 122.496 0.319 . . . . 72.04 110.626 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -84.91 91.29 8.0 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.589 0.356 . . . . 61.23 110.933 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.5 p80 36.64 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 126.02 1.728 . . . . 74.43 115.271 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -70.15 148.07 49.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.093 0.557 . . . . 73.23 112.273 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.2 t60 69.25 133.9 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.38 1.472 . . . . 73.1 113.413 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -138.94 176.36 8.76 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.221 1.009 . . . . 74.54 110.835 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.239 0.542 . . . . 73.44 110.302 169.74 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.649 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 46.5 ttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.499 0.19 . . . . 64.32 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB2' HD11 ' A' ' 7' ' ' LEU . 19.4 mmt180 -79.07 162.87 25.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.89 0.876 . . . . 65.22 110.783 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.8 t -80.73 155.09 26.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.183 0.593 . . . . 64.21 110.203 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.39 67.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.86 0.464 . . . . 63.32 112.103 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -70.0 -44.27 69.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.128 0.571 . . . . 64.41 110.602 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.8 -48.99 79.47 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.041 0.936 . . . . 61.52 111.398 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD22 HD12 ' A' ' 20' ' ' ILE . 80.8 mt -74.43 -31.67 62.37 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.039 -0.982 . . . . 63.02 112.867 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.34 -46.83 81.76 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.937 0.495 . . . . 75.05 110.264 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.26 -33.34 73.38 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.195 -0.911 . . . . 73.35 110.789 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.1 tp10 -70.49 -41.92 72.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.594 0.758 . . . . 73.53 110.933 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.2 mt -59.13 -43.16 91.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.983 0.913 . . . . 74.32 111.918 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -68.56 -32.37 72.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.193 0.597 . . . . 64.34 111.274 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.79 68.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.718 0.807 . . . . 73.11 112.072 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.79 148.39 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.377 0.608 . . . . 72.33 111.389 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.72 -14.89 55.94 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 75.44 111.635 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.07 153.46 25.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.648 0.779 . . . . 63.54 110.582 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.5 m -73.99 92.13 2.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.742 0.417 . . . . 64.52 111.101 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.48 -65.43 1.01 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.382 0.673 . . . . 61.23 112.264 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -119.11 -15.59 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.356 1.062 . . . . 60.05 110.001 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.568 HD12 HD22 ' A' ' 7' ' ' LEU . 31.5 mm -111.53 119.14 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.603 1.161 . . . . 53.41 108.023 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.45 141.1 48.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.486 0.714 . . . . 71.43 110.792 -171.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.57 127.26 52.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.667 0.787 . . . . 51.15 110.151 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 25.2 mmmt -132.24 136.5 47.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.977 0.911 . . . . 64.41 109.407 -176.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -81.99 168.01 18.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.255 0.55 . . . . 73.43 111.76 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.55 69.38 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.713 0.805 . . . . 62.41 112.507 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -65.72 -37.27 85.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 43.02 111.004 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -76.99 -6.82 54.14 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.379 1.072 . . . . 75.53 113.411 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -69.58 120.29 15.13 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.286 0.565 . . . . 70.11 110.287 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.11 -129.16 5.0 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.853 -0.612 . . . . 65.0 112.436 -172.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -59.33 -39.11 82.08 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.669 0.787 . . . . 73.21 112.097 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 m -65.45 -29.2 69.85 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.086 0.955 . . . . 34.11 112.61 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 81' ' ' LEU . 54.3 t -71.12 -51.08 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.726 0.41 . . . . 73.44 110.275 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -33.74 69.54 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.007 0.923 . . . . 72.01 112.924 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.35 -44.98 72.63 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.128 0.971 . . . . 73.23 111.159 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.3 m -76.89 -39.2 51.81 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.89 . . . . 63.52 112.461 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.25 -34.74 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 124.237 1.015 . . . . 65.33 112.444 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 33' ' ' MET . 58.5 mt -45.14 -45.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 124.087 0.955 . . . . 72.34 112.931 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.44 -60.07 4.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.106 0.562 . . . . 54.43 112.303 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.44 -24.43 62.9 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.622 0.601 . . . . 73.11 112.622 -169.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.82 -48.33 9.47 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.506 0.722 . . . . 62.32 112.353 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -93.3 -27.11 17.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.876 1.065 . . . . 74.13 113.876 -169.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 68.6 mm-40 -64.33 121.76 74.16 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 118.283 0.492 . . . . 74.21 111.731 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 23.7 Cg_exo -64.15 110.48 1.36 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.598 2.199 . . . . 63.43 112.549 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.73 59.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.058 -0.857 . . . . 35.35 115.207 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.91 20.82 13.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.104 1.452 . . . . 72.45 110.831 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -41.45 114.2 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.218 1.007 . . . . 74.33 112.332 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.15 68.33 0.64 Allowed Glycine 0 N--CA 1.471 0.994 0 N-CA-C 113.738 0.255 . . . . 61.52 113.738 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.63 142.0 17.29 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.925 -0.87 . . . . 50.12 110.925 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.649 ' HE1' ' HG3' ' A' ' 1' ' ' MET . 94.6 m-85 -118.12 129.76 55.72 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.511 0.655 . . . . 75.55 112.11 -170.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 32' ' ' VAL . 5.6 mp -112.07 124.96 53.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.955 0.902 . . . . 74.21 109.329 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.2 mm? -104.61 109.11 20.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.065 0.546 . . . . 71.53 109.707 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 8.4 mp -92.95 122.32 35.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.409 0.684 . . . . 73.45 109.196 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.14 26.34 3.81 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.571 -0.286 . . . . 63.44 113.374 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.21 133.96 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.409 -0.589 . . . . 50.33 109.409 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -119.12 137.07 53.84 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.457 -0.942 . . . . 72.21 108.457 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -122.88 139.63 53.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.046 0.539 . . . . 72.52 111.58 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.92 151.95 35.55 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.925 0.89 . . . . 75.22 111.177 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.04 122.67 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.356 0.662 . . . . 74.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -96.79 -168.43 1.71 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.629 0.772 . . . . 63.52 112.088 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.89 -32.37 67.65 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.57 1.148 . . . . 64.54 112.925 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -79.54 -11.77 59.88 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.48 0.712 . . . . 74.45 111.561 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.92 84.92 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 116.487 -0.324 . . . . 62.41 112.792 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.43 149.21 30.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.507 1.123 . . . . 64.13 111.914 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -104.62 115.52 30.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.253 1.021 . . . . 75.23 110.404 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.92 128.91 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.42 0.688 . . . . 61.33 109.603 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.77 119.1 32.3 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.177 0.591 . . . . 74.24 110.233 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -129.91 129.17 22.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 123.325 0.65 . . . . 74.45 110.601 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 67.5 Cg_endo -78.68 109.84 2.69 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 72.4 112.421 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.21 -14.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.678 -0.639 . . . . 71.11 111.356 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.82 53.6 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.011 -0.541 . . . . 74.24 113.929 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.34 131.07 23.55 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.055 0.942 . . . . 74.24 110.809 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -32.03 87.9 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.054 2.503 . . . . 53.45 113.009 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -138.74 87.14 15.0 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 108.221 -1.029 . . . . 74.43 108.221 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.1 -28.42 34.68 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.661 2.241 . . . . 71.43 113.505 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -47.63 66.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.082 0.953 . . . . 72.15 111.268 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.65 -44.43 70.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.631 -0.713 . . . . 72.34 111.443 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -58.9 -37.25 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 122.908 0.483 . . . . 75.35 111.47 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.05 -52.38 49.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.842 0.682 . . . . 75.13 112.842 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -75.77 -33.86 60.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 112.434 0.531 . . . . 70.12 112.434 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.56 -33.29 73.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.413 0.685 . . . . 73.25 110.343 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 HG11 ' A' ' 32' ' ' VAL . 41.2 tp -63.46 -42.93 98.61 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.53 0.732 . . . . 54.53 111.415 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.25 95.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.286 0.634 . . . . 53.53 111.728 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -63.52 -52.32 61.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.983 0.913 . . . . 62.55 112.036 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.74 -32.52 74.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.101 0.56 . . . . 53.32 112.244 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.178 0.513 . . . . 73.53 112.223 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.51 -20.7 36.21 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.464 0.706 . . . . 34.43 112.016 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -112.31 -2.78 14.72 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.792 1.034 . . . . 42.4 113.792 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.7 mmm -99.6 -26.91 13.93 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.44 0.696 . . . . 72.12 111.327 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -108.32 142.79 38.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.561 0.745 . . . . 63.13 109.212 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' A' ' 91' ' ' VAL . 7.6 p-10 -57.66 -26.19 61.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.325 0.861 . . . . 63.44 113.325 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 119' ' ' HIS . 6.6 m -122.22 163.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.479 1.112 . . . . 64.43 111.499 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.28 98.25 7.33 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.273 0.559 . . . . 74.45 110.935 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 122' ' ' ILE . 4.7 tt -96.24 138.57 33.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.143 0.977 . . . . 72.23 108.686 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -106.77 95.34 12.06 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.004 0.521 . . . . 72.24 111.766 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.75 155.46 15.61 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.783 1.655 . . . . 62.24 111.198 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 41.7 tt0 -108.12 120.53 42.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.529 0.732 . . . . 61.13 110.906 -171.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD11 ' A' ' 108' ' ' LEU . 1.8 mpt? -111.7 141.74 44.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.73 0.812 . . . . 60.11 111.413 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 133.53 15.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.681 -0.489 . . . . 75.3 109.681 167.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.0 mt -81.46 116.21 21.15 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.571 0.748 . . . . 62.02 110.74 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -123.25 130.77 53.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.799 1.24 . . . . 63.01 110.221 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -94.61 125.45 39.27 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.168 0.587 . . . . 73.44 111.281 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.45 119.15 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.913 0.885 . . . . 72.22 109.225 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.43 41.53 63.51 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.453 0.941 . . . . 74.2 115.453 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.98 88.66 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.883 0.713 . . . . 70.31 114.883 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.7 mmtt -110.0 139.85 44.66 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.791 0.837 . . . . 71.45 109.292 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.9 m -100.3 124.57 45.94 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.777 0.717 . . . . 74.4 111.024 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.49 164.9 14.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.127 0.971 . . . . 70.31 108.981 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.5 tp -115.64 116.52 28.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.58 0.352 . . . . 65.2 110.11 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.38 121.88 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 109.21 -0.663 . . . . 52.35 109.21 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.88 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.002 0.521 . . . . 72.0 110.623 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.721 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 63.4 t80 -80.49 114.77 19.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.12 109.715 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.23 102.13 34.88 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.516 -0.92 . . . . 72.24 108.516 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.42 169.8 15.25 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.396 2.064 . . . . 74.2 112.481 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -80.79 128.09 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.547 -0.751 . . . . 71.32 109.286 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.93 173.91 9.05 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.185 0.594 . . . . 72.11 111.669 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.59 155.97 37.89 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.679 0.792 . . . . 75.45 110.677 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.8 t -47.41 -42.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 114.85 1.426 . . . . 64.55 114.85 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 123.515 0.726 . . . . 64.12 112.471 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -129.37 78.21 1.84 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 103.605 -2.739 . . . . 62.33 103.605 169.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 32.2 mmtp -44.16 -159.01 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.781 1 C-N-CA 132.04 4.136 . . . . 64.03 120.861 66.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo 5.03 71.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.265 2.644 . . . . 71.31 118.059 -132.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 93' ' ' LEU . 1.8 mp -76.6 101.28 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.13 -1.063 . . . . 75.44 108.13 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -105.67 154.68 20.11 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.338 0.655 . . . . 73.24 109.813 168.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HD3' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -78.81 151.56 31.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.809 0.443 . . . . 73.03 110.603 -176.599 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.9 -10.32 58.07 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.664 0.786 . . . . 60.33 110.97 172.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.83 168.15 9.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.62 1.168 . . . . 72.43 111.107 173.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -150.22 139.59 21.38 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.624 0.77 . . . . 75.21 110.268 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.82 76.46 1.08 Allowed Glycine 0 C--N 1.349 1.295 0 O-C-N 123.014 0.196 . . . . 71.23 112.651 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.15 91.41 36.56 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.639 0.775 . . . . 64.34 110.739 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -94.85 13.8 1.35 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.184 2.589 . . . . 63.44 113.774 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.95 -172.31 54.22 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 116.94 -0.118 . . . . 74.01 112.96 -171.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.38 54.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.227 0 O-C-N 122.766 -0.256 . . . . 33.23 112.73 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.09 158.76 43.88 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.604 0.762 . . . . 50.43 111.981 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.55 143.97 29.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.956 0.902 . . . . 70.43 110.192 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -80.25 115.02 19.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.328 0.651 . . . . 73.44 111.764 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -77.75 99.91 6.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.08 0.552 . . . . 75.24 110.084 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 35.6 mt -91.1 124.4 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.945 0.898 . . . . 71.54 109.654 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.12 158.12 29.93 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 113.939 0.335 . . . . 54.22 113.939 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -153.07 158.79 42.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.457 0.703 . . . . 73.01 111.715 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.4 p -163.57 -155.09 0.3 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.493 1.117 . . . . 75.15 109.718 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t70 76.22 -8.1 1.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.079 1.14 . . . . 73.31 114.079 163.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -79.73 76.05 6.39 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.741 0.781 . . . . 72.24 112.866 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -164.36 96.71 0.78 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.312 -0.995 . . . . 75.14 108.312 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 47.9 t -104.38 156.42 17.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.16 0.584 . . . . 73.15 111.908 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.33 171.91 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.931 0.892 . . . . 64.14 110.389 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.52 154.09 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.008 0.523 . . . . 65.24 111.393 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -136.12 135.62 39.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.783 0.833 . . . . 71.32 110.05 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -142.82 166.29 25.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.703 0.801 . . . . 75.33 110.942 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -144.64 131.06 19.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.292 0.637 . . . . 64.12 109.697 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -99.03 128.62 45.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.301 0.641 . . . . 75.44 110.258 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -75.6 145.47 41.13 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.834 0.35 . . . . 73.11 110.821 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -136.89 107.27 6.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.521 0.729 . . . . 72.32 110.54 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 p80 . . . . . 0 N--CA 1.487 1.417 0 C-N-CA 123.07 0.548 . . . . 72.15 111.705 178.042 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.99 -0.374 . . . . 74.31 109.99 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -40.08 134.67 1.5 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.85 1.26 . . . . 73.13 114.328 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -69.38 159.86 32.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.048 0.939 . . . . 61.1 112.007 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.08 70.37 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.26 0.624 . . . . 75.53 112.596 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -65.87 -43.79 87.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.13 110.641 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.61 -43.29 76.71 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 115.199 -0.91 . . . . 73.21 111.566 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 20' ' ' ILE . 86.1 mt -65.94 -42.14 90.42 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.533 0.733 . . . . 55.21 111.406 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 11' ' ' LEU . 25.9 tp -52.04 -48.68 64.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.628 1.171 . . . . 72.53 111.075 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.9 -46.22 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.814 -1.084 . . . . 74.32 111.878 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.34 -30.18 61.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.412 -0.358 . . . . 74.2 111.726 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 8' ' ' LEU . 79.7 mt -57.82 -52.88 63.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.518 0.727 . . . . 63.04 111.596 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -82.57 -1.1 49.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.563 0.579 . . . . 70.34 112.563 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.6 -50.06 8.01 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.051 0.54 . . . . 55.2 110.611 170.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 m -80.24 150.51 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.101 0.56 . . . . 30.1 111.191 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -72.76 -27.76 62.21 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.482 0.713 . . . . 63.43 112.478 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.57 134.1 24.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.814 0.845 . . . . 72.31 109.389 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.634 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 50.9 p -72.91 80.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.483 0.713 . . . . 73.14 111.234 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.71 -64.28 1.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.611 0.765 . . . . 71.43 112.272 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.6 -26.97 14.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.008 0.523 . . . . 74.5 110.739 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 HD22 ' A' ' 7' ' ' LEU . 36.4 mt -116.18 109.0 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 8.9 tp10 -100.73 151.57 21.51 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.076 1.351 . . . . 74.32 111.307 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.44 134.25 53.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.562 0.745 . . . . 72.11 110.987 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 32' ' ' VAL . 13.8 mptt -130.87 149.8 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.753 0.821 . . . . 75.41 110.338 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.46 169.24 13.03 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.801 0.841 . . . . 72.32 111.653 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.61 88.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.951 0.501 . . . . 73.2 111.03 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -60.28 -35.66 76.05 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.336 1.054 . . . . 60.44 112.166 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.74 3.64 50.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.903 0.881 . . . . 52.11 112.416 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.8 mmm -65.93 128.29 35.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.324 0.649 . . . . 51.04 111.73 170.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.4 -146.84 15.84 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.098 -0.501 . . . . 50.33 112.573 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.4 -18.34 65.3 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.292 0.637 . . . . 53.21 112.568 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -73.72 -37.08 65.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.207 0.603 . . . . 53.3 111.44 176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 23' ' ' LYS . 58.7 t -65.72 -47.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.12 0.486 . . . . 53.35 109.792 172.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.524 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 86.4 mmm -62.71 -35.19 78.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.962 -1.017 . . . . 61.02 112.662 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -40.08 91.5 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.817 0.847 . . . . 75.34 111.012 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -71.01 -35.6 72.1 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.708 -0.678 . . . . 75.22 111.11 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.09 -46.23 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.635 0.774 . . . . 74.11 110.785 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.4 -36.81 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.908 0.883 . . . . 74.04 110.931 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.35 62.65 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.919 0.888 . . . . 63.35 113.045 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -91.47 -42.25 10.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 122.103 -0.373 . . . . 63.01 111.011 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.81 -55.29 10.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.831 1.049 . . . . 73.12 113.831 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.27 -16.32 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.441 0.696 . . . . 73.25 112.668 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 54.1 mm-40 -79.78 132.59 60.61 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.152 0.581 . . . . 74.4 112.124 -177.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 21.4 Cg_exo -65.34 101.84 0.44 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.176 2.584 . . . . 72.45 113.218 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.75 74.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.075 1.19 . . . . 45.12 116.075 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 42' ' ' GLU . 10.1 mp -96.38 22.11 8.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.532 1.166 . . . . 70.14 110.905 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 16.9 t70 -50.41 153.77 1.46 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.208 1.403 . . . . 73.51 112.686 165.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 92.59 36.58 6.1 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.715 -0.675 . . . . 75.44 112.936 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.3 141.11 15.29 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 117.503 0.651 . . . . 73.42 112.661 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -118.49 127.32 53.52 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.269 0.627 . . . . 74.35 112.02 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 64.6 mt -100.73 109.5 21.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.013 1.325 . . . . 72.24 109.529 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD13 HG22 ' A' ' 109' ' ' VAL . 21.1 tp -101.67 109.95 21.84 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.406 0.622 . . . . 72.25 109.762 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 108' ' ' LEU . 47.2 mt -99.35 136.32 39.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 72.43 110.416 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.23 5.93 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-O 121.224 0.347 . . . . 71.24 112.723 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.5 t -111.54 138.17 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.486 0.715 . . . . 62.02 109.636 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 18.0 t70 -103.64 148.42 26.04 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.146 -1.057 . . . . 75.22 108.146 174.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -145.29 143.01 29.96 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.152 0.501 . . . . 74.54 111.608 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.68 152.73 37.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.746 0.818 . . . . 74.44 110.428 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.08 126.87 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.927 0.491 . . . . 75.04 110.555 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -87.77 -179.29 6.24 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.359 0.663 . . . . 75.32 111.514 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -61.17 -19.17 61.25 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.962 1.097 . . . . 74.45 113.962 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -80.95 -14.87 57.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.228 0.611 . . . . 72.42 112.498 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.05 41.54 17.91 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.737 -0.545 . . . . 64.34 111.737 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.39 139.03 51.81 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.774 1.23 . . . . 71.05 110.32 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -84.87 119.89 25.85 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.201 0.601 . . . . 71.13 110.592 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.89 124.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.144 0.578 . . . . 41.35 110.056 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.05 122.05 41.78 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.459 0.703 . . . . 75.51 110.597 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 9.0 ptm180 -127.06 139.1 34.15 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.605 1.162 . . . . 52.33 110.76 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' HD21 ' A' ' 8' ' ' LEU . 77.2 Cg_endo -86.3 98.47 0.55 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.714 2.276 . . . . 61.02 112.837 -176.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.5 -17.93 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 70.14 111.687 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.41 46.52 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 116.302 -0.408 . . . . 63.41 113.561 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.14 136.74 21.89 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-O 118.868 -0.587 . . . . 55.21 110.064 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.62 -36.29 92.82 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.609 2.206 . . . . 63.55 112.473 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -130.35 87.52 50.38 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.416 0.687 . . . . 70.42 109.342 168.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.69 -26.71 9.59 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.84 2.36 . . . . 75.24 114.047 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 6.3 m-20 -72.22 -47.21 52.17 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.444 0.698 . . . . 74.14 111.163 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -61.56 -36.49 80.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.262 0.351 . . . . 60.31 110.762 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.99 -43.69 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.013 0.925 . . . . 61.24 111.221 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -59.99 -45.98 90.97 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.624 0.769 . . . . 63.51 111.962 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 28.8 mmm180 -70.67 -45.33 65.25 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.716 -0.675 . . . . 74.01 111.875 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.36 -28.07 64.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.759 0.824 . . . . 74.52 111.884 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.9 tp -69.76 -40.01 76.38 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.588 0.355 . . . . 74.4 110.748 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.53 91.03 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.057 0.543 . . . . 63.31 111.252 173.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -64.93 -52.64 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.873 0.869 . . . . 64.01 111.712 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -64.78 -31.69 73.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.878 0.471 . . . . 73.42 111.901 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.7 t -69.73 -25.42 63.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 64.42 112.048 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.05 -33.58 20.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.428 0.691 . . . . 70.43 112.267 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 p -92.21 -37.28 12.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.667 0.988 . . . . 71.33 113.667 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.524 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 82.4 mtp -76.28 -47.48 23.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.031 0.532 . . . . 65.21 112.059 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.75 148.3 36.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.304 0.642 . . . . 74.11 112.11 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -53.78 -32.27 51.83 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.825 1.25 . . . . 72.34 112.864 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.7 m -129.41 172.37 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.281 1.032 . . . . 64.01 111.338 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.82 104.4 13.88 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.912 -0.586 . . . . 53.41 110.986 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 tt -93.02 133.23 36.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.791 -1.189 . . . . 74.22 107.791 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -109.61 95.3 19.08 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 122.808 0.443 . . . . 64.34 111.633 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.73 158.93 10.54 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.563 2.175 . . . . 73.23 112.405 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.2 tp10 -100.77 131.8 46.49 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.535 0.734 . . . . 74.21 109.483 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.9 mtt -125.71 116.66 22.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.08 0.552 . . . . 75.35 111.324 -172.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -114.99 133.28 56.17 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 75.42 111.05 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.68 109.73 21.15 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.122 0.569 . . . . 71.11 109.538 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -109.43 128.1 54.89 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.724 1.209 . . . . 61.42 112.309 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -97.97 109.33 22.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.341 0.591 . . . . 64.12 110.718 174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -121.17 112.73 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.624 1.17 . . . . 61.41 108.63 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.36 29.68 66.59 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 113.886 0.314 . . . . 71.1 113.886 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.03 0.44 90.3 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.197 0.439 . . . . 62.04 114.197 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -100.81 137.2 39.52 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.511 0.724 . . . . 74.24 109.301 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -98.56 121.38 40.43 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 119.047 0.84 . . . . 72.25 111.997 -174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.78 166.98 11.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.124 1.37 . . . . 65.24 108.864 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 52' ' ' LEU . 26.4 tp -123.72 109.84 14.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.086 -0.384 . . . . 73.04 110.513 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG22 HD13 ' A' ' 51' ' ' LEU . 59.0 t -84.3 123.24 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.938 -0.764 . . . . 63.23 108.938 171.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 40.9 t -118.41 99.84 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.394 0.678 . . . . 72.03 109.607 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HE1' ' HA2' ' A' ' 47' ' ' GLY . 87.5 t80 -79.88 122.5 26.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.78 -0.646 . . . . 63.54 110.021 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.29 112.08 65.12 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 109.085 -0.709 . . . . 60.45 109.085 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.49 172.78 15.6 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.612 2.208 . . . . 74.33 113.044 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -58.24 160.59 4.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.485 0.714 . . . . 42.1 112.366 172.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 120' ' ' LYS . . . -110.46 135.15 51.58 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 115.851 -0.613 . . . . 72.51 110.063 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 18.5 t70 -65.57 160.66 21.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.669 1.187 . . . . 73.52 112.001 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -47.3 -38.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.188 1.181 . . . . 74.31 114.188 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -75.21 -39.46 60.08 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.309 0.485 . . . . 63.53 112.309 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 4.3 p-80 -142.75 94.98 2.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.821 -1.548 . . . . 74.31 106.821 171.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 22.2 pttp -47.14 -163.77 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.39 2 C-N-CA 133.965 4.906 . . . . 61.32 123.298 43.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo 7.69 77.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.603 2.202 . . . . 65.24 116.566 -113.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' A' ' 120' ' ' LYS . 60.0 mt -94.65 113.59 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.781 -1.1 . . . . 73.24 109.267 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -131.3 141.27 49.93 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.568 0.699 . . . . 75.3 111.508 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -61.86 134.93 57.31 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.52 -1.218 . . . . 62.35 110.523 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.9 153.03 44.6 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 120.545 0.212 . . . . 64.1 110.93 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 67.07 18.84 10.52 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.47 1.108 . . . . 53.42 111.744 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.7 m -140.59 105.36 4.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.333 1.053 . . . . 74.11 109.361 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.61 -76.97 0.8 Allowed Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.22 -0.445 . . . . 51.44 113.209 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 1.6 pp -137.07 140.32 30.98 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.603 0.761 . . . . 75.42 111.185 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 129' ' ' LEU . 21.9 Cg_exo -67.11 -57.92 0.16 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.832 2.355 . . . . 42.14 112.897 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.02 71.44 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 115.895 -0.593 . . . . 71.42 113.114 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.79 78.87 Favored Glycine 0 CA--C 1.546 2.007 0 N-CA-C 115.032 0.773 . . . . 53.31 115.032 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 72.47 -59.46 0.56 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.799 1.64 . . . . 62.33 113.948 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.64 153.04 17.26 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.733 1.213 . . . . 61.32 113.315 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -79.23 34.96 0.26 Allowed 'General case' 0 CA--C 1.577 2.004 0 C-N-CA 124.862 1.265 . . . . 60.5 112.754 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -74.55 99.8 3.71 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.352 -0.842 . . . . 72.13 110.229 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.5 mt -83.02 77.06 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.596 0.712 . . . . 64.53 110.315 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.94 -34.3 5.22 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 115.545 -0.752 . . . . 52.32 112.904 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -72.7 121.4 19.75 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.725 0.81 . . . . 72.31 111.659 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.2 t -74.58 126.64 31.24 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.06 0.544 . . . . 25.45 110.405 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.97 128.03 33.78 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.569 0.699 . . . . 64.11 111.997 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -82.36 -178.4 7.03 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.186 0.995 . . . . 50.04 111.446 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -67.82 85.06 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.37 0.668 . . . . 70.14 110.847 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 28.2 p -167.37 162.15 14.55 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.907 0.883 . . . . 72.15 111.549 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -81.75 129.92 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.935 0.494 . . . . 62.31 110.98 173.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.64 -175.12 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.443 0.697 . . . . 73.04 110.398 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -88.24 95.05 10.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.195 0.598 . . . . 71.53 110.004 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -146.89 117.44 7.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.862 0.865 . . . . 72.15 109.987 173.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -70.99 103.29 2.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.684 -0.858 . . . . 71.34 108.684 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -57.23 112.69 1.45 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.238 0.615 . . . . 73.41 112.104 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -74.15 98.8 3.22 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.482 0.713 . . . . 71.04 109.94 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -110.16 -59.54 1.92 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.424 0.69 . . . . 60.5 111.332 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 . . . . . 0 N--CA 1.491 1.576 0 C-N-CA 123.858 0.863 . . . . 74.3 111.682 -174.781 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' H ' ' A' ' 2' ' ' ARG . 10.8 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.322 -0.251 . . . . 73.42 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.0 ttt180 174.43 144.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.744 . . . . 72.13 109.882 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.34 154.43 30.83 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.431 0.293 . . . . 44.22 111.401 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.99 74.61 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.467 0.707 . . . . 72.55 112.423 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.621 HG23 HG13 ' A' ' 102' ' ' VAL . 3.7 m -65.3 -41.72 93.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.708 0.803 . . . . 71.15 110.71 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.0 -38.81 69.58 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.19 -0.914 . . . . 65.4 110.857 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD11 HG13 ' A' ' 109' ' ' VAL . 61.4 mt -65.03 -40.42 94.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.034 0.534 . . . . 60.3 111.301 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 11' ' ' LEU . 33.6 tp -62.42 -46.5 88.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.636 0.774 . . . . 74.44 110.559 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.0 -41.01 86.62 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.744 -1.116 . . . . 72.25 111.514 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.71 -38.48 83.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.472 0.709 . . . . 72.03 111.545 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 8' ' ' LEU . 44.6 mt -60.29 -39.79 88.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.191 0.996 . . . . 72.14 111.155 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.93 -32.28 69.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.765 0.826 . . . . 74.13 111.903 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.07 -46.02 58.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.876 0.87 . . . . 75.52 112.012 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.22 151.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.352 0.596 . . . . 63.52 112.121 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.22 -33.33 61.35 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.853 0.861 . . . . 75.43 111.113 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -147.95 156.52 42.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 72.24 109.958 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -66.44 76.07 0.1 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.865 0.866 . . . . 63.15 111.552 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -61.87 2.29 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.209 1.004 . . . . 51.12 111.996 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -133.98 8.38 3.78 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.024 0.93 . . . . 71.34 110.717 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.62 107.67 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.924 0.89 . . . . 72.13 110.347 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -92.33 148.65 21.96 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.35 1.06 . . . . 70.55 111.24 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.1 54.18 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.314 1.045 . . . . 73.54 109.882 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 65.0 mttm -139.62 141.02 37.13 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 71.42 111.74 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -84.92 164.21 18.49 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 115.308 -0.86 . . . . 73.54 110.449 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' MET . . . -62.65 -31.99 72.95 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.589 0.589 . . . . 75.04 112.589 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -69.61 -21.97 63.53 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.094 0.775 . . . . 71.04 113.094 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.87 -8.45 48.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.701 0.8 . . . . 63.21 111.937 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -55.03 119.95 6.2 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.108 1.363 . . . . 74.01 112.035 -176.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.98 -147.07 18.95 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.95 -0.46 . . . . 53.01 111.95 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -64.07 -25.01 67.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.239 0.616 . . . . 73.45 112.547 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -59.63 -36.92 77.31 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.232 0.613 . . . . 71.44 111.898 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 34.8 t -71.97 -43.62 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.311 0.577 . . . . 71.23 111.105 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.632 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 80.0 mmm -69.65 -40.9 76.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.118 1.155 . . . . 71.51 114.118 -166.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.73 -31.04 71.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.813 0.34 . . . . 72.22 110.909 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 m -67.75 -37.56 82.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.387 0.675 . . . . 75.43 111.004 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.07 -41.09 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.29 0.636 . . . . 61.24 110.86 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.76 -35.07 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.256 0.622 . . . . 54.22 110.39 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.24 63.45 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.807 0.843 . . . . 61.21 112.636 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -99.07 -29.49 12.86 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.307 0.643 . . . . 73.34 111.921 170.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.82 -34.69 75.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 55.2 112.377 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -8.08 58.81 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.545 0.738 . . . . 74.35 112.79 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -81.81 116.42 63.12 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.768 0.827 . . . . 72.41 112.275 -173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.49 111.74 3.39 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.662 2.241 . . . . 64.12 112.438 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.79 19.56 57.7 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.326 0.89 . . . . 72.2 115.326 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.25 21.62 14.53 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 118.716 1.258 . . . . 74.52 111.908 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -40.95 123.05 1.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.637 0.977 . . . . 74.43 113.637 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.64 53.75 0.91 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 116.343 -0.39 . . . . 44.12 113.007 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.81 135.57 12.29 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.423 -1.071 . . . . 70.55 110.423 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.21 128.53 56.27 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.936 0.868 . . . . 73.31 111.914 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.0 mp -112.54 117.81 33.37 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.78 -1.193 . . . . 64.24 107.78 167.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.24 109.83 21.57 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.924 -0.485 . . . . 64.53 109.976 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.7 134.37 40.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.885 0.874 . . . . 73.42 110.575 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.94 28.54 6.16 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 116.293 -0.412 . . . . 60.33 112.13 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.25 138.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.199 0.999 . . . . 74.32 110.252 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -116.71 165.6 13.1 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.864 -1.162 . . . . 63.0 107.864 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -148.58 141.84 25.11 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.387 0.613 . . . . 74.44 111.537 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.04 135.55 53.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.282 1.033 . . . . 65.1 110.536 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 49.6 mm -99.82 118.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.187 0.518 . . . . 62.33 111.515 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -75.99 172.23 13.1 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.846 0.858 . . . . 71.41 111.419 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.52 -21.45 66.62 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.006 0.522 . . . . 62.25 112.144 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -71.61 -14.37 62.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.149 0.98 . . . . 71.33 112.168 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.84 35.22 25.42 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.317 -0.713 . . . . 70.53 111.317 -168.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 25.3 t0 -99.86 140.26 34.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.972 0.909 . . . . 74.04 111.395 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -105.76 107.24 18.13 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.392 0.677 . . . . 74.14 110.633 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.54 120.17 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.833 0.853 . . . . 74.43 109.78 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.77 119.42 32.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.188 0.595 . . . . 54.5 110.422 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -121.85 153.52 60.36 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.52 1.128 . . . . 62.31 110.912 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' HD21 ' A' ' 8' ' ' LEU . 89.8 Cg_endo -82.67 141.44 10.96 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.202 1.935 . . . . 71.14 112.738 177.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.87 -26.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.859 0.864 . . . . 70.31 110.681 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 -178.22 53.88 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 121.852 0.696 . . . . 71.03 114.736 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 108' ' ' LEU . 51.4 mt -101.28 142.35 24.43 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.44 110.904 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.79 -27.98 67.93 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.842 2.361 . . . . 75.34 112.424 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -145.49 97.57 4.67 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 107.817 -1.179 . . . . 62.5 107.817 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.34 -51.47 10.94 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.975 3.117 . . . . 72.31 114.689 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 23.1 t70 -64.58 -51.46 62.64 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.325 -0.852 . . . . 53.32 110.551 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 ttmp? -59.84 -36.93 77.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.582 0.753 . . . . 73.54 112.839 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.91 -41.82 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.043 0.537 . . . . 71.54 111.249 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.15 -33.35 75.23 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.528 0.731 . . . . 74.25 111.528 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 44.3 mmm-85 -72.41 -51.19 21.46 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.546 0.738 . . . . 71.24 110.886 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.22 -44.49 92.29 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.197 0.999 . . . . 75.12 111.821 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.7 tp -67.22 -32.81 74.1 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 111.79 0.293 . . . . 64.24 111.79 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.37 96.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.018 0.527 . . . . 75.53 111.212 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 -45.96 90.55 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.412 0.685 . . . . 74.44 111.524 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -53.92 -53.2 55.94 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.994 0.918 . . . . 74.44 111.24 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 10.6 t -72.61 -18.37 61.6 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.865 0.691 . . . . 64.03 112.865 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -88.41 -39.6 14.15 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.386 0.675 . . . . 71.42 112.197 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -92.85 -39.86 10.95 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.371 0.878 . . . . 75.41 113.371 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.632 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 66.8 mtp -68.85 -40.95 79.09 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.13 0.49 . . . . 71.34 111.913 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.4 mt -84.12 151.46 24.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.946 0.898 . . . . 73.35 110.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.2 p30 -57.33 -32.27 66.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.382 0.882 . . . . 73.04 113.382 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.38 160.01 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.871 0.868 . . . . 73.24 110.413 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -77.12 103.6 7.14 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.109 -0.496 . . . . 65.25 110.513 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.674 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.8 tt -99.04 128.83 45.26 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.486 -0.931 . . . . 64.44 108.486 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.9 ttt85 -98.49 109.61 53.42 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 75.03 110.611 172.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.88 126.77 5.94 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 121.874 1.716 . . . . 74.24 110.311 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.88 100.8 4.92 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.047 -0.524 . . . . 62.11 109.777 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.616 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.0 mtm -110.15 133.51 53.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.427 0.691 . . . . 65.33 112.228 -171.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.27 136.5 39.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.098 0.959 . . . . 71.41 111.111 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 69.9 mt -88.29 116.02 26.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.404 1.082 . . . . 72.23 111.153 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -125.87 131.54 52.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.598 1.159 . . . . 73.4 110.63 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -92.09 125.66 36.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.26 0.624 . . . . 64.51 111.85 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.621 HG13 HG23 ' A' ' 5' ' ' THR . 12.1 t -121.18 114.04 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.584 1.154 . . . . 74.32 109.38 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.32 30.88 61.91 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.561 0.985 . . . . 72.14 115.561 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.14 8.84 83.22 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 114.219 0.448 . . . . 63.42 114.219 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -107.44 137.62 45.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 72.05 108.896 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.0 m -98.43 117.71 33.47 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.278 0.944 . . . . 73.45 111.854 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.66 163.59 13.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.357 1.063 . . . . 72.04 109.452 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -117.33 115.61 25.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.051 0.54 . . . . 71.24 110.538 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.419 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -82.53 106.43 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.885 -0.783 . . . . 73.13 108.885 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 60.7 t -92.88 100.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.503 -0.925 . . . . 70.31 108.503 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -85.02 115.2 22.71 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.869 -1.06 . . . . 73.45 108.872 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 63.6 t -106.52 98.39 20.05 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.359 0.663 . . . . 75.45 109.273 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.94 162.72 40.3 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.09 1.86 . . . . 74.4 110.519 167.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -70.34 132.97 46.47 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.053 -0.351 . . . . 65.21 110.053 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -64.34 158.03 24.63 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 122.987 0.515 . . . . 65.51 111.041 172.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.38 178.92 0.49 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.118 0.967 . . . . 64.14 111.2 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.84 -52.29 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.264 -1.522 . . . . 72.44 113.602 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.1 p -67.66 -48.15 67.5 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 123.711 0.805 . . . . 65.44 111.614 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -115.22 83.49 1.92 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 103.919 -2.623 . . . . 74.21 103.919 163.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.0 mttp -50.58 -143.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.131 1 C-N-CA 133.734 4.814 . . . . 65.41 120.989 49.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo 7.15 71.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.253 2.635 . . . . 75.4 115.797 -122.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 120' ' ' LYS . 35.4 mm -81.54 77.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 114.909 -1.041 . . . . 75.25 108.936 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -88.51 146.87 24.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.646 -0.707 . . . . 75.43 110.955 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? . . . . . 0 CA--C 1.549 0.932 0 CA-C-N 114.946 -1.024 . . . . 60.33 110.102 177.425 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.799 -0.445 . . . . 50.24 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 11.6 ptm180 -99.04 151.66 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.822 0.449 . . . . 74.22 110.572 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.5 p -75.3 159.98 30.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.119 0.967 . . . . 72.34 113.285 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.63 69.65 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.191 0.996 . . . . 75.05 112.132 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -66.74 -48.73 68.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.816 0.846 . . . . 72.33 111.145 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.23 -34.3 74.61 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.007 -0.997 . . . . 75.24 111.358 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.31 -36.5 81.61 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.239 1.016 . . . . 62.32 112.373 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.05 -44.94 94.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.682 0.393 . . . . 71.22 110.393 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.43 -36.34 82.1 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.215 0.606 . . . . 41.13 112.325 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.559 ' HG2' HG13 ' A' ' 20' ' ' ILE . 4.6 tp10 -66.54 -41.35 88.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.846 0.458 . . . . 73.33 111.246 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.4 mt -57.81 -47.77 81.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.118 0.967 . . . . 65.05 112.163 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.295 0.479 . . . . 64.51 112.295 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.87 -39.52 61.49 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.311 0.644 . . . . 72.5 112.142 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -91.36 143.81 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.543 0.687 . . . . 73.24 111.894 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.51 -13.79 39.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.097 0.959 . . . . 73.34 110.934 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -141.21 136.68 31.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.262 1.025 . . . . 73.31 109.989 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.6 m -74.33 77.25 1.86 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.508 0.671 . . . . 65.54 111.021 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -60.67 2.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.041 -0.982 . . . . 70.32 111.166 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -111.95 -23.23 10.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.718 0.807 . . . . 70.15 111.567 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.559 HG13 ' HG2' ' A' ' 10' ' ' GLU . 21.6 mm -115.4 107.26 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 -170.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.2 114.52 24.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.884 0.473 . . . . 73.23 110.187 -171.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.97 116.59 23.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.544 0.738 . . . . 70.33 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.44 153.34 33.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.179 0.514 . . . . 63.51 111.638 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -93.54 170.77 9.34 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.351 1.06 . . . . 74.1 111.593 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.74 88.42 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.967 -0.56 . . . . 54.32 110.937 169.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.4 p -57.61 -30.78 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.893 0.877 . . . . 71.51 112.455 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -84.74 -0.25 52.99 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.028 0.751 . . . . 62.44 113.028 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 88.3 mmm -68.49 131.65 45.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.004 0.521 . . . . 61.32 111.421 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.14 -132.76 6.25 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.684 -0.689 . . . . 54.55 111.746 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -39.72 89.46 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.17 0.588 . . . . 74.42 111.409 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 m -53.22 -33.6 53.54 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.564 1.145 . . . . 54.43 113.509 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.46 -35.31 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.152 0.581 . . . . 60.55 111.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.4 mmm -73.91 -41.49 62.03 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.263 0.838 . . . . 73.35 113.263 -164.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -65.34 -26.41 68.02 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 111.746 0.276 . . . . 54.32 111.746 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.0 m -72.24 -41.01 67.3 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 122.316 0.246 . . . . 53.2 111.115 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.4 0.68 . . . . 42.22 111.955 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 pt -63.27 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.651 0.38 . . . . 74.41 111.62 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.89 77.61 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.119 0.568 . . . . 73.43 111.687 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' HD23 ' A' ' 45' ' ' LEU . 32.2 m-85 -82.4 -37.29 25.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.474 0.71 . . . . 71.44 111.338 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.7 -23.48 62.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.933 1.086 . . . . 70.41 113.933 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -108.08 -8.51 15.81 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.737 1.014 . . . . 74.32 113.737 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.89 107.06 25.17 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.232 0.469 . . . . 62.22 110.563 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.96 123.68 11.62 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.933 2.422 . . . . 53.13 112.732 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.51 60.7 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-O 119.912 -0.382 . . . . 63.11 114.033 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' PHE . 19.1 tp -89.86 13.44 14.51 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 117.713 0.756 . . . . 54.14 111.214 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -32.22 112.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.183 1.793 . . . . 71.21 114.158 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.632 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 103.78 68.63 0.77 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.395 -0.366 . . . . 45.31 112.779 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.06 124.61 5.4 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 109.618 -1.393 . . . . 43.41 109.618 171.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 2' ' ' ARG . 56.0 m-85 -120.86 127.77 52.21 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.386 0.593 . . . . 61.52 111.819 -169.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -93.3 118.27 31.07 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.33 110.43 22.42 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.666 0.667 . . . . 62.43 109.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 9.3 mp -99.0 132.16 44.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.979 0.912 . . . . 64.11 110.793 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.5 33.15 4.91 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.247 -0.433 . . . . 73.21 112.429 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.6 138.6 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.116 0.566 . . . . 61.31 110.692 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.76 146.99 31.42 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.462 -1.31 . . . . 60.52 107.462 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -128.97 126.47 39.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.024 0.44 . . . . 74.52 110.399 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 123.4 46.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 54.03 109.969 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.52 131.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.578 0.751 . . . . 63.1 111.355 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -87.26 -178.5 6.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.608 0.763 . . . . 71.31 112.394 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.24 -28.55 69.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.584 0.754 . . . . 74.22 111.846 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -82.73 2.11 35.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.308 0.643 . . . . 74.52 112.274 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.36 32.34 58.07 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 120.933 0.185 . . . . 62.22 112.732 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.94 111.54 23.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.756 0.823 . . . . 75.13 110.631 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 m -82.8 115.05 21.53 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.604 0.762 . . . . 75.53 111.046 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.56 122.78 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.873 0.869 . . . . 75.42 110.293 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -95.7 129.04 43.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.483 0.713 . . . . 71.53 110.44 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -137.36 142.41 37.41 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.139 0.976 . . . . 71.32 111.054 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.64 80.19 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.029 2.486 . . . . 75.31 113.931 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.86 -23.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 112.703 0.631 . . . . 64.32 112.703 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.61 -173.46 53.28 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 121.313 0.396 . . . . 72.15 113.886 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 61.1 mt -115.98 124.59 29.57 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.032 0.933 . . . . 41.43 109.78 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.64 -27.02 39.03 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.473 2.115 . . . . 74.3 112.631 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.81 73.82 75.67 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.452 0.701 . . . . 74.33 109.485 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 83.4 Cg_endo -81.03 -28.3 2.56 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.78 2.32 . . . . 71.21 114.483 -170.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.39 -42.9 87.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 74.22 110.771 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.45 -33.86 76.01 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.558 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.14 -47.83 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.034 0.533 . . . . 74.41 110.784 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.456 ' OE1' ' HG ' ' A' ' 99' ' ' LEU . 41.6 tt0 -62.7 -50.28 71.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.873 0.694 . . . . 61.22 112.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -33.96 62.43 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 112.6 0.592 . . . . 72.21 112.6 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.54 -31.2 65.11 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.922 0.489 . . . . 65.04 110.895 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.78 -41.39 83.31 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.68 0.392 . . . . 35.33 111.248 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.83 92.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.896 0.479 . . . . 53.53 111.31 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -52.62 64.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.799 0.84 . . . . 62.21 112.007 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.04 -34.72 77.0 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 111.995 0.368 . . . . 62.54 111.995 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 36.8 t -67.81 -25.99 65.85 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.338 0.517 . . . . 73.43 112.102 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -78.42 -27.37 46.59 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.958 0.725 . . . . 33.03 112.958 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.7 t -106.59 -29.38 9.67 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.32 0.859 . . . . 64.2 113.32 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.1 mmt -67.3 -52.86 35.35 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.037 0.935 . . . . 74.52 111.405 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 mt -90.04 162.0 15.57 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.684 -1.144 . . . . 72.31 110.717 -169.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -29.65 -58.09 0.16 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 126.135 1.774 . . . . 70.2 114.804 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 122' ' ' ILE . 16.9 m -124.16 176.77 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.389 0.675 . . . . 53.41 110.182 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.1 98.77 0.61 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.287 0.565 . . . . 73.44 111.039 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 122' ' ' ILE . 2.5 tt -92.02 121.65 33.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 71.52 108.017 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -101.62 99.36 11.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.154 0.582 . . . . 74.55 109.644 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.64 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 4.3 Cg_exo -76.58 168.19 24.16 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.838 1.692 . . . . 72.3 110.787 168.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 43.5 tt0 -105.12 96.99 6.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.066 0.546 . . . . 75.32 109.589 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.734 ' HB3' HD11 ' A' ' 108' ' ' LEU . 4.4 mpp? -105.13 134.89 47.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 71.52 111.458 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -139.61 133.79 31.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.074 0.55 . . . . 72.15 111.197 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 78' ' ' GLN . 91.6 mt -84.26 133.29 34.57 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.897 0.879 . . . . 71.53 110.752 174.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -138.17 145.75 41.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.466 1.106 . . . . 73.4 110.595 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.9 119.97 38.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.963 0.505 . . . . 71.3 109.803 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.32 111.73 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.703 -1.221 . . . . 74.12 107.703 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.73 27.59 61.8 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 114.548 0.579 . . . . 50.44 114.548 -168.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.64 -1.02 88.86 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 114.987 0.755 . . . . 72.32 114.987 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 131.9 46.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.612 0.765 . . . . 75.34 109.964 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.6 m -92.4 106.09 18.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.318 0.858 . . . . 74.51 113.318 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.98 156.26 17.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.325 1.05 . . . . 72.11 111.126 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 97' ' ' MET . 50.4 tp -112.93 116.41 29.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.466 0.707 . . . . 52.3 110.78 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.4 113.35 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.389 0.676 . . . . 63.44 109.831 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 45.4 t -105.65 101.37 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 122.898 0.479 . . . . 43.51 110.263 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 40.4 t80 -84.46 128.51 34.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.627 0.771 . . . . 71.52 110.19 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.29 102.61 14.68 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 109.441 -0.578 . . . . 74.45 109.441 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.79 147.66 21.88 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.607 2.204 . . . . 64.41 112.163 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -75.61 134.49 40.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.853 0.358 . . . . 73.41 111.259 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -93.39 172.87 8.01 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.746 0.818 . . . . 74.44 112.968 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.62 139.31 36.31 Favored 'General case' 0 C--O 1.193 -1.914 0 C-N-CA 123.707 0.803 . . . . 62.31 110.617 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.74 -38.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 115.945 1.831 . . . . 74.25 115.945 -170.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.7 p -65.43 -49.41 69.26 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.864 0.466 . . . . 72.04 111.745 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 9.0 m-70 -127.93 69.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.88 -2.267 . . . . 64.14 104.88 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.62 ' HA ' HG12 ' A' ' 122' ' ' ILE . 27.8 mtpp -45.06 -152.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.386 1 C-N-CA 132.91 4.484 . . . . 70.14 120.844 58.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo 7.68 65.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.113 2.542 . . . . 70.54 116.153 -126.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 93' ' ' LEU . 30.5 mm -80.0 77.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.094 0 CA-C-N 115.361 -0.836 . . . . 61.52 109.184 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -80.76 141.96 34.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.246 -0.433 . . . . 73.04 110.938 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 tptm . . . . . 0 CA--C 1.55 0.949 0 CA-C-N 115.704 -0.68 . . . . 73.44 109.527 171.227 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.089 -0.338 . . . . 62.23 110.089 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -88.09 146.43 25.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.429 0.692 . . . . 73.5 110.742 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -70.24 166.71 19.48 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 122.997 0.519 . . . . 73.45 111.76 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . . . -62.42 -50.27 72.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.639 0.607 . . . . 42.4 112.639 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -70.47 -28.78 65.26 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 112.009 0.374 . . . . 72.13 112.009 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.55 -46.37 86.26 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.89 0.876 . . . . 31.14 111.256 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HG13 ' A' ' 109' ' ' VAL . 60.5 mt -65.95 -38.46 88.67 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.722 0.809 . . . . 75.25 112.166 172.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 24.3 tp -59.17 -50.09 75.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.036 0.934 . . . . 75.22 110.399 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.47 -40.31 78.28 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.759 -1.109 . . . . 63.22 111.064 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.83 -41.75 95.49 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.988 0.915 . . . . 74.34 111.843 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 8' ' ' LEU . 29.3 mt -60.3 -38.62 84.23 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.659 1.184 . . . . 72.34 112.149 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -80.17 -28.95 38.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.029 0.531 . . . . 71.15 111.864 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -47.19 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.452 0.701 . . . . 54.13 111.949 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.3 154.8 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.131 0.572 . . . . 73.34 111.115 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.22 -20.61 21.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.011 0.924 . . . . 72.32 111.124 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -140.85 134.75 30.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.604 1.162 . . . . 62.31 109.688 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -69.6 87.13 0.48 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.88 0.872 . . . . 64.3 110.456 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.06 -64.59 1.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.45 0.7 . . . . 73.21 112.488 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -107.38 -14.05 14.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.43 0.692 . . . . 61.41 110.207 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 mm -109.49 155.17 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.216 -1.031 . . . . 72.32 108.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.46 150.13 10.41 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.005 -0.739 . . . . 62.22 109.005 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.87 46.13 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.029 0.532 . . . . 70.34 112.005 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 32' ' ' VAL . 74.9 mmtt -130.61 150.37 51.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.182 0.993 . . . . 31.44 110.076 175.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' VAL . 57.7 mtt-85 -85.63 165.16 17.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.734 0.814 . . . . 73.12 110.157 171.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.46 -30.85 68.81 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 120.879 0.371 . . . . 62.52 111.526 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -71.97 -19.25 61.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.649 0.78 . . . . 74.25 112.803 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -84.38 -4.99 59.22 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.527 0.565 . . . . 61.22 112.527 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.6 mmm -59.5 108.45 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.315 0.579 . . . . 63.3 111.313 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 142.14 -143.53 12.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 114.878 -1.055 . . . . 71.05 110.863 -171.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -52.57 -39.24 61.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.233 1.013 . . . . 71.05 113.253 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -36.51 75.34 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.065 0.765 . . . . 62.44 113.065 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' A' ' 23' ' ' LYS . 44.2 t -72.52 -50.34 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 120.968 0.413 . . . . 75.05 110.385 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 88' ' ' MET . 91.3 mmm -57.45 -41.2 80.09 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.57 1.322 . . . . 75.43 114.57 -170.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.18 -34.24 77.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.157 0.583 . . . . 72.04 111.611 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -79.32 -28.48 42.13 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.758 0.823 . . . . 42.35 111.242 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.82 -40.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 123.48 0.712 . . . . 61.22 110.511 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.96 -31.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.507 -0.769 . . . . 63.23 111.134 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 42' ' ' GLU . . . -60.08 -49.96 75.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.228 0.611 . . . . 74.32 112.178 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.28 -27.56 35.06 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.681 . . . . 72.1 111.657 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.66 -32.26 60.1 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.363 0.665 . . . . 62.32 112.275 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -92.57 -17.11 24.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.163 0.585 . . . . 72.52 111.525 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.1 tp10 -75.43 106.88 3.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 123.578 0.751 . . . . 73.23 112.367 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.07 106.12 2.21 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.142 2.561 . . . . 73.52 113.201 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.08 -7.1 40.63 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 114.87 0.708 . . . . 71.34 114.87 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -92.78 -52.43 4.62 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.203 1.002 . . . . 64.13 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 36.93 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 126.296 1.839 . . . . 75.45 115.378 -170.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.09 48.09 64.51 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 116.012 1.165 . . . . 71.23 116.012 166.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.72 152.59 22.56 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.53 -0.628 . . . . 74.14 111.53 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.89 127.1 51.56 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.844 0.822 . . . . 63.21 112.074 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 97.2 mt -115.21 114.04 24.72 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.879 1.271 . . . . 44.25 108.59 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.14 109.06 20.66 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.508 -0.552 . . . . 65.05 109.508 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 108' ' ' LEU . 29.9 mt -93.03 132.17 37.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.494 0.718 . . . . 73.01 110.533 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 36.64 4.43 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 121.298 0.388 . . . . 75.23 112.371 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 43.1 t -115.53 143.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.537 0.735 . . . . 75.4 109.813 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -113.47 154.1 27.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.765 -1.198 . . . . 63.42 107.765 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 41.7 p90 -145.73 129.03 16.78 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.408 0.623 . . . . 75.31 112.005 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.74 135.61 51.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.835 0.854 . . . . 61.22 110.933 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.6 mt -83.7 123.52 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.737 0.815 . . . . 64.24 110.582 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 63' ' ' ASP . 29.5 p30 -82.5 -176.3 6.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.795 0.838 . . . . 74.15 112.08 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.77 -14.16 57.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.737 1.014 . . . . 64.12 113.737 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -86.8 -22.89 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.151 0.58 . . . . 64.22 112.021 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.4 16.05 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 116.576 -0.284 . . . . 34.23 112.512 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HD21 ' A' ' 59' ' ' ASN . 23.4 t70 -107.74 132.71 53.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.263 1.025 . . . . 74.01 110.915 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -89.09 119.03 29.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.806 0.842 . . . . 71.11 111.509 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 67.5 t -103.44 120.8 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.169 0.988 . . . . 75.22 110.704 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -94.19 130.69 40.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.271 1.028 . . . . 73.31 110.387 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.87 147.44 48.24 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.877 0.871 . . . . 74.04 110.485 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 83.2 Cg_endo -78.31 108.16 2.43 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.251 1.967 . . . . 64.32 114.534 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 m -91.1 -24.42 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 122.968 0.507 . . . . 62.2 111.199 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 76.58 -170.12 54.95 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 114.81 0.684 . . . . 34.5 114.81 174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -121.57 124.24 27.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.97 0.908 . . . . 53.43 109.979 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.97 -17.04 22.71 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.457 2.105 . . . . 61.15 113.023 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -134.38 59.77 38.97 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.404 1.081 . . . . 70.42 110.223 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HB2' HD22 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -62.06 -36.81 68.39 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.905 2.403 . . . . 73.34 114.265 -162.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.31 -39.27 74.92 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.472 0.709 . . . . 74.22 110.58 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.47 -36.3 80.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.979 0.511 . . . . 73.21 111.205 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.35 -45.6 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 123.474 0.71 . . . . 71.35 110.813 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.9 -49.77 74.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.808 0.843 . . . . 62.53 112.043 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -67.32 -40.67 85.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.279 0.632 . . . . 64.43 111.578 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.9 -36.57 84.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.552 0.741 . . . . 65.4 110.389 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.56 HD23 ' SD ' ' A' ' 97' ' ' MET . 24.3 tp -67.78 -38.27 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.969 0.508 . . . . 72.12 111.282 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.67 90.58 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.99 0.516 . . . . 55.33 111.553 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.8 m -65.76 -48.31 72.28 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.639 0.776 . . . . 74.12 111.721 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.98 -30.36 69.61 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.797 0.439 . . . . 74.42 111.478 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 16.1 t -65.98 -19.91 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.899 -0.5 . . . . 65.33 112.292 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -39.2 17.73 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.455 0.702 . . . . 40.1 112.016 170.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -85.93 -25.67 25.98 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.153 1.168 . . . . 33.01 114.153 -173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 33' ' ' MET . 85.7 mmm -81.91 -58.08 3.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.815 0.846 . . . . 72.34 110.085 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.98 146.55 37.39 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.352 -0.84 . . . . 63.0 111.138 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -50.84 -37.57 43.92 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.997 0.919 . . . . 63.33 113.051 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.2 m -121.1 160.03 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.053 0.941 . . . . 71.32 110.713 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.29 105.34 7.29 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.085 0.554 . . . . 72.45 111.85 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.5 tt -93.24 137.19 32.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.28 -1.378 . . . . 63.45 107.28 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -98.83 104.73 26.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 122.692 0.397 . . . . 62.33 110.131 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.68 119.38 5.69 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.303 1.335 . . . . 50.22 110.667 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 14.3 tp10 -71.65 98.74 1.97 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.373 -0.83 . . . . 72.14 109.826 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.1 mtm -116.73 127.16 54.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.311 0.644 . . . . 72.1 112.198 -169.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -132.9 128.67 37.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.303 1.041 . . . . 75.1 110.2 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 74' ' ' PRO . 53.6 mt -81.91 132.14 35.26 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.167 0.987 . . . . 71.4 111.408 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 11.4 mm-40 -128.38 128.46 44.55 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.162 0.985 . . . . 73.23 111.1 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.2 117.27 29.7 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.857 0.863 . . . . 73.44 110.986 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.2 t -132.98 117.42 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.565 1.146 . . . . 74.25 110.577 -172.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.3 28.54 27.66 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 116.443 1.337 . . . . 74.22 116.443 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -4.48 67.91 Favored Glycine 0 N--CA 1.484 1.852 0 CA-C-N 117.472 0.636 . . . . 53.22 114.179 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.483 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -110.88 119.2 38.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.377 1.071 . . . . 52.52 110.074 -177.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -88.55 103.53 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.982 0.81 . . . . 53.13 110.576 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.44 168.77 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.858 0.863 . . . . 72.32 110.717 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 52' ' ' LEU . 60.1 tp -119.2 119.07 33.04 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.994 0.517 . . . . 73.43 110.577 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.507 HG13 HD11 ' A' ' 7' ' ' LEU . 93.1 t -83.63 111.01 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.135 -0.691 . . . . 52.3 109.135 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 48.1 t -103.5 99.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.527 0.679 . . . . 75.53 110.177 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 58.2 t80 -79.05 119.16 21.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.145 0.978 . . . . 70.3 109.026 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.79 102.49 53.66 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.079 0.952 . . . . 64.1 108.774 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.96 165.48 31.98 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.942 1.761 . . . . 74.2 111.607 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -72.14 136.56 46.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.781 -0.822 . . . . 54.13 108.781 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -71.51 156.35 39.53 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.451 0.7 . . . . 73.24 111.522 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.4 -175.61 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 124.926 1.29 . . . . 63.3 111.601 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.94 -51.56 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 O-C-N 119.756 -1.84 . . . . 74.42 113.614 162.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 t -68.39 -49.94 56.49 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.363 0.529 . . . . 53.5 111.468 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 8.5 m-70 -117.94 84.65 2.21 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 101.341 -3.577 . . . . 73.11 101.341 165.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.686 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.256 36.2 mtmm -48.79 -140.77 0.0 OUTLIER Pre-proline 0 CA--C 1.577 1.986 1 C-N-CA 133.664 4.786 . . . . 70.14 121.204 50.908 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo 10.16 62.93 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 124.207 3.272 . . . . 51.1 116.136 -121.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.686 HG12 ' HA ' ' A' ' 120' ' ' LYS . 48.5 mm -76.78 116.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.994 0.918 . . . . 73.24 110.344 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -150.52 144.19 25.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.906 0.483 . . . . 73.24 110.16 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 120.912 0.387 . . . . 73.41 110.288 171.782 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 46.0 ttm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.788 0.328 . . . . 74.41 111.565 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.0 mmm180 -95.44 157.57 15.84 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.402 1.081 . . . . 71.31 111.037 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -77.45 152.35 34.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.908 0.707 . . . . 62.32 112.908 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.88 -53.05 54.67 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.505 1.122 . . . . 73.12 113.183 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HG11 ' A' ' 102' ' ' VAL . 2.9 t -62.35 -41.5 98.65 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.234 0.613 . . . . 74.31 112.621 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -55.16 -45.31 75.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.495 1.118 . . . . 33.53 111.68 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 2' ' ' ARG . 47.3 mt -73.68 -33.27 64.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.306 1.042 . . . . 72.01 112.749 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.36 -31.36 71.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.271 0.628 . . . . 63.53 110.587 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.49 -30.68 69.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.863 0.865 . . . . 44.2 112.802 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.2 tt0 -60.85 -52.94 62.95 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.875 -0.417 . . . . 74.23 109.875 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.71 -27.46 62.08 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.836 0.854 . . . . 73.35 112.914 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.66 -11.1 60.67 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.214 0.605 . . . . 74.45 111.847 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 -36.11 8.24 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.839 0.856 . . . . 73.21 111.948 172.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 10' ' ' GLU . 29.5 m -117.54 117.54 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.616 0.767 . . . . 75.43 111.241 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.84 -44.49 82.16 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.684 1.193 . . . . 74.23 111.1 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.77 149.57 25.66 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.982 0.913 . . . . 61.35 110.601 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.1 m -87.24 129.64 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.867 0.467 . . . . 75.53 111.982 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.46 -64.94 1.0 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.833 0.453 . . . . 71.45 111.32 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -14.68 9.08 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.569 0.747 . . . . 73.21 112.013 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 49' ' ' TYR . 18.8 mm -113.87 142.99 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 118.193 0.452 . . . . 73.01 110.649 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 3.7 mm-40 -128.27 112.6 14.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.365 0.666 . . . . 61.14 110.632 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.29 118.2 30.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.314 0.645 . . . . 51.41 109.843 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' A' ' 32' ' ' VAL . 73.6 mmtt -124.11 142.95 50.76 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.848 0.859 . . . . 64.23 110.632 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -89.56 174.76 7.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.548 0.739 . . . . 71.01 110.714 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -37.85 71.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.131 0.572 . . . . 63.45 112.21 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -60.45 -23.56 64.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.162 1.171 . . . . 74.23 114.162 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -88.13 -13.72 40.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.381 0.882 . . . . 72.01 113.381 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.512 ' SD ' HG13 ' A' ' 77' ' ' VAL . 84.4 mtp -58.3 109.16 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.056 0.542 . . . . 75.23 112.24 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.01 -122.46 1.18 Allowed Glycine 0 C--N 1.344 0.988 0 CA-C-N 116.136 -0.483 . . . . 43.01 112.326 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.47 -46.55 63.55 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.518 0.727 . . . . 75.04 111.57 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.6 m -63.86 -37.4 87.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.611 0.764 . . . . 61.21 112.369 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' A' ' 23' ' ' LYS . 87.5 t -67.69 -42.33 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.847 0.459 . . . . 74.01 111.192 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.491 ' SD ' HD21 ' A' ' 89' ' ' LEU . 36.2 tpp -67.6 -47.31 70.07 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.75 0.648 . . . . 73.24 112.75 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.31 -27.24 66.13 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 62.11 113.041 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.46 HG23 HD21 ' A' ' 50' ' ' LEU . 14.7 t -78.22 -29.13 48.16 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 121.615 -0.678 . . . . 73.03 111.91 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.08 -43.21 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 123.055 0.542 . . . . 74.21 109.569 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 122' ' ' ILE . 48.4 mt -53.73 -45.21 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.203 1.001 . . . . 75.42 111.078 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.35 90.72 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.855 0.462 . . . . 50.3 111.611 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.07 -38.88 89.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.923 0.489 . . . . 71.25 111.726 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.53 -30.76 69.64 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.543 0.737 . . . . 64.31 112.721 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -105.63 17.13 24.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.024 0.75 . . . . 54.43 113.024 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -108.25 89.19 5.53 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 122.821 0.449 . . . . 73.33 110.53 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.07 118.92 5.96 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.302 2.001 . . . . 71.35 112.132 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.82 -12.52 32.29 Favored Glycine 0 N--CA 1.477 1.406 0 CA-C-N 115.547 -0.751 . . . . 71.4 113.216 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.25 -7.56 14.83 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.474 0.71 . . . . 75.4 109.754 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -42.87 132.08 3.96 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.923 1.289 . . . . 63.32 113.845 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.89 37.64 2.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.831 -0.622 . . . . 41.32 111.747 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.82 152.67 20.38 Favored Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.698 -0.561 . . . . 71.12 111.698 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.505 ' HB2' HD12 ' A' ' 20' ' ' ILE . 98.2 m-85 -120.69 148.74 43.54 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.768 0.784 . . . . 72.32 112.303 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.2 mp -119.93 130.96 55.05 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.893 0.877 . . . . 75.14 109.69 170.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.05 109.47 21.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.568 0.747 . . . . 70.33 109.752 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD12 HD23 ' A' ' 108' ' ' LEU . 63.5 mt -92.07 127.56 37.58 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.938 -0.393 . . . . 72.42 109.938 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.93 30.86 4.07 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 115.9 -0.591 . . . . 63.04 112.604 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.25 133.35 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.252 0.621 . . . . 74.31 110.365 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.81 176.84 5.04 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.688 -1.227 . . . . 74.43 107.688 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -157.05 144.67 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.566 -0.709 . . . . 64.41 112.454 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.71 128.29 53.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.281 1.032 . . . . 72.03 110.294 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.6 mm -82.62 123.14 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 122.9 0.48 . . . . 64.22 111.049 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.28 154.54 37.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.897 0.879 . . . . 72.25 110.185 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.37 0.26 20.16 Favored 'General case' 0 CA--C 1.559 1.289 0 O-C-N 121.997 -0.44 . . . . 70.51 111.8 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -96.71 3.51 52.37 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.87 0.868 . . . . 53.45 111.494 166.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.56 57.88 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 115.576 0.991 . . . . 71.24 115.576 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.61 148.38 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.105 0.779 . . . . 73.12 113.105 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -96.72 128.29 43.52 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.354 0.662 . . . . 60.12 111.088 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.1 119.15 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 108.781 -0.822 . . . . 75.32 108.781 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.74 113.43 25.49 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.679 0.752 . . . . 72.25 110.382 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.17 145.1 31.8 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.541 1.136 . . . . 72.31 110.143 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 88.6 Cg_endo -96.2 109.31 0.11 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.371 2.047 . . . . 63.44 113.869 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.8 -11.65 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.66 -0.65 . . . . 71.25 111.142 161.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.6 -167.54 54.34 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.466 0.481 . . . . 64.12 113.61 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 77' ' ' VAL . 95.2 mt -99.74 131.43 24.65 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.113 0.965 . . . . 72.24 110.838 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.24 -37.51 61.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.329 2.019 . . . . 74.21 111.218 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 10.8 m-20 -130.52 86.05 54.34 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.004 0.921 . . . . 74.42 109.374 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 -37.34 89.92 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.562 2.841 . . . . 74.04 114.319 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.97 -53.42 46.57 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.009 -0.996 . . . . 65.02 110.92 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 73' ' ' ASP . 67.4 mmtt -64.46 -49.08 72.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 54.55 112.064 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.512 HG13 ' SD ' ' A' ' 28' ' ' MET . 95.3 t -56.51 -40.94 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.709 0.803 . . . . 61.33 112.329 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.41 -46.12 90.02 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.414 0.686 . . . . 71.5 112.004 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.66 -44.7 61.51 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.738 0.815 . . . . 73.35 112.212 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.02 -33.25 75.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.604 0.762 . . . . 71.45 111.926 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -66.76 -45.11 79.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.656 0.265 . . . . 72.23 110.973 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.09 89.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.335 0.654 . . . . 71.22 111.86 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -64.34 -53.04 54.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.107 0.963 . . . . 70.24 111.028 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.29 -33.42 75.26 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.072 -0.513 . . . . 74.03 112.017 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.4 -29.22 63.92 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.486 0.585 . . . . 74.45 112.412 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.26 -42.65 13.59 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.679 0.792 . . . . 65.03 111.341 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -69.33 -28.52 66.31 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.975 1.102 . . . . 71.14 113.975 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.489 ' SD ' ' HD2' ' A' ' 124' ' ' LYS . 14.0 mmt -80.25 -60.94 2.14 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.313 0.645 . . . . 53.53 111.769 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.491 HD21 ' SD ' ' A' ' 33' ' ' MET . 22.7 mt -81.93 159.9 23.5 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.388 -0.823 . . . . 61.13 112.796 -161.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.616 HD21 ' HA ' ' A' ' 122' ' ' ILE . 6.1 p30 -50.65 -52.26 41.46 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.036 0.754 . . . . 75.33 113.036 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.5 m -107.47 171.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.303 0.573 . . . . 73.41 111.441 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.65 99.6 5.09 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.496 -0.775 . . . . 65.43 110.062 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 122' ' ' ILE . 3.9 tt -84.53 127.05 33.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.593 -1.262 . . . . 73.3 107.593 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 94.29 15.91 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.391 0.677 . . . . 74.44 110.583 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.01 162.09 23.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.531 2.154 . . . . 74.3 111.692 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.693 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.6 tp10 -95.75 128.81 42.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 108' ' ' LEU . 62.5 mtt -126.29 114.12 17.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.017 0.527 . . . . 72.41 110.277 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -124.15 133.69 53.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.568 0.747 . . . . 72.23 111.008 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.13 125.06 41.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.007 0.923 . . . . 75.5 110.41 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -135.27 146.09 48.21 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.481 0.713 . . . . 63.04 111.156 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -101.21 117.38 34.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.23 0.538 . . . . 71.23 110.739 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 5' ' ' THR . 88.3 t -126.63 120.08 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.149 1.38 . . . . 73.4 108.375 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.19 60.57 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.109 0.404 . . . . 33.04 114.109 -170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.92 88.03 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 114.152 0.421 . . . . 70.52 114.152 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.2 mmtt -103.01 134.88 45.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.918 0.887 . . . . 74.23 109.928 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.2 m -96.98 123.27 40.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.779 0.718 . . . . 64.42 111.289 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 68' ' ' PRO . 6.7 mp -113.58 161.5 17.34 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.52 0.728 . . . . 72.04 109.198 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 35.9 tp -114.89 111.51 21.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.469 -0.567 . . . . 72.3 109.469 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.2 t -84.76 122.27 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.219 -0.66 . . . . 75.13 109.219 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 37.3 t -113.2 99.97 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.458 0.703 . . . . 73.02 110.039 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 56.8 t80 -84.08 119.61 25.17 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 71.35 110.555 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.42 100.97 28.85 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.931 0.893 . . . . 70.41 109.175 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 176.28 10.17 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.603 2.202 . . . . 71.41 112.356 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.22 156.78 24.38 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.679 0.752 . . . . 73.52 112.934 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -124.34 141.48 52.04 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.145 0.978 . . . . 71.25 109.898 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.24 150.51 37.03 Favored 'General case' 0 C--O 1.183 -2.4 0 C-N-CA 124.27 1.028 . . . . 63.11 110.933 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.0 t -38.72 -37.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 N-CA-C 115.933 1.827 . . . . 72.22 115.933 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 t -78.36 -39.57 38.89 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 112.909 0.707 . . . . 72.42 112.909 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 p-80 -136.88 77.31 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.745 -1.576 . . . . 54.22 106.745 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.727 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.263 14.1 ptmm? -51.48 -152.48 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.35 2 C-N-CA 132.81 4.444 . . . . 72.32 122.097 46.338 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo 14.4 62.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 O-C-N 117.239 -2.032 . . . . 72.05 115.844 -123.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.727 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.9 mm -75.67 95.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 114.401 -1.272 . . . . 72.53 109.451 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.428 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.3 p90 -110.53 155.18 22.65 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.928 0.491 . . . . 74.55 109.876 169.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD2' ' SD ' ' A' ' 88' ' ' MET . 5.7 ttpm? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 169.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' HG3' ' A' ' 98' ' ' GLN . 10.3 tpt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.919 -0.4 . . . . 63.32 109.919 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -85.73 123.43 31.1 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.149 0.58 . . . . 75.53 110.607 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -59.47 153.71 18.78 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.103 0.961 . . . . 75.2 112.718 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.82 74.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.653 0.781 . . . . 62.3 112.642 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -65.11 -40.76 94.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.615 0.766 . . . . 70.22 110.931 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.78 -37.53 87.92 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.002 0.921 . . . . 70.43 112.239 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 109' ' ' VAL . 68.8 mt -63.0 -41.66 99.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.124 0.569 . . . . 74.52 111.829 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.89 -32.38 69.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 61.02 112.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.14 -40.61 94.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.072 0.549 . . . . 72.03 111.553 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 14' ' ' VAL . 34.6 tt0 -72.61 -50.16 27.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 110.319 -0.252 . . . . 72.13 110.319 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -49.44 -55.78 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.505 1.122 . . . . 55.33 113.119 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -68.49 -20.78 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.445 0.906 . . . . 75.13 113.445 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.32 -29.0 15.87 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.232 0.827 . . . . 73.25 113.232 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 10' ' ' GLU . 23.0 m -111.76 128.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 112.59 0.589 . . . . 72.51 112.59 -172.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.82 -20.93 54.85 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.963 0.905 . . . . 75.31 113.334 164.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -124.49 98.83 5.91 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.547 0.739 . . . . 64.52 110.392 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 p -75.7 94.66 3.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.563 0.745 . . . . 75.54 109.831 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 -63.81 0.99 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.373 0.879 . . . . 42.02 113.373 -167.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -121.55 6.96 10.03 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.11 0.564 . . . . 72.13 112.1 179.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mt -116.6 112.81 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.155 -0.683 . . . . 53.23 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.99 115.97 22.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.969 -0.382 . . . . 72.54 109.969 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.75 131.61 37.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.652 0.781 . . . . 72.53 111.97 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 62.3 mttm -130.0 151.64 50.33 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.097 0.959 . . . . 71.01 110.678 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -90.06 170.73 10.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.085 0.554 . . . . 74.03 111.085 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.38 70.7 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.406 0.682 . . . . 64.44 111.659 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -60.6 -30.16 69.65 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.902 0.881 . . . . 63.35 112.88 171.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -86.89 -2.5 58.64 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.272 0.629 . . . . 73.13 112.646 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.2 tpt -63.83 123.06 17.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.795 0.838 . . . . 75.43 112.293 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.75 -135.76 5.73 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.644 -0.253 . . . . 64.51 113.116 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -31.19 70.57 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.579 0.752 . . . . 63.54 111.337 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.4 m -62.8 -31.21 72.14 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.499 0.72 . . . . 64.2 111.955 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.594 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 25.9 t -73.36 -44.06 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 120.909 0.385 . . . . 72.14 110.996 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.566 ' SD ' HD21 ' A' ' 89' ' ' LEU . 38.1 tpp -62.51 -50.47 71.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.212 -0.903 . . . . 72.25 113.076 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -27.4 69.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.924 0.49 . . . . 72.4 112.287 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.9 m -70.54 -40.32 73.48 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.002 0.521 . . . . 52.43 110.858 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.16 -43.79 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 123.497 0.719 . . . . 72.31 110.665 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.97 -37.54 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.363 0.665 . . . . 74.44 110.735 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.35 -48.41 79.9 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.546 0.738 . . . . 62.43 112.456 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -71.95 -32.45 67.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 120.698 0.285 . . . . 75.13 111.566 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . . . -76.07 -25.68 55.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.317 0.647 . . . . 64.03 112.563 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.75 -33.46 12.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.304 0.642 . . . . 74.1 112.161 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.5 mm-40 -67.52 127.16 93.37 Favored Pre-proline 0 CA--C 1.563 1.479 0 O-C-N 122.07 -0.394 . . . . 72.01 111.927 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 40.7 Cg_exo -58.03 109.94 0.56 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.639 2.893 . . . . 75.23 114.747 -173.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.79 26.23 67.64 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.882 0.713 . . . . 64.12 114.882 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.66 13.1 35.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 118.819 1.309 . . . . 74.42 112.295 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 8.0 p-10 -51.47 116.54 2.13 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.132 0.573 . . . . 71.34 110.884 167.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 120.62 36.18 0.8 Allowed Glycine 0 N--CA 1.47 0.957 0 CA-C-N 115.931 -0.577 . . . . 41.32 112.117 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -111.79 127.25 8.03 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 110.77 -0.932 . . . . 52.32 110.77 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.08 125.82 53.96 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.282 0.541 . . . . 54.22 110.819 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -94.89 121.78 36.85 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.345 -0.983 . . . . 63.04 108.345 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.52 108.71 20.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.53 0.681 . . . . 63.34 110.256 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD21 ' A' ' 71' ' ' LEU . 3.5 mm? -91.65 132.19 36.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.192 0.997 . . . . 72.31 110.357 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.65 32.07 4.63 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 116.048 -0.524 . . . . 73.41 112.966 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.3 133.99 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.976 0.511 . . . . 60.31 110.181 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.44 129.07 56.44 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.223 -1.399 . . . . 70.53 107.223 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -110.9 129.6 55.83 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.173 0.511 . . . . 73.41 111.702 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.51 54.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.287 1.035 . . . . 73.33 110.334 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.5 mm -96.2 126.76 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.292 0.637 . . . . 74.11 110.476 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 63' ' ' ASP . 30.9 p30 -87.95 -174.1 4.56 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.526 0.73 . . . . 52.54 111.61 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.92 -22.98 67.17 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.654 0.782 . . . . 72.43 112.621 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -74.11 -23.4 59.31 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.903 0.881 . . . . 73.41 112.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.74 78.64 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.625 -0.261 . . . . 75.15 112.722 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' HD21 ' A' ' 59' ' ' ASN . 26.0 t70 -75.03 142.41 43.79 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.617 1.167 . . . . 71.23 111.278 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.3 m -93.95 108.85 20.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.693 0.797 . . . . 74.41 110.335 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.76 121.81 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.625 0.77 . . . . 70.23 109.757 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -92.08 127.34 37.52 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.404 0.682 . . . . 74.05 110.225 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -123.11 120.89 27.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.809 0.844 . . . . 75.44 110.458 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.13 90.31 0.66 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.575 2.183 . . . . 60.14 112.761 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.95 -12.18 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.289 0.636 . . . . 62.03 112.015 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.63 179.03 44.36 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.234 -0.439 . . . . 53.23 113.627 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 52' ' ' LEU . 3.5 mp -105.18 139.94 20.62 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 109.686 -0.487 . . . . 61.05 109.686 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.25 -30.17 25.1 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.137 1.891 . . . . 64.42 112.056 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.62 71.1 81.27 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.856 0.863 . . . . 75.24 110.226 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.69 -24.94 17.83 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.914 2.409 . . . . 74.21 112.764 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.17 -45.3 77.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 74.13 110.044 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 7.9 mtpm? -61.39 -53.89 50.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.708 -0.678 . . . . 63.22 111.198 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.2 -35.32 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.571 0.749 . . . . 52.12 112.103 -172.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 54.2 tt0 -63.81 -46.09 86.68 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 120.99 0.424 . . . . 74.23 111.5 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -70.29 -47.61 60.45 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.566 0.746 . . . . 55.2 112.07 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.195 0.998 . . . . 53.21 111.409 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 tp -71.32 -41.47 69.81 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.647 0.379 . . . . 72.55 111.276 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.2 86.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.192 0.597 . . . . 72.31 111.297 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 -52.19 55.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.938 0.895 . . . . 72.41 111.191 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -68.32 -29.57 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.731 0.412 . . . . 73.52 111.596 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 45.5 t -60.27 -27.4 67.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.74 -0.6 . . . . 74.11 112.043 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.11 -49.61 6.3 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.161 0.584 . . . . 60.23 111.825 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 t -68.7 -32.14 71.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.372 0.879 . . . . 43.21 113.372 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 5.7 mmt -78.93 -48.15 15.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.368 0.667 . . . . 63.41 111.366 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD21 ' SD ' ' A' ' 33' ' ' MET . 31.0 mt -88.39 151.4 22.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.688 0.625 . . . . 71.23 112.688 -166.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -55.27 -58.62 6.96 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.138 1.375 . . . . 70.11 112.369 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' HB3' ' A' ' 119' ' ' HIS . 43.1 t -102.36 146.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.621 0.769 . . . . 74.12 109.535 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.27 97.23 0.71 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.41 0.624 . . . . 63.15 110.822 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.474 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.5 tt -81.75 136.72 35.43 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.146 -1.057 . . . . 44.51 108.146 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -107.16 91.16 6.28 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.246 0.619 . . . . 73.22 109.948 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.71 118.61 4.21 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.135 1.89 . . . . 70.31 111.583 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 37.5 tt0 -73.44 109.24 6.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 74.22 109.084 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.509 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 66.7 mtt -116.39 133.21 56.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.132 0.573 . . . . 74.43 111.747 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.429 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 15.1 mm100 -134.75 139.61 45.3 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.251 1.021 . . . . 75.44 110.471 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.7 mt -104.85 113.05 26.41 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.175 0.99 . . . . 73.04 110.946 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -118.01 136.48 53.5 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.224 1.009 . . . . 54.32 110.147 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -92.44 118.7 31.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.557 0.343 . . . . 73.32 110.313 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.16 113.99 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 63.4 108.925 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.8 29.49 67.53 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 114.804 0.682 . . . . 62.45 114.804 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.69 79.95 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.507 0.563 . . . . 73.13 114.507 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.34 136.43 49.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.995 0.918 . . . . 53.1 110.19 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.3 m -87.77 120.97 29.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.701 0.682 . . . . 74.45 110.903 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.5 mp -116.36 156.46 26.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.856 0.862 . . . . 64.3 109.813 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 52.5 tp -115.75 121.57 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.097 0.559 . . . . 74.22 110.117 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HD11 ' A' ' 7' ' ' LEU . 51.3 t -99.05 121.79 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.532 0.733 . . . . 73.24 109.153 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.39 101.38 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.957 0.503 . . . . 70.51 110.36 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 77.6 t80 -73.33 122.7 22.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.321 0.648 . . . . 74.34 109.826 170.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.65 110.51 63.3 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.371 0.668 . . . . 45.45 109.771 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.13 145.84 24.88 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.308 2.005 . . . . 74.22 112.235 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 42.7 tt0 -74.27 145.0 44.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.159 -0.682 . . . . 74.33 109.159 169.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -84.96 173.83 10.25 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 123.239 0.616 . . . . 64.1 111.691 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.97 176.87 0.64 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 124.829 1.251 . . . . 75.15 111.044 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.89 -56.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.714 -1.241 . . . . 63.02 114.117 167.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -82.72 -41.45 19.26 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.354 0.525 . . . . 74.22 111.379 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.66 ' HB3' HG21 ' A' ' 91' ' ' VAL . 19.1 m-70 -104.7 73.65 1.1 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 103.734 -2.691 . . . . 74.01 103.734 162.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.5 mttt -46.87 -139.08 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.8 1 C-N-CA 133.526 4.73 . . . . 73.02 121.301 53.163 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo 6.43 67.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 124.592 3.528 . . . . 54.35 116.225 -122.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 120' ' ' LYS . 23.5 mm -76.72 80.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-N 115.287 -0.87 . . . . 51.42 109.595 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -82.95 152.97 25.26 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.923 0.392 . . . . 65.05 110.224 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 CA--C 1.554 1.122 0 N-CA-C 109.439 -0.578 . . . . 71.01 109.439 172.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HB ' ' A' ' 109' ' ' VAL . 56.6 ttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.221 0.452 . . . . 60.51 112.221 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 1' ' ' MET . 86.5 mtt180 -47.26 145.65 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.827 0.676 . . . . 72.23 112.827 158.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -64.11 151.65 42.64 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 71.13 111.268 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.12 -26.69 68.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.953 -0.567 . . . . 51.4 111.993 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.605 HG23 HG13 ' A' ' 102' ' ' VAL . 2.0 m -66.53 -47.37 73.1 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.152 0.981 . . . . 61.25 111.131 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.83 -44.06 97.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.987 0.915 . . . . 72.12 111.502 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.04 -30.81 69.25 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.074 -0.966 . . . . 74.32 112.246 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -66.03 -43.43 87.64 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.129 0.571 . . . . 74.52 109.962 171.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.8 -37.71 85.39 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.49 0.716 . . . . 71.4 111.591 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.71 -41.97 99.41 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.074 0.95 . . . . 72.13 110.925 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.03 -44.68 94.48 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.142 0.977 . . . . 71.12 112.113 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -76.99 -16.13 59.42 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.645 0.609 . . . . 74.4 112.645 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.43 43.38 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.239 0.616 . . . . 61.52 111.147 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 17' ' ' SER . 17.1 m -115.82 119.16 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.863 0.865 . . . . 63.03 110.02 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.21 -47.48 83.33 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.774 0.83 . . . . 65.04 111.27 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.95 95.96 9.81 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 62.34 108.656 165.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 14' ' ' VAL . 35.8 t -58.57 122.08 12.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.123 -0.489 . . . . 64.42 111.929 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.96 76.95 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.698 0.629 . . . . 65.21 112.698 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -150.88 15.48 0.75 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.089 0.774 . . . . 73.32 113.089 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.0 mm -102.21 106.47 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.342 -0.984 . . . . 72.41 108.342 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.523 ' HG2' HG21 ' A' ' 35' ' ' THR . 10.6 tp10 -94.8 114.35 26.23 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.323 0.649 . . . . 75.24 111.504 -169.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.53 35.38 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.651 0.781 . . . . 52.52 112.136 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -153.19 156.24 38.18 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.906 0.86 . . . . 64.12 112.235 176.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -81.37 163.19 23.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.42 -1.264 . . . . 75.34 110.362 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.05 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.787 0.435 . . . . 74.12 112.078 173.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 m -64.52 -29.97 71.01 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.866 0.867 . . . . 71.11 112.572 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 63.8 m-20 -82.53 -16.08 49.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.263 0.625 . . . . 75.35 112.337 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.506 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.8 tmm? -63.64 120.1 11.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.976 0.511 . . . . 73.24 111.822 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.19 -139.46 6.13 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.147 -0.478 . . . . 65.43 112.324 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -58.64 -41.65 86.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.988 1.107 . . . . 71.12 113.988 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -64.61 -41.12 96.43 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.583 0.753 . . . . 71.31 112.225 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.546 HG22 ' HE3' ' A' ' 23' ' ' LYS . 84.5 t -67.08 -43.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.581 0.752 . . . . 71.22 110.517 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.4 tpp -56.45 -40.92 75.61 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.965 1.306 . . . . 60.43 112.479 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.71 -39.23 90.77 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.47 0.708 . . . . 64.2 110.432 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.523 HG21 ' HG2' ' A' ' 21' ' ' GLU . 23.4 m -75.51 -30.74 59.91 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.06 0.544 . . . . 75.32 111.416 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 112' ' ' VAL . 69.2 t -59.39 -41.82 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.343 0.657 . . . . 73.12 110.657 174.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mt -59.86 -36.55 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 122.843 0.457 . . . . 73.24 111.326 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.38 97.27 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.827 1.047 . . . . 74.34 113.827 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' HD23 ' A' ' 45' ' ' LEU . 87.9 m-85 -70.76 -35.41 72.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.931 0.492 . . . . 73.14 111.206 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -22.7 46.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.693 0.797 . . . . 53.11 112.397 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -74.59 -50.09 19.23 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 54.21 111.754 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.06 142.18 72.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.175 0.59 . . . . 73.53 112.076 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.53 123.0 7.8 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.584 2.19 . . . . 74.22 113.107 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.39 34.71 85.76 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.83 -0.623 . . . . 52.11 114.551 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 39' ' ' PHE . 16.4 tp -97.97 18.79 15.15 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 117.738 0.769 . . . . 60.55 111.143 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -45.55 122.62 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.898 1.073 . . . . 72.11 113.898 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.1 51.12 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.421 -0.655 . . . . 34.2 114.554 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.66 137.27 9.2 Favored Glycine 0 C--N 1.364 2.094 0 CA-C-N 118.847 1.323 . . . . 71.23 111.9 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -121.27 138.68 54.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.462 0.705 . . . . 73.4 111.623 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 21' ' ' GLU . 5.4 mp -106.87 121.27 44.07 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.896 0.878 . . . . 71.44 109.392 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.84 109.56 21.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.501 0.72 . . . . 72.01 110.103 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 108' ' ' LEU . 9.5 mp -95.53 136.47 35.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.304 1.041 . . . . 74.24 109.989 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.33 31.55 8.91 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.894 -0.594 . . . . 42.02 112.372 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.3 t -112.18 139.68 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.597 0.759 . . . . 75.53 109.481 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -114.16 159.13 20.42 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.835 -1.172 . . . . 50.3 107.835 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.454 ' HH2' ' HA ' ' A' ' 23' ' ' LYS . 41.3 p90 -150.65 137.16 18.81 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 73.35 111.296 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.91 49.14 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.583 0.753 . . . . 55.14 110.701 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -88.91 130.89 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.362 0.665 . . . . 62.34 110.666 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 63' ' ' ASP . 31.9 p30 -82.13 -172.49 3.99 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.631 0.772 . . . . 72.32 112.486 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.07 -33.12 75.04 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.745 0.818 . . . . 75.14 112.433 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -83.04 -12.61 57.05 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.246 0.618 . . . . 73.53 112.335 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.08 37.02 6.11 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.228 0.451 . . . . 45.33 114.228 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' HD21 ' A' ' 59' ' ' ASN . 8.7 m-20 -116.77 134.72 54.44 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.479 0.711 . . . . 72.54 110.413 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -86.68 118.5 26.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.415 0.686 . . . . 73.44 110.548 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.39 118.34 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.126 0.57 . . . . 74.32 109.885 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.06 120.39 34.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.575 0.75 . . . . 73.34 109.821 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -124.02 151.02 64.57 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.847 0.859 . . . . 73.3 112.088 -170.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.47 121.7 5.28 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.606 2.204 . . . . 74.31 112.823 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.41 -40.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.9 -1.045 . . . . 64.54 110.557 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.44 170.28 46.76 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.695 -0.684 . . . . 53.4 113.362 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.09 139.76 22.18 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 109.619 -0.512 . . . . 70.44 109.619 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 -29.92 31.35 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.569 2.179 . . . . 53.22 111.954 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -133.19 83.06 51.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 108.328 -0.99 . . . . 61.35 108.328 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.21 -36.65 56.18 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.904 2.403 . . . . 63.5 113.564 -172.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.8 -43.01 60.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.191 0.596 . . . . 64.01 110.969 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.1 -45.57 94.15 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.407 0.283 . . . . 71.12 111.39 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.33 -43.64 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.479 0.712 . . . . 71.22 111.352 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.48 -48.42 81.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.523 0.729 . . . . 64.15 111.953 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -66.76 -40.93 88.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.171 -0.922 . . . . 61.45 111.474 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.83 -35.81 82.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.232 0.613 . . . . 74.01 110.91 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.34 -37.05 71.73 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.624 0.769 . . . . 74.31 111.329 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.56 86.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.439 0.696 . . . . 72.43 111.399 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.2 t -65.07 -52.55 55.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.839 0.855 . . . . 73.43 111.503 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.39 -31.82 73.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.21 0.604 . . . . 75.31 111.922 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 44.8 t -60.05 -35.3 74.83 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.163 0.506 . . . . 71.13 112.153 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.78 37.2 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.615 -0.721 . . . . 74.23 112.187 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.8 p -95.35 -2.59 48.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.593 0.961 . . . . 72.5 113.593 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.3 mmt -93.16 -55.45 3.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.371 0.605 . . . . 71.23 109.955 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.94 146.82 26.01 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.36 -0.836 . . . . 72.53 110.548 -171.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.537 HD21 ' HA ' ' A' ' 122' ' ' ILE . 4.8 p30 -52.75 -33.1 46.75 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.59 1.156 . . . . 41.32 113.161 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.25 162.57 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.25 1.02 . . . . 62.42 110.773 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.28 101.75 6.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.657 -0.701 . . . . 74.51 110.427 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.421 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.4 tt -83.24 124.12 30.25 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.57 -1.27 . . . . 73.11 107.57 172.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -102.89 98.75 12.04 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 122.76 0.424 . . . . 71.02 110.856 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.82 163.06 7.63 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.284 1.99 . . . . 64.54 112.433 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 60.4 tt0 -88.23 121.69 30.92 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtt -124.4 117.78 25.22 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.241 0.617 . . . . 71.04 110.799 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.692 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 28.6 mm-40 -131.38 138.78 49.29 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.686 0.794 . . . . 54.31 110.615 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.31 117.27 29.52 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.504 0.721 . . . . 63.5 109.439 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.7 133.53 53.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.394 1.078 . . . . 64.41 110.297 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -89.86 129.9 36.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.988 0.515 . . . . 73.25 111.095 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.605 HG13 HG23 ' A' ' 5' ' ' THR . 23.9 t -128.13 107.74 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.97 0.908 . . . . 63.33 108.828 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.6 28.95 57.11 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.727 0.651 . . . . 53.11 114.727 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.75 0.93 83.42 Favored Glycine 0 CA--C 1.543 1.794 0 N-CA-C 114.82 0.688 . . . . 74.12 114.82 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.7 133.05 41.74 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.611 0.706 . . . . 71.03 109.303 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -86.74 102.72 14.51 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.418 0.554 . . . . 74.11 110.796 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.2 154.42 18.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.52 0.728 . . . . 71.02 110.26 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 52' ' ' LEU . 52.0 tp -116.69 120.1 37.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.401 0.681 . . . . 72.1 109.288 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 17.3 t -95.87 132.63 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.105 -0.702 . . . . 74.12 109.105 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.06 99.22 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.862 -0.792 . . . . 74.52 108.862 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 54.1 t80 -83.67 131.65 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.08 0.552 . . . . 55.43 110.107 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 36' ' ' VAL . 36.6 t -121.92 116.26 30.23 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 109.434 -0.58 . . . . 73.04 109.434 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.23 -176.15 1.76 Allowed 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.708 2.272 . . . . 54.44 112.832 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.81 131.68 44.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.93 0.492 . . . . 70.2 109.85 166.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.08 157.02 23.02 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.038 0.535 . . . . 53.45 111.339 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.93 150.99 46.91 Favored 'General case' 0 C--O 1.186 -2.24 0 C-N-CA 123.963 0.905 . . . . 72.45 111.417 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -38.01 -52.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 N-CA-C 115.738 1.755 . . . . 44.24 115.738 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -69.59 -37.86 77.11 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.124 0.787 . . . . 64.45 113.124 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.8 m-70 -125.73 66.66 1.17 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 105.273 -2.121 . . . . 75.4 105.273 171.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 122' ' ' ILE . 62.8 mttm -44.14 -153.0 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.207 1 C-N-CA 132.863 4.465 . . . . 70.13 121.316 60.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -1.85 71.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.584 2.19 . . . . 65.03 116.244 -117.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.612 HG13 ' HA ' ' A' ' 120' ' ' LYS . 59.5 mt -85.88 111.0 20.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.805 -1.089 . . . . 71.23 110.248 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -113.14 139.53 48.67 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.836 -1.075 . . . . 72.14 110.401 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.4 tttp . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 123.322 0.649 . . . . 71.52 109.443 173.2 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 23.3 ttt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.353 -0.239 . . . . 73.31 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.88 153.53 18.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.13 0.572 . . . . 72.44 111.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.3 t -74.41 156.82 36.61 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.442 0.697 . . . . 62.15 111.249 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.89 -27.73 67.75 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.934 0.493 . . . . 64.21 111.355 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.576 HG23 HG13 ' A' ' 102' ' ' VAL . 3.8 m -70.18 -41.75 73.34 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.658 0.783 . . . . 70.34 110.395 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.18 -51.04 67.96 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.622 1.169 . . . . 72.14 110.952 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 51' ' ' LEU . 85.3 mt -69.67 -33.25 72.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.1 0.96 . . . . 75.21 113.081 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.93 -44.8 88.32 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.013 0.435 . . . . 44.33 110.404 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.33 -37.61 86.31 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.519 -0.764 . . . . 63.24 111.096 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.29 -43.12 98.8 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.885 0.874 . . . . 74.41 110.703 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 22' ' ' ALA . 71.4 mt -67.09 -38.56 85.92 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.518 1.127 . . . . 71.43 111.96 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -72.61 -23.8 60.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.118 0.567 . . . . 62.1 111.942 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.2 17.59 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.475 0.71 . . . . 52.05 110.965 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.33 116.54 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.179 0.514 . . . . 64.01 110.77 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.17 -43.21 87.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.67 0.388 . . . . 72.21 110.629 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.24 101.2 1.44 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.232 0.539 . . . . 73.22 109.931 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 25.3 m -80.89 78.64 7.67 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.589 0.756 . . . . 75.22 110.161 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.07 40.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.955 1.095 . . . . 73.52 113.955 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -123.72 -9.35 7.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 113.047 0.758 . . . . 74.25 113.047 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 17' ' ' SER . 42.3 mt -131.92 133.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.684 0.794 . . . . 73.41 109.301 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -125.7 129.4 49.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.826 0.739 . . . . 72.05 111.316 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -89.02 131.74 35.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.705 0.802 . . . . 71.52 110.612 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.34 151.94 51.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.834 0.854 . . . . 72.12 111.046 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -92.39 165.63 12.97 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.705 . . . . 72.34 112.474 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -24.54 67.31 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.141 0.976 . . . . 72.23 112.276 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.1 -36.02 82.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.865 0.466 . . . . 53.43 111.982 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -86.04 -2.48 58.35 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.466 0.706 . . . . 70.14 112.238 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.4 tpt -52.59 105.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.346 1.059 . . . . 72.34 111.909 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.471 ' HA2' ' OE1' ' A' ' 84' ' ' GLN . . . 138.05 -124.72 3.03 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.802 -0.635 . . . . 61.13 112.83 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.31 -36.85 76.38 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.461 1.105 . . . . 74.15 112.157 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.0 m -72.53 -18.85 61.61 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.264 -0.88 . . . . 63.31 112.991 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -34.34 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.659 0 C-N-CA 122.902 0.481 . . . . 62.23 111.709 167.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 24.7 mmt -74.69 -37.52 62.61 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.367 1.618 . . . . 73.24 115.367 -158.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.44 70.52 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.38 0.537 . . . . 72.2 112.19 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 HD21 ' A' ' 50' ' ' LEU . 31.8 m -77.31 -30.76 54.25 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.186 0.594 . . . . 65.04 111.28 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.53 -39.93 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 122.837 0.455 . . . . 72.32 110.266 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB2' ' A' ' 124' ' ' LYS . 68.6 mt -57.2 -35.61 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.533 0.733 . . . . 73.03 111.637 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.3 1.61 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.47 0.308 . . . . 73.04 110.891 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -65.46 -30.51 71.31 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.498 0.719 . . . . 73.43 112.359 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.81 -24.85 55.93 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.782 0.66 . . . . 51.44 112.782 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 121' ' ' PRO . 49.0 m-80 -115.95 -4.69 12.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.149 1.166 . . . . 63.14 114.149 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -92.52 107.15 21.75 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.0 0.818 . . . . 73.35 110.773 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.52 126.74 8.47 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.464 2.11 . . . . 32.21 112.997 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.21 -7.05 32.48 Favored Glycine 0 N--CA 1.474 1.216 0 CA-C-N 116.002 -0.544 . . . . 73.3 113.734 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.07 -37.93 9.95 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.986 0.893 . . . . 72.54 108.935 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' GLU . 11.0 m-20 39.6 71.81 0.16 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.309 1.844 . . . . 64.53 115.401 171.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.41 74.45 0.43 Allowed Glycine 0 C--N 1.352 1.425 0 N-CA-C 115.362 0.905 . . . . 54.33 115.362 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.13 44.45 Favored Glycine 0 N--CA 1.482 1.72 0 CA-C-N 117.237 0.518 . . . . 53.33 113.234 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -129.26 142.43 50.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.575 0.954 . . . . 74.11 113.575 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 35' ' ' THR . 95.8 mt -132.28 125.44 31.02 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.24 1.416 . . . . 63.11 109.891 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.7 mm? -103.56 108.81 20.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.743 0.417 . . . . 70.31 110.851 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.71 124.93 38.04 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 61.52 109.857 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.98 33.15 4.13 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.158 -0.474 . . . . 73.13 112.94 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.88 146.33 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.545 0.738 . . . . 73.13 109.875 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -130.55 134.3 46.91 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.997 -0.742 . . . . 74.31 108.997 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -117.44 129.65 55.97 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.291 1.036 . . . . 74.3 110.881 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.76 135.22 54.19 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.604 0.762 . . . . 75.04 110.813 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -80.54 129.68 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.606 0.762 . . . . 63.35 110.487 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 40.7 p30 -90.89 -168.17 2.01 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.88 0.696 . . . . 63.55 112.88 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.17 -44.6 68.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.755 1.222 . . . . 74.13 113.48 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -26.8 27.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.013 0.525 . . . . 75.11 111.635 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.16 7.39 14.69 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 119.913 -0.382 . . . . 71.42 114.023 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 8.3 m-20 -74.48 143.1 44.77 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.471 0.636 . . . . 75.02 111.013 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.1 m -90.11 114.28 26.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.871 0.869 . . . . 71.03 110.156 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.55 117.28 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.437 0.695 . . . . 73.43 110.443 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -92.66 116.39 28.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.088 0.955 . . . . 74.45 110.422 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -118.46 149.76 46.67 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 123.885 0.874 . . . . 75.53 111.383 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.63 104.92 1.78 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.66 2.24 . . . . 74.44 112.014 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.94 -29.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 116.052 -0.522 . . . . 74.25 110.397 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -174.16 55.11 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.615 -0.721 . . . . 55.41 113.57 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 77' ' ' VAL . 82.0 mt -104.51 133.14 20.34 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.718 0.807 . . . . 73.21 110.542 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.43 -31.34 42.77 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.521 2.148 . . . . 74.53 111.763 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 5.8 m-20 -122.52 75.43 44.53 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 124.077 0.951 . . . . 64.14 109.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.83 -60.26 0.62 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.24 2.627 . . . . 73.14 114.223 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 5.2 p-10 -66.28 -39.36 89.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.263 -0.426 . . . . 54.43 110.65 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 57.4 tptt -60.96 -40.77 94.59 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.627 0.771 . . . . 62.31 112.089 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG21 HD22 ' A' ' 71' ' ' LEU . 79.2 t -62.84 -44.92 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.037 0.535 . . . . 70.44 110.888 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.49 -50.34 73.93 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.586 0.754 . . . . 71.22 112.313 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 16.5 mmt85 -68.51 -43.96 75.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.495 0.718 . . . . 75.44 111.521 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.72 -33.54 72.63 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.541 -0.754 . . . . 74.33 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.559 HD23 ' SD ' ' A' ' 97' ' ' MET . 21.6 tp -66.98 -40.19 87.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.688 0.395 . . . . 62.51 110.936 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.2 93.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.97 0.508 . . . . 40.55 111.695 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -66.52 -52.47 45.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.813 0.845 . . . . 64.14 112.016 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.471 ' OE1' ' HA2' ' A' ' 29' ' ' GLY . 11.7 pt20 -71.13 -31.17 67.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.003 0.521 . . . . 72.24 112.321 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 42.4 t -60.89 -26.92 67.78 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.435 0.636 . . . . 64.35 111.373 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -76.48 -25.15 53.98 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 113.721 1.008 . . . . 51.0 113.721 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.5 p -110.44 -37.24 5.55 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.288 0.847 . . . . 71.52 113.288 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 92.1 mmm -68.29 -46.89 69.11 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.393 1.077 . . . . 70.53 111.542 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.407 HD12 ' SG ' ' A' ' 85' ' ' CYS . 53.9 mt -85.89 161.91 18.84 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.718 -0.674 . . . . 72.2 111.374 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.4 HD22 HD13 ' A' ' 122' ' ' ILE . 46.2 t30 -37.33 -53.05 1.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.873 1.669 . . . . 75.41 114.051 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 122' ' ' ILE . 28.7 m -119.64 174.33 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.507 0.723 . . . . 73.41 111.441 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -68.73 97.4 0.81 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.202 -0.666 . . . . 54.32 109.202 163.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 122' ' ' ILE . 4.9 tt -98.84 130.84 45.27 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.47 0.708 . . . . 61.13 109.465 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -106.62 98.55 20.92 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 124.061 0.944 . . . . 73.14 110.985 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.4 149.93 15.03 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.238 1.959 . . . . 51.03 111.407 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 9.9 tp10 -87.21 102.68 14.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.097 -0.705 . . . . 64.12 109.097 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 108' ' ' LEU . 51.9 mtm -112.43 140.25 47.32 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.536 0.735 . . . . 70.04 110.679 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -149.88 150.86 32.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.352 0.661 . . . . 74.13 110.46 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.73 119.28 38.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.295 1.038 . . . . 63.34 110.59 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -127.23 133.54 50.22 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.085 0.954 . . . . 75.32 109.711 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.85 122.16 40.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.073 0.463 . . . . 70.32 110.879 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 5' ' ' THR . 9.2 t -119.95 113.44 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.502 1.121 . . . . 73.32 108.41 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.29 28.67 55.25 Favored Glycine 0 CA--C 1.547 2.064 0 N-CA-C 115.169 0.828 . . . . 54.32 115.169 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.12 1.92 66.69 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 115.088 0.795 . . . . 65.23 115.088 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -109.96 130.51 55.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.993 0.897 . . . . 75.44 109.685 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 102.41 14.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.484 0.583 . . . . 73.13 111.685 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.39 166.45 14.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.895 0.878 . . . . 63.33 111.046 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 97' ' ' MET . 49.3 tp -119.21 121.84 40.62 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.56 0.744 . . . . 74.03 110.782 175.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' MET . 52.6 t -86.93 113.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.299 0.639 . . . . 74.02 109.576 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 55.3 t -100.22 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.37 0.605 . . . . 74.41 109.691 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.6 119.28 24.54 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.929 0.892 . . . . 75.34 109.252 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.87 100.34 39.17 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.488 0.715 . . . . 62.14 109.55 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.25 157.29 41.78 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.5 2.133 . . . . 71.43 112.175 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.5 tm-20 -75.94 115.94 16.15 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.23 -0.655 . . . . 71.42 109.23 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.47 152.22 35.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.346 1.058 . . . . 53.2 112.425 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' HB3' HG22 ' A' ' 118' ' ' THR . 14.9 t70 -77.55 156.93 30.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.049 -0.523 . . . . 73.43 111.238 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -64.99 -19.92 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.412 0.685 . . . . 71.32 112.426 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 116' ' ' ASP . 14.9 t -58.01 -18.31 23.22 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 123.534 0.733 . . . . 51.44 112.277 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 83.8 m-70 -79.88 -76.65 0.21 Allowed 'General case' 0 CA--C 1.591 2.548 0 N-CA-C 106.979 -1.489 . . . . 71.03 106.979 166.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 5.8 tmtp? -79.92 -142.57 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.414 0 C-N-CA 129.519 3.127 . . . . 72.43 110.742 -49.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 1.24 112.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.592 1 C-N-CA 125.611 4.207 . . . . 65.54 119.424 -133.832 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.701 HG21 HD12 ' A' ' 93' ' ' LEU . 36.8 mm -95.52 102.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 115.312 -0.858 . . . . 75.02 109.634 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -101.6 167.5 10.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.769 0.828 . . . . 65.42 110.714 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.586 ' HB2' HD11 ' A' ' 37' ' ' ILE . 37.8 ttpt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.41 -0.959 . . . . 73.3 108.41 171.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 98' ' ' GLN . 14.9 ptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 111.383 0.142 . . . . 71.42 111.383 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.09 149.22 21.9 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.681 0.392 . . . . 72.52 111.143 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -74.03 157.31 36.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.943 0.897 . . . . 74.32 112.453 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 102' ' ' VAL . . . -61.27 -43.68 98.47 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.034 0.534 . . . . 64.54 112.208 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -65.0 -35.09 80.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.229 0.612 . . . . 73.21 112.154 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.284 0.634 . . . . 71.33 111.262 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 20' ' ' ILE . 60.2 mt -68.76 -39.56 80.21 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.541 0.736 . . . . 63.21 111.456 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 31.7 tp -65.12 -29.07 69.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.94 0.896 . . . . 75.23 111.276 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.28 -35.09 71.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.638 0.775 . . . . 75.43 111.525 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.89 -50.09 32.29 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 110.232 -0.285 . . . . 75.13 110.232 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 69.6 mt -55.31 -46.86 76.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.489 1.116 . . . . 73.53 113.65 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -87.76 -4.08 58.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.486 0.921 . . . . 55.42 113.486 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.59 -59.84 2.16 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.383 0.611 . . . . 65.52 110.3 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.26 139.09 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 73.43 110.775 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -64.92 -47.24 78.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.633 0.773 . . . . 74.43 112.408 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.85 148.15 24.74 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -93.33 143.58 26.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.748 0.309 . . . . 71.54 110.721 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.58 3.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.361 0.664 . . . . 61.23 111.485 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -137.11 1.59 2.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.043 0.756 . . . . 71.4 113.043 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.576 HD12 HD22 ' A' ' 7' ' ' LEU . 11.0 mm -108.7 107.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 118.78 0.718 . . . . 74.31 110.483 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -94.2 113.81 25.81 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.46 -0.775 . . . . 75.04 110.881 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.09 129.12 35.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.277 0.631 . . . . 73.14 109.919 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -133.82 164.59 26.91 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.721 0.772 . . . . 74.23 111.892 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -101.42 177.73 4.84 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.662 -1.154 . . . . 75.12 110.945 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.06 62.65 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 73.33 111.467 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 p -65.67 -29.9 70.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 53.2 112.274 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.08 -17.01 62.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.164 0.801 . . . . 70.0 113.164 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.409 ' SD ' HG13 ' A' ' 77' ' ' VAL . 92.0 mmm -55.52 107.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.706 0.802 . . . . 70.13 112.111 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.92 -125.38 2.94 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.279 -0.873 . . . . 40.44 111.158 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 2.9 mptp? -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.294 0.638 . . . . 71.43 112.371 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 m -68.18 -45.32 73.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.48 0.712 . . . . 50.4 111.884 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.47 -52.71 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.822 0.449 . . . . 64.43 110.222 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.575 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 39.8 tpp -52.66 -46.52 67.2 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.283 1.033 . . . . 74.03 113.745 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.54 -27.87 64.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.163 0.585 . . . . 74.0 111.914 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.6 m -69.48 -39.3 77.74 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.133 0.573 . . . . 54.12 111.029 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.39 -35.51 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 123.001 0.521 . . . . 73.31 110.756 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 33' ' ' MET . 47.9 mm -57.56 -39.1 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.629 0.772 . . . . 75.44 110.929 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.98 82.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.77 -0.65 . . . . 74.54 112.035 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.4 -38.87 40.62 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.113 0.565 . . . . 72.4 112.204 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . -63.76 -42.41 97.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.298 0.639 . . . . 65.32 111.939 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -90.61 7.22 40.34 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.203 0.601 . . . . 55.01 112.154 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.51 116.05 65.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.416 -0.587 . . . . 73.35 109.416 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.5 111.19 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.264 2.643 . . . . 74.4 115.412 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 25.39 64.59 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.855 1.502 . . . . 52.04 116.855 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -101.06 23.37 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.816 1.308 . . . . 72.53 111.604 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.8 p-10 -46.64 124.85 6.43 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.314 0.645 . . . . 70.31 111.535 167.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.3 -12.68 7.97 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.949 -0.569 . . . . 54.43 112.176 -165.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.15 104.54 0.17 Allowed Glycine 0 CA--C 1.548 2.114 0 N-CA-C 112.259 -0.336 . . . . 41.12 112.259 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.31 132.53 51.39 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.696 0.798 . . . . 74.03 111.405 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.32 118.84 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.952 0.901 . . . . 62.12 108.634 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.487 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.42 106.74 17.33 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.956 -0.387 . . . . 75.34 109.956 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 4.2 mm? -93.01 133.41 36.18 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.736 0.814 . . . . 52.4 111.535 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 33.85 4.71 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 115.697 -0.683 . . . . 62.03 112.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.19 139.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.199 0.6 . . . . 74.3 109.859 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 19.7 t70 -105.63 159.25 16.11 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.128 -1.434 . . . . 74.14 107.128 171.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -148.02 141.11 24.96 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.283 0.563 . . . . 53.25 111.331 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.5 142.03 46.91 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.703 0.801 . . . . 74.03 110.934 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mm -80.31 123.89 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.728 0.811 . . . . 61.4 110.402 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 63' ' ' ASP . 37.6 p30 -82.53 -175.95 5.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.494 0.318 . . . . 72.43 111.642 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.27 -31.42 69.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.877 0.871 . . . . 71.41 113.267 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -81.04 -31.21 34.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.186 0.594 . . . . 73.14 111.483 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.03 9.94 11.54 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 114.389 0.515 . . . . 75.22 114.389 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 59' ' ' ASN . 27.8 m-20 -85.74 147.66 26.23 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.533 0.733 . . . . 75.32 112.298 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -86.64 109.83 19.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.669 0.787 . . . . 70.13 110.868 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.98 123.56 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.465 0.706 . . . . 71.4 110.144 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.33 114.32 26.36 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.585 0.707 . . . . 73.13 111.651 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -117.05 109.95 42.13 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.146 1.379 . . . . 74.21 110.32 -177.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.83 106.42 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.268 1.979 . . . . 61.43 112.359 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.43 -8.47 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.099 0.559 . . . . 64.44 112.505 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.9 -174.14 53.77 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.687 0.635 . . . . 73.43 114.687 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.92 124.59 27.81 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.778 1.231 . . . . 72.42 109.069 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.17 -39.1 71.86 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.601 2.2 . . . . 74.43 112.867 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.18 77.0 42.47 Favored Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 123.511 0.724 . . . . 62.34 109.605 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 99' ' ' LEU . 71.8 Cg_endo -73.43 -37.8 2.98 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.76 2.306 . . . . 74.11 114.347 -168.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HA ' HD11 ' A' ' 99' ' ' LEU . 20.3 t70 -66.36 -37.77 86.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.724 0.41 . . . . 71.04 109.915 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.28 -39.02 92.01 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 116.087 -0.506 . . . . 54.41 111.798 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 28' ' ' MET . 76.6 t -57.05 -40.72 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.727 0.411 . . . . 73.0 110.612 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -64.35 -43.11 95.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.734 0.814 . . . . 63.31 112.567 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 22.8 mmt180 -69.77 -48.29 59.8 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.711 0.405 . . . . 75.14 111.479 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.53 -33.75 75.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.664 1.186 . . . . 65.55 111.788 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.545 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.5 tp -71.5 -42.99 67.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.58 0.352 . . . . 71.52 111.272 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.46 78.46 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.849 0.46 . . . . 74.21 111.568 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 t -66.22 -52.24 49.8 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.641 0.776 . . . . 64.14 111.156 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 88' ' ' MET . 10.8 pt20 -67.71 -34.63 77.26 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 116.459 -0.337 . . . . 71.4 111.797 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.575 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 69.6 m -65.37 -19.6 66.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.993 -1.067 . . . . 73.42 112.78 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.94 -42.67 11.67 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.524 0.73 . . . . 62.13 112.111 169.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 t -85.06 -21.08 29.52 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.802 1.038 . . . . 62.24 113.802 -170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -90.52 -36.6 14.4 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.473 1.109 . . . . 73.04 110.102 -173.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.485 HD21 ' SD ' ' A' ' 33' ' ' MET . 68.0 mt -95.72 147.28 23.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.421 -1.263 . . . . 64.25 110.281 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.413 HD22 HG13 ' A' ' 91' ' ' VAL . 2.9 p-10 -56.17 -28.35 57.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.943 0.897 . . . . 73.45 112.781 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.7 m -124.28 159.87 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.879 0.872 . . . . 74.35 110.91 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.11 99.4 3.93 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.052 0.541 . . . . 62.21 111.449 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tt -94.38 123.38 37.75 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.733 -1.21 . . . . 73.55 107.733 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -108.43 96.03 17.83 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 123.191 0.597 . . . . 72.53 110.51 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.84 158.05 59.42 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.529 2.153 . . . . 74.41 112.761 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.1 tp10 -85.53 107.35 17.43 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.09 -0.707 . . . . 73.34 109.09 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.554 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.0 mtm -122.24 130.95 53.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.309 0.644 . . . . 62.22 111.321 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 14.1 tm0? -146.04 143.83 29.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.481 0.712 . . . . 64.44 110.904 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 75' ' ' ASP . 94.6 mt -92.04 114.08 26.53 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.327 1.051 . . . . 60.04 112.031 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -102.16 124.86 48.5 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.399 1.08 . . . . 62.13 112.173 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.537 HE21 HG23 ' A' ' 106' ' ' THR . 1.8 mp0 -91.58 104.06 16.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.003 0.43 . . . . 74.32 110.105 172.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 4' ' ' ALA . 56.3 t -137.31 131.58 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.521 1.129 . . . . 64.12 110.244 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.73 65.36 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 115.456 0.943 . . . . 72.55 115.456 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.52 4.77 90.32 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 117.091 0.445 . . . . 74.02 113.137 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -115.18 165.76 12.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.299 1.04 . . . . 71.31 110.358 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.537 HG23 HE21 ' A' ' 101' ' ' GLN . 91.7 m -120.43 131.22 54.68 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 120.857 0.36 . . . . 65.14 110.585 171.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.39 170.44 10.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.405 1.082 . . . . 64.4 109.474 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 97' ' ' MET . 46.6 tp -120.06 111.31 17.72 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.975 -0.38 . . . . 74.44 109.975 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.565 HG13 HD11 ' A' ' 7' ' ' LEU . 92.6 t -83.95 120.1 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.332 -0.618 . . . . 61.15 109.332 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 97' ' ' MET . 60.8 t -114.04 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.401 0.619 . . . . 63.4 110.948 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.735 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 75.7 t80 -78.12 125.83 29.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.979 0.912 . . . . 71.31 109.591 168.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.68 106.5 33.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.478 -0.934 . . . . 74.21 108.478 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.12 148.63 27.62 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.01 1.806 . . . . 61.42 110.852 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 36.8 tt0 -75.45 133.91 41.0 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.282 -1.007 . . . . 71.51 108.282 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.66 178.8 8.02 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.278 0.631 . . . . 62.21 110.89 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.2 176.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 122.967 0.507 . . . . 64.22 111.214 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.28 -41.92 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 O-C-N 121.004 -1.06 . . . . 73.35 113.349 166.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -69.3 -44.03 72.6 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 118.492 0.587 . . . . 73.55 111.193 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 21.2 m-70 -118.32 90.15 3.27 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 101.751 -3.426 . . . . 33.13 101.751 163.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.751 ' HA ' HG13 ' A' ' 122' ' ' ILE . 91.6 mttt -51.93 -144.49 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.048 2 C-N-CA 133.335 4.654 . . . . 74.43 122.017 45.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo 10.02 70.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 123.448 2.765 . . . . 75.3 116.805 -119.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.751 HG13 ' HA ' ' A' ' 120' ' ' LYS . 57.6 mt -102.32 131.73 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.015 -1.448 . . . . 73.45 109.492 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -155.74 162.56 40.51 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.015 0.926 . . . . 72.43 110.954 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt . . . . . 0 CA--C 1.554 1.116 0 CA-C-N 115.146 -0.934 . . . . 74.22 110.587 174.053 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 19.4 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 119.595 -0.24 . . . . 55.31 110.509 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -40.31 118.86 0.97 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.019 0.928 . . . . 71.52 112.66 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.5 m -58.1 157.63 7.88 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.105 1.362 . . . . 75.12 114.544 -171.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -61.01 -44.95 96.66 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.546 0.738 . . . . 51.22 111.817 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.42 HG23 HG13 ' A' ' 102' ' ' VAL . 2.6 m -62.88 -35.55 80.37 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-N 114.711 -1.131 . . . . 75.21 110.601 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.22 -48.23 71.27 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.025 0.93 . . . . 74.53 111.753 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 20' ' ' ILE . 35.6 mt -65.01 -36.51 84.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.624 0.37 . . . . 74.4 111.039 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.265 0.626 . . . . 65.23 110.795 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.91 -33.92 76.95 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.504 0.722 . . . . 71.13 111.277 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.418 ' HG2' HD12 ' A' ' 20' ' ' ILE . 8.8 tp10 -67.11 -41.94 85.36 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.44 0.696 . . . . 71.13 110.504 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 72.9 mt -64.47 -34.69 78.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.894 0.878 . . . . 75.43 111.363 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -80.35 -20.86 43.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.56 0.744 . . . . 74.23 112.253 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.78 -55.26 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.247 0.619 . . . . 63.21 110.46 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.4 141.73 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.059 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.54 -45.99 64.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.826 -0.546 . . . . 74.21 111.184 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.62 128.0 56.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.033 0.933 . . . . 73.41 109.896 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 m -36.13 108.64 0.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.411 1.484 . . . . 74.02 114.085 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.46 -7.93 59.46 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.159 0.8 . . . . 63.54 113.159 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -165.9 -34.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.011 0.524 . . . . 71.45 111.35 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 7' ' ' LEU . 55.5 mt -97.15 105.4 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.935 -0.765 . . . . 52.34 108.935 -167.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.03 113.15 24.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.083 -1.08 . . . . 61.25 108.083 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.81 145.83 40.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.808 0.843 . . . . 72.0 110.41 -171.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 160.96 42.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.798 0.808 . . . . 73.3 113.124 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -75.77 166.21 23.87 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 114.194 -1.366 . . . . 71.54 111.717 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.47 -33.3 43.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.224 1.01 . . . . 75.41 113.604 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.6 m -66.68 -30.48 70.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.936 0.894 . . . . 65.12 113.126 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.78 -6.23 58.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.888 0.699 . . . . 72.55 112.888 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mmm -52.79 108.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.14 0.576 . . . . 75.31 112.142 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 151.66 -123.62 1.53 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.51 -0.768 . . . . 73.53 112.417 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -57.58 -55.33 36.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.991 1.108 . . . . 75.32 113.991 -168.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -60.61 -40.47 91.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.149 0.579 . . . . 72.55 112.462 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.39 -42.22 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.045 0.538 . . . . 62.42 111.417 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 54.6 mmm -78.63 -33.83 46.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.112 -0.495 . . . . 74.54 111.713 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.002 0.921 . . . . 73.32 111.387 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' HD21 ' A' ' 50' ' ' LEU . 43.7 m -72.97 -36.45 67.11 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.692 0.797 . . . . 55.41 111.699 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.96 -37.58 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.331 0.652 . . . . 70.02 111.184 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 122' ' ' ILE . 84.7 mt -57.2 -41.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.83 0.852 . . . . 54.12 111.383 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -64.74 -48.55 74.17 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.451 0.7 . . . . 41.41 112.033 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -67.05 -37.59 84.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.187 0.595 . . . . 62.25 111.868 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.77 77.81 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.117 0.567 . . . . 71.14 111.553 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -71.59 -41.76 68.58 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.827 0.851 . . . . 72.21 111.716 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 13.6 mm-40 -72.91 128.7 87.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 123.157 0.583 . . . . 54.31 112.148 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -87.73 118.98 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.11 2.54 . . . . 75.22 112.929 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.09 14.99 58.31 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 115.066 0.786 . . . . 72.01 115.066 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.27 23.55 13.54 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 118.774 1.287 . . . . 74.31 110.966 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -40.37 132.81 1.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.827 0.851 . . . . 54.13 112.613 165.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.46 ' H ' ' HE1' ' A' ' 111' ' ' TYR . . . 119.25 -0.35 14.44 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.447 -0.661 . . . . 52.02 111.447 -161.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.74 100.25 0.11 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.052 0.834 . . . . 40.25 113.835 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -116.88 144.71 44.2 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.54 0.686 . . . . 74.22 112.532 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.7 mp -119.25 131.3 55.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.926 1.291 . . . . 63.1 108.167 165.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 7' ' ' LEU . 29.7 tp -110.9 111.99 23.51 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.027 0.442 . . . . 72.34 110.878 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 3.9 mm? -89.12 133.43 34.39 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.927 0.891 . . . . 73.23 111.416 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 34.11 5.37 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.9 -0.591 . . . . 51.25 112.609 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.1 137.21 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.29 0.636 . . . . 71.03 110.47 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -130.03 130.65 45.23 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.503 -0.925 . . . . 73.55 108.503 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -116.77 138.27 51.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.538 0.735 . . . . 73.01 110.892 -174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.37 141.84 47.0 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.358 0.663 . . . . 73.42 110.891 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.52 133.8 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.994 0.918 . . . . 71.5 111.072 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -87.15 -173.73 4.56 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.019 0.527 . . . . 75.13 111.889 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.99 -25.58 67.92 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 113.45 0.907 . . . . 72.42 113.45 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -82.64 -30.43 29.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.212 0.46 . . . . 64.04 110.942 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.36 11.98 8.46 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 114.675 0.63 . . . . 55.14 114.675 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.85 117.69 19.45 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.342 0.657 . . . . 70.5 111.654 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -79.62 107.97 12.8 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.555 0.742 . . . . 74.42 109.852 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.21 123.59 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.491 0.716 . . . . 72.12 110.301 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.1 124.15 37.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.984 0.914 . . . . 74.32 110.517 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -121.93 149.26 53.35 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 124.227 1.011 . . . . 74.31 111.755 -172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.01 102.81 1.4 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.504 2.136 . . . . 74.12 112.748 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.24 -24.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.816 -0.629 . . . . 74.51 110.901 170.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.23 -169.23 54.87 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.716 -0.674 . . . . 40.52 114.216 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.0 mt -115.53 124.38 30.1 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.074 0.95 . . . . 75.55 109.464 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.83 -27.53 80.54 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.787 2.324 . . . . 75.43 113.125 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.1 p-10 -131.45 63.05 68.28 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 123.834 0.854 . . . . 72.34 111.501 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.84 -31.14 32.35 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.699 2.266 . . . . 65.42 113.345 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.38 -37.27 85.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.249 1.019 . . . . 75.44 111.157 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 8.4 mtpm? -72.31 -54.77 8.54 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.82 -0.627 . . . . 73.51 110.723 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 73' ' ' ASP . 87.4 t -52.24 -38.13 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.395 1.078 . . . . 73.21 112.838 -167.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.45 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 53.1 tt0 -62.41 -47.26 84.88 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.472 0.709 . . . . 73.33 111.961 174.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.02 -48.28 53.97 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.964 0.905 . . . . 62.03 112.529 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.34 -37.08 66.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.527 1.131 . . . . 73.12 111.461 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.9 -41.83 86.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.398 0.679 . . . . 63.01 111.553 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.08 75.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.185 0.594 . . . . 63.03 112.122 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.4 t -69.92 -52.92 20.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.433 0.693 . . . . 75.23 111.447 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.63 -27.98 69.3 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.937 0.495 . . . . 63.31 111.553 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 93' ' ' LEU . 17.2 t -61.04 -30.1 70.12 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.322 0.649 . . . . 62.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.21 -25.56 29.39 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 113.259 0.837 . . . . 74.05 113.259 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -98.68 -33.91 10.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.627 0.973 . . . . 75.1 113.627 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.0 mmm -88.12 -35.79 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.945 0.898 . . . . 75.43 111.781 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -95.76 148.72 22.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.316 0.647 . . . . 75.53 111.048 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -42.18 -51.19 4.75 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 125.292 1.437 . . . . 53.34 112.766 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 HD12 ' A' ' 122' ' ' ILE . 32.8 m -111.0 156.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.019 -0.537 . . . . 44.4 110.613 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.82 117.57 14.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.02 -0.536 . . . . 52.33 109.611 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.657 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.9 mt -111.0 142.66 42.84 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.581 0.753 . . . . 62.53 110.895 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.1 82.25 11.08 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.031 0.932 . . . . 74.22 108.825 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.22 161.54 42.49 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.423 2.082 . . . . 72.42 113.28 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.0 tp10 -77.31 127.91 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.416 -0.811 . . . . 65.21 109.031 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 65.7 mtt -136.14 140.25 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.075 0.55 . . . . 71.34 111.407 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -144.65 151.9 39.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.522 0.729 . . . . 73.23 110.786 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.8 mt -115.13 132.75 56.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.777 0.831 . . . . 73.53 110.695 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 46.8 mt-10 -137.31 149.52 47.12 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.394 0.678 . . . . 54.34 111.102 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -94.97 124.91 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.172 -0.677 . . . . 73.53 109.172 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.42 HG13 HG23 ' A' ' 5' ' ' THR . 21.4 t -121.34 114.37 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 107.581 -1.266 . . . . 72.23 107.581 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.36 26.63 51.56 Favored Glycine 0 CA--C 1.548 2.108 0 N-CA-C 114.614 0.606 . . . . 75.15 114.614 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.94 60.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 114.681 0.632 . . . . 70.0 114.681 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -119.74 129.58 54.57 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.748 0.774 . . . . 74.32 109.73 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 m -85.27 104.35 15.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.746 0.703 . . . . 63.24 112.37 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.6 mp -86.98 160.53 18.62 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.298 1.039 . . . . 63.51 111.456 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 62.0 tp -114.96 131.32 56.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.474 0.71 . . . . 75.25 110.303 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 4' ' ' ALA . 2.5 t -98.58 122.41 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.464 1.105 . . . . 72.54 108.719 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.92 110.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 118.084 0.402 . . . . 72.22 110.927 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 60.2 t80 -94.54 132.43 39.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.222 -0.659 . . . . 75.34 109.222 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.51 105.12 23.8 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.487 -0.931 . . . . 75.23 108.487 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.78 122.3 9.88 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.033 1.822 . . . . 62.32 109.27 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -64.76 134.61 54.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.445 0.698 . . . . 73.31 111.102 -168.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.86 129.63 40.3 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.226 0.61 . . . . 71.43 112.38 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.59 ' HB3' HG22 ' A' ' 118' ' ' THR . 36.2 t70 -86.85 168.84 13.07 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.072 0.949 . . . . 73.11 110.314 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 120' ' ' LYS . 22.8 t -56.44 -22.19 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 124.401 1.081 . . . . 74.33 112.507 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.59 HG22 ' HB3' ' A' ' 116' ' ' ASP . 9.2 t -55.87 -23.86 33.52 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.745 0.818 . . . . 74.23 111.723 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 56.1 m-70 -87.24 -89.28 0.13 Allowed 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 106.206 -1.775 . . . . 73.5 106.206 166.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 29.0 mmmt -59.46 -148.62 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.164 0 CA-C-N 124.838 3.472 . . . . 74.53 113.035 -49.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -0.68 120.94 0.0 OUTLIER 'Trans proline' 1 C--N 1.416 4.093 1 C-N-CA 126.182 4.588 . . . . 72.45 119.917 -139.132 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.527 HD12 HG22 ' A' ' 91' ' ' VAL . 41.1 mm -96.62 91.91 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.299 -0.864 . . . . 73.1 108.86 171.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -81.82 162.22 22.93 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.726 0.298 . . . . 65.11 111.33 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? . . . . . 0 CA--C 1.557 1.225 0 N-CA-C 108.384 -0.969 . . . . 70.13 108.384 173.106 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 51.1 ttm . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 111.508 0.188 . . . . 73.43 111.508 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 1' ' ' MET . 91.5 mtt180 -86.89 -169.48 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.512 0.725 . . . . 70.34 110.431 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -82.95 150.49 26.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 122.047 -0.408 . . . . 73.12 109.908 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.53 70.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.344 0.498 . . . . 75.04 112.344 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.6 p -62.38 -47.72 82.91 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.606 0.762 . . . . 74.24 111.172 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.14 -42.18 98.07 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 121.716 0.769 . . . . 75.31 111.07 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.19 -39.79 93.33 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.651 -1.159 . . . . 53.11 111.628 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.64 -34.57 78.13 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.41 -0.813 . . . . 51.4 111.124 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.23 -41.65 85.35 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.062 0.545 . . . . 74.14 111.414 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.36 -39.69 94.39 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 122.517 0.327 . . . . 54.31 110.642 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.46 -50.96 69.38 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.157 0.983 . . . . 73.03 112.739 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.01 -12.53 61.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.016 0.747 . . . . 74.21 113.016 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.13 -42.76 30.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.489 0.716 . . . . 73.13 111.021 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -98.01 161.17 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.025 0.917 . . . . 63.11 112.602 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -106.52 0.85 24.97 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.88 -1.055 . . . . 71.15 110.788 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.39 130.18 22.96 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.202 1.001 . . . . 71.01 110.113 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m -80.29 85.91 5.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.1 0.56 . . . . 75.41 110.775 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.24 -63.95 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.343 1.057 . . . . 63.44 112.731 -174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtp-105 -102.09 -5.12 24.87 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.645 0.778 . . . . 75.31 111.478 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.9 mm -104.53 167.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.62 115.02 3.89 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.293 -1.002 . . . . 70.34 108.293 167.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.42 32.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.17 0.588 . . . . 63.21 111.442 -171.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -152.46 158.21 42.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.041 0.924 . . . . 61.05 112.774 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -77.06 163.77 26.34 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 113.806 -1.543 . . . . 73.53 111.331 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.64 74.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.495 0.554 . . . . 73.22 112.495 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -76.66 -13.75 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.374 0.67 . . . . 71.21 112.559 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 18.8 t70 -85.24 -5.69 59.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.234 0.613 . . . . 64.13 111.957 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.595 ' SD ' HG13 ' A' ' 77' ' ' VAL . 82.8 mtp -57.08 113.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.01 112.0 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.4 -155.23 10.52 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.225 -0.443 . . . . 55.25 113.531 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -73.9 -25.32 59.95 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.383 1.073 . . . . 72.44 111.442 -174.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.4 p -65.17 -48.1 74.66 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.078 0.951 . . . . 74.24 111.699 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HE3' ' A' ' 23' ' ' LYS . 60.0 t -58.2 -40.58 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.845 0.858 . . . . 75.04 110.819 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.425 ' SD ' HD21 ' A' ' 89' ' ' LEU . 40.1 tpp -71.46 -32.56 68.45 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.92 -1.036 . . . . 65.53 112.253 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.93 -37.73 84.86 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.535 0.734 . . . . 72.12 111.285 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.558 HG21 ' HG3' ' A' ' 21' ' ' GLU . 17.8 m -69.8 -32.43 70.89 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 72.31 112.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.39 -37.14 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.023 0.929 . . . . 74.53 112.075 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.16 -41.06 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.028 0.931 . . . . 64.41 111.911 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.92 68.03 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.901 0.881 . . . . 72.24 112.217 -171.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -61.46 -22.23 64.87 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.806 0.842 . . . . 74.11 112.999 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.99 -26.49 59.61 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.238 0.615 . . . . 65.42 112.055 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -117.65 5.38 12.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.945 1.091 . . . . 74.22 113.945 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -58.58 117.15 18.36 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 118.748 0.704 . . . . 65.0 112.507 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.3 102.07 0.18 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.293 2.662 . . . . 70.21 113.802 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.5 9.93 59.34 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.134 1.214 . . . . 54.32 116.134 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.0 tp -115.62 -64.6 1.29 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.383 1.092 . . . . 71.33 110.965 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 37.71 -157.47 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 125.931 1.692 . . . . 74.11 114.919 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.81 58.71 7.92 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.69 -0.232 . . . . 54.23 113.501 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.21 157.39 17.8 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 112.375 -0.29 . . . . 23.31 112.375 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 90.5 m-85 -124.36 126.13 45.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.824 0.45 . . . . 74.45 111.064 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -98.92 118.17 35.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.596 -0.89 . . . . 72.43 108.596 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.42 109.01 21.15 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.719 -0.474 . . . . 75.34 109.719 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.4 128.5 46.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.254 1.022 . . . . 60.42 109.777 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.9 28.27 7.89 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 115.959 -0.564 . . . . 64.33 112.401 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.1 t -113.27 145.65 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.726 0.81 . . . . 60.13 110.699 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -121.89 151.62 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.451 1.1 . . . . 74.42 108.375 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.6 p90 -126.39 125.76 42.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.261 0.624 . . . . 75.23 109.611 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.22 140.51 51.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.655 0.782 . . . . 63.14 111.144 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.49 129.6 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.553 0.741 . . . . 63.35 111.087 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 87.3 m-20 -78.97 176.56 9.53 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.706 0.802 . . . . 65.21 112.407 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.5 -31.08 69.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.021 0.528 . . . . 74.05 111.789 170.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.73 -17.69 40.4 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.557 0.743 . . . . 70.25 111.089 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.26 34.72 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 114.818 0.687 . . . . 23.52 114.818 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.9 m-20 -79.81 147.35 31.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 117.604 0.702 . . . . 75.1 111.878 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 117.16 29.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.315 0.646 . . . . 63.54 110.528 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 59.8 t -110.86 122.26 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.725 0.81 . . . . 64.53 110.532 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -92.47 124.85 36.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.357 0.663 . . . . 71.41 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -132.35 141.0 39.7 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.995 0.918 . . . . 50.01 111.011 -171.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.35 76.92 4.28 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.916 2.41 . . . . 71.33 113.138 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.61 -18.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 115.923 -0.58 . . . . 71.11 112.399 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.81 49.35 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.427 0.531 . . . . 70.04 114.427 168.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 77' ' ' VAL . 83.0 mt -97.71 132.02 25.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.425 1.09 . . . . 71.55 110.189 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.0 -36.14 23.38 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.074 1.849 . . . . 75.13 111.535 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -123.13 81.3 51.6 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 123.754 0.822 . . . . 71.22 109.876 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.89 -57.23 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.416 2.744 . . . . 70.41 114.57 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.7 -42.53 95.23 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.96 0.504 . . . . 64.24 111.224 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -59.26 -40.88 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.428 0.455 . . . . 73.43 111.656 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 28' ' ' MET . 46.7 t -60.98 -43.29 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.23 0.612 . . . . 71.22 111.549 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.45 -42.58 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.274 0.472 . . . . 73.3 112.274 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -75.85 -42.57 49.1 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 112.69 0.626 . . . . 64.43 112.69 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 -37.36 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.594 0.757 . . . . 65.54 111.709 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.31 -40.2 74.34 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.559 0.344 . . . . 72.11 110.955 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.09 73.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.483 0.713 . . . . 75.04 112.294 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 t -73.75 -53.23 10.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.255 0.622 . . . . 64.54 111.611 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.44 -31.56 72.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 112.722 0.638 . . . . 75.53 112.722 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.8 p -67.22 -29.72 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.512 0.325 . . . . 74.33 111.711 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.71 -25.66 59.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.277 0.631 . . . . 61.41 111.999 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.9 m -90.58 -44.85 9.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.364 0.666 . . . . 53.53 112.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.93 -34.73 19.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.544 0.737 . . . . 73.12 112.727 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD21 ' SD ' ' A' ' 33' ' ' MET . 70.7 mt -88.96 142.7 27.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 122.162 -0.336 . . . . 42.55 110.769 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -36.1 -58.96 0.64 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.88 1.672 . . . . 70.21 113.583 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 119' ' ' HIS . 13.9 m -102.31 168.75 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.334 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.87 1.47 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.609 -0.885 . . . . 71.42 108.609 168.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 122' ' ' ILE . 1.5 tt -102.17 106.67 17.56 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.799 -0.815 . . . . 73.35 108.799 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -96.2 103.71 14.67 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 108.798 -0.815 . . . . 65.23 108.798 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -68.45 172.95 10.47 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 121.531 1.487 . . . . 75.54 111.492 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 86.1 tt0 -86.86 107.49 18.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.732 -1.581 . . . . 74.12 106.732 172.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.612 ' HB3' HD11 ' A' ' 108' ' ' LEU . 76.8 mtm -119.29 117.33 28.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.771 0.428 . . . . 71.32 111.234 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -120.17 131.82 55.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.878 0.871 . . . . 74.53 110.805 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.26 112.02 20.99 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.683 0.793 . . . . 74.01 109.446 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.38 128.64 55.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.494 1.118 . . . . 74.43 111.427 -167.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.66 110.22 22.34 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.879 0.472 . . . . 53.54 110.813 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.7 116.29 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.828 1.251 . . . . 63.11 108.42 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.89 30.19 62.89 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 114.768 0.667 . . . . 70.42 114.768 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.95 89.32 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 114.254 0.462 . . . . 54.21 114.254 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -102.8 129.76 49.57 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.708 0.803 . . . . 72.53 109.709 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.7 m -94.34 126.73 39.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.891 0.769 . . . . 74.13 110.76 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.57 170.47 9.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.393 1.077 . . . . 72.35 109.259 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.9 tp -115.95 118.9 34.23 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.089 -0.338 . . . . 72.33 110.089 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.18 124.71 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.009 -0.737 . . . . 53.51 109.009 169.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 42.8 t -109.76 99.86 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.186 0.517 . . . . 75.35 109.67 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 25.9 t80 -85.5 119.75 26.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.571 . . . . 74.35 109.88 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.21 95.32 45.87 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 108.357 -0.979 . . . . 73.43 108.357 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.51 -177.33 3.56 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.294 1.996 . . . . 71.31 111.766 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.15 137.82 33.91 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.098 -0.705 . . . . 73.24 109.098 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.87 179.92 4.64 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.829 0.852 . . . . 53.33 111.257 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.69 135.95 43.72 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-O 118.314 -0.85 . . . . 75.4 108.95 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.9 t -46.88 -26.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.402 1.63 . . . . 75.23 115.402 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -66.43 -49.47 66.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.685 -0.634 . . . . 55.43 111.039 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 1.6 m-70 -128.43 68.76 1.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.925 -2.621 . . . . 65.55 103.925 168.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 57.3 mtpt -46.82 -153.03 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.428 1 C-N-CA 133.332 4.653 . . . . 74.52 121.155 55.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo 4.77 67.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 123.277 2.652 . . . . 64.15 117.142 -124.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.608 HG21 HD12 ' A' ' 93' ' ' LEU . 53.0 mt -98.35 127.9 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.981 -1.009 . . . . 71.22 109.258 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.49 146.43 38.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 60.41 109.498 -175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 108.533 -0.914 . . . . 73.12 108.533 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.179 -1.045 . . . . 55.21 108.179 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.404 ' O ' HG11 ' A' ' 109' ' ' VAL . 26.6 mmm180 -82.98 159.61 22.19 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.336 0.655 . . . . 75.41 112.183 -171.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m -81.43 156.5 25.35 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.817 0.673 . . . . 42.22 112.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.88 94.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.782 0.833 . . . . 45.51 112.078 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -62.09 -46.87 87.15 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.576 -0.738 . . . . 75.33 110.639 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.21 -47.2 87.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.918 -1.037 . . . . 72.21 111.911 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.35 -36.79 85.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.172 0.589 . . . . 71.34 111.755 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 28.1 tp -65.05 -48.49 73.63 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.017 0.527 . . . . 74.34 111.212 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -63.7 -35.69 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.091 0.556 . . . . 62.52 111.846 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -63.32 -45.87 89.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.487 0.715 . . . . 75.22 111.229 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 22' ' ' ALA . 41.8 mt -59.8 -39.63 85.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.955 0.902 . . . . 75.33 111.069 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.436 HD21 ' H ' ' A' ' 66' ' ' TYR . 18.9 m120 -65.26 -34.45 78.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.809 0.844 . . . . 73.21 112.133 174.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.46 -41.91 72.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.629 0.771 . . . . 73.32 112.187 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -114.84 118.35 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-O 121.653 0.74 . . . . 75.24 112.37 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.64 -9.9 16.09 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.73 1.212 . . . . 73.24 113.574 172.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.32 117.07 23.68 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.7 -0.625 . . . . 74.5 110.36 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.9 p -78.17 91.72 4.37 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.631 0.773 . . . . 70.31 111.493 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.67 -59.52 5.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.633 0.773 . . . . 73.33 111.732 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.6 HH21 ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.42 26.04 1.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.043 0.537 . . . . 70.13 111.693 170.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.24 109.61 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.407 -0.96 . . . . 60.04 108.407 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.07 130.07 49.22 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 120.93 0.395 . . . . 70.12 111.129 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -84.69 143.3 29.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.595 0.758 . . . . 51.43 111.773 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 74.5 mmtt -129.26 145.76 51.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.965 0.906 . . . . 74.44 109.565 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.95 161.49 24.29 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.239 0.616 . . . . 75.33 111.084 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 -36.95 85.55 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.091 0.556 . . . . 65.41 111.703 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 -18.99 61.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.605 0.762 . . . . 71.11 112.584 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.82 -7.12 57.56 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.38 0.672 . . . . 73.43 112.712 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.541 ' SD ' HG13 ' A' ' 77' ' ' VAL . 34.3 mtp -55.9 124.27 17.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.446 0.906 . . . . 51.05 113.446 -176.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.23 -144.91 15.16 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.366 -0.833 . . . . 75.32 111.758 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -59.57 -26.85 65.74 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.137 0.975 . . . . 71.32 113.544 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.0 m -73.52 -27.23 61.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.303 0.641 . . . . 71.23 112.26 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 46.3 t -74.66 -48.94 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 121.244 0.545 . . . . 73.34 110.436 166.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.73 -34.45 67.52 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.322 1.23 . . . . 75.51 114.322 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.63 -41.76 82.01 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.14 0.576 . . . . 73.35 111.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -78.14 -27.67 48.24 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.289 0.636 . . . . 75.32 111.712 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.64 -45.54 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.626 0.77 . . . . 54.53 110.604 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -51.85 -44.02 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.778 1.231 . . . . 64.31 112.111 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.54 89.47 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.341 0.656 . . . . 43.33 112.75 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.63 -35.64 70.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.904 0.705 . . . . 64.5 112.904 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.2 55.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.163 0.585 . . . . 75.11 112.444 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -103.99 -48.33 3.93 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.733 1.012 . . . . 65.01 113.733 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.1 121.09 76.72 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.39 111.73 0.91 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.294 2.662 . . . . 75.31 113.626 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.89 -11.16 29.68 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.34 -0.845 . . . . 70.11 114.633 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HG ' HH21 ' A' ' 19' ' ' ARG . 6.5 mp -94.64 -1.18 53.65 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.574 1.687 . . . . 75.0 110.991 173.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.74 ' HB3' ' HB3' ' A' ' 114' ' ' GLU . 10.0 m-20 -34.53 102.31 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.527 1.931 . . . . 55.5 114.371 174.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.95 0.82 Allowed Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.87 -0.605 . . . . 40.33 112.866 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.94 172.52 47.96 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 113.981 0.352 . . . . 65.54 113.981 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.38 147.16 52.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.765 0.826 . . . . 63.34 112.635 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.1 mt -129.4 124.7 34.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 74.4 108.552 172.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.59 109.21 20.8 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 122.111 -0.368 . . . . 74.04 110.138 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 108' ' ' LEU . 56.6 mt -88.96 129.44 35.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.151 0.58 . . . . 64.41 110.964 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.48 30.36 5.0 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.195 -0.457 . . . . 54.2 112.482 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 48.3 t -116.3 139.52 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.374 0.67 . . . . 65.25 110.631 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.66 131.71 31.88 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.302 -1.369 . . . . 75.55 107.302 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -115.68 140.62 49.02 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.128 0.49 . . . . 75.12 112.282 -171.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.48 141.63 48.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 75.11 110.404 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.8 mt -101.91 133.67 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.595 0.758 . . . . 72.23 111.422 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -74.81 169.37 18.03 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.186 0.994 . . . . 61.22 111.882 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.91 -33.98 75.23 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.393 0.677 . . . . 75.15 111.231 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -71.03 -27.64 63.82 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.483 0.713 . . . . 53.02 111.683 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.47 41.14 2.24 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 116.302 -0.408 . . . . 72.41 113.08 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -100.29 121.63 41.79 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.325 0.65 . . . . 71.21 109.876 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -84.7 108.48 17.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.139 0.575 . . . . 73.53 110.574 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -100.43 112.61 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.492 1.117 . . . . 74.12 109.76 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.436 ' H ' HD21 ' A' ' 12' ' ' ASN . 81.0 m-85 -89.22 115.0 26.39 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.583 -0.525 . . . . 75.12 109.583 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -115.85 134.49 22.71 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.783 0.833 . . . . 72.02 111.19 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 88.3 Cg_endo -75.8 86.86 1.45 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.779 2.319 . . . . 75.12 112.634 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.33 -26.21 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.997 -0.547 . . . . 61.52 111.422 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 82.54 -176.16 53.52 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.115 0.806 . . . . 73.31 115.115 172.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -113.91 116.2 45.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.404 1.082 . . . . 75.52 109.988 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.56 -33.33 96.36 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.711 2.274 . . . . 75.04 112.665 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.57 75.82 78.37 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.852 0.861 . . . . 71.2 109.137 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.84 -39.46 61.9 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.064 2.509 . . . . 73.53 114.522 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.6 p-10 -72.99 -40.4 65.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.512 0.725 . . . . 74.35 111.102 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.31 -37.92 89.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.965 0.506 . . . . 53.5 111.328 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.541 HG13 ' SD ' ' A' ' 28' ' ' MET . 42.5 t -58.93 -47.55 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.045 0.938 . . . . 74.2 111.071 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.549 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 51.9 tt0 -59.84 -45.59 91.93 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.854 0.862 . . . . 61.34 112.199 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 20.8 mmm-85 -74.86 -40.04 61.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.72 -0.673 . . . . 70.12 112.085 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.39 -44.49 92.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.916 0.886 . . . . 71.04 110.778 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 52' ' ' LEU . 22.8 tp -66.76 -40.46 88.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.423 -0.808 . . . . 73.22 111.795 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.91 82.51 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.183 0.593 . . . . 61.44 112.176 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -66.99 -52.0 48.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.386 0.674 . . . . 71.44 111.5 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' A' ' 81' ' ' LEU . 29.7 pt20 -67.74 -28.48 67.67 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.508 0.558 . . . . 71.34 112.508 176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.2 -33.23 69.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.187 0.439 . . . . 63.12 112.187 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.17 -38.05 13.76 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.559 0.743 . . . . 61.21 112.183 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.3 m -74.29 -33.21 63.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.51 0.929 . . . . 71.02 113.51 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.8 mmm -88.33 -55.48 3.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.152 0.581 . . . . 53.25 111.203 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.34 148.65 43.27 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.312 0.645 . . . . 73.21 112.573 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.494 ' HB3' HG23 ' A' ' 122' ' ' ILE . 41.7 t30 -41.98 -63.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.019 1.727 . . . . 64.02 112.85 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.08 167.68 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.744 -0.662 . . . . 73.44 110.861 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.7 97.48 2.19 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.136 0.493 . . . . 72.41 110.323 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.79 123.68 35.35 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.529 -0.915 . . . . 74.54 108.529 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -104.52 106.04 52.63 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 122.934 0.494 . . . . 72.34 110.941 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -87.99 170.56 6.06 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.403 2.069 . . . . 74.3 112.928 166.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.0 tp10 -104.06 136.87 42.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.829 0.852 . . . . 70.34 109.324 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 108' ' ' LEU . 66.1 mtt -134.53 122.11 21.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.155 0.582 . . . . 74.43 110.917 -172.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -124.93 134.42 52.66 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.306 0.642 . . . . 73.32 112.135 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.17 123.19 45.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.813 0.845 . . . . 73.25 111.701 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -142.24 147.05 35.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.24 1.016 . . . . 61.0 110.443 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -97.73 123.4 41.65 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.968 0.413 . . . . 43.34 110.649 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.51 114.12 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.902 1.281 . . . . 73.14 108.511 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.15 29.57 59.87 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 115.439 0.936 . . . . 62.1 115.439 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.94 3.72 73.15 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.062 0.785 . . . . 63.42 115.062 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 11.6 mptt -117.58 132.91 56.44 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.6 0.76 . . . . 63.13 109.444 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 m -83.15 131.28 35.14 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.593 0.633 . . . . 74.43 111.087 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.25 159.44 24.06 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.602 1.161 . . . . 75.53 109.225 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 97' ' ' MET . 36.8 tp -116.74 118.19 31.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.82 0.448 . . . . 72.31 109.988 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 2' ' ' ARG . 29.7 t -82.74 105.63 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.804 -0.813 . . . . 60.2 108.804 172.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 38.7 t -95.35 98.69 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.489 0.661 . . . . 74.01 109.764 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 17.1 t80 -80.58 115.76 20.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.209 -0.905 . . . . 63.11 108.705 171.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.27 94.49 3.37 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 108.462 -0.94 . . . . 71.53 108.462 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.99 166.91 27.12 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.593 2.195 . . . . 50.41 112.571 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . 12.4 pt-20 -59.97 119.78 8.4 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 113.864 1.061 . . . . 71.23 113.864 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 141.25 51.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 162.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.641 ' HB3' HG22 ' A' ' 118' ' ' THR . 38.6 t70 -75.98 161.94 28.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.909 0.483 . . . . 63.12 112.17 -174.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.05 -21.11 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 C-N-CA 124.791 1.236 . . . . 41.44 112.603 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.641 HG22 ' HB3' ' A' ' 116' ' ' ASP . 15.1 t -54.23 -21.94 10.32 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.647 0.779 . . . . 75.4 112.03 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 39.8 m-70 -90.54 -98.08 0.11 Allowed 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 104.724 -2.325 . . . . 71.03 104.724 164.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 55.3 mttm -68.14 -146.14 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.476 0 CA-C-N 125.902 3.955 . . . . 72.01 110.556 -45.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo 7.62 89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 124.721 3.614 . . . . 54.14 118.364 -138.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 90' ' ' ASN . 60.5 mt -74.59 101.54 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.516 -1.22 . . . . 75.3 109.507 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -92.18 168.89 11.03 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.686 -1.143 . . . . 73.02 109.535 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.825 -0.547 . . . . 75.34 109.58 173.76 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.599 ' SD ' ' HB2' ' A' ' 111' ' ' TYR . 5.0 ttm . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.106 -0.331 . . . . 63.04 110.106 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -85.69 152.51 23.03 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.447 0.699 . . . . 73.51 110.561 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.23 152.17 32.73 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.096 0.558 . . . . 75.14 111.566 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.02 66.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.154 0.581 . . . . 73.53 112.47 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -63.77 -36.31 83.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.137 0.791 . . . . 73.11 113.137 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.78 -35.44 80.72 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.039 0.447 . . . . 73.02 111.058 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.63 -36.44 80.79 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.401 0.68 . . . . 74.34 111.795 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.58 -37.22 79.67 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.602 0.361 . . . . 61.41 111.266 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.61 -38.91 92.02 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.804 0.442 . . . . 71.32 110.02 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.09 -37.14 78.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.732 0.813 . . . . 55.04 111.634 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 mt -61.83 -45.26 94.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.747 0.819 . . . . 74.35 111.708 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -77.17 -19.82 56.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.184 0.594 . . . . 74.14 112.128 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.51 -51.97 17.74 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.031 0.533 . . . . 71.45 111.097 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.95 159.14 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.213 0.53 . . . . 62.52 111.216 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.92 -21.86 24.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.371 0.668 . . . . 62.21 112.055 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -145.69 144.63 30.5 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.992 0.917 . . . . 73.14 111.097 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 t -75.13 116.2 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.664 0.786 . . . . 62.13 112.352 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.63 -58.83 1.8 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.154 0.982 . . . . 75.3 111.983 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -115.15 -13.17 11.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 123.822 0.849 . . . . 73.34 112.892 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -129.6 121.8 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.776 0.83 . . . . 74.23 110.244 -167.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -127.52 138.95 53.05 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.626 0.37 . . . . 64.02 110.768 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -93.26 151.98 19.47 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.77 0.828 . . . . 70.42 111.288 175.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HB2' HD23 ' A' ' 52' ' ' LEU . 69.6 mmtt -140.01 141.36 36.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.444 1.097 . . . . 63.11 110.454 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -84.87 160.53 20.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.391 0.676 . . . . 71.52 110.657 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.89 64.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.82 1.044 . . . . 74.34 113.82 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 m -81.86 -11.98 58.69 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 113.137 0.791 . . . . 70.52 113.137 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.5 -9.03 59.79 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.425 0.69 . . . . 64.24 112.148 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mmm -52.09 115.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.222 1.009 . . . . 74.24 112.905 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.93 -131.35 5.69 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 116.217 -0.447 . . . . 72.33 113.615 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.41 -38.31 68.78 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.699 1.2 . . . . 71.13 113.857 -168.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.12 -32.98 69.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.346 0.658 . . . . 61.33 112.093 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.74 -48.68 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.177 0.591 . . . . 72.14 110.059 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -41.44 59.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.246 1.419 . . . . 71.31 113.797 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.6 -43.48 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.207 0.527 . . . . 75.44 111.531 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 m -76.59 -30.7 57.09 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.349 0.659 . . . . 52.24 111.439 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.47 -45.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.197 0.599 . . . . 62.05 110.302 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.65 -38.39 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.301 0.64 . . . . 72.33 110.921 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.01 91.41 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.425 0.69 . . . . 63.2 112.284 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -70.01 -38.98 76.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.153 0.581 . . . . 64.03 111.917 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.9 73.14 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.061 0.544 . . . . 51.11 111.714 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.88 -17.14 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.848 0.859 . . . . 72.42 111.148 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.98 109.82 9.26 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.016 0.526 . . . . 73.02 110.459 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.44 117.05 4.95 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.222 1.948 . . . . 75.32 112.095 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 2.48 90.52 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.944 0.738 . . . . 71.21 114.944 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 tp -113.33 18.64 17.65 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.598 1.199 . . . . 74.32 109.918 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 114' ' ' GLU . 8.6 p-10 -43.51 114.03 0.58 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.22 1.408 . . . . 64.22 113.771 168.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.42 59.21 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.927 -0.579 . . . . 73.43 113.591 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.36 156.29 24.02 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 112.507 -0.237 . . . . 54.12 112.507 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.94 128.06 55.46 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.247 0.524 . . . . 64.52 112.041 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.2 mt -121.15 123.82 43.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.973 0.909 . . . . 63.12 110.121 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.42 109.3 20.88 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.314 0.646 . . . . 72.11 110.287 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.681 HD12 HD23 ' A' ' 108' ' ' LEU . 57.0 mt -94.56 122.73 37.45 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.888 0.475 . . . . 73.04 109.874 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.24 3.76 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 116.503 -0.317 . . . . 75.11 112.919 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 45.0 t -115.38 139.52 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.515 0.726 . . . . 75.33 110.134 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.66 133.29 49.63 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.958 -1.497 . . . . 72.34 106.958 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -110.37 138.41 46.8 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.029 0.532 . . . . 75.2 111.404 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.33 141.32 48.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.083 0.953 . . . . 74.51 110.544 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -92.0 134.75 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.801 0.84 . . . . 72.25 110.902 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.676 HD21 HG23 ' A' ' 65' ' ' VAL . 21.4 m-80 -85.81 -179.13 6.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.464 0.706 . . . . 75.51 112.194 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.58 -38.09 80.26 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.039 0.936 . . . . 64.45 111.758 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -82.79 7.13 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.273 0.842 . . . . 72.2 113.273 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.13 85.96 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 114.885 0.714 . . . . 75.04 114.885 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.409 ' HB3' HD22 ' A' ' 59' ' ' ASN . 25.5 t70 -71.28 157.58 37.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.799 0.84 . . . . 61.22 112.423 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -103.92 124.65 49.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.053 0.941 . . . . 71.24 111.274 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.676 HG23 HD21 ' A' ' 59' ' ' ASN . 78.2 t -116.49 130.28 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.854 0.862 . . . . 54.12 109.892 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -93.82 119.63 33.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.931 0.893 . . . . 70.14 111.166 -173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -112.41 133.7 21.73 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.58 0.752 . . . . 72.52 111.644 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.28 88.4 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.286 1.991 . . . . 72.41 112.212 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -81.37 -19.03 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 122.994 0.517 . . . . 60.44 111.604 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 77.15 -173.41 54.92 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 121.881 0.712 . . . . 54.12 114.378 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 77' ' ' VAL . 55.0 mt -115.2 127.65 26.63 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.643 1.177 . . . . 73.22 108.765 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.15 -23.57 52.75 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.284 1.989 . . . . 74.5 112.485 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.3 73.58 36.75 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 125.219 1.407 . . . . 64.54 110.208 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.18 -42.77 12.76 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.613 2.875 . . . . 75.21 114.821 -165.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.72 -31.31 66.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.57 0.748 . . . . 61.43 111.967 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -72.27 -34.17 68.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 120.603 0.239 . . . . 74.35 110.412 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 71' ' ' LEU . 98.7 t -59.26 -40.76 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.707 0.803 . . . . 50.21 110.918 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -63.99 -49.26 73.15 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.375 1.07 . . . . 73.43 113.173 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -34.66 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 112.614 0.598 . . . . 73.53 112.614 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 3.9 m-20 -62.11 -45.06 95.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.378 0.271 . . . . 71.4 110.573 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.665 HD23 ' SD ' ' A' ' 97' ' ' MET . 35.1 tp -63.07 -38.58 91.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.967 0.507 . . . . 73.5 112.163 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.68 72.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.626 . . . . 65.02 111.47 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 t -73.6 -44.69 56.54 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.682 0.793 . . . . 71.24 111.676 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 80.7 mt-30 -58.06 -44.87 87.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.649 0.78 . . . . 72.34 111.553 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.5 t -74.93 -18.42 60.4 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.183 0.993 . . . . 23.53 111.986 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -82.81 -43.63 16.46 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.294 0.638 . . . . 54.05 112.367 171.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -83.91 -52.43 6.36 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.8 0.84 . . . . 73.43 113.038 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.0 mmm -67.86 -17.62 64.55 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.852 0.861 . . . . 54.4 112.89 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 mt -108.73 148.5 30.38 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 71.24 110.166 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -39.07 -53.67 1.79 Allowed 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.741 1.216 . . . . 75.31 113.532 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.04 157.92 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 114.903 -1.044 . . . . 61.31 109.564 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.71 97.2 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.847 0.832 . . . . 62.14 109.453 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tt -94.15 117.38 30.03 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.065 -1.457 . . . . 73.31 107.065 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -110.71 92.56 14.64 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.914 0.885 . . . . 74.5 110.167 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.32 165.59 24.16 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.742 2.295 . . . . 74.34 113.671 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 13.2 tp10 -85.13 107.57 17.27 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.665 ' SD ' HD23 ' A' ' 81' ' ' LEU . 76.2 mtm -119.1 122.53 42.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.781 0.433 . . . . 52.32 111.64 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -129.09 123.75 33.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.122 0.969 . . . . 74.54 110.741 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.67 114.79 12.32 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.73 0.812 . . . . 73.31 110.737 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.74 125.63 53.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.879 0.872 . . . . 75.12 111.211 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -97.16 117.75 32.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.348 0.659 . . . . 70.32 111.382 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.52 118.8 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.085 1.354 . . . . 64.2 110.034 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.06 52.67 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 115.817 1.087 . . . . 62.53 115.817 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.26 -3.12 85.71 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 117.05 0.425 . . . . 74.11 114.119 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 74.2 mmtt -99.17 137.57 37.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.492 1.117 . . . . 60.45 109.078 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -107.77 131.1 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.273 0.942 . . . . 54.45 111.305 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.42 168.67 11.43 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.253 1.021 . . . . 73.11 109.267 -174.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD23 HD12 ' A' ' 52' ' ' LEU . 34.7 tp -121.89 116.68 24.82 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.894 -0.41 . . . . 71.21 109.894 173.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 1' ' ' MET . 38.2 t -87.8 120.81 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.92 -0.77 . . . . 70.45 108.92 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 46.2 t -110.69 104.82 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 64.0 110.394 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 74.3 t80 -90.47 113.28 25.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.136 0.974 . . . . 74.51 110.222 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.53 100.82 46.72 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.568 0.747 . . . . 74.33 110.495 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -86.31 -173.27 1.2 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.716 2.277 . . . . 64.45 113.309 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 36.4 tt0 -93.64 153.18 18.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.866 0.866 . . . . 64.41 109.71 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.08 155.2 40.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.41 0.624 . . . . 61.41 112.323 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.18 158.76 35.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.952 0.901 . . . . 73.42 110.997 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.4 t -56.46 -22.21 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.525 0.935 . . . . 74.22 113.525 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -52.08 -22.13 3.86 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 123.766 0.827 . . . . 64.33 112.366 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.659 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 81.3 m-70 -104.23 -84.29 0.48 Allowed 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 106.354 -1.721 . . . . 62.52 106.354 162.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 16.1 ptpt -79.81 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.665 0 CA-C-N 125.655 3.843 . . . . 71.33 110.909 -34.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 3.3 Cg_exo 7.52 116.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.305 1 C-N-CA 125.489 4.126 . . . . 74.44 120.102 -137.259 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.48 93.8 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.317 -1.311 . . . . 72.12 109.039 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -79.49 170.74 16.14 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.34 0.656 . . . . 72.14 111.017 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.0 tttt . . . . . 0 CA--C 1.55 0.944 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.162 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 16.6 ptm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 110.784 -0.08 . . . . 74.5 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -83.87 156.71 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.508 0.723 . . . . 61.21 111.893 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -82.16 161.23 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.781 0.832 . . . . 63.13 112.046 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB1' HD22 ' A' ' 107' ' ' LEU . . . -62.25 -44.63 96.1 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.338 0.655 . . . . 72.44 112.018 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -72.22 -31.13 65.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.954 0.724 . . . . 73.03 112.954 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.23 -49.36 77.92 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 121.786 0.803 . . . . 65.43 111.447 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.4 mt -72.73 -26.36 61.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.768 -1.106 . . . . 72.15 112.654 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.93 -43.69 98.27 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.008 0.523 . . . . 52.33 110.353 169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.51 -36.33 75.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.482 1.113 . . . . 75.43 111.333 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp10 -65.02 -52.36 56.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.616 0.766 . . . . 71.22 111.267 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -56.57 -37.61 70.81 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.463 1.105 . . . . 73.41 113.503 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -78.09 -24.06 47.71 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.057 0.543 . . . . 73.43 111.501 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.67 -38.97 53.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.506 0.722 . . . . 65.53 112.314 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.35 146.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 121.296 0.57 . . . . 65.31 111.919 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.96 -39.55 82.05 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.677 1.191 . . . . 74.24 111.596 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.29 167.79 29.29 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.779 0.832 . . . . 74.13 111.623 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -66.8 89.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.471 0.709 . . . . 14.24 112.445 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.38 10.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.645 0.778 . . . . 63.05 112.017 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -121.67 -28.8 4.48 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.449 0.7 . . . . 64.32 111.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 10' ' ' GLU . 33.9 mm -112.22 119.19 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 70.33 110.046 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 143.6 42.3 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.101 0.56 . . . . 53.52 109.76 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.9 27.41 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.458 0.703 . . . . 73.42 110.638 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 54.6 mtmt -141.0 152.94 45.31 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.828 0.851 . . . . 72.35 112.245 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 mtm-85 -80.58 170.4 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.676 0.79 . . . . 73.34 112.681 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 28' ' ' MET . . . -60.83 -26.7 67.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.346 0.869 . . . . 71.22 113.346 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -64.59 -1.22 1.7 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.429 1.27 . . . . 63.03 114.429 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -111.88 -9.29 14.06 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.974 0.51 . . . . 72.34 112.185 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.9 ptm -60.76 104.39 0.35 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.663 0.744 . . . . 74.13 111.519 -173.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.26 -122.37 1.21 Allowed Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.669 -0.696 . . . . 65.43 112.388 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -52.78 -58.18 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.292 1.037 . . . . 75.34 113.797 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.5 m -76.2 -32.06 58.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.404 0.52 . . . . 70.4 112.404 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.75 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.178 0.444 . . . . 60.22 110.314 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 39.0 tpp -58.85 -43.62 90.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.622 0.769 . . . . 75.25 111.611 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -59.7 -39.32 84.2 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.779 . . . . 71.12 111.991 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -70.12 -35.52 74.16 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 122.847 0.459 . . . . 63.33 110.996 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.14 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.462 0.705 . . . . 54.35 110.474 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.27 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 74.15 110.585 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -62.38 -47.17 85.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.428 0.691 . . . . 64.11 112.045 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -67.42 -40.84 85.53 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 122.71 0.404 . . . . 74.55 111.501 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.07 67.15 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.287 0.635 . . . . 63.45 111.89 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -80.87 -37.43 29.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.892 0.877 . . . . 32.43 110.719 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 32.3 mm-40 -56.97 109.32 1.64 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.505 0.722 . . . . 75.24 111.944 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.68 111.07 2.9 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.25 1.966 . . . . 64.25 112.712 -173.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.93 22.49 65.94 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 114.486 0.554 . . . . 34.41 114.486 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 26.69 10.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 117.702 0.751 . . . . 55.32 110.135 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 31.7 t70 -48.76 119.06 2.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.523 0.729 . . . . 62.51 111.777 168.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.501 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 114.41 48.04 0.57 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.101 -0.5 . . . . 60.23 112.899 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.72 137.25 13.39 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 110.613 -0.995 . . . . 33.4 110.613 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -118.43 152.68 35.42 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.325 0.861 . . . . 73.34 113.325 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.4 mt -123.06 122.32 38.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.171 1.389 . . . . 74.21 109.953 175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.27 108.43 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.721 -0.474 . . . . 73.0 109.721 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 7.5 mp -95.19 120.71 35.89 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.114 -0.698 . . . . 70.21 109.114 176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.48 25.99 5.28 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.312 -0.404 . . . . 51.44 113.232 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.71 133.06 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.34 -0.615 . . . . 65.11 109.34 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -109.72 154.18 23.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.25 -1.018 . . . . 72.42 108.25 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.54 139.69 38.79 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.058 0.456 . . . . 61.24 111.124 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.68 140.31 52.82 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.87 0.868 . . . . 60.44 110.536 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.39 127.33 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.248 0.619 . . . . 73.52 110.809 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -71.98 171.38 11.92 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.854 0.462 . . . . 70.45 111.435 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.37 -31.03 69.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.067 0.547 . . . . 74.1 111.725 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -98.32 11.0 39.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.911 0.708 . . . . 75.23 112.911 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.3 -3.67 59.96 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 116.859 1.503 . . . . 73.41 116.859 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 128.07 34.59 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 118.905 1.353 . . . . 74.25 112.97 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -80.09 106.54 12.19 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.876 -0.787 . . . . 72.54 108.876 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -103.11 119.95 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.405 0.682 . . . . 64.44 109.589 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.93 142.47 27.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.136 0.574 . . . . 74.1 110.407 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -147.99 137.25 11.96 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.155 0.582 . . . . 74.35 111.414 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -82.18 89.53 1.18 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.907 2.405 . . . . 72.5 112.428 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.61 -13.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.865 0.466 . . . . 61.43 111.747 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.37 172.19 46.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 121.616 0.565 . . . . 72.33 114.309 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -95.44 140.16 22.26 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.202 1.001 . . . . 71.13 109.762 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.86 -37.18 98.75 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.631 2.221 . . . . 55.33 112.274 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -140.58 101.55 6.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.806 -1.183 . . . . 65.43 107.806 166.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HB2' HD22 ' A' ' 99' ' ' LEU . 90.4 Cg_endo -74.13 -22.99 16.29 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.635 2.223 . . . . 70.31 113.838 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.55 -43.29 66.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.509 0.724 . . . . 41.12 110.591 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -40.02 87.48 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.549 -0.296 . . . . 62.45 111.275 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.49 -43.64 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.347 0.659 . . . . 74.23 111.748 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.21 -41.91 99.22 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.876 0.47 . . . . 53.34 111.978 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -72.86 -46.94 50.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.362 0.665 . . . . 71.13 111.915 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.35 -30.54 70.38 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.141 0.576 . . . . 71.53 112.01 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.87 -37.96 67.18 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.406 0.283 . . . . 75.04 111.027 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.55 76.19 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.19 0.596 . . . . 75.43 111.763 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.6 m -66.07 -51.5 57.56 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.364 0.666 . . . . 74.02 111.347 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -65.62 -29.68 70.29 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.74 0.416 . . . . 74.05 111.419 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.35 -32.28 71.12 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.377 0.51 . . . . 63.53 112.377 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.87 16.76 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.982 0.513 . . . . 63.13 111.381 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 64.7 m -74.22 -32.05 62.86 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.847 0.859 . . . . 74.21 113.207 -174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.5 mmm -94.87 -42.97 8.42 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.435 0.694 . . . . 70.53 112.013 -175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.01 132.19 37.7 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.45 -0.204 . . . . 74.23 110.45 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -58.16 -40.28 80.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.829 0.851 . . . . 72.21 112.223 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -97.36 155.56 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.294 0.638 . . . . 42.14 109.824 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 96.15 2.33 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.667 -0.494 . . . . 74.11 109.667 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.56 123.47 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.038 -1.097 . . . . 72.42 108.038 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -103.39 95.15 6.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.82 0.848 . . . . 71.43 110.062 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.44 156.28 9.32 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.545 2.163 . . . . 74.14 112.054 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.5 tp10 -83.44 122.56 28.67 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.967 -0.753 . . . . 64.45 108.967 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.4 mtt -128.39 124.27 35.91 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.07 0.548 . . . . 70.43 110.391 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -135.68 133.76 38.45 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.985 0.421 . . . . 74.15 110.309 175.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 74' ' ' PRO . 94.5 mt -81.72 111.06 17.63 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.196 0.999 . . . . 60.32 110.641 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.36 130.13 55.22 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.954 0.902 . . . . 72.21 111.936 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -96.78 118.91 34.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.364 0.665 . . . . 72.03 111.282 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.83 121.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.658 1.183 . . . . 75.12 109.59 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 29.09 57.63 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.795 1.078 . . . . 32.52 115.795 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.86 81.39 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.035 0.774 . . . . 70.12 115.035 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -107.59 137.25 45.96 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.558 0.743 . . . . 63.25 109.681 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.9 m -102.01 134.88 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.684 0.675 . . . . 74.22 110.751 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.437 HD22 ' HB1' ' A' ' 4' ' ' ALA . 6.0 mp -124.48 170.18 11.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.393 1.077 . . . . 73.13 108.737 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 97' ' ' MET . 60.9 tp -117.31 116.54 27.42 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.671 -0.492 . . . . 62.01 109.671 172.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t -94.42 128.58 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.512 -0.921 . . . . 72.22 108.512 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 56.6 t -121.92 106.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.087 0.555 . . . . 60.42 111.006 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 92.3 t80 -82.52 123.95 29.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.026 0.93 . . . . 75.33 110.148 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.39 114.19 62.43 Favored Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 109.456 -0.572 . . . . 51.43 109.456 173.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.84 161.82 38.51 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.273 . . . . 62.43 112.602 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -75.02 150.15 39.02 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.94 -0.393 . . . . 72.43 109.94 176.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -74.02 145.76 44.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.281 0.562 . . . . 72.23 111.776 169.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.68 -179.95 1.95 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.452 1.101 . . . . 63.23 110.736 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.86 -49.69 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 62.31 112.974 167.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -73.2 -49.17 29.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.16 0.505 . . . . 75.12 110.708 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.7 m-70 -103.92 83.05 2.06 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 102.199 -3.26 . . . . 61.32 102.199 159.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 31.6 mmtp -43.5 -152.9 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.521 1 C-N-CA 132.562 4.345 . . . . 72.25 121.263 61.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo 4.14 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.007 2.471 . . . . 63.32 116.046 -126.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 120' ' ' LYS . 46.0 mm -100.74 125.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.754 0.822 . . . . 64.34 109.503 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -156.44 -176.86 6.2 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.539 0.736 . . . . 74.4 111.264 -174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt . . . . . 0 N--CA 1.482 1.173 0 C-N-CA 123.524 0.729 . . . . 73.41 111.908 177.016 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.607 ' HG2' ' HB2' ' A' ' 111' ' ' TYR . 3.0 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 111.208 0.077 . . . . 63.02 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -41.52 132.19 2.84 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.338 1.055 . . . . 73.21 112.668 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -62.84 159.36 16.79 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.348 0.659 . . . . 61.54 112.154 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.38 81.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.09 0.556 . . . . 61.31 112.049 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -68.93 -36.77 78.36 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.318 0.647 . . . . 53.14 112.481 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.42 -53.68 54.65 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.113 0.565 . . . . 73.14 111.152 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 109' ' ' VAL . 93.3 mt -59.64 -38.92 82.7 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.634 0.773 . . . . 62.23 112.029 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.5 tm? -62.55 -42.34 99.47 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.717 0.807 . . . . 75.43 110.862 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.73 -37.48 87.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.031 0.533 . . . . 60.55 110.56 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -66.09 -40.14 90.56 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.679 -0.691 . . . . 74.13 111.474 173.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 87.2 mt -61.03 -39.02 88.18 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.569 0.747 . . . . 73.41 111.79 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -78.51 -22.75 46.93 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.142 0.577 . . . . 74.14 111.851 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.81 -44.46 49.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.263 0.625 . . . . 51.21 111.226 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.5 m -86.82 151.63 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 74.42 110.994 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.36 -18.46 38.78 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.566 0.747 . . . . 74.2 110.977 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.68 150.81 36.14 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.326 0.65 . . . . 72.4 111.013 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 57.4 p -83.88 80.44 9.15 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.434 0.635 . . . . 71.5 110.717 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.62 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.68 -0.691 . . . . 65.04 112.0 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -120.44 -11.83 9.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 73.2 110.926 175.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mt -115.04 106.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.294 -1.002 . . . . 74.32 108.294 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 10.2 tp10 -96.04 151.81 19.1 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.299 1.44 . . . . 74.25 111.713 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.76 28.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.919 . . . . 72.22 110.162 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HG2' ' A' ' 21' ' ' GLU . 62.5 mttm -136.23 166.42 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 54.13 112.167 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -105.36 167.24 9.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.577 1.151 . . . . 64.14 112.042 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.57 -26.01 67.67 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.64 0.776 . . . . 75.41 112.448 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.6 t -56.4 -37.12 69.71 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.294 0.85 . . . . 23.21 113.294 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.33 18.35 16.12 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.555 0.946 . . . . 62.14 113.555 -170.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.1 ptm -63.74 103.19 0.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.049 0.928 . . . . 71.23 110.736 166.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.08 -130.97 2.7 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.307 -0.86 . . . . 75.45 111.939 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -55.14 -34.4 63.73 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.213 1.005 . . . . 74.34 112.862 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -67.39 -40.72 85.68 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.473 0.709 . . . . 65.43 111.89 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.49 -53.29 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.829 0.451 . . . . 73.44 110.033 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -48.22 -40.69 25.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.901 1.281 . . . . 72.25 113.34 175.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.07 -47.14 65.32 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.836 0.854 . . . . 73.13 111.927 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 m -77.62 -37.73 49.55 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.652 0.781 . . . . 61.34 111.912 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.24 -42.32 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.215 1.006 . . . . 62.31 112.254 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -54.14 -34.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.341 1.056 . . . . 62.21 112.379 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.78 92.55 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.249 0.62 . . . . 61.24 111.784 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -72.68 -30.22 64.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.961 0.504 . . . . 74.51 111.721 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.88 19.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.199 0.6 . . . . 75.51 112.23 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -85.16 -43.09 14.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.228 0.825 . . . . 73.43 113.228 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.63 108.23 5.49 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 122.92 0.488 . . . . 70.02 111.373 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 116.36 4.63 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.462 2.108 . . . . 65.12 111.683 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.74 3.31 40.01 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.243 -0.754 . . . . 63.14 114.24 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.53 -23.89 11.27 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 118.88 1.34 . . . . 75.45 108.401 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -44.94 155.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.246 1.819 . . . . 73.53 115.699 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 39.0 4.95 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.546 -0.752 . . . . 75.54 113.06 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.95 165.4 29.31 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 113.547 0.179 . . . . 71.0 113.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -123.22 126.75 47.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.318 0.647 . . . . 72.51 110.278 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.6 mp -112.32 118.08 34.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 75.43 108.438 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.5 tp -102.33 111.82 24.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.666 -0.494 . . . . 74.5 109.666 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 108' ' ' LEU . 71.7 mt -92.35 138.95 31.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.213 0.605 . . . . 74.12 111.149 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.12 41.07 5.65 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.548 -0.751 . . . . 64.41 112.634 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.92 141.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.122 0.569 . . . . 74.43 110.728 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -104.73 158.6 16.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.228 . . . . 62.02 108.322 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -143.87 126.73 16.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.203 0.525 . . . . 73.32 110.295 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.13 137.34 53.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.354 1.062 . . . . 73.12 110.707 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.56 122.86 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.53 0.732 . . . . 62.32 111.54 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -72.21 177.63 4.35 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.465 1.106 . . . . 74.33 111.986 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.17 -28.61 66.57 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.003 0.521 . . . . 62.22 110.821 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.107 0.963 . . . . 75.53 112.273 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.12 10.88 70.78 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 116.786 -0.188 . . . . 74.44 112.852 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.31 158.72 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.124 0.97 . . . . 72.43 111.969 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -109.71 113.03 25.45 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.361 0.665 . . . . 63.53 110.906 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.62 124.3 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.651 0.781 . . . . 64.13 109.586 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.486 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 66.9 m-85 -93.17 127.17 38.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.262 0.625 . . . . 65.4 110.206 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -117.28 131.78 23.85 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.847 0.859 . . . . 74.3 110.601 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.03 97.3 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.268 1.979 . . . . 62.54 111.573 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.48 -20.63 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.405 0.682 . . . . 71.3 112.309 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.61 178.08 51.24 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 121.56 0.533 . . . . 60.24 114.267 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.12 138.75 20.63 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.226 1.011 . . . . 61.32 110.854 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.52 -38.37 19.52 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.481 2.121 . . . . 65.31 112.592 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 77' ' ' VAL . 14.5 m-20 -124.78 67.23 50.6 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 123.701 0.801 . . . . 64.44 109.627 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 99' ' ' LEU . 39.2 Cg_endo -60.22 -42.65 40.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.106 2.537 . . . . 64.22 114.638 -164.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.92 -38.0 87.55 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.133 0.573 . . . . 71.04 110.979 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -71.95 -37.23 69.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.258 0.623 . . . . 74.42 111.515 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.8 t -60.91 -39.61 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.665 0.386 . . . . 74.42 110.058 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.52 -47.92 79.67 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.24 0.616 . . . . 72.53 112.208 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -63.63 -50.06 70.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.823 0.849 . . . . 75.11 112.238 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.74 -30.31 69.76 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.895 0.878 . . . . 74.33 111.328 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.7 tp -67.56 -42.06 83.22 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.929 0.492 . . . . 74.54 111.122 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.44 98.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.445 0.698 . . . . 75.4 111.382 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -61.65 -52.61 63.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 60.2 111.668 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.94 -30.77 70.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.055 0.391 . . . . 75.24 112.055 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.19 -32.19 71.94 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.431 0.56 . . . . 70.24 112.071 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.3 -29.71 28.13 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.701 -0.681 . . . . 60.15 112.447 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -94.35 -24.41 17.4 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.549 1.314 . . . . 74.14 114.549 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.402 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 48.1 mmm -91.09 -27.1 18.79 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.46 0.704 . . . . 71.43 111.861 -173.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.6 162.0 13.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.139 0.576 . . . . 74.25 112.536 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -39.54 -63.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.083 1.753 . . . . 55.44 112.835 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.437 HG21 ' ND1' ' A' ' 119' ' ' HIS . 30.3 m -116.61 172.03 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.69 0.796 . . . . 71.54 110.16 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.17 99.66 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.197 0.523 . . . . 72.23 110.661 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.16 134.05 35.57 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.999 -1.112 . . . . 73.25 107.999 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -110.39 91.6 12.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.123 0.569 . . . . 75.21 111.462 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -90.62 169.07 3.9 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.831 2.354 . . . . 62.14 112.531 171.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.85 135.13 53.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.191 0.596 . . . . 72.41 109.838 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.661 ' HB3' HD11 ' A' ' 108' ' ' LEU . 46.9 mtt -130.03 132.57 46.27 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.203 0.601 . . . . 72.13 111.156 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -135.37 144.31 46.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.481 0.712 . . . . 71.43 111.741 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 74' ' ' PRO . 74.1 mt -104.23 117.12 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.092 0.957 . . . . 74.23 110.098 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -117.49 133.23 56.2 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.492 1.117 . . . . 75.35 111.651 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -94.21 114.36 26.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.822 0.849 . . . . 72.05 110.527 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.95 113.95 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.788 1.235 . . . . 63.44 109.149 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 51.42 28.49 20.73 Favored Glycine 0 CA--C 1.543 1.803 0 N-CA-C 115.642 1.017 . . . . 62.31 115.642 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.23 -5.71 78.23 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.546 0.578 . . . . 60.52 114.546 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -98.92 137.57 37.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 61.34 110.699 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 m -102.39 104.73 15.23 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.191 0.451 . . . . 74.44 111.461 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.09 163.7 12.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.663 0.785 . . . . 62.32 111.623 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 97' ' ' MET . 39.4 tp -115.4 114.14 24.68 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.146 0.578 . . . . 62.14 110.962 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 7' ' ' LEU . 90.8 t -83.29 112.53 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.711 0.804 . . . . 71.12 109.506 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 25.1 t -108.49 100.05 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.637 0.732 . . . . 61.2 110.602 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 51.9 t80 -84.6 124.47 31.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.433 1.093 . . . . 74.14 110.535 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.07 103.02 48.66 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 122.655 0.382 . . . . 63.43 110.44 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.65 166.18 28.91 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.736 2.291 . . . . 71.53 112.011 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.51 161.74 24.82 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.915 1.079 . . . . 74.25 113.915 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.38 47.17 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.739 -1.119 . . . . 33.13 109.18 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.14 163.43 24.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 122.737 0.415 . . . . 62.21 111.058 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.0 -22.18 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.305 1.042 . . . . 73.54 112.467 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.3 p -58.28 -27.39 64.01 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.191 0.597 . . . . 75.33 111.448 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 5.4 m170 -75.84 -86.07 0.05 OUTLIER 'General case' 0 CA--C 1.591 2.53 0 N-CA-C 105.512 -2.033 . . . . 65.13 105.512 166.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 45.1 tttp -82.49 -145.04 0.0 OUTLIER Pre-proline 0 CA--C 1.591 2.538 0 C-N-CA 129.298 3.039 . . . . 71.23 109.636 -49.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo 5.47 102.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 124.884 3.723 . . . . 53.24 119.326 -136.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.2 mt -88.85 115.11 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 114.735 -1.12 . . . . 75.43 109.48 168.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -108.38 166.5 10.71 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.555 0.742 . . . . 72.24 111.458 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 26.5 tptp . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 122.937 0.495 . . . . 72.23 109.871 169.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.539 0.685 . . . . 75.05 112.789 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.39 179.53 4.12 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.944 -1.026 . . . . 71.31 110.189 165.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -71.76 157.25 38.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.656 -0.702 . . . . 70.45 112.063 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.22 84.47 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.402 0.681 . . . . 62.13 111.543 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -65.6 -33.95 77.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.447 0.699 . . . . 73.3 112.593 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -43.74 80.9 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 120.847 0.356 . . . . 63.45 111.092 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.72 -29.12 69.03 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.074 0.55 . . . . 72.23 111.646 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 11' ' ' LEU . 17.9 tp -63.73 -29.77 70.95 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.647 0.779 . . . . 73.22 111.324 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.49 -34.2 75.08 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.176 0.59 . . . . 64.02 111.821 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.0 tt0 -67.66 -52.11 41.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.595 0.634 . . . . 75.22 109.659 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 8' ' ' LEU . 77.5 mt -49.38 -45.63 46.22 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.489 1.116 . . . . 73.01 112.762 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.46 -26.38 38.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.501 0.926 . . . . 61.02 113.501 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.33 -53.41 16.82 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.339 0.518 . . . . 71.04 111.427 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.2 m -81.79 139.89 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.927 0.491 . . . . 73.33 110.379 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.79 -45.06 90.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.522 0.729 . . . . 72.42 111.605 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -123.53 138.21 54.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.922 0.889 . . . . 72.42 110.487 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -44.17 124.62 4.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 71.01 113.669 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.94 -65.08 1.01 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.167 0.587 . . . . 64.31 112.328 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -119.82 -6.61 10.08 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.819 0.848 . . . . 75.11 111.406 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' A' ' 49' ' ' TYR . 45.5 mt -128.96 121.84 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.872 0.869 . . . . 55.43 108.806 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.55 129.06 46.44 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.949 -0.389 . . . . 74.12 109.949 169.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -81.38 133.86 35.48 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.517 0.727 . . . . 64.22 109.067 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -130.86 151.13 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.41 0.624 . . . . 65.24 111.438 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -97.85 159.67 14.79 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.008 -0.997 . . . . 72.02 110.241 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.627 0.771 . . . . 74.23 112.302 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -59.88 -36.42 76.88 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.93 0.892 . . . . 73.24 113.041 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.53 -10.55 55.83 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.12 0.568 . . . . 74.13 112.094 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.2 ttt -59.43 104.28 0.25 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.171 0.51 . . . . 51.13 111.239 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 170.65 -150.35 14.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.241 -0.744 . . . . 61.43 111.241 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.13 -27.14 52.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.12 1.156 . . . . 63.22 114.12 -175.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -65.44 -43.62 89.87 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.938 0.495 . . . . 63.2 111.26 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.26 -42.86 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.81 0.844 . . . . 74.11 110.773 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 84.6 mmm -64.34 -33.27 75.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.82 0.848 . . . . 71.14 112.038 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.63 -36.58 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.187 0.595 . . . . 75.43 110.936 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 50' ' ' LEU . 3.0 m -70.64 -29.85 66.32 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 116.258 -0.428 . . . . 72.14 110.899 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.1 -38.41 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.511 0.725 . . . . 74.33 110.146 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.78 -36.55 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.42 0.288 . . . . 64.3 110.898 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.18 -57.86 7.45 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 120.965 0.412 . . . . 60.04 111.192 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -67.43 -20.79 65.55 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.447 0.906 . . . . 73.34 113.447 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.98 -33.45 19.61 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.209 0.818 . . . . 72.32 113.209 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -101.08 -27.82 13.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.761 1.023 . . . . 63.42 113.761 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.46 115.45 56.72 Favored Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 118.079 0.4 . . . . 72.13 111.739 -176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.99 160.24 38.59 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.485 2.124 . . . . 75.55 111.785 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.31 -41.15 3.07 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 114.031 0.373 . . . . 75.31 114.031 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -94.55 -34.44 12.66 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.065 0.933 . . . . 51.05 110.716 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 2.71 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.649 2.38 . . . . 75.05 116.284 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.44 0.57 Allowed Glycine 0 CA--C 1.537 1.432 0 CA-C-N 116.324 -0.398 . . . . 43.25 113.405 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.07 173.48 43.0 Favored Glycine 0 N--CA 1.478 1.45 0 O-C-N 122.833 -0.216 . . . . 60.3 112.971 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.624 ' HB2' HG12 ' A' ' 20' ' ' ILE . 76.7 m-85 -121.02 155.67 33.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.433 0.635 . . . . 74.14 111.907 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 60.8 mt -128.31 118.47 23.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.623 1.169 . . . . 73.43 108.585 170.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.3 tp -103.52 109.07 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 75.32 109.788 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 108' ' ' LEU . 25.1 mt -99.74 126.32 45.78 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.265 0.626 . . . . 62.22 110.67 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-N 116.6 -0.273 . . . . 40.53 113.058 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 58.4 t -112.65 137.52 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.207 0.603 . . . . 63.24 109.943 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -109.89 157.41 19.25 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.05 -1.093 . . . . 74.3 108.05 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -144.02 136.11 26.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.875 0.369 . . . . 74.04 111.662 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.15 135.33 47.36 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.767 0.827 . . . . 42.1 110.669 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.3 mt -96.83 134.89 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.416 0.686 . . . . 73.44 110.996 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -84.7 -177.19 6.53 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.426 0.69 . . . . 75.21 111.665 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.3 -25.05 66.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.934 0.716 . . . . 72.12 112.934 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -78.28 -22.94 47.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.774 0.83 . . . . 71.14 112.555 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.96 -0.96 31.64 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 114.585 0.594 . . . . 53.13 114.585 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -75.51 120.79 21.42 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.475 0.637 . . . . 70.33 110.935 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -80.94 118.95 22.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.122 0.569 . . . . 65.33 109.811 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.51 114.89 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.682 0.793 . . . . 72.25 109.326 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.85 130.25 41.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.079 -0.711 . . . . 72.41 109.079 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -143.57 131.11 10.79 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.048 0.539 . . . . 64.54 111.169 -172.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.53 101.43 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.759 2.306 . . . . 75.03 112.571 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.12 -6.45 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.127 0.571 . . . . 71.33 112.062 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.47 175.18 50.29 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 114.601 0.6 . . . . 73.13 114.601 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -105.48 137.77 19.38 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.854 1.262 . . . . 63.4 109.889 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.31 -30.5 19.62 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.071 1.847 . . . . 71.11 112.291 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 6.2 m-20 -125.98 66.43 58.66 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.871 0.868 . . . . 55.41 110.617 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -43.55 23.97 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.707 2.271 . . . . 75.2 114.27 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -71.04 -39.38 72.33 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.999 -0.546 . . . . 74.52 110.654 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 14.1 ttmm -60.41 -44.42 95.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.445 0.698 . . . . 74.12 111.15 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 73' ' ' ASP . 78.4 t -59.85 -43.41 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 122.632 0.373 . . . . 61.44 110.691 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.94 -50.2 67.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.541 0.571 . . . . 71.14 112.541 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -68.82 -49.59 57.25 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.865 0.466 . . . . 74.03 111.766 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.28 -28.54 67.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.512 0.725 . . . . 54.13 112.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.8 tp -72.65 -41.52 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.385 0.539 . . . . 73.41 111.432 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.28 84.22 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.12 0.568 . . . . 72.12 112.189 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 p -73.87 -41.39 62.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 63.51 112.071 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -65.34 -30.15 70.96 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 117.665 0.211 . . . . 73.55 111.228 173.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.7 t -59.35 -21.07 59.28 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 112.923 0.712 . . . . 73.22 112.923 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.01 -35.15 17.75 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.824 0.85 . . . . 72.23 111.587 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 -14.46 31.13 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.585 0.958 . . . . 72.21 113.585 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.3 mmm -90.05 -47.51 7.79 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.82 0.848 . . . . 71.14 110.081 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.82 154.23 17.36 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.047 -0.979 . . . . 74.14 110.627 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.0 p30 -48.29 -47.56 36.33 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.2 1.0 . . . . 74.44 112.705 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.66 173.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.244 1.018 . . . . 75.35 110.138 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.29 100.54 3.17 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.811 -0.631 . . . . 51.35 110.462 169.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 122' ' ' ILE . 5.9 tt -75.7 131.41 39.86 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.263 -1.755 . . . . 71.15 106.263 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -106.28 95.71 11.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 122.866 0.466 . . . . 74.12 111.869 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.19 161.65 5.72 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.105 1.87 . . . . 44.32 111.928 166.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 111' ' ' TYR . 37.9 mm-40 -92.04 141.13 28.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.44 -0.8 . . . . 65.31 108.935 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.632 ' HB3' HD11 ' A' ' 108' ' ' LEU . 67.3 mtt -137.8 122.74 18.97 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.32 111.121 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -130.87 136.84 49.0 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.811 0.844 . . . . 42.15 110.13 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.91 109.82 20.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.72 -0.845 . . . . 60.2 108.72 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.96 128.53 55.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.012 0.525 . . . . 62.32 110.848 -166.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -101.2 123.85 45.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.534 0.734 . . . . 71.31 111.765 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.93 122.45 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.677 1.191 . . . . 72.31 109.881 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.75 28.85 48.11 Favored Glycine 0 CA--C 1.544 1.89 0 N-CA-C 115.733 1.053 . . . . 61.41 115.733 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.15 5.37 76.62 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.015 0.766 . . . . 71.1 115.015 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.08 134.88 50.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 74.22 109.963 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.7 m -97.7 129.18 44.77 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.751 0.705 . . . . 72.02 110.603 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.05 171.41 8.69 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.402 1.081 . . . . 72.23 109.047 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 97' ' ' MET . 47.2 tp -117.49 114.81 24.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.918 0.389 . . . . 74.15 110.155 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.55 113.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 39.5 t -107.46 101.09 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.756 -0.461 . . . . 73.54 109.756 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 62.8 t80 -85.79 119.93 26.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.756 -0.831 . . . . 74.32 108.756 172.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.61 98.39 28.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.042 0.537 . . . . 55.54 109.64 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.38 162.43 22.38 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.767 2.312 . . . . 73.3 113.381 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HG3' ' HE3' ' A' ' 120' ' ' LYS . 10.8 tt0 -73.29 128.37 35.3 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.239 0.616 . . . . 73.33 111.679 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.76 171.51 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.184 0.994 . . . . 50.43 112.059 -175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.16 132.88 34.64 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 123.63 0.772 . . . . 71.31 110.574 -169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -38.49 -38.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.876 0 N-CA-C 116.79 2.144 . . . . 70.35 116.79 -160.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.9 t -63.98 -42.93 97.08 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.021 0.528 . . . . 62.24 111.675 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 23.1 m-70 -128.97 70.89 1.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 104.822 -2.288 . . . . 75.04 104.822 167.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.1 mttt -48.17 -156.95 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.744 0 C-N-CA 131.647 3.979 . . . . 74.21 121.59 57.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo 4.57 70.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.908 2.405 . . . . 62.35 116.04 -127.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 93' ' ' LEU . 34.0 mm -73.92 89.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.726 -0.67 . . . . 71.41 110.032 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -89.67 150.45 22.34 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.955 -0.566 . . . . 70.5 109.921 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 109.85 -0.426 . . . . 72.33 109.85 171.407 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptm . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.489 0.185 . . . . 73.44 111.293 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -105.54 154.29 20.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.707 0.803 . . . . 73.42 111.366 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -75.73 160.24 30.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.834 0.453 . . . . 64.02 111.768 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 -27.99 69.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.641 -0.709 . . . . 63.22 112.268 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.61 HG23 HG13 ' A' ' 102' ' ' VAL . 5.8 m -71.47 -45.88 61.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.149 0.58 . . . . 71.41 110.864 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.74 -46.42 90.48 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.511 -0.768 . . . . 74.51 111.759 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.72 -34.57 67.2 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.638 0.775 . . . . 75.3 112.242 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.37 -47.7 72.56 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.129 0.571 . . . . 42.33 110.515 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.85 -35.29 79.46 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.293 -0.867 . . . . 71.53 111.128 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.62 -37.75 88.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.476 0.71 . . . . 73.33 111.171 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.418 HD13 ' HB2' ' A' ' 22' ' ' ALA . 59.2 mt -60.74 -37.06 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.964 0.906 . . . . 63.41 111.768 174.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 66' ' ' TYR . 53.3 m-80 -80.69 -21.75 41.0 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.299 0.639 . . . . 51.54 112.186 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.24 -47.61 12.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.506 0.722 . . . . 64.32 112.567 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.34 163.71 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.573 0.702 . . . . 72.23 112.829 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.23 -33.83 22.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.271 -0.877 . . . . 74.41 110.48 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -139.81 136.77 34.39 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.133 0.973 . . . . 74.44 109.766 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 m -75.21 90.88 2.59 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.315 0.578 . . . . 61.14 110.144 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.19 82.86 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.731 1.212 . . . . 61.32 113.263 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -160.57 14.9 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.499 0.72 . . . . 75.13 111.731 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.86 117.1 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.794 -1.187 . . . . 74.13 107.794 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 150.17 38.49 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.224 0.61 . . . . 63.34 111.053 -173.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -121.59 124.38 44.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.734 0.814 . . . . 72.44 110.411 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 32' ' ' VAL . 31.2 mmtp -122.87 144.68 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.551 0.74 . . . . 73.14 110.303 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -75.89 158.26 32.27 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.316 0.646 . . . . 70.13 111.386 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -24.51 63.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.582 0.956 . . . . 55.22 113.582 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.0 t -84.16 -11.93 55.76 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.647 0.61 . . . . 64.54 112.647 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.3 -18.87 34.92 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.595 0.758 . . . . 71.02 111.515 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.78 131.26 50.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.19 0.519 . . . . 75.25 112.309 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.56 -122.6 2.81 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.159 -0.473 . . . . 75.32 112.081 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -68.24 -38.44 81.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.81 0.844 . . . . 74.24 111.748 -173.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.3 m -69.2 -42.03 76.33 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.667 0.787 . . . . 74.53 111.732 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 23' ' ' LYS . 88.0 t -70.44 -41.84 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.693 0.397 . . . . 72.22 110.825 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 89' ' ' LEU . 35.0 tpp -56.28 -44.4 79.74 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.813 0.845 . . . . 75.31 111.847 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.97 -30.57 71.02 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.722 0.809 . . . . 62.0 110.953 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -76.39 -36.35 58.15 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.745 0.818 . . . . 54.33 111.321 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 32' ' ' VAL . 97.1 t -60.97 -38.73 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 123.767 0.827 . . . . 73.21 111.129 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -57.4 -33.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.941 0.896 . . . . 63.24 111.071 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.63 71.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.146 0.578 . . . . 65.42 111.759 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.402 ' HE2' HD21 ' A' ' 50' ' ' LEU . 89.5 m-85 -67.98 -18.17 64.65 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.377 0.51 . . . . 65.34 112.377 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.06 -37.41 18.91 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.581 0.752 . . . . 73.51 112.603 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.572 HD21 ' HB ' ' A' ' 122' ' ' ILE . 58.6 m-80 -104.52 -46.06 4.47 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.102 0.778 . . . . 52.51 113.102 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.21 121.82 78.34 Favored Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 123.813 0.845 . . . . 75.23 111.721 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.96 -178.46 2.82 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.199 2.599 . . . . 55.11 113.503 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.13 -40.46 2.92 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 114.869 0.708 . . . . 75.01 114.869 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.92 -48.24 25.62 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.798 0.799 . . . . 74.41 112.876 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t70 41.21 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.249 1.203 . . . . 65.24 114.249 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 113' ' ' PRO . . . 78.01 72.21 1.17 Allowed Glycine 0 CA--C 1.535 1.294 0 C-N-CA 121.155 -0.545 . . . . 54.32 114.051 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.74 168.35 27.67 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 116.665 0.233 . . . . 22.04 113.143 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -121.36 144.23 48.77 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.83 0.678 . . . . 65.01 112.83 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 76.2 mt -122.55 123.13 40.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.702 1.201 . . . . 51.4 109.302 171.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.18 108.98 20.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.365 -0.605 . . . . 61.11 109.365 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.631 HD12 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -94.76 129.91 41.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.181 0.592 . . . . 71.45 110.21 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 34.59 4.85 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.296 -0.411 . . . . 61.01 112.622 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -112.37 140.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.826 0.85 . . . . 72.03 109.964 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -124.04 154.88 39.26 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.102 -1.073 . . . . 61.04 108.102 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -136.16 128.99 31.05 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.914 0.485 . . . . 65.12 110.828 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.764 0.825 . . . . 62.13 110.63 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -100.01 128.63 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.727 0.811 . . . . 70.33 111.646 -170.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 73.8 m-20 -76.63 178.05 7.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.208 0.603 . . . . 62.34 112.181 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.23 -37.53 87.55 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.11 0.564 . . . . 72.22 111.252 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -68.17 -29.91 68.89 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.307 0.643 . . . . 71.2 111.47 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.26 6.0 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.024 -0.535 . . . . 42.42 113.924 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.7 m-20 -78.67 138.32 38.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.978 0.511 . . . . 73.13 111.663 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.6 m -89.54 102.76 15.44 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.47 0.708 . . . . 73.11 109.975 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' HH12 ' A' ' 67' ' ' ARG . 57.6 t -109.96 129.26 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.552 0.741 . . . . 71.21 110.396 -176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB2' HD21 ' A' ' 12' ' ' ASN . 75.9 m-85 -95.76 120.81 36.68 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.73 0.812 . . . . 74.34 111.96 -171.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.43 HH12 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.69 150.91 45.61 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.128 0.971 . . . . 72.01 111.427 174.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.53 108.89 2.53 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.477 2.118 . . . . 73.01 113.229 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 m -91.86 -28.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 116.112 -0.494 . . . . 62.14 110.647 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 -176.73 53.97 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.734 -0.666 . . . . 64.15 113.83 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.4 mt -102.66 143.25 26.22 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.94 0.896 . . . . 75.34 110.856 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.0 -56.58 1.32 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.64 2.226 . . . . 64.02 111.743 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.514 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 12.1 m-20 -120.34 89.22 43.38 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.897 0.879 . . . . 70.44 108.656 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -54.98 -44.9 45.29 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.483 2.789 . . . . 73.34 114.664 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.22 -41.65 85.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.213 0.605 . . . . 74.0 110.634 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 36.9 ttpt -61.32 -43.4 98.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.795 0.438 . . . . 71.42 111.172 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.37 -43.69 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.821 0.849 . . . . 73.54 111.289 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.68 -39.67 94.9 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.838 0.855 . . . . 50.21 111.735 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -67.39 -46.2 74.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.673 0.789 . . . . 63.03 112.128 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.51 -41.17 96.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.919 0.888 . . . . 63.55 111.185 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.05 -44.23 80.69 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.025 -0.534 . . . . 63.21 111.487 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.69 97.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 73.1 111.369 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -60.89 -52.01 66.84 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.266 1.026 . . . . 72.41 111.887 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.45 -29.81 68.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.19 0.596 . . . . 71.35 112.052 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.3 t -61.57 -23.89 66.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.785 -0.572 . . . . 74.31 112.206 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.03 -48.74 7.0 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.639 0.776 . . . . 74.53 111.414 170.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 t -74.55 -22.69 58.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.387 1.255 . . . . 71.22 114.387 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.8 mmm -88.51 -51.89 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.218 0.607 . . . . 74.42 111.602 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 33' ' ' MET . 88.6 mt -70.01 -103.26 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 113.847 1.054 . . . . 62.05 113.847 -165.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 123' ' ' TYR . 3.7 p30 -170.01 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.662 0.664 . . . . 55.2 110.123 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG11 ' ND1' ' A' ' 119' ' ' HIS . 23.9 m -114.59 157.22 15.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.078 0.951 . . . . 63.34 109.055 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 96.06 1.16 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.258 -0.645 . . . . 63.03 109.258 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.75 122.02 34.73 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.263 -1.384 . . . . 61.14 107.263 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -104.41 100.44 22.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 122.619 0.368 . . . . 75.12 110.473 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.18 161.62 26.12 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.981 1.787 . . . . 71.22 110.948 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.7 tp10 -104.03 101.89 11.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.356 -0.609 . . . . 75.25 109.356 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 108' ' ' LEU . 5.3 mpp? -101.71 135.06 43.87 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 112.501 0.556 . . . . 54.12 112.501 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -136.03 127.01 27.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.539 0.735 . . . . 74.33 111.242 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.0 112.01 9.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.209 1.003 . . . . 64.33 110.892 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -126.38 129.59 49.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.781 0.832 . . . . 75.45 111.179 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.35 126.67 39.75 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.533 0.733 . . . . 74.44 111.405 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' THR . 13.1 t -119.33 118.4 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.256 1.022 . . . . 73.33 108.877 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 28.59 63.63 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.718 0.647 . . . . 75.3 114.718 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.07 10.61 78.03 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.419 0.527 . . . . 74.41 114.419 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.6 133.03 55.51 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.019 0.928 . . . . 74.34 108.961 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 m -89.88 123.74 34.09 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.059 0.845 . . . . 72.43 111.584 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.68 170.92 8.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.513 1.125 . . . . 72.31 109.078 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -122.28 120.11 33.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.581 0.353 . . . . 64.11 110.863 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' MET . 38.4 t -88.54 120.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.143 -0.688 . . . . 64.52 109.143 170.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 21.5 t -108.51 101.51 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.262 -0.644 . . . . 51.21 109.262 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.5 t80 -85.4 116.16 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.189 0.596 . . . . 70.43 109.733 175.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.77 96.89 50.19 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 108.011 -1.107 . . . . 53.34 108.011 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 72.8 Cg_endo -70.49 171.13 15.85 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.656 2.237 . . . . 51.35 112.753 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.29 121.36 19.3 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.357 -0.979 . . . . 61.22 108.357 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -79.55 166.87 21.48 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.566 0.746 . . . . 51.55 112.103 -173.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 38.2 t70 -62.48 165.77 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 124.001 0.921 . . . . 75.11 112.471 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -52.88 -51.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.094 -1.004 . . . . 63.14 113.542 168.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.7 p -84.68 6.44 24.15 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.583 0.586 . . . . 72.14 112.583 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.572 ' ND1' HG11 ' A' ' 91' ' ' VAL . 52.0 m-70 -170.96 64.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 103.026 -2.953 . . . . 74.44 103.026 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.752 ' HA ' HG12 ' A' ' 122' ' ' ILE . 9.4 ptpp? -48.04 -156.67 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.399 2 C-N-CA 133.584 4.754 . . . . 63.11 122.096 42.256 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 10.9 Cg_exo 14.13 73.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.983 1.788 . . . . 63.43 115.204 -118.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.752 HG12 ' HA ' ' A' ' 120' ' ' LYS . 49.7 mm -90.2 125.34 43.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 114.006 -1.452 . . . . 60.44 108.654 172.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.483 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 36.7 p90 -149.97 155.53 40.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.196 0.998 . . . . 73.23 108.893 -174.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 122.601 0.36 . . . . 75.43 110.784 175.803 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 11.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.555 0.217 . . . . 64.2 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -62.73 156.77 22.77 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.462 0.648 . . . . 71.01 112.494 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 m -67.2 160.6 26.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.775 -1.102 . . . . 73.02 112.973 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.97 -27.67 67.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.956 0.502 . . . . 62.25 111.211 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 102' ' ' VAL . 39.4 p -57.15 -51.29 69.9 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.407 0.683 . . . . 73.23 111.055 168.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.23 -36.59 74.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.596 -1.184 . . . . 73.0 111.394 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 mt -70.46 -30.23 67.0 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.52 1.128 . . . . 71.02 113.008 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.41 -31.6 72.8 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.997 -0.547 . . . . 73.35 110.161 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.32 -37.72 86.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.734 0.814 . . . . 74.24 112.465 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.45 -46.99 74.58 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.308 0.504 . . . . 71.44 110.721 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.1 mt -60.18 -42.97 96.14 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 124.132 0.973 . . . . 62.31 112.25 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -80.76 -13.95 58.53 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.692 0.797 . . . . 53.41 112.915 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.85 -62.12 1.8 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.001 0.52 . . . . 55.43 110.761 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -100.14 143.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.817 -0.629 . . . . 60.22 110.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.67 -46.76 89.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.872 0.869 . . . . 62.44 111.84 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.32 111.7 15.49 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.944 0.897 . . . . 60.35 109.706 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 66.5 m -74.72 126.86 31.77 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.423 0.689 . . . . 74.54 111.716 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.71 22.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.567 0.951 . . . . 64.34 113.567 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -108.76 -2.73 18.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.408 0.683 . . . . 72.23 111.764 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 17' ' ' SER . 29.3 mm -111.17 145.24 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.917 -0.771 . . . . 64.11 108.917 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -139.7 152.12 46.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.758 0.423 . . . . 73.04 110.7 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.95 125.02 42.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.746 0.818 . . . . 63.1 109.988 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HD2' HG22 ' A' ' 32' ' ' VAL . 37.8 mttp -125.18 153.65 42.75 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.584 0.754 . . . . 71.14 111.263 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.34 155.15 24.91 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.756 -1.111 . . . . 73.24 111.356 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.03 -30.64 62.19 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.096 0.958 . . . . 55.33 113.523 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.0 p -65.89 -35.41 80.56 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.657 0.783 . . . . 74.42 112.816 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.62 13.49 6.96 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.505 0.928 . . . . 60.44 113.505 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.609 ' SD ' HD13 ' A' ' 52' ' ' LEU . 85.6 mmm -57.1 104.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.258 0.466 . . . . 34.43 112.258 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.69 -148.4 12.37 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.009 -0.541 . . . . 72.41 112.557 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -55.83 -31.53 62.79 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.552 1.141 . . . . 71.32 113.934 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -68.74 -42.62 77.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.058 0.543 . . . . 75.02 111.583 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 23' ' ' LYS . 52.3 t -60.96 -53.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.255 0.55 . . . . 75.32 109.9 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.521 ' SD ' ' HG3' ' A' ' 84' ' ' GLN . 81.0 mmm -49.2 -44.12 42.91 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.449 -1.251 . . . . 63.0 113.993 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.53 -31.25 69.36 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.614 0.598 . . . . 70.51 112.614 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.598 ' HB ' HD21 ' A' ' 50' ' ' LEU . 28.2 m -70.4 -37.41 74.47 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.541 0.336 . . . . 73.11 110.573 174.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.51 -44.17 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.375 0.67 . . . . 73.51 110.419 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.91 -40.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.319 1.048 . . . . 73.34 111.257 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.15 90.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 75.33 111.832 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 112' ' ' VAL . 21.2 m-85 -81.19 -35.7 31.05 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.959 0.504 . . . . 75.3 111.386 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.14 73.21 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.659 0.784 . . . . 63.21 112.497 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -76.99 -24.58 52.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.172 0.589 . . . . 74.44 112.191 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.21 110.6 11.67 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 123.023 0.529 . . . . 72.52 110.047 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.84 118.15 4.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.509 2.806 . . . . 64.12 114.992 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.28 26.73 74.06 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.44 -0.8 . . . . 74.13 114.777 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -103.78 8.83 37.2 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.978 0.889 . . . . 63.33 110.196 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -51.49 141.48 15.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.815 0.846 . . . . 72.21 112.25 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 122.21 -29.77 5.42 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 111.347 -0.701 . . . . 64.12 111.347 -166.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.53 121.93 9.8 Favored Glycine 0 CA--C 1.548 2.117 0 N-CA-C 114.483 0.553 . . . . 73.34 114.483 175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -114.05 142.39 46.25 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.916 0.886 . . . . 74.1 112.416 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.598 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.1 mp -117.33 128.36 54.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.238 1.015 . . . . 75.11 109.022 170.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.86 109.65 21.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.238 0.615 . . . . 74.23 109.864 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.662 HD12 HD23 ' A' ' 108' ' ' LEU . 82.0 mt -97.8 125.67 42.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.561 0.744 . . . . 72.35 110.649 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 35.08 4.13 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.046 -0.524 . . . . 71.44 112.52 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.53 144.02 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.285 0.634 . . . . 71.52 110.34 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 131.76 44.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.132 0.973 . . . . 52.1 108.56 172.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 p90 -111.08 131.36 55.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.738 0.815 . . . . 72.51 111.197 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.36 129.9 56.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.545 1.138 . . . . 71.51 110.172 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.95 123.84 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 53.04 111.721 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.46 170.7 13.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.952 0.901 . . . . 62.34 111.9 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.36 -25.89 68.23 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.036 0.534 . . . . 71.4 111.618 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.85 -1.53 35.42 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.453 0.701 . . . . 75.44 112.107 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.18 32.57 51.95 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 122.656 0.17 . . . . 45.42 113.124 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.75 134.76 40.49 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.481 0.712 . . . . 71.22 111.176 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -92.82 106.32 18.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.579 0.752 . . . . 62.44 110.854 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.51 112.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.846 0.859 . . . . 73.33 109.843 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.18 115.55 27.5 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.12 109.536 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -116.48 136.39 23.1 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.121 0.969 . . . . 62.24 111.066 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.75 96.48 1.0 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.873 2.382 . . . . 73.2 112.793 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.72 -20.39 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 116.091 -0.504 . . . . 43.11 111.065 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.57 -169.47 53.53 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.989 0.756 . . . . 73.15 114.989 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 77' ' ' VAL . 62.7 mt -117.95 130.63 24.6 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.97 1.308 . . . . 75.45 109.11 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.04 -27.49 29.85 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.204 1.936 . . . . 54.43 111.94 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -137.97 77.71 36.95 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.341 1.456 . . . . 71.23 108.991 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.48 -35.52 29.99 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.956 2.437 . . . . 64.34 114.268 -167.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.93 -39.89 83.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.232 0.613 . . . . 75.35 110.428 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.45 -49.81 75.33 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.972 -0.558 . . . . 75.51 110.676 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 71' ' ' LEU . 81.9 t -55.93 -43.91 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.332 1.053 . . . . 74.04 111.919 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -62.84 -41.82 99.5 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.473 0.709 . . . . 73.01 112.113 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.43 -32.88 64.64 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.296 0.639 . . . . 71.3 112.359 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.22 -38.86 88.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.067 0.547 . . . . 65.35 110.107 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.99 -39.01 87.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.332 0.653 . . . . 70.15 110.877 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.47 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.706 0.802 . . . . 52.42 112.101 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 t -73.95 -53.13 10.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.166 0.586 . . . . 40.32 111.253 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.521 ' HG3' ' SD ' ' A' ' 33' ' ' MET . 9.9 pt20 -67.68 -28.93 68.1 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.711 0.804 . . . . 74.41 112.664 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.7 p -64.02 -26.57 68.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.291 0.478 . . . . 64.31 112.291 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -90.43 -41.79 11.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.572 0.749 . . . . 54.2 112.27 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -77.81 -43.97 28.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.784 1.031 . . . . 74.14 113.784 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 mmt -69.1 -44.07 73.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.766 0.826 . . . . 62.22 112.571 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.87 150.14 20.79 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.418 0.687 . . . . 54.44 111.097 -165.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.642 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.8 p30 -52.76 -34.47 53.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.307 0.854 . . . . 73.54 113.307 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 119' ' ' HIS . 26.2 m -120.48 170.83 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.719 0.808 . . . . 64.31 110.224 169.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -78.69 102.04 7.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 120.987 0.422 . . . . 64.2 110.129 170.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.74 116.97 27.4 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.183 -1.414 . . . . 73.2 107.183 174.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -103.76 98.32 12.84 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 122.858 0.463 . . . . 74.33 110.476 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.56 165.53 18.22 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.178 1.919 . . . . 74.24 112.294 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 9.5 tp10 -84.69 129.45 34.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.494 0.718 . . . . 75.4 109.418 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB3' HD11 ' A' ' 108' ' ' LEU . 53.4 mtt -132.84 120.62 21.79 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.49 0.716 . . . . 63.44 110.862 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.589 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.4 mm-40 -128.49 137.97 52.05 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.198 0.599 . . . . 73.52 110.446 173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.44 112.66 24.66 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.537 0.735 . . . . 74.23 110.348 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -114.9 127.16 55.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.885 0.874 . . . . 63.25 111.757 -170.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -88.38 118.72 28.2 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.384 0.674 . . . . 74.22 110.689 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 5' ' ' THR . 15.0 t -124.68 113.52 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.631 1.172 . . . . 72.43 108.885 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.21 65.64 Favored Glycine 0 CA--C 1.543 1.84 0 N-CA-C 115.495 0.958 . . . . 42.25 115.495 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.63 6.05 70.88 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.348 0.499 . . . . 72.21 114.348 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -114.36 136.55 52.87 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.884 0.873 . . . . 62.25 108.73 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 m -93.37 132.33 37.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.569 0.622 . . . . 74.23 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.77 169.14 11.4 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.382 1.073 . . . . 75.31 109.002 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 52' ' ' LEU . 55.1 tp -120.0 116.39 25.66 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.733 0.302 . . . . 74.4 110.446 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 51.6 t -87.78 130.89 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.297 -0.631 . . . . 54.32 109.297 173.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 24.0 t -116.19 100.92 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 122.959 0.504 . . . . 71.04 110.062 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.724 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 81.8 t80 -83.74 126.61 33.07 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.13 -0.693 . . . . 73.44 109.13 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 39' ' ' PHE . 38.7 t -99.61 112.66 64.02 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.907 -0.405 . . . . 73.02 109.907 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.29 152.08 15.83 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.721 2.28 . . . . 63.23 111.941 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -65.99 111.57 3.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.979 0.912 . . . . 74.41 111.365 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -68.73 156.01 39.06 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.353 0.661 . . . . 71.24 112.364 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.98 141.43 51.03 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 123.717 0.807 . . . . 62.24 109.631 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.45 -40.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 115.664 1.727 . . . . 75.22 115.664 -171.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -72.48 -35.02 68.09 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.973 0.731 . . . . 64.01 112.973 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -139.03 79.17 1.71 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.936 -1.505 . . . . 71.5 106.936 169.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 122' ' ' ILE . 17.5 ptpt -47.98 -155.2 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.733 2 N-CA-C 123.596 4.665 . . . . 71.21 123.596 43.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo 13.98 67.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.214 1.943 . . . . 73.42 116.085 -121.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.7 mm -77.63 102.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 114.467 -1.242 . . . . 72.44 110.048 175.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.457 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.0 p90 -108.94 147.65 31.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.739 0.815 . . . . 61.05 110.329 169.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm . . . . . 0 N--CA 1.477 0.914 0 C-N-CA 123.345 0.658 . . . . 74.1 110.232 173.081 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.683 ' SD ' ' HG2' ' A' ' 96' ' ' GLU . 17.2 ptm . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 112.471 0.545 . . . . 75.14 112.471 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -98.41 168.12 10.4 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.891 0.876 . . . . 70.4 111.668 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 t -76.99 155.82 32.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.757 0.823 . . . . 75.34 112.119 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.02 -34.13 77.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.357 0.663 . . . . 75.22 111.797 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.503 HG23 HG13 ' A' ' 102' ' ' VAL . 2.4 m -66.7 -44.06 82.72 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.472 0.653 . . . . 75.11 110.557 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.55 -50.57 73.37 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 125.246 1.418 . . . . 74.44 111.962 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' ' 51' ' ' LEU . 86.7 mt -62.92 -44.37 96.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.644 0.778 . . . . 74.14 111.871 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 11' ' ' LEU . 51.9 tp -59.36 -40.36 86.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.224 1.01 . . . . 63.34 111.601 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.41 -41.95 99.07 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.007 -0.997 . . . . 72.35 110.875 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 14' ' ' VAL . 13.2 mm-40 -72.57 -30.3 64.29 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.572 -0.74 . . . . 72.44 112.308 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 8' ' ' LEU . 78.5 mt -57.36 -44.82 84.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.348 0.659 . . . . 75.24 112.244 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -88.49 -5.12 58.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.922 0.489 . . . . 75.25 112.313 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.24 -55.84 3.51 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.226 0.61 . . . . 50.3 111.671 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 10' ' ' GLU . 33.1 m -90.55 118.79 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.185 0.517 . . . . 63.11 111.541 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -43.85 -25.53 0.2 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.493 1.664 . . . . 71.34 115.493 172.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -127.78 122.54 33.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.862 0.465 . . . . 65.03 110.841 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.5 m -74.5 92.08 2.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.532 0.733 . . . . 52.21 110.496 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.92 -63.31 1.16 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.394 0.678 . . . . 73.14 111.769 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -119.82 -1.08 10.56 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 119.247 -0.406 . . . . 63.43 112.049 175.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.5 105.84 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.021 0.828 . . . . 61.31 109.085 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -121.57 130.21 53.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.055 0.542 . . . . 71.31 110.816 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.65 134.93 45.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 70.54 112.45 -172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 151.53 46.42 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.045 0.938 . . . . 74.23 111.076 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -84.08 154.05 23.42 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.97 0.908 . . . . 74.22 110.288 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.37 70.08 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 112.99 0.737 . . . . 74.42 112.99 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.1 p -81.22 13.41 2.88 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.786 1.032 . . . . 74.51 113.786 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.05 4.52 19.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.054 0.542 . . . . 63.21 112.118 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mtp -53.69 104.56 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.533 0.568 . . . . 73.55 112.533 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.74 -142.83 7.95 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.395 -0.366 . . . . 60.54 113.188 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -70.9 -21.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.238 1.015 . . . . 74.24 113.039 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 m -75.12 -43.39 53.01 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.95 0.5 . . . . 63.22 110.941 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -37.92 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.239 0.615 . . . . 74.42 110.607 168.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.536 ' HA ' HG22 ' A' ' 36' ' ' VAL . 20.7 mmt -71.19 -31.86 68.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.773 -0.649 . . . . 73.22 112.592 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.29 -32.75 74.47 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.398 0.618 . . . . 53.04 110.054 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -78.05 -46.38 21.03 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.699 0.8 . . . . 65.51 112.171 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 33' ' ' MET . 19.8 m -59.58 -39.01 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 118.11 0.414 . . . . 70.42 112.116 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.15 -35.75 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.287 0.635 . . . . 74.52 110.996 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.1 -38.41 91.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.849 0.46 . . . . 70.23 112.102 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -73.87 -47.68 36.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.172 0.589 . . . . 60.32 111.481 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.77 -21.85 60.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.585 0.957 . . . . 61.53 113.585 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -93.37 -42.75 9.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.21 0.604 . . . . 71.25 111.442 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.44 111.58 4.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.666 0.786 . . . . 74.12 112.019 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.08 105.3 0.67 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.791 2.327 . . . . 72.34 112.831 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.19 19.63 11.38 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.674 -0.694 . . . . 70.52 114.749 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.9 tp -106.84 5.49 28.52 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.764 1.282 . . . . 72.23 112.205 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -40.91 124.47 2.15 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 125.11 1.364 . . . . 71.34 113.711 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 105.57 51.52 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.896 -0.593 . . . . 71.11 112.627 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -112.55 149.27 18.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 111.673 -0.571 . . . . 34.43 111.673 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -123.47 126.84 47.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.648 0.779 . . . . 71.01 111.354 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -104.73 116.68 32.45 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.471 -1.307 . . . . 65.42 107.471 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 7' ' ' LEU . 31.2 tp -103.4 112.35 25.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.724 0.409 . . . . 74.33 111.021 -173.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 108' ' ' LEU . 93.1 mt -92.88 140.16 29.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.601 0.76 . . . . 64.54 111.65 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.21 7.04 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.926 -0.579 . . . . 60.3 112.739 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.08 144.37 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.507 0.723 . . . . 43.34 110.672 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -124.6 163.85 21.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 62.54 108.002 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -154.77 138.69 16.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.423 0.527 . . . . 71.15 112.423 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 151.97 47.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.799 0.84 . . . . 72.23 111.279 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -91.62 131.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.592 0.757 . . . . 73.25 111.467 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -84.89 -172.09 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.912 0.485 . . . . 52.31 111.659 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.06 -37.71 80.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.268 0.627 . . . . 61.42 112.562 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -77.33 -29.35 53.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 63.22 112.264 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.12 9.55 15.46 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.626 0.61 . . . . 63.5 114.626 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.05 138.7 37.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.283 0.633 . . . . 53.44 111.378 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -83.87 111.2 19.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.306 0.642 . . . . 62.55 109.584 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.45 115.32 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.786 . . . . 72.14 109.863 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -93.3 115.27 27.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.205 0.602 . . . . 74.43 111.095 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -110.67 153.34 43.66 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.131 0.972 . . . . 53.34 111.405 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.42 116.55 2.99 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.305 2.004 . . . . 74.02 113.032 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.01 -30.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 122.824 0.449 . . . . 54.22 110.745 168.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.58 -175.91 53.97 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.729 -0.668 . . . . 43.14 112.613 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.69 138.7 23.38 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 122.358 -0.496 . . . . 75.4 110.37 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.38 -33.9 28.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.698 2.265 . . . . 61.22 112.618 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -127.37 66.49 69.07 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.015 0.926 . . . . 61.14 109.648 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HB2' HD22 ' A' ' 99' ' ' LEU . 60.5 Cg_endo -65.34 -36.04 37.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.863 2.375 . . . . 62.02 113.725 -164.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.19 -40.59 82.17 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.645 0.778 . . . . 61.41 110.41 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -70.34 -35.69 73.75 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.2 -0.909 . . . . 63.14 111.551 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.35 -43.07 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.655 0.782 . . . . 60.22 110.815 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.523 ' HG2' HH21 ' A' ' 79' ' ' ARG . 53.2 tt0 -56.59 -45.04 81.59 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.578 0.751 . . . . 65.41 111.85 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.523 HH21 ' HG2' ' A' ' 78' ' ' GLN . 4.0 mmp_? -75.45 -36.95 60.61 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.668 -0.697 . . . . 61.32 112.626 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.33 -35.15 75.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.243 0.617 . . . . 73.54 110.42 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 26.8 tp -70.68 -39.62 73.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.613 0.765 . . . . 75.01 110.739 176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.12 77.3 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.152 0.581 . . . . 63.43 111.817 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -72.14 -53.2 13.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.289 0.635 . . . . 64.45 111.436 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 81' ' ' LEU . 11.9 pt20 -71.05 -32.46 69.17 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.056 0.762 . . . . 71.3 113.056 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 p -64.85 -31.3 72.46 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 118.877 0.762 . . . . 75.23 112.228 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -81.45 -27.1 34.81 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 116.033 -0.531 . . . . 74.11 112.381 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -92.14 -33.89 14.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.694 0.628 . . . . 74.21 112.694 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -79.86 -48.04 14.14 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.09 0.556 . . . . 75.01 111.294 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -81.63 157.61 24.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.849 -0.614 . . . . 74.34 111.294 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -45.96 -35.39 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.358 1.463 . . . . 70.31 114.16 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.62 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.458 0.703 . . . . 74.53 111.093 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -71.72 97.53 1.78 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.725 -0.67 . . . . 53.43 110.216 170.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.89 123.89 28.17 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.944 -1.132 . . . . 75.33 107.944 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -104.01 96.02 8.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.398 0.679 . . . . 64.35 110.694 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.91 166.63 7.14 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.09 1.86 . . . . 74.43 111.977 172.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.683 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 40.9 tt0 -101.23 115.71 31.13 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.924 -0.769 . . . . 64.21 108.924 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 61.5 mtt -115.07 131.14 57.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.326 0.65 . . . . 73.24 112.006 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -142.02 146.71 35.84 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.813 0.845 . . . . 75.03 110.964 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 74' ' ' PRO . 42.6 mt -102.37 119.35 38.66 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.984 0.913 . . . . 63.01 110.329 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -124.87 130.32 52.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.695 1.198 . . . . 62.42 109.584 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -94.49 121.76 36.37 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.955 0.407 . . . . 74.11 111.643 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 5' ' ' THR . 12.4 t -126.4 127.08 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.285 1.034 . . . . 62.22 109.46 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.89 30.87 57.75 Favored Glycine 0 CA--C 1.548 2.124 0 N-CA-C 115.265 0.866 . . . . 71.21 115.265 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.98 81.78 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.905 0.352 . . . . 74.22 113.938 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -116.38 146.18 42.67 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.088 0.955 . . . . 75.42 109.803 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -95.34 104.58 16.47 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.969 0.804 . . . . 71.24 111.105 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.0 162.01 14.56 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.829 0.851 . . . . 72.35 111.497 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 52' ' ' LEU . 61.9 tp -120.28 118.36 30.22 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.738 0.815 . . . . 73.33 110.366 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.56 119.91 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.273 -0.64 . . . . 52.33 109.273 171.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.33 101.1 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.126 -0.694 . . . . 51.52 109.126 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.2 t80 -76.83 113.81 14.91 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.36 -0.607 . . . . 74.25 109.36 174.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.11 99.29 42.63 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 108.903 -0.777 . . . . 63.21 108.903 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.38 -176.44 1.55 Allowed 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.733 2.288 . . . . 72.34 113.093 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 44.4 mt-10 -84.92 148.33 26.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.825 -0.625 . . . . 72.33 109.748 165.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.11 178.81 4.45 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.668 0.787 . . . . 55.14 110.481 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.61 124.35 24.51 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 118.282 -0.866 . . . . 75.12 110.368 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -38.06 -37.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 116.54 2.052 . . . . 51.21 116.54 -157.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -57.01 -40.53 76.8 Favored 'General case' 0 N--CA 1.509 2.483 0 CA-C-N 118.963 0.802 . . . . 74.05 112.003 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 14.5 m-70 -133.58 77.92 1.75 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 103.986 -2.598 . . . . 70.35 103.986 165.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.587 ' HA ' HG12 ' A' ' 122' ' ' ILE . 47.5 mtmt -46.86 -149.78 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 2 C-N-CA 133.016 4.526 . . . . 74.1 122.456 46.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo 12.06 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.808 2.339 . . . . 61.44 115.112 -120.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 120' ' ' LYS . 51.1 mm -86.31 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 115.158 -0.928 . . . . 72.11 110.56 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -156.37 165.38 36.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.807 0.843 . . . . 73.33 110.386 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt . . . . . 0 N--CA 1.481 1.105 0 C-N-CA 122.458 0.303 . . . . 72.22 110.59 178.845 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.649 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 46.5 ttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.499 0.19 . . . . 64.32 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB2' HD11 ' A' ' 7' ' ' LEU . 19.4 mmt180 -79.07 162.87 25.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.89 0.876 . . . . 65.22 110.783 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.8 t -80.73 155.09 26.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.183 0.593 . . . . 64.21 110.203 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.39 67.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.86 0.464 . . . . 63.32 112.103 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -70.0 -44.27 69.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.128 0.571 . . . . 64.41 110.602 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.8 -48.99 79.47 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.041 0.936 . . . . 61.52 111.398 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.568 HD22 HD12 ' A' ' 20' ' ' ILE . 80.8 mt -74.43 -31.67 62.37 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.039 -0.982 . . . . 63.02 112.867 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.34 -46.83 81.76 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.937 0.495 . . . . 75.05 110.264 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.26 -33.34 73.38 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.195 -0.911 . . . . 73.35 110.789 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.1 tp10 -70.49 -41.92 72.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.594 0.758 . . . . 73.53 110.933 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.2 mt -59.13 -43.16 91.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.983 0.913 . . . . 74.32 111.918 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -68.56 -32.37 72.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.193 0.597 . . . . 64.34 111.274 176.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.79 68.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.718 0.807 . . . . 73.11 112.072 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.79 148.39 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.377 0.608 . . . . 72.33 111.389 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.72 -14.89 55.94 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 75.44 111.635 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.07 153.46 25.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.648 0.779 . . . . 63.54 110.582 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.5 m -73.99 92.13 2.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.742 0.417 . . . . 64.52 111.101 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.48 -65.43 1.01 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.382 0.673 . . . . 61.23 112.264 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -119.11 -15.59 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.356 1.062 . . . . 60.05 110.001 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.568 HD12 HD22 ' A' ' 7' ' ' LEU . 31.5 mm -111.53 119.14 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.603 1.161 . . . . 53.41 108.023 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.45 141.1 48.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.486 0.714 . . . . 71.43 110.792 -171.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.57 127.26 52.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.667 0.787 . . . . 51.15 110.151 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 25.2 mmmt -132.24 136.5 47.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.977 0.911 . . . . 64.41 109.407 -176.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -81.99 168.01 18.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.255 0.55 . . . . 73.43 111.76 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.55 69.38 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.713 0.805 . . . . 62.41 112.507 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -65.72 -37.27 85.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 43.02 111.004 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -76.99 -6.82 54.14 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.379 1.072 . . . . 75.53 113.411 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -69.58 120.29 15.13 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.286 0.565 . . . . 70.11 110.287 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.11 -129.16 5.0 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.853 -0.612 . . . . 65.0 112.436 -172.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -59.33 -39.11 82.08 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.669 0.787 . . . . 73.21 112.097 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 m -65.45 -29.2 69.85 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.086 0.955 . . . . 34.11 112.61 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 81' ' ' LEU . 54.3 t -71.12 -51.08 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.726 0.41 . . . . 73.44 110.275 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -33.74 69.54 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.007 0.923 . . . . 72.01 112.924 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.35 -44.98 72.63 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.128 0.971 . . . . 73.23 111.159 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.3 m -76.89 -39.2 51.81 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.89 . . . . 63.52 112.461 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.25 -34.74 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 124.237 1.015 . . . . 65.33 112.444 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 33' ' ' MET . 58.5 mt -45.14 -45.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 124.087 0.955 . . . . 72.34 112.931 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.44 -60.07 4.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.106 0.562 . . . . 54.43 112.303 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.44 -24.43 62.9 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.622 0.601 . . . . 73.11 112.622 -169.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.82 -48.33 9.47 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.506 0.722 . . . . 62.32 112.353 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -93.3 -27.11 17.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.876 1.065 . . . . 74.13 113.876 -169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 68.6 mm-40 -64.33 121.76 74.16 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 118.283 0.492 . . . . 74.21 111.731 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 23.7 Cg_exo -64.15 110.48 1.36 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.598 2.199 . . . . 63.43 112.549 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.73 59.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.058 -0.857 . . . . 35.35 115.207 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.91 20.82 13.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.104 1.452 . . . . 72.45 110.831 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -41.45 114.2 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.218 1.007 . . . . 74.33 112.332 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.15 68.33 0.64 Allowed Glycine 0 N--CA 1.471 0.994 0 N-CA-C 113.738 0.255 . . . . 61.52 113.738 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.63 142.0 17.29 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.925 -0.87 . . . . 50.12 110.925 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.649 ' HE1' ' HG3' ' A' ' 1' ' ' MET . 94.6 m-85 -118.12 129.76 55.72 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.511 0.655 . . . . 75.55 112.11 -170.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 32' ' ' VAL . 5.6 mp -112.07 124.96 53.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.955 0.902 . . . . 74.21 109.329 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.2 mm? -104.61 109.11 20.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.065 0.546 . . . . 71.53 109.707 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 8.4 mp -92.95 122.32 35.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.409 0.684 . . . . 73.45 109.196 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.14 26.34 3.81 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.571 -0.286 . . . . 63.44 113.374 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.21 133.96 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.409 -0.589 . . . . 50.33 109.409 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -119.12 137.07 53.84 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.457 -0.942 . . . . 72.21 108.457 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -122.88 139.63 53.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.046 0.539 . . . . 72.52 111.58 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.92 151.95 35.55 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.925 0.89 . . . . 75.22 111.177 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.04 122.67 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.356 0.662 . . . . 74.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -96.79 -168.43 1.71 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.629 0.772 . . . . 63.52 112.088 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.89 -32.37 67.65 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.57 1.148 . . . . 64.54 112.925 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -79.54 -11.77 59.88 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.48 0.712 . . . . 74.45 111.561 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.92 84.92 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 116.487 -0.324 . . . . 62.41 112.792 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.43 149.21 30.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.507 1.123 . . . . 64.13 111.914 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -104.62 115.52 30.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.253 1.021 . . . . 75.23 110.404 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.92 128.91 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.42 0.688 . . . . 61.33 109.603 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.77 119.1 32.3 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.177 0.591 . . . . 74.24 110.233 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -129.91 129.17 22.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 123.325 0.65 . . . . 74.45 110.601 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 67.5 Cg_endo -78.68 109.84 2.69 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 72.4 112.421 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.21 -14.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.678 -0.639 . . . . 71.11 111.356 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.82 53.6 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.011 -0.541 . . . . 74.24 113.929 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.34 131.07 23.55 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.055 0.942 . . . . 74.24 110.809 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -32.03 87.9 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.054 2.503 . . . . 53.45 113.009 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -138.74 87.14 15.0 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 108.221 -1.029 . . . . 74.43 108.221 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.1 -28.42 34.68 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.661 2.241 . . . . 71.43 113.505 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -47.63 66.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.082 0.953 . . . . 72.15 111.268 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.65 -44.43 70.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.631 -0.713 . . . . 72.34 111.443 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -58.9 -37.25 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 122.908 0.483 . . . . 75.35 111.47 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.05 -52.38 49.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.842 0.682 . . . . 75.13 112.842 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -75.77 -33.86 60.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 112.434 0.531 . . . . 70.12 112.434 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.56 -33.29 73.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.413 0.685 . . . . 73.25 110.343 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 HG11 ' A' ' 32' ' ' VAL . 41.2 tp -63.46 -42.93 98.61 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.53 0.732 . . . . 54.53 111.415 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.25 95.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.286 0.634 . . . . 53.53 111.728 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -63.52 -52.32 61.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.983 0.913 . . . . 62.55 112.036 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.74 -32.52 74.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.101 0.56 . . . . 53.32 112.244 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.178 0.513 . . . . 73.53 112.223 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.51 -20.7 36.21 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.464 0.706 . . . . 34.43 112.016 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -112.31 -2.78 14.72 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.792 1.034 . . . . 42.4 113.792 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.7 mmm -99.6 -26.91 13.93 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.44 0.696 . . . . 72.12 111.327 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -108.32 142.79 38.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.561 0.745 . . . . 63.13 109.212 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' A' ' 91' ' ' VAL . 7.6 p-10 -57.66 -26.19 61.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.325 0.861 . . . . 63.44 113.325 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 119' ' ' HIS . 6.6 m -122.22 163.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.479 1.112 . . . . 64.43 111.499 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.28 98.25 7.33 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.273 0.559 . . . . 74.45 110.935 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 122' ' ' ILE . 4.7 tt -96.24 138.57 33.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.143 0.977 . . . . 72.23 108.686 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -106.77 95.34 12.06 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.004 0.521 . . . . 72.24 111.766 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.75 155.46 15.61 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.783 1.655 . . . . 62.24 111.198 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 41.7 tt0 -108.12 120.53 42.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.529 0.732 . . . . 61.13 110.906 -171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD11 ' A' ' 108' ' ' LEU . 1.8 mpt? -111.7 141.74 44.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.73 0.812 . . . . 60.11 111.413 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 133.53 15.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.681 -0.489 . . . . 75.3 109.681 167.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.0 mt -81.46 116.21 21.15 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.571 0.748 . . . . 62.02 110.74 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -123.25 130.77 53.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.799 1.24 . . . . 63.01 110.221 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -94.61 125.45 39.27 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.168 0.587 . . . . 73.44 111.281 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.45 119.15 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.913 0.885 . . . . 72.22 109.225 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.43 41.53 63.51 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.453 0.941 . . . . 74.2 115.453 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.98 88.66 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.883 0.713 . . . . 70.31 114.883 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.7 mmtt -110.0 139.85 44.66 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.791 0.837 . . . . 71.45 109.292 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.9 m -100.3 124.57 45.94 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.777 0.717 . . . . 74.4 111.024 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.49 164.9 14.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.127 0.971 . . . . 70.31 108.981 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.5 tp -115.64 116.52 28.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.58 0.352 . . . . 65.2 110.11 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.38 121.88 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 109.21 -0.663 . . . . 52.35 109.21 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.88 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.002 0.521 . . . . 72.0 110.623 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.721 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 63.4 t80 -80.49 114.77 19.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.12 109.715 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.23 102.13 34.88 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.516 -0.92 . . . . 72.24 108.516 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.42 169.8 15.25 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.396 2.064 . . . . 74.2 112.481 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -80.79 128.09 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.547 -0.751 . . . . 71.32 109.286 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.93 173.91 9.05 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.185 0.594 . . . . 72.11 111.669 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.59 155.97 37.89 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.679 0.792 . . . . 75.45 110.677 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.8 t -47.41 -42.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 114.85 1.426 . . . . 64.55 114.85 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 123.515 0.726 . . . . 64.12 112.471 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -129.37 78.21 1.84 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 103.605 -2.739 . . . . 62.33 103.605 169.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 32.2 mmtp -44.16 -159.01 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.781 1 C-N-CA 132.04 4.136 . . . . 64.03 120.861 66.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo 5.03 71.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.265 2.644 . . . . 71.31 118.059 -132.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 93' ' ' LEU . 1.8 mp -76.6 101.28 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.13 -1.063 . . . . 75.44 108.13 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -105.67 154.68 20.11 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.338 0.655 . . . . 73.24 109.813 168.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HD3' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.477 0.922 0 C-N-CA 122.809 0.443 . . . . 73.03 110.603 -176.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.99 -0.374 . . . . 74.31 109.99 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -40.08 134.67 1.5 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.85 1.26 . . . . 73.13 114.328 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -69.38 159.86 32.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.048 0.939 . . . . 61.1 112.007 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.08 70.37 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.26 0.624 . . . . 75.53 112.596 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -65.87 -43.79 87.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.13 110.641 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.61 -43.29 76.71 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 115.199 -0.91 . . . . 73.21 111.566 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 20' ' ' ILE . 86.1 mt -65.94 -42.14 90.42 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.533 0.733 . . . . 55.21 111.406 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 11' ' ' LEU . 25.9 tp -52.04 -48.68 64.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.628 1.171 . . . . 72.53 111.075 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.9 -46.22 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.814 -1.084 . . . . 74.32 111.878 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.34 -30.18 61.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.412 -0.358 . . . . 74.2 111.726 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 8' ' ' LEU . 79.7 mt -57.82 -52.88 63.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.518 0.727 . . . . 63.04 111.596 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.57 -1.1 49.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.563 0.579 . . . . 70.34 112.563 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.6 -50.06 8.01 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.051 0.54 . . . . 55.2 110.611 170.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 m -80.24 150.51 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.101 0.56 . . . . 30.1 111.191 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -72.76 -27.76 62.21 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.482 0.713 . . . . 63.43 112.478 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.57 134.1 24.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.814 0.845 . . . . 72.31 109.389 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.634 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 50.9 p -72.91 80.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.483 0.713 . . . . 73.14 111.234 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.71 -64.28 1.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.611 0.765 . . . . 71.43 112.272 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.6 -26.97 14.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.008 0.523 . . . . 74.5 110.739 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 HD22 ' A' ' 7' ' ' LEU . 36.4 mt -116.18 109.0 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 8.9 tp10 -100.73 151.57 21.51 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.076 1.351 . . . . 74.32 111.307 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.44 134.25 53.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.562 0.745 . . . . 72.11 110.987 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 32' ' ' VAL . 13.8 mptt -130.87 149.8 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.753 0.821 . . . . 75.41 110.338 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.46 169.24 13.03 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.801 0.841 . . . . 72.32 111.653 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.61 88.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.951 0.501 . . . . 73.2 111.03 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -60.28 -35.66 76.05 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.336 1.054 . . . . 60.44 112.166 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.74 3.64 50.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.903 0.881 . . . . 52.11 112.416 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.8 mmm -65.93 128.29 35.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.324 0.649 . . . . 51.04 111.73 170.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.4 -146.84 15.84 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.098 -0.501 . . . . 50.33 112.573 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.4 -18.34 65.3 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.292 0.637 . . . . 53.21 112.568 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -73.72 -37.08 65.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.207 0.603 . . . . 53.3 111.44 176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 23' ' ' LYS . 58.7 t -65.72 -47.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.12 0.486 . . . . 53.35 109.792 172.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.524 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 86.4 mmm -62.71 -35.19 78.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.962 -1.017 . . . . 61.02 112.662 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -40.08 91.5 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.817 0.847 . . . . 75.34 111.012 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -71.01 -35.6 72.1 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.708 -0.678 . . . . 75.22 111.11 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.09 -46.23 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.635 0.774 . . . . 74.11 110.785 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.4 -36.81 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.908 0.883 . . . . 74.04 110.931 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.35 62.65 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.919 0.888 . . . . 63.35 113.045 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -91.47 -42.25 10.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 122.103 -0.373 . . . . 63.01 111.011 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.81 -55.29 10.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.831 1.049 . . . . 73.12 113.831 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.27 -16.32 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.441 0.696 . . . . 73.25 112.668 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 54.1 mm-40 -79.78 132.59 60.61 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.152 0.581 . . . . 74.4 112.124 -177.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 21.4 Cg_exo -65.34 101.84 0.44 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.176 2.584 . . . . 72.45 113.218 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.75 74.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.075 1.19 . . . . 45.12 116.075 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 42' ' ' GLU . 10.1 mp -96.38 22.11 8.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.532 1.166 . . . . 70.14 110.905 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 16.9 t70 -50.41 153.77 1.46 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.208 1.403 . . . . 73.51 112.686 165.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 92.59 36.58 6.1 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.715 -0.675 . . . . 75.44 112.936 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.3 141.11 15.29 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 117.503 0.651 . . . . 73.42 112.661 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -118.49 127.32 53.52 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.269 0.627 . . . . 74.35 112.02 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 64.6 mt -100.73 109.5 21.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.013 1.325 . . . . 72.24 109.529 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.521 HD13 HG22 ' A' ' 109' ' ' VAL . 21.1 tp -101.67 109.95 21.84 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.406 0.622 . . . . 72.25 109.762 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 108' ' ' LEU . 47.2 mt -99.35 136.32 39.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 72.43 110.416 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.23 5.93 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-O 121.224 0.347 . . . . 71.24 112.723 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.5 t -111.54 138.17 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.486 0.715 . . . . 62.02 109.636 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 18.0 t70 -103.64 148.42 26.04 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.146 -1.057 . . . . 75.22 108.146 174.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -145.29 143.01 29.96 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.152 0.501 . . . . 74.54 111.608 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.68 152.73 37.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.746 0.818 . . . . 74.44 110.428 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.08 126.87 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.927 0.491 . . . . 75.04 110.555 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -87.77 -179.29 6.24 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.359 0.663 . . . . 75.32 111.514 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -61.17 -19.17 61.25 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.962 1.097 . . . . 74.45 113.962 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -80.95 -14.87 57.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.228 0.611 . . . . 72.42 112.498 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.05 41.54 17.91 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.737 -0.545 . . . . 64.34 111.737 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.39 139.03 51.81 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.774 1.23 . . . . 71.05 110.32 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -84.87 119.89 25.85 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.201 0.601 . . . . 71.13 110.592 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.89 124.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.144 0.578 . . . . 41.35 110.056 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.05 122.05 41.78 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.459 0.703 . . . . 75.51 110.597 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 9.0 ptm180 -127.06 139.1 34.15 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.605 1.162 . . . . 52.33 110.76 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' HD21 ' A' ' 8' ' ' LEU . 77.2 Cg_endo -86.3 98.47 0.55 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.714 2.276 . . . . 61.02 112.837 -176.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.5 -17.93 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 70.14 111.687 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.41 46.52 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 116.302 -0.408 . . . . 63.41 113.561 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.14 136.74 21.89 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-O 118.868 -0.587 . . . . 55.21 110.064 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.62 -36.29 92.82 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.609 2.206 . . . . 63.55 112.473 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -130.35 87.52 50.38 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.416 0.687 . . . . 70.42 109.342 168.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.69 -26.71 9.59 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.84 2.36 . . . . 75.24 114.047 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 6.3 m-20 -72.22 -47.21 52.17 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.444 0.698 . . . . 74.14 111.163 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -61.56 -36.49 80.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.262 0.351 . . . . 60.31 110.762 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.99 -43.69 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.013 0.925 . . . . 61.24 111.221 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.99 -45.98 90.97 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.624 0.769 . . . . 63.51 111.962 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 28.8 mmm180 -70.67 -45.33 65.25 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.716 -0.675 . . . . 74.01 111.875 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.36 -28.07 64.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.759 0.824 . . . . 74.52 111.884 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.9 tp -69.76 -40.01 76.38 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.588 0.355 . . . . 74.4 110.748 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.53 91.03 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.057 0.543 . . . . 63.31 111.252 173.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -64.93 -52.64 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.873 0.869 . . . . 64.01 111.712 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -64.78 -31.69 73.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.878 0.471 . . . . 73.42 111.901 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.7 t -69.73 -25.42 63.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 64.42 112.048 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.05 -33.58 20.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.428 0.691 . . . . 70.43 112.267 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 p -92.21 -37.28 12.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.667 0.988 . . . . 71.33 113.667 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.524 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 82.4 mtp -76.28 -47.48 23.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.031 0.532 . . . . 65.21 112.059 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.75 148.3 36.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.304 0.642 . . . . 74.11 112.11 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -53.78 -32.27 51.83 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.825 1.25 . . . . 72.34 112.864 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.7 m -129.41 172.37 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.281 1.032 . . . . 64.01 111.338 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.82 104.4 13.88 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.912 -0.586 . . . . 53.41 110.986 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 tt -93.02 133.23 36.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.791 -1.189 . . . . 74.22 107.791 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -109.61 95.3 19.08 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 122.808 0.443 . . . . 64.34 111.633 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.73 158.93 10.54 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.563 2.175 . . . . 73.23 112.405 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.2 tp10 -100.77 131.8 46.49 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.535 0.734 . . . . 74.21 109.483 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.9 mtt -125.71 116.66 22.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.08 0.552 . . . . 75.35 111.324 -172.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -114.99 133.28 56.17 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 75.42 111.05 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.68 109.73 21.15 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.122 0.569 . . . . 71.11 109.538 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -109.43 128.1 54.89 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.724 1.209 . . . . 61.42 112.309 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -97.97 109.33 22.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.341 0.591 . . . . 64.12 110.718 174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -121.17 112.73 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.624 1.17 . . . . 61.41 108.63 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.36 29.68 66.59 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 113.886 0.314 . . . . 71.1 113.886 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.03 0.44 90.3 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.197 0.439 . . . . 62.04 114.197 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -100.81 137.2 39.52 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.511 0.724 . . . . 74.24 109.301 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -98.56 121.38 40.43 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 119.047 0.84 . . . . 72.25 111.997 -174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.78 166.98 11.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.124 1.37 . . . . 65.24 108.864 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 52' ' ' LEU . 26.4 tp -123.72 109.84 14.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.086 -0.384 . . . . 73.04 110.513 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG22 HD13 ' A' ' 51' ' ' LEU . 59.0 t -84.3 123.24 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.938 -0.764 . . . . 63.23 108.938 171.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 40.9 t -118.41 99.84 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.394 0.678 . . . . 72.03 109.607 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HE1' ' HA2' ' A' ' 47' ' ' GLY . 87.5 t80 -79.88 122.5 26.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.78 -0.646 . . . . 63.54 110.021 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.29 112.08 65.12 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 109.085 -0.709 . . . . 60.45 109.085 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.49 172.78 15.6 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.612 2.208 . . . . 74.33 113.044 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -58.24 160.59 4.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.485 0.714 . . . . 42.1 112.366 172.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 120' ' ' LYS . . . -110.46 135.15 51.58 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 115.851 -0.613 . . . . 72.51 110.063 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 18.5 t70 -65.57 160.66 21.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.669 1.187 . . . . 73.52 112.001 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -47.3 -38.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.188 1.181 . . . . 74.31 114.188 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -75.21 -39.46 60.08 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.309 0.485 . . . . 63.53 112.309 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 4.3 p-80 -142.75 94.98 2.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.821 -1.548 . . . . 74.31 106.821 171.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 22.2 pttp -47.14 -163.77 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.39 2 C-N-CA 133.965 4.906 . . . . 61.32 123.298 43.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo 7.69 77.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.603 2.202 . . . . 65.24 116.566 -113.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' A' ' 120' ' ' LYS . 60.0 mt -94.65 113.59 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.781 -1.1 . . . . 73.24 109.267 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -131.3 141.27 49.93 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.568 0.699 . . . . 75.3 111.508 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tttm . . . . . 0 CA--C 1.558 1.265 0 CA-C-N 114.52 -1.218 . . . . 62.35 110.523 169.506 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG2' ' H ' ' A' ' 2' ' ' ARG . 10.8 ttt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 110.322 -0.251 . . . . 73.42 110.322 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.0 ttt180 174.43 144.13 0.05 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.509 -0.744 . . . . 72.13 109.882 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.34 154.43 30.83 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 122.431 0.293 . . . . 44.22 111.401 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.55 -32.99 74.61 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.467 0.707 . . . . 72.55 112.423 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.621 HG23 HG13 ' A' ' 102' ' ' VAL . 3.7 m -65.3 -41.72 93.79 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.708 0.803 . . . . 71.15 110.71 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.0 -38.81 69.58 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 115.19 -0.914 . . . . 65.4 110.857 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD11 HG13 ' A' ' 109' ' ' VAL . 61.4 mt -65.03 -40.42 94.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.034 0.534 . . . . 60.3 111.301 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HA ' HD12 ' A' ' 11' ' ' LEU . 33.6 tp -62.42 -46.5 88.29 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.636 0.774 . . . . 74.44 110.559 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.0 -41.01 86.62 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 114.744 -1.116 . . . . 72.25 111.514 172.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -67.71 -38.48 83.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.472 0.709 . . . . 72.03 111.545 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 8' ' ' LEU . 44.6 mt -60.29 -39.79 88.16 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.191 0.996 . . . . 72.14 111.155 173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.93 -32.28 69.15 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.765 0.826 . . . . 74.13 111.903 174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.07 -46.02 58.47 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.876 0.87 . . . . 75.52 112.012 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.22 151.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.352 0.596 . . . . 63.52 112.121 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.22 -33.33 61.35 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.853 0.861 . . . . 75.43 111.113 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -147.95 156.52 42.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.093 0.957 . . . . 72.24 109.958 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -66.44 76.07 0.1 Allowed 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.865 0.866 . . . . 63.15 111.552 176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.08 -61.87 2.29 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.209 1.004 . . . . 51.12 111.996 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -133.98 8.38 3.78 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.024 0.93 . . . . 71.34 110.717 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 44.7 mt -127.62 107.67 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.924 0.89 . . . . 72.13 110.347 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -92.33 148.65 21.96 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.35 1.06 . . . . 70.55 111.24 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -112.47 134.1 54.18 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.314 1.045 . . . . 73.54 109.882 174.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 65.0 mttm -139.62 141.02 37.13 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.17 0.588 . . . . 71.42 111.74 -173.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -84.92 164.21 18.49 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 115.308 -0.86 . . . . 73.54 110.449 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' MET . . . -62.65 -31.99 72.95 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 112.589 0.589 . . . . 75.04 112.589 178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.0 t -69.61 -21.97 63.53 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.094 0.775 . . . . 71.04 113.094 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.87 -8.45 48.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.701 0.8 . . . . 63.21 111.937 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -55.03 119.95 6.2 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.108 1.363 . . . . 74.01 112.035 -176.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 138.98 -147.07 18.95 Favored Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.95 -0.46 . . . . 53.01 111.95 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -64.07 -25.01 67.92 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.239 0.616 . . . . 73.45 112.547 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.8 m -59.63 -36.92 77.31 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.232 0.613 . . . . 71.44 111.898 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 34.8 t -71.97 -43.62 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 121.311 0.577 . . . . 71.23 111.105 171.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.632 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 80.0 mmm -69.65 -40.9 76.21 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.118 1.155 . . . . 71.51 114.118 -166.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -65.73 -31.04 71.82 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.813 0.34 . . . . 72.22 110.909 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.0 m -67.75 -37.56 82.31 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.387 0.675 . . . . 75.43 111.004 175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.7 t -63.07 -41.09 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.29 0.636 . . . . 61.24 110.86 175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.76 -35.07 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.256 0.622 . . . . 54.22 110.39 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.82 -18.24 63.45 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.807 0.843 . . . . 61.21 112.636 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -99.07 -29.49 12.86 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.307 0.643 . . . . 73.34 111.921 170.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.82 -34.69 75.92 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 55.2 112.377 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.34 -8.08 58.81 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.545 0.738 . . . . 74.35 112.79 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -81.81 116.42 63.12 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 123.768 0.827 . . . . 72.41 112.275 -173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.49 111.74 3.39 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.662 2.241 . . . . 64.12 112.438 173.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.79 19.56 57.7 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.326 0.89 . . . . 72.2 115.326 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.25 21.62 14.53 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 118.716 1.258 . . . . 74.52 111.908 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -40.95 123.05 1.87 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 113.637 0.977 . . . . 74.43 113.637 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.64 53.75 0.91 Allowed Glycine 0 C--N 1.348 1.237 0 CA-C-N 116.343 -0.39 . . . . 44.12 113.007 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.81 135.57 12.29 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.423 -1.071 . . . . 70.55 110.423 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -112.21 128.53 56.27 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.936 0.868 . . . . 73.31 111.914 -170.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.0 mp -112.54 117.81 33.37 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.78 -1.193 . . . . 64.24 107.78 167.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.2 tp -103.24 109.83 21.57 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.924 -0.485 . . . . 64.53 109.976 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -96.7 134.37 40.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.885 0.874 . . . . 73.42 110.575 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.94 28.54 6.16 Favored Glycine 0 N--CA 1.479 1.536 0 CA-C-N 116.293 -0.412 . . . . 60.33 112.13 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.6 t -111.25 138.7 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.199 0.999 . . . . 74.32 110.252 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -116.71 165.6 13.1 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 107.864 -1.162 . . . . 63.0 107.864 170.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.8 p90 -148.58 141.84 25.11 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.387 0.613 . . . . 74.44 111.537 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.04 135.55 53.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.282 1.033 . . . . 65.1 110.536 -173.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 49.6 mm -99.82 118.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-O 121.187 0.518 . . . . 62.33 111.515 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -75.99 172.23 13.1 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.846 0.858 . . . . 71.41 111.419 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.52 -21.45 66.62 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.006 0.522 . . . . 62.25 112.144 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -71.61 -14.37 62.05 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.149 0.98 . . . . 71.33 112.168 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.84 35.22 25.42 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 111.317 -0.713 . . . . 70.53 111.317 -168.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 25.3 t0 -99.86 140.26 34.33 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.972 0.909 . . . . 74.04 111.395 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -105.76 107.24 18.13 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.392 0.677 . . . . 74.14 110.633 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.54 120.17 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.833 0.853 . . . . 74.43 109.78 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.77 119.42 32.11 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.188 0.595 . . . . 54.5 110.422 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -121.85 153.52 60.36 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.52 1.128 . . . . 62.31 110.912 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' HD21 ' A' ' 8' ' ' LEU . 89.8 Cg_endo -82.67 141.44 10.96 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.202 1.935 . . . . 71.14 112.738 177.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.87 -26.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.859 0.864 . . . . 70.31 110.681 176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.49 -178.22 53.88 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 121.852 0.696 . . . . 71.03 114.736 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 108' ' ' LEU . 51.4 mt -101.28 142.35 24.43 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.52 1.128 . . . . 73.44 110.904 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.79 -27.98 67.93 Favored 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 122.842 2.361 . . . . 75.34 112.424 177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -145.49 97.57 4.67 Favored Pre-proline 0 CA--C 1.556 1.177 0 N-CA-C 107.817 -1.179 . . . . 62.5 107.817 171.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.34 -51.47 10.94 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.975 3.117 . . . . 72.31 114.689 -174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 23.1 t70 -64.58 -51.46 62.64 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.325 -0.852 . . . . 53.32 110.551 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' A' ' 76' ' ' LYS . 4.3 ttmp? -59.84 -36.93 77.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.582 0.753 . . . . 73.54 112.839 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 87.6 t -61.91 -41.82 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.043 0.537 . . . . 71.54 111.249 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.15 -33.35 75.23 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.528 0.731 . . . . 74.25 111.528 175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 44.3 mmm-85 -72.41 -51.19 21.46 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.546 0.738 . . . . 71.24 110.886 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.22 -44.49 92.29 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.197 0.999 . . . . 75.12 111.821 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.7 tp -67.22 -32.81 74.1 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 111.79 0.293 . . . . 64.24 111.79 -175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.17 -42.37 96.74 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.018 0.527 . . . . 75.53 111.212 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.5 t -62.55 -45.96 90.55 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.412 0.685 . . . . 74.44 111.524 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -53.92 -53.2 55.94 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.994 0.918 . . . . 74.44 111.24 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 10.6 t -72.61 -18.37 61.6 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.865 0.691 . . . . 64.03 112.865 -172.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -88.41 -39.6 14.15 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.386 0.675 . . . . 71.42 112.197 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.7 t -92.85 -39.86 10.95 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.371 0.878 . . . . 75.41 113.371 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.632 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 66.8 mtp -68.85 -40.95 79.09 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.13 0.49 . . . . 71.34 111.913 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 54.4 mt -84.12 151.46 24.9 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.946 0.898 . . . . 73.35 110.73 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.2 p30 -57.33 -32.27 66.55 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 113.382 0.882 . . . . 73.04 113.382 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.9 m -115.38 160.01 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.871 0.868 . . . . 73.24 110.413 172.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -77.12 103.6 7.14 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.109 -0.496 . . . . 65.25 110.513 174.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.674 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.8 tt -99.04 128.83 45.26 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.486 -0.931 . . . . 64.44 108.486 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.9 ttt85 -98.49 109.61 53.42 Favored Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 123.295 0.638 . . . . 75.03 110.611 172.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -80.88 126.77 5.94 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 121.874 1.716 . . . . 74.24 110.311 163.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -75.88 100.8 4.92 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 116.047 -0.524 . . . . 62.11 109.777 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.616 ' HB3' HD11 ' A' ' 108' ' ' LEU . 70.0 mtm -110.15 133.51 53.14 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.427 0.691 . . . . 65.33 112.228 -171.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -136.27 136.5 39.86 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.098 0.959 . . . . 71.41 111.111 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 69.9 mt -88.29 116.02 26.2 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.404 1.082 . . . . 72.23 111.153 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -125.87 131.54 52.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.598 1.159 . . . . 73.4 110.63 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -92.09 125.66 36.87 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.26 0.624 . . . . 64.51 111.85 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.621 HG13 HG23 ' A' ' 5' ' ' THR . 12.1 t -121.18 114.04 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.584 1.154 . . . . 74.32 109.38 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.32 30.88 61.91 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 115.561 0.985 . . . . 72.14 115.561 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.14 8.84 83.22 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 114.219 0.448 . . . . 63.42 114.219 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -107.44 137.62 45.15 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.19 0.996 . . . . 72.05 108.896 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.0 m -98.43 117.71 33.47 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 119.278 0.944 . . . . 73.45 111.854 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.5 mp -111.66 163.59 13.95 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.357 1.063 . . . . 72.04 109.452 -175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -117.33 115.61 25.59 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.051 0.54 . . . . 71.24 110.538 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.419 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -82.53 106.43 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.885 -0.783 . . . . 73.13 108.885 170.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 60.7 t -92.88 100.04 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.503 -0.925 . . . . 70.31 108.503 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -85.02 115.2 22.71 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.869 -1.06 . . . . 73.45 108.872 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 63.6 t -106.52 98.39 20.05 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 123.359 0.663 . . . . 75.45 109.273 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.94 162.72 40.3 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.09 1.86 . . . . 74.4 110.519 167.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -70.34 132.97 46.47 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.053 -0.351 . . . . 65.21 110.053 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -64.34 158.03 24.63 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 122.987 0.515 . . . . 65.51 111.041 172.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.38 178.92 0.49 Allowed 'General case' 0 CA--C 1.574 1.866 0 C-N-CA 124.118 0.967 . . . . 64.14 111.2 176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.7 t -61.84 -52.29 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.264 -1.522 . . . . 72.44 113.602 165.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.1 p -67.66 -48.15 67.5 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 123.711 0.805 . . . . 65.44 111.614 -172.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.625 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.1 OUTLIER -115.22 83.49 1.92 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 103.919 -2.623 . . . . 74.21 103.919 163.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 47.0 mttp -50.58 -143.43 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.131 1 C-N-CA 133.734 4.814 . . . . 65.41 120.989 49.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo 7.15 71.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.253 2.635 . . . . 75.4 115.797 -122.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 120' ' ' LYS . 35.4 mm -81.54 77.44 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 114.909 -1.041 . . . . 75.25 108.936 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -88.51 146.87 24.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.646 -0.707 . . . . 75.43 110.955 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -79.65 135.72 36.63 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.946 -1.024 . . . . 60.33 110.102 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 90' ' ' ASN . 50.5 mtmt -86.05 26.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.284 0.634 . . . . 71.43 111.925 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -146.53 168.99 19.88 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.765 1.226 . . . . 64.21 109.714 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 63.3 m -64.55 115.75 5.49 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.943 0.497 . . . . 74.43 110.47 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.96 95.99 0.11 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 116.194 -0.457 . . . . 71.01 112.088 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.418 HD12 ' HD2' ' A' ' 130' ' ' PRO . 51.5 tp -85.83 116.89 67.46 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 123.392 0.677 . . . . 73.5 110.781 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD2' HD12 ' A' ' 129' ' ' LEU . 60.0 Cg_endo -70.72 114.95 4.02 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.572 2.182 . . . . 70.24 112.534 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -94.78 139.07 14.32 Favored Glycine 0 N--CA 1.477 1.419 0 CA-C-N 116.494 -0.321 . . . . 70.32 113.622 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 142.55 171.18 13.11 Favored Glycine 0 N--CA 1.478 1.476 0 CA-C-N 116.818 0.309 . . . . 63.41 113.52 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -125.76 -62.34 1.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.3 1.04 . . . . 65.34 109.519 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -168.79 153.13 5.72 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.102 0.961 . . . . 72.45 110.137 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -112.34 132.22 55.1 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.823 0.449 . . . . 74.34 109.804 171.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -59.25 123.57 17.13 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.185 0.594 . . . . 73.41 111.146 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.0 tt -74.0 127.13 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 C-N-CA 123.128 0.571 . . . . 74.15 110.935 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -89.19 -78.82 1.31 Allowed Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.46 -0.656 . . . . 70.33 111.46 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.5 p -90.39 141.96 28.21 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.892 0.877 . . . . 71.05 110.789 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 44.2 t -108.96 152.32 25.12 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.675 0.79 . . . . 61.31 111.727 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -154.41 138.17 16.16 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.845 0.858 . . . . 71.04 110.303 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -144.56 20.69 1.68 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.703 0.801 . . . . 73.22 109.733 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.55 79.74 2.56 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.667 0.746 . . . . 74.13 109.194 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.81 118.49 36.99 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.759 0.823 . . . . 64.21 111.28 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.01 141.39 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.823 0.849 . . . . 72.54 109.772 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.6 pp -114.08 150.78 33.51 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.503 0.721 . . . . 62.1 111.057 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -159.49 128.71 5.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.898 0.879 . . . . 74.24 109.722 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -88.74 46.8 1.42 Allowed 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.285 0.634 . . . . 74.23 111.449 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -59.13 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.015 0.926 . . . . 63.1 111.706 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -105.89 121.24 43.68 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.335 1.054 . . . . 72.11 111.012 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -95.86 145.27 25.5 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.584 -0.524 . . . . 71.52 109.584 169.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -142.5 148.51 37.79 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.195 0.598 . . . . 70.21 111.462 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 . . . . . 0 N--CA 1.481 1.075 0 C-N-CA 124.427 1.091 . . . . 74.01 110.754 178.231 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ttt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.799 -0.445 . . . . 50.24 109.799 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HG2' ' CZ ' ' A' ' 49' ' ' TYR . 11.6 ptm180 -99.04 151.66 20.69 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.822 0.449 . . . . 74.22 110.572 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.5 p -75.3 159.98 30.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.119 0.967 . . . . 72.34 113.285 -169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.59 -31.63 69.65 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.191 0.996 . . . . 75.05 112.132 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 65.3 p -66.74 -48.73 68.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.816 0.846 . . . . 72.33 111.145 176.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -69.23 -34.3 74.61 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.007 -0.997 . . . . 75.24 111.358 -176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.31 -36.5 81.61 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.239 1.016 . . . . 62.32 112.373 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.5 tp -63.05 -44.94 94.44 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.682 0.393 . . . . 71.22 110.393 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -62.43 -36.34 82.1 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.215 0.606 . . . . 41.13 112.325 173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.559 ' HG2' HG13 ' A' ' 20' ' ' ILE . 4.6 tp10 -66.54 -41.35 88.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.846 0.458 . . . . 73.33 111.246 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 64.4 mt -57.81 -47.77 81.66 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.118 0.967 . . . . 65.05 112.163 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -68.74 -24.08 64.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.295 0.479 . . . . 64.51 112.295 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.87 -39.52 61.49 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.311 0.644 . . . . 72.5 112.142 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.8 m -91.36 143.81 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 121.543 0.687 . . . . 73.24 111.894 -176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.51 -13.79 39.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.097 0.959 . . . . 73.34 110.934 173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -141.21 136.68 31.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.262 1.025 . . . . 73.31 109.989 -176.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.6 m -74.33 77.25 1.86 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.508 0.671 . . . . 65.54 111.021 176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.98 -60.67 2.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.041 -0.982 . . . . 70.32 111.166 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -111.95 -23.23 10.64 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.718 0.807 . . . . 70.15 111.567 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.559 HG13 ' HG2' ' A' ' 10' ' ' GLU . 21.6 mm -115.4 107.26 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 -170.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.2 114.52 24.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.884 0.473 . . . . 73.23 110.187 -171.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.97 116.59 23.46 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.544 0.738 . . . . 70.33 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -117.44 153.34 33.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.179 0.514 . . . . 63.51 111.638 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -93.54 170.77 9.34 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.351 1.06 . . . . 74.1 111.593 174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -37.74 88.42 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.967 -0.56 . . . . 54.32 110.937 169.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.4 p -57.61 -30.78 65.61 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.893 0.877 . . . . 71.51 112.455 173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -84.74 -0.25 52.99 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 113.028 0.751 . . . . 62.44 113.028 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 88.3 mmm -68.49 131.65 45.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.004 0.521 . . . . 61.32 111.421 175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.14 -132.76 6.25 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 115.684 -0.689 . . . . 54.55 111.746 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 -39.72 89.46 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.17 0.588 . . . . 74.42 111.409 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 m -53.22 -33.6 53.54 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.564 1.145 . . . . 54.43 113.509 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.6 t -70.46 -35.31 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.267 0 C-N-CA 123.152 0.581 . . . . 60.55 111.72 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 56.4 mmm -73.91 -41.49 62.03 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.263 0.838 . . . . 73.35 113.263 -164.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.7 pm0 -65.34 -26.41 68.02 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 111.746 0.276 . . . . 54.32 111.746 173.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.0 m -72.24 -41.01 67.3 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 122.316 0.246 . . . . 53.2 111.115 173.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -64.64 -44.15 96.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 123.4 0.68 . . . . 42.22 111.955 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 pt -63.27 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 122.651 0.38 . . . . 74.41 111.62 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.13 -42.89 77.61 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.119 0.568 . . . . 73.43 111.687 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HA ' HD23 ' A' ' 45' ' ' LEU . 32.2 m-85 -82.4 -37.29 25.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.474 0.71 . . . . 71.44 111.338 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.7 -23.48 62.48 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.933 1.086 . . . . 70.41 113.933 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -108.08 -8.51 15.81 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 113.737 1.014 . . . . 74.32 113.737 -175.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -93.89 107.06 25.17 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-N 118.232 0.469 . . . . 62.22 110.563 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.96 123.68 11.62 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.933 2.422 . . . . 53.13 112.732 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.51 60.7 Favored Glycine 0 N--CA 1.473 1.148 0 CA-C-O 119.912 -0.382 . . . . 63.11 114.033 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.591 HD23 ' HA ' ' A' ' 39' ' ' PHE . 19.1 tp -89.86 13.44 14.51 Favored 'General case' 0 CA--C 1.566 1.559 0 CA-C-N 117.713 0.756 . . . . 54.14 111.214 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -32.22 112.5 0.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 126.183 1.793 . . . . 71.21 114.158 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.632 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 103.78 68.63 0.77 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.395 -0.366 . . . . 45.31 112.779 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.06 124.61 5.4 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 109.618 -1.393 . . . . 43.41 109.618 171.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.416 ' CZ ' ' HG2' ' A' ' 2' ' ' ARG . 56.0 m-85 -120.86 127.77 52.21 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.386 0.593 . . . . 61.52 111.819 -169.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -93.3 118.27 31.07 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 108.23 -1.026 . . . . 72.31 108.23 169.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.33 110.43 22.42 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 118.666 0.667 . . . . 62.43 109.856 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 9.3 mp -99.0 132.16 44.52 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.979 0.912 . . . . 64.11 110.793 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.5 33.15 4.91 Favored Glycine 0 N--CA 1.472 1.055 0 CA-C-N 116.247 -0.433 . . . . 73.21 112.429 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.2 t -112.6 138.6 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.116 0.566 . . . . 61.31 110.692 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -107.76 146.99 31.42 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.462 -1.31 . . . . 60.52 107.462 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -128.97 126.47 39.66 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.024 0.44 . . . . 74.52 110.399 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.09 123.4 46.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 54.03 109.969 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.4 mt -90.52 131.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.578 0.751 . . . . 63.1 111.355 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -87.26 -178.5 6.22 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.608 0.763 . . . . 71.31 112.394 -175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.24 -28.55 69.81 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.584 0.754 . . . . 74.22 111.846 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -82.73 2.11 35.41 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.308 0.643 . . . . 74.52 112.274 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.36 32.34 58.07 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 120.933 0.185 . . . . 62.22 112.732 -172.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.94 111.54 23.91 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.756 0.823 . . . . 75.13 110.631 -172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.1 m -82.8 115.05 21.53 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.604 0.762 . . . . 75.53 111.046 -176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.56 122.78 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 123.873 0.869 . . . . 75.42 110.293 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -95.7 129.04 43.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.483 0.713 . . . . 71.53 110.44 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -137.36 142.41 37.41 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.139 0.976 . . . . 71.32 111.054 -173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.64 80.19 1.33 Allowed 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 123.029 2.486 . . . . 75.31 113.931 -170.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.0 m -70.86 -23.42 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 112.703 0.631 . . . . 64.32 112.703 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.61 -173.46 53.28 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 121.313 0.396 . . . . 72.15 113.886 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 74' ' ' PRO . 61.1 mt -115.98 124.59 29.57 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.032 0.933 . . . . 41.43 109.78 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.64 -27.02 39.03 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.473 2.115 . . . . 74.3 112.631 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -126.81 73.82 75.67 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.452 0.701 . . . . 74.33 109.485 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 83.4 Cg_endo -81.03 -28.3 2.56 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.78 2.32 . . . . 71.21 114.483 -170.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -66.39 -42.9 87.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 74.22 110.771 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -67.45 -33.86 76.01 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.21 -0.45 . . . . 73.44 111.558 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.14 -47.83 91.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.034 0.533 . . . . 74.41 110.784 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.456 ' OE1' ' HG ' ' A' ' 99' ' ' LEU . 41.6 tt0 -62.7 -50.28 71.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.873 0.694 . . . . 61.22 112.873 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -33.96 62.43 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 112.6 0.592 . . . . 72.21 112.6 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -72.54 -31.2 65.11 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.922 0.489 . . . . 65.04 110.895 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 27.2 tp -67.78 -41.39 83.31 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.68 0.392 . . . . 35.33 111.248 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.78 -44.83 92.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.896 0.479 . . . . 53.53 111.31 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.3 t -59.23 -52.62 64.87 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.799 0.84 . . . . 62.21 112.007 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -68.04 -34.72 77.0 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 111.995 0.368 . . . . 62.54 111.995 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 36.8 t -67.81 -25.99 65.85 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.338 0.517 . . . . 73.43 112.102 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -78.42 -27.37 46.59 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 112.958 0.725 . . . . 33.03 112.958 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 38.7 t -106.59 -29.38 9.67 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.32 0.859 . . . . 64.2 113.32 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 7.1 mmt -67.3 -52.86 35.35 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.037 0.935 . . . . 74.52 111.405 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.6 mt -90.04 162.0 15.57 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.684 -1.144 . . . . 72.31 110.717 -169.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -29.65 -58.09 0.16 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 126.135 1.774 . . . . 70.2 114.804 -177.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG22 HD12 ' A' ' 122' ' ' ILE . 16.9 m -124.16 176.77 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.389 0.675 . . . . 53.41 110.182 176.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.1 98.77 0.61 Allowed 'General case' 0 CA--C 1.557 1.227 0 CA-C-O 121.287 0.565 . . . . 73.44 111.039 175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.738 HD12 HG21 ' A' ' 122' ' ' ILE . 2.5 tt -92.02 121.65 33.8 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 71.52 108.017 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -101.62 99.36 11.42 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 123.154 0.582 . . . . 74.55 109.644 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.64 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 4.3 Cg_exo -76.58 168.19 24.16 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 121.838 1.692 . . . . 72.3 110.787 168.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.654 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 43.5 tt0 -105.12 96.99 6.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.066 0.546 . . . . 75.32 109.589 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.734 ' HB3' HD11 ' A' ' 108' ' ' LEU . 4.4 mpp? -105.13 134.89 47.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.535 0.734 . . . . 71.52 111.458 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -139.61 133.79 31.19 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.074 0.55 . . . . 72.15 111.197 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.456 ' HG ' ' OE1' ' A' ' 78' ' ' GLN . 91.6 mt -84.26 133.29 34.57 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.897 0.879 . . . . 71.53 110.752 174.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -138.17 145.75 41.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.466 1.106 . . . . 73.4 110.595 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.9 119.97 38.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.963 0.505 . . . . 71.3 109.803 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.32 111.73 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.703 -1.221 . . . . 74.12 107.703 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.73 27.59 61.8 Favored Glycine 0 CA--C 1.543 1.841 0 N-CA-C 114.548 0.579 . . . . 50.44 114.548 -168.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.64 -1.02 88.86 Favored Glycine 0 CA--C 1.545 1.923 0 N-CA-C 114.987 0.755 . . . . 72.32 114.987 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 131.9 46.66 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.612 0.765 . . . . 75.34 109.964 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 48.6 m -92.4 106.09 18.15 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.318 0.858 . . . . 74.51 113.318 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.98 156.26 17.02 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.325 1.05 . . . . 72.11 111.126 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.734 HD11 ' HB3' ' A' ' 97' ' ' MET . 50.4 tp -112.93 116.41 29.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.466 0.707 . . . . 52.3 110.78 176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.0 t -86.4 113.35 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.389 0.676 . . . . 63.44 109.831 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 45.4 t -105.65 101.37 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 122.898 0.479 . . . . 43.51 110.263 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.654 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 40.4 t80 -84.46 128.51 34.63 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.627 0.771 . . . . 71.52 110.19 173.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.6 t -98.29 102.61 14.68 Favored Pre-proline 0 CA--C 1.557 1.234 0 N-CA-C 109.441 -0.578 . . . . 74.45 109.441 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.79 147.66 21.88 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.607 2.204 . . . . 64.41 112.163 173.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -75.61 134.49 40.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 120.853 0.358 . . . . 73.41 111.259 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -93.39 172.87 8.01 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.746 0.818 . . . . 74.44 112.968 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -80.62 139.31 36.31 Favored 'General case' 0 C--O 1.193 -1.914 0 C-N-CA 123.707 0.803 . . . . 62.31 110.617 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -38.74 -38.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 N-CA-C 115.945 1.831 . . . . 74.25 115.945 -170.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.7 p -65.43 -49.41 69.26 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.864 0.466 . . . . 72.04 111.745 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 9.0 m-70 -127.93 69.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.88 -2.267 . . . . 64.14 104.88 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.62 ' HA ' HG12 ' A' ' 122' ' ' ILE . 27.8 mtpp -45.06 -152.15 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.386 1 C-N-CA 132.91 4.484 . . . . 70.14 120.844 58.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo 7.68 65.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.113 2.542 . . . . 70.54 116.153 -126.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.738 HG21 HD12 ' A' ' 93' ' ' LEU . 30.5 mm -80.0 77.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.094 0 CA-C-N 115.361 -0.836 . . . . 61.52 109.184 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -80.76 141.96 34.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.246 -0.433 . . . . 73.04 110.938 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -62.86 117.84 6.92 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.704 -0.68 . . . . 73.44 109.527 171.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -79.12 66.12 4.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.848 0.832 . . . . 63.04 110.31 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 167.99 -162.49 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 127.429 2.292 . . . . 70.53 108.46 -170.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 t -71.05 127.02 31.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.908 -0.495 . . . . 70.12 110.602 170.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -151.43 112.65 0.55 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 112.074 -0.411 . . . . 33.43 112.074 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.401 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 2.0 pp -77.84 156.06 80.21 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 123.733 0.813 . . . . 64.1 112.768 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.68 152.31 74.42 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.576 2.184 . . . . 73.2 112.5 169.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -83.62 155.32 32.04 Favored Glycine 0 N--CA 1.477 1.416 0 CA-C-O 120.219 -0.212 . . . . 63.35 113.228 176.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -108.7 104.2 1.94 Allowed Glycine 0 N--CA 1.475 1.265 0 CA-C-N 116.793 0.297 . . . . 75.1 112.873 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -76.5 79.98 3.2 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.982 0.513 . . . . 71.51 111.482 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -98.81 117.19 32.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.788 0.835 . . . . 72.41 110.703 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 45.0 ttm105 -80.46 115.94 20.25 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 123.442 0.697 . . . . 64.31 111.343 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.36 160.92 14.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.768 0.827 . . . . 75.25 111.345 174.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 62.0 mt -82.33 117.48 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 122.629 0.372 . . . . 60.14 110.834 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -85.82 -173.36 49.4 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-N 116.11 -0.496 . . . . 74.14 112.893 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 94.0 p -156.29 170.93 21.14 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.301 0.572 . . . . 64.55 112.116 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 71.1 m -135.25 94.55 3.14 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.776 0.83 . . . . 74.5 109.472 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.22 123.75 22.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.857 0.863 . . . . 72.14 111.808 -176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -131.63 134.55 46.11 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.489 0.715 . . . . 72.32 109.681 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.5 ttp180 -147.73 126.54 12.67 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.273 0.629 . . . . 71.54 109.957 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 73.9 m -83.35 147.98 27.6 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.781 0.832 . . . . 71.34 112.118 -176.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.0 m -95.57 146.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.51 0.724 . . . . 61.2 110.329 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -124.18 106.16 10.09 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.628 0.728 . . . . 71.13 111.159 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.01 171.67 13.98 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.213 1.005 . . . . 72.02 110.392 171.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -59.19 -45.13 91.87 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 114.897 1.443 . . . . 73.51 114.897 -169.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.0 m80 70.9 -27.53 0.17 Allowed 'General case' 0 N--CA 1.511 2.621 0 C-N-CA 125.115 1.366 . . . . 71.53 114.575 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -55.12 132.57 47.72 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.411 1.084 . . . . 75.24 112.929 -169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -107.82 179.15 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.275 1.03 . . . . 65.25 111.59 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -77.47 108.33 10.56 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.251 0.62 . . . . 73.41 110.548 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.803 0.811 . . . . 74.21 111.83 177.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.089 -0.338 . . . . 62.23 110.089 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -88.09 146.43 25.44 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.429 0.692 . . . . 73.5 110.742 -175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.1 t -70.24 166.71 19.48 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 122.997 0.519 . . . . 73.45 111.76 175.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 100' ' ' GLU . . . -62.42 -50.27 72.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.639 0.607 . . . . 42.4 112.639 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -70.47 -28.78 65.26 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 112.009 0.374 . . . . 72.13 112.009 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -63.55 -46.37 86.26 Favored 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 123.89 0.876 . . . . 31.14 111.256 173.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.507 HD11 HG13 ' A' ' 109' ' ' VAL . 60.5 mt -65.95 -38.46 88.67 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.722 0.809 . . . . 75.25 112.166 172.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 24.3 tp -59.17 -50.09 75.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.036 0.934 . . . . 75.22 110.399 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -57.47 -40.31 78.28 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.759 -1.109 . . . . 63.22 111.064 174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.83 -41.75 95.49 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.988 0.915 . . . . 74.34 111.843 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 8' ' ' LEU . 29.3 mt -60.3 -38.62 84.23 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.659 1.184 . . . . 72.34 112.149 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -80.17 -28.95 38.67 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.029 0.531 . . . . 71.15 111.864 175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -47.19 65.11 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.452 0.701 . . . . 54.13 111.949 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -79.3 154.8 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.131 0.572 . . . . 73.34 111.115 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -91.22 -20.61 21.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.011 0.924 . . . . 72.32 111.124 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.48 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 9.6 tp10 -140.85 134.75 30.56 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.604 1.162 . . . . 62.31 109.688 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -69.6 87.13 0.48 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.88 0.872 . . . . 64.3 110.456 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.06 -64.59 1.13 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.45 0.7 . . . . 73.21 112.488 -172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -107.38 -14.05 14.96 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.43 0.692 . . . . 61.41 110.207 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 mm -109.49 155.17 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.216 -1.031 . . . . 72.32 108.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.46 150.13 10.41 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.005 -0.739 . . . . 62.22 109.005 177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.87 144.87 46.13 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.029 0.532 . . . . 70.34 112.005 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 32' ' ' VAL . 74.9 mmtt -130.61 150.37 51.84 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.182 0.993 . . . . 31.44 110.076 175.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 54' ' ' VAL . 57.7 mtt-85 -85.63 165.16 17.24 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.734 0.814 . . . . 73.12 110.157 171.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.46 -30.85 68.81 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 120.879 0.371 . . . . 62.52 111.526 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.6 m -71.97 -19.25 61.92 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.649 0.78 . . . . 74.25 112.803 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -84.38 -4.99 59.22 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 112.527 0.565 . . . . 61.22 112.527 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.682 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.6 mmm -59.5 108.45 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.315 0.579 . . . . 63.3 111.313 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 142.14 -143.53 12.98 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 114.878 -1.055 . . . . 71.05 110.863 -171.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -52.57 -39.24 61.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.233 1.013 . . . . 71.05 113.253 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 m -59.13 -36.51 75.34 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.065 0.765 . . . . 62.44 113.065 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' A' ' 23' ' ' LYS . 44.2 t -72.52 -50.34 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 120.968 0.413 . . . . 75.05 110.385 171.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 88' ' ' MET . 91.3 mmm -57.45 -41.2 80.09 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.57 1.322 . . . . 75.43 114.57 -170.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -63.18 -34.24 77.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.157 0.583 . . . . 72.04 111.611 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.5 m -79.32 -28.48 42.13 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.758 0.823 . . . . 42.35 111.242 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.82 -40.55 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 123.48 0.712 . . . . 61.22 110.511 172.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.0 mt -60.96 -31.92 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-N 115.507 -0.769 . . . . 63.23 111.134 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 42' ' ' GLU . . . -60.08 -49.96 75.59 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.228 0.611 . . . . 74.32 112.178 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -81.28 -27.56 35.06 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.401 0.681 . . . . 72.1 111.657 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.66 -32.26 60.1 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.363 0.665 . . . . 62.32 112.275 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -92.57 -17.11 24.84 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.163 0.585 . . . . 72.52 111.525 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 13.1 tp10 -75.43 106.88 3.32 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 123.578 0.751 . . . . 73.23 112.367 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.07 106.12 2.21 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 123.142 2.561 . . . . 73.52 113.201 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.08 -7.1 40.63 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 114.87 0.708 . . . . 71.34 114.87 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -92.78 -52.43 4.62 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 118.203 1.002 . . . . 64.13 110.944 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 p30 36.93 -169.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 126.296 1.839 . . . . 75.45 115.378 -170.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.09 48.09 64.51 Favored Glycine 0 C--N 1.355 1.637 0 N-CA-C 116.012 1.165 . . . . 71.23 116.012 166.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -89.72 152.59 22.56 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.53 -0.628 . . . . 74.14 111.53 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -120.89 127.1 51.56 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.844 0.822 . . . . 63.21 112.074 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 97.2 mt -115.21 114.04 24.72 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.879 1.271 . . . . 44.25 108.59 173.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.14 109.06 20.66 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.508 -0.552 . . . . 65.05 109.508 -173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.749 HD12 HD23 ' A' ' 108' ' ' LEU . 29.9 mt -93.03 132.17 37.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.494 0.718 . . . . 73.01 110.533 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 36.64 4.43 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 121.298 0.388 . . . . 75.23 112.371 -177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' O ' ' HG2' ' A' ' 24' ' ' ARG . 43.1 t -115.53 143.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.537 0.735 . . . . 75.4 109.813 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -113.47 154.1 27.58 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.765 -1.198 . . . . 63.42 107.765 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 41.7 p90 -145.73 129.03 16.78 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.408 0.623 . . . . 75.31 112.005 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -126.74 135.61 51.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.835 0.854 . . . . 61.22 110.933 -176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.6 mt -83.7 123.52 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.737 0.815 . . . . 64.24 110.582 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 63' ' ' ASP . 29.5 p30 -82.5 -176.3 6.17 Favored 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.795 0.838 . . . . 74.15 112.08 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.77 -14.16 57.91 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.737 1.014 . . . . 64.12 113.737 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -86.8 -22.89 25.59 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.151 0.58 . . . . 64.22 112.021 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.64 23.4 16.05 Favored Glycine 0 N--CA 1.477 1.426 0 CA-C-N 116.576 -0.284 . . . . 34.23 112.512 -171.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HD21 ' A' ' 59' ' ' ASN . 23.4 t70 -107.74 132.71 53.09 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.263 1.025 . . . . 74.01 110.915 -176.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.5 m -89.09 119.03 29.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.806 0.842 . . . . 71.11 111.509 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 67.5 t -103.44 120.8 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 124.169 0.988 . . . . 75.22 110.704 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -94.19 130.69 40.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.271 1.028 . . . . 73.31 110.387 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.87 147.44 48.24 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.877 0.871 . . . . 74.04 110.485 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 83.2 Cg_endo -78.31 108.16 2.43 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 122.251 1.967 . . . . 64.32 114.534 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.6 m -91.1 -24.42 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 C-N-CA 122.968 0.507 . . . . 62.2 111.199 164.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 76.58 -170.12 54.95 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 114.81 0.684 . . . . 34.5 114.81 174.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.5 mt -121.57 124.24 27.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 C-N-CA 123.97 0.908 . . . . 53.43 109.979 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.97 -17.04 22.71 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.457 2.105 . . . . 61.15 113.023 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -134.38 59.77 38.97 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.404 1.081 . . . . 70.42 110.223 176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HB2' HD22 ' A' ' 99' ' ' LEU . 54.0 Cg_endo -62.06 -36.81 68.39 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.905 2.403 . . . . 73.34 114.265 -162.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -70.31 -39.27 74.92 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.472 0.709 . . . . 74.22 110.58 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -67.47 -36.3 80.88 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.979 0.511 . . . . 73.21 111.205 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.35 -45.6 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 123.474 0.71 . . . . 71.35 110.813 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.9 -49.77 74.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.808 0.843 . . . . 62.53 112.043 177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -67.32 -40.67 85.98 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.279 0.632 . . . . 64.43 111.578 -177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.9 -36.57 84.78 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.552 0.741 . . . . 65.4 110.389 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.56 HD23 ' SD ' ' A' ' 97' ' ' MET . 24.3 tp -67.78 -38.27 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.969 0.508 . . . . 72.12 111.282 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.67 90.58 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.99 0.516 . . . . 55.33 111.553 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.8 m -65.76 -48.31 72.28 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.639 0.776 . . . . 74.12 111.721 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -67.98 -30.36 69.61 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.797 0.439 . . . . 74.42 111.478 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 16.1 t -65.98 -19.91 66.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.899 -0.5 . . . . 65.33 112.292 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.49 -39.2 17.73 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.455 0.702 . . . . 40.1 112.016 170.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.1 m -85.93 -25.67 25.98 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.153 1.168 . . . . 33.01 114.153 -173.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.556 ' HG3' ' HG3' ' A' ' 33' ' ' MET . 85.7 mmm -81.91 -58.08 3.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.815 0.846 . . . . 72.34 110.085 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.98 146.55 37.39 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.352 -0.84 . . . . 63.0 111.138 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -50.84 -37.57 43.92 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.997 0.919 . . . . 63.33 113.051 177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.503 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.2 m -121.1 160.03 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.053 0.941 . . . . 71.32 110.713 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.29 105.34 7.29 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.085 0.554 . . . . 72.45 111.85 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 1.5 tt -93.24 137.19 32.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.28 -1.378 . . . . 63.45 107.28 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -98.83 104.73 26.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 C-N-CA 122.692 0.397 . . . . 62.33 110.131 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.68 119.38 5.69 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.303 1.335 . . . . 50.22 110.667 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 14.3 tp10 -71.65 98.74 1.97 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 115.373 -0.83 . . . . 72.14 109.826 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.716 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.1 mtm -116.73 127.16 54.11 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.311 0.644 . . . . 72.1 112.198 -169.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -132.9 128.67 37.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.303 1.041 . . . . 75.1 110.2 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.423 HD22 ' HB2' ' A' ' 74' ' ' PRO . 53.6 mt -81.91 132.14 35.26 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.167 0.987 . . . . 71.4 111.408 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 4' ' ' ALA . 11.4 mm-40 -128.38 128.46 44.55 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.162 0.985 . . . . 73.23 111.1 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.2 117.27 29.7 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.857 0.863 . . . . 73.44 110.986 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 77.2 t -132.98 117.42 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.565 1.146 . . . . 74.25 110.577 -172.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 52.3 28.54 27.66 Favored Glycine 0 CA--C 1.547 2.077 0 N-CA-C 116.443 1.337 . . . . 74.22 116.443 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -4.48 67.91 Favored Glycine 0 N--CA 1.484 1.852 0 CA-C-N 117.472 0.636 . . . . 53.22 114.179 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.483 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 0.1 OUTLIER -110.88 119.2 38.28 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.377 1.071 . . . . 52.52 110.074 -177.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.7 m -88.55 103.53 15.98 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.982 0.81 . . . . 53.13 110.576 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.0 mp -86.44 168.77 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.858 0.863 . . . . 72.32 110.717 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.749 HD23 HD12 ' A' ' 52' ' ' LEU . 60.1 tp -119.2 119.07 33.04 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.994 0.517 . . . . 73.43 110.577 176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.507 HG13 HD11 ' A' ' 7' ' ' LEU . 93.1 t -83.63 111.01 19.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 109.135 -0.691 . . . . 52.3 109.135 171.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 48.1 t -103.5 99.97 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-O 121.527 0.679 . . . . 75.53 110.177 177.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 58.2 t80 -79.05 119.16 21.79 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.145 0.978 . . . . 70.3 109.026 170.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.79 102.49 53.66 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.079 0.952 . . . . 64.1 108.774 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -73.96 165.48 31.98 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 121.942 1.761 . . . . 74.2 111.607 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -72.14 136.56 46.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.781 -0.822 . . . . 54.13 108.781 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -71.51 156.35 39.53 Favored 'General case' 0 CA--C 1.564 1.488 0 C-N-CA 123.451 0.7 . . . . 73.24 111.522 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -62.4 -175.61 0.08 Allowed 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 124.926 1.29 . . . . 63.3 111.601 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.94 -51.56 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.689 0 O-C-N 119.756 -1.84 . . . . 74.42 113.614 162.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 t -68.39 -49.94 56.49 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.363 0.529 . . . . 53.5 111.468 -172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 8.5 m-70 -117.94 84.65 2.21 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 101.341 -3.577 . . . . 73.11 101.341 165.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.686 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.256 36.2 mtmm -48.79 -140.77 0.0 OUTLIER Pre-proline 0 CA--C 1.577 1.986 1 C-N-CA 133.664 4.786 . . . . 70.14 121.204 50.908 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo 10.16 62.93 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.947 0 C-N-CA 124.207 3.272 . . . . 51.1 116.136 -121.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.686 HG12 ' HA ' ' A' ' 120' ' ' LYS . 48.5 mm -76.78 116.42 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.994 0.918 . . . . 73.24 110.344 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -150.52 144.19 25.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.906 0.483 . . . . 73.24 110.16 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -77.07 128.14 33.93 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.912 0.387 . . . . 73.41 110.288 171.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -71.01 -7.71 48.23 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 123.924 0.89 . . . . 75.22 111.827 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.96 169.73 16.85 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.076 0.95 . . . . 61.21 111.41 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.7 p -70.3 151.62 45.08 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.336 0.655 . . . . 64.32 112.672 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.15 164.83 29.88 Favored Glycine 0 CA--C 1.535 1.33 0 CA-C-N 115.587 -0.733 . . . . 64.04 114.151 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -71.12 159.77 84.56 Favored Pre-proline 0 CA--C 1.574 1.898 0 C-N-CA 124.426 1.09 . . . . 75.41 112.384 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -77.33 -171.17 1.09 Allowed 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.74 2.293 . . . . 62.1 112.973 170.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.61 161.06 12.87 Favored Glycine 0 CA--C 1.539 1.532 0 CA-C-N 116.662 -0.245 . . . . 72.13 113.696 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -144.74 134.73 5.76 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.706 0.67 . . . . 75.4 111.596 176.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.96 157.35 15.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.229 0.612 . . . . 73.44 111.678 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -91.63 142.68 27.36 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 120.863 0.363 . . . . 73.52 111.423 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 12.6 mmm-85 -102.74 112.28 24.99 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.041 0.936 . . . . 61.12 110.417 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.48 ' NH2' ' HB3' ' A' ' 16' ' ' GLU . 67.3 mtt180 -108.81 159.87 16.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.686 0.794 . . . . 72.44 112.456 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.7 mm -103.63 131.13 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.927 0.891 . . . . 73.23 109.901 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.19 157.82 15.13 Favored Glycine 0 N--CA 1.481 1.658 0 N-CA-C 113.86 0.304 . . . . 61.01 113.86 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.8 m -92.2 115.7 28.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.876 0.87 . . . . 74.41 111.09 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 85.1 p -96.78 12.72 31.05 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.33 0.652 . . . . 75.45 112.464 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -71.85 114.75 10.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.957 0.503 . . . . 61.33 111.42 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -120.45 121.93 39.59 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.367 1.067 . . . . 73.11 109.425 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.77 161.68 27.92 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 112.468 0.544 . . . . 73.24 112.468 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 147' ' ' GLU . 45.3 t -79.18 138.45 37.86 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.336 0.655 . . . . 73.02 112.326 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.42 162.99 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.414 1.085 . . . . 74.33 110.173 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.3 mt 57.64 28.69 16.09 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 124.244 1.017 . . . . 75.54 112.564 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.518 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . 8.3 pt-20 -79.79 89.58 5.23 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 124.091 0.957 . . . . 74.11 112.216 -174.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.2 p80 34.78 79.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 126.164 1.786 . . . . 73.32 114.525 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -86.07 12.59 9.24 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.215 0.606 . . . . 72.43 111.215 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.33 116.92 5.46 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.75 1.22 . . . . 75.3 111.976 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -125.02 130.66 52.78 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.228 1.011 . . . . 65.42 109.761 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -129.94 120.31 24.64 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.637 0.775 . . . . 74.23 109.921 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.663 0.744 . . . . 65.2 111.973 178.47 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 46.0 ttm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.788 0.328 . . . . 74.41 111.565 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.626 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.0 mmm180 -95.44 157.57 15.84 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.402 1.081 . . . . 71.31 111.037 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -77.45 152.35 34.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.908 0.707 . . . . 62.32 112.908 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.88 -53.05 54.67 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.505 1.122 . . . . 73.12 113.183 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HG11 ' A' ' 102' ' ' VAL . 2.9 t -62.35 -41.5 98.65 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.234 0.613 . . . . 74.31 112.621 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -55.16 -45.31 75.69 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.495 1.118 . . . . 33.53 111.68 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 2' ' ' ARG . 47.3 mt -73.68 -33.27 64.36 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.306 1.042 . . . . 72.01 112.749 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.4 tp -67.36 -31.36 71.56 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.271 0.628 . . . . 63.53 110.587 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -60.49 -30.68 69.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.863 0.865 . . . . 44.2 112.802 174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.2 tt0 -60.85 -52.94 62.95 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.875 -0.417 . . . . 74.23 109.875 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -72.71 -27.46 62.08 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.836 0.854 . . . . 73.35 112.914 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.66 -11.1 60.67 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.214 0.605 . . . . 74.45 111.847 170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 -36.11 8.24 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 123.839 0.856 . . . . 73.21 111.948 172.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 10' ' ' GLU . 29.5 m -117.54 117.54 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 123.616 0.767 . . . . 75.43 111.241 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -56.84 -44.49 82.16 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.684 1.193 . . . . 74.23 111.1 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -84.77 149.57 25.66 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.982 0.913 . . . . 61.35 110.601 170.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 66.1 m -87.24 129.64 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 122.867 0.467 . . . . 75.53 111.982 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.46 -64.94 1.0 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.833 0.453 . . . . 71.45 111.32 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.57 -14.68 9.08 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.569 0.747 . . . . 73.21 112.013 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 49' ' ' TYR . 18.8 mm -113.87 142.99 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 118.193 0.452 . . . . 73.01 110.649 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 3.7 mm-40 -128.27 112.6 14.65 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.365 0.666 . . . . 61.14 110.632 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.29 118.2 30.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.314 0.645 . . . . 51.41 109.843 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HG3' HG22 ' A' ' 32' ' ' VAL . 73.6 mmtt -124.11 142.95 50.76 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.848 0.859 . . . . 64.23 110.632 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -89.56 174.76 7.59 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.548 0.739 . . . . 71.01 110.714 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.85 -37.85 71.85 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.131 0.572 . . . . 63.45 112.21 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.5 m -60.45 -23.56 64.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.162 1.171 . . . . 74.23 114.162 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -88.13 -13.72 40.59 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 113.381 0.882 . . . . 72.01 113.381 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.512 ' SD ' HG13 ' A' ' 77' ' ' VAL . 84.4 mtp -58.3 109.16 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.056 0.542 . . . . 75.23 112.24 -176.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.01 -122.46 1.18 Allowed Glycine 0 C--N 1.344 0.988 0 CA-C-N 116.136 -0.483 . . . . 43.01 112.326 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.47 -46.55 63.55 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.518 0.727 . . . . 75.04 111.57 -173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 52.6 m -63.86 -37.4 87.26 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.611 0.764 . . . . 61.21 112.369 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' A' ' 23' ' ' LYS . 87.5 t -67.69 -42.33 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.847 0.459 . . . . 74.01 111.192 172.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.491 ' SD ' HD21 ' A' ' 89' ' ' LEU . 36.2 tpp -67.6 -47.31 70.07 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.75 0.648 . . . . 73.24 112.75 -175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.31 -27.24 66.13 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.773 0.829 . . . . 62.11 113.041 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.46 HG23 HD21 ' A' ' 50' ' ' LEU . 14.7 t -78.22 -29.13 48.16 Favored 'General case' 0 CA--C 1.561 1.382 0 O-C-N 121.615 -0.678 . . . . 73.03 111.91 174.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.08 -43.21 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 123.055 0.542 . . . . 74.21 109.569 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 122' ' ' ILE . 48.4 mt -53.73 -45.21 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.203 1.001 . . . . 75.42 111.078 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.71 -46.35 90.72 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.855 0.462 . . . . 50.3 111.611 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -66.07 -38.88 89.42 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 122.923 0.489 . . . . 71.25 111.726 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.53 -30.76 69.64 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.543 0.737 . . . . 64.31 112.721 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -105.63 17.13 24.29 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.024 0.75 . . . . 54.43 113.024 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -108.25 89.19 5.53 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 122.821 0.449 . . . . 73.33 110.53 168.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.07 118.92 5.96 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.302 2.001 . . . . 71.35 112.132 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.82 -12.52 32.29 Favored Glycine 0 N--CA 1.477 1.406 0 CA-C-N 115.547 -0.751 . . . . 71.4 113.216 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 tt -110.25 -7.56 14.83 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.474 0.71 . . . . 75.4 109.754 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -42.87 132.08 3.96 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.923 1.289 . . . . 63.32 113.845 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.89 37.64 2.16 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.831 -0.622 . . . . 41.32 111.747 -168.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.82 152.67 20.38 Favored Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.698 -0.561 . . . . 71.12 111.698 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.505 ' HB2' HD12 ' A' ' 20' ' ' ILE . 98.2 m-85 -120.69 148.74 43.54 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.768 0.784 . . . . 72.32 112.303 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 6.2 mp -119.93 130.96 55.05 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.893 0.877 . . . . 75.14 109.69 170.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -104.05 109.47 21.27 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.568 0.747 . . . . 70.33 109.752 176.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD12 HD23 ' A' ' 108' ' ' LEU . 63.5 mt -92.07 127.56 37.58 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.938 -0.393 . . . . 72.42 109.938 175.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.93 30.86 4.07 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 115.9 -0.591 . . . . 63.04 112.604 -178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.25 133.35 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.252 0.621 . . . . 74.31 110.365 176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -106.81 176.84 5.04 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.688 -1.227 . . . . 74.43 107.688 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 10.0 p90 -157.05 144.67 19.0 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.566 -0.709 . . . . 64.41 112.454 -178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -119.71 128.29 53.66 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.281 1.032 . . . . 72.03 110.294 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.6 mm -82.62 123.14 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 122.9 0.48 . . . . 64.22 111.049 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -65.28 154.54 37.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.897 0.879 . . . . 72.25 110.185 169.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.37 0.26 20.16 Favored 'General case' 0 CA--C 1.559 1.289 0 O-C-N 121.997 -0.44 . . . . 70.51 111.8 177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -96.71 3.51 52.37 Favored 'General case' 0 CA--C 1.566 1.564 0 C-N-CA 123.87 0.868 . . . . 53.45 111.494 166.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.11 -17.56 57.88 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 115.576 0.991 . . . . 71.24 115.576 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.61 148.38 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.105 0.779 . . . . 73.12 113.105 -174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.8 m -96.72 128.29 43.52 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.354 0.662 . . . . 60.12 111.088 -177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.1 119.15 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 N-CA-C 108.781 -0.822 . . . . 75.32 108.781 176.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -93.74 113.43 25.49 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.679 0.752 . . . . 72.25 110.382 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -111.17 145.1 31.8 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.541 1.136 . . . . 72.31 110.143 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 88.6 Cg_endo -96.2 109.31 0.11 Allowed 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.371 2.047 . . . . 63.44 113.869 172.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.8 -11.65 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.66 -0.65 . . . . 71.25 111.142 161.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.6 -167.54 54.34 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.466 0.481 . . . . 64.12 113.61 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 HG21 ' A' ' 77' ' ' VAL . 95.2 mt -99.74 131.43 24.65 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.113 0.965 . . . . 72.24 110.838 -179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.24 -37.51 61.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.329 2.019 . . . . 74.21 111.218 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.502 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 10.8 m-20 -130.52 86.05 54.34 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 124.004 0.921 . . . . 74.42 109.374 175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.49 -37.34 89.92 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.562 2.841 . . . . 74.04 114.319 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -64.97 -53.42 46.57 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.009 -0.996 . . . . 65.02 110.92 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 73' ' ' ASP . 67.4 mmtt -64.46 -49.08 72.82 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.264 0.626 . . . . 54.55 112.064 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.512 HG13 ' SD ' ' A' ' 28' ' ' MET . 95.3 t -56.51 -40.94 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.709 0.803 . . . . 61.33 112.329 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -62.41 -46.12 90.02 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.414 0.686 . . . . 71.5 112.004 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -72.66 -44.7 61.51 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.738 0.815 . . . . 73.35 112.212 -173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -63.02 -33.25 75.02 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.604 0.762 . . . . 71.45 111.926 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -66.76 -45.11 79.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 120.656 0.265 . . . . 72.23 110.973 174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.09 89.81 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.335 0.654 . . . . 71.22 111.86 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.0 t -64.34 -53.04 54.9 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.107 0.963 . . . . 70.24 111.028 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.29 -33.42 75.26 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 116.072 -0.513 . . . . 74.03 112.017 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.4 t -57.4 -29.22 63.92 Favored 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 118.486 0.585 . . . . 74.45 112.412 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.26 -42.65 13.59 Favored 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.679 0.792 . . . . 65.03 111.341 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -69.33 -28.52 66.31 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 113.975 1.102 . . . . 71.14 113.975 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.489 ' SD ' ' HD2' ' A' ' 124' ' ' LYS . 14.0 mmt -80.25 -60.94 2.14 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.313 0.645 . . . . 53.53 111.769 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.491 HD21 ' SD ' ' A' ' 33' ' ' MET . 22.7 mt -81.93 159.9 23.5 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 115.388 -0.823 . . . . 61.13 112.796 -161.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.616 HD21 ' HA ' ' A' ' 122' ' ' ILE . 6.1 p30 -50.65 -52.26 41.46 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 113.036 0.754 . . . . 75.33 113.036 176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.5 m -107.47 171.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.303 0.573 . . . . 73.41 111.441 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.65 99.6 5.09 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.496 -0.775 . . . . 65.43 110.062 170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.442 HD12 HG21 ' A' ' 122' ' ' ILE . 3.9 tt -84.53 127.05 33.83 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.593 -1.262 . . . . 73.3 107.593 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.51 94.29 15.91 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 123.391 0.677 . . . . 74.44 110.583 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -80.01 162.09 23.53 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.531 2.154 . . . . 74.3 111.692 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.693 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.6 tp10 -95.75 128.81 42.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 175.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HB3' HD11 ' A' ' 108' ' ' LEU . 62.5 mtt -126.29 114.12 17.85 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.017 0.527 . . . . 72.41 110.277 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -124.15 133.69 53.51 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.568 0.747 . . . . 72.23 111.008 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.13 125.06 41.36 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.007 0.923 . . . . 75.5 110.41 177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -135.27 146.09 48.21 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.481 0.713 . . . . 63.04 111.156 -176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -101.21 117.38 34.87 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.23 0.538 . . . . 71.23 110.739 177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 ' HB ' ' A' ' 5' ' ' THR . 88.3 t -126.63 120.08 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.149 1.38 . . . . 73.4 108.375 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.54 29.19 60.57 Favored Glycine 0 CA--C 1.541 1.678 0 N-CA-C 114.109 0.404 . . . . 33.04 114.109 -170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.96 1.92 88.03 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 114.152 0.421 . . . . 70.52 114.152 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.2 mmtt -103.01 134.88 45.71 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.918 0.887 . . . . 74.23 109.928 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.2 m -96.98 123.27 40.65 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.779 0.718 . . . . 64.42 111.289 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 68' ' ' PRO . 6.7 mp -113.58 161.5 17.34 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.52 0.728 . . . . 72.04 109.198 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 97' ' ' MET . 35.9 tp -114.89 111.51 21.3 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.469 -0.567 . . . . 72.3 109.469 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.2 t -84.76 122.27 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.219 -0.66 . . . . 75.13 109.219 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 37.3 t -113.2 99.97 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.458 0.703 . . . . 73.02 110.039 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.693 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 56.8 t80 -84.08 119.61 25.17 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.037 0.935 . . . . 71.35 110.555 179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.1 t -105.42 100.97 28.85 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.931 0.893 . . . . 70.41 109.175 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.45 176.28 10.17 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.603 2.202 . . . . 71.41 112.356 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.22 156.78 24.38 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.679 0.752 . . . . 73.52 112.934 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -124.34 141.48 52.04 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.145 0.978 . . . . 71.25 109.898 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -76.24 150.51 37.03 Favored 'General case' 0 C--O 1.183 -2.4 0 C-N-CA 124.27 1.028 . . . . 63.11 110.933 -172.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.0 t -38.72 -37.83 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 N-CA-C 115.933 1.827 . . . . 72.22 115.933 -173.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.9 t -78.36 -39.57 38.89 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 112.909 0.707 . . . . 72.42 112.909 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.597 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 3.6 p-80 -136.88 77.31 1.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 106.745 -1.576 . . . . 54.22 106.745 171.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.727 ' HA ' HG12 ' A' ' 122' ' ' ILE 0.263 14.1 ptmm? -51.48 -152.48 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.35 2 C-N-CA 132.81 4.444 . . . . 72.32 122.097 46.338 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo 14.4 62.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.831 0 O-C-N 117.239 -2.032 . . . . 72.05 115.844 -123.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.727 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.9 mm -75.67 95.72 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 114.401 -1.272 . . . . 72.53 109.451 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.428 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.3 p90 -110.53 155.18 22.65 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.928 0.491 . . . . 74.55 109.876 169.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' HD2' ' SD ' ' A' ' 88' ' ' MET . 5.7 ttpm? -75.31 136.67 40.86 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.86 -0.792 . . . . 74.31 108.86 169.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -56.1 -40.95 74.45 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.038 0.535 . . . . 75.04 111.002 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.418 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . . . -77.19 141.83 39.9 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.031 0.533 . . . . 54.24 109.863 165.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -58.63 145.44 39.67 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 113.488 0.922 . . . . 74.43 113.488 -173.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -142.18 -106.82 0.61 Allowed Glycine 0 N--CA 1.478 1.481 0 CA-C-N 116.333 -0.394 . . . . 74.4 113.301 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.79 130.41 67.39 Favored Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 123.208 0.603 . . . . 74.41 111.568 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.69 138.59 64.9 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.761 2.307 . . . . 61.44 112.819 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.3 84.62 0.61 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 116.799 -0.182 . . . . 65.32 112.656 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.43 -113.84 0.37 Allowed Glycine 0 CA--C 1.54 1.61 0 N-CA-C 113.939 0.335 . . . . 70.33 113.939 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -145.36 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.532 0.733 . . . . 72.15 111.798 -174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -84.21 136.41 33.96 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.653 0.781 . . . . 75.14 111.041 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.54 129.14 34.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.138 0.975 . . . . 73.12 110.982 -173.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -93.33 96.12 9.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.589 0.756 . . . . 63.11 110.555 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tt -158.58 116.98 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 C-N-CA 123.516 0.726 . . . . 42.4 111.11 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.17 105.47 1.58 Allowed Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.315 -0.402 . . . . 70.11 112.767 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 36.2 t -127.89 117.72 22.3 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.639 0.776 . . . . 74.52 110.852 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 87.7 p -83.97 156.59 22.23 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.064 0.546 . . . . 62.15 110.829 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -146.51 161.87 39.53 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.407 0.622 . . . . 72.32 111.967 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -96.99 43.03 1.08 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.614 0.766 . . . . 74.4 111.486 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -75.53 135.04 40.62 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 72.43 110.907 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 25.7 p -120.88 154.47 35.81 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.589 0.756 . . . . 62.24 110.547 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.6 143.69 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 123.27 0.628 . . . . 73.55 111.402 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 53.1 tp -141.84 119.41 11.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.276 1.031 . . . . 71.43 109.024 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.1 123.31 20.3 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.993 0.517 . . . . 75.45 111.603 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -76.86 94.77 3.95 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 106.956 -1.498 . . . . 70.04 106.956 164.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -66.07 100.64 0.61 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.329 0.652 . . . . 62.33 112.181 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -68.02 123.66 21.25 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.456 1.103 . . . . 71.23 110.652 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -65.06 125.12 23.94 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.569 0.348 . . . . 72.25 110.986 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 59.6 t60 -110.59 137.06 48.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.214 0.606 . . . . 62.12 111.054 -170.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 68.3 m80 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 123.895 0.878 . . . . 74.13 111.346 178.529 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.429 ' HG2' ' HG3' ' A' ' 98' ' ' GLN . 10.3 tpt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.919 -0.4 . . . . 63.32 109.919 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -85.73 123.43 31.1 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.149 0.58 . . . . 75.53 110.607 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 t -59.47 153.71 18.78 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.103 0.961 . . . . 75.2 112.718 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.65 -41.82 74.17 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.653 0.781 . . . . 62.3 112.642 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 m -65.11 -40.76 94.96 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.615 0.766 . . . . 70.22 110.931 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.78 -37.53 87.92 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.002 0.921 . . . . 70.43 112.239 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD11 HG13 ' A' ' 109' ' ' VAL . 68.8 mt -63.0 -41.66 99.64 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.124 0.569 . . . . 74.52 111.829 175.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.89 -32.38 69.46 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 61.02 112.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -61.14 -40.61 94.48 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.072 0.549 . . . . 72.03 111.553 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.439 ' O ' HG22 ' A' ' 14' ' ' VAL . 34.6 tt0 -72.61 -50.16 27.16 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 110.319 -0.252 . . . . 72.13 110.319 176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -49.44 -55.78 11.97 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.505 1.122 . . . . 55.33 113.119 -175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -68.49 -20.78 64.61 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 113.445 0.906 . . . . 75.13 113.445 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.32 -29.0 15.87 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.232 0.827 . . . . 73.25 113.232 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 10' ' ' GLU . 23.0 m -111.76 128.14 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 112.59 0.589 . . . . 72.51 112.59 -172.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -58.82 -20.93 54.85 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.963 0.905 . . . . 75.31 113.334 164.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -124.49 98.83 5.91 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.547 0.739 . . . . 64.52 110.392 -177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.3 p -75.7 94.66 3.28 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.563 0.745 . . . . 75.54 109.831 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.06 -63.81 0.99 Allowed 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.373 0.879 . . . . 42.02 113.373 -167.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.548 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -121.55 6.96 10.03 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.11 0.564 . . . . 72.13 112.1 179.35 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.1 mt -116.6 112.81 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.155 -0.683 . . . . 53.23 109.155 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.99 115.97 22.09 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.969 -0.382 . . . . 72.54 109.969 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.75 131.61 37.0 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.652 0.781 . . . . 72.53 111.97 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 62.3 mttm -130.0 151.64 50.33 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.097 0.959 . . . . 71.01 110.678 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -90.06 170.73 10.08 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.085 0.554 . . . . 74.03 111.085 167.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.69 -30.38 70.7 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.406 0.682 . . . . 64.44 111.659 173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.2 p -60.6 -30.16 69.65 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.902 0.881 . . . . 63.35 112.88 171.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -86.89 -2.5 58.64 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.272 0.629 . . . . 73.13 112.646 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.2 tpt -63.83 123.06 17.97 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.795 0.838 . . . . 75.43 112.293 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 147.75 -135.76 5.73 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.644 -0.253 . . . . 64.51 113.116 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -31.19 70.57 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 123.579 0.752 . . . . 63.54 111.337 -178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.4 m -62.8 -31.21 72.14 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.499 0.72 . . . . 64.2 111.955 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.594 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 25.9 t -73.36 -44.06 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 120.909 0.385 . . . . 72.14 110.996 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.566 ' SD ' HD21 ' A' ' 89' ' ' LEU . 38.1 tpp -62.51 -50.47 71.26 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 115.212 -0.903 . . . . 72.25 113.076 -170.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -27.4 69.17 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.924 0.49 . . . . 72.4 112.287 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.9 m -70.54 -40.32 73.48 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.002 0.521 . . . . 52.43 110.858 173.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.16 -43.79 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 123.497 0.719 . . . . 72.31 110.665 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.1 mt -59.97 -37.54 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.363 0.665 . . . . 74.44 110.735 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.35 -48.41 79.9 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.546 0.738 . . . . 62.43 112.456 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -71.95 -32.45 67.31 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 120.698 0.285 . . . . 75.13 111.566 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . . . -76.07 -25.68 55.77 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.317 0.647 . . . . 64.03 112.563 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.75 -33.46 12.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.304 0.642 . . . . 74.1 112.161 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 45.5 mm-40 -67.52 127.16 93.37 Favored Pre-proline 0 CA--C 1.563 1.479 0 O-C-N 122.07 -0.394 . . . . 72.01 111.927 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 40.7 Cg_exo -58.03 109.94 0.56 Allowed 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 123.639 2.893 . . . . 75.23 114.747 -173.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.79 26.23 67.64 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.882 0.713 . . . . 64.12 114.882 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.66 13.1 35.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 118.819 1.309 . . . . 74.42 112.295 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 8.0 p-10 -51.47 116.54 2.13 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.132 0.573 . . . . 71.34 110.884 167.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 120.62 36.18 0.8 Allowed Glycine 0 N--CA 1.47 0.957 0 CA-C-N 115.931 -0.577 . . . . 41.32 112.117 -169.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -111.79 127.25 8.03 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 110.77 -0.932 . . . . 52.32 110.77 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -115.08 125.82 53.96 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 117.282 0.541 . . . . 54.22 110.819 -171.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.0 mp -94.89 121.78 36.85 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.345 -0.983 . . . . 63.04 108.345 172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.52 108.71 20.08 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.53 0.681 . . . . 63.34 110.256 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.627 ' HB3' HD21 ' A' ' 71' ' ' LEU . 3.5 mm? -91.65 132.19 36.52 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.192 0.997 . . . . 72.31 110.357 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.65 32.07 4.63 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 116.048 -0.524 . . . . 73.41 112.966 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.3 133.99 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 122.976 0.511 . . . . 60.31 110.181 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -115.44 129.07 56.44 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.223 -1.399 . . . . 70.53 107.223 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -110.9 129.6 55.83 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-O 121.173 0.511 . . . . 73.41 111.702 -174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -114.73 135.51 54.08 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.287 1.035 . . . . 73.33 110.334 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.5 mm -96.2 126.76 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.292 0.637 . . . . 74.11 110.476 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 63' ' ' ASP . 30.9 p30 -87.95 -174.1 4.56 Favored 'General case' 0 CA--C 1.56 1.346 0 C-N-CA 123.526 0.73 . . . . 52.54 111.61 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.92 -22.98 67.17 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.654 0.782 . . . . 72.43 112.621 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HE3' ' H ' ' A' ' 142' ' ' GLN . 14.3 mmmm -74.11 -23.4 59.31 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.903 0.881 . . . . 73.41 112.535 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.74 78.64 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.625 -0.261 . . . . 75.15 112.722 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' HD21 ' A' ' 59' ' ' ASN . 26.0 t70 -75.03 142.41 43.79 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.617 1.167 . . . . 71.23 111.278 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.3 m -93.95 108.85 20.61 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.693 0.797 . . . . 74.41 110.335 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -100.76 121.81 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 123.625 0.77 . . . . 70.23 109.757 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -92.08 127.34 37.52 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.404 0.682 . . . . 74.05 110.225 -175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -123.11 120.89 27.26 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.809 0.844 . . . . 75.44 110.458 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.13 90.31 0.66 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.575 2.183 . . . . 60.14 112.761 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -90.95 -12.18 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.289 0.636 . . . . 62.03 112.015 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.63 179.03 44.36 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 116.234 -0.439 . . . . 53.23 113.627 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 52' ' ' LEU . 3.5 mp -105.18 139.94 20.62 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 109.686 -0.487 . . . . 61.05 109.686 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.25 -30.17 25.1 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.137 1.891 . . . . 64.42 112.056 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -131.62 71.1 81.27 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 123.856 0.863 . . . . 75.24 110.226 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -72.69 -24.94 17.83 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.914 2.409 . . . . 74.21 112.764 -174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.17 -45.3 77.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 74.13 110.044 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 7.9 mtpm? -61.39 -53.89 50.79 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.708 -0.678 . . . . 63.22 111.198 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.5 t -59.2 -35.32 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.571 0.749 . . . . 52.12 112.103 -172.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.509 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 54.2 tt0 -63.81 -46.09 86.68 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 120.99 0.424 . . . . 74.23 111.5 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 24.2 mtp180 -70.29 -47.61 60.45 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.566 0.746 . . . . 55.2 112.07 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -64.82 -34.55 78.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.195 0.998 . . . . 53.21 111.409 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.4 tp -71.32 -41.47 69.81 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.647 0.379 . . . . 72.55 111.276 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.06 -37.2 86.79 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.192 0.597 . . . . 72.31 111.297 174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.2 t -65.4 -52.19 55.15 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.938 0.895 . . . . 72.41 111.191 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -68.32 -29.57 68.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.731 0.412 . . . . 73.52 111.596 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 45.5 t -60.27 -27.4 67.24 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.74 -0.6 . . . . 74.11 112.043 176.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.11 -49.61 6.3 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.161 0.584 . . . . 60.23 111.825 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 t -68.7 -32.14 71.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.372 0.879 . . . . 43.21 113.372 -173.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.427 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 5.7 mmt -78.93 -48.15 15.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.368 0.667 . . . . 63.41 111.366 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD21 ' SD ' ' A' ' 33' ' ' MET . 31.0 mt -88.39 151.4 22.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.688 0.625 . . . . 71.23 112.688 -166.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -55.27 -58.62 6.96 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 125.138 1.375 . . . . 70.11 112.369 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' HB3' ' A' ' 119' ' ' HIS . 43.1 t -102.36 146.63 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.621 0.769 . . . . 74.12 109.535 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.27 97.23 0.71 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.41 0.624 . . . . 63.15 110.822 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.474 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.5 tt -81.75 136.72 35.43 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.146 -1.057 . . . . 44.51 108.146 177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -107.16 91.16 6.28 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 123.246 0.619 . . . . 73.22 109.948 177.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.71 118.61 4.21 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.135 1.89 . . . . 70.31 111.583 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 37.5 tt0 -73.44 109.24 6.8 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 74.22 109.084 -179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.509 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 66.7 mtt -116.39 133.21 56.27 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.132 0.573 . . . . 74.43 111.747 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.429 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 15.1 mm100 -134.75 139.61 45.3 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.251 1.021 . . . . 75.44 110.471 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.7 mt -104.85 113.05 26.41 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.175 0.99 . . . . 73.04 110.946 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -118.01 136.48 53.5 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.224 1.009 . . . . 54.32 110.147 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -92.44 118.7 31.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.557 0.343 . . . . 73.32 110.313 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -115.16 113.99 45.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.861 0.864 . . . . 63.4 108.925 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.8 29.49 67.53 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 114.804 0.682 . . . . 62.45 114.804 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.69 79.95 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 114.507 0.563 . . . . 73.13 114.507 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -110.34 136.43 49.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.995 0.918 . . . . 53.1 110.19 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.3 m -87.77 120.97 29.62 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 118.701 0.682 . . . . 74.45 110.903 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.5 mp -116.36 156.46 26.67 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.856 0.862 . . . . 64.3 109.813 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 52.5 tp -115.75 121.57 42.86 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.097 0.559 . . . . 74.22 110.117 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.62 HG13 HD11 ' A' ' 7' ' ' LEU . 51.3 t -99.05 121.79 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.532 0.733 . . . . 73.24 109.153 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.4 t -111.39 101.38 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 122.957 0.503 . . . . 70.51 110.36 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.65 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 77.6 t80 -73.33 122.7 22.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.321 0.648 . . . . 74.34 109.826 170.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.2 t -102.65 110.51 63.3 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.371 0.668 . . . . 45.45 109.771 174.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.13 145.84 24.88 Favored 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.308 2.005 . . . . 74.22 112.235 169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 42.7 tt0 -74.27 145.0 44.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.159 -0.682 . . . . 74.33 109.159 169.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -84.96 173.83 10.25 Favored 'General case' 0 CA--C 1.565 1.544 0 C-N-CA 123.239 0.616 . . . . 64.1 111.691 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.97 176.87 0.64 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 124.829 1.251 . . . . 75.15 111.044 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.8 t -57.89 -56.17 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.714 -1.241 . . . . 63.02 114.117 167.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t -82.72 -41.45 19.26 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.354 0.525 . . . . 74.22 111.379 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.66 ' HB3' HG21 ' A' ' 91' ' ' VAL . 19.1 m-70 -104.7 73.65 1.1 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 103.734 -2.691 . . . . 74.01 103.734 162.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.5 mttt -46.87 -139.08 0.0 OUTLIER Pre-proline 0 CA--C 1.572 1.8 1 C-N-CA 133.526 4.73 . . . . 73.02 121.301 53.163 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo 6.43 67.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 124.592 3.528 . . . . 54.35 116.225 -122.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 120' ' ' LYS . 23.5 mm -76.72 80.7 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-N 115.287 -0.87 . . . . 51.42 109.595 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -82.95 152.97 25.26 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.923 0.392 . . . . 65.05 110.224 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -89.89 155.72 18.95 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 109.439 -0.578 . . . . 71.01 109.439 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 88' ' ' MET . 73.8 mmtt -73.02 -2.0 19.43 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.863 0.865 . . . . 64.4 112.44 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -140.7 -178.3 5.46 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.399 1.08 . . . . 32.43 111.111 176.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.3 t -74.91 158.06 33.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 123.638 0.775 . . . . 54.22 112.012 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -112.08 -82.84 1.25 Allowed Glycine 0 N--CA 1.477 1.37 0 CA-C-O 120.153 -0.248 . . . . 75.22 113.459 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 tt 59.4 82.12 0.24 Allowed Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 124.757 1.223 . . . . 73.51 110.393 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -76.88 168.92 22.64 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.847 2.364 . . . . 73.54 112.799 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.56 162.33 30.4 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 116.043 -0.526 . . . . 73.32 113.751 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.67 -172.65 37.9 Favored Glycine 0 N--CA 1.478 1.465 0 C-N-CA 122.662 0.172 . . . . 71.23 113.087 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.6 169.23 18.21 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.133 0.492 . . . . 70.43 111.967 176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -125.91 172.74 9.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.73 0.812 . . . . 74.13 109.74 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -62.03 108.78 1.11 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.273 0.559 . . . . 71.13 110.835 171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -96.38 8.09 44.85 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.215 1.006 . . . . 73.22 111.194 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.9 mt -99.43 132.6 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.517 1.127 . . . . 74.34 111.02 -172.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.41 170.32 33.91 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.478 -0.328 . . . . 61.44 113.304 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.7 p -93.05 -61.52 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.526 0.731 . . . . 52.54 111.546 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 t -154.59 134.63 13.08 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.219 0.608 . . . . 75.44 111.426 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.82 92.42 8.24 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.375 0.67 . . . . 74.31 111.001 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.513 ' H ' ' HE3' ' A' ' 61' ' ' LYS . 13.2 mm100 -74.14 155.72 38.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.552 -0.749 . . . . 70.4 110.871 171.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.75 143.79 26.16 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.486 0.314 . . . . 65.44 110.826 -178.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 80.4 m -73.16 86.75 1.4 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.28 0.562 . . . . 71.21 110.615 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.5 p -80.63 139.95 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 C-N-CA 123.484 0.714 . . . . 75.11 111.246 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -140.86 157.01 45.98 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.691 0.796 . . . . 71.23 110.113 176.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.29 153.93 31.36 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.009 0.524 . . . . 62.25 110.977 174.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -154.42 107.7 2.88 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.659 0.784 . . . . 73.41 108.906 174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -70.66 85.44 0.64 Allowed 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.937 0.875 . . . . 64.52 112.216 -173.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -73.07 129.9 39.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.175 -1.375 . . . . 61.42 110.034 174.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -80.08 178.86 7.94 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.525 0.73 . . . . 45.22 111.278 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -103.9 146.83 28.1 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.005 0.522 . . . . 75.42 111.867 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 26.9 p80 . . . . . 0 N--CA 1.488 1.457 0 C-N-CA 124.39 1.076 . . . . 73.2 112.621 176.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HB ' ' A' ' 109' ' ' VAL . 56.6 ttm . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 112.221 0.452 . . . . 60.51 112.221 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 1' ' ' MET . 86.5 mtt180 -47.26 145.65 2.23 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 112.827 0.676 . . . . 72.23 112.827 158.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.8 m -64.11 151.65 42.64 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 71.13 111.268 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.12 -26.69 68.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.953 -0.567 . . . . 51.4 111.993 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.605 HG23 HG13 ' A' ' 102' ' ' VAL . 2.0 m -66.53 -47.37 73.1 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.152 0.981 . . . . 61.25 111.131 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -61.83 -44.06 97.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.987 0.915 . . . . 72.12 111.502 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.04 -30.81 69.25 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.074 -0.966 . . . . 74.32 112.246 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -66.03 -43.43 87.64 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.129 0.571 . . . . 74.52 109.962 171.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -61.8 -37.71 85.39 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.49 0.716 . . . . 71.4 111.591 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -62.71 -41.97 99.41 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 124.074 0.95 . . . . 72.13 110.925 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 65.1 mt -60.03 -44.68 94.48 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.142 0.977 . . . . 71.12 112.113 173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -76.99 -16.13 59.42 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.645 0.609 . . . . 74.4 112.645 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.24 -49.43 43.38 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.239 0.616 . . . . 61.52 111.147 176.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 17' ' ' SER . 17.1 m -115.82 119.16 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.863 0.865 . . . . 63.03 110.02 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.21 -47.48 83.33 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 123.774 0.83 . . . . 65.04 111.27 -174.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -92.95 95.96 9.81 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.222 -0.899 . . . . 62.34 108.656 165.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' HG23 ' A' ' 14' ' ' VAL . 35.8 t -58.57 122.08 12.53 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.123 -0.489 . . . . 64.42 111.929 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.72 -48.96 76.95 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.698 0.629 . . . . 65.21 112.698 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -150.88 15.48 0.75 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.089 0.774 . . . . 73.32 113.089 -177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.0 mm -102.21 106.47 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.342 -0.984 . . . . 72.41 108.342 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.523 ' HG2' HG21 ' A' ' 35' ' ' THR . 10.6 tp10 -94.8 114.35 26.23 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.323 0.649 . . . . 75.24 111.504 -169.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.53 35.38 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.651 0.781 . . . . 52.52 112.136 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HE3' HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -153.19 156.24 38.18 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.906 0.86 . . . . 64.12 112.235 176.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 54.8 mtt85 -81.37 163.19 23.02 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.42 -1.264 . . . . 75.34 110.362 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -30.05 69.93 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 122.787 0.435 . . . . 74.12 112.078 173.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.6 m -64.52 -29.97 71.01 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.866 0.867 . . . . 71.11 112.572 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 63.8 m-20 -82.53 -16.08 49.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.263 0.625 . . . . 75.35 112.337 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.506 ' HA ' HG21 ' A' ' 32' ' ' VAL . 13.8 tmm? -63.64 120.1 11.13 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.976 0.511 . . . . 73.24 111.822 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.19 -139.46 6.13 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.147 -0.478 . . . . 65.43 112.324 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -58.64 -41.65 86.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.988 1.107 . . . . 71.12 113.988 -175.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -64.61 -41.12 96.43 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.583 0.753 . . . . 71.31 112.225 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.546 HG22 ' HE3' ' A' ' 23' ' ' LYS . 84.5 t -67.08 -43.38 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.581 0.752 . . . . 71.22 110.517 175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.4 tpp -56.45 -40.92 75.61 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.965 1.306 . . . . 60.43 112.479 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -61.71 -39.23 90.77 Favored 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 123.47 0.708 . . . . 64.2 110.432 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.523 HG21 ' HG2' ' A' ' 21' ' ' GLU . 23.4 m -75.51 -30.74 59.91 Favored 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 123.06 0.544 . . . . 75.32 111.416 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 112' ' ' VAL . 69.2 t -59.39 -41.82 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.343 0.657 . . . . 73.12 110.657 174.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.2 mt -59.86 -36.55 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 122.843 0.457 . . . . 73.24 111.326 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.38 97.27 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.827 1.047 . . . . 74.34 113.827 -170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.565 ' HA ' HD23 ' A' ' 45' ' ' LEU . 87.9 m-85 -70.76 -35.41 72.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.931 0.492 . . . . 73.14 111.206 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.73 -22.7 46.15 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.693 0.797 . . . . 53.11 112.397 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -74.59 -50.09 19.23 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.998 0.919 . . . . 54.21 111.754 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -76.06 142.18 72.06 Favored Pre-proline 0 CA--C 1.56 1.356 0 C-N-CA 123.175 0.59 . . . . 73.53 112.076 -175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.53 123.0 7.8 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.584 2.19 . . . . 74.22 113.107 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.39 34.71 85.76 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.83 -0.623 . . . . 52.11 114.551 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 39' ' ' PHE . 16.4 tp -97.97 18.79 15.15 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 117.738 0.769 . . . . 60.55 111.143 177.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -45.55 122.62 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.898 1.073 . . . . 72.11 113.898 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.1 51.12 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.421 -0.655 . . . . 34.2 114.554 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.66 137.27 9.2 Favored Glycine 0 C--N 1.364 2.094 0 CA-C-N 118.847 1.323 . . . . 71.23 111.9 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -121.27 138.68 54.12 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.462 0.705 . . . . 73.4 111.623 -171.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 21' ' ' GLU . 5.4 mp -106.87 121.27 44.07 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.896 0.878 . . . . 71.44 109.392 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.84 109.56 21.54 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.501 0.72 . . . . 72.01 110.103 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.601 HD22 HD23 ' A' ' 108' ' ' LEU . 9.5 mp -95.53 136.47 35.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.304 1.041 . . . . 74.24 109.989 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.33 31.55 8.91 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.894 -0.594 . . . . 42.02 112.372 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.3 t -112.18 139.68 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.597 0.759 . . . . 75.53 109.481 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -114.16 159.13 20.42 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.835 -1.172 . . . . 50.3 107.835 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.454 ' HH2' ' HA ' ' A' ' 23' ' ' LYS . 41.3 p90 -150.65 137.16 18.81 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.899 0.38 . . . . 73.35 111.296 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -130.81 136.91 49.14 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.583 0.753 . . . . 55.14 110.701 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.7 mt -88.91 130.89 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.362 0.665 . . . . 62.34 110.666 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 63' ' ' ASP . 31.9 p30 -82.13 -172.49 3.99 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 123.631 0.772 . . . . 72.32 112.486 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -64.07 -33.12 75.04 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.745 0.818 . . . . 75.14 112.433 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -83.04 -12.61 57.05 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.246 0.618 . . . . 73.53 112.335 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.08 37.02 6.11 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 114.228 0.451 . . . . 45.33 114.228 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' HB2' HD21 ' A' ' 59' ' ' ASN . 8.7 m-20 -116.77 134.72 54.44 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.479 0.711 . . . . 72.54 110.413 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -86.68 118.5 26.13 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.415 0.686 . . . . 73.44 110.548 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.39 118.34 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.126 0.57 . . . . 74.32 109.885 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -94.06 120.39 34.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.575 0.75 . . . . 73.34 109.821 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -124.02 151.02 64.57 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.847 0.859 . . . . 73.3 112.088 -170.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.47 121.7 5.28 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.606 2.204 . . . . 74.31 112.823 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.41 -40.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 114.9 -1.045 . . . . 64.54 110.557 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.44 170.28 46.76 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.695 -0.684 . . . . 53.4 113.362 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.09 139.76 22.18 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 109.619 -0.512 . . . . 70.44 109.619 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.29 -29.92 31.35 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.569 2.179 . . . . 53.22 111.954 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -133.19 83.06 51.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 N-CA-C 108.328 -0.99 . . . . 61.35 108.328 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.21 -36.65 56.18 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.904 2.403 . . . . 63.5 113.564 -172.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.8 -43.01 60.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.191 0.596 . . . . 64.01 110.969 177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.1 -45.57 94.15 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 122.407 0.283 . . . . 71.12 111.39 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 80.2 t -65.33 -43.64 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.479 0.712 . . . . 71.22 111.352 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -59.48 -48.42 81.71 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.523 0.729 . . . . 64.15 111.953 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -66.76 -40.93 88.44 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.171 -0.922 . . . . 61.45 111.474 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -64.83 -35.81 82.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.232 0.613 . . . . 74.01 110.91 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.34 -37.05 71.73 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.624 0.769 . . . . 74.31 111.329 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.56 86.6 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.439 0.696 . . . . 72.43 111.399 173.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.2 t -65.07 -52.55 55.03 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.839 0.855 . . . . 73.43 111.503 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.39 -31.82 73.19 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.21 0.604 . . . . 75.31 111.922 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 44.8 t -60.05 -35.3 74.83 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.163 0.506 . . . . 71.13 112.153 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.24 -37.78 37.2 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.615 -0.721 . . . . 74.23 112.187 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 54.8 p -95.35 -2.59 48.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 113.593 0.961 . . . . 72.5 113.593 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 8.3 mmt -93.16 -55.45 3.32 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.371 0.605 . . . . 71.23 109.955 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mt -86.94 146.82 26.01 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.36 -0.836 . . . . 72.53 110.548 -171.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.537 HD21 ' HA ' ' A' ' 122' ' ' ILE . 4.8 p30 -52.75 -33.1 46.75 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.59 1.156 . . . . 41.32 113.161 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.1 m -120.25 162.57 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.25 1.02 . . . . 62.42 110.773 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.28 101.75 6.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 115.657 -0.701 . . . . 74.51 110.427 175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.421 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 5.4 tt -83.24 124.12 30.25 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.57 -1.27 . . . . 73.11 107.57 172.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -102.89 98.75 12.04 Favored Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 122.76 0.424 . . . . 71.02 110.856 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -87.82 163.06 7.63 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.284 1.99 . . . . 64.54 112.433 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 60.4 tt0 -88.23 121.69 30.92 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 108.182 -1.044 . . . . 74.13 108.182 177.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 64.9 mtt -124.4 117.78 25.22 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.241 0.617 . . . . 71.04 110.799 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.692 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 28.6 mm-40 -131.38 138.78 49.29 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.686 0.794 . . . . 54.31 110.615 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.0 mt -91.31 117.27 29.52 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.504 0.721 . . . . 63.5 109.439 173.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.7 133.53 53.87 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.394 1.078 . . . . 64.41 110.297 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -89.86 129.9 36.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.988 0.515 . . . . 73.25 111.095 -177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.605 HG13 HG23 ' A' ' 5' ' ' THR . 23.9 t -128.13 107.74 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.97 0.908 . . . . 63.33 108.828 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.6 28.95 57.11 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 114.727 0.651 . . . . 53.11 114.727 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.75 0.93 83.42 Favored Glycine 0 CA--C 1.543 1.794 0 N-CA-C 114.82 0.688 . . . . 74.12 114.82 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.7 133.05 41.74 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 117.611 0.706 . . . . 71.03 109.303 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -86.74 102.72 14.51 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 118.418 0.554 . . . . 74.11 110.796 -178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -93.2 154.42 18.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.52 0.728 . . . . 71.02 110.26 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 52' ' ' LEU . 52.0 tp -116.69 120.1 37.57 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.401 0.681 . . . . 72.1 109.288 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.698 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 17.3 t -95.87 132.63 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.105 -0.702 . . . . 74.12 109.105 173.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.8 t -120.06 99.22 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.862 -0.792 . . . . 74.52 108.862 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 54.1 t80 -83.67 131.65 34.93 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.08 0.552 . . . . 55.43 110.107 176.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 36' ' ' VAL . 36.6 t -121.92 116.26 30.23 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 109.434 -0.58 . . . . 73.04 109.434 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.23 -176.15 1.76 Allowed 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.708 2.272 . . . . 54.44 112.832 172.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -70.81 131.68 44.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.93 0.492 . . . . 70.2 109.85 166.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.08 157.02 23.02 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 123.038 0.535 . . . . 53.45 111.339 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -64.93 150.99 46.91 Favored 'General case' 0 C--O 1.186 -2.24 0 C-N-CA 123.963 0.905 . . . . 72.45 111.417 -174.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.8 t -38.01 -52.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 N-CA-C 115.738 1.755 . . . . 44.24 115.738 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.4 t -69.59 -37.86 77.11 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.124 0.787 . . . . 64.45 113.124 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.8 m-70 -125.73 66.66 1.17 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 105.273 -2.121 . . . . 75.4 105.273 171.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.612 ' HA ' HG13 ' A' ' 122' ' ' ILE . 62.8 mttm -44.14 -153.0 0.0 OUTLIER Pre-proline 0 CA--C 1.582 2.207 1 C-N-CA 132.863 4.465 . . . . 70.13 121.316 60.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -1.85 71.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.584 2.19 . . . . 65.03 116.244 -117.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.612 HG13 ' HA ' ' A' ' 120' ' ' LYS . 59.5 mt -85.88 111.0 20.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.805 -1.089 . . . . 71.23 110.248 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -113.14 139.53 48.67 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 114.836 -1.075 . . . . 72.14 110.401 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.0 120.0 13.55 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.322 0.649 . . . . 71.52 109.443 173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.9 mtmp? -60.1 -33.79 72.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 112.547 0.573 . . . . 50.33 112.547 -174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.7 105.89 14.1 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.265 0.626 . . . . 72.04 109.571 171.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 37.5 p -57.3 105.48 0.24 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.45 112.501 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -78.68 -147.44 3.59 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 115.897 -0.592 . . . . 64.51 113.986 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 1.3 pp -145.7 143.85 20.88 Favored Pre-proline 0 N--CA 1.485 1.286 0 N-CA-C 112.547 0.573 . . . . 64.31 112.547 -176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 129' ' ' LEU . 12.6 Cg_exo -73.69 151.68 46.82 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.991 2.461 . . . . 72.01 112.548 169.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 106.7 107.4 3.2 Favored Glycine 0 N--CA 1.475 1.293 0 CA-C-N 116.704 -0.226 . . . . 64.43 113.09 178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -112.49 -145.65 9.69 Favored Glycine 0 C--N 1.35 1.325 0 C-N-CA 123.153 0.406 . . . . 42.22 112.818 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -133.32 150.83 51.85 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.25 0.62 . . . . 65.53 111.329 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -134.31 145.4 49.01 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.504 0.722 . . . . 74.1 110.403 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.4 mtm180 -97.54 178.44 5.18 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.775 0.83 . . . . 73.54 112.205 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 133.95 47.18 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.377 -0.374 . . . . 73.31 110.099 167.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.1 mt -65.19 109.98 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 123.724 0.81 . . . . 71.44 112.187 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.4 149.27 19.21 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 115.639 -0.709 . . . . 64.02 111.771 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 75.8 p -76.99 138.29 39.52 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.274 0.63 . . . . 64.51 111.676 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -84.77 85.97 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.107 0.563 . . . . 71.21 109.695 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.64 155.21 41.04 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.996 0.739 . . . . 74.35 112.996 -175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -86.54 11.93 11.59 Favored 'General case' 0 CA--C 1.565 1.545 0 C-N-CA 124.297 1.039 . . . . 73.22 111.537 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -79.24 27.21 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.641 0.978 . . . . 73.03 113.641 -174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 24.6 p -78.71 79.18 5.14 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.487 0.715 . . . . 65.51 110.94 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.36 94.36 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.555 0.742 . . . . 73.53 111.235 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.8 102.55 14.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.038 0.535 . . . . 61.22 109.786 176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.11 -168.02 1.5 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 122.989 0.516 . . . . 55.1 111.526 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -135.87 127.34 28.65 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.896 0.478 . . . . 71.22 111.588 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -152.23 137.19 17.22 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.473 0.709 . . . . 71.22 110.352 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -96.39 144.22 26.72 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.434 0.693 . . . . 54.41 110.922 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -94.35 139.49 31.02 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.412 0.685 . . . . 72.23 110.891 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 67.42 -69.19 0.14 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.26 1.424 . . . . 75.31 111.662 -177.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.452 0.644 . . . . 54.25 110.673 174.494 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 23.3 ttt . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 110.353 -0.239 . . . . 73.31 110.353 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -92.88 153.53 18.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.13 0.572 . . . . 72.44 111.538 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.3 t -74.41 156.82 36.61 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.442 0.697 . . . . 62.15 111.249 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.89 -27.73 67.75 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.934 0.493 . . . . 64.21 111.355 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.576 HG23 HG13 ' A' ' 102' ' ' VAL . 3.8 m -70.18 -41.75 73.34 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.658 0.783 . . . . 70.34 110.395 177.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.18 -51.04 67.96 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.622 1.169 . . . . 72.14 110.952 176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 51' ' ' LEU . 85.3 mt -69.67 -33.25 72.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.1 0.96 . . . . 75.21 113.081 -177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.7 tp -64.93 -44.8 88.32 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.013 0.435 . . . . 44.33 110.404 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.33 -37.61 86.31 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.519 -0.764 . . . . 63.24 111.096 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -63.29 -43.12 98.8 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.885 0.874 . . . . 74.41 110.703 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 22' ' ' ALA . 71.4 mt -67.09 -38.56 85.92 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.518 1.127 . . . . 71.43 111.96 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -72.61 -23.8 60.99 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.118 0.567 . . . . 62.1 111.942 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.2 17.59 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.475 0.71 . . . . 52.05 110.965 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.0 m -110.33 116.54 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-O 121.179 0.514 . . . . 64.01 110.77 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.17 -43.21 87.57 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.67 0.388 . . . . 72.21 110.629 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -69.24 101.2 1.44 Allowed 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.232 0.539 . . . . 73.22 109.931 168.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 20' ' ' ILE . 25.3 m -80.89 78.64 7.67 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.589 0.756 . . . . 75.22 110.161 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.78 -34.07 40.03 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 113.955 1.095 . . . . 73.52 113.955 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -123.72 -9.35 7.86 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 113.047 0.758 . . . . 74.25 113.047 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 17' ' ' SER . 42.3 mt -131.92 133.36 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.684 0.794 . . . . 73.41 109.301 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -125.7 129.4 49.46 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.826 0.739 . . . . 72.05 111.316 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -89.02 131.74 35.06 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.705 0.802 . . . . 71.52 110.612 173.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -134.34 151.94 51.52 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.834 0.854 . . . . 72.12 111.046 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 -92.39 165.63 12.97 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.461 0.705 . . . . 72.34 112.474 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -24.54 67.31 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.141 0.976 . . . . 72.23 112.276 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.3 t -64.1 -36.02 82.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.865 0.466 . . . . 53.43 111.982 169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -86.04 -2.48 58.35 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.466 0.706 . . . . 70.14 112.238 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.4 tpt -52.59 105.84 0.13 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.346 1.059 . . . . 72.34 111.909 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' HA2' ' OE1' ' A' ' 84' ' ' GLN . . . 138.05 -124.72 3.03 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.802 -0.635 . . . . 61.13 112.83 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -59.31 -36.85 76.38 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.461 1.105 . . . . 74.15 112.157 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.0 m -72.53 -18.85 61.61 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.264 -0.88 . . . . 63.31 112.991 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -34.34 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.659 0 C-N-CA 122.902 0.481 . . . . 62.23 111.709 167.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 24.7 mmt -74.69 -37.52 62.61 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.367 1.618 . . . . 73.24 115.367 -158.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.44 70.52 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.38 0.537 . . . . 72.2 112.19 -173.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.443 HG21 HD21 ' A' ' 50' ' ' LEU . 31.8 m -77.31 -30.76 54.25 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.186 0.594 . . . . 65.04 111.28 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.53 -39.93 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 122.837 0.455 . . . . 72.32 110.266 171.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB2' ' A' ' 124' ' ' LYS . 68.6 mt -57.2 -35.61 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 123.533 0.733 . . . . 73.03 111.637 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.3 1.61 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.47 0.308 . . . . 73.04 110.891 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -65.46 -30.51 71.31 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.498 0.719 . . . . 73.43 112.359 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.81 -24.85 55.93 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.782 0.66 . . . . 51.44 112.782 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 121' ' ' PRO . 49.0 m-80 -115.95 -4.69 12.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 114.149 1.166 . . . . 63.14 114.149 -174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -92.52 107.15 21.75 Favored Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 119.0 0.818 . . . . 73.35 110.773 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.52 126.74 8.47 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.464 2.11 . . . . 32.21 112.997 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.21 -7.05 32.48 Favored Glycine 0 N--CA 1.474 1.216 0 CA-C-N 116.002 -0.544 . . . . 73.3 113.734 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.07 -37.93 9.95 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 117.986 0.893 . . . . 72.54 108.935 168.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 114' ' ' GLU . 11.0 m-20 39.6 71.81 0.16 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.309 1.844 . . . . 64.53 115.401 171.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.41 74.45 0.43 Allowed Glycine 0 C--N 1.352 1.425 0 N-CA-C 115.362 0.905 . . . . 54.33 115.362 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.61 174.13 44.45 Favored Glycine 0 N--CA 1.482 1.72 0 CA-C-N 117.237 0.518 . . . . 53.33 113.234 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -129.26 142.43 50.85 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 113.575 0.954 . . . . 74.11 113.575 -176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 35' ' ' THR . 95.8 mt -132.28 125.44 31.02 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.24 1.416 . . . . 63.11 109.891 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.7 mm? -103.56 108.81 20.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.743 0.417 . . . . 70.31 110.851 -176.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -93.71 124.93 38.04 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.551 0.74 . . . . 61.52 109.857 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.98 33.15 4.13 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 116.158 -0.474 . . . . 73.13 112.94 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.88 146.33 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.545 0.738 . . . . 73.13 109.875 173.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -130.55 134.3 46.91 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.997 -0.742 . . . . 74.31 108.997 171.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -117.44 129.65 55.97 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.291 1.036 . . . . 74.3 110.881 -172.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -117.76 135.22 54.19 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.604 0.762 . . . . 75.04 110.813 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -80.54 129.68 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.606 0.762 . . . . 63.35 110.487 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 40.7 p30 -90.89 -168.17 2.01 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.88 0.696 . . . . 63.55 112.88 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.17 -44.6 68.01 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.755 1.222 . . . . 74.13 113.48 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.56 -26.8 27.75 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.013 0.525 . . . . 75.11 111.635 -175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.16 7.39 14.69 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 119.913 -0.382 . . . . 71.42 114.023 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 8.3 m-20 -74.48 143.1 44.77 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 117.471 0.636 . . . . 75.02 111.013 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.1 m -90.11 114.28 26.18 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.871 0.869 . . . . 71.03 110.156 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.1 t -103.55 117.28 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.437 0.695 . . . . 73.43 110.443 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -92.66 116.39 28.96 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.088 0.955 . . . . 74.45 110.422 -175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -118.46 149.76 46.67 Favored Pre-proline 0 N--CA 1.485 1.284 0 C-N-CA 123.885 0.874 . . . . 75.53 111.383 -176.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -79.63 104.92 1.78 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.66 2.24 . . . . 74.44 112.014 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.4 m -93.94 -29.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 116.052 -0.522 . . . . 74.25 110.397 167.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -174.16 55.11 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.615 -0.721 . . . . 55.41 113.57 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 77' ' ' VAL . 82.0 mt -104.51 133.14 20.34 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.718 0.807 . . . . 73.21 110.542 177.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.43 -31.34 42.77 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.521 2.148 . . . . 74.53 111.763 172.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 5.8 m-20 -122.52 75.43 44.53 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 124.077 0.951 . . . . 64.14 109.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -54.83 -60.26 0.62 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.24 2.627 . . . . 73.14 114.223 -170.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.532 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 5.2 p-10 -66.28 -39.36 89.35 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.263 -0.426 . . . . 54.43 110.65 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 57.4 tptt -60.96 -40.77 94.59 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.627 0.771 . . . . 62.31 112.089 -175.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG21 HD22 ' A' ' 71' ' ' LEU . 79.2 t -62.84 -44.92 99.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.037 0.535 . . . . 70.44 110.888 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -60.49 -50.34 73.93 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.586 0.754 . . . . 71.22 112.313 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 16.5 mmt85 -68.51 -43.96 75.68 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.495 0.718 . . . . 75.44 111.521 -175.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.72 -33.54 72.63 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.541 -0.754 . . . . 74.33 111.182 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.559 HD23 ' SD ' ' A' ' 97' ' ' MET . 21.6 tp -66.98 -40.19 87.35 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.688 0.395 . . . . 62.51 110.936 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.2 93.93 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 122.97 0.508 . . . . 40.55 111.695 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -66.52 -52.47 45.44 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.813 0.845 . . . . 64.14 112.016 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.471 ' OE1' ' HA2' ' A' ' 29' ' ' GLY . 11.7 pt20 -71.13 -31.17 67.4 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.003 0.521 . . . . 72.24 112.321 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 93' ' ' LEU . 42.4 t -60.89 -26.92 67.78 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.435 0.636 . . . . 64.35 111.373 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -76.48 -25.15 53.98 Favored 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 113.721 1.008 . . . . 51.0 113.721 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 86.5 p -110.44 -37.24 5.55 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 113.288 0.847 . . . . 71.52 113.288 -173.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 92.1 mmm -68.29 -46.89 69.11 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.393 1.077 . . . . 70.53 111.542 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.407 HD12 ' SG ' ' A' ' 85' ' ' CYS . 53.9 mt -85.89 161.91 18.84 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 115.718 -0.674 . . . . 72.2 111.374 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.4 HD22 HD13 ' A' ' 122' ' ' ILE . 46.2 t30 -37.33 -53.05 1.11 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.873 1.669 . . . . 75.41 114.051 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG22 HD12 ' A' ' 122' ' ' ILE . 28.7 m -119.64 174.33 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 123.507 0.723 . . . . 73.41 111.441 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -68.73 97.4 0.81 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 109.202 -0.666 . . . . 54.32 109.202 163.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 122' ' ' ILE . 4.9 tt -98.84 130.84 45.27 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.47 0.708 . . . . 61.13 109.465 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 -106.62 98.55 20.92 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 124.061 0.944 . . . . 73.14 110.985 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -82.4 149.93 15.03 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 122.238 1.959 . . . . 51.03 111.407 169.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.41 ' HG3' ' SD ' ' A' ' 1' ' ' MET . 9.9 tp10 -87.21 102.68 14.71 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.097 -0.705 . . . . 64.12 109.097 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.585 ' HB3' HD11 ' A' ' 108' ' ' LEU . 51.9 mtm -112.43 140.25 47.32 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.536 0.735 . . . . 70.04 110.679 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -149.88 150.86 32.54 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.352 0.661 . . . . 74.13 110.46 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 66.4 mt -104.73 119.28 38.62 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.295 1.038 . . . . 63.34 110.59 -171.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -127.23 133.54 50.22 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.085 0.954 . . . . 75.32 109.711 -174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -97.85 122.16 40.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.073 0.463 . . . . 70.32 110.879 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.576 HG13 HG23 ' A' ' 5' ' ' THR . 9.2 t -119.95 113.44 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 124.502 1.121 . . . . 73.32 108.41 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.29 28.67 55.25 Favored Glycine 0 CA--C 1.547 2.064 0 N-CA-C 115.169 0.828 . . . . 54.32 115.169 -172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.12 1.92 66.69 Favored Glycine 0 CA--C 1.544 1.86 0 N-CA-C 115.088 0.795 . . . . 65.23 115.088 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -109.96 130.51 55.52 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 117.993 0.897 . . . . 75.44 109.685 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 m -87.3 102.41 14.48 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 118.484 0.583 . . . . 73.13 111.685 -176.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -88.39 166.45 14.24 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.895 0.878 . . . . 63.33 111.046 173.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.585 HD11 ' HB3' ' A' ' 97' ' ' MET . 49.3 tp -119.21 121.84 40.62 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.56 0.744 . . . . 74.03 110.782 175.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' MET . 52.6 t -86.93 113.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 123.299 0.639 . . . . 74.02 109.576 170.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 55.3 t -100.22 100.59 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.37 0.605 . . . . 74.41 109.691 172.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -83.6 119.28 24.54 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.929 0.892 . . . . 75.34 109.252 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -108.87 100.34 39.17 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 123.488 0.715 . . . . 62.14 109.55 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.25 157.29 41.78 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.5 2.133 . . . . 71.43 112.175 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.5 tm-20 -75.94 115.94 16.15 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.23 -0.655 . . . . 71.42 109.23 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.47 152.22 35.08 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.346 1.058 . . . . 53.2 112.425 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' HB3' HG22 ' A' ' 118' ' ' THR . 14.9 t70 -77.55 156.93 30.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.049 -0.523 . . . . 73.43 111.238 -174.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -64.99 -19.92 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 C-N-CA 123.412 0.685 . . . . 71.32 112.426 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 116' ' ' ASP . 14.9 t -58.01 -18.31 23.22 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 123.534 0.733 . . . . 51.44 112.277 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 83.8 m-70 -79.88 -76.65 0.21 Allowed 'General case' 0 CA--C 1.591 2.548 0 N-CA-C 106.979 -1.489 . . . . 71.03 106.979 166.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 5.8 tmtp? -79.92 -142.57 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.414 0 C-N-CA 129.519 3.127 . . . . 72.43 110.742 -49.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.469 ' CD ' ' HB3' ' A' ' 120' ' ' LYS . 1.0 OUTLIER 1.24 112.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.387 2.592 1 C-N-CA 125.611 4.207 . . . . 65.54 119.424 -133.832 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.701 HG21 HD12 ' A' ' 93' ' ' LEU . 36.8 mm -95.52 102.18 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 115.312 -0.858 . . . . 75.02 109.634 171.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.3 p90 -101.6 167.5 10.08 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.769 0.828 . . . . 65.42 110.714 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.586 ' HB2' HD11 ' A' ' 37' ' ' ILE . 37.8 ttpt -85.95 119.13 25.92 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.41 -0.959 . . . . 73.3 108.41 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -66.7 -11.84 55.93 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 113.646 0.98 . . . . 74.34 113.646 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.31 67.37 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.036 0.534 . . . . 74.45 111.42 170.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.5 m 76.22 -52.14 0.61 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.97 1.708 . . . . 73.41 113.245 173.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -57.19 116.26 7.69 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 113.914 0.326 . . . . 75.25 113.914 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.6 mp 65.83 78.84 0.25 Allowed Pre-proline 0 CA--C 1.565 1.55 0 C-N-CA 124.82 1.248 . . . . 75.41 112.261 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -90.81 168.63 3.77 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.095 2.53 . . . . 71.54 113.282 170.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -97.75 77.72 0.62 Allowed Glycine 0 CA--C 1.54 1.602 0 CA-C-N 116.599 -0.273 . . . . 70.51 113.023 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -105.74 79.94 0.28 Allowed Glycine 0 C--N 1.351 1.397 0 C-N-CA 122.826 0.251 . . . . 63.42 113.654 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.15 125.82 41.91 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.31 0.644 . . . . 65.25 110.562 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -86.8 147.12 25.96 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.245 0.618 . . . . 74.33 112.452 -174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -164.15 146.75 9.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.11 0.964 . . . . 64.33 109.968 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -77.57 90.01 3.91 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.198 0.523 . . . . 72.24 110.151 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.604 HD13 ' H ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -101.57 174.56 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 123.959 0.904 . . . . 72.35 112.418 -173.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 93.02 144.62 15.12 Favored Glycine 0 C--N 1.35 1.331 0 CA-C-N 116.192 -0.458 . . . . 74.51 112.362 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 37.3 t -147.4 -72.66 0.21 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 117.034 0.417 . . . . 44.3 111.451 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 82.2 p -105.63 175.41 5.51 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.207 0.603 . . . . 70.34 111.674 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -79.28 -0.32 31.84 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.952 1.093 . . . . 74.23 113.952 -172.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.1 -2.87 8.68 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.154 1.168 . . . . 74.3 114.154 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -69.24 -11.68 61.02 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.496 0.718 . . . . 73.5 112.638 175.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 75.8 m -69.43 139.0 53.99 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.621 0.768 . . . . 55.51 112.491 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.98 145.21 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.209 1.003 . . . . 73.14 110.251 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.05 142.71 57.71 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 122.782 0.433 . . . . 73.34 110.768 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -74.46 121.74 21.93 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.387 0.675 . . . . 61.43 109.922 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -148.66 102.2 3.28 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.304 0.641 . . . . 72.03 109.579 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -74.31 77.14 1.85 Allowed 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 123.59 0.756 . . . . 75.22 110.799 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.3 t60 47.74 83.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.909 1.683 . . . . 70.11 113.176 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -68.17 131.81 46.07 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 123.112 0.565 . . . . 62.31 109.756 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.1 m80 69.16 85.06 0.14 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.104 1.361 . . . . 75.34 109.69 -163.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 124.15 0.98 . . . . 75.11 111.457 -175.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 98' ' ' GLN . 14.9 ptm . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 111.383 0.142 . . . . 71.42 111.383 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -91.09 149.22 21.9 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.681 0.392 . . . . 72.52 111.143 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.8 m -74.03 157.31 36.34 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.943 0.897 . . . . 74.32 112.453 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' A' ' 102' ' ' VAL . . . -61.27 -43.68 98.47 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.034 0.534 . . . . 64.54 112.208 -178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 t -65.0 -35.09 80.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.229 0.612 . . . . 73.21 112.154 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -66.51 -38.97 88.36 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.284 0.634 . . . . 71.33 111.262 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.576 HD22 HD12 ' A' ' 20' ' ' ILE . 60.2 mt -68.76 -39.56 80.21 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.541 0.736 . . . . 63.21 111.456 173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 31.7 tp -65.12 -29.07 69.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.94 0.896 . . . . 75.23 111.276 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.28 -35.09 71.27 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.638 0.775 . . . . 75.43 111.525 175.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -71.89 -50.09 32.29 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 110.232 -0.285 . . . . 75.13 110.232 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 69.6 mt -55.31 -46.86 76.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.489 1.116 . . . . 73.53 113.65 -174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -87.76 -4.08 58.91 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 113.486 0.921 . . . . 55.42 113.486 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.59 -59.84 2.16 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.383 0.611 . . . . 65.52 110.3 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.26 139.09 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.065 0.946 . . . . 73.43 110.775 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -64.92 -47.24 78.44 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.633 0.773 . . . . 74.43 112.408 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.85 148.15 24.74 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.758 -0.83 . . . . 73.33 108.758 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p -93.33 143.58 26.13 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 120.748 0.309 . . . . 71.54 110.721 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.88 -58.58 3.2 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.361 0.664 . . . . 61.23 111.485 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -137.11 1.59 2.47 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.043 0.756 . . . . 71.4 113.043 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.576 HD12 HD22 ' A' ' 7' ' ' LEU . 11.0 mm -108.7 107.24 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 118.78 0.718 . . . . 74.31 110.483 -175.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -94.2 113.81 25.81 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.46 -0.775 . . . . 75.04 110.881 170.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.09 129.12 35.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.277 0.631 . . . . 73.14 109.919 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -133.82 164.59 26.91 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.721 0.772 . . . . 74.23 111.892 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -101.42 177.73 4.84 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.662 -1.154 . . . . 75.12 110.945 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.06 62.65 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 73.33 111.467 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 p -65.67 -29.9 70.52 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.301 1.04 . . . . 53.2 112.274 174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.08 -17.01 62.03 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.164 0.801 . . . . 70.0 113.164 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.409 ' SD ' HG13 ' A' ' 77' ' ' VAL . 92.0 mmm -55.52 107.16 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.706 0.802 . . . . 70.13 112.111 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.92 -125.38 2.94 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 115.279 -0.873 . . . . 40.44 111.158 -172.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 2.9 mptp? -74.23 -30.11 62.02 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.294 0.638 . . . . 71.43 112.371 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 m -68.18 -45.32 73.76 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 123.48 0.712 . . . . 50.4 111.884 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.47 -52.71 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 122.822 0.449 . . . . 64.43 110.222 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.575 ' HE1' ' HA ' ' A' ' 85' ' ' CYS . 39.8 tpp -52.66 -46.52 67.2 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.283 1.033 . . . . 74.03 113.745 -177.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.54 -27.87 64.48 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.163 0.585 . . . . 74.0 111.914 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.6 m -69.48 -39.3 77.74 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.133 0.573 . . . . 54.12 111.029 169.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.6 t -62.39 -35.51 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 123.001 0.521 . . . . 73.31 110.756 174.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 33' ' ' MET . 47.9 mm -57.56 -39.1 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 123.629 0.772 . . . . 75.44 110.929 174.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.32 -45.98 82.14 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.77 -0.65 . . . . 74.54 112.035 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -78.4 -38.87 40.62 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.113 0.565 . . . . 72.4 112.204 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' O ' ' HE2' ' A' ' 120' ' ' LYS . . . -63.76 -42.41 97.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.298 0.639 . . . . 65.32 111.939 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -90.61 7.22 40.34 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.203 0.601 . . . . 55.01 112.154 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -93.51 116.05 65.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 109.416 -0.587 . . . . 73.35 109.416 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.5 111.19 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.264 2.643 . . . . 74.4 115.412 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 25.39 64.59 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.855 1.502 . . . . 52.04 116.855 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -101.06 23.37 10.88 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 118.816 1.308 . . . . 72.53 111.604 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.8 p-10 -46.64 124.85 6.43 Favored 'General case' 0 CA--C 1.563 1.468 0 C-N-CA 123.314 0.645 . . . . 70.31 111.535 167.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.3 -12.68 7.97 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 115.949 -0.569 . . . . 54.43 112.176 -165.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -52.15 104.54 0.17 Allowed Glycine 0 CA--C 1.548 2.114 0 N-CA-C 112.259 -0.336 . . . . 41.12 112.259 160.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.31 132.53 51.39 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.696 0.798 . . . . 74.03 111.405 -175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.32 118.84 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.952 0.901 . . . . 62.12 108.634 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.487 HD13 HD12 ' A' ' 7' ' ' LEU . 31.1 tp -103.42 106.74 17.33 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 109.956 -0.387 . . . . 75.34 109.956 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 4.2 mm? -93.01 133.41 36.18 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.736 0.814 . . . . 52.4 111.535 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 33.85 4.71 Favored Glycine 0 N--CA 1.473 1.121 0 CA-C-N 115.697 -0.683 . . . . 62.03 112.433 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.4 t -114.19 139.5 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.199 0.6 . . . . 74.3 109.859 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.432 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 19.7 t70 -105.63 159.25 16.11 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.128 -1.434 . . . . 74.14 107.128 171.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -148.02 141.11 24.96 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.283 0.563 . . . . 53.25 111.331 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.5 142.03 46.91 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.703 0.801 . . . . 74.03 110.934 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mm -80.31 123.89 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.728 0.811 . . . . 61.4 110.402 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 63' ' ' ASP . 37.6 p30 -82.53 -175.95 5.99 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.494 0.318 . . . . 72.43 111.642 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.27 -31.42 69.09 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.877 0.871 . . . . 71.41 113.267 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -81.04 -31.21 34.62 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.186 0.594 . . . . 73.14 111.483 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.03 9.94 11.54 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 114.389 0.515 . . . . 75.22 114.389 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' HB2' HD21 ' A' ' 59' ' ' ASN . 27.8 m-20 -85.74 147.66 26.23 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.533 0.733 . . . . 75.32 112.298 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.6 m -86.64 109.83 19.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.669 0.787 . . . . 70.13 110.868 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.98 123.56 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.465 0.706 . . . . 71.4 110.144 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -94.33 114.32 26.36 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.585 0.707 . . . . 73.13 111.651 -175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.432 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 0.5 OUTLIER -117.05 109.95 42.13 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.146 1.379 . . . . 74.21 110.32 -177.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.83 106.42 1.99 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.268 1.979 . . . . 61.43 112.359 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.43 -8.47 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.099 0.559 . . . . 64.44 112.505 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.9 -174.14 53.77 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 114.687 0.635 . . . . 73.43 114.687 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 56.0 mt -119.92 124.59 27.81 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.778 1.231 . . . . 72.42 109.069 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.17 -39.1 71.86 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.601 2.2 . . . . 74.43 112.867 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -122.18 77.0 42.47 Favored Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 123.511 0.724 . . . . 62.34 109.605 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.494 ' HB2' HD22 ' A' ' 99' ' ' LEU . 71.8 Cg_endo -73.43 -37.8 2.98 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.76 2.306 . . . . 74.11 114.347 -168.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HA ' HD11 ' A' ' 99' ' ' LEU . 20.3 t70 -66.36 -37.77 86.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.724 0.41 . . . . 71.04 109.915 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.28 -39.02 92.01 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 116.087 -0.506 . . . . 54.41 111.798 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 ' SD ' ' A' ' 28' ' ' MET . 76.6 t -57.05 -40.72 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.727 0.411 . . . . 73.0 110.612 174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -64.35 -43.11 95.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.734 0.814 . . . . 63.31 112.567 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 22.8 mmt180 -69.77 -48.29 59.8 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.711 0.405 . . . . 75.14 111.479 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.53 -33.75 75.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.664 1.186 . . . . 65.55 111.788 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.545 HD23 ' SD ' ' A' ' 97' ' ' MET . 14.5 tp -71.5 -42.99 67.34 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 122.58 0.352 . . . . 71.52 111.272 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.91 -34.46 78.46 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.849 0.46 . . . . 74.21 111.568 175.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 t -66.22 -52.24 49.8 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.641 0.776 . . . . 64.14 111.156 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.454 ' O ' ' HB2' ' A' ' 88' ' ' MET . 10.8 pt20 -67.71 -34.63 77.26 Favored 'General case' 0 C--O 1.2 -1.521 0 CA-C-N 116.459 -0.337 . . . . 71.4 111.797 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.575 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 69.6 m -65.37 -19.6 66.02 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.993 -1.067 . . . . 73.42 112.78 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.94 -42.67 11.67 Favored 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 123.524 0.73 . . . . 62.13 112.111 169.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.9 t -85.06 -21.08 29.52 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 113.802 1.038 . . . . 62.24 113.802 -170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -90.52 -36.6 14.4 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.473 1.109 . . . . 73.04 110.102 -173.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.485 HD21 ' SD ' ' A' ' 33' ' ' MET . 68.0 mt -95.72 147.28 23.78 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 114.421 -1.263 . . . . 64.25 110.281 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.413 HD22 HG13 ' A' ' 91' ' ' VAL . 2.9 p-10 -56.17 -28.35 57.83 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.943 0.897 . . . . 73.45 112.781 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' A' ' 119' ' ' HIS . 27.7 m -124.28 159.87 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.879 0.872 . . . . 74.35 110.91 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.11 99.4 3.93 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.052 0.541 . . . . 62.21 111.449 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 tt -94.38 123.38 37.75 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.733 -1.21 . . . . 73.55 107.733 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -108.43 96.03 17.83 Favored Pre-proline 0 N--CA 1.483 1.199 0 C-N-CA 123.191 0.597 . . . . 72.53 110.51 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.84 158.05 59.42 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.529 2.153 . . . . 74.41 112.761 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.1 tp10 -85.53 107.35 17.43 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.09 -0.707 . . . . 73.34 109.09 176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.554 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.0 mtm -122.24 130.95 53.66 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.309 0.644 . . . . 62.22 111.321 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 14.1 tm0? -146.04 143.83 29.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.481 0.712 . . . . 64.44 110.904 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 75' ' ' ASP . 94.6 mt -92.04 114.08 26.53 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.327 1.051 . . . . 60.04 112.031 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -102.16 124.86 48.5 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.399 1.08 . . . . 62.13 112.173 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.537 HE21 HG23 ' A' ' 106' ' ' THR . 1.8 mp0 -91.58 104.06 16.58 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 121.003 0.43 . . . . 74.32 110.105 172.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 4' ' ' ALA . 56.3 t -137.31 131.58 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.521 1.129 . . . . 64.12 110.244 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.48 28.73 65.36 Favored Glycine 0 C--N 1.355 1.636 0 N-CA-C 115.456 0.943 . . . . 72.55 115.456 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.52 4.77 90.32 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 117.091 0.445 . . . . 74.02 113.137 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -115.18 165.76 12.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.299 1.04 . . . . 71.31 110.358 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.537 HG23 HE21 ' A' ' 101' ' ' GLN . 91.7 m -120.43 131.22 54.68 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 120.857 0.36 . . . . 65.14 110.585 171.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.39 170.44 10.83 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.405 1.082 . . . . 64.4 109.474 -173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.554 HD11 ' HB3' ' A' ' 97' ' ' MET . 46.6 tp -120.06 111.31 17.72 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.975 -0.38 . . . . 74.44 109.975 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.565 HG13 HD11 ' A' ' 7' ' ' LEU . 92.6 t -83.95 120.1 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 N-CA-C 109.332 -0.618 . . . . 61.15 109.332 173.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 97' ' ' MET . 60.8 t -114.04 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-O 121.401 0.619 . . . . 63.4 110.948 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.735 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 75.7 t80 -78.12 125.83 29.92 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.979 0.912 . . . . 71.31 109.591 168.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.68 106.5 33.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.478 -0.934 . . . . 74.21 108.478 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.12 148.63 27.62 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.01 1.806 . . . . 61.42 110.852 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 36.8 tt0 -75.45 133.91 41.0 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.282 -1.007 . . . . 71.51 108.282 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.66 178.8 8.02 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.278 0.631 . . . . 62.21 110.89 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -65.2 176.11 1.43 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 122.967 0.507 . . . . 64.22 111.214 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.28 -41.92 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.639 0 O-C-N 121.004 -1.06 . . . . 73.35 113.349 166.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -69.3 -44.03 72.6 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 118.492 0.587 . . . . 73.55 111.193 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 21.2 m-70 -118.32 90.15 3.27 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 101.751 -3.426 . . . . 33.13 101.751 163.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.751 ' HA ' HG13 ' A' ' 122' ' ' ILE . 91.6 mttt -51.93 -144.49 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.048 2 C-N-CA 133.335 4.654 . . . . 74.43 122.017 45.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo 10.02 70.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 123.448 2.765 . . . . 75.3 116.805 -119.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.751 HG13 ' HA ' ' A' ' 120' ' ' LYS . 57.6 mt -102.32 131.73 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 114.015 -1.448 . . . . 73.45 109.492 176.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -155.74 162.56 40.51 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.015 0.926 . . . . 72.43 110.954 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -70.07 144.43 52.15 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.146 -0.934 . . . . 74.22 110.587 174.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -79.25 17.32 0.82 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 112.88 0.696 . . . . 73.34 112.88 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.84 41.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.385 1.074 . . . . 53.03 110.05 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.1 m -64.44 101.84 0.48 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.991 0.917 . . . . 42.11 111.071 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -137.99 163.19 25.63 Favored Glycine 0 N--CA 1.476 1.348 0 CA-C-N 115.896 -0.593 . . . . 51.14 112.922 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.03 123.53 1.79 Allowed Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.756 0.823 . . . . 71.5 110.071 -175.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.77 -33.59 32.98 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 123.195 2.596 . . . . 74.22 113.821 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 68.01 -112.68 4.88 Favored Glycine 0 CA--C 1.537 1.439 0 CA-C-N 115.475 -0.784 . . . . 54.24 114.048 173.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.83 101.64 0.16 Allowed Glycine 0 C--N 1.354 1.54 0 N-CA-C 112.088 -0.405 . . . . 74.42 112.088 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.73 -52.1 65.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.024 0.53 . . . . 70.43 111.102 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -103.87 -179.97 4.1 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.876 0.87 . . . . 64.05 110.629 172.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -149.3 99.21 2.9 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.881 -0.785 . . . . 64.5 108.881 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -60.29 152.35 25.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.847 0.859 . . . . 72.41 112.642 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 13.4 tt -129.44 127.73 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 123.623 0.769 . . . . 51.13 109.739 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -101.5 -143.74 14.16 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 111.492 -0.643 . . . . 62.52 111.492 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 44.8 t -162.14 136.05 6.5 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.353 0.576 . . . . 72.1 111.166 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.4 t -74.09 142.66 45.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.271 0.629 . . . . 50.14 110.381 171.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.59 156.15 27.82 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.148 0.579 . . . . 65.45 111.517 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.28 147.33 28.22 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.458 0.703 . . . . 71.2 109.951 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -108.38 115.74 30.66 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.961 -0.385 . . . . 74.24 109.961 174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 15.0 p -65.61 124.06 21.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.785 0.434 . . . . 71.01 109.893 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.33 100.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.353 0.597 . . . . 70.33 111.495 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.07 92.6 0.54 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.228 -0.897 . . . . 74.32 110.15 171.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -81.12 162.8 23.53 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 115.399 -0.819 . . . . 54.23 111.556 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -115.2 79.66 1.31 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.326 0.584 . . . . 62.34 111.184 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -69.52 138.0 52.96 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 116.138 -0.483 . . . . 73.35 110.67 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -104.19 171.52 7.3 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 73.43 111.872 -172.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -63.0 138.96 58.72 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 115.672 -0.694 . . . . 62.54 111.336 170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -84.88 -22.28 29.41 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.282 0.633 . . . . 73.13 112.181 -177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 121.55 0.691 . . . . 71.33 111.465 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' HG3' ' A' ' 96' ' ' GLU . 19.4 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 119.595 -0.24 . . . . 55.31 110.509 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -40.31 118.86 0.97 Allowed 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.019 0.928 . . . . 71.52 112.66 170.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 66.5 m -58.1 157.63 7.88 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.105 1.362 . . . . 75.12 114.544 -171.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.461 ' HB2' HG22 ' A' ' 109' ' ' VAL . . . -61.01 -44.95 96.66 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.546 0.738 . . . . 51.22 111.817 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.42 HG23 HG13 ' A' ' 102' ' ' VAL . 2.6 m -62.88 -35.55 80.37 Favored 'General case' 0 CA--C 1.552 1.058 0 CA-C-N 114.711 -1.131 . . . . 75.21 110.601 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -66.22 -48.23 71.27 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.025 0.93 . . . . 74.53 111.753 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 20' ' ' ILE . 35.6 mt -65.01 -36.51 84.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.624 0.37 . . . . 74.4 111.039 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.265 0.626 . . . . 65.23 110.795 176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.91 -33.92 76.95 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.504 0.722 . . . . 71.13 111.277 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' HG2' HD12 ' A' ' 20' ' ' ILE . 8.8 tp10 -67.11 -41.94 85.36 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.44 0.696 . . . . 71.13 110.504 175.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 72.9 mt -64.47 -34.69 78.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.894 0.878 . . . . 75.43 111.363 175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -80.35 -20.86 43.2 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.56 0.744 . . . . 74.23 112.253 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.78 -55.26 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.247 0.619 . . . . 63.21 110.46 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.4 m -86.4 141.73 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.059 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -70.54 -45.99 64.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.826 -0.546 . . . . 74.21 111.184 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -113.62 128.0 56.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.033 0.933 . . . . 73.41 109.896 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.0 m -36.13 108.64 0.07 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 125.411 1.484 . . . . 74.02 114.085 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.46 -7.93 59.46 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.159 0.8 . . . . 63.54 113.159 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -165.9 -34.83 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.011 0.524 . . . . 71.45 111.35 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 7' ' ' LEU . 55.5 mt -97.15 105.4 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.935 -0.765 . . . . 52.34 108.935 -167.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.03 113.15 24.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.083 -1.08 . . . . 61.25 108.083 -176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.81 145.83 40.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.808 0.843 . . . . 72.0 110.41 -171.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.2 160.96 42.4 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.798 0.808 . . . . 73.3 113.124 -176.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -75.77 166.21 23.87 Favored 'General case' 0 CA--C 1.555 1.138 0 CA-C-N 114.194 -1.366 . . . . 71.54 111.717 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.47 -33.3 43.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.224 1.01 . . . . 75.41 113.604 175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.6 m -66.68 -30.48 70.74 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.936 0.894 . . . . 65.12 113.126 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -80.78 -6.23 58.24 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.888 0.699 . . . . 72.55 112.888 -174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mmm -52.79 108.22 0.29 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.14 0.576 . . . . 75.31 112.142 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 151.66 -123.62 1.53 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.51 -0.768 . . . . 73.53 112.417 -177.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -57.58 -55.33 36.17 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.991 1.108 . . . . 75.32 113.991 -168.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.7 m -60.61 -40.47 91.96 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.149 0.579 . . . . 72.55 112.462 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.5 t -59.39 -42.22 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.045 0.538 . . . . 62.42 111.417 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 54.6 mmm -78.63 -33.83 46.99 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 116.112 -0.495 . . . . 74.54 111.713 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.88 -31.44 71.24 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.002 0.921 . . . . 73.32 111.387 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' HD21 ' A' ' 50' ' ' LEU . 43.7 m -72.97 -36.45 67.11 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.692 0.797 . . . . 55.41 111.699 175.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.2 t -59.96 -37.58 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.331 0.652 . . . . 70.02 111.184 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 122' ' ' ILE . 84.7 mt -57.2 -41.78 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.83 0.852 . . . . 54.12 111.383 174.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -64.74 -48.55 74.17 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.451 0.7 . . . . 41.41 112.033 -174.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -67.05 -37.59 84.33 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.187 0.595 . . . . 62.25 111.868 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.77 77.81 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.117 0.567 . . . . 71.14 111.553 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -71.59 -41.76 68.58 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.827 0.851 . . . . 72.21 111.716 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 13.6 mm-40 -72.91 128.7 87.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 C-N-CA 123.157 0.583 . . . . 54.31 112.148 -175.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -87.73 118.98 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.11 2.54 . . . . 75.22 112.929 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.09 14.99 58.31 Favored Glycine 0 CA--C 1.533 1.18 0 N-CA-C 115.066 0.786 . . . . 72.01 115.066 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.27 23.55 13.54 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 118.774 1.287 . . . . 74.31 110.966 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -40.37 132.81 1.97 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.827 0.851 . . . . 54.13 112.613 165.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.46 ' H ' ' HE1' ' A' ' 111' ' ' TYR . . . 119.25 -0.35 14.44 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.447 -0.661 . . . . 52.02 111.447 -161.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.74 100.25 0.11 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 124.052 0.834 . . . . 40.25 113.835 172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -116.88 144.71 44.2 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.54 0.686 . . . . 74.22 112.532 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.7 mp -119.25 131.3 55.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.926 1.291 . . . . 63.1 108.167 165.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 7' ' ' LEU . 29.7 tp -110.9 111.99 23.51 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.027 0.442 . . . . 72.34 110.878 178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 3.9 mm? -89.12 133.43 34.39 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.927 0.891 . . . . 73.23 111.416 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.61 34.11 5.37 Favored Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.9 -0.591 . . . . 51.25 112.609 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -113.1 137.21 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.29 0.636 . . . . 71.03 110.47 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -130.03 130.65 45.23 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.503 -0.925 . . . . 73.55 108.503 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.5 p90 -116.77 138.27 51.6 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.538 0.735 . . . . 73.01 110.892 -174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -134.37 141.84 47.0 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.358 0.663 . . . . 73.42 110.891 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.52 133.8 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.994 0.918 . . . . 71.5 111.072 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -87.15 -173.73 4.56 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.019 0.527 . . . . 75.13 111.889 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -64.99 -25.58 67.92 Favored 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 113.45 0.907 . . . . 72.42 113.45 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -82.64 -30.43 29.4 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 118.212 0.46 . . . . 64.04 110.942 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.36 11.98 8.46 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 114.675 0.63 . . . . 55.14 114.675 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.85 117.69 19.45 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.342 0.657 . . . . 70.5 111.654 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -79.62 107.97 12.8 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.555 0.742 . . . . 74.42 109.852 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.21 123.59 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.491 0.716 . . . . 72.12 110.301 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -94.1 124.15 37.93 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.984 0.914 . . . . 74.32 110.517 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -121.93 149.26 53.35 Favored Pre-proline 0 N--CA 1.484 1.238 0 C-N-CA 124.227 1.011 . . . . 74.31 111.755 -172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.01 102.81 1.4 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.504 2.136 . . . . 74.12 112.748 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -96.24 -24.8 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.816 -0.629 . . . . 74.51 110.901 170.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.23 -169.23 54.87 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 115.716 -0.674 . . . . 40.52 114.216 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.0 mt -115.53 124.38 30.1 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.074 0.95 . . . . 75.55 109.464 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.83 -27.53 80.54 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.787 2.324 . . . . 75.43 113.125 174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.1 p-10 -131.45 63.05 68.28 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 123.834 0.854 . . . . 72.34 111.501 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -67.84 -31.14 32.35 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.699 2.266 . . . . 65.42 113.345 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.38 -37.27 85.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.249 1.019 . . . . 75.44 111.157 175.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 76' ' ' LYS . 8.4 mtpm? -72.31 -54.77 8.54 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.82 -0.627 . . . . 73.51 110.723 175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 73' ' ' ASP . 87.4 t -52.24 -38.13 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 124.395 1.078 . . . . 73.21 112.838 -167.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.45 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 53.1 tt0 -62.41 -47.26 84.88 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 123.472 0.709 . . . . 73.33 111.961 174.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 mmt180 -71.02 -48.28 53.97 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.964 0.905 . . . . 62.03 112.529 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.34 -37.08 66.97 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.527 1.131 . . . . 73.12 111.461 175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.9 -41.83 86.47 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.398 0.679 . . . . 63.01 111.553 176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.35 -33.08 75.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.185 0.594 . . . . 63.03 112.122 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 41.4 t -69.92 -52.92 20.56 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.433 0.693 . . . . 75.23 111.447 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.63 -27.98 69.3 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.937 0.495 . . . . 63.31 111.553 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 93' ' ' LEU . 17.2 t -61.04 -30.1 70.12 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.322 0.649 . . . . 62.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.21 -25.56 29.39 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 113.259 0.837 . . . . 74.05 113.259 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -98.68 -33.91 10.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.627 0.973 . . . . 75.1 113.627 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.0 mmm -88.12 -35.79 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.945 0.898 . . . . 75.43 111.781 -174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.5 mt -95.76 148.72 22.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.316 0.647 . . . . 75.53 111.048 -173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -42.18 -51.19 4.75 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 125.292 1.437 . . . . 53.34 112.766 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 HD12 ' A' ' 122' ' ' ILE . 32.8 m -111.0 156.28 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 116.019 -0.537 . . . . 44.4 110.613 177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.82 117.57 14.69 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 116.02 -0.536 . . . . 52.33 109.611 170.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.657 ' HB2' ' SG ' ' A' ' 85' ' ' CYS . 23.9 mt -111.0 142.66 42.84 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.581 0.753 . . . . 62.53 110.895 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.1 82.25 11.08 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.031 0.932 . . . . 74.22 108.825 169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.22 161.54 42.49 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.423 2.082 . . . . 72.42 113.28 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 10.0 tp10 -77.31 127.91 33.4 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.416 -0.811 . . . . 65.21 109.031 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.45 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 65.7 mtt -136.14 140.25 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.075 0.55 . . . . 71.34 111.407 -173.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -144.65 151.9 39.65 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.522 0.729 . . . . 73.23 110.786 173.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.8 mt -115.13 132.75 56.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.777 0.831 . . . . 73.53 110.695 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 46.8 mt-10 -137.31 149.52 47.12 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.394 0.678 . . . . 54.34 111.102 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -94.97 124.91 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.172 -0.677 . . . . 73.53 109.172 170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.42 HG13 HG23 ' A' ' 5' ' ' THR . 21.4 t -121.34 114.37 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 107.581 -1.266 . . . . 72.23 107.581 177.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.36 26.63 51.56 Favored Glycine 0 CA--C 1.548 2.108 0 N-CA-C 114.614 0.606 . . . . 75.15 114.614 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.88 7.94 60.91 Favored Glycine 0 N--CA 1.48 1.575 0 N-CA-C 114.681 0.632 . . . . 70.0 114.681 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -119.74 129.58 54.57 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 117.748 0.774 . . . . 74.32 109.73 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.1 m -85.27 104.35 15.04 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.746 0.703 . . . . 63.24 112.37 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.6 mp -86.98 160.53 18.62 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.298 1.039 . . . . 63.51 111.456 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.649 ' HB3' ' HB2' ' A' ' 52' ' ' LEU . 62.0 tp -114.96 131.32 56.94 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 123.474 0.71 . . . . 75.25 110.303 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.461 HG22 ' HB2' ' A' ' 4' ' ' ALA . 2.5 t -98.58 122.41 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.464 1.105 . . . . 72.54 108.719 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.92 110.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 118.084 0.402 . . . . 72.22 110.927 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.74 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 60.2 t80 -94.54 132.43 39.23 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.222 -0.659 . . . . 75.34 109.222 170.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 59.9 t -97.51 105.12 23.8 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.487 -0.931 . . . . 75.23 108.487 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -65.78 122.3 9.88 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.033 1.822 . . . . 62.32 109.27 170.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -64.76 134.61 54.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.445 0.698 . . . . 73.31 111.102 -168.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.86 129.63 40.3 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.226 0.61 . . . . 71.43 112.38 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.59 ' HB3' HG22 ' A' ' 118' ' ' THR . 36.2 t70 -86.85 168.84 13.07 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 124.072 0.949 . . . . 73.11 110.314 178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HA ' ' HG2' ' A' ' 120' ' ' LYS . 22.8 t -56.44 -22.19 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 124.401 1.081 . . . . 74.33 112.507 175.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.59 HG22 ' HB3' ' A' ' 116' ' ' ASP . 9.2 t -55.87 -23.86 33.52 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.745 0.818 . . . . 74.23 111.723 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.513 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 56.1 m-70 -87.24 -89.28 0.13 Allowed 'General case' 0 CA--C 1.585 2.313 0 N-CA-C 106.206 -1.775 . . . . 73.5 106.206 166.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 117' ' ' VAL . 29.0 mmmt -59.46 -148.62 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.164 0 CA-C-N 124.838 3.472 . . . . 74.53 113.035 -49.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -0.68 120.94 0.0 OUTLIER 'Trans proline' 1 C--N 1.416 4.093 1 C-N-CA 126.182 4.588 . . . . 72.45 119.917 -139.132 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.527 HD12 HG22 ' A' ' 91' ' ' VAL . 41.1 mm -96.62 91.91 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.299 -0.864 . . . . 73.1 108.86 171.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -81.82 162.22 22.93 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.726 0.298 . . . . 65.11 111.33 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -78.99 131.94 36.48 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.384 -0.969 . . . . 70.13 108.384 173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -70.44 74.54 0.54 Allowed 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 123.934 0.894 . . . . 75.23 111.555 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 168.8 -171.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 126.227 1.811 . . . . 43.33 109.67 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.1 t -80.44 -176.77 5.87 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.113 0.565 . . . . 72.33 110.51 171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.66 -87.67 1.39 Allowed Glycine 0 N--CA 1.47 0.948 0 CA-C-O 119.718 -0.49 . . . . 50.54 112.085 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 tt 67.59 114.71 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.775 0 C-N-CA 125.003 1.321 . . . . 52.43 111.167 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.81 176.85 9.29 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.852 2.368 . . . . 53.44 114.437 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.97 178.19 45.08 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 115.518 -0.764 . . . . 70.34 112.654 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 122.18 175.72 14.89 Favored Glycine 0 N--CA 1.48 1.618 0 CA-C-N 116.807 0.303 . . . . 65.24 113.291 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -156.47 112.97 3.07 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.456 0.702 . . . . 63.23 110.999 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -80.96 141.46 34.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.517 0.727 . . . . 73.3 109.75 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.53 80.72 4.0 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.372 0.606 . . . . 71.25 109.845 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -53.15 131.4 36.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 125.032 1.333 . . . . 74.52 112.986 -178.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 pt -102.36 146.46 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.411 0.685 . . . . 74.13 111.271 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -86.4 125.22 7.28 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-N 116.09 -0.505 . . . . 63.1 112.854 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 78.1 p -120.09 136.19 54.68 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.619 0.768 . . . . 74.15 110.854 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 83.2 p -164.43 173.78 11.75 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.468 0.707 . . . . 61.15 111.576 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -127.5 -174.24 3.12 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.59 0.756 . . . . 70.24 111.352 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -144.9 38.45 1.2 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.432 0.693 . . . . 73.25 110.912 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -54.02 131.23 40.19 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 123.573 0.749 . . . . 63.14 112.758 -173.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 30.3 p -109.26 -177.29 3.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 123.996 0.918 . . . . 64.51 111.648 -174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.93 129.55 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 123.179 0.592 . . . . 73.34 111.184 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pp -119.03 166.73 12.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.932 0.893 . . . . 71.12 110.171 171.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -150.44 124.66 9.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 120.663 0.268 . . . . 71.1 110.578 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -110.77 97.87 7.17 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.286 1.034 . . . . 75.22 109.892 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -95.4 143.62 26.61 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.304 0.573 . . . . 73.03 112.47 -176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -104.4 124.68 49.65 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.496 1.118 . . . . 74.55 111.034 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -134.78 160.15 39.11 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.831 0.853 . . . . 73.25 110.656 173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.8 m80 63.48 87.61 0.11 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 124.5 1.12 . . . . 75.14 112.599 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.5 t60 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 123.722 0.809 . . . . 63.21 110.24 179.281 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' HE2' ' A' ' 49' ' ' TYR . 51.1 ttm . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 111.508 0.188 . . . . 73.43 111.508 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 1' ' ' MET . 91.5 mtt180 -86.89 -169.48 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.512 0.725 . . . . 70.34 110.431 170.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.6 p -82.95 150.49 26.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 122.047 -0.408 . . . . 73.12 109.908 166.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.05 -29.53 70.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 112.344 0.498 . . . . 75.04 112.344 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.6 p -62.38 -47.72 82.91 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.606 0.762 . . . . 74.24 111.172 174.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.14 -42.18 98.07 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-O 121.716 0.769 . . . . 75.31 111.07 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.5 mt -65.19 -39.79 93.33 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.651 -1.159 . . . . 53.11 111.628 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.64 -34.57 78.13 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 115.41 -0.813 . . . . 51.4 111.124 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.23 -41.65 85.35 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.062 0.545 . . . . 74.14 111.414 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.36 -39.69 94.39 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 122.517 0.327 . . . . 54.31 110.642 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.46 -50.96 69.38 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.157 0.983 . . . . 73.03 112.739 172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -69.01 -12.53 61.77 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.016 0.747 . . . . 74.21 113.016 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.13 -42.76 30.83 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.489 0.716 . . . . 73.13 111.021 169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 m -98.01 161.17 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 122.025 0.917 . . . . 63.11 112.602 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -106.52 0.85 24.97 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.88 -1.055 . . . . 71.15 110.788 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -141.39 130.18 22.96 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.202 1.001 . . . . 71.01 110.113 -176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m -80.29 85.91 5.74 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.1 0.56 . . . . 75.41 110.775 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.24 -63.95 1.01 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.343 1.057 . . . . 63.44 112.731 -174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtp-105 -102.09 -5.12 24.87 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.645 0.778 . . . . 75.31 111.478 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.9 mm -104.53 167.78 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 109.124 -0.695 . . . . 75.02 109.124 -173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.558 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -154.62 115.02 3.89 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.293 -1.002 . . . . 70.34 108.293 167.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -99.9 141.42 32.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.17 0.588 . . . . 63.21 111.442 -171.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -152.46 158.21 42.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.041 0.924 . . . . 61.05 112.774 -179.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -77.06 163.77 26.34 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-N 113.806 -1.543 . . . . 73.53 111.331 169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.35 -32.64 74.12 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.495 0.554 . . . . 73.22 112.495 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.8 t -76.66 -13.75 60.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.374 0.67 . . . . 71.21 112.559 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 23' ' ' LYS . 18.8 t70 -85.24 -5.69 59.31 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.234 0.613 . . . . 64.13 111.957 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.595 ' SD ' HG13 ' A' ' 77' ' ' VAL . 82.8 mtp -57.08 113.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.01 112.0 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.4 -155.23 10.52 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 116.225 -0.443 . . . . 55.25 113.531 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -73.9 -25.32 59.95 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.383 1.073 . . . . 72.44 111.442 -174.618 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.4 p -65.17 -48.1 74.66 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.078 0.951 . . . . 74.24 111.699 173.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HE3' ' A' ' 23' ' ' LYS . 60.0 t -58.2 -40.58 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.845 0.858 . . . . 75.04 110.819 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.425 ' SD ' HD21 ' A' ' 89' ' ' LEU . 40.1 tpp -71.46 -32.56 68.45 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 114.92 -1.036 . . . . 65.53 112.253 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG3' ' HA ' ' A' ' 130' ' ' PRO . 7.3 tp10 -66.93 -37.73 84.86 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 123.535 0.734 . . . . 72.12 111.285 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.558 HG21 ' HG3' ' A' ' 21' ' ' GLU . 17.8 m -69.8 -32.43 70.89 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.656 0.783 . . . . 72.31 112.242 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.3 t -57.39 -37.14 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.023 0.929 . . . . 74.53 112.075 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.16 -41.06 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 124.028 0.931 . . . . 64.41 111.911 177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.92 68.03 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.901 0.881 . . . . 72.24 112.217 -171.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -61.46 -22.23 64.87 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.806 0.842 . . . . 74.11 112.999 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.99 -26.49 59.61 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.238 0.615 . . . . 65.42 112.055 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -117.65 5.38 12.36 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 113.945 1.091 . . . . 74.22 113.945 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -58.58 117.15 18.36 Favored Pre-proline 0 N--CA 1.498 1.928 0 CA-C-N 118.748 0.704 . . . . 65.0 112.507 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.3 102.07 0.18 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.293 2.662 . . . . 70.21 113.802 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.5 9.93 59.34 Favored Glycine 0 CA--C 1.535 1.33 0 N-CA-C 116.134 1.214 . . . . 54.32 116.134 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.0 tp -115.62 -64.6 1.29 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 118.383 1.092 . . . . 71.33 110.965 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 37.71 -157.47 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 125.931 1.692 . . . . 74.11 114.919 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.81 58.71 7.92 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.69 -0.232 . . . . 54.23 113.501 172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -103.21 157.39 17.8 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 112.375 -0.29 . . . . 23.31 112.375 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' HE2' ' HG3' ' A' ' 1' ' ' MET . 90.5 m-85 -124.36 126.13 45.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.824 0.45 . . . . 74.45 111.064 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.1 mp -98.92 118.17 35.09 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.596 -0.89 . . . . 72.43 108.596 169.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.42 109.01 21.15 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.719 -0.474 . . . . 75.34 109.719 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.8 mp -100.4 128.5 46.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.254 1.022 . . . . 60.42 109.777 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.9 28.27 7.89 Favored Glycine 0 N--CA 1.472 1.096 0 CA-C-N 115.959 -0.564 . . . . 64.33 112.401 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.1 t -113.27 145.65 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.726 0.81 . . . . 60.13 110.699 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -121.89 151.62 40.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.451 1.1 . . . . 74.42 108.375 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 7.6 p90 -126.39 125.76 42.73 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.261 0.624 . . . . 75.23 109.611 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -120.22 140.51 51.05 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.655 0.782 . . . . 63.14 111.144 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.49 129.6 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.553 0.741 . . . . 63.35 111.087 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 87.3 m-20 -78.97 176.56 9.53 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.706 0.802 . . . . 65.21 112.407 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -59.5 -31.08 69.03 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.021 0.528 . . . . 74.05 111.789 170.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -83.73 -17.69 40.4 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.557 0.743 . . . . 70.25 111.089 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.89 13.26 34.72 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 114.818 0.687 . . . . 23.52 114.818 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.9 m-20 -79.81 147.35 31.83 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 117.604 0.702 . . . . 75.1 111.878 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 117.16 29.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.315 0.646 . . . . 63.54 110.528 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' TRP . 59.8 t -110.86 122.26 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.725 0.81 . . . . 64.53 110.532 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -92.47 124.85 36.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.357 0.663 . . . . 71.41 109.413 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -132.35 141.0 39.7 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 123.995 0.918 . . . . 50.01 111.011 -171.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.35 76.92 4.28 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.916 2.41 . . . . 71.33 113.138 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.8 m -69.61 -18.95 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 115.923 -0.58 . . . . 71.11 112.399 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.22 172.81 49.35 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.427 0.531 . . . . 70.04 114.427 168.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.588 HD22 HG21 ' A' ' 77' ' ' VAL . 83.0 mt -97.71 132.02 25.82 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.425 1.09 . . . . 71.55 110.189 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.0 -36.14 23.38 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.074 1.849 . . . . 75.13 111.535 170.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -123.13 81.3 51.6 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 123.754 0.822 . . . . 71.22 109.876 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.89 -57.23 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.416 2.744 . . . . 70.41 114.57 -173.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.7 -42.53 95.23 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.96 0.504 . . . . 64.24 111.224 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -59.26 -40.88 87.42 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.428 0.455 . . . . 73.43 111.656 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.595 HG13 ' SD ' ' A' ' 28' ' ' MET . 46.7 t -60.98 -43.29 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 C-N-CA 123.23 0.612 . . . . 71.22 111.549 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -65.45 -42.58 92.18 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 112.274 0.472 . . . . 73.3 112.274 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -75.85 -42.57 49.1 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 112.69 0.626 . . . . 64.43 112.69 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.88 -37.36 79.13 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.594 0.757 . . . . 65.54 111.709 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.31 -40.2 74.34 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.559 0.344 . . . . 72.11 110.955 177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.09 73.64 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.483 0.713 . . . . 75.04 112.294 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.7 t -73.75 -53.23 10.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.255 0.622 . . . . 64.54 111.611 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -66.44 -31.56 72.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 112.722 0.638 . . . . 75.53 112.722 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.8 p -67.22 -29.72 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 122.512 0.325 . . . . 74.33 111.711 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.71 -25.66 59.29 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.277 0.631 . . . . 61.41 111.999 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.9 m -90.58 -44.85 9.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.364 0.666 . . . . 53.53 112.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.93 -34.73 19.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.544 0.737 . . . . 73.12 112.727 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD21 ' SD ' ' A' ' 33' ' ' MET . 70.7 mt -88.96 142.7 27.41 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 122.162 -0.336 . . . . 42.55 110.769 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -36.1 -58.96 0.64 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.88 1.672 . . . . 70.21 113.583 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' A' ' 119' ' ' HIS . 13.9 m -102.31 168.75 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.622 -0.717 . . . . 73.32 110.334 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.87 1.47 Allowed 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.609 -0.885 . . . . 71.42 108.609 168.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 122' ' ' ILE . 1.5 tt -102.17 106.67 17.56 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.799 -0.815 . . . . 73.35 108.799 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -96.2 103.71 14.67 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 108.798 -0.815 . . . . 65.23 108.798 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -68.45 172.95 10.47 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 121.531 1.487 . . . . 75.54 111.492 167.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 86.1 tt0 -86.86 107.49 18.35 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 106.732 -1.581 . . . . 74.12 106.732 172.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.612 ' HB3' HD11 ' A' ' 108' ' ' LEU . 76.8 mtm -119.29 117.33 28.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.771 0.428 . . . . 71.32 111.234 -175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -120.17 131.82 55.15 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.878 0.871 . . . . 74.53 110.805 -174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.6 mt -86.26 112.02 20.99 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.683 0.793 . . . . 74.01 109.446 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -117.38 128.64 55.23 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.494 1.118 . . . . 74.43 111.427 -167.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.66 110.22 22.34 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 122.879 0.472 . . . . 53.54 110.813 -177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.2 t -122.7 116.29 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.828 1.251 . . . . 63.11 108.42 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.89 30.19 62.89 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 114.768 0.667 . . . . 70.42 114.768 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.94 5.95 89.32 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 114.254 0.462 . . . . 54.21 114.254 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -102.8 129.76 49.57 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.708 0.803 . . . . 72.53 109.709 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.7 m -94.34 126.73 39.78 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.891 0.769 . . . . 74.13 110.76 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.57 170.47 9.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.393 1.077 . . . . 72.35 109.259 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.612 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.9 tp -115.95 118.9 34.23 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.089 -0.338 . . . . 72.33 110.089 170.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 46.7 t -94.18 124.71 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.009 -0.737 . . . . 53.51 109.009 169.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 42.8 t -109.76 99.86 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 121.186 0.517 . . . . 75.35 109.67 176.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 25.9 t80 -85.5 119.75 26.19 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.945 -0.571 . . . . 74.35 109.88 175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.4 t -123.21 95.32 45.87 Favored Pre-proline 0 CA--C 1.551 0.985 0 N-CA-C 108.357 -0.979 . . . . 73.43 108.357 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.51 -177.33 3.56 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.294 1.996 . . . . 71.31 111.766 169.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.15 137.82 33.91 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.098 -0.705 . . . . 73.24 109.098 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.87 179.92 4.64 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.829 0.852 . . . . 53.33 111.257 -171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -73.69 135.95 43.72 Favored 'General case' 0 C--O 1.2 -1.519 0 CA-C-O 118.314 -0.85 . . . . 75.4 108.95 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.9 t -46.88 -26.21 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.402 1.63 . . . . 75.23 115.402 -167.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.1 p -66.43 -49.47 66.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.685 -0.634 . . . . 55.43 111.039 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 1.6 m-70 -128.43 68.76 1.36 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.925 -2.621 . . . . 65.55 103.925 168.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 57.3 mtpt -46.82 -153.03 0.0 OUTLIER Pre-proline 0 CA--C 1.588 2.428 1 C-N-CA 133.332 4.653 . . . . 74.52 121.155 55.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo 4.77 67.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 123.277 2.652 . . . . 64.15 117.142 -124.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.608 HG21 HD12 ' A' ' 93' ' ' LEU . 53.0 mt -98.35 127.9 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.981 -1.009 . . . . 71.22 109.258 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.49 146.43 38.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.306 1.042 . . . . 60.41 109.498 -175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 124' ' ' LYS . 0.0 OUTLIER -78.36 124.19 27.83 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.533 -0.914 . . . . 73.12 108.533 173.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -60.65 -68.57 0.29 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.937 1.295 . . . . 71.51 113.924 -163.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.01 111.79 7.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.68 0.392 . . . . 73.12 110.687 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p 64.09 174.96 0.18 Allowed 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 125.952 1.701 . . . . 74.43 112.44 -175.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -155.11 -146.19 4.37 Favored Glycine 0 N--CA 1.477 1.369 0 O-C-N 121.863 -0.523 . . . . 65.45 113.922 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 51.6 tp 65.0 90.16 0.09 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 125.14 1.376 . . . . 71.15 111.406 -173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HA ' ' HG3' ' A' ' 34' ' ' GLU . 63.2 Cg_endo -86.92 167.97 8.12 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.763 2.309 . . . . 60.55 113.741 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.89 109.74 3.47 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 115.744 -0.662 . . . . 75.34 111.517 173.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.02 136.78 6.14 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-N 117.055 0.428 . . . . 72.54 113.246 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -150.87 113.07 4.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.544 0.738 . . . . 65.23 110.405 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -70.72 80.91 0.61 Allowed 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 122.103 0.954 . . . . 64.42 111.609 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.5 mmm-85 -108.53 139.43 43.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.988 0.915 . . . . 63.43 110.749 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.9 ttm-85 -134.12 137.84 44.83 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.686 0.795 . . . . 74.5 110.328 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -151.7 115.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 C-N-CA 123.456 0.702 . . . . 54.21 110.497 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -93.16 116.41 5.15 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-N 115.894 -0.594 . . . . 55.41 112.001 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 45.0 m -78.53 -64.41 1.18 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.089 0.556 . . . . 74.42 110.721 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 t -165.16 152.5 10.93 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.614 0.766 . . . . 72.12 111.196 177.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -102.92 119.62 39.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.985 0.914 . . . . 71.55 109.93 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -114.26 109.74 18.84 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.24 0.616 . . . . 71.04 110.831 -173.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -122.03 157.64 30.92 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.89 0.876 . . . . 72.22 110.413 170.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.3 t -159.62 117.7 2.74 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.369 0.667 . . . . 62.11 111.034 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.78 144.81 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 123.857 0.863 . . . . 62.44 110.538 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.3 mt -123.53 133.72 53.96 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.695 0.798 . . . . 74.21 110.333 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -88.86 146.56 24.88 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.104 0.478 . . . . 75.33 111.547 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -80.75 145.06 31.7 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.585 0.754 . . . . 74.34 110.943 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -82.22 107.8 15.18 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.186 -0.672 . . . . 71.23 109.186 167.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -66.76 123.35 19.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.805 0.442 . . . . 64.14 110.578 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -54.41 98.28 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 123.687 0.795 . . . . 70.34 112.329 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -79.45 124.35 28.38 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 108.609 -0.885 . . . . 75.11 108.609 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 . . . . . 0 N--CA 1.496 1.874 0 C-N-CA 125.056 1.342 . . . . 74.25 110.771 -168.129 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.179 -1.045 . . . . 55.21 108.179 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' O ' HG11 ' A' ' 109' ' ' VAL . 26.6 mmm180 -82.98 159.61 22.19 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.336 0.655 . . . . 75.41 112.183 -171.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.1 m -81.43 156.5 25.35 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 112.817 0.673 . . . . 42.22 112.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.52 -39.88 94.96 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.782 0.833 . . . . 45.51 112.078 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.1 p -62.09 -46.87 87.15 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.576 -0.738 . . . . 75.33 110.639 172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.21 -47.2 87.2 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.918 -1.037 . . . . 72.21 111.911 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.35 -36.79 85.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.172 0.589 . . . . 71.34 111.755 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' HD3' ' A' ' 68' ' ' PRO . 28.1 tp -65.05 -48.49 73.63 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.017 0.527 . . . . 74.34 111.212 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -63.7 -35.69 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.091 0.556 . . . . 62.52 111.846 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -63.32 -45.87 89.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.487 0.715 . . . . 75.22 111.229 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 22' ' ' ALA . 41.8 mt -59.8 -39.63 85.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.955 0.902 . . . . 75.33 111.069 176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.436 HD21 ' H ' ' A' ' 66' ' ' TYR . 18.9 m120 -65.26 -34.45 78.38 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.809 0.844 . . . . 73.21 112.133 174.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.46 -41.91 72.18 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.629 0.771 . . . . 73.32 112.187 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.2 m -114.84 118.35 58.46 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 CA-C-O 121.653 0.74 . . . . 75.24 112.37 -174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -63.64 -9.9 16.09 Favored 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 124.73 1.212 . . . . 73.24 113.574 172.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -124.32 117.07 23.68 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 121.7 -0.625 . . . . 74.5 110.36 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.9 p -78.17 91.72 4.37 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.631 0.773 . . . . 70.31 111.493 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.67 -59.52 5.06 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.633 0.773 . . . . 73.33 111.732 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.6 HH21 ' HG ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -147.42 26.04 1.07 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.043 0.537 . . . . 70.13 111.693 170.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.9 mt -127.24 109.61 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.407 -0.96 . . . . 60.04 108.407 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -127.07 130.07 49.22 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 120.93 0.395 . . . . 70.12 111.129 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.497 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -84.69 143.3 29.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.595 0.758 . . . . 51.43 111.773 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 74.5 mmtt -129.26 145.76 51.29 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.965 0.906 . . . . 74.44 109.565 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.95 161.49 24.29 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.239 0.616 . . . . 75.33 111.084 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 -36.95 85.55 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.091 0.556 . . . . 65.41 111.703 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 -18.99 61.45 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.605 0.762 . . . . 71.11 112.584 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.82 -7.12 57.56 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.38 0.672 . . . . 73.43 112.712 -176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.541 ' SD ' HG13 ' A' ' 77' ' ' VAL . 34.3 mtp -55.9 124.27 17.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.446 0.906 . . . . 51.05 113.446 -176.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.23 -144.91 15.16 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.366 -0.833 . . . . 75.32 111.758 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.9 pttt -59.57 -26.85 65.74 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.137 0.975 . . . . 71.32 113.544 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.0 m -73.52 -27.23 61.25 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.303 0.641 . . . . 71.23 112.26 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 46.3 t -74.66 -48.94 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 121.244 0.545 . . . . 73.34 110.436 166.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 86.9 mmm -56.73 -34.45 67.52 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 114.322 1.23 . . . . 75.51 114.322 -174.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -57.63 -41.76 82.01 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.14 0.576 . . . . 73.35 111.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 m -78.14 -27.67 48.24 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 123.289 0.636 . . . . 75.32 111.712 -177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.1 t -57.64 -45.54 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 123.626 0.77 . . . . 54.53 110.604 172.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -51.85 -44.02 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.778 1.231 . . . . 64.31 112.111 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.56 -46.54 89.47 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.341 0.656 . . . . 43.33 112.75 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -71.63 -35.64 70.5 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.904 0.705 . . . . 64.5 112.904 -174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.2 55.74 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.163 0.585 . . . . 75.11 112.444 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -103.99 -48.33 3.93 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 113.733 1.012 . . . . 65.01 113.733 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.1 121.09 76.72 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -57.39 111.73 0.91 Allowed 'Trans proline' 0 C--N 1.387 2.554 0 C-N-CA 123.294 2.662 . . . . 75.31 113.626 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.89 -11.16 29.68 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 115.34 -0.845 . . . . 70.11 114.633 171.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HG ' HH21 ' A' ' 19' ' ' ARG . 6.5 mp -94.64 -1.18 53.65 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 119.574 1.687 . . . . 75.0 110.991 173.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.74 ' HB3' ' HB3' ' A' ' 114' ' ' GLU . 10.0 m-20 -34.53 102.31 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 126.527 1.931 . . . . 55.5 114.371 174.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.65 48.95 0.82 Allowed Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.87 -0.605 . . . . 40.33 112.866 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.94 172.52 47.96 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 113.981 0.352 . . . . 65.54 113.981 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -132.38 147.16 52.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.765 0.826 . . . . 63.34 112.635 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.1 mt -129.4 124.7 34.82 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 74.4 108.552 172.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.59 109.21 20.8 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 122.111 -0.368 . . . . 74.04 110.138 -177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD12 HD23 ' A' ' 108' ' ' LEU . 56.6 mt -88.96 129.44 35.63 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.151 0.58 . . . . 64.41 110.964 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.48 30.36 5.0 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.195 -0.457 . . . . 54.2 112.482 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 48.3 t -116.3 139.52 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.374 0.67 . . . . 65.25 110.631 175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -137.66 131.71 31.88 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.302 -1.369 . . . . 75.55 107.302 175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -115.68 140.62 49.02 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.128 0.49 . . . . 75.12 112.282 -171.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.48 141.63 48.37 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.308 1.043 . . . . 75.11 110.404 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.8 mt -101.91 133.67 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.595 0.758 . . . . 72.23 111.422 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -74.81 169.37 18.03 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.186 0.994 . . . . 61.22 111.882 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -61.91 -33.98 75.23 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.393 0.677 . . . . 75.15 111.231 174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -71.03 -27.64 63.82 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.483 0.713 . . . . 53.02 111.683 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 103.47 41.14 2.24 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-N 116.302 -0.408 . . . . 72.41 113.08 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -100.29 121.63 41.79 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.325 0.65 . . . . 71.21 109.876 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.9 m -84.7 108.48 17.43 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.139 0.575 . . . . 73.53 110.574 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.2 t -100.43 112.61 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.492 1.117 . . . . 74.12 109.76 -176.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.436 ' H ' HD21 ' A' ' 12' ' ' ASN . 81.0 m-85 -89.22 115.0 26.39 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.583 -0.525 . . . . 75.12 109.583 -175.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -115.85 134.49 22.71 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 123.783 0.833 . . . . 72.02 111.19 -169.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.581 ' HD3' HD21 ' A' ' 8' ' ' LEU . 88.3 Cg_endo -75.8 86.86 1.45 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.779 2.319 . . . . 75.12 112.634 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.33 -26.21 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 115.997 -0.547 . . . . 61.52 111.422 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 82.54 -176.16 53.52 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 115.115 0.806 . . . . 73.31 115.115 172.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -113.91 116.2 45.31 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.404 1.082 . . . . 75.52 109.988 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.56 -33.33 96.36 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.711 2.274 . . . . 75.04 112.665 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -130.57 75.82 78.37 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.852 0.861 . . . . 71.2 109.137 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.84 -39.46 61.9 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 123.064 2.509 . . . . 73.53 114.522 -166.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 10.6 p-10 -72.99 -40.4 65.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.512 0.725 . . . . 74.35 111.102 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -63.31 -37.92 89.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.965 0.506 . . . . 53.5 111.328 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.541 HG13 ' SD ' ' A' ' 28' ' ' MET . 42.5 t -58.93 -47.55 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.045 0.938 . . . . 74.2 111.071 175.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.549 ' HG3' ' SD ' ' A' ' 97' ' ' MET . 51.9 tt0 -59.84 -45.59 91.93 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.854 0.862 . . . . 61.34 112.199 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 20.8 mmm-85 -74.86 -40.04 61.22 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.72 -0.673 . . . . 70.12 112.085 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.39 -44.49 92.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.916 0.886 . . . . 71.04 110.778 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.623 HD22 HD11 ' A' ' 52' ' ' LEU . 22.8 tp -66.76 -40.46 88.27 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.423 -0.808 . . . . 73.22 111.795 -179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -35.91 82.51 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.183 0.593 . . . . 61.44 112.176 176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.9 t -66.99 -52.0 48.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.386 0.674 . . . . 71.44 111.5 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.474 HE21 ' HA ' ' A' ' 81' ' ' LEU . 29.7 pt20 -67.74 -28.48 67.67 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 112.508 0.558 . . . . 71.34 112.508 176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 49.7 t -58.2 -33.23 69.07 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.187 0.439 . . . . 63.12 112.187 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.17 -38.05 13.76 Favored 'General case' 0 CA--C 1.559 1.321 0 C-N-CA 123.559 0.743 . . . . 61.21 112.183 176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.3 m -74.29 -33.21 63.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 113.51 0.929 . . . . 71.02 113.51 -175.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.8 mmm -88.33 -55.48 3.72 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.152 0.581 . . . . 53.25 111.203 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -73.34 148.65 43.27 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.312 0.645 . . . . 73.21 112.573 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.494 ' HB3' HG23 ' A' ' 122' ' ' ILE . 41.7 t30 -41.98 -63.41 0.74 Allowed 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 126.019 1.727 . . . . 64.02 112.85 -177.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 m -102.08 167.68 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.744 -0.662 . . . . 73.44 110.861 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.7 97.48 2.19 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.136 0.493 . . . . 72.41 110.323 174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tt -91.79 123.68 35.35 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.529 -0.915 . . . . 74.54 108.529 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -104.52 106.04 52.63 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 122.934 0.494 . . . . 72.34 110.941 173.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -87.99 170.56 6.06 Favored 'Trans proline' 0 CA--C 1.561 1.835 0 C-N-CA 122.403 2.069 . . . . 74.3 112.928 166.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.0 tp10 -104.06 136.87 42.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.829 0.852 . . . . 70.34 109.324 176.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.726 ' HB3' HD11 ' A' ' 108' ' ' LEU . 66.1 mtt -134.53 122.11 21.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.155 0.582 . . . . 74.43 110.917 -172.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -124.93 134.42 52.66 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.306 0.642 . . . . 73.32 112.135 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 79.0 mt -102.17 123.19 45.59 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.813 0.845 . . . . 73.25 111.701 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -142.24 147.05 35.85 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.24 1.016 . . . . 61.0 110.443 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -97.73 123.4 41.65 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 120.968 0.413 . . . . 43.34 110.649 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.51 114.12 44.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 124.902 1.281 . . . . 73.14 108.511 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 57.15 29.57 59.87 Favored Glycine 0 CA--C 1.547 2.074 0 N-CA-C 115.439 0.936 . . . . 62.1 115.439 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.94 3.72 73.15 Favored Glycine 0 CA--C 1.54 1.631 0 N-CA-C 115.062 0.785 . . . . 63.42 115.062 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 11.6 mptt -117.58 132.91 56.44 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 123.6 0.76 . . . . 63.13 109.444 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.5 m -83.15 131.28 35.14 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 118.593 0.633 . . . . 74.43 111.087 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.25 159.44 24.06 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.602 1.161 . . . . 75.53 109.225 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 97' ' ' MET . 36.8 tp -116.74 118.19 31.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.82 0.448 . . . . 72.31 109.988 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.404 HG11 ' O ' ' A' ' 2' ' ' ARG . 29.7 t -82.74 105.63 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.804 -0.813 . . . . 60.2 108.804 172.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.41 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 38.7 t -95.35 98.69 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.489 0.661 . . . . 74.01 109.764 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 17.1 t80 -80.58 115.76 20.26 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.209 -0.905 . . . . 63.11 108.705 171.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.27 94.49 3.37 Favored Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 108.462 -0.94 . . . . 71.53 108.462 174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.99 166.91 27.12 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.593 2.195 . . . . 50.41 112.571 -178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . 12.4 pt-20 -59.97 119.78 8.4 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 113.864 1.061 . . . . 71.23 113.864 -177.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.58 141.25 51.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.663 -0.495 . . . . 75.2 109.663 162.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.641 ' HB3' HG22 ' A' ' 118' ' ' THR . 38.6 t70 -75.98 161.94 28.5 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.909 0.483 . . . . 63.12 112.17 -174.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.05 -21.11 14.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 C-N-CA 124.791 1.236 . . . . 41.44 112.603 174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.641 HG22 ' HB3' ' A' ' 116' ' ' ASP . 15.1 t -54.23 -21.94 10.32 Favored 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 123.647 0.779 . . . . 75.4 112.03 170.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.497 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 39.8 m-70 -90.54 -98.08 0.11 Allowed 'General case' 0 CA--C 1.583 2.248 0 N-CA-C 104.724 -2.325 . . . . 71.03 104.724 164.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 55.3 mttm -68.14 -146.14 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.476 0 CA-C-N 125.902 3.955 . . . . 72.01 110.556 -45.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_exo 7.62 89.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.398 3.151 0 C-N-CA 124.721 3.614 . . . . 54.14 118.364 -138.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 90' ' ' ASN . 60.5 mt -74.59 101.54 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.516 -1.22 . . . . 75.3 109.507 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -92.18 168.89 11.03 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 114.686 -1.143 . . . . 73.02 109.535 176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mtmm -84.53 155.48 22.11 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.825 -0.547 . . . . 75.34 109.58 173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -64.48 -25.88 68.19 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.146 0.498 . . . . 45.53 110.682 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.0 100.49 3.58 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.2 0.6 . . . . 75.34 109.382 163.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.1 t -63.49 144.74 56.73 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 113.74 1.015 . . . . 53.24 113.74 -170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -173.37 135.32 3.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.456 -0.793 . . . . 65.41 111.15 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 41.3 tp -116.71 94.64 44.31 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.239 0.616 . . . . 61.44 111.272 -174.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -70.0 -45.24 1.53 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.903 2.402 . . . . 54.34 112.87 172.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.47 105.32 0.57 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 116.315 -0.402 . . . . 60.42 112.749 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.75 -179.06 37.8 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 113.918 0.327 . . . . 70.25 113.918 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -78.44 118.23 20.4 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.328 0.651 . . . . 63.41 110.357 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -74.98 138.59 42.37 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.742 0.817 . . . . 65.12 112.541 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -82.35 141.79 32.56 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.433 0.693 . . . . 71.23 109.159 171.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -56.8 170.66 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 125.084 1.354 . . . . 73.43 114.252 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.8 pt -61.98 149.33 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 123.095 0.558 . . . . 44.13 112.189 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 131.2 64.08 0.09 OUTLIER Glycine 0 N--CA 1.472 1.092 0 N-CA-C 111.237 -0.745 . . . . 42.5 111.237 -172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 40.4 t -164.38 -64.21 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.831 0.852 . . . . 71.43 110.436 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 80.1 p -166.26 148.07 6.76 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.238 1.015 . . . . 73.4 109.865 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.11 122.1 18.77 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.078 0.466 . . . . 64.53 112.101 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.68 -22.28 60.94 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.502 -0.772 . . . . 71.34 110.213 168.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -68.52 99.87 1.03 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.345 1.058 . . . . 60.33 111.454 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.4 124.31 39.37 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.151 0.58 . . . . 52.34 110.09 173.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.19 156.1 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-O 121.207 0.527 . . . . 74.51 111.933 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.62 -21.95 62.59 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.426 0.69 . . . . 64.0 111.637 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.69 111.63 18.14 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.442 0.697 . . . . 63.32 110.624 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -158.73 141.45 14.4 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.857 0.863 . . . . 73.45 110.56 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -63.49 110.92 2.12 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.522 0.729 . . . . 70.31 111.9 -176.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -129.24 135.66 49.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.803 0.841 . . . . 74.52 109.188 172.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -69.08 142.74 54.41 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.254 0.622 . . . . 70.31 111.653 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -151.07 -178.19 6.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.852 0.861 . . . . 65.04 110.905 -177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 N--CA 1.482 1.175 0 C-N-CA 123.352 0.661 . . . . 73.24 111.544 179.679 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.599 ' SD ' ' HB2' ' A' ' 111' ' ' TYR . 5.0 ttm . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.106 -0.331 . . . . 63.04 110.106 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -85.69 152.51 23.03 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 123.447 0.699 . . . . 73.51 110.561 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.7 p -78.23 152.17 32.73 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.096 0.558 . . . . 75.14 111.566 175.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.02 66.67 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.154 0.581 . . . . 73.53 112.47 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -63.77 -36.31 83.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 113.137 0.791 . . . . 73.11 113.137 -175.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.78 -35.44 80.72 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.039 0.447 . . . . 73.02 111.058 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.63 -36.44 80.79 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.401 0.68 . . . . 74.34 111.795 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.58 -37.22 79.67 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.602 0.361 . . . . 61.41 111.266 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -62.61 -38.91 92.02 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.804 0.442 . . . . 71.32 110.02 174.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.09 -37.14 78.26 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.732 0.813 . . . . 55.04 111.634 176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 mt -61.83 -45.26 94.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.747 0.819 . . . . 74.35 111.708 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -77.17 -19.82 56.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.184 0.594 . . . . 74.14 112.128 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.51 -51.97 17.74 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.031 0.533 . . . . 71.45 111.097 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -78.95 159.14 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-O 121.213 0.53 . . . . 62.52 111.216 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.92 -21.86 24.69 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.371 0.668 . . . . 62.21 112.055 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -145.69 144.63 30.5 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.992 0.917 . . . . 73.14 111.097 -176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 t -75.13 116.2 15.6 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.664 0.786 . . . . 62.13 112.352 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.63 -58.83 1.8 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.154 0.982 . . . . 75.3 111.983 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -115.15 -13.17 11.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 123.822 0.849 . . . . 73.34 112.892 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -129.6 121.8 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.776 0.83 . . . . 74.23 110.244 -167.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -127.52 138.95 53.05 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.626 0.37 . . . . 64.02 110.768 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -93.26 151.98 19.47 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.77 0.828 . . . . 70.42 111.288 175.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HB2' HD23 ' A' ' 52' ' ' LEU . 69.6 mmtt -140.01 141.36 36.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.444 1.097 . . . . 63.11 110.454 -175.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.6 mtm180 -84.87 160.53 20.14 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.391 0.676 . . . . 71.52 110.657 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.89 64.58 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.82 1.044 . . . . 74.34 113.82 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 m -81.86 -11.98 58.69 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 113.137 0.791 . . . . 70.52 113.137 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.5 -9.03 59.79 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.425 0.69 . . . . 64.24 112.148 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 95.0 mmm -52.09 115.21 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.222 1.009 . . . . 74.24 112.905 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.93 -131.35 5.69 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 116.217 -0.447 . . . . 72.33 113.615 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.41 -38.31 68.78 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.699 1.2 . . . . 71.13 113.857 -168.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.12 -32.98 69.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.346 0.658 . . . . 61.33 112.093 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.74 -48.68 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.177 0.591 . . . . 72.14 110.059 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.96 -41.44 59.2 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 125.246 1.419 . . . . 71.31 113.797 179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -57.6 -43.48 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.207 0.527 . . . . 75.44 111.531 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 m -76.59 -30.7 57.09 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.349 0.659 . . . . 52.24 111.439 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.47 -45.44 98.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.197 0.599 . . . . 62.05 110.302 171.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.65 -38.39 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 123.301 0.64 . . . . 72.33 110.921 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.01 91.41 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.425 0.69 . . . . 63.2 112.284 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -70.01 -38.98 76.11 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.153 0.581 . . . . 64.03 111.917 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.9 73.14 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.061 0.544 . . . . 51.11 111.714 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.88 -17.14 53.9 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.848 0.859 . . . . 72.42 111.148 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.98 109.82 9.26 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 123.016 0.526 . . . . 73.02 110.459 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.44 117.05 4.95 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.222 1.948 . . . . 75.32 112.095 -174.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.4 2.48 90.52 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 114.944 0.738 . . . . 71.21 114.944 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 tp -113.33 18.64 17.65 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.598 1.199 . . . . 74.32 109.918 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 114' ' ' GLU . 8.6 p-10 -43.51 114.03 0.58 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.22 1.408 . . . . 64.22 113.771 168.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.42 59.21 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.927 -0.579 . . . . 73.43 113.591 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.36 156.29 24.02 Favored Glycine 0 N--CA 1.471 0.993 0 N-CA-C 112.507 -0.237 . . . . 54.12 112.507 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.94 128.06 55.46 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.247 0.524 . . . . 64.52 112.041 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 96.2 mt -121.15 123.82 43.21 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.973 0.909 . . . . 63.12 110.121 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.42 109.3 20.88 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.314 0.646 . . . . 72.11 110.287 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.681 HD12 HD23 ' A' ' 108' ' ' LEU . 57.0 mt -94.56 122.73 37.45 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.888 0.475 . . . . 73.04 109.874 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.24 3.76 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 116.503 -0.317 . . . . 75.11 112.919 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 45.0 t -115.38 139.52 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.515 0.726 . . . . 75.33 110.134 173.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.66 133.29 49.63 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.958 -1.497 . . . . 72.34 106.958 172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -110.37 138.41 46.8 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.029 0.532 . . . . 75.2 111.404 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.33 141.32 48.32 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.083 0.953 . . . . 74.51 110.544 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mm -92.0 134.75 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.801 0.84 . . . . 72.25 110.902 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.676 HD21 HG23 ' A' ' 65' ' ' VAL . 21.4 m-80 -85.81 -179.13 6.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.464 0.706 . . . . 75.51 112.194 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -59.58 -38.09 80.26 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.039 0.936 . . . . 64.45 111.758 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -82.79 7.13 15.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.273 0.842 . . . . 72.2 113.273 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.13 85.96 Favored Glycine 0 CA--C 1.542 1.729 0 N-CA-C 114.885 0.714 . . . . 75.04 114.885 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.409 ' HB3' HD22 ' A' ' 59' ' ' ASN . 25.5 t70 -71.28 157.58 37.86 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.799 0.84 . . . . 61.22 112.423 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -103.92 124.65 49.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.053 0.941 . . . . 71.24 111.274 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.676 HG23 HD21 ' A' ' 59' ' ' ASN . 78.2 t -116.49 130.28 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 123.854 0.862 . . . . 54.12 109.892 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -93.82 119.63 33.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.931 0.893 . . . . 70.14 111.166 -173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -112.41 133.7 21.73 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.58 0.752 . . . . 72.52 111.644 -175.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -77.28 88.4 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.286 1.991 . . . . 72.41 112.212 175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.7 m -81.37 -19.03 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 122.994 0.517 . . . . 60.44 111.604 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 105' ' ' LYS . . . 77.15 -173.41 54.92 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 121.881 0.712 . . . . 54.12 114.378 177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD22 HG21 ' A' ' 77' ' ' VAL . 55.0 mt -115.2 127.65 26.63 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 124.643 1.177 . . . . 73.22 108.765 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.15 -23.57 52.75 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.284 1.989 . . . . 74.5 112.485 175.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -139.3 73.58 36.75 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 125.219 1.407 . . . . 64.54 110.208 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.18 -42.77 12.76 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.613 2.875 . . . . 75.21 114.821 -165.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -71.72 -31.31 66.59 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.57 0.748 . . . . 61.43 111.967 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -72.27 -34.17 68.02 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 120.603 0.239 . . . . 74.35 110.412 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.475 HG21 HD22 ' A' ' 71' ' ' LEU . 98.7 t -59.26 -40.76 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.707 0.803 . . . . 50.21 110.918 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -63.99 -49.26 73.15 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.375 1.07 . . . . 73.43 113.173 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -34.66 64.08 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 112.614 0.598 . . . . 73.53 112.614 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 84' ' ' GLN . 3.9 m-20 -62.11 -45.06 95.15 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.378 0.271 . . . . 71.4 110.573 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.665 HD23 ' SD ' ' A' ' 97' ' ' MET . 35.1 tp -63.07 -38.58 91.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.967 0.507 . . . . 73.5 112.163 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.68 72.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.264 0.626 . . . . 65.02 111.47 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.2 t -73.6 -44.69 56.54 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 123.682 0.793 . . . . 71.24 111.676 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 80' ' ' ASP . 80.7 mt-30 -58.06 -44.87 87.72 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.649 0.78 . . . . 72.34 111.553 177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.5 t -74.93 -18.42 60.4 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.183 0.993 . . . . 23.53 111.986 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -82.81 -43.63 16.46 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.294 0.638 . . . . 54.05 112.367 171.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.5 t -83.91 -52.43 6.36 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 123.8 0.84 . . . . 73.43 113.038 -170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.0 mmm -67.86 -17.62 64.55 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.852 0.861 . . . . 54.4 112.89 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.2 mt -108.73 148.5 30.38 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.422 0.689 . . . . 71.24 110.166 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -39.07 -53.67 1.79 Allowed 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.741 1.216 . . . . 75.31 113.532 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.04 157.92 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 114.903 -1.044 . . . . 61.31 109.564 -176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -67.71 97.2 0.61 Allowed 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 121.847 0.832 . . . . 62.14 109.453 171.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tt -94.15 117.38 30.03 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.065 -1.457 . . . . 73.31 107.065 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -110.71 92.56 14.64 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.914 0.885 . . . . 74.5 110.167 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.32 165.59 24.16 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.742 2.295 . . . . 74.34 113.671 176.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 13.2 tp10 -85.13 107.57 17.27 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.726 -1.213 . . . . 74.14 107.726 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.665 ' SD ' HD23 ' A' ' 81' ' ' LEU . 76.2 mtm -119.1 122.53 42.3 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 122.781 0.433 . . . . 52.32 111.64 -173.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -129.09 123.75 33.02 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.122 0.969 . . . . 74.54 110.741 -174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.67 114.79 12.32 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.73 0.812 . . . . 73.31 110.737 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -115.74 125.63 53.03 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.879 0.872 . . . . 75.12 111.211 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -97.16 117.75 32.05 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.348 0.659 . . . . 70.32 111.382 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.0 t -123.52 118.8 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.085 1.354 . . . . 64.2 110.034 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.92 35.06 52.67 Favored Glycine 0 CA--C 1.547 2.056 0 N-CA-C 115.817 1.087 . . . . 62.53 115.817 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.26 -3.12 85.71 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 117.05 0.425 . . . . 74.11 114.119 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HA3' ' A' ' 70' ' ' GLY . 74.2 mmtt -99.17 137.57 37.5 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.492 1.117 . . . . 60.45 109.078 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -107.77 131.1 54.81 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 119.273 0.942 . . . . 54.45 111.305 -178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.42 168.67 11.43 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.253 1.021 . . . . 73.11 109.267 -174.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD23 HD12 ' A' ' 52' ' ' LEU . 34.7 tp -121.89 116.68 24.82 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.894 -0.41 . . . . 71.21 109.894 173.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.432 HG12 ' SD ' ' A' ' 1' ' ' MET . 38.2 t -87.8 120.81 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 108.92 -0.77 . . . . 70.45 108.92 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 46.2 t -110.69 104.82 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.365 0.666 . . . . 64.0 110.394 -175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 74.3 t80 -90.47 113.28 25.2 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.136 0.974 . . . . 74.51 110.222 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.7 t -110.53 100.82 46.72 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.568 0.747 . . . . 74.33 110.495 -176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -86.31 -173.27 1.2 Allowed 'Trans proline' 0 CA--C 1.56 1.823 0 C-N-CA 122.716 2.277 . . . . 64.45 113.309 173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . 36.4 tt0 -93.64 153.18 18.51 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.866 0.866 . . . . 64.41 109.71 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.08 155.2 40.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.41 0.624 . . . . 61.41 112.323 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.18 158.76 35.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 123.952 0.901 . . . . 73.42 110.997 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' HD2' ' A' ' 134' ' ' TYR . 16.4 t -56.46 -22.21 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.525 0.935 . . . . 74.22 113.525 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.0 p -52.08 -22.13 3.86 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 123.766 0.827 . . . . 64.33 112.366 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.659 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 81.3 m-70 -104.23 -84.29 0.48 Allowed 'General case' 0 CA--C 1.584 2.263 0 N-CA-C 106.354 -1.721 . . . . 62.52 106.354 162.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 16.1 ptpt -79.81 -148.0 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.665 0 CA-C-N 125.655 3.843 . . . . 71.33 110.909 -34.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 3.3 Cg_exo 7.52 116.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.401 3.305 1 C-N-CA 125.489 4.126 . . . . 74.44 120.102 -137.259 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.48 93.8 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 114.317 -1.311 . . . . 72.12 109.039 169.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -79.49 170.74 16.14 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.34 0.656 . . . . 72.14 111.017 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -90.67 90.74 8.09 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 18.29 101.54 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.618 0 C-N-CA 127.005 2.122 . . . . 51.23 115.503 -174.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.54 167.9 18.59 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.329 0.652 . . . . 73.03 112.058 -175.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.4 m -68.66 -29.23 67.66 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.904 0.882 . . . . 74.23 111.992 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -73.07 163.84 54.93 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.492 -0.322 . . . . 72.25 113.264 176.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 129' ' ' LEU . 2.5 pt? -117.49 154.08 50.49 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.111 0.964 . . . . 72.24 109.96 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -70.29 -166.08 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.688 2.259 . . . . 75.02 112.987 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -58.99 -87.78 0.02 OUTLIER Glycine 0 CA--C 1.541 1.679 0 N-CA-C 114.621 0.609 . . . . 72.52 114.621 -175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.43 -28.3 3.89 Favored Glycine 0 N--CA 1.484 1.855 0 N-CA-C 114.631 0.613 . . . . 53.35 114.631 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.78 -17.51 64.26 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.781 0.832 . . . . 71.23 112.954 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.45 ' HD2' HG11 ' A' ' 117' ' ' VAL . 16.4 t80 -126.43 44.42 2.88 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.589 0.755 . . . . 54.21 109.731 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -67.96 87.2 0.25 Allowed 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 121.84 0.829 . . . . 73.24 111.738 177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -77.04 143.61 39.2 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.812 0.845 . . . . 75.24 111.495 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.32 94.2 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.084 0.469 . . . . 60.15 110.06 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.24 -57.16 3.04 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 111.557 -0.617 . . . . 74.4 111.557 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.7 p 57.56 2.94 0.16 Allowed 'General case' 0 N--CA 1.507 2.402 0 C-N-CA 125.916 1.686 . . . . 53.42 114.842 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t -89.45 91.51 8.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.772 0.829 . . . . 71.21 109.484 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -134.57 135.66 42.43 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.462 0.705 . . . . 71.43 110.029 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -97.35 134.9 40.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.268 0.627 . . . . 62.4 111.148 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -78.28 125.87 29.97 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 123.039 0.535 . . . . 73.34 110.123 175.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.9 m -74.75 84.98 2.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.327 0.651 . . . . 74.43 110.12 174.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.59 -36.3 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 115.211 -0.904 . . . . 61.32 110.6 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 73.1 mt -65.95 102.51 0.8 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.691 0.796 . . . . 41.22 110.966 175.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -85.81 142.75 28.7 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 109.101 -0.703 . . . . 74.02 109.101 176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -93.89 128.78 40.37 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.875 0.87 . . . . 72.01 111.215 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -63.48 87.46 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.532 0.733 . . . . 74.32 111.013 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -89.72 125.42 35.27 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.018 0.927 . . . . 73.25 110.918 -177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -111.69 129.57 56.06 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.119 0.485 . . . . 63.33 111.48 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -132.78 166.94 21.08 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.343 1.057 . . . . 63.51 109.845 170.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 121.279 0.561 . . . . 51.34 110.701 177.53 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 16.6 ptm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 110.784 -0.08 . . . . 74.5 110.784 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -83.87 156.71 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.508 0.723 . . . . 61.21 111.893 175.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -82.16 161.23 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.781 0.832 . . . . 63.13 112.046 176.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB1' HD22 ' A' ' 107' ' ' LEU . . . -62.25 -44.63 96.1 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.338 0.655 . . . . 72.44 112.018 176.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -72.22 -31.13 65.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.954 0.724 . . . . 73.03 112.954 176.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -60.23 -49.36 77.92 Favored 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 121.786 0.803 . . . . 65.43 111.447 173.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 50.4 mt -72.73 -26.36 61.55 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 114.768 -1.106 . . . . 72.15 112.654 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.93 -43.69 98.27 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.008 0.523 . . . . 52.33 110.353 169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -59.51 -36.33 75.87 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.482 1.113 . . . . 75.43 111.333 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' HG13 ' A' ' 20' ' ' ILE . 7.0 tp10 -65.02 -52.36 56.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.616 0.766 . . . . 71.22 111.267 172.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 73.8 mt -56.57 -37.61 70.81 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 124.463 1.105 . . . . 73.41 113.503 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -78.09 -24.06 47.71 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.057 0.543 . . . . 73.43 111.501 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.67 -38.97 53.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.506 0.722 . . . . 65.53 112.314 176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -86.35 146.35 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 121.296 0.57 . . . . 65.31 111.919 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.96 -39.55 82.05 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.677 1.191 . . . . 74.24 111.596 171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.29 167.79 29.29 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.779 0.832 . . . . 74.13 111.623 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.5 m -66.8 89.56 0.16 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.471 0.709 . . . . 14.24 112.445 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.68 -46.38 10.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.645 0.778 . . . . 63.05 112.017 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -121.67 -28.8 4.48 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.449 0.7 . . . . 64.32 111.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.719 HG13 ' HG2' ' A' ' 10' ' ' GLU . 33.9 mm -112.22 119.19 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 70.33 110.046 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 143.6 42.3 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.101 0.56 . . . . 53.52 109.76 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.9 27.41 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.458 0.703 . . . . 73.42 110.638 -174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' LEU . 54.6 mtmt -141.0 152.94 45.31 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.828 0.851 . . . . 72.35 112.245 -177.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.6 mtm-85 -80.58 170.4 16.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.676 0.79 . . . . 73.34 112.681 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' O ' ' HG2' ' A' ' 28' ' ' MET . . . -60.83 -26.7 67.52 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 113.346 0.869 . . . . 71.22 113.346 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.1 p -64.59 -1.22 1.7 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.429 1.27 . . . . 63.03 114.429 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -111.88 -9.29 14.06 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.974 0.51 . . . . 72.34 112.185 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 25' ' ' ALA . 26.9 ptm -60.76 104.39 0.35 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.663 0.744 . . . . 74.13 111.519 -173.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.26 -122.37 1.21 Allowed Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.669 -0.696 . . . . 65.43 112.388 -172.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -52.78 -58.18 7.73 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.292 1.037 . . . . 75.34 113.797 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.5 m -76.2 -32.06 58.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 112.404 0.52 . . . . 70.4 112.404 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.3 t -64.75 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 118.178 0.444 . . . . 60.22 110.314 174.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 39.0 tpp -58.85 -43.62 90.84 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.622 0.769 . . . . 75.25 111.611 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -59.7 -39.32 84.2 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.649 0.779 . . . . 71.12 111.991 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 m -70.12 -35.52 74.16 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 122.847 0.459 . . . . 63.33 110.996 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.14 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 123.462 0.705 . . . . 54.35 110.474 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 76.6 mt -57.27 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.632 0.773 . . . . 74.15 110.585 174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -62.38 -47.17 85.34 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.428 0.691 . . . . 64.11 112.045 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -67.42 -40.84 85.53 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 122.71 0.404 . . . . 74.55 111.501 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.95 -28.07 67.15 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.287 0.635 . . . . 63.45 111.89 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -80.87 -37.43 29.87 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.892 0.877 . . . . 32.43 110.719 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 38' ' ' ALA . 32.3 mm-40 -56.97 109.32 1.64 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 123.505 0.722 . . . . 75.24 111.944 -176.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HB2' ' HB3' ' A' ' 141' ' ' ASP . 72.9 Cg_endo -70.68 111.07 2.9 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.25 1.966 . . . . 64.25 112.712 -173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.93 22.49 65.94 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 114.486 0.554 . . . . 34.41 114.486 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.14 26.69 10.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 117.702 0.751 . . . . 55.32 110.135 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 31.7 t70 -48.76 119.06 2.89 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.523 0.729 . . . . 62.51 111.777 168.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.501 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 114.41 48.04 0.57 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-N 116.101 -0.5 . . . . 60.23 112.899 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -116.72 137.25 13.39 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 110.613 -0.995 . . . . 33.4 110.613 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -118.43 152.68 35.42 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.325 0.861 . . . . 73.34 113.325 -171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 95.4 mt -123.06 122.32 38.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.171 1.389 . . . . 74.21 109.953 175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.27 108.43 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.721 -0.474 . . . . 73.0 109.721 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 23' ' ' LYS . 7.5 mp -95.19 120.71 35.89 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 109.114 -0.698 . . . . 70.21 109.114 176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.48 25.99 5.28 Favored Glycine 0 N--CA 1.475 1.237 0 CA-C-N 116.312 -0.404 . . . . 51.44 113.232 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.71 133.06 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 109.34 -0.615 . . . . 65.11 109.34 173.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -109.72 154.18 23.27 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.25 -1.018 . . . . 72.42 108.25 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 34.0 p90 -138.54 139.69 38.79 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.058 0.456 . . . . 61.24 111.124 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -125.68 140.31 52.82 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.87 0.868 . . . . 60.44 110.536 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.8 mm -90.39 127.33 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.248 0.619 . . . . 73.52 110.809 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -71.98 171.38 11.92 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.854 0.462 . . . . 70.45 111.435 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.37 -31.03 69.95 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 123.067 0.547 . . . . 74.1 111.725 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -98.32 11.0 39.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.911 0.708 . . . . 75.23 112.911 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 98.3 -3.67 59.96 Favored Glycine 0 N--CA 1.477 1.372 0 N-CA-C 116.859 1.503 . . . . 73.41 116.859 164.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -61.3 128.07 34.59 Favored 'General case' 0 N--CA 1.51 2.574 0 CA-C-N 118.905 1.353 . . . . 74.25 112.97 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -80.09 106.54 12.19 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.876 -0.787 . . . . 72.54 108.876 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -103.11 119.95 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.405 0.682 . . . . 64.44 109.589 -175.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.93 142.47 27.34 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.136 0.574 . . . . 74.1 110.407 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -147.99 137.25 11.96 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.155 0.582 . . . . 74.35 111.414 -176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -82.18 89.53 1.18 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.907 2.405 . . . . 72.5 112.428 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.61 -13.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 122.865 0.466 . . . . 61.43 111.747 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.37 172.19 46.29 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 121.616 0.565 . . . . 72.33 114.309 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -95.44 140.16 22.26 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.202 1.001 . . . . 71.13 109.762 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.86 -37.18 98.75 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.631 2.221 . . . . 55.33 112.274 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -140.58 101.55 6.63 Favored Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 107.806 -1.183 . . . . 65.43 107.806 166.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HB2' HD22 ' A' ' 99' ' ' LEU . 90.4 Cg_endo -74.13 -22.99 16.29 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 122.635 2.223 . . . . 70.31 113.838 -176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -71.55 -43.29 66.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.509 0.724 . . . . 41.12 110.591 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -40.02 87.48 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.549 -0.296 . . . . 62.45 111.275 177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 97.6 t -60.49 -43.64 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.347 0.659 . . . . 74.23 111.748 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -63.21 -41.91 99.22 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.876 0.47 . . . . 53.34 111.978 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -72.86 -46.94 50.15 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.362 0.665 . . . . 71.13 111.915 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -67.35 -30.54 70.38 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.141 0.576 . . . . 71.53 112.01 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.4 tp -72.87 -37.96 67.18 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.406 0.283 . . . . 75.04 111.027 177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.55 76.19 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.19 0.596 . . . . 75.43 111.763 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.6 m -66.07 -51.5 57.56 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.364 0.666 . . . . 74.02 111.347 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -65.62 -29.68 70.29 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.74 0.416 . . . . 74.05 111.419 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.35 -32.28 71.12 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.377 0.51 . . . . 63.53 112.377 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.55 -38.87 16.76 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 122.982 0.513 . . . . 63.13 111.381 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 64.7 m -74.22 -32.05 62.86 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.847 0.859 . . . . 74.21 113.207 -174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 96.5 mmm -94.87 -42.97 8.42 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.435 0.694 . . . . 70.53 112.013 -175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.01 132.19 37.7 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 110.45 -0.204 . . . . 74.23 110.45 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -58.16 -40.28 80.98 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.829 0.851 . . . . 72.21 112.223 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.7 m -97.36 155.56 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.294 0.638 . . . . 42.14 109.824 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.44 96.15 2.33 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 109.667 -0.494 . . . . 74.11 109.667 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.56 123.47 33.67 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.038 -1.097 . . . . 72.42 108.038 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -103.39 95.15 6.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.82 0.848 . . . . 71.43 110.062 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.44 156.28 9.32 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.545 2.163 . . . . 74.14 112.054 174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.5 tp10 -83.44 122.56 28.67 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.967 -0.753 . . . . 64.45 108.967 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 108' ' ' LEU . 65.4 mtt -128.39 124.27 35.91 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.07 0.548 . . . . 70.43 110.391 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.535 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -135.68 133.76 38.45 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 120.985 0.421 . . . . 74.15 110.309 175.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 74' ' ' PRO . 94.5 mt -81.72 111.06 17.63 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.196 0.999 . . . . 60.32 110.641 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -108.36 130.13 55.22 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.954 0.902 . . . . 72.21 111.936 -173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -96.78 118.91 34.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.364 0.665 . . . . 72.03 111.282 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.83 121.29 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 C-N-CA 124.658 1.183 . . . . 75.12 109.59 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 56.68 29.09 57.63 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 115.795 1.078 . . . . 32.52 115.795 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.86 81.39 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.035 0.774 . . . . 70.12 115.035 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -107.59 137.25 45.96 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.558 0.743 . . . . 63.25 109.681 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.9 m -102.01 134.88 44.53 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.684 0.675 . . . . 74.22 110.751 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.437 HD22 ' HB1' ' A' ' 4' ' ' ALA . 6.0 mp -124.48 170.18 11.13 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.393 1.077 . . . . 73.13 108.737 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 97' ' ' MET . 60.9 tp -117.31 116.54 27.42 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 109.671 -0.492 . . . . 62.01 109.671 172.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.7 t -94.42 128.58 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.512 -0.921 . . . . 72.22 108.512 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 56.6 t -121.92 106.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.087 0.555 . . . . 60.42 111.006 -176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.69 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 92.3 t80 -82.52 123.95 29.66 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.026 0.93 . . . . 75.33 110.148 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.5 t -106.39 114.19 62.43 Favored Pre-proline 0 CA--C 1.558 1.269 0 N-CA-C 109.456 -0.572 . . . . 51.43 109.456 173.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.84 161.82 38.51 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.71 2.273 . . . . 62.43 112.602 173.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -75.02 150.15 39.02 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.94 -0.393 . . . . 72.43 109.94 176.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -74.02 145.76 44.28 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.281 0.562 . . . . 72.23 111.776 169.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.68 -179.95 1.95 Allowed 'General case' 0 CA--C 1.565 1.555 0 C-N-CA 124.452 1.101 . . . . 63.23 110.736 174.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.6 t -59.86 -49.69 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 62.31 112.974 167.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 63.9 p -73.2 -49.17 29.49 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.16 0.505 . . . . 75.12 110.708 -169.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 22.7 m-70 -103.92 83.05 2.06 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 102.199 -3.26 . . . . 61.32 102.199 159.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 31.6 mmtp -43.5 -152.9 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.521 1 C-N-CA 132.562 4.345 . . . . 72.25 121.263 61.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo 4.14 80.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.007 2.471 . . . . 63.32 116.046 -126.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 120' ' ' LYS . 46.0 mm -100.74 125.05 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.754 0.822 . . . . 64.34 109.503 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -156.44 -176.86 6.2 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.539 0.736 . . . . 74.4 111.264 -174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -72.44 157.27 37.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.524 0.729 . . . . 73.41 111.908 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -64.46 -38.17 90.09 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.176 0.59 . . . . 70.24 110.884 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.11 142.72 30.24 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.055 0.942 . . . . 53.32 109.97 170.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 43.4 m -66.14 120.96 14.12 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.467 0.707 . . . . 51.35 111.934 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.61 71.19 0.01 OUTLIER Glycine 0 N--CA 1.48 1.593 0 N-CA-C 113.779 0.272 . . . . 45.44 113.779 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 52.6 tp -118.71 105.23 46.01 Favored Pre-proline 0 CA--C 1.564 1.489 0 C-N-CA 123.606 0.763 . . . . 72.1 109.868 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.79 -46.96 0.68 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.156 2.571 . . . . 73.05 114.0 -175.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.9 92.32 0.94 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 111.618 -0.593 . . . . 73.41 111.618 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.21 83.09 0.43 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 123.118 0.389 . . . . 71.52 113.902 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.21 83.66 7.77 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.564 0.746 . . . . 73.03 110.774 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -93.21 -48.17 6.58 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.696 0.799 . . . . 64.54 110.311 175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.1 mtp180 -94.64 154.09 17.51 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.624 0.77 . . . . 74.12 110.071 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -72.96 84.16 1.25 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 122.086 0.946 . . . . 72.23 112.036 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 36.7 pt -95.3 136.81 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.362 0.665 . . . . 74.41 110.755 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -121.9 -135.48 4.74 Favored Glycine 0 N--CA 1.478 1.497 0 C-N-CA 123.04 0.352 . . . . 71.34 112.801 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.4 t -148.21 107.46 3.9 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.347 0.659 . . . . 70.25 110.83 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.9 t -103.84 1.81 31.96 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.774 0.829 . . . . 71.54 111.217 174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 43' ' ' PRO . 18.5 t70 -153.46 141.92 20.73 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.377 0.671 . . . . 73.31 110.517 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -154.45 120.61 5.32 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.195 0.998 . . . . 73.32 110.09 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -104.97 79.13 1.47 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.236 0.615 . . . . 62.35 111.795 -171.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 31.5 p 35.27 74.85 0.06 Allowed 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 126.496 1.918 . . . . 64.44 116.126 168.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.01 136.96 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.873 -0.417 . . . . 64.23 109.873 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.1 pp -116.76 178.65 4.26 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.116 0.566 . . . . 71.25 112.354 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -130.36 130.15 44.05 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.504 0.722 . . . . 74.42 110.335 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -63.18 118.25 7.68 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.531 0.732 . . . . 74.23 111.604 172.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -76.08 157.11 33.27 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.121 0.968 . . . . 72.12 112.42 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -93.76 -174.18 3.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.535 0.734 . . . . 75.01 110.184 171.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -126.27 142.28 51.59 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.751 0.82 . . . . 73.14 110.039 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -83.33 131.66 35.05 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.795 0.438 . . . . 74.25 110.26 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 11.0 m170 . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 123.555 0.742 . . . . 73.21 111.299 -175.176 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.607 ' HG2' ' HB2' ' A' ' 111' ' ' TYR . 3.0 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 111.208 0.077 . . . . 63.02 111.208 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -41.52 132.19 2.84 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.338 1.055 . . . . 73.21 112.668 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -62.84 159.36 16.79 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.348 0.659 . . . . 61.54 112.154 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.38 81.79 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.09 0.556 . . . . 61.31 112.049 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -68.93 -36.77 78.36 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.318 0.647 . . . . 53.14 112.481 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.42 -53.68 54.65 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.113 0.565 . . . . 73.14 111.152 175.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.47 HD11 HG13 ' A' ' 109' ' ' VAL . 93.3 mt -59.64 -38.92 82.7 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.634 0.773 . . . . 62.23 112.029 174.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.5 tm? -62.55 -42.34 99.47 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.717 0.807 . . . . 75.43 110.862 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.73 -37.48 87.52 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.031 0.533 . . . . 60.55 110.56 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -66.09 -40.14 90.56 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.679 -0.691 . . . . 74.13 111.474 173.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 8' ' ' LEU . 87.2 mt -61.03 -39.02 88.18 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.569 0.747 . . . . 73.41 111.79 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -78.51 -22.75 46.93 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.142 0.577 . . . . 74.14 111.851 178.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.81 -44.46 49.27 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.263 0.625 . . . . 51.21 111.226 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 10' ' ' GLU . 31.5 m -86.82 151.63 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.398 0.679 . . . . 74.42 110.994 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.36 -18.46 38.78 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.566 0.747 . . . . 74.2 110.977 176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -146.68 150.81 36.14 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.326 0.65 . . . . 72.4 111.013 -169.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 57.4 p -83.88 80.44 9.15 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.434 0.635 . . . . 71.5 110.717 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.62 0.85 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.68 -0.691 . . . . 65.04 112.0 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -120.44 -11.83 9.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 73.2 110.926 175.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mt -115.04 106.99 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.294 -1.002 . . . . 74.32 108.294 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 10.2 tp10 -96.04 151.81 19.1 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.299 1.44 . . . . 74.25 111.713 -174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.76 28.64 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.999 0.919 . . . . 72.22 110.162 173.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.423 ' HE2' ' HG2' ' A' ' 21' ' ' GLU . 62.5 mttm -136.23 166.42 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.445 0.64 . . . . 54.13 112.167 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -105.36 167.24 9.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.577 1.151 . . . . 64.14 112.042 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.57 -26.01 67.67 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.64 0.776 . . . . 75.41 112.448 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.6 t -56.4 -37.12 69.71 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.294 0.85 . . . . 23.21 113.294 173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.33 18.35 16.12 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.555 0.946 . . . . 62.14 113.555 -170.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.1 ptm -63.74 103.19 0.53 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.049 0.928 . . . . 71.23 110.736 166.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.08 -130.97 2.7 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.307 -0.86 . . . . 75.45 111.939 -174.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -55.14 -34.4 63.73 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.213 1.005 . . . . 74.34 112.862 -177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -67.39 -40.72 85.68 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.473 0.709 . . . . 65.43 111.89 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.49 -53.29 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 122.829 0.451 . . . . 73.44 110.033 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.461 ' N ' ' SD ' ' A' ' 33' ' ' MET . 0.0 OUTLIER -48.22 -40.69 25.2 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.901 1.281 . . . . 72.25 113.34 175.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -52.07 -47.14 65.32 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.836 0.854 . . . . 73.13 111.927 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 m -77.62 -37.73 49.55 Favored 'General case' 0 CA--C 1.566 1.575 0 C-N-CA 123.652 0.781 . . . . 61.34 111.912 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.5 t -61.24 -42.32 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 124.215 1.006 . . . . 62.31 112.254 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 93.0 mt -54.14 -34.26 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.341 1.056 . . . . 62.21 112.379 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.78 92.55 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.249 0.62 . . . . 61.24 111.784 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -72.68 -30.22 64.06 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.961 0.504 . . . . 74.51 111.721 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.18 -51.88 19.14 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.199 0.6 . . . . 75.51 112.23 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -85.16 -43.09 14.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 113.228 0.825 . . . . 73.43 113.228 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.63 108.23 5.49 Favored Pre-proline 0 N--CA 1.485 1.291 0 C-N-CA 122.92 0.488 . . . . 70.02 111.373 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.01 116.36 4.63 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.462 2.108 . . . . 65.12 111.683 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.74 3.31 40.01 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 119.243 -0.754 . . . . 63.14 114.24 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tt -109.53 -23.89 11.27 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 118.88 1.34 . . . . 75.45 108.401 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -44.94 155.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.246 1.819 . . . . 73.53 115.699 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.15 39.0 4.95 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.546 -0.752 . . . . 75.54 113.06 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.95 165.4 29.31 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 113.547 0.179 . . . . 71.0 113.547 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -123.22 126.75 47.54 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.318 0.647 . . . . 72.51 110.278 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 5.6 mp -112.32 118.08 34.27 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.343 1.057 . . . . 75.43 108.438 175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 26.5 tp -102.33 111.82 24.27 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.666 -0.494 . . . . 74.5 109.666 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 108' ' ' LEU . 71.7 mt -92.35 138.95 31.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.213 0.605 . . . . 74.12 111.149 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.12 41.07 5.65 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 115.548 -0.751 . . . . 64.41 112.634 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.92 141.85 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.122 0.569 . . . . 74.43 110.728 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -104.73 158.6 16.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.228 . . . . 62.02 108.322 173.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -143.87 126.73 16.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.203 0.525 . . . . 73.32 110.295 172.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.13 137.34 53.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.354 1.062 . . . . 73.12 110.707 -173.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -88.56 122.86 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.53 0.732 . . . . 62.32 111.54 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -72.21 177.63 4.35 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.465 1.106 . . . . 74.33 111.986 177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.17 -28.61 66.57 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 123.003 0.521 . . . . 62.22 110.821 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -66.54 -16.96 64.54 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 124.107 0.963 . . . . 75.53 112.273 169.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.12 10.88 70.78 Favored Glycine 0 CA--C 1.539 1.561 0 CA-C-N 116.786 -0.188 . . . . 74.44 112.852 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -80.31 158.72 26.03 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.124 0.97 . . . . 72.43 111.969 -175.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -109.71 113.03 25.45 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.361 0.665 . . . . 63.53 110.906 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.0 t -108.62 124.3 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.651 0.781 . . . . 64.13 109.586 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.486 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 66.9 m-85 -93.17 127.17 38.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.262 0.625 . . . . 65.4 110.206 -175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -117.28 131.78 23.85 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.847 0.859 . . . . 74.3 110.601 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.03 97.3 1.11 Allowed 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.268 1.979 . . . . 62.54 111.573 177.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.48 -20.63 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.405 0.682 . . . . 71.3 112.309 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.61 178.08 51.24 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 121.56 0.533 . . . . 60.24 114.267 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.12 138.75 20.63 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.226 1.011 . . . . 61.32 110.854 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.52 -38.37 19.52 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 122.481 2.121 . . . . 65.31 112.592 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 77' ' ' VAL . 14.5 m-20 -124.78 67.23 50.6 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 123.701 0.801 . . . . 64.44 109.627 177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HB2' HD22 ' A' ' 99' ' ' LEU . 39.2 Cg_endo -60.22 -42.65 40.95 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.106 2.537 . . . . 64.22 114.638 -164.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -65.92 -38.0 87.55 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.133 0.573 . . . . 71.04 110.979 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -71.95 -37.23 69.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.258 0.623 . . . . 74.42 111.515 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 73' ' ' ASP . 72.8 t -60.91 -39.61 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 122.665 0.386 . . . . 74.42 110.058 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -63.52 -47.92 79.67 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.24 0.616 . . . . 72.53 112.208 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -63.63 -50.06 70.83 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.823 0.849 . . . . 75.11 112.238 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.74 -30.31 69.76 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.895 0.878 . . . . 74.33 111.328 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 36.7 tp -67.56 -42.06 83.22 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.929 0.492 . . . . 74.54 111.122 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.44 -42.44 98.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.445 0.698 . . . . 75.4 111.382 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.3 t -61.65 -52.61 63.61 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.786 0.834 . . . . 60.2 111.668 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.94 -30.77 70.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.055 0.391 . . . . 75.24 112.055 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.19 -32.19 71.94 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 118.431 0.56 . . . . 70.24 112.071 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.3 -29.71 28.13 Favored 'General case' 0 CA--C 1.557 1.247 0 CA-C-N 115.701 -0.681 . . . . 60.15 112.447 174.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -94.35 -24.41 17.4 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.549 1.314 . . . . 74.14 114.549 -171.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.402 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 48.1 mmm -91.09 -27.1 18.79 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.46 0.704 . . . . 71.43 111.861 -173.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.8 mt -103.6 162.0 13.42 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.139 0.576 . . . . 74.25 112.536 -172.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -39.54 -63.55 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.083 1.753 . . . . 55.44 112.835 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.437 HG21 ' ND1' ' A' ' 119' ' ' HIS . 30.3 m -116.61 172.03 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.69 0.796 . . . . 71.54 110.16 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.17 99.66 1.92 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-O 121.197 0.523 . . . . 72.23 110.661 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tt -81.16 134.05 35.57 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.999 -1.112 . . . . 73.25 107.999 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -110.39 91.6 12.1 Favored Pre-proline 0 N--CA 1.486 1.37 0 C-N-CA 123.123 0.569 . . . . 75.21 111.462 -176.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -90.62 169.07 3.9 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.831 2.354 . . . . 62.14 112.531 171.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.85 135.13 53.95 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.191 0.596 . . . . 72.41 109.838 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.661 ' HB3' HD11 ' A' ' 108' ' ' LEU . 46.9 mtt -130.03 132.57 46.27 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.203 0.601 . . . . 72.13 111.156 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -135.37 144.31 46.53 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.481 0.712 . . . . 71.43 111.741 176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 74' ' ' PRO . 74.1 mt -104.23 117.12 33.45 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.092 0.957 . . . . 74.23 110.098 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -117.49 133.23 56.2 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.492 1.117 . . . . 75.35 111.651 -167.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -94.21 114.36 26.45 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.822 0.849 . . . . 72.05 110.527 176.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.95 113.95 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.788 1.235 . . . . 63.44 109.149 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 51.42 28.49 20.73 Favored Glycine 0 CA--C 1.543 1.803 0 N-CA-C 115.642 1.017 . . . . 62.31 115.642 -172.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.23 -5.71 78.23 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 114.546 0.578 . . . . 60.52 114.546 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -98.92 137.57 37.29 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 117.772 0.786 . . . . 61.34 110.699 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.1 m -102.39 104.73 15.23 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.191 0.451 . . . . 74.44 111.461 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.09 163.7 12.46 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.663 0.785 . . . . 62.32 111.623 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 97' ' ' MET . 39.4 tp -115.4 114.14 24.68 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.146 0.578 . . . . 62.14 110.962 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 7' ' ' LEU . 90.8 t -83.29 112.53 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.711 0.804 . . . . 71.12 109.506 173.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 25.1 t -108.49 100.05 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.637 0.732 . . . . 61.2 110.602 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 51.9 t80 -84.6 124.47 31.48 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.433 1.093 . . . . 74.14 110.535 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.07 103.02 48.66 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 122.655 0.382 . . . . 63.43 110.44 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.65 166.18 28.91 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.736 2.291 . . . . 71.53 112.011 171.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.51 161.74 24.82 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.915 1.079 . . . . 74.25 113.915 -176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -102.21 133.38 47.17 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.739 -1.119 . . . . 33.13 109.18 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.14 163.43 24.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 122.737 0.415 . . . . 62.21 111.058 -177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.0 -22.18 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.305 1.042 . . . . 73.54 112.467 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.3 p -58.28 -27.39 64.01 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.191 0.597 . . . . 75.33 111.448 173.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.562 ' HB2' ' HA ' ' A' ' 120' ' ' LYS . 5.4 m170 -75.84 -86.07 0.05 OUTLIER 'General case' 0 CA--C 1.591 2.53 0 N-CA-C 105.512 -2.033 . . . . 65.13 105.512 166.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.562 ' HA ' ' HB2' ' A' ' 119' ' ' HIS . 45.1 tttp -82.49 -145.04 0.0 OUTLIER Pre-proline 0 CA--C 1.591 2.538 0 C-N-CA 129.298 3.039 . . . . 71.23 109.636 -49.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo 5.47 102.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 124.884 3.723 . . . . 53.24 119.326 -136.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 31.2 mt -88.85 115.11 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 114.735 -1.12 . . . . 75.43 109.48 168.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -108.38 166.5 10.71 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.555 0.742 . . . . 72.24 111.458 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 26.5 tptp -79.75 130.68 35.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.937 0.495 . . . . 72.23 109.871 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -76.64 76.63 3.31 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-O 121.305 0.574 . . . . 75.44 110.439 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -172.48 98.28 0.15 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.971 1.308 . . . . 61.42 109.094 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.2 t -70.41 149.93 46.77 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.268 0.627 . . . . 61.32 112.568 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.64 -39.08 0.32 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.901 -0.59 . . . . 73.1 112.377 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.83 106.51 37.83 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.108 0.963 . . . . 61.41 110.123 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -72.59 115.4 4.32 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.161 2.574 . . . . 64.0 113.131 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 81.55 -77.35 2.06 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 116.364 -0.38 . . . . 61.0 113.38 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.11 -106.21 1.77 Allowed Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.97 -0.452 . . . . 74.31 111.97 -173.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -83.62 67.38 9.41 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.588 0.708 . . . . 65.01 110.108 170.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -70.39 -34.72 72.89 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.173 0.989 . . . . 74.33 112.014 -174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -78.42 154.29 30.78 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.624 0.77 . . . . 72.42 111.653 -172.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.82 103.72 0.6 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.694 0.798 . . . . 74.42 112.465 -170.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.79 115.18 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.189 0.996 . . . . 63.24 109.188 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.38 160.96 34.66 Favored Glycine 0 N--CA 1.473 1.157 0 N-CA-C 113.927 0.331 . . . . 62.44 113.927 -178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.5 t -92.56 58.14 3.07 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.002 0.921 . . . . 71.1 110.798 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 51.1 m 53.29 72.86 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.629 1.172 . . . . 72.24 111.883 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -65.43 89.17 0.09 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.964 0.906 . . . . 61.24 112.853 -172.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.66 -26.89 5.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.805 1.242 . . . . 71.22 110.534 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -86.36 87.56 7.46 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.306 0.642 . . . . 73.34 110.262 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.4 t -97.03 142.83 28.5 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.933 0.493 . . . . 74.2 111.431 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.7 m -86.75 147.77 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.219 0.608 . . . . 64.03 111.088 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.92 123.67 27.99 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.236 -0.653 . . . . 53.44 109.236 173.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -126.45 121.35 32.16 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.5 0.667 . . . . 71.41 112.68 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -148.42 117.5 6.8 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 63.31 108.124 169.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -98.06 106.39 18.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.211 -0.663 . . . . 71.23 109.211 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -62.31 144.01 56.2 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.907 0.483 . . . . 60.13 111.597 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -139.75 136.69 34.4 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.516 0.726 . . . . 64.35 110.211 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -124.0 -170.72 2.18 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.609 0.763 . . . . 50.4 110.653 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 65.0 t60 . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 123.259 0.623 . . . . 74.03 111.06 177.402 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.539 0.685 . . . . 75.05 112.789 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.39 179.53 4.12 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.944 -1.026 . . . . 71.31 110.189 165.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -71.76 157.25 38.25 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.656 -0.702 . . . . 70.45 112.063 176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.22 84.47 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.402 0.681 . . . . 62.13 111.543 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 t -65.6 -33.95 77.1 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.447 0.699 . . . . 73.3 112.593 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.31 -43.74 80.9 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-O 120.847 0.356 . . . . 63.45 111.092 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.2 mt -66.72 -29.12 69.03 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.074 0.55 . . . . 72.23 111.646 175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 11' ' ' LEU . 17.9 tp -63.73 -29.77 70.95 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.647 0.779 . . . . 73.22 111.324 174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.49 -34.2 75.08 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.176 0.59 . . . . 64.02 111.821 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' O ' HG22 ' A' ' 14' ' ' VAL . 29.0 tt0 -67.66 -52.11 41.99 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.595 0.634 . . . . 75.22 109.659 173.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 8' ' ' LEU . 77.5 mt -49.38 -45.63 46.22 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.489 1.116 . . . . 73.01 112.762 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -80.46 -26.38 38.34 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.501 0.926 . . . . 61.02 113.501 178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.33 -53.41 16.82 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.339 0.518 . . . . 71.04 111.427 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 10' ' ' GLU . 27.2 m -81.79 139.89 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 122.927 0.491 . . . . 73.33 110.379 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.79 -45.06 90.75 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.522 0.729 . . . . 72.42 111.605 176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -123.53 138.21 54.61 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.922 0.889 . . . . 72.42 110.487 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.4 p -44.17 124.62 4.03 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 125.227 1.411 . . . . 71.01 113.669 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.94 -65.08 1.01 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.167 0.587 . . . . 64.31 112.328 -173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -119.82 -6.61 10.08 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.819 0.848 . . . . 75.11 111.406 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' HB2' ' A' ' 49' ' ' TYR . 45.5 mt -128.96 121.84 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.872 0.869 . . . . 55.43 108.806 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -100.55 129.06 46.44 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 109.949 -0.389 . . . . 74.12 109.949 169.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 54' ' ' VAL . . . -81.38 133.86 35.48 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.517 0.727 . . . . 64.22 109.067 171.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -130.86 151.13 51.62 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.41 0.624 . . . . 65.24 111.438 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -97.85 159.67 14.79 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 115.008 -0.997 . . . . 72.02 110.241 164.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.97 -29.3 65.11 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.627 0.771 . . . . 74.23 112.302 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.9 p -59.88 -36.42 76.88 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.93 0.892 . . . . 73.24 113.041 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.53 -10.55 55.83 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.12 0.568 . . . . 74.13 112.094 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.2 ttt -59.43 104.28 0.25 Allowed 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.171 0.51 . . . . 51.13 111.239 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' HG2' ' A' ' 33' ' ' MET . . . 170.65 -150.35 14.04 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.241 -0.744 . . . . 61.43 111.241 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' H ' ' HD2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -56.13 -27.14 52.92 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.12 1.156 . . . . 63.22 114.12 -175.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.0 m -65.44 -43.62 89.87 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 122.938 0.495 . . . . 63.2 111.26 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.26 -42.86 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.81 0.844 . . . . 74.11 110.773 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 84.6 mmm -64.34 -33.27 75.46 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.82 0.848 . . . . 71.14 112.038 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -68.63 -36.58 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.187 0.595 . . . . 75.43 110.936 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.403 HG21 HD21 ' A' ' 50' ' ' LEU . 3.0 m -70.64 -29.85 66.32 Favored 'General case' 0 CA--C 1.558 1.277 0 CA-C-N 116.258 -0.428 . . . . 72.14 110.899 177.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.1 -38.41 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 123.511 0.725 . . . . 74.33 110.146 170.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.4 mt -63.78 -36.55 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 122.42 0.288 . . . . 64.3 110.898 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.18 -57.86 7.45 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 120.965 0.412 . . . . 60.04 111.192 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -67.43 -20.79 65.55 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.447 0.906 . . . . 73.34 113.447 -173.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.98 -33.45 19.61 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 113.209 0.818 . . . . 72.32 113.209 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -101.08 -27.82 13.05 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.761 1.023 . . . . 63.42 113.761 -170.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -81.46 115.45 56.72 Favored Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 118.079 0.4 . . . . 72.13 111.739 -176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.99 160.24 38.59 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.485 2.124 . . . . 75.55 111.785 170.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.31 -41.15 3.07 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 114.031 0.373 . . . . 75.31 114.031 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.0 tt -94.55 -34.44 12.66 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 118.065 0.933 . . . . 51.05 110.716 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 2.71 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.649 2.38 . . . . 75.05 116.284 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 59.44 0.57 Allowed Glycine 0 CA--C 1.537 1.432 0 CA-C-N 116.324 -0.398 . . . . 43.25 113.405 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.07 173.48 43.0 Favored Glycine 0 N--CA 1.478 1.45 0 O-C-N 122.833 -0.216 . . . . 60.3 112.971 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.624 ' HB2' HG12 ' A' ' 20' ' ' ILE . 76.7 m-85 -121.02 155.67 33.86 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.433 0.635 . . . . 74.14 111.907 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 60.8 mt -128.31 118.47 23.3 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.623 1.169 . . . . 73.43 108.585 170.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.3 tp -103.52 109.07 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.095 0.474 . . . . 75.32 109.788 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 108' ' ' LEU . 25.1 mt -99.74 126.32 45.78 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.265 0.626 . . . . 62.22 110.67 -173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.17 32.26 3.55 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-N 116.6 -0.273 . . . . 40.53 113.058 -178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HB ' ' HB1' ' A' ' 22' ' ' ALA . 58.4 t -112.65 137.52 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.207 0.603 . . . . 63.24 109.943 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -109.89 157.41 19.25 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.05 -1.093 . . . . 74.3 108.05 172.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -144.02 136.11 26.47 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.875 0.369 . . . . 74.04 111.662 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -131.15 135.33 47.36 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.767 0.827 . . . . 42.1 110.669 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.3 mt -96.83 134.89 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 C-N-CA 123.416 0.686 . . . . 73.44 110.996 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -84.7 -177.19 6.53 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.426 0.69 . . . . 75.21 111.665 175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.3 -25.05 66.67 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 112.934 0.716 . . . . 72.12 112.934 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -78.28 -22.94 47.52 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.774 0.83 . . . . 71.14 112.555 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.96 -0.96 31.64 Favored Glycine 0 N--CA 1.48 1.587 0 N-CA-C 114.585 0.594 . . . . 53.13 114.585 178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -75.51 120.79 21.42 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.475 0.637 . . . . 70.33 110.935 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.2 m -80.94 118.95 22.88 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.122 0.569 . . . . 65.33 109.811 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -98.51 114.89 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.682 0.793 . . . . 72.25 109.326 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -94.85 130.25 41.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.079 -0.711 . . . . 72.41 109.079 -177.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -143.57 131.11 10.79 Favored Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 123.048 0.539 . . . . 64.54 111.169 -172.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.53 101.43 1.49 Allowed 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.759 2.306 . . . . 75.03 112.571 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.5 m -98.12 -6.45 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.127 0.571 . . . . 71.33 112.062 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.47 175.18 50.29 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 114.601 0.6 . . . . 73.13 114.601 174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -105.48 137.77 19.38 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 124.854 1.262 . . . . 63.4 109.889 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.31 -30.5 19.62 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.071 1.847 . . . . 71.11 112.291 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 6.2 m-20 -125.98 66.43 58.66 Favored Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 123.871 0.868 . . . . 55.41 110.617 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -43.55 23.97 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.707 2.271 . . . . 75.2 114.27 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -71.04 -39.38 72.33 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.999 -0.546 . . . . 74.52 110.654 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 73' ' ' ASP . 14.1 ttmm -60.41 -44.42 95.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.445 0.698 . . . . 74.12 111.15 174.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 73' ' ' ASP . 78.4 t -59.85 -43.41 91.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 122.632 0.373 . . . . 61.44 110.691 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -64.94 -50.2 67.37 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 112.541 0.571 . . . . 71.14 112.541 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -68.82 -49.59 57.25 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.865 0.466 . . . . 74.03 111.766 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.28 -28.54 67.28 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.512 0.725 . . . . 54.13 112.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.8 tp -72.65 -41.52 65.37 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 118.385 0.539 . . . . 73.41 111.432 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.28 84.22 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.12 0.568 . . . . 72.12 112.189 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.4 p -73.87 -41.39 62.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 63.51 112.071 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -65.34 -30.15 70.96 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 117.665 0.211 . . . . 73.55 111.228 173.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 36.7 t -59.35 -21.07 59.28 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 112.923 0.712 . . . . 73.22 112.923 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.01 -35.15 17.75 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.824 0.85 . . . . 72.23 111.587 173.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 -14.46 31.13 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 113.585 0.958 . . . . 72.21 113.585 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.3 mmm -90.05 -47.51 7.79 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.82 0.848 . . . . 71.14 110.081 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.82 154.23 17.36 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.047 -0.979 . . . . 74.14 110.627 -172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.538 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.0 p30 -48.29 -47.56 36.33 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 124.2 1.0 . . . . 74.44 112.705 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.0 m -116.66 173.35 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.244 1.018 . . . . 75.35 110.138 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.29 100.54 3.17 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.811 -0.631 . . . . 51.35 110.462 169.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.551 HD12 HG21 ' A' ' 122' ' ' ILE . 5.9 tt -75.7 131.41 39.86 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 106.263 -1.755 . . . . 71.15 106.263 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -106.28 95.71 11.98 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 122.866 0.466 . . . . 74.12 111.869 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.19 161.65 5.72 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.105 1.87 . . . . 44.32 111.928 166.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 111' ' ' TYR . 37.9 mm-40 -92.04 141.13 28.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.44 -0.8 . . . . 65.31 108.935 173.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.632 ' HB3' HD11 ' A' ' 108' ' ' LEU . 67.3 mtt -137.8 122.74 18.97 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 70.32 111.121 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -130.87 136.84 49.0 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.811 0.844 . . . . 42.15 110.13 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.91 109.82 20.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.72 -0.845 . . . . 60.2 108.72 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.96 128.53 55.82 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.012 0.525 . . . . 62.32 110.848 -166.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -101.2 123.85 45.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.534 0.734 . . . . 71.31 111.765 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.93 122.45 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.677 1.191 . . . . 72.31 109.881 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 54.75 28.85 48.11 Favored Glycine 0 CA--C 1.544 1.89 0 N-CA-C 115.733 1.053 . . . . 61.41 115.733 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.15 5.37 76.62 Favored Glycine 0 CA--C 1.541 1.682 0 N-CA-C 115.015 0.766 . . . . 71.1 115.015 -177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -108.08 134.88 50.34 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.797 0.839 . . . . 74.22 109.963 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.7 m -97.7 129.18 44.77 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.751 0.705 . . . . 72.02 110.603 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.6 mp -121.05 171.41 8.69 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.402 1.081 . . . . 72.23 109.047 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 97' ' ' MET . 47.2 tp -117.49 114.81 24.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 120.918 0.389 . . . . 74.15 110.155 171.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.55 113.34 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 108.421 -0.955 . . . . 74.52 108.421 169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 39.5 t -107.46 101.09 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 109.756 -0.461 . . . . 73.54 109.756 174.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 62.8 t80 -85.79 119.93 26.65 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.756 -0.831 . . . . 74.32 108.756 172.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.61 98.39 28.31 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 123.042 0.537 . . . . 55.54 109.64 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.38 162.43 22.38 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.767 2.312 . . . . 73.3 113.381 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HG3' ' HE3' ' A' ' 120' ' ' LYS . 10.8 tt0 -73.29 128.37 35.3 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.239 0.616 . . . . 73.33 111.679 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -92.76 171.51 8.95 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.184 0.994 . . . . 50.43 112.059 -175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.16 132.88 34.64 Favored 'General case' 0 C--O 1.2 -1.511 0 C-N-CA 123.63 0.772 . . . . 71.31 110.574 -169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -38.49 -38.09 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.876 0 N-CA-C 116.79 2.144 . . . . 70.35 116.79 -160.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.9 t -63.98 -42.93 97.08 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.021 0.528 . . . . 62.24 111.675 178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 23.1 m-70 -128.97 70.89 1.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 104.822 -2.288 . . . . 75.04 104.822 167.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 94.1 mttt -48.17 -156.95 0.0 OUTLIER Pre-proline 0 CA--C 1.596 2.744 0 C-N-CA 131.647 3.979 . . . . 74.21 121.59 57.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo 4.57 70.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 122.908 2.405 . . . . 62.35 116.04 -127.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 93' ' ' LEU . 34.0 mm -73.92 89.25 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 115.726 -0.67 . . . . 71.41 110.032 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -89.67 150.45 22.34 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.955 -0.566 . . . . 70.5 109.921 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -69.85 149.38 47.95 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 109.85 -0.426 . . . . 72.33 109.85 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -53.11 97.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.592 0.757 . . . . 75.11 111.976 -173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.55 136.76 38.33 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.652 0.982 . . . . 74.34 113.652 -165.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.7 m -94.75 113.8 25.62 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.728 0.811 . . . . 73.13 109.735 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.33 -90.63 0.09 OUTLIER Glycine 0 CA--C 1.533 1.171 0 N-CA-C 112.499 -0.24 . . . . 52.3 112.499 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.65 152.74 53.51 Favored Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 123.515 0.726 . . . . 64.35 110.898 -176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.99 -34.32 91.86 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.945 2.43 . . . . 63.21 113.287 169.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.51 -166.66 54.59 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.981 -0.554 . . . . 51.1 113.264 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -93.7 153.17 21.13 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 112.456 -0.257 . . . . 61.15 112.456 173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.08 77.67 5.56 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 117.221 0.511 . . . . 63.41 110.631 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.43 -49.34 27.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.501 0.72 . . . . 73.22 110.328 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -107.22 106.69 17.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.658 0.783 . . . . 63.24 110.065 173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 15.4 ptt-85 -75.34 165.16 25.59 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.065 0.546 . . . . 74.42 110.726 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.3 mp -69.62 92.93 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 CA-C-O 121.372 0.606 . . . . 63.32 109.651 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.45 53.26 1.15 Allowed Glycine 0 N--CA 1.474 1.222 0 CA-C-N 115.576 -0.738 . . . . 51.04 111.75 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 44.1 t -159.24 151.92 21.67 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.872 0.869 . . . . 62.23 110.627 -174.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.5 t -90.03 113.82 25.58 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 73.54 110.996 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -77.84 95.12 4.65 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.644 0.735 . . . . 74.22 112.479 -177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.29 156.41 35.65 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.872 -1.058 . . . . 72.12 110.72 167.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -74.2 78.46 1.79 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.424 0.69 . . . . 62.4 111.488 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 53.6 t -99.86 94.23 6.2 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.55 -0.908 . . . . 71.44 108.55 172.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 79.2 t -68.1 99.08 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 121.327 0.585 . . . . 73.51 111.411 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.9 mt -80.92 93.07 6.24 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 108.626 -0.879 . . . . 70.21 108.626 173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.33 -41.25 94.17 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.437 1.095 . . . . 74.44 112.977 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 38.54 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 126.6 1.96 . . . . 53.5 114.635 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -80.57 104.51 11.15 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.753 -0.592 . . . . 72.43 109.47 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -60.78 -48.23 82.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 115.024 1.49 . . . . 74.32 115.024 -166.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 67.1 m80 56.21 30.43 16.55 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 124.055 0.942 . . . . 74.54 112.966 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -62.7 100.76 0.21 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 122.898 0.479 . . . . 74.23 111.076 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 124.05 0.94 . . . . 71.3 111.576 -177.105 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptm . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 120.489 0.185 . . . . 73.44 111.293 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 mtm-85 -105.54 154.29 20.59 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.707 0.803 . . . . 73.42 111.366 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -75.73 160.24 30.23 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 122.834 0.453 . . . . 64.02 111.768 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.47 -27.99 69.36 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.641 -0.709 . . . . 63.22 112.268 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.61 HG23 HG13 ' A' ' 102' ' ' VAL . 5.8 m -71.47 -45.88 61.39 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.149 0.58 . . . . 71.41 110.864 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.74 -46.42 90.48 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.511 -0.768 . . . . 74.51 111.759 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.3 mt -72.72 -34.57 67.2 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.638 0.775 . . . . 75.3 112.242 -177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.3 tp -66.37 -47.7 72.56 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.129 0.571 . . . . 42.33 110.515 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -62.85 -35.29 79.46 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 115.293 -0.867 . . . . 71.53 111.128 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -64.62 -37.75 88.65 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.476 0.71 . . . . 73.33 111.171 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.418 HD13 ' HB2' ' A' ' 22' ' ' ALA . 59.2 mt -60.74 -37.06 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.964 0.906 . . . . 63.41 111.768 174.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.446 HD21 ' HB2' ' A' ' 66' ' ' TYR . 53.3 m-80 -80.69 -21.75 41.0 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.299 0.639 . . . . 51.54 112.186 175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.24 -47.61 12.23 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.506 0.722 . . . . 64.32 112.567 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.34 163.71 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.573 0.702 . . . . 72.23 112.829 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.23 -33.83 22.13 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.271 -0.877 . . . . 74.41 110.48 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -139.81 136.77 34.39 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.133 0.973 . . . . 74.44 109.766 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 m -75.21 90.88 2.59 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.315 0.578 . . . . 61.14 110.144 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.13 -46.19 82.86 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.731 1.212 . . . . 61.32 113.263 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -160.57 14.9 0.12 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.499 0.72 . . . . 75.13 111.731 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -111.86 117.1 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 107.794 -1.187 . . . . 74.13 107.794 178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.61 150.17 38.49 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.224 0.61 . . . . 63.34 111.053 -173.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HB2' HD13 ' A' ' 11' ' ' LEU . . . -121.59 124.38 44.2 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.734 0.814 . . . . 72.44 110.411 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 32' ' ' VAL . 31.2 mmtp -122.87 144.68 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.551 0.74 . . . . 73.14 110.303 176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -75.89 158.26 32.27 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.316 0.646 . . . . 70.13 111.386 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.39 -24.51 63.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 113.582 0.956 . . . . 55.22 113.582 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.0 t -84.16 -11.93 55.76 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.647 0.61 . . . . 64.54 112.647 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.3 -18.87 34.92 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.595 0.758 . . . . 71.02 111.515 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 ptm -60.78 131.26 50.11 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.19 0.519 . . . . 75.25 112.309 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.56 -122.6 2.81 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 116.159 -0.473 . . . . 75.32 112.081 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -68.24 -38.44 81.82 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.81 0.844 . . . . 74.24 111.748 -173.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.3 m -69.2 -42.03 76.33 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.667 0.787 . . . . 74.53 111.732 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 23' ' ' LYS . 88.0 t -70.44 -41.84 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.693 0.397 . . . . 72.22 110.825 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 89' ' ' LEU . 35.0 tpp -56.28 -44.4 79.74 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.813 0.845 . . . . 75.31 111.847 174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -61.97 -30.57 71.02 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.722 0.809 . . . . 62.0 110.953 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -76.39 -36.35 58.15 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 123.745 0.818 . . . . 54.33 111.321 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 32' ' ' VAL . 97.1 t -60.97 -38.73 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 123.767 0.827 . . . . 73.21 111.129 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 70.2 mt -57.4 -33.92 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 123.941 0.896 . . . . 63.24 111.071 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.86 -47.63 71.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.146 0.578 . . . . 65.42 111.759 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.402 ' HE2' HD21 ' A' ' 50' ' ' LEU . 89.5 m-85 -67.98 -18.17 64.65 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 112.377 0.51 . . . . 65.34 112.377 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.06 -37.41 18.91 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.581 0.752 . . . . 73.51 112.603 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.572 HD21 ' HB ' ' A' ' 122' ' ' ILE . 58.6 m-80 -104.52 -46.06 4.47 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.102 0.778 . . . . 52.51 113.102 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.21 121.82 78.34 Favored Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 123.813 0.845 . . . . 75.23 111.721 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.96 -178.46 2.82 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.199 2.599 . . . . 55.11 113.503 176.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.13 -40.46 2.92 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 114.869 0.708 . . . . 75.01 114.869 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.1 mp -74.92 -48.24 25.62 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 117.798 0.799 . . . . 74.41 112.876 -175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.7 t70 41.21 94.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.249 1.203 . . . . 65.24 114.249 -173.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 113' ' ' PRO . . . 78.01 72.21 1.17 Allowed Glycine 0 CA--C 1.535 1.294 0 C-N-CA 121.155 -0.545 . . . . 54.32 114.051 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.74 168.35 27.67 Favored Glycine 0 N--CA 1.474 1.214 0 CA-C-N 116.665 0.233 . . . . 22.04 113.143 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -121.36 144.23 48.77 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.83 0.678 . . . . 65.01 112.83 -177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.683 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 76.2 mt -122.55 123.13 40.52 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.702 1.201 . . . . 51.4 109.302 171.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -104.18 108.98 20.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.365 -0.605 . . . . 61.11 109.365 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.631 HD12 HD23 ' A' ' 108' ' ' LEU . 80.2 mt -94.76 129.91 41.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.181 0.592 . . . . 71.45 110.21 178.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.91 34.59 4.85 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 116.296 -0.411 . . . . 61.01 112.622 -177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.4 t -112.37 140.34 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.826 0.85 . . . . 72.03 109.964 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -124.04 154.88 39.26 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.102 -1.073 . . . . 61.04 108.102 171.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.3 p90 -136.16 128.99 31.05 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.914 0.485 . . . . 65.12 110.828 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.82 37.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.764 0.825 . . . . 62.13 110.63 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.8 mm -100.01 128.63 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.727 0.811 . . . . 70.33 111.646 -170.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 63' ' ' ASP . 73.8 m-20 -76.63 178.05 7.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.208 0.603 . . . . 62.34 112.181 177.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.23 -37.53 87.55 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.11 0.564 . . . . 72.22 111.252 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -68.17 -29.91 68.89 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.307 0.643 . . . . 71.2 111.47 172.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.35 24.26 6.0 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.024 -0.535 . . . . 42.42 113.924 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.427 ' HB2' ' ND2' ' A' ' 59' ' ' ASN . 5.7 m-20 -78.67 138.32 38.24 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.978 0.511 . . . . 73.13 111.663 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.6 m -89.54 102.76 15.44 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.47 0.708 . . . . 73.11 109.975 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' HH12 ' A' ' 67' ' ' ARG . 57.6 t -109.96 129.26 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.552 0.741 . . . . 71.21 110.396 -176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.446 ' HB2' HD21 ' A' ' 12' ' ' ASN . 75.9 m-85 -95.76 120.81 36.68 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.73 0.812 . . . . 74.34 111.96 -171.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.43 HH12 ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -115.69 150.91 45.61 Favored Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.128 0.971 . . . . 72.01 111.427 174.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.53 108.89 2.53 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.477 2.118 . . . . 73.01 113.229 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.6 m -91.86 -28.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 116.112 -0.494 . . . . 62.14 110.647 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 -176.73 53.97 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 115.734 -0.666 . . . . 64.15 113.83 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.4 mt -102.66 143.25 26.22 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 123.94 0.896 . . . . 75.34 110.856 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -59.0 -56.58 1.32 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.64 2.226 . . . . 64.02 111.743 176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.514 ' HB2' ' HE2' ' A' ' 76' ' ' LYS . 12.1 m-20 -120.34 89.22 43.38 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 123.897 0.879 . . . . 70.44 108.656 170.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -54.98 -44.9 45.29 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.483 2.789 . . . . 73.34 114.664 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -67.22 -41.65 85.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.213 0.605 . . . . 74.0 110.634 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.514 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 36.9 ttpt -61.32 -43.4 98.94 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.795 0.438 . . . . 71.42 111.172 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.37 -43.69 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.821 0.849 . . . . 73.54 111.289 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.68 -39.67 94.9 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 123.838 0.855 . . . . 50.21 111.735 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -67.39 -46.2 74.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.673 0.789 . . . . 63.03 112.128 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -61.51 -41.17 96.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.919 0.888 . . . . 63.55 111.185 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.7 tp -67.05 -44.23 80.69 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.025 -0.534 . . . . 63.21 111.487 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.69 97.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.284 0.634 . . . . 73.1 111.369 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.9 t -60.89 -52.01 66.84 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.266 1.026 . . . . 72.41 111.887 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -68.45 -29.81 68.54 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.19 0.596 . . . . 71.35 112.052 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.3 t -61.57 -23.89 66.28 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.785 -0.572 . . . . 74.31 112.206 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.03 -48.74 7.0 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 123.639 0.776 . . . . 74.53 111.414 170.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 t -74.55 -22.69 58.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 114.387 1.255 . . . . 71.22 114.387 -170.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.8 mmm -88.51 -51.89 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.218 0.607 . . . . 74.42 111.602 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 125' ' ' LYS . 88.6 mt -70.01 -103.26 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 113.847 1.054 . . . . 62.05 113.847 -165.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 123' ' ' TYR . 3.7 p30 -170.01 -45.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 118.662 0.664 . . . . 55.2 110.123 -168.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG11 ' ND1' ' A' ' 119' ' ' HIS . 23.9 m -114.59 157.22 15.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.078 0.951 . . . . 63.34 109.055 170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 96.06 1.16 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.258 -0.645 . . . . 63.03 109.258 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tt -92.75 122.02 34.73 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.263 -1.384 . . . . 61.14 107.263 176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -104.41 100.44 22.21 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 122.619 0.368 . . . . 75.12 110.473 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.18 161.62 26.12 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 121.981 1.787 . . . . 71.22 110.948 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 8.7 tp10 -104.03 101.89 11.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.356 -0.609 . . . . 75.25 109.356 -175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.671 ' HB3' HD11 ' A' ' 108' ' ' LEU . 5.3 mpp? -101.71 135.06 43.87 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 112.501 0.556 . . . . 54.12 112.501 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -136.03 127.01 27.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.539 0.735 . . . . 74.33 111.242 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.5 mt -74.0 112.01 9.72 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.209 1.003 . . . . 64.33 110.892 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -126.38 129.59 49.08 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.781 0.832 . . . . 75.45 111.179 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.35 126.67 39.75 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.533 0.733 . . . . 74.44 111.405 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.61 HG13 HG23 ' A' ' 5' ' ' THR . 13.1 t -119.33 118.4 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.256 1.022 . . . . 73.33 108.877 177.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 58.9 28.59 63.63 Favored Glycine 0 CA--C 1.542 1.721 0 N-CA-C 114.718 0.647 . . . . 75.3 114.718 -177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.07 10.61 78.03 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 114.419 0.527 . . . . 74.41 114.419 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.6 133.03 55.51 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.019 0.928 . . . . 74.34 108.961 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.5 m -89.88 123.74 34.09 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.059 0.845 . . . . 72.43 111.584 -175.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.68 170.92 8.22 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.513 1.125 . . . . 72.31 109.078 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.671 HD11 ' HB3' ' A' ' 97' ' ' MET . 31.9 tp -122.28 120.11 33.14 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.581 0.353 . . . . 64.11 110.863 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 97' ' ' MET . 38.4 t -88.54 120.16 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 109.143 -0.688 . . . . 64.52 109.143 170.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.683 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 21.5 t -108.51 101.51 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.262 -0.644 . . . . 51.21 109.262 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.5 t80 -85.4 116.16 23.56 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.189 0.596 . . . . 70.43 109.733 175.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -117.77 96.89 50.19 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 108.011 -1.107 . . . . 53.34 108.011 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.573 ' HA ' ' HA2' ' A' ' 47' ' ' GLY . 72.8 Cg_endo -70.49 171.13 15.85 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.656 2.237 . . . . 51.35 112.753 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.29 121.36 19.3 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.357 -0.979 . . . . 61.22 108.357 176.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -79.55 166.87 21.48 Favored 'General case' 0 CA--C 1.563 1.447 0 C-N-CA 123.566 0.746 . . . . 51.55 112.103 -173.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 38.2 t70 -62.48 165.77 5.87 Favored 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 124.001 0.921 . . . . 75.11 112.471 -177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -52.88 -51.96 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.094 -1.004 . . . . 63.14 113.542 168.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.7 p -84.68 6.44 24.15 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 112.583 0.586 . . . . 72.14 112.583 -173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.572 ' ND1' HG11 ' A' ' 91' ' ' VAL . 52.0 m-70 -170.96 64.08 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 103.026 -2.953 . . . . 74.44 103.026 -173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.752 ' HA ' HG12 ' A' ' 122' ' ' ILE . 9.4 ptpp? -48.04 -156.67 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.399 2 C-N-CA 133.584 4.754 . . . . 63.11 122.096 42.256 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HD2' ' HG3' ' A' ' 120' ' ' LYS . 10.9 Cg_exo 14.13 73.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 121.983 1.788 . . . . 63.43 115.204 -118.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.752 HG12 ' HA ' ' A' ' 120' ' ' LYS . 49.7 mm -90.2 125.34 43.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 CA-C-N 114.006 -1.452 . . . . 60.44 108.654 172.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.483 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 36.7 p90 -149.97 155.53 40.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.196 0.998 . . . . 73.23 108.893 -174.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -81.85 147.83 29.13 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.601 0.36 . . . . 75.43 110.784 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -62.62 -37.68 87.27 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.499 -0.556 . . . . 73.34 109.499 165.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -75.76 90.75 2.89 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.793 -0.64 . . . . 60.22 110.067 170.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.7 m -62.69 113.35 2.96 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.203 0.601 . . . . 73.01 110.354 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.92 -155.76 49.77 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 116.204 -0.453 . . . . 73.22 112.483 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.27 138.42 8.16 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.1 0.56 . . . . 74.5 111.193 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -88.39 161.64 6.79 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 122.723 2.282 . . . . 73.21 112.83 170.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.03 162.94 35.2 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 113.978 0.351 . . . . 53.41 113.978 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 167.09 108.85 0.21 Allowed Glycine 0 CA--C 1.541 1.657 0 CA-C-O 120.179 -0.234 . . . . 75.11 112.757 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -123.85 117.99 26.11 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.903 0.881 . . . . 72.04 110.884 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -128.21 140.33 51.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.94 0.896 . . . . 63.24 110.749 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.78 87.35 0.97 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.139 0.495 . . . . 65.23 110.275 172.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -95.65 -18.92 20.14 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.835 0.854 . . . . 70.32 111.877 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.7 -39.23 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.194 0 C-N-CA 122.772 0.429 . . . . 75.45 111.069 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.87 24.01 77.44 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 114.806 0.682 . . . . 72.15 114.806 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 80.6 p -111.08 118.04 34.92 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.418 0.687 . . . . 63.32 110.75 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 44.1 t -115.52 144.98 43.05 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.82 0.848 . . . . 73.23 110.484 178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -72.49 91.56 1.4 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.476 0.655 . . . . 61.41 111.863 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -119.42 124.34 46.31 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.856 -1.165 . . . . 62.12 107.856 172.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -66.74 108.35 2.47 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.292 0.567 . . . . 63.41 111.906 -175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 57.8 m -102.74 131.28 49.68 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.673 1.189 . . . . 70.12 110.057 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -137.38 126.34 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 123.486 0.715 . . . . 72.41 109.807 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.21 166.29 23.44 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.761 0.825 . . . . 74.12 111.065 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -146.64 150.07 34.73 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.31 0.644 . . . . 73.52 110.012 177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -140.1 153.85 46.85 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.71 0.804 . . . . 64.33 110.398 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -135.85 119.57 17.21 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.264 0.626 . . . . 74.01 111.625 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -84.03 175.83 9.26 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.36 0.664 . . . . 62.2 110.796 169.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -130.99 37.88 3.73 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.489 0.715 . . . . 64.43 111.707 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.53 96.73 0.54 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.582 0.753 . . . . 61.24 110.826 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.617 0.767 . . . . 72.41 110.723 -179.077 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' HB2' ' A' ' 98' ' ' GLN . 11.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.555 0.217 . . . . 64.2 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -62.73 156.77 22.77 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-O 121.462 0.648 . . . . 71.01 112.494 165.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 m -67.2 160.6 26.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.775 -1.102 . . . . 73.02 112.973 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.97 -27.67 67.64 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.956 0.502 . . . . 62.25 111.211 176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 102' ' ' VAL . 39.4 p -57.15 -51.29 69.9 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.407 0.683 . . . . 73.23 111.055 168.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -70.23 -36.59 74.62 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-N 114.596 -1.184 . . . . 73.0 111.394 -172.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.9 mt -70.46 -30.23 67.0 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.52 1.128 . . . . 71.02 113.008 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 tp -63.41 -31.6 72.8 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.997 -0.547 . . . . 73.35 110.161 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.32 -37.72 86.7 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.734 0.814 . . . . 74.24 112.465 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.45 -46.99 74.58 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.308 0.504 . . . . 71.44 110.721 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 62.1 mt -60.18 -42.97 96.14 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 124.132 0.973 . . . . 62.31 112.25 178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -80.76 -13.95 58.53 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.692 0.797 . . . . 53.41 112.915 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.85 -62.12 1.8 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.001 0.52 . . . . 55.43 110.761 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.6 m -100.14 143.54 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.817 -0.629 . . . . 60.22 110.83 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.67 -46.76 89.11 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.872 0.869 . . . . 62.44 111.84 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.32 111.7 15.49 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.944 0.897 . . . . 60.35 109.706 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 66.5 m -74.72 126.86 31.77 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.423 0.689 . . . . 74.54 111.716 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.07 -49.71 22.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.567 0.951 . . . . 64.34 113.567 -170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -108.76 -2.73 18.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 123.408 0.683 . . . . 72.23 111.764 177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 17' ' ' SER . 29.3 mm -111.17 145.24 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 108.917 -0.771 . . . . 64.11 108.917 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -139.7 152.12 46.43 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.758 0.423 . . . . 73.04 110.7 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.95 125.02 42.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.746 0.818 . . . . 63.1 109.988 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HD2' HG22 ' A' ' 32' ' ' VAL . 37.8 mttp -125.18 153.65 42.75 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.584 0.754 . . . . 71.14 111.263 173.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -82.34 155.15 24.91 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 114.756 -1.111 . . . . 73.24 111.356 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.03 -30.64 62.19 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.096 0.958 . . . . 55.33 113.523 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.0 p -65.89 -35.41 80.56 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.657 0.783 . . . . 74.42 112.816 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.62 13.49 6.96 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.505 0.928 . . . . 60.44 113.505 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.609 ' SD ' HD13 ' A' ' 52' ' ' LEU . 85.6 mmm -57.1 104.43 0.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.258 0.466 . . . . 34.43 112.258 171.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.69 -148.4 12.37 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-N 116.009 -0.541 . . . . 72.41 112.557 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -55.83 -31.53 62.79 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.552 1.141 . . . . 71.32 113.934 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -68.74 -42.62 77.3 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.058 0.543 . . . . 75.02 111.583 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.488 HG22 ' HD2' ' A' ' 23' ' ' LYS . 52.3 t -60.96 -53.24 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-O 121.255 0.55 . . . . 75.32 109.9 172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.521 ' SD ' ' HG3' ' A' ' 84' ' ' GLN . 81.0 mmm -49.2 -44.12 42.91 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.449 -1.251 . . . . 63.0 113.993 178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -69.53 -31.25 69.36 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.614 0.598 . . . . 70.51 112.614 -173.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.598 ' HB ' HD21 ' A' ' 50' ' ' LEU . 28.2 m -70.4 -37.41 74.47 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 122.541 0.336 . . . . 73.11 110.573 174.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.3 t -61.51 -44.17 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 123.375 0.67 . . . . 73.51 110.419 171.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.7 mt -59.91 -40.84 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 C-N-CA 124.319 1.048 . . . . 73.34 111.257 176.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.15 90.01 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.734 0.814 . . . . 75.33 111.832 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB2' HG11 ' A' ' 112' ' ' VAL . 21.2 m-85 -81.19 -35.7 31.05 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.959 0.504 . . . . 75.3 111.386 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.65 -43.14 73.21 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.659 0.784 . . . . 63.21 112.497 -176.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -76.99 -24.58 52.22 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.172 0.589 . . . . 74.44 112.191 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -76.21 110.6 11.67 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 123.023 0.529 . . . . 72.52 110.047 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.84 118.15 4.8 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.509 2.806 . . . . 64.12 114.992 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.28 26.73 74.06 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.44 -0.8 . . . . 74.13 114.777 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.414 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -103.78 8.83 37.2 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 117.978 0.889 . . . . 63.33 110.196 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -51.49 141.48 15.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 123.815 0.846 . . . . 72.21 112.25 172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 122.21 -29.77 5.42 Favored Glycine 0 N--CA 1.475 1.24 0 N-CA-C 111.347 -0.701 . . . . 64.12 111.347 -166.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.53 121.93 9.8 Favored Glycine 0 CA--C 1.548 2.117 0 N-CA-C 114.483 0.553 . . . . 73.34 114.483 175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -114.05 142.39 46.25 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.916 0.886 . . . . 74.1 112.416 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.598 HD21 ' HB ' ' A' ' 35' ' ' THR . 5.1 mp -117.33 128.36 54.97 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.238 1.015 . . . . 75.11 109.022 170.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -105.86 109.65 21.67 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.238 0.615 . . . . 74.23 109.864 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.662 HD12 HD23 ' A' ' 108' ' ' LEU . 82.0 mt -97.8 125.67 42.76 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.561 0.744 . . . . 72.35 110.649 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.82 35.08 4.13 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.046 -0.524 . . . . 71.44 112.52 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.6 t -114.53 144.02 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.285 0.634 . . . . 71.52 110.34 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.97 131.76 44.6 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.132 0.973 . . . . 52.1 108.56 172.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.5 p90 -111.08 131.36 55.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.738 0.815 . . . . 72.51 111.197 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.36 129.9 56.49 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.545 1.138 . . . . 71.51 110.172 -173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.4 mm -90.95 123.84 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 122.972 0.509 . . . . 53.04 111.721 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -72.46 170.7 13.74 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.952 0.901 . . . . 62.34 111.9 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -64.36 -25.89 68.23 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.036 0.534 . . . . 71.4 111.618 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -78.85 -1.53 35.42 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.453 0.701 . . . . 75.44 112.107 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.18 32.57 51.95 Favored Glycine 0 C--N 1.351 1.412 0 C-N-CA 122.656 0.17 . . . . 45.42 113.124 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -97.75 134.76 40.49 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.481 0.712 . . . . 71.22 111.176 -177.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 m -92.82 106.32 18.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.579 0.752 . . . . 62.44 110.854 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.51 112.04 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.846 0.859 . . . . 73.33 109.843 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -90.18 115.55 27.5 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.12 109.536 -176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -116.48 136.39 23.1 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.121 0.969 . . . . 62.24 111.066 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.75 96.48 1.0 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.873 2.382 . . . . 73.2 112.793 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.2 m -83.72 -20.39 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 116.091 -0.504 . . . . 43.11 111.065 170.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.57 -169.47 53.53 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.989 0.756 . . . . 73.15 114.989 172.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 77' ' ' VAL . 62.7 mt -117.95 130.63 24.6 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 124.97 1.308 . . . . 75.45 109.11 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.04 -27.49 29.85 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 122.204 1.936 . . . . 54.43 111.94 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -137.97 77.71 36.95 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.341 1.456 . . . . 71.23 108.991 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.48 -35.52 29.99 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.956 2.437 . . . . 64.34 114.268 -167.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.93 -39.89 83.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.232 0.613 . . . . 75.35 110.428 177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -61.45 -49.81 75.33 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.972 -0.558 . . . . 75.51 110.676 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 71' ' ' LEU . 81.9 t -55.93 -43.91 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 124.332 1.053 . . . . 74.04 111.919 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -62.84 -41.82 99.5 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.473 0.709 . . . . 73.01 112.113 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -73.43 -32.88 64.64 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.296 0.639 . . . . 71.3 112.359 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -66.22 -38.86 88.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.067 0.547 . . . . 65.35 110.107 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.2 tp -66.99 -39.01 87.06 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.332 0.653 . . . . 70.15 110.877 176.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.47 65.34 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.706 0.802 . . . . 52.42 112.101 175.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 45.3 t -73.95 -53.13 10.76 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.166 0.586 . . . . 40.32 111.253 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.521 ' HG3' ' SD ' ' A' ' 33' ' ' MET . 9.9 pt20 -67.68 -28.93 68.1 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.711 0.804 . . . . 74.41 112.664 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.7 p -64.02 -26.57 68.62 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 112.291 0.478 . . . . 64.31 112.291 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -90.43 -41.79 11.26 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.572 0.749 . . . . 54.2 112.27 172.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.2 m -77.81 -43.97 28.91 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.784 1.031 . . . . 74.14 113.784 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 9.0 mmt -69.1 -44.07 73.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.766 0.826 . . . . 62.22 112.571 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.9 mt -92.87 150.14 20.79 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.418 0.687 . . . . 54.44 111.097 -165.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.642 HD21 ' HA ' ' A' ' 122' ' ' ILE . 8.8 p30 -52.76 -34.47 53.13 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.307 0.854 . . . . 73.54 113.307 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 119' ' ' HIS . 26.2 m -120.48 170.83 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 123.719 0.808 . . . . 64.31 110.224 169.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -78.69 102.04 7.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 120.987 0.422 . . . . 64.2 110.129 170.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tt -88.74 116.97 27.4 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.183 -1.414 . . . . 73.2 107.183 174.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -103.76 98.32 12.84 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 122.858 0.463 . . . . 74.33 110.476 178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.56 165.53 18.22 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.178 1.919 . . . . 74.24 112.294 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 9.5 tp10 -84.69 129.45 34.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.494 0.718 . . . . 75.4 109.418 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.552 ' HB3' HD11 ' A' ' 108' ' ' LEU . 53.4 mtt -132.84 120.62 21.79 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.49 0.716 . . . . 63.44 110.862 -172.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.589 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 33.4 mm-40 -128.49 137.97 52.05 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.198 0.599 . . . . 73.52 110.446 173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.44 112.66 24.66 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.537 0.735 . . . . 74.23 110.348 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -114.9 127.16 55.53 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.885 0.874 . . . . 63.25 111.757 -170.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -88.38 118.72 28.2 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.384 0.674 . . . . 74.22 110.689 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 5' ' ' THR . 15.0 t -124.68 113.52 36.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 C-N-CA 124.631 1.172 . . . . 72.43 108.885 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.9 28.21 65.64 Favored Glycine 0 CA--C 1.543 1.84 0 N-CA-C 115.495 0.958 . . . . 42.25 115.495 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.63 6.05 70.88 Favored Glycine 0 CA--C 1.541 1.688 0 N-CA-C 114.348 0.499 . . . . 72.21 114.348 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -114.36 136.55 52.87 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.884 0.873 . . . . 62.25 108.73 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 m -93.37 132.33 37.71 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.569 0.622 . . . . 74.23 111.13 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.77 169.14 11.4 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.382 1.073 . . . . 75.31 109.002 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.662 HD23 HD12 ' A' ' 52' ' ' LEU . 55.1 tp -120.0 116.39 25.66 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 120.733 0.302 . . . . 74.4 110.446 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.417 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 51.6 t -87.78 130.89 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 109.297 -0.631 . . . . 54.32 109.297 173.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 24.0 t -116.19 100.92 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 122.959 0.504 . . . . 71.04 110.062 178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.724 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 81.8 t80 -83.74 126.61 33.07 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.13 -0.693 . . . . 73.44 109.13 171.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 39' ' ' PHE . 38.7 t -99.61 112.66 64.02 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.907 -0.405 . . . . 73.02 109.907 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -82.29 152.08 15.83 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.721 2.28 . . . . 63.23 111.941 172.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -65.99 111.57 3.41 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 123.979 0.912 . . . . 74.41 111.365 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 119' ' ' HIS . . . -68.73 156.01 39.06 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.353 0.661 . . . . 71.24 112.364 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.98 141.43 51.03 Favored 'General case' 0 C--O 1.195 -1.811 0 C-N-CA 123.717 0.807 . . . . 62.24 109.631 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.0 t -41.45 -40.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 115.664 1.727 . . . . 75.22 115.664 -171.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -72.48 -35.02 68.09 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.973 0.731 . . . . 64.01 112.973 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.596 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.2 OUTLIER -139.03 79.17 1.71 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.936 -1.505 . . . . 71.5 106.936 169.081 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.65 ' HA ' HG12 ' A' ' 122' ' ' ILE . 17.5 ptpt -47.98 -155.2 0.0 OUTLIER Pre-proline 0 N--CA 1.514 2.733 2 N-CA-C 123.596 4.665 . . . . 71.21 123.596 43.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo 13.98 67.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 122.214 1.943 . . . . 73.42 116.085 -121.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 120' ' ' LYS . 50.7 mm -77.63 102.95 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 114.467 -1.242 . . . . 72.44 110.048 175.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.457 ' H ' ' ND2' ' A' ' 90' ' ' ASN . 44.0 p90 -108.94 147.65 31.91 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.739 0.815 . . . . 61.05 110.329 169.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -78.75 142.3 37.13 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.345 0.658 . . . . 74.1 110.232 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.16 -28.53 69.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 120.808 0.337 . . . . 73.25 110.107 168.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.11 101.04 1.08 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.74 0.816 . . . . 62.11 110.161 167.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 77.0 p -85.46 176.76 8.06 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.926 0.89 . . . . 45.25 112.534 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 155.0 -15.12 0.51 Allowed Glycine 0 N--CA 1.477 1.427 0 CA-C-N 115.685 -0.688 . . . . 74.54 112.512 -176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 31.5 tp 51.14 67.76 3.97 Favored Pre-proline 0 CA--C 1.564 1.504 0 C-N-CA 125.403 1.481 . . . . 75.13 111.543 -171.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -92.97 -143.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.839 3.026 . . . . 75.32 111.246 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 84.8 123.87 1.2 Allowed Glycine 0 CA--C 1.539 1.565 0 CA-C-N 118.248 0.477 . . . . 73.12 113.062 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.81 92.78 0.54 Allowed Glycine 0 N--CA 1.477 1.41 0 CA-C-N 116.92 0.36 . . . . 72.11 113.682 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.5 -36.51 65.77 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.379 0.671 . . . . 71.11 111.644 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -96.84 136.74 36.97 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.441 0.697 . . . . 52.23 110.582 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -138.05 -179.14 5.6 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.585 0.754 . . . . 70.33 111.636 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -128.29 179.08 5.82 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.855 0.862 . . . . 70.23 111.882 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.8 pt -117.36 170.32 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 123.803 0.841 . . . . 71.52 110.823 170.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.83 177.39 48.08 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 116.439 -0.346 . . . . 63.13 113.609 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.6 t 69.46 151.7 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 125.409 1.483 . . . . 73.2 113.441 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.1 p -161.94 -67.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.254 0.622 . . . . 64.34 111.016 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.2 27.25 2.57 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.749 0.82 . . . . 75.55 112.211 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -70.93 103.0 2.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.184 0.594 . . . . 63.14 110.753 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.58 172.76 12.54 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.84 0.856 . . . . 74.3 111.078 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 27.7 p -141.28 174.16 10.8 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.495 0.718 . . . . 50.53 111.004 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.0 137.85 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.505 0.722 . . . . 64.35 110.576 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 66.0 tp -118.64 129.22 55.18 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.062 0.945 . . . . 54.2 109.598 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -159.64 121.87 3.4 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.737 0.415 . . . . 63.01 111.858 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -133.72 104.58 6.4 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.143 0.977 . . . . 73.31 109.213 172.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -85.09 114.79 22.5 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.843 0.457 . . . . 74.14 110.494 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -91.48 166.44 12.85 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.451 0.7 . . . . 73.04 112.268 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -131.59 111.68 11.95 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.924 0.89 . . . . 44.3 109.672 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -104.89 131.89 51.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.836 0.855 . . . . 74.32 111.054 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 121.787 0.803 . . . . 73.12 110.288 176.034 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.683 ' SD ' ' HG2' ' A' ' 96' ' ' GLU . 17.2 ptm . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 112.471 0.545 . . . . 75.14 112.471 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -98.41 168.12 10.4 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.891 0.876 . . . . 70.4 111.668 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.0 t -76.99 155.82 32.33 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.757 0.823 . . . . 75.34 112.119 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.02 -34.13 77.05 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.357 0.663 . . . . 75.22 111.797 178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.503 HG23 HG13 ' A' ' 102' ' ' VAL . 2.4 m -66.7 -44.06 82.72 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.472 0.653 . . . . 75.11 110.557 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.55 -50.57 73.37 Favored 'General case' 0 CA--C 1.56 1.329 0 C-N-CA 125.246 1.418 . . . . 74.44 111.962 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' ' 51' ' ' LEU . 86.7 mt -62.92 -44.37 96.27 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.644 0.778 . . . . 74.14 111.871 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.704 ' HA ' HD12 ' A' ' 11' ' ' LEU . 51.9 tp -59.36 -40.36 86.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.224 1.01 . . . . 63.34 111.601 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -62.41 -41.95 99.07 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.007 -0.997 . . . . 72.35 110.875 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' O ' HG22 ' A' ' 14' ' ' VAL . 13.2 mm-40 -72.57 -30.3 64.29 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.572 -0.74 . . . . 72.44 112.308 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 8' ' ' LEU . 78.5 mt -57.36 -44.82 84.71 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.348 0.659 . . . . 75.24 112.244 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -88.49 -5.12 58.43 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.922 0.489 . . . . 75.25 112.313 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.24 -55.84 3.51 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.226 0.61 . . . . 50.3 111.671 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 10' ' ' GLU . 33.1 m -90.55 118.79 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-O 121.185 0.517 . . . . 63.11 111.541 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -43.85 -25.53 0.2 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 115.493 1.664 . . . . 71.34 115.493 172.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -127.78 122.54 33.02 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.862 0.465 . . . . 65.03 110.841 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.5 m -74.5 92.08 2.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.532 0.733 . . . . 52.21 110.496 173.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.92 -63.31 1.16 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.394 0.678 . . . . 73.14 111.769 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -119.82 -1.08 10.56 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 119.247 -0.406 . . . . 63.43 112.049 175.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.0 mt -117.5 105.84 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.021 0.828 . . . . 61.31 109.085 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -121.57 130.21 53.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.055 0.542 . . . . 71.31 110.816 -176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.65 134.93 45.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 70.54 112.45 -172.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.65 151.53 46.42 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.045 0.938 . . . . 74.23 111.076 175.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -84.08 154.05 23.42 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.97 0.908 . . . . 74.22 110.288 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.19 -31.37 70.08 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 112.99 0.737 . . . . 74.42 112.99 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 78.1 p -81.22 13.41 2.88 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.786 1.032 . . . . 74.51 113.786 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.05 4.52 19.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.054 0.542 . . . . 63.21 112.118 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 79.1 mtp -53.69 104.56 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 112.533 0.568 . . . . 73.55 112.533 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.74 -142.83 7.95 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-N 116.395 -0.366 . . . . 60.54 113.188 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -70.9 -21.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.238 1.015 . . . . 74.24 113.039 -171.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 m -75.12 -43.39 53.01 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.95 0.5 . . . . 63.22 110.941 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.17 -37.92 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.239 0.615 . . . . 74.42 110.607 168.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.536 ' HA ' HG22 ' A' ' 36' ' ' VAL . 20.7 mmt -71.19 -31.86 68.16 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.773 -0.649 . . . . 73.22 112.592 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.29 -32.75 74.47 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.398 0.618 . . . . 53.04 110.054 175.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -78.05 -46.38 21.03 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.699 0.8 . . . . 65.51 112.171 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 33' ' ' MET . 19.8 m -59.58 -39.01 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 118.11 0.414 . . . . 70.42 112.116 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.15 -35.75 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.287 0.635 . . . . 74.52 110.996 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.1 -38.41 91.09 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 122.849 0.46 . . . . 70.23 112.102 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -73.87 -47.68 36.52 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.172 0.589 . . . . 60.32 111.481 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.77 -21.85 60.94 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 113.585 0.957 . . . . 61.53 113.585 -173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -93.37 -42.75 9.12 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.21 0.604 . . . . 71.25 111.442 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.44 111.58 4.95 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 123.666 0.786 . . . . 74.12 112.019 -171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.08 105.3 0.67 Allowed 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.791 2.327 . . . . 72.34 112.831 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.19 19.63 11.38 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.674 -0.694 . . . . 70.52 114.749 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.9 tp -106.84 5.49 28.52 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 118.764 1.282 . . . . 72.23 112.205 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -40.91 124.47 2.15 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 125.11 1.364 . . . . 71.34 113.711 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 105.57 51.52 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.896 -0.593 . . . . 71.11 112.627 -177.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 19' ' ' ARG . . . -112.55 149.27 18.39 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 111.673 -0.571 . . . . 34.43 111.673 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -123.47 126.84 47.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.648 0.779 . . . . 71.01 111.354 -177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 tt -104.73 116.68 32.45 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.471 -1.307 . . . . 65.42 107.471 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 7' ' ' LEU . 31.2 tp -103.4 112.35 25.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.724 0.409 . . . . 74.33 111.021 -173.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.66 HD12 HD23 ' A' ' 108' ' ' LEU . 93.1 mt -92.88 140.16 29.79 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.601 0.76 . . . . 64.54 111.65 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 33.21 7.04 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.926 -0.579 . . . . 60.3 112.739 177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.2 t -113.08 144.37 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.507 0.723 . . . . 43.34 110.672 178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -124.6 163.85 21.08 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.002 -1.11 . . . . 62.54 108.002 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 25.7 p90 -154.77 138.69 16.32 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.423 0.527 . . . . 71.15 112.423 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 151.97 47.36 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.799 0.84 . . . . 72.23 111.279 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.3 mm -91.62 131.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.592 0.757 . . . . 73.25 111.467 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -84.89 -172.09 3.99 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.912 0.485 . . . . 52.31 111.659 176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.06 -37.71 80.66 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 123.268 0.627 . . . . 61.42 112.562 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -77.33 -29.35 53.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 63.22 112.264 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.12 9.55 15.46 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.626 0.61 . . . . 63.5 114.626 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.05 138.7 37.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.283 0.633 . . . . 53.44 111.378 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.4 m -83.87 111.2 19.01 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.306 0.642 . . . . 62.55 109.584 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.45 115.32 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.786 . . . . 72.14 109.863 -174.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -93.3 115.27 27.86 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.205 0.602 . . . . 74.43 111.095 -174.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -110.67 153.34 43.66 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 124.131 0.972 . . . . 53.34 111.405 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.42 116.55 2.99 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.305 2.004 . . . . 74.02 113.032 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -99.01 -30.25 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 122.824 0.449 . . . . 54.22 110.745 168.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.58 -175.91 53.97 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.729 -0.668 . . . . 43.14 112.613 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.69 138.7 23.38 Favored Pre-proline 0 CA--C 1.553 1.071 0 O-C-N 122.358 -0.496 . . . . 75.4 110.37 177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.38 -33.9 28.42 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.698 2.265 . . . . 61.22 112.618 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -127.37 66.49 69.07 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 124.015 0.926 . . . . 61.14 109.648 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.522 ' HB2' HD22 ' A' ' 99' ' ' LEU . 60.5 Cg_endo -65.34 -36.04 37.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.863 2.375 . . . . 62.02 113.725 -164.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.19 -40.59 82.17 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.645 0.778 . . . . 61.41 110.41 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -70.34 -35.69 73.75 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.2 -0.909 . . . . 63.14 111.551 -176.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 79.7 t -65.35 -43.07 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.655 0.782 . . . . 60.22 110.815 176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.523 ' HG2' HH21 ' A' ' 79' ' ' ARG . 53.2 tt0 -56.59 -45.04 81.59 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.578 0.751 . . . . 65.41 111.85 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.523 HH21 ' HG2' ' A' ' 78' ' ' GLN . 4.0 mmp_? -75.45 -36.95 60.61 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.668 -0.697 . . . . 61.32 112.626 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.33 -35.15 75.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.243 0.617 . . . . 73.54 110.42 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 26.8 tp -70.68 -39.62 73.41 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.613 0.765 . . . . 75.01 110.739 176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.06 -34.12 77.3 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.152 0.581 . . . . 63.43 111.817 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 t -72.14 -53.2 13.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.289 0.635 . . . . 64.45 111.436 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 81' ' ' LEU . 11.9 pt20 -71.05 -32.46 69.17 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.056 0.762 . . . . 71.3 113.056 -175.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 30.2 p -64.85 -31.3 72.46 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 118.877 0.762 . . . . 75.23 112.228 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 92' ' ' ALA . . . -81.45 -27.1 34.81 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 116.033 -0.531 . . . . 74.11 112.381 177.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.0 t -92.14 -33.89 14.55 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.694 0.628 . . . . 74.21 112.694 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -79.86 -48.04 14.14 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.09 0.556 . . . . 75.01 111.294 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.6 mt -81.63 157.61 24.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.849 -0.614 . . . . 74.34 111.294 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -45.96 -35.39 4.65 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.358 1.463 . . . . 70.31 114.16 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.62 173.43 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 123.458 0.703 . . . . 74.53 111.093 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . . . -71.72 97.53 1.78 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.725 -0.67 . . . . 53.43 110.216 170.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.89 123.89 28.17 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 107.944 -1.132 . . . . 75.33 107.944 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -104.01 96.02 8.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.398 0.679 . . . . 64.35 110.694 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -87.91 166.63 7.14 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 122.09 1.86 . . . . 74.43 111.977 172.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.683 ' HG2' ' SD ' ' A' ' 1' ' ' MET . 40.9 tt0 -101.23 115.71 31.13 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.924 -0.769 . . . . 64.21 108.924 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.425 ' SD ' ' HG3' ' A' ' 78' ' ' GLN . 61.5 mtt -115.07 131.14 57.02 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.326 0.65 . . . . 73.24 112.006 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.7 mm-40 -142.02 146.71 35.84 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.813 0.845 . . . . 75.03 110.964 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 74' ' ' PRO . 42.6 mt -102.37 119.35 38.66 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.984 0.913 . . . . 63.01 110.329 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -124.87 130.32 52.14 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.695 1.198 . . . . 62.42 109.584 -173.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -94.49 121.76 36.37 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.955 0.407 . . . . 74.11 111.643 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.503 HG13 HG23 ' A' ' 5' ' ' THR . 12.4 t -126.4 127.08 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.285 1.034 . . . . 62.22 109.46 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 55.89 30.87 57.75 Favored Glycine 0 CA--C 1.548 2.124 0 N-CA-C 115.265 0.866 . . . . 71.21 115.265 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.33 5.98 81.78 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.905 0.352 . . . . 74.22 113.938 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -116.38 146.18 42.67 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.088 0.955 . . . . 75.42 109.803 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.4 m -95.34 104.58 16.47 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 118.969 0.804 . . . . 71.24 111.105 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.9 mp -92.0 162.01 14.56 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.829 0.851 . . . . 72.35 111.497 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 HD12 ' A' ' 52' ' ' LEU . 61.9 tp -120.28 118.36 30.22 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.738 0.815 . . . . 73.33 110.366 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.56 119.91 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.273 -0.64 . . . . 52.33 109.273 171.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.0 t -108.33 101.1 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.126 -0.694 . . . . 51.52 109.126 173.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.2 t80 -76.83 113.81 14.91 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 109.36 -0.607 . . . . 74.25 109.36 174.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.11 99.29 42.63 Favored Pre-proline 0 CA--C 1.553 1.069 0 N-CA-C 108.903 -0.777 . . . . 63.21 108.903 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.38 -176.44 1.55 Allowed 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 122.733 2.288 . . . . 72.34 113.093 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 44.4 mt-10 -84.92 148.33 26.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.825 -0.625 . . . . 72.33 109.748 165.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.11 178.81 4.45 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.668 0.787 . . . . 55.14 110.481 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.61 124.35 24.51 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 118.282 -0.866 . . . . 75.12 110.368 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.3 t -38.06 -37.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 116.54 2.052 . . . . 51.21 116.54 -157.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.4 t -57.01 -40.53 76.8 Favored 'General case' 0 N--CA 1.509 2.483 0 CA-C-N 118.963 0.802 . . . . 74.05 112.003 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 14.5 m-70 -133.58 77.92 1.75 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 103.986 -2.598 . . . . 70.35 103.986 165.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.587 ' HA ' HG12 ' A' ' 122' ' ' ILE . 47.5 mtmt -46.86 -149.78 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.351 2 C-N-CA 133.016 4.526 . . . . 74.1 122.456 46.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo 12.06 76.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.808 2.339 . . . . 61.44 115.112 -120.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.587 HG12 ' HA ' ' A' ' 120' ' ' LYS . 51.1 mm -86.31 131.38 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 115.158 -0.928 . . . . 72.11 110.56 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -156.37 165.38 36.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.807 0.843 . . . . 73.33 110.386 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -79.41 139.82 37.59 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.458 0.303 . . . . 72.22 110.59 178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -79.96 -10.17 59.75 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.76 0.424 . . . . 74.34 111.297 172.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.28 85.0 1.42 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.606 0.762 . . . . 65.01 111.114 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.8 m -78.08 121.02 23.73 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.636 0.774 . . . . 74.13 110.076 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 121.09 72.12 0.3 Allowed Glycine 0 N--CA 1.473 1.148 0 N-CA-C 111.742 -0.543 . . . . 61.54 111.742 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.76 92.46 42.55 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.586 0.755 . . . . 74.14 111.056 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.21 102.28 1.52 Allowed 'Trans proline' 0 CA--C 1.563 1.955 0 C-N-CA 122.497 2.131 . . . . 73.01 112.464 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -70.36 109.77 3.01 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-N 116.229 -0.441 . . . . 74.12 112.958 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.48 -130.68 0.39 Allowed Glycine 0 N--CA 1.478 1.467 0 N-CA-C 114.203 0.441 . . . . 60.33 114.203 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.83 95.03 2.85 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.062 0.545 . . . . 62.33 111.785 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -75.89 -54.47 6.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.947 -0.569 . . . . 74.54 110.07 171.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -75.07 108.82 8.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.803 0.841 . . . . 53.31 110.501 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.83 124.56 26.33 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-O 120.858 0.361 . . . . 53.53 110.194 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.0 tt -90.08 -41.45 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.981 0.513 . . . . 72.12 111.658 -175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.21 158.93 34.87 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.418 -0.355 . . . . 22.0 113.401 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.9 m -131.04 -166.65 1.73 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.224 1.01 . . . . 35.54 109.503 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -68.58 93.06 0.48 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.762 0.315 . . . . 61.41 110.258 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.65 123.76 19.23 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.61 0.764 . . . . 74.33 110.745 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -65.24 111.86 3.18 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.312 0.645 . . . . 75.21 111.877 -169.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -66.47 103.94 1.15 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.298 -0.864 . . . . 70.11 108.988 168.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 29.1 p -61.92 153.14 30.06 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.702 0.801 . . . . 63.4 111.635 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 35.4 m -61.57 142.32 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.264 0.625 . . . . 63.53 111.493 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -73.81 164.07 27.12 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.979 0.512 . . . . 63.51 111.197 176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -68.94 120.18 14.43 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 122.496 0.319 . . . . 72.04 110.626 174.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -84.91 91.29 8.0 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 122.589 0.356 . . . . 61.23 110.933 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.5 p80 36.64 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 C-N-CA 126.02 1.728 . . . . 74.43 115.271 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -70.15 148.07 49.14 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.093 0.557 . . . . 73.23 112.273 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.2 t60 69.25 133.9 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.38 1.472 . . . . 73.1 113.413 176.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -138.94 176.36 8.76 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.221 1.009 . . . . 74.54 110.835 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.239 0.542 . . . . 73.44 110.302 169.74 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.649 ' HG3' ' HE1' ' A' ' 49' ' ' TYR . 46.5 ttp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.499 0.19 . . . . 64.32 111.134 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HB2' HD11 ' A' ' 7' ' ' LEU . 19.4 mmt180 -79.07 162.87 25.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.89 0.876 . . . . 65.22 110.783 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.8 t -80.73 155.09 26.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.183 0.593 . . . . 64.21 110.203 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.86 -24.39 67.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.86 0.464 . . . . 63.32 112.103 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -70.0 -44.27 69.72 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.128 0.571 . . . . 64.41 110.602 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.8 -48.99 79.47 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.041 0.936 . . . . 61.52 111.398 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD22 HD12 ' A' ' 20' ' ' ILE . 80.8 mt -74.43 -31.67 62.37 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.039 -0.982 . . . . 63.02 112.867 -175.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.3 tp -64.34 -46.83 81.76 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.937 0.495 . . . . 75.05 110.264 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.26 -33.34 73.38 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.195 -0.911 . . . . 73.35 110.789 177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.467 ' HG2' HG13 ' A' ' 20' ' ' ILE . 10.1 tp10 -70.49 -41.92 72.06 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.594 0.758 . . . . 73.53 110.933 176.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.2 mt -59.13 -43.16 91.96 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.983 0.913 . . . . 74.32 111.918 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 12' ' ' ASN . 0.8 OUTLIER -68.56 -32.37 72.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.193 0.597 . . . . 64.34 111.274 176.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.9 -40.79 68.61 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.718 0.807 . . . . 73.11 112.072 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.0 m -84.79 148.39 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 121.377 0.608 . . . . 72.33 111.389 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.72 -14.89 55.94 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.537 0.735 . . . . 75.44 111.635 176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -158.07 153.46 25.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.648 0.779 . . . . 63.54 110.582 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.5 m -73.99 92.13 2.09 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.742 0.417 . . . . 64.52 111.101 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.48 -65.43 1.01 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.382 0.673 . . . . 61.23 112.264 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -119.11 -15.59 9.22 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.356 1.062 . . . . 60.05 110.001 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.568 HD12 HD22 ' A' ' 7' ' ' LEU . 31.5 mm -111.53 119.14 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.603 1.161 . . . . 53.41 108.023 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.45 141.1 48.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.486 0.714 . . . . 71.43 110.792 -171.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.57 127.26 52.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.667 0.787 . . . . 51.15 110.151 177.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 27' ' ' ASP . 25.2 mmmt -132.24 136.5 47.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.977 0.911 . . . . 64.41 109.407 -176.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -81.99 168.01 18.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.255 0.55 . . . . 73.43 111.76 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.55 69.38 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.713 0.805 . . . . 62.41 112.507 174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -65.72 -37.27 85.95 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.311 0.644 . . . . 43.02 111.004 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -76.99 -6.82 54.14 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.379 1.072 . . . . 75.53 113.411 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -69.58 120.29 15.13 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.286 0.565 . . . . 70.11 110.287 178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.11 -129.16 5.0 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.853 -0.612 . . . . 65.0 112.436 -172.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -59.33 -39.11 82.08 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.669 0.787 . . . . 73.21 112.097 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 m -65.45 -29.2 69.85 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.086 0.955 . . . . 34.11 112.61 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 81' ' ' LEU . 54.3 t -71.12 -51.08 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 122.726 0.41 . . . . 73.44 110.275 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -58.16 -33.74 69.54 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.007 0.923 . . . . 72.01 112.924 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.35 -44.98 72.63 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 124.128 0.971 . . . . 73.23 111.159 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.3 m -76.89 -39.2 51.81 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 123.924 0.89 . . . . 63.52 112.461 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.25 -34.74 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 124.237 1.015 . . . . 65.33 112.444 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 33' ' ' MET . 58.5 mt -45.14 -45.81 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 124.087 0.955 . . . . 72.34 112.931 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.44 -60.07 4.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.106 0.562 . . . . 54.43 112.303 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -70.44 -24.43 62.9 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 112.622 0.601 . . . . 73.11 112.622 -169.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.82 -48.33 9.47 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.506 0.722 . . . . 62.32 112.353 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -93.3 -27.11 17.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.876 1.065 . . . . 74.13 113.876 -169.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 68.6 mm-40 -64.33 121.76 74.16 Favored Pre-proline 0 N--CA 1.491 1.591 0 CA-C-N 118.283 0.492 . . . . 74.21 111.731 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 23.7 Cg_exo -64.15 110.48 1.36 Allowed 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.598 2.199 . . . . 63.43 112.549 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.73 59.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.058 -0.857 . . . . 35.35 115.207 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.91 20.82 13.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.104 1.452 . . . . 72.45 110.831 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -41.45 114.2 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.218 1.007 . . . . 74.33 112.332 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.15 68.33 0.64 Allowed Glycine 0 N--CA 1.471 0.994 0 N-CA-C 113.738 0.255 . . . . 61.52 113.738 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -115.63 142.0 17.29 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.925 -0.87 . . . . 50.12 110.925 169.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.649 ' HE1' ' HG3' ' A' ' 1' ' ' MET . 94.6 m-85 -118.12 129.76 55.72 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 117.511 0.655 . . . . 75.55 112.11 -170.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 32' ' ' VAL . 5.6 mp -112.07 124.96 53.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.955 0.902 . . . . 74.21 109.329 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD21 ' HB3' ' A' ' 7' ' ' LEU . 3.2 mm? -104.61 109.11 20.89 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.065 0.546 . . . . 71.53 109.707 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 8.4 mp -92.95 122.32 35.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.409 0.684 . . . . 73.45 109.196 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.14 26.34 3.81 Favored Glycine 0 N--CA 1.474 1.168 0 CA-C-N 116.571 -0.286 . . . . 63.44 113.374 -176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.1 t -111.21 133.96 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 109.409 -0.589 . . . . 50.33 109.409 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -119.12 137.07 53.84 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.457 -0.942 . . . . 72.21 108.457 176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -122.88 139.63 53.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.046 0.539 . . . . 72.52 111.58 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -116.92 151.95 35.55 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.925 0.89 . . . . 75.22 111.177 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.04 122.67 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.356 0.662 . . . . 74.0 110.413 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -96.79 -168.43 1.71 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.629 0.772 . . . . 63.52 112.088 -177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -57.89 -32.37 67.65 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 124.57 1.148 . . . . 64.54 112.925 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -79.54 -11.77 59.88 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.48 0.712 . . . . 74.45 111.561 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.2 10.92 84.92 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 116.487 -0.324 . . . . 62.41 112.792 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.43 149.21 30.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.507 1.123 . . . . 64.13 111.914 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.7 m -104.62 115.52 30.48 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.253 1.021 . . . . 75.23 110.404 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.92 128.91 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.42 0.688 . . . . 61.33 109.603 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -93.77 119.1 32.3 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.177 0.591 . . . . 74.24 110.233 -175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.7 mtp85 -129.91 129.17 22.99 Favored Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 123.325 0.65 . . . . 74.45 110.601 -171.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 67.5 Cg_endo -78.68 109.84 2.69 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.39 2.06 . . . . 72.4 112.421 -175.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.9 m -99.21 -14.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.678 -0.639 . . . . 71.11 111.356 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -175.82 53.6 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 116.011 -0.541 . . . . 74.24 113.929 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.4 mt -101.34 131.07 23.55 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.055 0.942 . . . . 74.24 110.809 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -61.52 -32.03 87.9 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.054 2.503 . . . . 53.45 113.009 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -138.74 87.14 15.0 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 108.221 -1.029 . . . . 74.43 108.221 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.1 -28.42 34.68 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.661 2.241 . . . . 71.43 113.505 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -47.63 66.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.082 0.953 . . . . 72.15 111.268 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -69.65 -44.43 70.58 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.631 -0.713 . . . . 72.34 111.443 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -58.9 -37.25 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 122.908 0.483 . . . . 75.35 111.47 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -66.05 -52.38 49.62 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.842 0.682 . . . . 75.13 112.842 177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -75.77 -33.86 60.21 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 112.434 0.531 . . . . 70.12 112.434 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.56 -33.29 73.84 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.413 0.685 . . . . 73.25 110.343 175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD11 HG11 ' A' ' 32' ' ' VAL . 41.2 tp -63.46 -42.93 98.61 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.53 0.732 . . . . 54.53 111.415 175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.26 -43.25 95.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.286 0.634 . . . . 53.53 111.728 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.0 t -63.52 -52.32 61.7 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.983 0.913 . . . . 62.55 112.036 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -64.74 -32.52 74.24 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.101 0.56 . . . . 53.32 112.244 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.57 -30.69 68.82 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.178 0.513 . . . . 73.53 112.223 177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.51 -20.7 36.21 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.464 0.706 . . . . 34.43 112.016 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.9 m -112.31 -2.78 14.72 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.792 1.034 . . . . 42.4 113.792 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.7 mmm -99.6 -26.91 13.93 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.44 0.696 . . . . 72.12 111.327 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.0 mt -108.32 142.79 38.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.561 0.745 . . . . 63.13 109.212 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.483 ' ND2' HG13 ' A' ' 91' ' ' VAL . 7.6 p-10 -57.66 -26.19 61.3 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.325 0.861 . . . . 63.44 113.325 -178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 119' ' ' HIS . 6.6 m -122.22 163.65 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.479 1.112 . . . . 64.43 111.499 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.28 98.25 7.33 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 121.273 0.559 . . . . 74.45 110.935 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD12 HG12 ' A' ' 122' ' ' ILE . 4.7 tt -96.24 138.57 33.66 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.143 0.977 . . . . 72.23 108.686 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -106.77 95.34 12.06 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.004 0.521 . . . . 72.24 111.766 177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.75 155.46 15.61 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.783 1.655 . . . . 62.24 111.198 165.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.721 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 41.7 tt0 -108.12 120.53 42.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.529 0.732 . . . . 61.13 110.906 -171.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HB3' HD11 ' A' ' 108' ' ' LEU . 1.8 mpt? -111.7 141.74 44.93 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.73 0.812 . . . . 60.11 111.413 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.59 133.53 15.02 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.681 -0.489 . . . . 75.3 109.681 167.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 93.0 mt -81.46 116.21 21.15 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.571 0.748 . . . . 62.02 110.74 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -123.25 130.77 53.2 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.799 1.24 . . . . 63.01 110.221 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -94.61 125.45 39.27 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.168 0.587 . . . . 73.44 111.281 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 6.6 t -124.45 119.15 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.913 0.885 . . . . 72.22 109.225 173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 53.43 41.53 63.51 Favored Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.453 0.941 . . . . 74.2 115.453 -177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.84 4.98 88.66 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 114.883 0.713 . . . . 70.31 114.883 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 68' ' ' PRO . 72.7 mmtt -110.0 139.85 44.66 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.791 0.837 . . . . 71.45 109.292 178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.9 m -100.3 124.57 45.94 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.777 0.717 . . . . 74.4 111.024 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.49 164.9 14.21 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.127 0.971 . . . . 70.31 108.981 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 97' ' ' MET . 43.5 tp -115.64 116.52 28.26 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.58 0.352 . . . . 65.2 110.11 176.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.38 121.88 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 109.21 -0.663 . . . . 52.35 109.21 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.5 t -113.88 102.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.002 0.521 . . . . 72.0 110.623 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.721 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 63.4 t80 -80.49 114.77 19.62 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.943 0.897 . . . . 73.12 109.715 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 62.2 t -105.23 102.13 34.88 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.516 -0.92 . . . . 72.24 108.516 174.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.42 169.8 15.25 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.396 2.064 . . . . 74.2 112.481 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -80.79 128.09 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.547 -0.751 . . . . 71.32 109.286 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.93 173.91 9.05 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.185 0.594 . . . . 72.11 111.669 -174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.59 155.97 37.89 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 123.679 0.792 . . . . 75.45 110.677 -177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.8 t -47.41 -42.92 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 114.85 1.426 . . . . 64.55 114.85 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.3 p -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 123.515 0.726 . . . . 64.12 112.471 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.602 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -129.37 78.21 1.84 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 103.605 -2.739 . . . . 62.33 103.605 169.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 32.2 mmtp -44.16 -159.01 0.0 OUTLIER Pre-proline 0 CA--C 1.597 2.781 1 C-N-CA 132.04 4.136 . . . . 64.03 120.861 66.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo 5.03 71.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 123.265 2.644 . . . . 71.31 118.059 -132.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.478 HG12 HD12 ' A' ' 93' ' ' LEU . 1.8 mp -76.6 101.28 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.13 -1.063 . . . . 75.44 108.13 168.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -105.67 154.68 20.11 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.338 0.655 . . . . 73.24 109.813 168.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.466 ' HD3' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -78.81 151.56 31.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.809 0.443 . . . . 73.03 110.603 -176.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -83.9 -10.32 58.07 Favored 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.664 0.786 . . . . 60.33 110.97 172.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.83 168.15 9.56 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.62 1.168 . . . . 72.43 111.107 173.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -150.22 139.59 21.38 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.624 0.77 . . . . 75.21 110.268 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.82 76.46 1.08 Allowed Glycine 0 C--N 1.349 1.295 0 O-C-N 123.014 0.196 . . . . 71.23 112.651 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.7 mt -117.15 91.41 36.56 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.639 0.775 . . . . 64.34 110.739 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -94.85 13.8 1.35 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.184 2.589 . . . . 63.44 113.774 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.95 -172.31 54.22 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 116.94 -0.118 . . . . 74.01 112.96 -171.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 173.38 54.85 0.05 OUTLIER Glycine 0 CA--C 1.534 1.227 0 O-C-N 122.766 -0.256 . . . . 33.23 112.73 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -146.09 158.76 43.88 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.604 0.762 . . . . 50.43 111.981 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.55 143.97 29.26 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.956 0.902 . . . . 70.43 110.192 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -80.25 115.02 19.57 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.328 0.651 . . . . 73.44 111.764 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -77.75 99.91 6.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.08 0.552 . . . . 75.24 110.084 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 35.6 mt -91.1 124.4 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 C-N-CA 123.945 0.898 . . . . 71.54 109.654 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.12 158.12 29.93 Favored Glycine 0 C--N 1.345 1.081 0 N-CA-C 113.939 0.335 . . . . 54.22 113.939 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.3 t -153.07 158.79 42.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.457 0.703 . . . . 73.01 111.715 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.4 p -163.57 -155.09 0.3 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.493 1.117 . . . . 75.15 109.718 -176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.0 t70 76.22 -8.1 1.7 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.079 1.14 . . . . 73.31 114.079 163.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -79.73 76.05 6.39 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.741 0.781 . . . . 72.24 112.866 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -164.36 96.71 0.78 Allowed 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.312 -0.995 . . . . 75.14 108.312 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 47.9 t -104.38 156.42 17.94 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.16 0.584 . . . . 73.15 111.908 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.33 171.91 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 123.931 0.892 . . . . 64.14 110.389 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.52 154.09 49.14 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.008 0.523 . . . . 65.24 111.393 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -136.12 135.62 39.42 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.783 0.833 . . . . 71.32 110.05 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -142.82 166.29 25.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.703 0.801 . . . . 75.33 110.942 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.1 p-80 -144.64 131.06 19.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.292 0.637 . . . . 64.12 109.697 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -99.03 128.62 45.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.301 0.641 . . . . 75.44 110.258 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.4 p80 -75.6 145.47 41.13 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.834 0.35 . . . . 73.11 110.821 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -136.89 107.27 6.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.521 0.729 . . . . 72.32 110.54 -176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 3.8 p80 . . . . . 0 N--CA 1.487 1.417 0 C-N-CA 123.07 0.548 . . . . 72.15 111.705 178.042 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.99 -0.374 . . . . 74.31 109.99 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -40.08 134.67 1.5 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 124.85 1.26 . . . . 73.13 114.328 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 92.4 p -69.38 159.86 32.4 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.048 0.939 . . . . 61.1 112.007 -177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.08 70.37 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.26 0.624 . . . . 75.53 112.596 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -65.87 -43.79 87.33 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.656 0.782 . . . . 75.13 110.641 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.61 -43.29 76.71 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 115.199 -0.91 . . . . 73.21 111.566 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 20' ' ' ILE . 86.1 mt -65.94 -42.14 90.42 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.533 0.733 . . . . 55.21 111.406 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 11' ' ' LEU . 25.9 tp -52.04 -48.68 64.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.628 1.171 . . . . 72.53 111.075 176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -52.9 -46.22 67.89 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.814 -1.084 . . . . 74.32 111.878 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -74.34 -30.18 61.91 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.412 -0.358 . . . . 74.2 111.726 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' A' ' 8' ' ' LEU . 79.7 mt -57.82 -52.88 63.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.518 0.727 . . . . 63.04 111.596 176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -82.57 -1.1 49.76 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 112.563 0.579 . . . . 70.34 112.563 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.6 -50.06 8.01 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.051 0.54 . . . . 55.2 110.611 170.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.4 m -80.24 150.51 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.101 0.56 . . . . 30.1 111.191 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -72.76 -27.76 62.21 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.482 0.713 . . . . 63.43 112.478 -178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -143.57 134.1 24.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.814 0.845 . . . . 72.31 109.389 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.634 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 50.9 p -72.91 80.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.483 0.713 . . . . 73.14 111.234 177.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.71 -64.28 1.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.611 0.765 . . . . 71.43 112.272 -173.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.6 -26.97 14.22 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.008 0.523 . . . . 74.5 110.739 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD13 HD22 ' A' ' 7' ' ' LEU . 36.4 mt -116.18 109.0 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.502 -0.925 . . . . 64.24 108.502 174.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 8.9 tp10 -100.73 151.57 21.51 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 125.076 1.351 . . . . 74.32 111.307 -176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.44 134.25 53.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.562 0.745 . . . . 72.11 110.987 173.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 32' ' ' VAL . 13.8 mptt -130.87 149.8 52.34 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.753 0.821 . . . . 75.41 110.338 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.46 169.24 13.03 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.801 0.841 . . . . 72.32 111.653 170.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.61 88.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.951 0.501 . . . . 73.2 111.03 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 39.3 t -60.28 -35.66 76.05 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.336 1.054 . . . . 60.44 112.166 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.74 3.64 50.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.903 0.881 . . . . 52.11 112.416 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 52' ' ' LEU . 83.8 mmm -65.93 128.29 35.45 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.324 0.649 . . . . 51.04 111.73 170.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 152.4 -146.84 15.84 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 116.098 -0.501 . . . . 50.33 112.573 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.4 -18.34 65.3 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.292 0.637 . . . . 53.21 112.568 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -73.72 -37.08 65.24 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.207 0.603 . . . . 53.3 111.44 176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 23' ' ' LYS . 58.7 t -65.72 -47.6 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 121.12 0.486 . . . . 53.35 109.792 172.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.524 ' HG3' ' SD ' ' A' ' 88' ' ' MET . 86.4 mmm -62.71 -35.19 78.92 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.962 -1.017 . . . . 61.02 112.662 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -40.08 91.5 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.817 0.847 . . . . 75.34 111.012 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 m -71.01 -35.6 72.1 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.708 -0.678 . . . . 75.22 111.11 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -59.09 -46.23 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 123.635 0.774 . . . . 74.11 110.785 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.4 mt -61.4 -36.81 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 123.908 0.883 . . . . 74.04 110.931 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.81 -15.35 62.65 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.919 0.888 . . . . 63.35 113.045 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -91.47 -42.25 10.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 122.103 -0.373 . . . . 63.01 111.011 168.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.81 -55.29 10.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.831 1.049 . . . . 73.12 113.831 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -73.27 -16.32 61.39 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.441 0.696 . . . . 73.25 112.668 -174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 54.1 mm-40 -79.78 132.59 60.61 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.152 0.581 . . . . 74.4 112.124 -177.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 42' ' ' GLU . 21.4 Cg_exo -65.34 101.84 0.44 Allowed 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 123.176 2.584 . . . . 72.45 113.218 -175.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.75 74.17 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 116.075 1.19 . . . . 45.12 116.075 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 42' ' ' GLU . 10.1 mp -96.38 22.11 8.25 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.532 1.166 . . . . 70.14 110.905 173.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' GLU . 16.9 t70 -50.41 153.77 1.46 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.208 1.403 . . . . 73.51 112.686 165.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA2' ' HE1' ' A' ' 111' ' ' TYR . . . 92.59 36.58 6.1 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 115.715 -0.675 . . . . 75.44 112.936 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.3 141.11 15.29 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 117.503 0.651 . . . . 73.42 112.661 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -118.49 127.32 53.52 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.269 0.627 . . . . 74.35 112.02 -176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 64.6 mt -100.73 109.5 21.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.013 1.325 . . . . 72.24 109.529 172.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.521 HD13 HG22 ' A' ' 109' ' ' VAL . 21.1 tp -101.67 109.95 21.84 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.406 0.622 . . . . 72.25 109.762 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD12 HD23 ' A' ' 108' ' ' LEU . 47.2 mt -99.35 136.32 39.46 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 72.43 110.416 -174.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.31 34.23 5.93 Favored Glycine 0 N--CA 1.474 1.223 0 CA-C-O 121.224 0.347 . . . . 71.24 112.723 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.5 t -111.54 138.17 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.486 0.715 . . . . 62.02 109.636 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 67' ' ' ARG . 18.0 t70 -103.64 148.42 26.04 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.146 -1.057 . . . . 75.22 108.146 174.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 15.6 p90 -145.29 143.01 29.96 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.152 0.501 . . . . 74.54 111.608 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.68 152.73 37.18 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.746 0.818 . . . . 74.44 110.428 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.08 126.87 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 122.927 0.491 . . . . 75.04 110.555 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -87.77 -179.29 6.24 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.359 0.663 . . . . 75.32 111.514 177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -61.17 -19.17 61.25 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.962 1.097 . . . . 74.45 113.962 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -80.95 -14.87 57.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.228 0.611 . . . . 72.42 112.498 178.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.05 41.54 17.91 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.737 -0.545 . . . . 64.34 111.737 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -129.39 139.03 51.81 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.774 1.23 . . . . 71.05 110.32 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.9 m -84.87 119.89 25.85 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.201 0.601 . . . . 71.13 110.592 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.2 t -101.89 124.17 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.144 0.578 . . . . 41.35 110.056 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -99.05 122.05 41.78 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.459 0.703 . . . . 75.51 110.597 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 55' ' ' ASP . 9.0 ptm180 -127.06 139.1 34.15 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 124.605 1.162 . . . . 52.33 110.76 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' HD21 ' A' ' 8' ' ' LEU . 77.2 Cg_endo -86.3 98.47 0.55 Allowed 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.714 2.276 . . . . 61.02 112.837 -176.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -97.5 -17.93 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 70.14 111.687 174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.73 174.41 46.52 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-N 116.302 -0.408 . . . . 63.41 113.561 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -96.14 136.74 21.89 Favored Pre-proline 0 N--CA 1.48 1.072 0 CA-C-O 118.868 -0.587 . . . . 55.21 110.064 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.62 -36.29 92.82 Favored 'Trans proline' 0 C--N 1.384 2.42 0 C-N-CA 122.609 2.206 . . . . 63.55 112.473 177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -130.35 87.52 50.38 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.416 0.687 . . . . 70.42 109.342 168.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.69 -26.71 9.59 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.84 2.36 . . . . 75.24 114.047 -174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 6.3 m-20 -72.22 -47.21 52.17 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.444 0.698 . . . . 74.14 111.163 -176.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -61.56 -36.49 80.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 123.262 0.351 . . . . 60.31 110.762 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.3 t -60.99 -43.69 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.013 0.925 . . . . 61.24 111.221 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -59.99 -45.98 90.97 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.624 0.769 . . . . 63.51 111.962 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 28.8 mmm180 -70.67 -45.33 65.25 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.716 -0.675 . . . . 74.01 111.875 -176.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -70.36 -28.07 64.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.759 0.824 . . . . 74.52 111.884 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 31.9 tp -69.76 -40.01 76.38 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.588 0.355 . . . . 74.4 110.748 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.53 91.03 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.057 0.543 . . . . 63.31 111.252 173.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 t -64.93 -52.64 55.27 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.873 0.869 . . . . 64.01 111.712 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -64.78 -31.69 73.03 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.878 0.471 . . . . 73.42 111.901 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.7 t -69.73 -25.42 63.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.57 -0.706 . . . . 64.42 112.048 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.05 -33.58 20.95 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.428 0.691 . . . . 70.43 112.267 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.2 p -92.21 -37.28 12.79 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.667 0.988 . . . . 71.33 113.667 -173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.524 ' SD ' ' HG3' ' A' ' 33' ' ' MET . 82.4 mtp -76.28 -47.48 23.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.031 0.532 . . . . 65.21 112.059 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.75 148.3 36.78 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.304 0.642 . . . . 74.11 112.11 -175.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -53.78 -32.27 51.83 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.825 1.25 . . . . 72.34 112.864 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 119' ' ' HIS . 34.7 m -129.41 172.37 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.281 1.032 . . . . 64.01 111.338 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.82 104.4 13.88 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.912 -0.586 . . . . 53.41 110.986 173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.6 tt -93.02 133.23 36.36 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 107.791 -1.189 . . . . 74.22 107.791 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -109.61 95.3 19.08 Favored Pre-proline 0 N--CA 1.489 1.513 0 C-N-CA 122.808 0.443 . . . . 64.34 111.633 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -85.73 158.93 10.54 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.563 2.175 . . . . 73.23 112.405 169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 111' ' ' TYR . 12.2 tp10 -100.77 131.8 46.49 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.535 0.734 . . . . 74.21 109.483 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.567 ' HB3' HD11 ' A' ' 108' ' ' LEU . 60.9 mtt -125.71 116.66 22.0 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.08 0.552 . . . . 75.35 111.324 -172.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -114.99 133.28 56.17 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.009 0.924 . . . . 75.42 111.05 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.68 109.73 21.15 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.122 0.569 . . . . 71.11 109.538 174.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -109.43 128.1 54.89 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.724 1.209 . . . . 61.42 112.309 -169.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -97.97 109.33 22.11 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.341 0.591 . . . . 64.12 110.718 174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -121.17 112.73 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.624 1.17 . . . . 61.41 108.63 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 59.36 29.68 66.59 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 113.886 0.314 . . . . 71.1 113.886 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.03 0.44 90.3 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.197 0.439 . . . . 62.04 114.197 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -100.81 137.2 39.52 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.511 0.724 . . . . 74.24 109.301 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 32.4 m -98.56 121.38 40.43 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 119.047 0.84 . . . . 72.25 111.997 -174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.78 166.98 11.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.124 1.37 . . . . 65.24 108.864 -177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.686 HD23 HD12 ' A' ' 52' ' ' LEU . 26.4 tp -123.72 109.84 14.21 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.086 -0.384 . . . . 73.04 110.513 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG22 HD13 ' A' ' 51' ' ' LEU . 59.0 t -84.3 123.24 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.938 -0.764 . . . . 63.23 108.938 171.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.691 ' HB ' ' HB2' ' A' ' 50' ' ' LEU . 40.9 t -118.41 99.84 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.394 0.678 . . . . 72.03 109.607 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HE1' ' HA2' ' A' ' 47' ' ' GLY . 87.5 t80 -79.88 122.5 26.74 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.78 -0.646 . . . . 63.54 110.021 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.29 112.08 65.12 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 109.085 -0.709 . . . . 60.45 109.085 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.49 172.78 15.6 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.612 2.208 . . . . 74.33 113.044 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -58.24 160.59 4.94 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.485 0.714 . . . . 42.1 112.366 172.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' HB1' ' N ' ' A' ' 120' ' ' LYS . . . -110.46 135.15 51.58 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-N 115.851 -0.613 . . . . 72.51 110.063 175.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 120' ' ' LYS . 18.5 t70 -65.57 160.66 21.96 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.669 1.187 . . . . 73.52 112.001 -174.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.2 t -47.3 -38.53 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 114.188 1.181 . . . . 74.31 114.188 173.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -75.21 -39.46 60.08 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 112.309 0.485 . . . . 63.53 112.309 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 120' ' ' LYS . 4.3 p-80 -142.75 94.98 2.71 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.821 -1.548 . . . . 74.31 106.821 171.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.656 ' O ' ' HA ' ' A' ' 119' ' ' HIS . 22.2 pttp -47.14 -163.77 0.0 OUTLIER Pre-proline 0 CA--C 1.587 2.39 2 C-N-CA 133.965 4.906 . . . . 61.32 123.298 43.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo 7.69 77.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.603 2.202 . . . . 65.24 116.566 -113.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.608 HG13 ' HA ' ' A' ' 120' ' ' LYS . 60.0 mt -94.65 113.59 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 114.781 -1.1 . . . . 73.24 109.267 174.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -131.3 141.27 49.93 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.568 0.699 . . . . 75.3 111.508 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -61.86 134.93 57.31 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.52 -1.218 . . . . 62.35 110.523 169.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.9 153.03 44.6 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 120.545 0.212 . . . . 64.1 110.93 172.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . 67.07 18.84 10.52 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.47 1.108 . . . . 53.42 111.744 -171.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.7 m -140.59 105.36 4.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.333 1.053 . . . . 74.11 109.361 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -76.61 -76.97 0.8 Allowed Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.22 -0.445 . . . . 51.44 113.209 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 1.6 pp -137.07 140.32 30.98 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 123.603 0.761 . . . . 75.42 111.185 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 129' ' ' LEU . 21.9 Cg_exo -67.11 -57.92 0.16 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.832 2.355 . . . . 42.14 112.897 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.02 71.44 0.98 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 115.895 -0.593 . . . . 71.42 113.114 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.79 78.87 Favored Glycine 0 CA--C 1.546 2.007 0 N-CA-C 115.032 0.773 . . . . 53.31 115.032 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . 72.47 -59.46 0.56 Allowed 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 125.799 1.64 . . . . 62.33 113.948 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.64 153.04 17.26 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.733 1.213 . . . . 61.32 113.315 -175.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -79.23 34.96 0.26 Allowed 'General case' 0 CA--C 1.577 2.004 0 C-N-CA 124.862 1.265 . . . . 60.5 112.754 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -74.55 99.8 3.71 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.352 -0.842 . . . . 72.13 110.229 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.5 mt -83.02 77.06 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.251 0 CA-C-O 121.596 0.712 . . . . 64.53 110.315 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -98.94 -34.3 5.22 Favored Glycine 0 N--CA 1.478 1.466 0 CA-C-N 115.545 -0.752 . . . . 52.32 112.904 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.6 m -72.7 121.4 19.75 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.725 0.81 . . . . 72.31 111.659 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.2 t -74.58 126.64 31.24 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.06 0.544 . . . . 25.45 110.405 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.97 128.03 33.78 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.569 0.699 . . . . 64.11 111.997 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -82.36 -178.4 7.03 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.186 0.995 . . . . 50.04 111.446 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -67.82 85.06 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.37 0.668 . . . . 70.14 110.847 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 28.2 p -167.37 162.15 14.55 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.907 0.883 . . . . 72.15 111.549 -174.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -81.75 129.92 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.935 0.494 . . . . 62.31 110.98 173.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.64 -175.12 2.62 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.443 0.697 . . . . 73.04 110.398 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -88.24 95.05 10.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.195 0.598 . . . . 71.53 110.004 169.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -146.89 117.44 7.5 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.862 0.865 . . . . 72.15 109.987 173.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -70.99 103.29 2.64 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.684 -0.858 . . . . 71.34 108.684 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -57.23 112.69 1.45 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.238 0.615 . . . . 73.41 112.104 -172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -74.15 98.8 3.22 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.482 0.713 . . . . 71.04 109.94 178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -110.16 -59.54 1.92 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.424 0.69 . . . . 60.5 111.332 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 . . . . . 0 N--CA 1.491 1.576 0 C-N-CA 123.858 0.863 . . . . 74.3 111.682 -174.781 . . . . . . . . 0 0 . 1 stop_ save_